rcept_no,reprt_code,bsns_year,corp_code,sj_div,sj_nm,account_id,account_nm,account_detail,thstrm_nm,thstrm_amount,frmtrm_nm,frmtrm_amount,bfefrmtrm_nm,bfefrmtrm_amount,ord,currency,thstrm_add_amount,source,requested_fs_div,requested_reprt_code,requested_sj_div,peer_stock_code,peer_corp_name
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 15,1825732428259,Term 14,1803063670498,Term 13,1567235920188,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 15,793728286323,Term 14,673580375450,Term 13,735510637941,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_ShortTermDepositsNotClassifiedAsCashEquivalents,금융기관예치금,-,Term 15,57882300000,Term 14,70600000000,Term 13,15100000000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognition,당기손익-공정가치금융자산,-,Term 15,166463243160,Term 14,137522926040,Term 13,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CurrentFinancialAssetsAtAmortisedCost,상각후원가측정금융자산,-,Term 15,0,Term 14,0,Term 13,30000000000,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_ShortTermTradeReceivable,매출채권,-,Term 15,283770117119,Term 14,365884445662,Term 13,286688931692,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,기타수취채권,-,Term 15,24723686702,Term 14,32485367549,Term 13,31274766157,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 15,19235955917,Term 14,4014569938,Term 13,4286808310,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 15,65445877705,Term 14,66386913917,Term 13,61069998973,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 15,414482961333,Term 14,452589071942,Term 13,403304777115,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 15,3876185747488,Term 14,4185944120149,Term 13,3803901297634,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_LongTermDepositsNotClassifiedAsCashEquivalents,금융기관예치금,-,Term 15,17556864840,Term 14,16425521080,Term 13,14828004820,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentReceivablesGross,기타수취채권,-,Term 15,100546922493,Term 14,145164887090,Term 13,168382199625,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognition,당기손익-공정가치금융자산,-,Term 15,1128984127,Term 14,4118831930,Term 13,3955641293,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtAmortisedCost,상각후원가측정금융자산,-,Term 15,2125074983,Term 14,2131335000,Term 13,3092380000,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산,-,Term 15,705503210,Term 14,1113546260,Term 13,2689834184,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 15,2566328198231,Term 14,2661841508240,Term 13,2713128203422,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 15,488815300039,Term 14,493010504975,Term 13,501437478949,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 15,227453263601,Term 14,432396245094,Term 13,0,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 15,208773970177,Term 14,226517106409,Term 13,254114866421,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_InvestmentsInAssociates,관계기업주식,-,Term 15,52514140370,Term 14,2160253079,Term 13,2345921573,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,-Standard account code not used-,순확정급여자산,-,Term 15,110633427860,Term 14,106098704183,Term 13,58528790183,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 15,82890358531,Term 14,72704996238,Term 13,57526495689,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_OtherNonCurrentAssets,기타비유동자산,-,Term 15,16713739026,Term 14,22260680571,Term 13,23871481475,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 15,5701918175747,Term 14,5989007790647,Term 13,5371137217822,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 15,965946712547,Term 14,1066567435582,Term 13,763211930043,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_ShortTermTradePayables,매입채무,-,Term 15,117617730697,Term 14,172459191473,Term 13,111832729984,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 15,154160189044,Term 14,99346553098,Term 13,71453273137,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,기타지급채무,-,Term 15,275762504709,Term 14,264808700940,Term 13,249628796027,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 15,6097005496,Term 14,67399350946,Term 13,62967163816,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CurrentContractLiabilities,계약부채,-,Term 15,42275345834,Term 14,50058558388,Term 13,56177685389,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CurrentProvisions,기타충당부채,-,Term 15,8652202062,Term 14,12871685529,Term 13,11085175074,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,리스유동부채,-,Term 15,132867105541,Term 14,197591533621,Term 13,0,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 15,228514629164,Term 14,202031861587,Term 13,200067106616,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 15,271573719005,Term 14,423599551940,Term 13,161508205332,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_LongTermBorrowingsGross,장기차입금,-,Term 15,0,Term 14,0,Term 13,44687010000,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,-Standard account code not used-,순확정급여부채,-,Term 15,3831674238,Term 14,3424822481,Term 13,3210941058,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 15,90075514181,Term 14,101731472413,Term 13,78768879835,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,기타충당부채,-,Term 15,18617523307,Term 14,19135594489,Term 13,13781214554,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,리스비유동부채,-,Term 15,133748488854,Term 14,267922153243,Term 13,0,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 15,25300518425,Term 14,31385509314,Term 13,21060159885,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 15,1237520431552,Term 14,1490166987522,Term 13,924720135375,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업의 소유주에게 귀속되는 자본,-,Term 15,4467854044953,Term 14,4489496528903,Term 13,4422046574241,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 15,34508160000,Term 14,34508160000,Term 13,34508160000,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_SharePremium,주식발행초과금,-,Term 15,712701764092,Term 14,712701764092,Term 13,712701764092,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 15,10807414056,Term 14,10807414056,Term 13,7770057440,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본구성요소,-,Term 15,-117631782499,Term 14,-117631782499,Term 13,-17624266599,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 15,-20278648131,Term 14,-24678605598,Term 13,-41311913173,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 15,3847747137435,Term 14,3873789578852,Term 13,3726002772481,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배주주지분,-,Term 15,-3456300758,Term 14,9344274222,Term 13,24370508206,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 15,4464397744195,Term 14,4498840803125,Term 13,4446417082447,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채와 자본총계,-,Term 15,5701918175747,Term 14,5989007790647,Term 13,5371137217822,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 15,4432179039394,Term 14,5580142192519,Term 13,5277844561808,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 15,1265398064748,Term 14,1500515578424,Term 13,1434875630857,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 15,3166780974646,Term 14,4079626614095,Term 13,3842968930951,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 15,3023771855339,Term 14,3651792017591,Term 13,3360988103012,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익,-,Term 15,143009119307,Term 14,427834596504,Term 13,481980827939,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 15,11882548495,Term 14,14739081054,Term 13,12690124378,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 15,17026833385,Term 14,19976729196,Term 13,2686931594,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,dart_OtherGains,기타영업외손익,-,Term 15,-113231972208,Term 14,-51693123255,Term 13,-39028127872,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,관계기업손익,-,Term 15,660159537,Term 14,-301604380,Term 13,30813947,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 15,25293021746,Term 14,370602220727,Term 13,452986706798,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 15,3424010057,Term 14,146841192961,Term 13,118142142832,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익,-,Term 15,21869011689,Term 14,223761027766,Term 13,334844563966,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 15,35132159662,Term 14,238804191604,Term 13,332195459028,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배주주지분,-,Term 15,-13263147973,Term 14,-15043163838,Term 13,2649104938,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,세후기타포괄손익,-,Term 15,12241704451,Term 14,7286612210,Term 13,23557705928,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,-,Term 15,7379173991,Term 14,-8917300059,Term 13,21500150375,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치금융자산 평가손익,-,Term 15,-306779895,Term 14,-425735392,Term 13,1646093788,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnHedgesOfNetInvestmentsInForeignOperationsNetOfTax,관계기업기타포괄손익지분,-,Term 15,141746006,Term 14,18983206,Term 13,-55193664,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업환산손익,-,Term 15,5027564349,Term 14,16610664455,Term 13,466655430,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,당기총포괄이익,-,Term 15,34110716140,Term 14,231047639976,Term 13,358402269894,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 15,46911291120,Term 14,246323873960,Term 13,355628393686,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배주주지분,-,Term 15,-12800574980,Term 14,-15276233984,Term 13,2773876208,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주기본주당순이익,-,Term 15,512,Term 14,3477,Term 13,4815,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,우선주기본주당순이익,-,Term 15,517,Term 14,3490,Term 13,4820,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동으로 인한 현금흐름,-,Term 15,554358724380,Term 14,718300781333,Term 13,646677307033,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업으로부터 창출된 현금흐름,-,Term 15,670456654579,Term 14,857524382916,Term 13,791112221268,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 15,4028241642,Term 14,10135538607,Term 13,11766290224,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자의 지급,-,Term 15,16008008153,Term 14,18049090334,Term 13,1903403292,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세의 납부,-,Term 15,104118163688,Term 14,131310049856,Term 13,154297801167,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동으로 인한 현금흐름,-,Term 15,-206408840887,Term 14,-403233395816,Term 13,-413917719397,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfShortTermFinancialInstruments,유동성 금융기관예치금의 순감소,-,Term 15,12162100000,Term 14,0,Term 13,17569000000,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherCurrentFinancialAssets,유동성 상각후원가측정금융자산의 감소,-,Term 15,0,Term 14,30511000000,Term 13,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익공정가치금융자산의 감소,-,Term 15,2991229925,Term 14,0,Term 13,20101369863,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfLoansAndReceivables,기타수취채권의 감소,-,Term 15,45815639463,Term 14,7616143350,Term 13,5977550749,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfLongTermFinancialInstruments,비유동성 금융기관예치금의 감소,-,Term 15,353988000,Term 14,0,Term 13,579033207,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherNonCurrentFinancialAssets,상각후원가측정금융자산의 처분,-,Term 15,6260017,Term 14,973000000,Term 13,1435365000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfNonCurrentFairValueFinancialAsset,기타포괄손익-공정가치금융자산의 처분,-,Term 15,0,Term 14,1070751960,Term 13,3198767940,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 15,24769903712,Term 14,27798931056,Term 13,1698472223,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 15,349269754,Term 14,2517072752,Term 13,1056370318,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 15,0,Term 14,0,Term 13,2016000000,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfNonCurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정비유동자산의 처분,-,Term 15,0,Term 14,0,Term 13,504000000,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsInvestingActivities,관계기업으로부터의 배당금수익,-,Term 15,3750046,Term 14,0,Term 13,107494108,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities,기타의 현금유입액,-,Term 15,0,Term 14,5110503360,Term 13,15256413670,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_PurchaseOfShortTermFinancialInstruments,유동성 금융기관예치금의 순증가,-,Term 15,0,Term 14,55439000000,Term 13,0,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익공정가치금융자산의 증가,-,Term 15,23523394856,Term 14,136299644042,Term 13,20000000000,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_PurchaseOfLoansAndReceivables,기타수취채권의 증가,-,Term 15,3826463221,Term 14,4137112924,Term 13,4877583342,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_PurchaseOfLongTermFinancialInstruments,비유동성 금융기관예치금의 증가,-,Term 15,1500002760,Term 14,1500002760,Term 13,1500002760,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_PurchaseOfOtherFinancialAssets,상각후원가측정금융자산의 취득,-,Term 15,0,Term 14,11955000,Term 13,337180000,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 15,183021787650,Term 14,246549723931,Term 13,405477300427,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 15,31983791822,Term 14,34863960005,Term 13,51225489946,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,-Standard account code not used-,사용권자산의 증가,-,Term 15,2269650,Term 14,29399632,Term 13,0,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_PurchaseOfInvestmentsInAssociates,관계기업투자주식의 증가,-,Term 15,49003271845,Term 14,0,Term 13,0,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동으로 인한 현금흐름,-,Term 15,-215987303706,Term 14,-387437264460,Term 13,-103444987469,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 증가,-,Term 15,110605478453,Term 14,12048075210,Term 13,24495222450,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_IncreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 수취,-,Term 15,578239965,Term 14,0,Term 13,0,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromIssuingShares,비지배주주의 유상증자,-,Term 15,0,Term 14,250000000,Term 13,0,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 감소,-,Term 15,49138368262,Term 14,32682146763,Term 13,39628288984,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_AcquisitionOfTreasuryShares,자사주 매입,-,Term 15,0,Term 14,100007515900,Term 13,0,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_PaymentsOfFinanceLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 상환,-,Term 15,206758281113,Term 14,185628639922,Term 13,0,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금의 지급,-,Term 15,68530023595,Term 14,81417037085,Term 13,88311920935,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_DecreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 반환,-,Term 15,2744349154,Term 14,0,Term 13,0,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,외화환산으로 인한 현금의 증감,-,Term 15,-11814668914,Term 14,10439616452,Term 13,2008514996,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalents,현금의 증가,-,Term 15,120147910873,Term 14,-61930262491,Term 13,131323115163,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초의 현금,-,Term 15,673580375450,Term 14,735510637941,Term 13,604187522778,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말의 현금,-,Term 15,793728286323,Term 14,673580375450,Term 13,735510637941,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 15,4498840803125,Term 14,4446417082447,Term 13,4175374154783,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배주주지분,Term 15,9344274222,Term 14,24370508206,Term 13,21592054069,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분,Term 15,4489496528903,Term 14,4422046574241,Term 13,4153782100714,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,-117631782499,Term 14,-17624266599,Term 13,-17624266599,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,712701764092,Term 14,712701764092,Term 13,712701764092,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,3873789578852,Term 14,3726002772481,Term 13,3456502861670,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,34508160000,Term 14,34508160000,Term 13,34508160000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,10807414056,Term 14,7770057440,Term 13,7770057440,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,-24678605598,Term 14,-41311913173,Term 13,-40076475889,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,0,Term 14,0,Term 13,979482406,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,0,Term 14,0,Term 13,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주지분,Term 15,0,Term 14,0,Term 13,979482406,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|비지배주주지분,Term 15,0,Term 14,0,Term 13,4577929,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,연결재무제표 [member],Term 15,0,Term 14,0,Term 13,984060335,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,수정후 금액,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,712701764092,Term 14,712701764092,Term 13,712701764092,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,수정후 금액,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,10807414056,Term 14,7770057440,Term 13,7770057440,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,수정후 금액,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,34508160000,Term 14,34508160000,Term 13,34508160000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,수정후 금액,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,3873789578852,Term 14,3726002772481,Term 13,3457482344076,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,수정후 금액,연결재무제표 [member],Term 15,4498840803125,Term 14,4446417082447,Term 13,4176358215118,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,수정후 금액,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,-117631782499,Term 14,-17624266599,Term 13,-17624266599,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,수정후 금액,자본 [member]|지배기업의 소유주지분,Term 15,4489496528903,Term 14,4422046574241,Term 13,4154761583120,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,수정후 금액,자본 [member]|비지배주주지분,Term 15,9344274222,Term 14,24370508206,Term 13,21596631998,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,수정후 금액,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,-24678605598,Term 14,-41311913173,Term 13,-40076475889,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,연결재무제표 [member],Term 15,21869011689,Term 14,223761027766,Term 13,334844563966,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|비지배주주지분,Term 15,-13263147973,Term 14,-15043163838,Term 13,2649104938,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주지분,Term 15,35132159662,Term 14,238804191604,Term 13,332195459028,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,0,Term 14,0,Term 13,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,35132159662,Term 14,238804191604,Term 13,332195459028,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,연결재무제표 [member],Term 15,7379173991,Term 14,-8917300059,Term 13,21500150375,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|비지배주주지분,Term 15,0,Term 14,0,Term 13,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주지분,Term 15,7379173991,Term 14,-8917300059,Term 13,21500150375,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,0,Term 14,0,Term 13,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,7379173991,Term 14,-8917300059,Term 13,21500150375,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,연결재무제표 [member],Term 15,-306779895,Term 14,-425735392,Term 13,1646093788,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|비지배주주지분,Term 15,0,Term 14,0,Term 13,12649059,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|지배기업의 소유주지분,Term 15,-306779895,Term 14,-425735392,Term 13,1633444729,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,-306779895,Term 14,-425735392,Term 13,1633444729,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,0,Term 14,0,Term 13,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherComprehensiveIncomeForStatementOfChangesInEquity,기타포괄손익-공정가치금융자산처분,연결재무제표 [member],Term 15,0,Term 14,0,Term 13,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherComprehensiveIncomeForStatementOfChangesInEquity,기타포괄손익-공정가치금융자산처분,자본 [member]|비지배주주지분,Term 15,0,Term 14,0,Term 13,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherComprehensiveIncomeForStatementOfChangesInEquity,기타포괄손익-공정가치금융자산처분,자본 [member]|지배기업의 소유주지분,Term 15,0,Term 14,0,Term 13,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherComprehensiveIncomeForStatementOfChangesInEquity,기타포괄손익-공정가치금융자산처분,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherComprehensiveIncomeForStatementOfChangesInEquity,기타포괄손익-공정가치금융자산처분,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,0,Term 14,196325160,Term 13,-3168221567,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherComprehensiveIncomeForStatementOfChangesInEquity,기타포괄손익-공정가치금융자산처분,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,0,Term 14,-196325160,Term 13,3168221567,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherComprehensiveIncomeForStatementOfChangesInEquity,기타포괄손익-공정가치금융자산처분,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherComprehensiveIncomeForStatementOfChangesInEquity,기타포괄손익-공정가치금융자산처분,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherComprehensiveIncomeForStatementOfChangesInEquity,기타포괄손익-공정가치금융자산처분,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,연결재무제표 [member],Term 15,141746006,Term 14,18983206,Term 13,-55193664,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|비지배주주지분,Term 15,14174601,Term 14,1898321,Term 13,-5519366,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주지분,Term 15,127571405,Term 14,17084885,Term 13,-49674298,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,127571405,Term 14,17084885,Term 13,-49674298,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,0,Term 14,0,Term 13,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,연결재무제표 [member],Term 15,5027564349,Term 14,16610664455,Term 13,466655430,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|비지배주주지분,Term 15,448398392,Term 14,-234968467,Term 13,117641578,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주지분,Term 15,4579165957,Term 14,16845632922,Term 13,349013852,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,4579165957,Term 14,16845632922,Term 13,349013852,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,0,Term 14,0,Term 13,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,연결재무제표 [member],Term 15,68553775070,Term 14,81445694780,Term 13,88343402565,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|비지배주주지분,Term 15,0,Term 14,0,Term 13,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주지분,Term 15,68553775070,Term 14,81445694780,Term 13,88343402565,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,0,Term 14,0,Term 13,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,68553775070,Term 14,81445694780,Term 13,88343402565,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식 취득,연결재무제표 [member],Term 15,0,Term 14,-100007515900,Term 13,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식 취득,자본 [member]|비지배주주지분,Term 15,0,Term 14,0,Term 13,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식 취득,자본 [member]|지배기업의 소유주지분,Term 15,0,Term 14,-100007515900,Term 13,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식 취득,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,-100007515900,Term 13,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식 취득,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,0,Term 14,0,Term 13,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식 취득,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,0,Term 14,0,Term 13,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식 취득,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식 취득,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식 취득,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,연결재무제표 [member],Term 15,0,Term 14,3037356616,Term 13,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|비지배주주지분,Term 15,0,Term 14,0,Term 13,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분,Term 15,0,Term 14,3037356616,Term 13,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,0,Term 14,0,Term 13,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,0,Term 14,0,Term 13,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,3037356616,Term 13,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,비지배주주의 유상증자,연결재무제표 [member],Term 15,0,Term 14,250000000,Term 13,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,비지배주주의 유상증자,자본 [member]|비지배주주지분,Term 15,0,Term 14,250000000,Term 13,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,비지배주주의 유상증자,자본 [member]|지배기업의 소유주지분,Term 15,0,Term 14,0,Term 13,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,비지배주주의 유상증자,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,비지배주주의 유상증자,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,0,Term 14,0,Term 13,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,비지배주주의 유상증자,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,0,Term 14,0,Term 13,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,비지배주주의 유상증자,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,비지배주주의 유상증자,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,비지배주주의 유상증자,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,연결재무제표 [member],Term 15,0,Term 14,-458065234,Term 13,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|비지배주주지분,Term 15,0,Term 14,0,Term 13,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분,Term 15,0,Term 14,-458065234,Term 13,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,0,Term 14,0,Term 13,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,0,Term 14,-458065234,Term 13,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 15,4464397744195,Term 14,4498840803125,Term 13,4446417082447,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|비지배주주지분,Term 15,-3456300758,Term 14,9344274222,Term 13,24370508206,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분,Term 15,4467854044953,Term 14,4489496528903,Term 13,4422046574241,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,-117631782499,Term 14,-117631782499,Term 13,-17624266599,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,-20278648131,Term 14,-24678605598,Term 13,-41311913173,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,3847747137435,Term 14,3873789578852,Term 13,3726002772481,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,34508160000,Term 14,34508160000,Term 13,34508160000,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,10807414056,Term 14,10807414056,Term 13,7770057440,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,712701764092,Term 14,712701764092,Term 13,712701764092,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 15,1825732428259,Term 14,1803063670498,Term 13,1567235920188,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 15,793728286323,Term 14,673580375450,Term 13,735510637941,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_ShortTermDepositsNotClassifiedAsCashEquivalents,금융기관예치금,-,Term 15,57882300000,Term 14,70600000000,Term 13,15100000000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognition,당기손익-공정가치금융자산,-,Term 15,166463243160,Term 14,137522926040,Term 13,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CurrentFinancialAssetsAtAmortisedCost,상각후원가측정금융자산,-,Term 15,0,Term 14,0,Term 13,30000000000,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_ShortTermTradeReceivable,매출채권,-,Term 15,283770117119,Term 14,365884445662,Term 13,286688931692,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,기타수취채권,-,Term 15,24723686702,Term 14,32485367549,Term 13,31274766157,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 15,19235955917,Term 14,4014569938,Term 13,4286808310,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 15,65445877705,Term 14,66386913917,Term 13,61069998973,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 15,414482961333,Term 14,452589071942,Term 13,403304777115,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 15,3876185747488,Term 14,4185944120149,Term 13,3803901297634,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_LongTermDepositsNotClassifiedAsCashEquivalents,금융기관예치금,-,Term 15,17556864840,Term 14,16425521080,Term 13,14828004820,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentReceivablesGross,기타수취채권,-,Term 15,100546922493,Term 14,145164887090,Term 13,168382199625,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognition,당기손익-공정가치금융자산,-,Term 15,1128984127,Term 14,4118831930,Term 13,3955641293,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtAmortisedCost,상각후원가측정금융자산,-,Term 15,2125074983,Term 14,2131335000,Term 13,3092380000,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산,-,Term 15,705503210,Term 14,1113546260,Term 13,2689834184,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 15,2566328198231,Term 14,2661841508240,Term 13,2713128203422,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 15,488815300039,Term 14,493010504975,Term 13,501437478949,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 15,227453263601,Term 14,432396245094,Term 13,0,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 15,208773970177,Term 14,226517106409,Term 13,254114866421,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_InvestmentsInAssociates,관계기업주식,-,Term 15,52514140370,Term 14,2160253079,Term 13,2345921573,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,-Standard account code not used-,순확정급여자산,-,Term 15,110633427860,Term 14,106098704183,Term 13,58528790183,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 15,82890358531,Term 14,72704996238,Term 13,57526495689,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_OtherNonCurrentAssets,기타비유동자산,-,Term 15,16713739026,Term 14,22260680571,Term 13,23871481475,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 15,5701918175747,Term 14,5989007790647,Term 13,5371137217822,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 15,965946712547,Term 14,1066567435582,Term 13,763211930043,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_ShortTermTradePayables,매입채무,-,Term 15,117617730697,Term 14,172459191473,Term 13,111832729984,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 15,154160189044,Term 14,99346553098,Term 13,71453273137,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,기타지급채무,-,Term 15,275762504709,Term 14,264808700940,Term 13,249628796027,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 15,6097005496,Term 14,67399350946,Term 13,62967163816,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CurrentContractLiabilities,계약부채,-,Term 15,42275345834,Term 14,50058558388,Term 13,56177685389,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CurrentProvisions,기타충당부채,-,Term 15,8652202062,Term 14,12871685529,Term 13,11085175074,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,리스유동부채,-,Term 15,132867105541,Term 14,197591533621,Term 13,0,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 15,228514629164,Term 14,202031861587,Term 13,200067106616,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 15,271573719005,Term 14,423599551940,Term 13,161508205332,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_LongTermBorrowingsGross,장기차입금,-,Term 15,0,Term 14,0,Term 13,44687010000,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,-Standard account code not used-,순확정급여부채,-,Term 15,3831674238,Term 14,3424822481,Term 13,3210941058,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 15,90075514181,Term 14,101731472413,Term 13,78768879835,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,기타충당부채,-,Term 15,18617523307,Term 14,19135594489,Term 13,13781214554,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,리스비유동부채,-,Term 15,133748488854,Term 14,267922153243,Term 13,0,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 15,25300518425,Term 14,31385509314,Term 13,21060159885,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 15,1237520431552,Term 14,1490166987522,Term 13,924720135375,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업의 소유주에게 귀속되는 자본,-,Term 15,4467854044953,Term 14,4489496528903,Term 13,4422046574241,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 15,34508160000,Term 14,34508160000,Term 13,34508160000,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_SharePremium,주식발행초과금,-,Term 15,712701764092,Term 14,712701764092,Term 13,712701764092,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 15,10807414056,Term 14,10807414056,Term 13,7770057440,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본구성요소,-,Term 15,-117631782499,Term 14,-117631782499,Term 13,-17624266599,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 15,-20278648131,Term 14,-24678605598,Term 13,-41311913173,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 15,3847747137435,Term 14,3873789578852,Term 13,3726002772481,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배주주지분,-,Term 15,-3456300758,Term 14,9344274222,Term 13,24370508206,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 15,4464397744195,Term 14,4498840803125,Term 13,4446417082447,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채와 자본총계,-,Term 15,5701918175747,Term 14,5989007790647,Term 13,5371137217822,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 15,4432179039394,Term 14,5580142192519,Term 13,5277844561808,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 15,1265398064748,Term 14,1500515578424,Term 13,1434875630857,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 15,3166780974646,Term 14,4079626614095,Term 13,3842968930951,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 15,3023771855339,Term 14,3651792017591,Term 13,3360988103012,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익,-,Term 15,143009119307,Term 14,427834596504,Term 13,481980827939,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 15,11882548495,Term 14,14739081054,Term 13,12690124378,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 15,17026833385,Term 14,19976729196,Term 13,2686931594,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,dart_OtherGains,기타영업외손익,-,Term 15,-113231972208,Term 14,-51693123255,Term 13,-39028127872,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,관계기업손익,-,Term 15,660159537,Term 14,-301604380,Term 13,30813947,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 15,25293021746,Term 14,370602220727,Term 13,452986706798,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 15,3424010057,Term 14,146841192961,Term 13,118142142832,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익,-,Term 15,21869011689,Term 14,223761027766,Term 13,334844563966,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 15,35132159662,Term 14,238804191604,Term 13,332195459028,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배주주지분,-,Term 15,-13263147973,Term 14,-15043163838,Term 13,2649104938,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,세후기타포괄손익,-,Term 15,12241704451,Term 14,7286612210,Term 13,23557705928,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,-,Term 15,7379173991,Term 14,-8917300059,Term 13,21500150375,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치금융자산 평가손익,-,Term 15,-306779895,Term 14,-425735392,Term 13,1646093788,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnHedgesOfNetInvestmentsInForeignOperationsNetOfTax,관계기업기타포괄손익지분,-,Term 15,141746006,Term 14,18983206,Term 13,-55193664,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업환산손익,-,Term 15,5027564349,Term 14,16610664455,Term 13,466655430,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,당기총포괄이익,-,Term 15,34110716140,Term 14,231047639976,Term 13,358402269894,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 15,46911291120,Term 14,246323873960,Term 13,355628393686,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배주주지분,-,Term 15,-12800574980,Term 14,-15276233984,Term 13,2773876208,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주기본주당순이익,-,Term 15,512,Term 14,3477,Term 13,4815,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,우선주기본주당순이익,-,Term 15,517,Term 14,3490,Term 13,4820,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동으로 인한 현금흐름,-,Term 15,554358724380,Term 14,718300781333,Term 13,646677307033,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업으로부터 창출된 현금흐름,-,Term 15,670456654579,Term 14,857524382916,Term 13,791112221268,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 15,4028241642,Term 14,10135538607,Term 13,11766290224,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자의 지급,-,Term 15,16008008153,Term 14,18049090334,Term 13,1903403292,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세의 납부,-,Term 15,104118163688,Term 14,131310049856,Term 13,154297801167,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동으로 인한 현금흐름,-,Term 15,-206408840887,Term 14,-403233395816,Term 13,-413917719397,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfShortTermFinancialInstruments,유동성 금융기관예치금의 순감소,-,Term 15,12162100000,Term 14,0,Term 13,17569000000,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherCurrentFinancialAssets,유동성 상각후원가측정금융자산의 감소,-,Term 15,0,Term 14,30511000000,Term 13,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익공정가치금융자산의 감소,-,Term 15,2991229925,Term 14,0,Term 13,20101369863,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfLoansAndReceivables,기타수취채권의 감소,-,Term 15,45815639463,Term 14,7616143350,Term 13,5977550749,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfLongTermFinancialInstruments,비유동성 금융기관예치금의 감소,-,Term 15,353988000,Term 14,0,Term 13,579033207,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherNonCurrentFinancialAssets,상각후원가측정금융자산의 처분,-,Term 15,6260017,Term 14,973000000,Term 13,1435365000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfNonCurrentFairValueFinancialAsset,기타포괄손익-공정가치금융자산의 처분,-,Term 15,0,Term 14,1070751960,Term 13,3198767940,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 15,24769903712,Term 14,27798931056,Term 13,1698472223,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 15,349269754,Term 14,2517072752,Term 13,1056370318,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 15,0,Term 14,0,Term 13,2016000000,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfNonCurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정비유동자산의 처분,-,Term 15,0,Term 14,0,Term 13,504000000,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsInvestingActivities,관계기업으로부터의 배당금수익,-,Term 15,3750046,Term 14,0,Term 13,107494108,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities,기타의 현금유입액,-,Term 15,0,Term 14,5110503360,Term 13,15256413670,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_PurchaseOfShortTermFinancialInstruments,유동성 금융기관예치금의 순증가,-,Term 15,0,Term 14,55439000000,Term 13,0,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익공정가치금융자산의 증가,-,Term 15,23523394856,Term 14,136299644042,Term 13,20000000000,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_PurchaseOfLoansAndReceivables,기타수취채권의 증가,-,Term 15,3826463221,Term 14,4137112924,Term 13,4877583342,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_PurchaseOfLongTermFinancialInstruments,비유동성 금융기관예치금의 증가,-,Term 15,1500002760,Term 14,1500002760,Term 13,1500002760,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_PurchaseOfOtherFinancialAssets,상각후원가측정금융자산의 취득,-,Term 15,0,Term 14,11955000,Term 13,337180000,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 15,183021787650,Term 14,246549723931,Term 13,405477300427,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 15,31983791822,Term 14,34863960005,Term 13,51225489946,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,-Standard account code not used-,사용권자산의 증가,-,Term 15,2269650,Term 14,29399632,Term 13,0,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_PurchaseOfInvestmentsInAssociates,관계기업투자주식의 증가,-,Term 15,49003271845,Term 14,0,Term 13,0,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동으로 인한 현금흐름,-,Term 15,-215987303706,Term 14,-387437264460,Term 13,-103444987469,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 증가,-,Term 15,110605478453,Term 14,12048075210,Term 13,24495222450,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_IncreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 수취,-,Term 15,578239965,Term 14,0,Term 13,0,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromIssuingShares,비지배주주의 유상증자,-,Term 15,0,Term 14,250000000,Term 13,0,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 감소,-,Term 15,49138368262,Term 14,32682146763,Term 13,39628288984,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_AcquisitionOfTreasuryShares,자사주 매입,-,Term 15,0,Term 14,100007515900,Term 13,0,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_PaymentsOfFinanceLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 상환,-,Term 15,206758281113,Term 14,185628639922,Term 13,0,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금의 지급,-,Term 15,68530023595,Term 14,81417037085,Term 13,88311920935,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_DecreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 반환,-,Term 15,2744349154,Term 14,0,Term 13,0,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,외화환산으로 인한 현금의 증감,-,Term 15,-11814668914,Term 14,10439616452,Term 13,2008514996,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalents,현금의 증가,-,Term 15,120147910873,Term 14,-61930262491,Term 13,131323115163,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초의 현금,-,Term 15,673580375450,Term 14,735510637941,Term 13,604187522778,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말의 현금,-,Term 15,793728286323,Term 14,673580375450,Term 13,735510637941,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 15,4498840803125,Term 14,4446417082447,Term 13,4175374154783,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배주주지분,Term 15,9344274222,Term 14,24370508206,Term 13,21592054069,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분,Term 15,4489496528903,Term 14,4422046574241,Term 13,4153782100714,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,-117631782499,Term 14,-17624266599,Term 13,-17624266599,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,712701764092,Term 14,712701764092,Term 13,712701764092,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,3873789578852,Term 14,3726002772481,Term 13,3456502861670,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,34508160000,Term 14,34508160000,Term 13,34508160000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,10807414056,Term 14,7770057440,Term 13,7770057440,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,-24678605598,Term 14,-41311913173,Term 13,-40076475889,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,0,Term 14,0,Term 13,979482406,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,0,Term 14,0,Term 13,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주지분,Term 15,0,Term 14,0,Term 13,979482406,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|비지배주주지분,Term 15,0,Term 14,0,Term 13,4577929,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,연결재무제표 [member],Term 15,0,Term 14,0,Term 13,984060335,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,수정후 금액,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,712701764092,Term 14,712701764092,Term 13,712701764092,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,수정후 금액,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,10807414056,Term 14,7770057440,Term 13,7770057440,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,수정후 금액,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,34508160000,Term 14,34508160000,Term 13,34508160000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,수정후 금액,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,3873789578852,Term 14,3726002772481,Term 13,3457482344076,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,수정후 금액,연결재무제표 [member],Term 15,4498840803125,Term 14,4446417082447,Term 13,4176358215118,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,수정후 금액,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,-117631782499,Term 14,-17624266599,Term 13,-17624266599,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,수정후 금액,자본 [member]|지배기업의 소유주지분,Term 15,4489496528903,Term 14,4422046574241,Term 13,4154761583120,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,수정후 금액,자본 [member]|비지배주주지분,Term 15,9344274222,Term 14,24370508206,Term 13,21596631998,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,수정후 금액,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,-24678605598,Term 14,-41311913173,Term 13,-40076475889,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,연결재무제표 [member],Term 15,21869011689,Term 14,223761027766,Term 13,334844563966,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|비지배주주지분,Term 15,-13263147973,Term 14,-15043163838,Term 13,2649104938,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주지분,Term 15,35132159662,Term 14,238804191604,Term 13,332195459028,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,0,Term 14,0,Term 13,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,35132159662,Term 14,238804191604,Term 13,332195459028,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,연결재무제표 [member],Term 15,7379173991,Term 14,-8917300059,Term 13,21500150375,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|비지배주주지분,Term 15,0,Term 14,0,Term 13,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주지분,Term 15,7379173991,Term 14,-8917300059,Term 13,21500150375,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,0,Term 14,0,Term 13,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,7379173991,Term 14,-8917300059,Term 13,21500150375,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,연결재무제표 [member],Term 15,-306779895,Term 14,-425735392,Term 13,1646093788,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|비지배주주지분,Term 15,0,Term 14,0,Term 13,12649059,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|지배기업의 소유주지분,Term 15,-306779895,Term 14,-425735392,Term 13,1633444729,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,-306779895,Term 14,-425735392,Term 13,1633444729,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,0,Term 14,0,Term 13,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherComprehensiveIncomeForStatementOfChangesInEquity,기타포괄손익-공정가치금융자산처분,연결재무제표 [member],Term 15,0,Term 14,0,Term 13,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherComprehensiveIncomeForStatementOfChangesInEquity,기타포괄손익-공정가치금융자산처분,자본 [member]|비지배주주지분,Term 15,0,Term 14,0,Term 13,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherComprehensiveIncomeForStatementOfChangesInEquity,기타포괄손익-공정가치금융자산처분,자본 [member]|지배기업의 소유주지분,Term 15,0,Term 14,0,Term 13,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherComprehensiveIncomeForStatementOfChangesInEquity,기타포괄손익-공정가치금융자산처분,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherComprehensiveIncomeForStatementOfChangesInEquity,기타포괄손익-공정가치금융자산처분,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,0,Term 14,196325160,Term 13,-3168221567,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherComprehensiveIncomeForStatementOfChangesInEquity,기타포괄손익-공정가치금융자산처분,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,0,Term 14,-196325160,Term 13,3168221567,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherComprehensiveIncomeForStatementOfChangesInEquity,기타포괄손익-공정가치금융자산처분,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherComprehensiveIncomeForStatementOfChangesInEquity,기타포괄손익-공정가치금융자산처분,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherComprehensiveIncomeForStatementOfChangesInEquity,기타포괄손익-공정가치금융자산처분,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,연결재무제표 [member],Term 15,141746006,Term 14,18983206,Term 13,-55193664,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|비지배주주지분,Term 15,14174601,Term 14,1898321,Term 13,-5519366,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주지분,Term 15,127571405,Term 14,17084885,Term 13,-49674298,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,127571405,Term 14,17084885,Term 13,-49674298,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,0,Term 14,0,Term 13,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,연결재무제표 [member],Term 15,5027564349,Term 14,16610664455,Term 13,466655430,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|비지배주주지분,Term 15,448398392,Term 14,-234968467,Term 13,117641578,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주지분,Term 15,4579165957,Term 14,16845632922,Term 13,349013852,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,4579165957,Term 14,16845632922,Term 13,349013852,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,0,Term 14,0,Term 13,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,연결재무제표 [member],Term 15,68553775070,Term 14,81445694780,Term 13,88343402565,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|비지배주주지분,Term 15,0,Term 14,0,Term 13,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주지분,Term 15,68553775070,Term 14,81445694780,Term 13,88343402565,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,0,Term 14,0,Term 13,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,68553775070,Term 14,81445694780,Term 13,88343402565,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식 취득,연결재무제표 [member],Term 15,0,Term 14,-100007515900,Term 13,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식 취득,자본 [member]|비지배주주지분,Term 15,0,Term 14,0,Term 13,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식 취득,자본 [member]|지배기업의 소유주지분,Term 15,0,Term 14,-100007515900,Term 13,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식 취득,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,-100007515900,Term 13,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식 취득,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,0,Term 14,0,Term 13,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식 취득,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,0,Term 14,0,Term 13,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식 취득,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식 취득,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식 취득,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,연결재무제표 [member],Term 15,0,Term 14,3037356616,Term 13,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|비지배주주지분,Term 15,0,Term 14,0,Term 13,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분,Term 15,0,Term 14,3037356616,Term 13,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,0,Term 14,0,Term 13,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,0,Term 14,0,Term 13,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,3037356616,Term 13,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,비지배주주의 유상증자,연결재무제표 [member],Term 15,0,Term 14,250000000,Term 13,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,비지배주주의 유상증자,자본 [member]|비지배주주지분,Term 15,0,Term 14,250000000,Term 13,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,비지배주주의 유상증자,자본 [member]|지배기업의 소유주지분,Term 15,0,Term 14,0,Term 13,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,비지배주주의 유상증자,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,비지배주주의 유상증자,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,0,Term 14,0,Term 13,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,비지배주주의 유상증자,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,0,Term 14,0,Term 13,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,비지배주주의 유상증자,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,비지배주주의 유상증자,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,비지배주주의 유상증자,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,연결재무제표 [member],Term 15,0,Term 14,-458065234,Term 13,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|비지배주주지분,Term 15,0,Term 14,0,Term 13,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분,Term 15,0,Term 14,-458065234,Term 13,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,0,Term 14,0,Term 13,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,0,Term 14,-458065234,Term 13,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 15,4464397744195,Term 14,4498840803125,Term 13,4446417082447,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|비지배주주지분,Term 15,-3456300758,Term 14,9344274222,Term 13,24370508206,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분,Term 15,4467854044953,Term 14,4489496528903,Term 13,4422046574241,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,-117631782499,Term 14,-117631782499,Term 13,-17624266599,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,-20278648131,Term 14,-24678605598,Term 13,-41311913173,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,3847747137435,Term 14,3873789578852,Term 13,3726002772481,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,34508160000,Term 14,34508160000,Term 13,34508160000,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,10807414056,Term 14,10807414056,Term 13,7770057440,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,712701764092,Term 14,712701764092,Term 13,712701764092,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 15,1825732428259,Term 14,1803063670498,Term 13,1567235920188,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 15,793728286323,Term 14,673580375450,Term 13,735510637941,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_ShortTermDepositsNotClassifiedAsCashEquivalents,금융기관예치금,-,Term 15,57882300000,Term 14,70600000000,Term 13,15100000000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognition,당기손익-공정가치금융자산,-,Term 15,166463243160,Term 14,137522926040,Term 13,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CurrentFinancialAssetsAtAmortisedCost,상각후원가측정금융자산,-,Term 15,0,Term 14,0,Term 13,30000000000,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_ShortTermTradeReceivable,매출채권,-,Term 15,283770117119,Term 14,365884445662,Term 13,286688931692,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,기타수취채권,-,Term 15,24723686702,Term 14,32485367549,Term 13,31274766157,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 15,19235955917,Term 14,4014569938,Term 13,4286808310,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 15,65445877705,Term 14,66386913917,Term 13,61069998973,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 15,414482961333,Term 14,452589071942,Term 13,403304777115,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 15,3876185747488,Term 14,4185944120149,Term 13,3803901297634,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_LongTermDepositsNotClassifiedAsCashEquivalents,금융기관예치금,-,Term 15,17556864840,Term 14,16425521080,Term 13,14828004820,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentReceivablesGross,기타수취채권,-,Term 15,100546922493,Term 14,145164887090,Term 13,168382199625,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognition,당기손익-공정가치금융자산,-,Term 15,1128984127,Term 14,4118831930,Term 13,3955641293,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtAmortisedCost,상각후원가측정금융자산,-,Term 15,2125074983,Term 14,2131335000,Term 13,3092380000,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산,-,Term 15,705503210,Term 14,1113546260,Term 13,2689834184,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 15,2566328198231,Term 14,2661841508240,Term 13,2713128203422,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 15,488815300039,Term 14,493010504975,Term 13,501437478949,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 15,227453263601,Term 14,432396245094,Term 13,0,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 15,208773970177,Term 14,226517106409,Term 13,254114866421,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_InvestmentsInAssociates,관계기업주식,-,Term 15,52514140370,Term 14,2160253079,Term 13,2345921573,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,-Standard account code not used-,순확정급여자산,-,Term 15,110633427860,Term 14,106098704183,Term 13,58528790183,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 15,82890358531,Term 14,72704996238,Term 13,57526495689,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_OtherNonCurrentAssets,기타비유동자산,-,Term 15,16713739026,Term 14,22260680571,Term 13,23871481475,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 15,5701918175747,Term 14,5989007790647,Term 13,5371137217822,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 15,965946712547,Term 14,1066567435582,Term 13,763211930043,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_ShortTermTradePayables,매입채무,-,Term 15,117617730697,Term 14,172459191473,Term 13,111832729984,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 15,154160189044,Term 14,99346553098,Term 13,71453273137,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,기타지급채무,-,Term 15,275762504709,Term 14,264808700940,Term 13,249628796027,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 15,6097005496,Term 14,67399350946,Term 13,62967163816,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CurrentContractLiabilities,계약부채,-,Term 15,42275345834,Term 14,50058558388,Term 13,56177685389,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CurrentProvisions,기타충당부채,-,Term 15,8652202062,Term 14,12871685529,Term 13,11085175074,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,리스유동부채,-,Term 15,132867105541,Term 14,197591533621,Term 13,0,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 15,228514629164,Term 14,202031861587,Term 13,200067106616,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 15,271573719005,Term 14,423599551940,Term 13,161508205332,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_LongTermBorrowingsGross,장기차입금,-,Term 15,0,Term 14,0,Term 13,44687010000,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,-Standard account code not used-,순확정급여부채,-,Term 15,3831674238,Term 14,3424822481,Term 13,3210941058,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 15,90075514181,Term 14,101731472413,Term 13,78768879835,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,기타충당부채,-,Term 15,18617523307,Term 14,19135594489,Term 13,13781214554,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,리스비유동부채,-,Term 15,133748488854,Term 14,267922153243,Term 13,0,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 15,25300518425,Term 14,31385509314,Term 13,21060159885,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 15,1237520431552,Term 14,1490166987522,Term 13,924720135375,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업의 소유주에게 귀속되는 자본,-,Term 15,4467854044953,Term 14,4489496528903,Term 13,4422046574241,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 15,34508160000,Term 14,34508160000,Term 13,34508160000,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_SharePremium,주식발행초과금,-,Term 15,712701764092,Term 14,712701764092,Term 13,712701764092,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 15,10807414056,Term 14,10807414056,Term 13,7770057440,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본구성요소,-,Term 15,-117631782499,Term 14,-117631782499,Term 13,-17624266599,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 15,-20278648131,Term 14,-24678605598,Term 13,-41311913173,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 15,3847747137435,Term 14,3873789578852,Term 13,3726002772481,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배주주지분,-,Term 15,-3456300758,Term 14,9344274222,Term 13,24370508206,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 15,4464397744195,Term 14,4498840803125,Term 13,4446417082447,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채와 자본총계,-,Term 15,5701918175747,Term 14,5989007790647,Term 13,5371137217822,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 15,4432179039394,Term 14,5580142192519,Term 13,5277844561808,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 15,1265398064748,Term 14,1500515578424,Term 13,1434875630857,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 15,3166780974646,Term 14,4079626614095,Term 13,3842968930951,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 15,3023771855339,Term 14,3651792017591,Term 13,3360988103012,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익,-,Term 15,143009119307,Term 14,427834596504,Term 13,481980827939,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 15,11882548495,Term 14,14739081054,Term 13,12690124378,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 15,17026833385,Term 14,19976729196,Term 13,2686931594,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,dart_OtherGains,기타영업외손익,-,Term 15,-113231972208,Term 14,-51693123255,Term 13,-39028127872,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,관계기업손익,-,Term 15,660159537,Term 14,-301604380,Term 13,30813947,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 15,25293021746,Term 14,370602220727,Term 13,452986706798,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 15,3424010057,Term 14,146841192961,Term 13,118142142832,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익,-,Term 15,21869011689,Term 14,223761027766,Term 13,334844563966,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 15,35132159662,Term 14,238804191604,Term 13,332195459028,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배주주지분,-,Term 15,-13263147973,Term 14,-15043163838,Term 13,2649104938,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,세후기타포괄손익,-,Term 15,12241704451,Term 14,7286612210,Term 13,23557705928,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,-,Term 15,7379173991,Term 14,-8917300059,Term 13,21500150375,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치금융자산 평가손익,-,Term 15,-306779895,Term 14,-425735392,Term 13,1646093788,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnHedgesOfNetInvestmentsInForeignOperationsNetOfTax,관계기업기타포괄손익지분,-,Term 15,141746006,Term 14,18983206,Term 13,-55193664,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업환산손익,-,Term 15,5027564349,Term 14,16610664455,Term 13,466655430,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,당기총포괄이익,-,Term 15,34110716140,Term 14,231047639976,Term 13,358402269894,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 15,46911291120,Term 14,246323873960,Term 13,355628393686,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배주주지분,-,Term 15,-12800574980,Term 14,-15276233984,Term 13,2773876208,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주기본주당순이익,-,Term 15,512,Term 14,3477,Term 13,4815,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,우선주기본주당순이익,-,Term 15,517,Term 14,3490,Term 13,4820,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동으로 인한 현금흐름,-,Term 15,554358724380,Term 14,718300781333,Term 13,646677307033,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업으로부터 창출된 현금흐름,-,Term 15,670456654579,Term 14,857524382916,Term 13,791112221268,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 15,4028241642,Term 14,10135538607,Term 13,11766290224,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자의 지급,-,Term 15,16008008153,Term 14,18049090334,Term 13,1903403292,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세의 납부,-,Term 15,104118163688,Term 14,131310049856,Term 13,154297801167,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동으로 인한 현금흐름,-,Term 15,-206408840887,Term 14,-403233395816,Term 13,-413917719397,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfShortTermFinancialInstruments,유동성 금융기관예치금의 순감소,-,Term 15,12162100000,Term 14,0,Term 13,17569000000,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherCurrentFinancialAssets,유동성 상각후원가측정금융자산의 감소,-,Term 15,0,Term 14,30511000000,Term 13,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익공정가치금융자산의 감소,-,Term 15,2991229925,Term 14,0,Term 13,20101369863,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfLoansAndReceivables,기타수취채권의 감소,-,Term 15,45815639463,Term 14,7616143350,Term 13,5977550749,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfLongTermFinancialInstruments,비유동성 금융기관예치금의 감소,-,Term 15,353988000,Term 14,0,Term 13,579033207,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherNonCurrentFinancialAssets,상각후원가측정금융자산의 처분,-,Term 15,6260017,Term 14,973000000,Term 13,1435365000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfNonCurrentFairValueFinancialAsset,기타포괄손익-공정가치금융자산의 처분,-,Term 15,0,Term 14,1070751960,Term 13,3198767940,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 15,24769903712,Term 14,27798931056,Term 13,1698472223,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 15,349269754,Term 14,2517072752,Term 13,1056370318,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 15,0,Term 14,0,Term 13,2016000000,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfNonCurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정비유동자산의 처분,-,Term 15,0,Term 14,0,Term 13,504000000,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsInvestingActivities,관계기업으로부터의 배당금수익,-,Term 15,3750046,Term 14,0,Term 13,107494108,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities,기타의 현금유입액,-,Term 15,0,Term 14,5110503360,Term 13,15256413670,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_PurchaseOfShortTermFinancialInstruments,유동성 금융기관예치금의 순증가,-,Term 15,0,Term 14,55439000000,Term 13,0,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익공정가치금융자산의 증가,-,Term 15,23523394856,Term 14,136299644042,Term 13,20000000000,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_PurchaseOfLoansAndReceivables,기타수취채권의 증가,-,Term 15,3826463221,Term 14,4137112924,Term 13,4877583342,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_PurchaseOfLongTermFinancialInstruments,비유동성 금융기관예치금의 증가,-,Term 15,1500002760,Term 14,1500002760,Term 13,1500002760,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_PurchaseOfOtherFinancialAssets,상각후원가측정금융자산의 취득,-,Term 15,0,Term 14,11955000,Term 13,337180000,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 15,183021787650,Term 14,246549723931,Term 13,405477300427,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 15,31983791822,Term 14,34863960005,Term 13,51225489946,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,-Standard account code not used-,사용권자산의 증가,-,Term 15,2269650,Term 14,29399632,Term 13,0,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_PurchaseOfInvestmentsInAssociates,관계기업투자주식의 증가,-,Term 15,49003271845,Term 14,0,Term 13,0,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동으로 인한 현금흐름,-,Term 15,-215987303706,Term 14,-387437264460,Term 13,-103444987469,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 증가,-,Term 15,110605478453,Term 14,12048075210,Term 13,24495222450,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_IncreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 수취,-,Term 15,578239965,Term 14,0,Term 13,0,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromIssuingShares,비지배주주의 유상증자,-,Term 15,0,Term 14,250000000,Term 13,0,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 감소,-,Term 15,49138368262,Term 14,32682146763,Term 13,39628288984,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_AcquisitionOfTreasuryShares,자사주 매입,-,Term 15,0,Term 14,100007515900,Term 13,0,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_PaymentsOfFinanceLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 상환,-,Term 15,206758281113,Term 14,185628639922,Term 13,0,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금의 지급,-,Term 15,68530023595,Term 14,81417037085,Term 13,88311920935,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_DecreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 반환,-,Term 15,2744349154,Term 14,0,Term 13,0,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,외화환산으로 인한 현금의 증감,-,Term 15,-11814668914,Term 14,10439616452,Term 13,2008514996,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalents,현금의 증가,-,Term 15,120147910873,Term 14,-61930262491,Term 13,131323115163,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초의 현금,-,Term 15,673580375450,Term 14,735510637941,Term 13,604187522778,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말의 현금,-,Term 15,793728286323,Term 14,673580375450,Term 13,735510637941,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 15,4498840803125,Term 14,4446417082447,Term 13,4175374154783,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배주주지분,Term 15,9344274222,Term 14,24370508206,Term 13,21592054069,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분,Term 15,4489496528903,Term 14,4422046574241,Term 13,4153782100714,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,-117631782499,Term 14,-17624266599,Term 13,-17624266599,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,712701764092,Term 14,712701764092,Term 13,712701764092,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,3873789578852,Term 14,3726002772481,Term 13,3456502861670,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,34508160000,Term 14,34508160000,Term 13,34508160000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,10807414056,Term 14,7770057440,Term 13,7770057440,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,-24678605598,Term 14,-41311913173,Term 13,-40076475889,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,0,Term 14,0,Term 13,979482406,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,0,Term 14,0,Term 13,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주지분,Term 15,0,Term 14,0,Term 13,979482406,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|비지배주주지분,Term 15,0,Term 14,0,Term 13,4577929,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,연결재무제표 [member],Term 15,0,Term 14,0,Term 13,984060335,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,수정후 금액,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,712701764092,Term 14,712701764092,Term 13,712701764092,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,수정후 금액,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,10807414056,Term 14,7770057440,Term 13,7770057440,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,수정후 금액,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,34508160000,Term 14,34508160000,Term 13,34508160000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,수정후 금액,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,3873789578852,Term 14,3726002772481,Term 13,3457482344076,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,수정후 금액,연결재무제표 [member],Term 15,4498840803125,Term 14,4446417082447,Term 13,4176358215118,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,수정후 금액,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,-117631782499,Term 14,-17624266599,Term 13,-17624266599,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,수정후 금액,자본 [member]|지배기업의 소유주지분,Term 15,4489496528903,Term 14,4422046574241,Term 13,4154761583120,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,수정후 금액,자본 [member]|비지배주주지분,Term 15,9344274222,Term 14,24370508206,Term 13,21596631998,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,수정후 금액,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,-24678605598,Term 14,-41311913173,Term 13,-40076475889,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,연결재무제표 [member],Term 15,21869011689,Term 14,223761027766,Term 13,334844563966,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|비지배주주지분,Term 15,-13263147973,Term 14,-15043163838,Term 13,2649104938,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주지분,Term 15,35132159662,Term 14,238804191604,Term 13,332195459028,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,0,Term 14,0,Term 13,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,35132159662,Term 14,238804191604,Term 13,332195459028,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,연결재무제표 [member],Term 15,7379173991,Term 14,-8917300059,Term 13,21500150375,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|비지배주주지분,Term 15,0,Term 14,0,Term 13,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주지분,Term 15,7379173991,Term 14,-8917300059,Term 13,21500150375,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,0,Term 14,0,Term 13,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,7379173991,Term 14,-8917300059,Term 13,21500150375,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,연결재무제표 [member],Term 15,-306779895,Term 14,-425735392,Term 13,1646093788,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|비지배주주지분,Term 15,0,Term 14,0,Term 13,12649059,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|지배기업의 소유주지분,Term 15,-306779895,Term 14,-425735392,Term 13,1633444729,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,-306779895,Term 14,-425735392,Term 13,1633444729,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,0,Term 14,0,Term 13,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherComprehensiveIncomeForStatementOfChangesInEquity,기타포괄손익-공정가치금융자산처분,연결재무제표 [member],Term 15,0,Term 14,0,Term 13,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherComprehensiveIncomeForStatementOfChangesInEquity,기타포괄손익-공정가치금융자산처분,자본 [member]|비지배주주지분,Term 15,0,Term 14,0,Term 13,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherComprehensiveIncomeForStatementOfChangesInEquity,기타포괄손익-공정가치금융자산처분,자본 [member]|지배기업의 소유주지분,Term 15,0,Term 14,0,Term 13,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherComprehensiveIncomeForStatementOfChangesInEquity,기타포괄손익-공정가치금융자산처분,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherComprehensiveIncomeForStatementOfChangesInEquity,기타포괄손익-공정가치금융자산처분,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,0,Term 14,196325160,Term 13,-3168221567,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherComprehensiveIncomeForStatementOfChangesInEquity,기타포괄손익-공정가치금융자산처분,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,0,Term 14,-196325160,Term 13,3168221567,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherComprehensiveIncomeForStatementOfChangesInEquity,기타포괄손익-공정가치금융자산처분,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherComprehensiveIncomeForStatementOfChangesInEquity,기타포괄손익-공정가치금융자산처분,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherComprehensiveIncomeForStatementOfChangesInEquity,기타포괄손익-공정가치금융자산처분,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,연결재무제표 [member],Term 15,141746006,Term 14,18983206,Term 13,-55193664,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|비지배주주지분,Term 15,14174601,Term 14,1898321,Term 13,-5519366,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주지분,Term 15,127571405,Term 14,17084885,Term 13,-49674298,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,127571405,Term 14,17084885,Term 13,-49674298,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,0,Term 14,0,Term 13,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,연결재무제표 [member],Term 15,5027564349,Term 14,16610664455,Term 13,466655430,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|비지배주주지분,Term 15,448398392,Term 14,-234968467,Term 13,117641578,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주지분,Term 15,4579165957,Term 14,16845632922,Term 13,349013852,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,4579165957,Term 14,16845632922,Term 13,349013852,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,0,Term 14,0,Term 13,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,연결재무제표 [member],Term 15,68553775070,Term 14,81445694780,Term 13,88343402565,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|비지배주주지분,Term 15,0,Term 14,0,Term 13,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주지분,Term 15,68553775070,Term 14,81445694780,Term 13,88343402565,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,0,Term 14,0,Term 13,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,68553775070,Term 14,81445694780,Term 13,88343402565,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식 취득,연결재무제표 [member],Term 15,0,Term 14,-100007515900,Term 13,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식 취득,자본 [member]|비지배주주지분,Term 15,0,Term 14,0,Term 13,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식 취득,자본 [member]|지배기업의 소유주지분,Term 15,0,Term 14,-100007515900,Term 13,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식 취득,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,-100007515900,Term 13,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식 취득,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,0,Term 14,0,Term 13,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식 취득,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,0,Term 14,0,Term 13,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식 취득,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식 취득,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식 취득,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,연결재무제표 [member],Term 15,0,Term 14,3037356616,Term 13,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|비지배주주지분,Term 15,0,Term 14,0,Term 13,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분,Term 15,0,Term 14,3037356616,Term 13,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,0,Term 14,0,Term 13,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,0,Term 14,0,Term 13,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,3037356616,Term 13,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,비지배주주의 유상증자,연결재무제표 [member],Term 15,0,Term 14,250000000,Term 13,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,비지배주주의 유상증자,자본 [member]|비지배주주지분,Term 15,0,Term 14,250000000,Term 13,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,비지배주주의 유상증자,자본 [member]|지배기업의 소유주지분,Term 15,0,Term 14,0,Term 13,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,비지배주주의 유상증자,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,비지배주주의 유상증자,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,0,Term 14,0,Term 13,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,비지배주주의 유상증자,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,0,Term 14,0,Term 13,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,비지배주주의 유상증자,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,비지배주주의 유상증자,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,-Standard account code not used-,비지배주주의 유상증자,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,연결재무제표 [member],Term 15,0,Term 14,-458065234,Term 13,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|비지배주주지분,Term 15,0,Term 14,0,Term 13,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분,Term 15,0,Term 14,-458065234,Term 13,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,0,Term 14,0,Term 13,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,0,Term 14,0,Term 13,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,0,Term 14,-458065234,Term 13,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,0,Term 14,0,Term 13,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,0,Term 14,0,Term 13,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,0,Term 14,0,Term 13,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 15,4464397744195,Term 14,4498840803125,Term 13,4446417082447,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|비지배주주지분,Term 15,-3456300758,Term 14,9344274222,Term 13,24370508206,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분,Term 15,4467854044953,Term 14,4489496528903,Term 13,4422046574241,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 15,-117631782499,Term 14,-117631782499,Term 13,-17624266599,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 15,-20278648131,Term 14,-24678605598,Term 13,-41311913173,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 15,3847747137435,Term 14,3873789578852,Term 13,3726002772481,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 15,34508160000,Term 14,34508160000,Term 13,34508160000,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 15,10807414056,Term 14,10807414056,Term 13,7770057440,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311000870,11011,2020,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 15,712701764092,Term 14,712701764092,Term 13,712701764092,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 16,2018526858100,Term 15,1825732428259,Term 14,1803063670498,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 16,537693630647,Term 15,793728286323,Term 14,673580375450,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_ShortTermDepositsNotClassifiedAsCashEquivalents,금융기관예치금,-,Term 16,101825500000,Term 15,57882300000,Term 14,70600000000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognition,당기손익-공정가치금융자산,-,Term 16,490839332272,Term 15,166463243160,Term 14,137522926040,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_ShortTermTradeReceivable,매출채권,-,Term 16,295769466239,Term 15,283770117119,Term 14,365884445662,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,기타수취채권,-,Term 16,41647242846,Term 15,24723686702,Term 14,32485367549,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 16,3330887323,Term 15,19235955917,Term 14,4014569938,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 16,50130929669,Term 15,65445877705,Term 14,66386913917,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 16,493223642997,Term 15,414482961333,Term 14,452589071942,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners,매각예정자산,-,Term 16,4066226107,Term 15,,Term 14,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 16,4098187074812,Term 15,3876185747488,Term 14,4185944120149,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_LongTermDepositsNotClassifiedAsCashEquivalents,금융기관예치금,-,Term 16,19512730100,Term 15,17556864840,Term 14,16425521080,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentReceivablesGross,기타수취채권,-,Term 16,115162575008,Term 15,100546922493,Term 14,145164887090,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognition,당기손익-공정가치금융자산,-,Term 16,104256383649,Term 15,1128984127,Term 14,4118831930,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtAmortisedCost,상각후원가측정금융자산,-,Term 16,811274982,Term 15,2125074983,Term 14,2131335000,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산,-,Term 16,4672325200,Term 15,705503210,Term 14,1113546260,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 16,2541362150975,Term 15,2566328198231,Term 14,2661841508240,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 16,534228580408,Term 15,488815300039,Term 14,493010504975,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 16,146465714306,Term 15,227453263601,Term 14,432396245094,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 16,201680029794,Term 15,208773970177,Term 14,226517106409,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_InvestmentsInAssociates,관계기업주식,-,Term 16,238445368790,Term 15,52514140370,Term 14,2160253079,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,-Standard account code not used-,순확정급여자산,-,Term 16,94729521034,Term 15,110633427860,Term 14,106098704183,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 16,84608399877,Term 15,82890358531,Term 14,72704996238,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_OtherNonCurrentAssets,기타비유동자산,-,Term 16,12252020689,Term 15,16713739026,Term 14,22260680571,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 16,6116713932912,Term 15,5701918175747,Term 14,5989007790647,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 16,1157485393842,Term 15,965946712547,Term 14,1066567435582,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_ShortTermTradePayables,매입채무,-,Term 16,123410292397,Term 15,117617730697,Term 14,172459191473,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 16,199124082671,Term 15,154160189044,Term 14,99346553098,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,기타지급채무,-,Term 16,324998426639,Term 15,275762504709,Term 14,264808700940,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 16,89962740389,Term 15,6097005496,Term 14,67399350946,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_CurrentContractLiabilities,계약부채,-,Term 16,37465486262,Term 15,42275345834,Term 14,50058558388,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_CurrentProvisions,기타충당부채,-,Term 16,8906185258,Term 15,8652202062,Term 14,12871685529,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,리스유동부채,-,Term 16,94760913961,Term 15,132867105541,Term 14,197591533621,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 16,278857266265,Term 15,228514629164,Term 14,202031861587,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 16,214928661448,Term 15,271573719005,Term 14,423599551940,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,-Standard account code not used-,순확정급여부채,-,Term 16,4059129237,Term 15,3831674238,Term 14,3424822481,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 16,79488075447,Term 15,90075514181,Term 14,101731472413,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,기타충당부채,-,Term 16,11556811260,Term 15,18617523307,Term 14,19135594489,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,리스비유동부채,-,Term 16,96221153680,Term 15,133748488854,Term 14,267922153243,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 16,23603491824,Term 15,25300518425,Term 14,31385509314,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 16,1372414055290,Term 15,1237520431552,Term 14,1490166987522,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업의 소유주에게 귀속되는 자본,-,Term 16,4761008405615,Term 15,4467854044953,Term 14,4489496528903,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 16,34525294500,Term 15,34508160000,Term 14,34508160000,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_SharePremium,주식발행초과금,-,Term 16,720480827092,Term 15,712701764092,Term 14,712701764092,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 16,75352826661,Term 15,10807414056,Term 14,10807414056,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본구성요소,-,Term 16,-19004134338,Term 15,-117631782499,Term 14,-117631782499,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 16,11879036721,Term 15,-20278648131,Term 14,-24678605598,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 16,3937774554979,Term 15,3847747137435,Term 14,3873789578852,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배주주지분,-,Term 16,-16708527993,Term 15,-3456300758,Term 14,9344274222,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 16,4744299877622,Term 15,4464397744195,Term 14,4498840803125,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채와 자본총계,-,Term 16,6116713932912,Term 15,5701918175747,Term 14,5989007790647,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 16,4863128496699,Term 15,4432179039394,Term 14,5580142192519,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 16,1362639202428,Term 15,1265398064748,Term 14,1500515578424,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 16,3500489294271,Term 15,3166780974646,Term 14,4079626614095,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 16,3157131485221,Term 15,3023771855339,Term 14,3651792017591,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익,-,Term 16,343357809050,Term 15,143009119307,Term 14,427834596504,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 16,10499109599,Term 15,11882548495,Term 14,14739081054,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 16,11410260207,Term 15,17026833385,Term 14,19976729196,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,dart_OtherGains,기타영업외손익,-,Term 16,-45496828367,Term 15,-113231972208,Term 14,-51693123255,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,관계기업손익,-,Term 16,927626457,Term 15,660159537,Term 14,-301604380,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 16,297877456532,Term 15,25293021746,Term 14,370602220727,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 16,117019762555,Term 15,3424010057,Term 14,146841192961,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익,-,Term 16,180857693977,Term 15,21869011689,Term 14,223761027766,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 16,193680578727,Term 15,35132159662,Term 14,238804191604,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배주주지분,-,Term 16,-12822884750,Term 15,-13263147973,Term 14,-15043163838,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,세후기타포괄손익,-,Term 16,-15641140883,Term 15,12241704451,Term 14,7286612210,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,-,Term 16,-47369483250,Term 15,7379173991,Term 14,-8917300059,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치금융자산 평가손익,-,Term 16,109285659,Term 15,-306779895,Term 14,-425735392,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnHedgesOfNetInvestmentsInForeignOperationsNetOfTax,관계기업기타포괄손익지분,-,Term 16,260637659,Term 15,141746006,Term 14,18983206,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업환산손익,-,Term 16,31358419049,Term 15,5027564349,Term 14,16610664455,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,당기총포괄이익,-,Term 16,165216553094,Term 15,34110716140,Term 14,231047639976,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 16,178468780329,Term 15,46911291120,Term 14,246323873960,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배주주지분,-,Term 16,-13252227235,Term 15,-12800574980,Term 14,-15276233984,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주기본주당순이익,-,Term 16,2820,Term 15,512,Term 14,3477,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,보통주희석주당순이익,-,Term 16,2818,Term 15,512,Term 14,3477,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,우선주기본주당순이익,-,Term 16,2821,Term 15,517,Term 14,3490,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,우선주희석주당순이익,-,Term 16,2821,Term 15,517,Term 14,3490,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동으로 인한 현금흐름,-,Term 16,691434410702,Term 15,554358724380,Term 14,718300781333,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업으로부터 창출된 현금흐름,-,Term 16,714854553223,Term 15,670456654579,Term 14,857524382916,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 16,4026044240,Term 15,4028241642,Term 14,10135538607,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자의 지급,-,Term 16,9899193484,Term 15,16008008153,Term 14,18049090334,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세의 납부,-,Term 16,17546993277,Term 15,104118163688,Term 14,131310049856,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동으로 인한 현금흐름,-,Term 16,-708415251302,Term 15,-206408840887,Term 14,-403233395816,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfShortTermFinancialInstruments,유동성 금융기관예치금의 순감소,-,Term 16,,Term 15,12162100000,Term 14,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익공정가치금융자산의？감소,-,Term 16,1184085953,Term 15,2991229925,Term 14,,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfLoansAndReceivables,기타수취채권의 감소,-,Term 16,31526378078,Term 15,45815639463,Term 14,7616143350,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfLongTermFinancialInstruments,비유동성 금융기관예치금의 감소,-,Term 16,,Term 15,353988000,Term 14,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherNonCurrentFinancialAssets,상각후원가측정금융자산의 처분,-,Term 16,1313800001,Term 15,6260017,Term 14,31484000000,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,-Standard account code not used-,기타포괄손익-공정가치금융자산의 처분,-,Term 16,,Term 15,,Term 14,1070751960,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 16,3276022744,Term 15,24769903712,Term 14,27798931056,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 16,414580271,Term 15,349269754,Term 14,2517072752,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 16,4226483920,Term 15,,Term 14,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsInvestingActivities,관계기업으로부터의 배당금수익,-,Term 16,,Term 15,3750046,Term 14,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,-Standard account code not used-,사업결합 등으로 인한 순현금유입,-,Term 16,44874437795,Term 15,,Term 14,,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,-Standard account code not used-,기타의 현금유입액,-,Term 16,11434877000,Term 15,,Term 14,5110503360,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_PurchaseOfShortTermFinancialInstruments,유동성 금융기관예치금의 순증가,-,Term 16,43094000000,Term 15,,Term 14,55439000000,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익공정가치금융자산의 증가,-,Term 16,425223672742,Term 15,23523394856,Term 14,136299644042,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_PurchaseOfAvailableForSaleFinancialAssets,기타포괄손익공정가치금융자산의 취득,-,Term 16,3000080160,Term 15,,Term 14,,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_PurchaseOfLoansAndReceivables,기타수취채권의 증가,-,Term 16,29564010651,Term 15,3826463221,Term 14,4137112924,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_PurchaseOfLongTermFinancialInstruments,비유동성 금융기관예치금의 증가,-,Term 16,1503002760,Term 15,1500002760,Term 14,1500002760,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,-Standard account code not used-,상각후원가측정금융자산의 취득,-,Term 16,,Term 15,,Term 14,11955000,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 16,91182844178,Term 15,183021787650,Term 14,246549723931,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 16,29815783627,Term 15,31983791822,Term 14,34863960005,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,-Standard account code not used-,사용권자산의 증가,-,Term 16,26671000,Term 15,2269650,Term 14,29399632,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_PurchaseOfInvestmentsInAssociates,관계기업투자주식의 증가,-,Term 16,183255851946,Term 15,49003271845,Term 14,,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동으로 인한 현금흐름,-,Term 16,-225980969342,Term 15,-215987303706,Term 14,-387437264460,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 증가,-,Term 16,17070110907,Term 15,110605478453,Term 14,12048075210,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_IncreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 수취,-,Term 16,5297434200,Term 15,578239965,Term 14,,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,-Standard account code not used-,비지배주주의 유상증자,-,Term 16,,Term 15,,Term 14,250000000,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 감소,-,Term 16,33166492045,Term 15,49138368262,Term 14,32682146763,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_AcquisitionOfTreasuryShares,자사주 매입,-,Term 16,18685151180,Term 15,,Term 14,100007515900,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_PaymentsOfFinanceLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 상환,-,Term 16,140273953288,Term 15,206758281113,Term 14,185628639922,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금의 지급,-,Term 16,54834267960,Term 15,68530023595,Term 14,81417037085,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_DecreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 반환,-,Term 16,1388649976,Term 15,2744349154,Term 14,,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,외화환산으로 인한 현금의 증감,-,Term 16,-13072845734,Term 15,-11814668914,Term 14,10439616452,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalents,현금및현금성자산의 증감,-,Term 16,-256034655676,Term 15,120147910873,Term 14,-61930262491,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초의 현금및현금성자산,-,Term 16,793728286323,Term 15,673580375450,Term 14,735510637941,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말의 현금및현금성자산,-,Term 16,537693630647,Term 15,793728286323,Term 14,673580375450,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 16,-117631782499,Term 15,-117631782499,Term 14,-17624266599,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분,Term 16,4467854044953,Term 15,4489496528903,Term 14,4422046574241,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 16,712701764092,Term 15,712701764092,Term 14,712701764092,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 16,10807414056,Term 15,10807414056,Term 14,7770057440,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배주주지분,Term 16,-3456300758,Term 15,9344274222,Term 14,24370508206,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 16,3847747137435,Term 15,3873789578852,Term 14,3726002772481,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 16,-20278648131,Term 15,-24678605598,Term 14,-41311913173,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 16,4464397744195,Term 15,4498840803125,Term 14,4446417082447,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 16,34508160000,Term 15,34508160000,Term 14,34508160000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,연결재무제표 [member],Term 16,180857693977,Term 15,21869011689,Term 14,223761027766,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주지분,Term 16,193680578727,Term 15,35132159662,Term 14,238804191604,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|비지배주주지분,Term 16,-12822884750,Term 15,-13263147973,Term 14,-15043163838,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 16,193680578727,Term 15,35132159662,Term 14,238804191604,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 16,-47369483250,Term 15,7379173991,Term 14,-8917300059,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주지분,Term 16,-47369483250,Term 15,7379173991,Term 14,-8917300059,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,연결재무제표 [member],Term 16,-47369483250,Term 15,7379173991,Term 14,-8917300059,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 16,109285659,Term 15,-306779895,Term 14,-425735392,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|지배기업의 소유주지분,Term 16,109285659,Term 15,-306779895,Term 14,-425735392,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,연결재무제표 [member],Term 16,109285659,Term 15,-306779895,Term 14,-425735392,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익-공정가치금융자산처분,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 16,,Term 15,,Term 14,-196325160,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익-공정가치금융자산처분,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 16,,Term 15,,Term 14,196325160,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주지분,Term 16,255539339,Term 15,127571405,Term 14,17084885,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|비지배주주지분,Term 16,5098320,Term 15,14174601,Term 14,1898321,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 16,255539339,Term 15,127571405,Term 14,17084885,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,연결재무제표 [member],Term 16,260637659,Term 15,141746006,Term 14,18983206,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 16,31792859854,Term 15,4579165957,Term 14,16845632922,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주지분,Term 16,31792859854,Term 15,4579165957,Term 14,16845632922,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|비지배주주지분,Term 16,-434440805,Term 15,448398392,Term 14,-234968467,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,연결재무제표 [member],Term 16,31358419049,Term 15,5027564349,Term 14,16610664455,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 16,54853570065,Term 15,68553775070,Term 14,81445694780,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주지분,Term 16,54853570065,Term 15,68553775070,Term 14,81445694780,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,연결재무제표 [member],Term 16,54853570065,Term 15,68553775070,Term 14,81445694780,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,주식발행,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 16,17134500,Term 15,,Term 14,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,주식발행,자본 [member]|지배기업의 소유주지분,Term 16,7796197500,Term 15,,Term 14,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,주식발행,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 16,7779063000,Term 15,,Term 14,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,주식발행,연결재무제표 [member],Term 16,7796197500,Term 15,,Term 14,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식처분,자본 [member]|지배기업의 소유주지분,Term 16,115817520000,Term 15,,Term 14,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식처분,연결재무제표 [member],Term 16,115817520000,Term 15,,Term 14,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식처분,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 16,101259270904,Term 15,,Term 14,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식처분,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 16,14558249096,Term 15,,Term 14,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식취득,자본 [member]|지배기업의 소유주지분,Term 16,-18685151180,Term 15,,Term 14,-100007515900,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식취득,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 16,-18685151180,Term 15,,Term 14,-100007515900,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식취득,연결재무제표 [member],Term 16,-18685151180,Term 15,,Term 14,-100007515900,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,연결재무제표 [member],Term 16,48557055641,Term 15,,Term 14,3037356616,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 16,-1430107868,Term 15,,Term 14,,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 16,49987163509,Term 15,,Term 14,3037356616,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분,Term 16,48557055641,Term 15,,Term 14,3037356616,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배주주의 유상증자,연결재무제표 [member],Term 16,,Term 15,,Term 14,250000000,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배주주의 유상증자,자본 [member]|비지배주주지분,Term 16,,Term 15,,Term 14,250000000,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,연결재무제표 [member],Term 16,16053528437,Term 15,,Term 14,-458065234,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 16,,Term 15,,Term 14,-458065234,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분,Term 16,16053528437,Term 15,,Term 14,-458065234,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 16,16053528437,Term 15,,Term 14,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 16,34525294500,Term 15,34508160000,Term 14,34508160000,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 16,3937774554979,Term 15,3847747137435,Term 14,3873789578852,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 16,11879036721,Term 15,-20278648131,Term 14,-24678605598,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 16,-19004134338,Term 15,-117631782499,Term 14,-117631782499,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 16,720480827092,Term 15,712701764092,Term 14,712701764092,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|비지배주주지분,Term 16,-16708527993,Term 15,-3456300758,Term 14,9344274222,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 16,4744299877622,Term 15,4464397744195,Term 14,4498840803125,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 16,75352826661,Term 15,10807414056,Term 14,10807414056,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분,Term 16,4761008405615,Term 15,4467854044953,Term 14,4489496528903,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 16,2018526858100,Term 15,1825732428259,Term 14,1803063670498,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 16,537693630647,Term 15,793728286323,Term 14,673580375450,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_ShortTermDepositsNotClassifiedAsCashEquivalents,금융기관예치금,-,Term 16,101825500000,Term 15,57882300000,Term 14,70600000000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognition,당기손익-공정가치금융자산,-,Term 16,490839332272,Term 15,166463243160,Term 14,137522926040,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_ShortTermTradeReceivable,매출채권,-,Term 16,295769466239,Term 15,283770117119,Term 14,365884445662,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,기타수취채권,-,Term 16,41647242846,Term 15,24723686702,Term 14,32485367549,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 16,3330887323,Term 15,19235955917,Term 14,4014569938,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 16,50130929669,Term 15,65445877705,Term 14,66386913917,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 16,493223642997,Term 15,414482961333,Term 14,452589071942,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners,매각예정자산,-,Term 16,4066226107,Term 15,,Term 14,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 16,4098187074812,Term 15,3876185747488,Term 14,4185944120149,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_LongTermDepositsNotClassifiedAsCashEquivalents,금융기관예치금,-,Term 16,19512730100,Term 15,17556864840,Term 14,16425521080,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentReceivablesGross,기타수취채권,-,Term 16,115162575008,Term 15,100546922493,Term 14,145164887090,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognition,당기손익-공정가치금융자산,-,Term 16,104256383649,Term 15,1128984127,Term 14,4118831930,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtAmortisedCost,상각후원가측정금융자산,-,Term 16,811274982,Term 15,2125074983,Term 14,2131335000,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산,-,Term 16,4672325200,Term 15,705503210,Term 14,1113546260,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 16,2541362150975,Term 15,2566328198231,Term 14,2661841508240,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 16,534228580408,Term 15,488815300039,Term 14,493010504975,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 16,146465714306,Term 15,227453263601,Term 14,432396245094,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 16,201680029794,Term 15,208773970177,Term 14,226517106409,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_InvestmentsInAssociates,관계기업주식,-,Term 16,238445368790,Term 15,52514140370,Term 14,2160253079,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,-Standard account code not used-,순확정급여자산,-,Term 16,94729521034,Term 15,110633427860,Term 14,106098704183,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 16,84608399877,Term 15,82890358531,Term 14,72704996238,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_OtherNonCurrentAssets,기타비유동자산,-,Term 16,12252020689,Term 15,16713739026,Term 14,22260680571,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 16,6116713932912,Term 15,5701918175747,Term 14,5989007790647,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 16,1157485393842,Term 15,965946712547,Term 14,1066567435582,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_ShortTermTradePayables,매입채무,-,Term 16,123410292397,Term 15,117617730697,Term 14,172459191473,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 16,199124082671,Term 15,154160189044,Term 14,99346553098,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,기타지급채무,-,Term 16,324998426639,Term 15,275762504709,Term 14,264808700940,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 16,89962740389,Term 15,6097005496,Term 14,67399350946,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_CurrentContractLiabilities,계약부채,-,Term 16,37465486262,Term 15,42275345834,Term 14,50058558388,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_CurrentProvisions,기타충당부채,-,Term 16,8906185258,Term 15,8652202062,Term 14,12871685529,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,리스유동부채,-,Term 16,94760913961,Term 15,132867105541,Term 14,197591533621,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 16,278857266265,Term 15,228514629164,Term 14,202031861587,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 16,214928661448,Term 15,271573719005,Term 14,423599551940,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,-Standard account code not used-,순확정급여부채,-,Term 16,4059129237,Term 15,3831674238,Term 14,3424822481,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 16,79488075447,Term 15,90075514181,Term 14,101731472413,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,기타충당부채,-,Term 16,11556811260,Term 15,18617523307,Term 14,19135594489,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,리스비유동부채,-,Term 16,96221153680,Term 15,133748488854,Term 14,267922153243,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 16,23603491824,Term 15,25300518425,Term 14,31385509314,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 16,1372414055290,Term 15,1237520431552,Term 14,1490166987522,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업의 소유주에게 귀속되는 자본,-,Term 16,4761008405615,Term 15,4467854044953,Term 14,4489496528903,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 16,34525294500,Term 15,34508160000,Term 14,34508160000,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_SharePremium,주식발행초과금,-,Term 16,720480827092,Term 15,712701764092,Term 14,712701764092,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 16,75352826661,Term 15,10807414056,Term 14,10807414056,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본구성요소,-,Term 16,-19004134338,Term 15,-117631782499,Term 14,-117631782499,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 16,11879036721,Term 15,-20278648131,Term 14,-24678605598,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 16,3937774554979,Term 15,3847747137435,Term 14,3873789578852,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배주주지분,-,Term 16,-16708527993,Term 15,-3456300758,Term 14,9344274222,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 16,4744299877622,Term 15,4464397744195,Term 14,4498840803125,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채와 자본총계,-,Term 16,6116713932912,Term 15,5701918175747,Term 14,5989007790647,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 16,4863128496699,Term 15,4432179039394,Term 14,5580142192519,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 16,1362639202428,Term 15,1265398064748,Term 14,1500515578424,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 16,3500489294271,Term 15,3166780974646,Term 14,4079626614095,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 16,3157131485221,Term 15,3023771855339,Term 14,3651792017591,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익,-,Term 16,343357809050,Term 15,143009119307,Term 14,427834596504,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 16,10499109599,Term 15,11882548495,Term 14,14739081054,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 16,11410260207,Term 15,17026833385,Term 14,19976729196,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,dart_OtherGains,기타영업외손익,-,Term 16,-45496828367,Term 15,-113231972208,Term 14,-51693123255,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,관계기업손익,-,Term 16,927626457,Term 15,660159537,Term 14,-301604380,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 16,297877456532,Term 15,25293021746,Term 14,370602220727,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 16,117019762555,Term 15,3424010057,Term 14,146841192961,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익,-,Term 16,180857693977,Term 15,21869011689,Term 14,223761027766,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 16,193680578727,Term 15,35132159662,Term 14,238804191604,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배주주지분,-,Term 16,-12822884750,Term 15,-13263147973,Term 14,-15043163838,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,세후기타포괄손익,-,Term 16,-15641140883,Term 15,12241704451,Term 14,7286612210,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,-,Term 16,-47369483250,Term 15,7379173991,Term 14,-8917300059,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치금융자산 평가손익,-,Term 16,109285659,Term 15,-306779895,Term 14,-425735392,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnHedgesOfNetInvestmentsInForeignOperationsNetOfTax,관계기업기타포괄손익지분,-,Term 16,260637659,Term 15,141746006,Term 14,18983206,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업환산손익,-,Term 16,31358419049,Term 15,5027564349,Term 14,16610664455,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,당기총포괄이익,-,Term 16,165216553094,Term 15,34110716140,Term 14,231047639976,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 16,178468780329,Term 15,46911291120,Term 14,246323873960,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배주주지분,-,Term 16,-13252227235,Term 15,-12800574980,Term 14,-15276233984,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주기본주당순이익,-,Term 16,2820,Term 15,512,Term 14,3477,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,보통주희석주당순이익,-,Term 16,2818,Term 15,512,Term 14,3477,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,우선주기본주당순이익,-,Term 16,2821,Term 15,517,Term 14,3490,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,우선주희석주당순이익,-,Term 16,2821,Term 15,517,Term 14,3490,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동으로 인한 현금흐름,-,Term 16,691434410702,Term 15,554358724380,Term 14,718300781333,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업으로부터 창출된 현금흐름,-,Term 16,714854553223,Term 15,670456654579,Term 14,857524382916,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 16,4026044240,Term 15,4028241642,Term 14,10135538607,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자의 지급,-,Term 16,9899193484,Term 15,16008008153,Term 14,18049090334,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세의 납부,-,Term 16,17546993277,Term 15,104118163688,Term 14,131310049856,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동으로 인한 현금흐름,-,Term 16,-708415251302,Term 15,-206408840887,Term 14,-403233395816,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfShortTermFinancialInstruments,유동성 금융기관예치금의 순감소,-,Term 16,,Term 15,12162100000,Term 14,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익공정가치금융자산의？감소,-,Term 16,1184085953,Term 15,2991229925,Term 14,,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfLoansAndReceivables,기타수취채권의 감소,-,Term 16,31526378078,Term 15,45815639463,Term 14,7616143350,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfLongTermFinancialInstruments,비유동성 금융기관예치금의 감소,-,Term 16,,Term 15,353988000,Term 14,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherNonCurrentFinancialAssets,상각후원가측정금융자산의 처분,-,Term 16,1313800001,Term 15,6260017,Term 14,31484000000,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,-Standard account code not used-,기타포괄손익-공정가치금융자산의 처분,-,Term 16,,Term 15,,Term 14,1070751960,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 16,3276022744,Term 15,24769903712,Term 14,27798931056,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 16,414580271,Term 15,349269754,Term 14,2517072752,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 16,4226483920,Term 15,,Term 14,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsInvestingActivities,관계기업으로부터의 배당금수익,-,Term 16,,Term 15,3750046,Term 14,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,-Standard account code not used-,사업결합 등으로 인한 순현금유입,-,Term 16,44874437795,Term 15,,Term 14,,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,-Standard account code not used-,기타의 현금유입액,-,Term 16,11434877000,Term 15,,Term 14,5110503360,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_PurchaseOfShortTermFinancialInstruments,유동성 금융기관예치금의 순증가,-,Term 16,43094000000,Term 15,,Term 14,55439000000,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익공정가치금융자산의 증가,-,Term 16,425223672742,Term 15,23523394856,Term 14,136299644042,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_PurchaseOfAvailableForSaleFinancialAssets,기타포괄손익공정가치금융자산의 취득,-,Term 16,3000080160,Term 15,,Term 14,,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_PurchaseOfLoansAndReceivables,기타수취채권의 증가,-,Term 16,29564010651,Term 15,3826463221,Term 14,4137112924,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_PurchaseOfLongTermFinancialInstruments,비유동성 금융기관예치금의 증가,-,Term 16,1503002760,Term 15,1500002760,Term 14,1500002760,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,-Standard account code not used-,상각후원가측정금융자산의 취득,-,Term 16,,Term 15,,Term 14,11955000,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 16,91182844178,Term 15,183021787650,Term 14,246549723931,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 16,29815783627,Term 15,31983791822,Term 14,34863960005,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,-Standard account code not used-,사용권자산의 증가,-,Term 16,26671000,Term 15,2269650,Term 14,29399632,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_PurchaseOfInvestmentsInAssociates,관계기업투자주식의 증가,-,Term 16,183255851946,Term 15,49003271845,Term 14,,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동으로 인한 현금흐름,-,Term 16,-225980969342,Term 15,-215987303706,Term 14,-387437264460,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 증가,-,Term 16,17070110907,Term 15,110605478453,Term 14,12048075210,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_IncreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 수취,-,Term 16,5297434200,Term 15,578239965,Term 14,,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,-Standard account code not used-,비지배주주의 유상증자,-,Term 16,,Term 15,,Term 14,250000000,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 감소,-,Term 16,33166492045,Term 15,49138368262,Term 14,32682146763,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_AcquisitionOfTreasuryShares,자사주 매입,-,Term 16,18685151180,Term 15,,Term 14,100007515900,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_PaymentsOfFinanceLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 상환,-,Term 16,140273953288,Term 15,206758281113,Term 14,185628639922,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금의 지급,-,Term 16,54834267960,Term 15,68530023595,Term 14,81417037085,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_DecreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 반환,-,Term 16,1388649976,Term 15,2744349154,Term 14,,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,외화환산으로 인한 현금의 증감,-,Term 16,-13072845734,Term 15,-11814668914,Term 14,10439616452,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalents,현금및현금성자산의 증감,-,Term 16,-256034655676,Term 15,120147910873,Term 14,-61930262491,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초의 현금및현금성자산,-,Term 16,793728286323,Term 15,673580375450,Term 14,735510637941,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말의 현금및현금성자산,-,Term 16,537693630647,Term 15,793728286323,Term 14,673580375450,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 16,-117631782499,Term 15,-117631782499,Term 14,-17624266599,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분,Term 16,4467854044953,Term 15,4489496528903,Term 14,4422046574241,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 16,712701764092,Term 15,712701764092,Term 14,712701764092,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 16,10807414056,Term 15,10807414056,Term 14,7770057440,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배주주지분,Term 16,-3456300758,Term 15,9344274222,Term 14,24370508206,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 16,3847747137435,Term 15,3873789578852,Term 14,3726002772481,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 16,-20278648131,Term 15,-24678605598,Term 14,-41311913173,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 16,4464397744195,Term 15,4498840803125,Term 14,4446417082447,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 16,34508160000,Term 15,34508160000,Term 14,34508160000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,연결재무제표 [member],Term 16,180857693977,Term 15,21869011689,Term 14,223761027766,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주지분,Term 16,193680578727,Term 15,35132159662,Term 14,238804191604,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|비지배주주지분,Term 16,-12822884750,Term 15,-13263147973,Term 14,-15043163838,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 16,193680578727,Term 15,35132159662,Term 14,238804191604,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 16,-47369483250,Term 15,7379173991,Term 14,-8917300059,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주지분,Term 16,-47369483250,Term 15,7379173991,Term 14,-8917300059,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,연결재무제표 [member],Term 16,-47369483250,Term 15,7379173991,Term 14,-8917300059,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 16,109285659,Term 15,-306779895,Term 14,-425735392,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|지배기업의 소유주지분,Term 16,109285659,Term 15,-306779895,Term 14,-425735392,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,연결재무제표 [member],Term 16,109285659,Term 15,-306779895,Term 14,-425735392,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익-공정가치금융자산처분,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 16,,Term 15,,Term 14,-196325160,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익-공정가치금융자산처분,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 16,,Term 15,,Term 14,196325160,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주지분,Term 16,255539339,Term 15,127571405,Term 14,17084885,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|비지배주주지분,Term 16,5098320,Term 15,14174601,Term 14,1898321,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 16,255539339,Term 15,127571405,Term 14,17084885,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,연결재무제표 [member],Term 16,260637659,Term 15,141746006,Term 14,18983206,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 16,31792859854,Term 15,4579165957,Term 14,16845632922,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주지분,Term 16,31792859854,Term 15,4579165957,Term 14,16845632922,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|비지배주주지분,Term 16,-434440805,Term 15,448398392,Term 14,-234968467,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,연결재무제표 [member],Term 16,31358419049,Term 15,5027564349,Term 14,16610664455,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 16,54853570065,Term 15,68553775070,Term 14,81445694780,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주지분,Term 16,54853570065,Term 15,68553775070,Term 14,81445694780,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,연결재무제표 [member],Term 16,54853570065,Term 15,68553775070,Term 14,81445694780,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,주식발행,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 16,17134500,Term 15,,Term 14,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,주식발행,자본 [member]|지배기업의 소유주지분,Term 16,7796197500,Term 15,,Term 14,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,주식발행,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 16,7779063000,Term 15,,Term 14,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,주식발행,연결재무제표 [member],Term 16,7796197500,Term 15,,Term 14,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식처분,자본 [member]|지배기업의 소유주지분,Term 16,115817520000,Term 15,,Term 14,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식처분,연결재무제표 [member],Term 16,115817520000,Term 15,,Term 14,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식처분,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 16,101259270904,Term 15,,Term 14,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식처분,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 16,14558249096,Term 15,,Term 14,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식취득,자본 [member]|지배기업의 소유주지분,Term 16,-18685151180,Term 15,,Term 14,-100007515900,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식취득,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 16,-18685151180,Term 15,,Term 14,-100007515900,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식취득,연결재무제표 [member],Term 16,-18685151180,Term 15,,Term 14,-100007515900,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,연결재무제표 [member],Term 16,48557055641,Term 15,,Term 14,3037356616,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 16,-1430107868,Term 15,,Term 14,,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 16,49987163509,Term 15,,Term 14,3037356616,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분,Term 16,48557055641,Term 15,,Term 14,3037356616,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배주주의 유상증자,연결재무제표 [member],Term 16,,Term 15,,Term 14,250000000,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배주주의 유상증자,자본 [member]|비지배주주지분,Term 16,,Term 15,,Term 14,250000000,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,연결재무제표 [member],Term 16,16053528437,Term 15,,Term 14,-458065234,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 16,,Term 15,,Term 14,-458065234,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분,Term 16,16053528437,Term 15,,Term 14,-458065234,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 16,16053528437,Term 15,,Term 14,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 16,34525294500,Term 15,34508160000,Term 14,34508160000,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 16,3937774554979,Term 15,3847747137435,Term 14,3873789578852,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 16,11879036721,Term 15,-20278648131,Term 14,-24678605598,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 16,-19004134338,Term 15,-117631782499,Term 14,-117631782499,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 16,720480827092,Term 15,712701764092,Term 14,712701764092,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|비지배주주지분,Term 16,-16708527993,Term 15,-3456300758,Term 14,9344274222,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 16,4744299877622,Term 15,4464397744195,Term 14,4498840803125,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 16,75352826661,Term 15,10807414056,Term 14,10807414056,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분,Term 16,4761008405615,Term 15,4467854044953,Term 14,4489496528903,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 16,2018526858100,Term 15,1825732428259,Term 14,1803063670498,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 16,537693630647,Term 15,793728286323,Term 14,673580375450,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_ShortTermDepositsNotClassifiedAsCashEquivalents,금융기관예치금,-,Term 16,101825500000,Term 15,57882300000,Term 14,70600000000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognition,당기손익-공정가치금융자산,-,Term 16,490839332272,Term 15,166463243160,Term 14,137522926040,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_ShortTermTradeReceivable,매출채권,-,Term 16,295769466239,Term 15,283770117119,Term 14,365884445662,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,기타수취채권,-,Term 16,41647242846,Term 15,24723686702,Term 14,32485367549,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 16,3330887323,Term 15,19235955917,Term 14,4014569938,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 16,50130929669,Term 15,65445877705,Term 14,66386913917,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 16,493223642997,Term 15,414482961333,Term 14,452589071942,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners,매각예정자산,-,Term 16,4066226107,Term 15,,Term 14,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 16,4098187074812,Term 15,3876185747488,Term 14,4185944120149,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_LongTermDepositsNotClassifiedAsCashEquivalents,금융기관예치금,-,Term 16,19512730100,Term 15,17556864840,Term 14,16425521080,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentReceivablesGross,기타수취채권,-,Term 16,115162575008,Term 15,100546922493,Term 14,145164887090,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognition,당기손익-공정가치금융자산,-,Term 16,104256383649,Term 15,1128984127,Term 14,4118831930,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtAmortisedCost,상각후원가측정금융자산,-,Term 16,811274982,Term 15,2125074983,Term 14,2131335000,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산,-,Term 16,4672325200,Term 15,705503210,Term 14,1113546260,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 16,2541362150975,Term 15,2566328198231,Term 14,2661841508240,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 16,534228580408,Term 15,488815300039,Term 14,493010504975,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 16,146465714306,Term 15,227453263601,Term 14,432396245094,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 16,201680029794,Term 15,208773970177,Term 14,226517106409,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_InvestmentsInAssociates,관계기업주식,-,Term 16,238445368790,Term 15,52514140370,Term 14,2160253079,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,-Standard account code not used-,순확정급여자산,-,Term 16,94729521034,Term 15,110633427860,Term 14,106098704183,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 16,84608399877,Term 15,82890358531,Term 14,72704996238,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_OtherNonCurrentAssets,기타비유동자산,-,Term 16,12252020689,Term 15,16713739026,Term 14,22260680571,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 16,6116713932912,Term 15,5701918175747,Term 14,5989007790647,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 16,1157485393842,Term 15,965946712547,Term 14,1066567435582,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_ShortTermTradePayables,매입채무,-,Term 16,123410292397,Term 15,117617730697,Term 14,172459191473,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 16,199124082671,Term 15,154160189044,Term 14,99346553098,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,기타지급채무,-,Term 16,324998426639,Term 15,275762504709,Term 14,264808700940,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 16,89962740389,Term 15,6097005496,Term 14,67399350946,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_CurrentContractLiabilities,계약부채,-,Term 16,37465486262,Term 15,42275345834,Term 14,50058558388,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_CurrentProvisions,기타충당부채,-,Term 16,8906185258,Term 15,8652202062,Term 14,12871685529,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,리스유동부채,-,Term 16,94760913961,Term 15,132867105541,Term 14,197591533621,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 16,278857266265,Term 15,228514629164,Term 14,202031861587,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 16,214928661448,Term 15,271573719005,Term 14,423599551940,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,-Standard account code not used-,순확정급여부채,-,Term 16,4059129237,Term 15,3831674238,Term 14,3424822481,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 16,79488075447,Term 15,90075514181,Term 14,101731472413,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,기타충당부채,-,Term 16,11556811260,Term 15,18617523307,Term 14,19135594489,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,리스비유동부채,-,Term 16,96221153680,Term 15,133748488854,Term 14,267922153243,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 16,23603491824,Term 15,25300518425,Term 14,31385509314,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 16,1372414055290,Term 15,1237520431552,Term 14,1490166987522,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업의 소유주에게 귀속되는 자본,-,Term 16,4761008405615,Term 15,4467854044953,Term 14,4489496528903,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 16,34525294500,Term 15,34508160000,Term 14,34508160000,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_SharePremium,주식발행초과금,-,Term 16,720480827092,Term 15,712701764092,Term 14,712701764092,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 16,75352826661,Term 15,10807414056,Term 14,10807414056,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본구성요소,-,Term 16,-19004134338,Term 15,-117631782499,Term 14,-117631782499,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 16,11879036721,Term 15,-20278648131,Term 14,-24678605598,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 16,3937774554979,Term 15,3847747137435,Term 14,3873789578852,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배주주지분,-,Term 16,-16708527993,Term 15,-3456300758,Term 14,9344274222,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 16,4744299877622,Term 15,4464397744195,Term 14,4498840803125,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채와 자본총계,-,Term 16,6116713932912,Term 15,5701918175747,Term 14,5989007790647,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 16,4863128496699,Term 15,4432179039394,Term 14,5580142192519,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 16,1362639202428,Term 15,1265398064748,Term 14,1500515578424,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 16,3500489294271,Term 15,3166780974646,Term 14,4079626614095,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 16,3157131485221,Term 15,3023771855339,Term 14,3651792017591,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익,-,Term 16,343357809050,Term 15,143009119307,Term 14,427834596504,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 16,10499109599,Term 15,11882548495,Term 14,14739081054,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 16,11410260207,Term 15,17026833385,Term 14,19976729196,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,dart_OtherGains,기타영업외손익,-,Term 16,-45496828367,Term 15,-113231972208,Term 14,-51693123255,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,관계기업손익,-,Term 16,927626457,Term 15,660159537,Term 14,-301604380,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 16,297877456532,Term 15,25293021746,Term 14,370602220727,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 16,117019762555,Term 15,3424010057,Term 14,146841192961,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익,-,Term 16,180857693977,Term 15,21869011689,Term 14,223761027766,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 16,193680578727,Term 15,35132159662,Term 14,238804191604,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배주주지분,-,Term 16,-12822884750,Term 15,-13263147973,Term 14,-15043163838,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,세후기타포괄손익,-,Term 16,-15641140883,Term 15,12241704451,Term 14,7286612210,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,-,Term 16,-47369483250,Term 15,7379173991,Term 14,-8917300059,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치금융자산 평가손익,-,Term 16,109285659,Term 15,-306779895,Term 14,-425735392,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnHedgesOfNetInvestmentsInForeignOperationsNetOfTax,관계기업기타포괄손익지분,-,Term 16,260637659,Term 15,141746006,Term 14,18983206,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업환산손익,-,Term 16,31358419049,Term 15,5027564349,Term 14,16610664455,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,당기총포괄이익,-,Term 16,165216553094,Term 15,34110716140,Term 14,231047639976,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 16,178468780329,Term 15,46911291120,Term 14,246323873960,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배주주지분,-,Term 16,-13252227235,Term 15,-12800574980,Term 14,-15276233984,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주기본주당순이익,-,Term 16,2820,Term 15,512,Term 14,3477,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,보통주희석주당순이익,-,Term 16,2818,Term 15,512,Term 14,3477,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,우선주기본주당순이익,-,Term 16,2821,Term 15,517,Term 14,3490,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,우선주희석주당순이익,-,Term 16,2821,Term 15,517,Term 14,3490,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동으로 인한 현금흐름,-,Term 16,691434410702,Term 15,554358724380,Term 14,718300781333,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업으로부터 창출된 현금흐름,-,Term 16,714854553223,Term 15,670456654579,Term 14,857524382916,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 16,4026044240,Term 15,4028241642,Term 14,10135538607,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자의 지급,-,Term 16,9899193484,Term 15,16008008153,Term 14,18049090334,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세의 납부,-,Term 16,17546993277,Term 15,104118163688,Term 14,131310049856,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동으로 인한 현금흐름,-,Term 16,-708415251302,Term 15,-206408840887,Term 14,-403233395816,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfShortTermFinancialInstruments,유동성 금융기관예치금의 순감소,-,Term 16,,Term 15,12162100000,Term 14,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익공정가치금융자산의？감소,-,Term 16,1184085953,Term 15,2991229925,Term 14,,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfLoansAndReceivables,기타수취채권의 감소,-,Term 16,31526378078,Term 15,45815639463,Term 14,7616143350,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfLongTermFinancialInstruments,비유동성 금융기관예치금의 감소,-,Term 16,,Term 15,353988000,Term 14,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherNonCurrentFinancialAssets,상각후원가측정금융자산의 처분,-,Term 16,1313800001,Term 15,6260017,Term 14,31484000000,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,-Standard account code not used-,기타포괄손익-공정가치금융자산의 처분,-,Term 16,,Term 15,,Term 14,1070751960,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 16,3276022744,Term 15,24769903712,Term 14,27798931056,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 16,414580271,Term 15,349269754,Term 14,2517072752,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 16,4226483920,Term 15,,Term 14,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsInvestingActivities,관계기업으로부터의 배당금수익,-,Term 16,,Term 15,3750046,Term 14,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,-Standard account code not used-,사업결합 등으로 인한 순현금유입,-,Term 16,44874437795,Term 15,,Term 14,,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,-Standard account code not used-,기타의 현금유입액,-,Term 16,11434877000,Term 15,,Term 14,5110503360,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_PurchaseOfShortTermFinancialInstruments,유동성 금융기관예치금의 순증가,-,Term 16,43094000000,Term 15,,Term 14,55439000000,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익공정가치금융자산의 증가,-,Term 16,425223672742,Term 15,23523394856,Term 14,136299644042,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_PurchaseOfAvailableForSaleFinancialAssets,기타포괄손익공정가치금융자산의 취득,-,Term 16,3000080160,Term 15,,Term 14,,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_PurchaseOfLoansAndReceivables,기타수취채권의 증가,-,Term 16,29564010651,Term 15,3826463221,Term 14,4137112924,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_PurchaseOfLongTermFinancialInstruments,비유동성 금융기관예치금의 증가,-,Term 16,1503002760,Term 15,1500002760,Term 14,1500002760,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,-Standard account code not used-,상각후원가측정금융자산의 취득,-,Term 16,,Term 15,,Term 14,11955000,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 16,91182844178,Term 15,183021787650,Term 14,246549723931,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 16,29815783627,Term 15,31983791822,Term 14,34863960005,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,-Standard account code not used-,사용권자산의 증가,-,Term 16,26671000,Term 15,2269650,Term 14,29399632,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_PurchaseOfInvestmentsInAssociates,관계기업투자주식의 증가,-,Term 16,183255851946,Term 15,49003271845,Term 14,,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동으로 인한 현금흐름,-,Term 16,-225980969342,Term 15,-215987303706,Term 14,-387437264460,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 증가,-,Term 16,17070110907,Term 15,110605478453,Term 14,12048075210,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_IncreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 수취,-,Term 16,5297434200,Term 15,578239965,Term 14,,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,-Standard account code not used-,비지배주주의 유상증자,-,Term 16,,Term 15,,Term 14,250000000,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 감소,-,Term 16,33166492045,Term 15,49138368262,Term 14,32682146763,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_AcquisitionOfTreasuryShares,자사주 매입,-,Term 16,18685151180,Term 15,,Term 14,100007515900,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_PaymentsOfFinanceLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 상환,-,Term 16,140273953288,Term 15,206758281113,Term 14,185628639922,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금의 지급,-,Term 16,54834267960,Term 15,68530023595,Term 14,81417037085,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_DecreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 반환,-,Term 16,1388649976,Term 15,2744349154,Term 14,,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,외화환산으로 인한 현금의 증감,-,Term 16,-13072845734,Term 15,-11814668914,Term 14,10439616452,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalents,현금및현금성자산의 증감,-,Term 16,-256034655676,Term 15,120147910873,Term 14,-61930262491,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초의 현금및현금성자산,-,Term 16,793728286323,Term 15,673580375450,Term 14,735510637941,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말의 현금및현금성자산,-,Term 16,537693630647,Term 15,793728286323,Term 14,673580375450,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 16,-117631782499,Term 15,-117631782499,Term 14,-17624266599,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분,Term 16,4467854044953,Term 15,4489496528903,Term 14,4422046574241,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 16,712701764092,Term 15,712701764092,Term 14,712701764092,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 16,10807414056,Term 15,10807414056,Term 14,7770057440,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배주주지분,Term 16,-3456300758,Term 15,9344274222,Term 14,24370508206,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 16,3847747137435,Term 15,3873789578852,Term 14,3726002772481,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 16,-20278648131,Term 15,-24678605598,Term 14,-41311913173,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 16,4464397744195,Term 15,4498840803125,Term 14,4446417082447,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 16,34508160000,Term 15,34508160000,Term 14,34508160000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,연결재무제표 [member],Term 16,180857693977,Term 15,21869011689,Term 14,223761027766,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주지분,Term 16,193680578727,Term 15,35132159662,Term 14,238804191604,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|비지배주주지분,Term 16,-12822884750,Term 15,-13263147973,Term 14,-15043163838,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 16,193680578727,Term 15,35132159662,Term 14,238804191604,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 16,-47369483250,Term 15,7379173991,Term 14,-8917300059,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주지분,Term 16,-47369483250,Term 15,7379173991,Term 14,-8917300059,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,연결재무제표 [member],Term 16,-47369483250,Term 15,7379173991,Term 14,-8917300059,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 16,109285659,Term 15,-306779895,Term 14,-425735392,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,자본 [member]|지배기업의 소유주지분,Term 16,109285659,Term 15,-306779895,Term 14,-425735392,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산평가손익,연결재무제표 [member],Term 16,109285659,Term 15,-306779895,Term 14,-425735392,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익-공정가치금융자산처분,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 16,,Term 15,,Term 14,-196325160,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익-공정가치금융자산처분,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 16,,Term 15,,Term 14,196325160,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주지분,Term 16,255539339,Term 15,127571405,Term 14,17084885,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|비지배주주지분,Term 16,5098320,Term 15,14174601,Term 14,1898321,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 16,255539339,Term 15,127571405,Term 14,17084885,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,연결재무제표 [member],Term 16,260637659,Term 15,141746006,Term 14,18983206,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 16,31792859854,Term 15,4579165957,Term 14,16845632922,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주지분,Term 16,31792859854,Term 15,4579165957,Term 14,16845632922,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|비지배주주지분,Term 16,-434440805,Term 15,448398392,Term 14,-234968467,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,연결재무제표 [member],Term 16,31358419049,Term 15,5027564349,Term 14,16610664455,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 16,54853570065,Term 15,68553775070,Term 14,81445694780,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주지분,Term 16,54853570065,Term 15,68553775070,Term 14,81445694780,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,연결재무제표 [member],Term 16,54853570065,Term 15,68553775070,Term 14,81445694780,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,주식발행,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 16,17134500,Term 15,,Term 14,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,주식발행,자본 [member]|지배기업의 소유주지분,Term 16,7796197500,Term 15,,Term 14,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,주식발행,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 16,7779063000,Term 15,,Term 14,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,주식발행,연결재무제표 [member],Term 16,7796197500,Term 15,,Term 14,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식처분,자본 [member]|지배기업의 소유주지분,Term 16,115817520000,Term 15,,Term 14,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식처분,연결재무제표 [member],Term 16,115817520000,Term 15,,Term 14,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식처분,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 16,101259270904,Term 15,,Term 14,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식처분,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 16,14558249096,Term 15,,Term 14,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식취득,자본 [member]|지배기업의 소유주지분,Term 16,-18685151180,Term 15,,Term 14,-100007515900,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식취득,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 16,-18685151180,Term 15,,Term 14,-100007515900,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식취득,연결재무제표 [member],Term 16,-18685151180,Term 15,,Term 14,-100007515900,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,연결재무제표 [member],Term 16,48557055641,Term 15,,Term 14,3037356616,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 16,-1430107868,Term 15,,Term 14,,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 16,49987163509,Term 15,,Term 14,3037356616,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주지분,Term 16,48557055641,Term 15,,Term 14,3037356616,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배주주의 유상증자,연결재무제표 [member],Term 16,,Term 15,,Term 14,250000000,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배주주의 유상증자,자본 [member]|비지배주주지분,Term 16,,Term 15,,Term 14,250000000,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,연결재무제표 [member],Term 16,16053528437,Term 15,,Term 14,-458065234,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 16,,Term 15,,Term 14,-458065234,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분,Term 16,16053528437,Term 15,,Term 14,-458065234,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 16,16053528437,Term 15,,Term 14,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|자본금 [member],Term 16,34525294500,Term 15,34508160000,Term 14,34508160000,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|이익잉여금 [member],Term 16,3937774554979,Term 15,3847747137435,Term 14,3873789578852,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|기타포괄손익누계액 [member],Term 16,11879036721,Term 15,-20278648131,Term 14,-24678605598,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|기타자본구성요소 [member],Term 16,-19004134338,Term 15,-117631782499,Term 14,-117631782499,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|주식발행초과금,Term 16,720480827092,Term 15,712701764092,Term 14,712701764092,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|비지배주주지분,Term 16,-16708527993,Term 15,-3456300758,Term 14,9344274222,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 16,4744299877622,Term 15,4464397744195,Term 14,4498840803125,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분|자본잉여금 [member],Term 16,75352826661,Term 15,10807414056,Term 14,10807414056,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20220316000772,11011,2021,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주지분,Term 16,4761008405615,Term 15,4467854044953,Term 14,4489496528903,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 17,1735019347862,Term 16,2018526858100,Term 15,1825732428259,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 17,449597948392,Term 16,537693630647,Term 15,793728286323,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_ShortTermDepositsNotClassifiedAsCashEquivalents,금융기관예치금,-,Term 17,74669238000,Term 16,101825500000,Term 15,57882300000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognition,당기손익-공정가치측정금융자산,-,Term 17,362939892414,Term 16,490839332272,Term 15,166463243160,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CurrentFinancialAssetsAtAmortisedCost,상각후원가측정금융자산,-,Term 17,30000000000,Term 16,,Term 15,,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_ShortTermTradeReceivable,매출채권,-,Term 17,285104514893,Term 16,295769466239,Term 15,283770117119,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,기타수취채권,-,Term 17,62646902451,Term 16,41647242846,Term 15,24723686702,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 17,1589648122,Term 16,3330887323,Term 15,19235955917,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 17,39587746609,Term 16,50130929669,Term 15,65445877705,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 17,408934396533,Term 16,493223642997,Term 15,414482961333,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners,매각예정비유동자산,-,Term 17,19949060448,Term 16,4066226107,Term 15,,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 17,4066763830297,Term 16,4098187074812,Term 15,3876185747488,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_LongTermDepositsNotClassifiedAsCashEquivalents,금융기관예치금,-,Term 17,21989149194,Term 16,19512730100,Term 15,17556864840,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentReceivablesGross,기타수취채권,-,Term 17,66737893651,Term 16,115162575008,Term 15,100546922493,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognition,당기손익-공정가치측정금융자산,-,Term 17,8017318251,Term 16,104256383649,Term 15,1128984127,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtAmortisedCost,상각후원가측정금융자산,-,Term 17,430315000,Term 16,811274982,Term 15,2125074983,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산,-,Term 17,6216765880,Term 16,4672325200,Term 15,705503210,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 17,2475276690492,Term 16,2541362150975,Term 15,2566328198231,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 17,357750954252,Term 16,201680029794,Term 15,208773970177,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 17,503268138559,Term 16,534228580408,Term 15,488815300039,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 17,128492275394,Term 16,146465714306,Term 15,227453263601,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_InvestmentsInAssociates,관계기업투자주식,-,Term 17,247279224799,Term 16,238445368790,Term 15,52514140370,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,-Standard account code not used-,순확정급여자산,-,Term 17,181406890326,Term 16,94729521034,Term 15,110633427860,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 17,57853971328,Term 16,84608399877,Term 15,82890358531,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_OtherNonCurrentAssets,기타비유동자산,-,Term 17,12044243171,Term 16,12252020689,Term 15,16713739026,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 17,5801783178159,Term 16,6116713932912,Term 15,5701918175747,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 17,831116935949,Term 16,1157485393842,Term 15,965946712547,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_ShortTermTradePayables,매입채무,-,Term 17,80676210540,Term 16,123410292397,Term 15,117617730697,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 17,223413563558,Term 16,199124082671,Term 15,154160189044,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,기타지급채무,-,Term 17,154937768894,Term 16,324998426639,Term 15,275762504709,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 17,41108987667,Term 16,89962740389,Term 15,6097005496,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CurrentContractLiabilities,계약부채,-,Term 17,36625353980,Term 16,37465486262,Term 15,42275345834,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CurrentProvisions,기타충당부채,-,Term 17,30597338613,Term 16,8906185258,Term 15,8652202062,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,리스유동부채,-,Term 17,69006139263,Term 16,94760913961,Term 15,132867105541,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 17,194751573434,Term 16,278857266265,Term 15,228514629164,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 17,191391138151,Term 16,214928661448,Term 15,271573719005,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,-Standard account code not used-,순확정급여부채,-,Term 17,4377774564,Term 16,4059129237,Term 15,3831674238,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 17,91265971878,Term 16,79488075447,Term 15,90075514181,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,기타충당부채,-,Term 17,9469113472,Term 16,11556811260,Term 15,18617523307,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,리스비유동부채,-,Term 17,64785225166,Term 16,96221153680,Term 15,133748488854,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 17,21493053071,Term 16,23603491824,Term 15,25300518425,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 17,1022508074100,Term 16,1372414055290,Term 15,1237520431552,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업의 소유주에게 귀속되는 자본,-,Term 17,4798613296098,Term 16,4761008405615,Term 15,4467854044953,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 17,34525294500,Term 16,34525294500,Term 15,34508160000,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_SharePremium,주식발행초과금,-,Term 17,720480827092,Term 16,720480827092,Term 15,712701764092,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 17,71118560015,Term 16,75352826661,Term 15,10807414056,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본구성요소,-,Term 17,-18139434036,Term 16,-19004134338,Term 15,-117631782499,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 17,-19458512997,Term 16,11879036721,Term 15,-20278648131,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 17,4010086561524,Term 16,3937774554979,Term 15,3847747137435,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배주주지분,-,Term 17,-19338192039,Term 16,-16708527993,Term 15,-3456300758,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 17,4779275104059,Term 16,4744299877622,Term 15,4464397744195,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채와 자본총계,-,Term 17,5801783178159,Term 16,6116713932912,Term 15,5701918175747,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 17,4134932512111,Term 16,4863128496699,Term 15,4432179039394,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 17,1337512406849,Term 16,1362639202428,Term 15,1265398064748,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 17,2797420105262,Term 16,3500489294271,Term 15,3166780974646,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 17,2583186849501,Term 16,3157131485221,Term 15,3023771855339,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익,-,Term 17,214233255761,Term 16,343357809050,Term 15,143009119307,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 17,22771702594,Term 16,10499109599,Term 15,11882548495,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 17,34413883142,Term 16,11410260207,Term 15,17026833385,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,dart_OtherGains,기타영업외손익,-,Term 17,13044673857,Term 16,-45496828367,Term 15,-113231972208,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,관계기업손익,-,Term 17,8858020099,Term 16,927626457,Term 15,660159537,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 17,224493769169,Term 16,297877456532,Term 15,25293021746,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 17,95229524211,Term 16,117019762555,Term 15,3424010057,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 17,129264244958,Term 16,180857693977,Term 15,21869011689,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 17,134474812450,Term 16,193680578727,Term 15,35132159662,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배주주지분,-,Term 17,-5210567492,Term 16,-12822884750,Term 15,-13263147973,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,-,Term 17,5482640916,Term 16,-47369483250,Term 15,7379173991,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정금융자산 평가손익,-,Term 17,-31630608,Term 16,109285659,Term 15,-306779895,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnHedgesOfNetInvestmentsInForeignOperationsNetOfTax,관계기업기타포괄손익지분,-,Term 17,-606664733,Term 16,260637659,Term 15,141746006,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업환산손익,-,Term 17,-31891807328,Term 16,31358419049,Term 15,5027564349,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,당기법인세비용차감후기타포괄손익,-,Term 17,-27047461753,Term 16,-15641140883,Term 15,12241704451,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,당기총포괄손익,-,Term 17,102216783205,Term 16,165216553094,Term 15,34110716140,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업의 소유주지분,-,Term 17,108599005752,Term 16,178468780329,Term 15,46911291120,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배주주지분,-,Term 17,-6382222547,Term 16,-13252227235,Term 15,-12800574980,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주기본주당이익,-,Term 17,1949,Term 16,2820,Term 15,512,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,보통주희석주당이익,-,Term 17,1948,Term 16,2818,Term 15,512,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,우선주기본주당이익,-,Term 17,1954,Term 16,2821,Term 15,517,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,우선주희석주당이익,-,Term 17,1954,Term 16,2821,Term 15,517,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동으로 인한 현금흐름,-,Term 17,151023730340,Term 16,691434410702,Term 15,554358724380,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업으로부터 창출된 현금흐름,-,Term 17,281138081103,Term 16,714854553223,Term 15,670456654579,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 17,6274261744,Term 16,4026044240,Term 15,4028241642,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자의 지급,-,Term 17,11472337649,Term 16,9899193484,Term 15,16008008153,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세의 납부,-,Term 17,124916274858,Term 16,17546993277,Term 15,104118163688,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동으로 인한 현금흐름,-,Term 17,-68513788688,Term 16,-708415251302,Term 15,-206408840887,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfShortTermFinancialInstruments,유동성 금융기관예치금의 순감소,-,Term 17,27325462000,Term 16,,Term 15,12162100000,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfCurrentFairValueFinancialAsset,유동성 당기손익-공정가치측정금융자산의 감소,-,Term 17,232549103448,Term 16,,Term 15,2991229925,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherNonCurrentFinancialAssets,상각후원가측정금융자산의 처분,-,Term 17,460580082,Term 16,1313800001,Term 15,6260017,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfLongTermFinancialInstruments,비유동성 금융기관예치금의 순감소,-,Term 17,,Term 16,,Term 15,353988000,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherCurrentFinancialAssets,기타포괄손익-공정가치측정금융자산의 처분,-,Term 17,730010465,Term 16,,Term 15,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfLoansAndReceivables,기타수취채권의 감소,-,Term 17,28546250251,Term 16,31526378078,Term 15,45815639463,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 17,4018992178,Term 16,3276022744,Term 15,24769903712,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 17,68619860,Term 16,414580271,Term 15,349269754,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 17,3105500000,Term 16,4226483920,Term 15,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfNonCurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정비유동자산의 처분,-,Term 17,6246100000,Term 16,,Term 15,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합 등으로 인한 순현금유입,-,Term 17,,Term 16,44874437795,Term 15,,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,-Standard account code not used-,관계기업으로부터의 배당금수익,-,Term 17,,Term 16,,Term 15,3750046,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities,기타의 현금유입액,-,Term 17,,Term 16,11434877000,Term 15,,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_PurchaseOfShortTermFinancialInstruments,유동성 금융기관예치금의 순증가,-,Term 17,,Term 16,43094000000,Term 15,,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_PurchaseOfCurrentFairValueFinancialAsset,유동성 당기손익-공정가치측정금융자산의 증가,-,Term 17,,Term 16,320522606869,Term 15,23523394856,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_PurchaseOfOtherNonCurrentFinancialAssets,유동성 상각후원가측정금융자산의 순증가,-,Term 17,30000000000,Term 16,,Term 15,,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_PurchaseOfLongTermFinancialInstruments,비유동성 금융기관예치금의 증가,-,Term 17,1500002760,Term 16,1503002760,Term 15,1500002760,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_PurchaseOfNonCurrentFairValueFinancialAsset,비유동성 당기손익-공정가치측정금융자산의 증가,-,Term 17,16917338331,Term 16,103516979920,Term 15,,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_PurchaseOfOtherCurrentFinancialAssets,기타포괄손익-공정가치측정금융자산의 취득,-,Term 17,2500004160,Term 16,3000080160,Term 15,,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_PurchaseOfLoansAndReceivables,기타수취채권의 증가,-,Term 17,10071148219,Term 16,29564010651,Term 15,3826463221,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 17,99289990911,Term 16,91182844178,Term 15,183021787650,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 17,35575628339,Term 16,29815783627,Term 15,31983791822,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,-Standard account code not used-,사용권자산의 증가,-,Term 17,125343250,Term 16,26671000,Term 15,2269650,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_PurchaseOfInvestmentsInAssociates,관계기업투자주식의 증가,-,Term 17,,Term 16,183255851946,Term 15,49003271845,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합 등으로 인한 순현금유출,-,Term 17,175584951002,Term 16,,Term 15,,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동으로 인한 현금흐름,-,Term 17,-154550827468,Term 16,-225980969342,Term 15,-215987303706,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 증가,-,Term 17,45369950991,Term 16,17070110907,Term 15,110605478453,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_IncreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 수취,-,Term 17,2012976000,Term 16,5297434200,Term 15,578239965,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금의 지급,-,Term 17,68147576757,Term 16,54834267960,Term 15,68530023595,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 감소,-,Term 17,22790212000,Term 16,33166492045,Term 15,49138368262,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_PaymentsOfFinanceLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 상환,-,Term 17,105600934697,Term 16,140273953288,Term 15,206758281113,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_AcquisitionOfTreasuryShares,자기주식의 취득,-,Term 17,2484434450,Term 16,18685151180,Term 15,,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_DecreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 반환,-,Term 17,2910596555,Term 16,1388649976,Term 15,2744349154,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,외화환산으로 인한 현금및현금성자산의 증감,-,Term 17,-16054796439,Term 16,-13072845734,Term 15,-11814668914,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalents,현금및현금성자산의 순증감,-,Term 17,-88095682255,Term 16,-256034655676,Term 15,120147910873,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초의 현금및현금성자산,-,Term 17,537693630647,Term 16,793728286323,Term 15,673580375450,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말의 현금및현금성자산,-,Term 17,449597948392,Term 16,537693630647,Term 15,793728286323,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 17,4744299877622,Term 16,4464397744195,Term 15,4498840803125,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배지분 [member],Term 17,-16708527993,Term 16,-3456300758,Term 15,9344274222,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,4761008405615,Term 16,4467854044953,Term 15,4489496528903,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본구성요소 [member],Term 17,-19004134338,Term 16,-117631782499,Term 15,-117631782499,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|주식발행초과금,Term 17,720480827092,Term 16,712701764092,Term 15,712701764092,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 17,3937774554979,Term 16,3847747137435,Term 15,3873789578852,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 17,34525294500,Term 16,34508160000,Term 15,34508160000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 17,75352826661,Term 16,10807414056,Term 15,10807414056,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 17,11879036721,Term 16,-20278648131,Term 15,-24678605598,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,134474812450,Term 16,193680578727,Term 15,35132159662,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 17,134474812450,Term 16,193680578727,Term 15,35132159662,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 17,129264244958,Term 16,180857693977,Term 15,21869011689,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|비지배지분 [member],Term 17,-5210567492,Term 16,-12822884750,Term 15,-13263147973,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,연결재무제표 [member],Term 17,5482640916,Term 16,-47369483250,Term 15,7379173991,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,5482640916,Term 16,-47369483250,Term 15,7379173991,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 17,5482640916,Term 16,-47369483250,Term 15,7379173991,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산 평가손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 17,-31630608,Term 16,109285659,Term 15,-306779895,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산 평가손익,연결재무제표 [member],Term 17,-31630608,Term 16,109285659,Term 15,-306779895,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산 평가손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,-31630608,Term 16,109285659,Term 15,-306779895,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타포괄손익-공정가치측정금융자산 처분에 따른 대체,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 17,-20897896,Term 16,,Term 15,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타포괄손익-공정가치측정금융자산 처분에 따른 대체,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 17,20897896,Term 16,,Term 15,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 17,-576187970,Term 16,255539339,Term 15,127571405,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,-576187970,Term 16,255539339,Term 15,127571405,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|비지배지분 [member],Term 17,-30476763,Term 16,5098320,Term 15,14174601,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,연결재무제표 [member],Term 17,-606664733,Term 16,260637659,Term 15,141746006,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,-30750629036,Term 16,31792859854,Term 15,4579165957,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|비지배지분 [member],Term 17,-1141178292,Term 16,-434440805,Term 15,448398392,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,연결재무제표 [member],Term 17,-31891807328,Term 16,31358419049,Term 15,5027564349,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 17,-30750629036,Term 16,31792859854,Term 15,4579165957,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 17,67624548925,Term 16,54853570065,Term 15,68553775070,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|비지배지분 [member],Term 17,546646607,Term 16,,Term 15,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,67624548925,Term 16,54853570065,Term 15,68553775070,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,연결재무제표 [member],Term 17,68171195532,Term 16,54853570065,Term 15,68553775070,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,주식발행,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 17,,Term 16,17134500,Term 15,,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,주식발행,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|주식발행초과금,Term 17,,Term 16,7779063000,Term 15,,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,주식발행,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,,Term 16,7796197500,Term 15,,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,주식발행,연결재무제표 [member],Term 17,,Term 16,7796197500,Term 15,,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식처분,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,10247005000,Term 16,115817520000,Term 15,,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식처분,연결재무제표 [member],Term 17,10247005000,Term 16,115817520000,Term 15,,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식처분,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 17,64938462,Term 16,14558249096,Term 15,,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식처분,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본구성요소 [member],Term 17,10182066538,Term 16,101259270904,Term 15,,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식취득,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,,Term 16,-18685151180,Term 15,,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식취득,연결재무제표 [member],Term 17,,Term 16,-18685151180,Term 15,,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식취득,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본구성요소 [member],Term 17,,Term 16,-18685151180,Term 15,,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,-4299205108,Term 16,,Term 15,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [member]|비지배지분 [member],Term 17,4299205108,Term 16,,Term 15,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 17,-4299205108,Term 16,,Term 15,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 17,,Term 16,49987163509,Term 15,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 17,,Term 16,-1430107868,Term 15,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,연결재무제표 [member],Term 17,,Term 16,48557055641,Term 15,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,,Term 16,48557055641,Term 15,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식기준보상,연결재무제표 [member],Term 17,-9317366236,Term 16,,Term 15,,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식기준보상,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본구성요소 [member],Term 17,-9317366236,Term 16,,Term 15,,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식기준보상,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,-9317366236,Term 16,,Term 15,,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본구성요소 [member],Term 17,,Term 16,16053528437,Term 15,,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,,Term 16,16053528437,Term 15,,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,연결재무제표 [member],Term 17,,Term 16,16053528437,Term 15,,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 17,-19458512997,Term 16,11879036721,Term 15,-20278648131,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본구성요소 [member],Term 17,-18139434036,Term 16,-19004134338,Term 15,-117631782499,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 17,4010086561524,Term 16,3937774554979,Term 15,3847747137435,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|비지배지분 [member],Term 17,-19338192039,Term 16,-16708527993,Term 15,-3456300758,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 17,4779275104059,Term 16,4744299877622,Term 15,4464397744195,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|주식발행초과금,Term 17,720480827092,Term 16,720480827092,Term 15,712701764092,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 17,71118560015,Term 16,75352826661,Term 15,10807414056,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 17,34525294500,Term 16,34525294500,Term 15,34508160000,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,4798613296098,Term 16,4761008405615,Term 15,4467854044953,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 17,1735019347862,Term 16,2018526858100,Term 15,1825732428259,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 17,449597948392,Term 16,537693630647,Term 15,793728286323,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_ShortTermDepositsNotClassifiedAsCashEquivalents,금융기관예치금,-,Term 17,74669238000,Term 16,101825500000,Term 15,57882300000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognition,당기손익-공정가치측정금융자산,-,Term 17,362939892414,Term 16,490839332272,Term 15,166463243160,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CurrentFinancialAssetsAtAmortisedCost,상각후원가측정금융자산,-,Term 17,30000000000,Term 16,,Term 15,,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_ShortTermTradeReceivable,매출채권,-,Term 17,285104514893,Term 16,295769466239,Term 15,283770117119,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,기타수취채권,-,Term 17,62646902451,Term 16,41647242846,Term 15,24723686702,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 17,1589648122,Term 16,3330887323,Term 15,19235955917,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 17,39587746609,Term 16,50130929669,Term 15,65445877705,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 17,408934396533,Term 16,493223642997,Term 15,414482961333,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners,매각예정비유동자산,-,Term 17,19949060448,Term 16,4066226107,Term 15,,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 17,4066763830297,Term 16,4098187074812,Term 15,3876185747488,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_LongTermDepositsNotClassifiedAsCashEquivalents,금융기관예치금,-,Term 17,21989149194,Term 16,19512730100,Term 15,17556864840,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentReceivablesGross,기타수취채권,-,Term 17,66737893651,Term 16,115162575008,Term 15,100546922493,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognition,당기손익-공정가치측정금융자산,-,Term 17,8017318251,Term 16,104256383649,Term 15,1128984127,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtAmortisedCost,상각후원가측정금융자산,-,Term 17,430315000,Term 16,811274982,Term 15,2125074983,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산,-,Term 17,6216765880,Term 16,4672325200,Term 15,705503210,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 17,2475276690492,Term 16,2541362150975,Term 15,2566328198231,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 17,357750954252,Term 16,201680029794,Term 15,208773970177,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 17,503268138559,Term 16,534228580408,Term 15,488815300039,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 17,128492275394,Term 16,146465714306,Term 15,227453263601,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_InvestmentsInAssociates,관계기업투자주식,-,Term 17,247279224799,Term 16,238445368790,Term 15,52514140370,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,-Standard account code not used-,순확정급여자산,-,Term 17,181406890326,Term 16,94729521034,Term 15,110633427860,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 17,57853971328,Term 16,84608399877,Term 15,82890358531,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_OtherNonCurrentAssets,기타비유동자산,-,Term 17,12044243171,Term 16,12252020689,Term 15,16713739026,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 17,5801783178159,Term 16,6116713932912,Term 15,5701918175747,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 17,831116935949,Term 16,1157485393842,Term 15,965946712547,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_ShortTermTradePayables,매입채무,-,Term 17,80676210540,Term 16,123410292397,Term 15,117617730697,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 17,223413563558,Term 16,199124082671,Term 15,154160189044,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,기타지급채무,-,Term 17,154937768894,Term 16,324998426639,Term 15,275762504709,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 17,41108987667,Term 16,89962740389,Term 15,6097005496,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CurrentContractLiabilities,계약부채,-,Term 17,36625353980,Term 16,37465486262,Term 15,42275345834,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CurrentProvisions,기타충당부채,-,Term 17,30597338613,Term 16,8906185258,Term 15,8652202062,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,리스유동부채,-,Term 17,69006139263,Term 16,94760913961,Term 15,132867105541,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 17,194751573434,Term 16,278857266265,Term 15,228514629164,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 17,191391138151,Term 16,214928661448,Term 15,271573719005,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,-Standard account code not used-,순확정급여부채,-,Term 17,4377774564,Term 16,4059129237,Term 15,3831674238,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 17,91265971878,Term 16,79488075447,Term 15,90075514181,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,기타충당부채,-,Term 17,9469113472,Term 16,11556811260,Term 15,18617523307,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,리스비유동부채,-,Term 17,64785225166,Term 16,96221153680,Term 15,133748488854,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 17,21493053071,Term 16,23603491824,Term 15,25300518425,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 17,1022508074100,Term 16,1372414055290,Term 15,1237520431552,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업의 소유주에게 귀속되는 자본,-,Term 17,4798613296098,Term 16,4761008405615,Term 15,4467854044953,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 17,34525294500,Term 16,34525294500,Term 15,34508160000,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_SharePremium,주식발행초과금,-,Term 17,720480827092,Term 16,720480827092,Term 15,712701764092,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 17,71118560015,Term 16,75352826661,Term 15,10807414056,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본구성요소,-,Term 17,-18139434036,Term 16,-19004134338,Term 15,-117631782499,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 17,-19458512997,Term 16,11879036721,Term 15,-20278648131,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 17,4010086561524,Term 16,3937774554979,Term 15,3847747137435,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배주주지분,-,Term 17,-19338192039,Term 16,-16708527993,Term 15,-3456300758,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 17,4779275104059,Term 16,4744299877622,Term 15,4464397744195,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채와 자본총계,-,Term 17,5801783178159,Term 16,6116713932912,Term 15,5701918175747,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 17,4134932512111,Term 16,4863128496699,Term 15,4432179039394,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 17,1337512406849,Term 16,1362639202428,Term 15,1265398064748,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 17,2797420105262,Term 16,3500489294271,Term 15,3166780974646,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 17,2583186849501,Term 16,3157131485221,Term 15,3023771855339,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익,-,Term 17,214233255761,Term 16,343357809050,Term 15,143009119307,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 17,22771702594,Term 16,10499109599,Term 15,11882548495,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 17,34413883142,Term 16,11410260207,Term 15,17026833385,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,dart_OtherGains,기타영업외손익,-,Term 17,13044673857,Term 16,-45496828367,Term 15,-113231972208,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,관계기업손익,-,Term 17,8858020099,Term 16,927626457,Term 15,660159537,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 17,224493769169,Term 16,297877456532,Term 15,25293021746,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 17,95229524211,Term 16,117019762555,Term 15,3424010057,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 17,129264244958,Term 16,180857693977,Term 15,21869011689,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 17,134474812450,Term 16,193680578727,Term 15,35132159662,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배주주지분,-,Term 17,-5210567492,Term 16,-12822884750,Term 15,-13263147973,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,-,Term 17,5482640916,Term 16,-47369483250,Term 15,7379173991,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정금융자산 평가손익,-,Term 17,-31630608,Term 16,109285659,Term 15,-306779895,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnHedgesOfNetInvestmentsInForeignOperationsNetOfTax,관계기업기타포괄손익지분,-,Term 17,-606664733,Term 16,260637659,Term 15,141746006,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업환산손익,-,Term 17,-31891807328,Term 16,31358419049,Term 15,5027564349,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,당기법인세비용차감후기타포괄손익,-,Term 17,-27047461753,Term 16,-15641140883,Term 15,12241704451,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,당기총포괄손익,-,Term 17,102216783205,Term 16,165216553094,Term 15,34110716140,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업의 소유주지분,-,Term 17,108599005752,Term 16,178468780329,Term 15,46911291120,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배주주지분,-,Term 17,-6382222547,Term 16,-13252227235,Term 15,-12800574980,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주기본주당이익,-,Term 17,1949,Term 16,2820,Term 15,512,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,보통주희석주당이익,-,Term 17,1948,Term 16,2818,Term 15,512,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,우선주기본주당이익,-,Term 17,1954,Term 16,2821,Term 15,517,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,우선주희석주당이익,-,Term 17,1954,Term 16,2821,Term 15,517,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동으로 인한 현금흐름,-,Term 17,151023730340,Term 16,691434410702,Term 15,554358724380,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업으로부터 창출된 현금흐름,-,Term 17,281138081103,Term 16,714854553223,Term 15,670456654579,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 17,6274261744,Term 16,4026044240,Term 15,4028241642,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자의 지급,-,Term 17,11472337649,Term 16,9899193484,Term 15,16008008153,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세의 납부,-,Term 17,124916274858,Term 16,17546993277,Term 15,104118163688,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동으로 인한 현금흐름,-,Term 17,-68513788688,Term 16,-708415251302,Term 15,-206408840887,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfShortTermFinancialInstruments,유동성 금융기관예치금의 순감소,-,Term 17,27325462000,Term 16,,Term 15,12162100000,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfCurrentFairValueFinancialAsset,유동성 당기손익-공정가치측정금융자산의 감소,-,Term 17,232549103448,Term 16,,Term 15,2991229925,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherNonCurrentFinancialAssets,상각후원가측정금융자산의 처분,-,Term 17,460580082,Term 16,1313800001,Term 15,6260017,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfLongTermFinancialInstruments,비유동성 금융기관예치금의 순감소,-,Term 17,,Term 16,,Term 15,353988000,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherCurrentFinancialAssets,기타포괄손익-공정가치측정금융자산의 처분,-,Term 17,730010465,Term 16,,Term 15,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfLoansAndReceivables,기타수취채권의 감소,-,Term 17,28546250251,Term 16,31526378078,Term 15,45815639463,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 17,4018992178,Term 16,3276022744,Term 15,24769903712,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 17,68619860,Term 16,414580271,Term 15,349269754,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 17,3105500000,Term 16,4226483920,Term 15,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfNonCurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정비유동자산의 처분,-,Term 17,6246100000,Term 16,,Term 15,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합 등으로 인한 순현금유입,-,Term 17,,Term 16,44874437795,Term 15,,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,-Standard account code not used-,관계기업으로부터의 배당금수익,-,Term 17,,Term 16,,Term 15,3750046,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities,기타의 현금유입액,-,Term 17,,Term 16,11434877000,Term 15,,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_PurchaseOfShortTermFinancialInstruments,유동성 금융기관예치금의 순증가,-,Term 17,,Term 16,43094000000,Term 15,,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_PurchaseOfCurrentFairValueFinancialAsset,유동성 당기손익-공정가치측정금융자산의 증가,-,Term 17,,Term 16,320522606869,Term 15,23523394856,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_PurchaseOfOtherNonCurrentFinancialAssets,유동성 상각후원가측정금융자산의 순증가,-,Term 17,30000000000,Term 16,,Term 15,,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_PurchaseOfLongTermFinancialInstruments,비유동성 금융기관예치금의 증가,-,Term 17,1500002760,Term 16,1503002760,Term 15,1500002760,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_PurchaseOfNonCurrentFairValueFinancialAsset,비유동성 당기손익-공정가치측정금융자산의 증가,-,Term 17,16917338331,Term 16,103516979920,Term 15,,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_PurchaseOfOtherCurrentFinancialAssets,기타포괄손익-공정가치측정금융자산의 취득,-,Term 17,2500004160,Term 16,3000080160,Term 15,,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_PurchaseOfLoansAndReceivables,기타수취채권의 증가,-,Term 17,10071148219,Term 16,29564010651,Term 15,3826463221,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 17,99289990911,Term 16,91182844178,Term 15,183021787650,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 17,35575628339,Term 16,29815783627,Term 15,31983791822,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,-Standard account code not used-,사용권자산의 증가,-,Term 17,125343250,Term 16,26671000,Term 15,2269650,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_PurchaseOfInvestmentsInAssociates,관계기업투자주식의 증가,-,Term 17,,Term 16,183255851946,Term 15,49003271845,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합 등으로 인한 순현금유출,-,Term 17,175584951002,Term 16,,Term 15,,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동으로 인한 현금흐름,-,Term 17,-154550827468,Term 16,-225980969342,Term 15,-215987303706,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 증가,-,Term 17,45369950991,Term 16,17070110907,Term 15,110605478453,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_IncreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 수취,-,Term 17,2012976000,Term 16,5297434200,Term 15,578239965,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금의 지급,-,Term 17,68147576757,Term 16,54834267960,Term 15,68530023595,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 감소,-,Term 17,22790212000,Term 16,33166492045,Term 15,49138368262,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_PaymentsOfFinanceLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 상환,-,Term 17,105600934697,Term 16,140273953288,Term 15,206758281113,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_AcquisitionOfTreasuryShares,자기주식의 취득,-,Term 17,2484434450,Term 16,18685151180,Term 15,,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_DecreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 반환,-,Term 17,2910596555,Term 16,1388649976,Term 15,2744349154,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,외화환산으로 인한 현금및현금성자산의 증감,-,Term 17,-16054796439,Term 16,-13072845734,Term 15,-11814668914,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalents,현금및현금성자산의 순증감,-,Term 17,-88095682255,Term 16,-256034655676,Term 15,120147910873,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초의 현금및현금성자산,-,Term 17,537693630647,Term 16,793728286323,Term 15,673580375450,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말의 현금및현금성자산,-,Term 17,449597948392,Term 16,537693630647,Term 15,793728286323,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 17,4744299877622,Term 16,4464397744195,Term 15,4498840803125,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배지분 [member],Term 17,-16708527993,Term 16,-3456300758,Term 15,9344274222,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,4761008405615,Term 16,4467854044953,Term 15,4489496528903,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본구성요소 [member],Term 17,-19004134338,Term 16,-117631782499,Term 15,-117631782499,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|주식발행초과금,Term 17,720480827092,Term 16,712701764092,Term 15,712701764092,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 17,3937774554979,Term 16,3847747137435,Term 15,3873789578852,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 17,34525294500,Term 16,34508160000,Term 15,34508160000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 17,75352826661,Term 16,10807414056,Term 15,10807414056,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 17,11879036721,Term 16,-20278648131,Term 15,-24678605598,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,134474812450,Term 16,193680578727,Term 15,35132159662,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 17,134474812450,Term 16,193680578727,Term 15,35132159662,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 17,129264244958,Term 16,180857693977,Term 15,21869011689,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|비지배지분 [member],Term 17,-5210567492,Term 16,-12822884750,Term 15,-13263147973,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,연결재무제표 [member],Term 17,5482640916,Term 16,-47369483250,Term 15,7379173991,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,5482640916,Term 16,-47369483250,Term 15,7379173991,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 17,5482640916,Term 16,-47369483250,Term 15,7379173991,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산 평가손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 17,-31630608,Term 16,109285659,Term 15,-306779895,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산 평가손익,연결재무제표 [member],Term 17,-31630608,Term 16,109285659,Term 15,-306779895,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산 평가손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,-31630608,Term 16,109285659,Term 15,-306779895,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타포괄손익-공정가치측정금융자산 처분에 따른 대체,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 17,-20897896,Term 16,,Term 15,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타포괄손익-공정가치측정금융자산 처분에 따른 대체,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 17,20897896,Term 16,,Term 15,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 17,-576187970,Term 16,255539339,Term 15,127571405,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,-576187970,Term 16,255539339,Term 15,127571405,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|비지배지분 [member],Term 17,-30476763,Term 16,5098320,Term 15,14174601,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,연결재무제표 [member],Term 17,-606664733,Term 16,260637659,Term 15,141746006,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,-30750629036,Term 16,31792859854,Term 15,4579165957,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|비지배지분 [member],Term 17,-1141178292,Term 16,-434440805,Term 15,448398392,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,연결재무제표 [member],Term 17,-31891807328,Term 16,31358419049,Term 15,5027564349,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 17,-30750629036,Term 16,31792859854,Term 15,4579165957,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 17,67624548925,Term 16,54853570065,Term 15,68553775070,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|비지배지분 [member],Term 17,546646607,Term 16,,Term 15,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,67624548925,Term 16,54853570065,Term 15,68553775070,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,연결재무제표 [member],Term 17,68171195532,Term 16,54853570065,Term 15,68553775070,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,주식발행,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 17,,Term 16,17134500,Term 15,,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,주식발행,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|주식발행초과금,Term 17,,Term 16,7779063000,Term 15,,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,주식발행,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,,Term 16,7796197500,Term 15,,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,주식발행,연결재무제표 [member],Term 17,,Term 16,7796197500,Term 15,,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식처분,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,10247005000,Term 16,115817520000,Term 15,,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식처분,연결재무제표 [member],Term 17,10247005000,Term 16,115817520000,Term 15,,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식처분,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 17,64938462,Term 16,14558249096,Term 15,,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식처분,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본구성요소 [member],Term 17,10182066538,Term 16,101259270904,Term 15,,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식취득,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,,Term 16,-18685151180,Term 15,,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식취득,연결재무제표 [member],Term 17,,Term 16,-18685151180,Term 15,,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식취득,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본구성요소 [member],Term 17,,Term 16,-18685151180,Term 15,,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,-4299205108,Term 16,,Term 15,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [member]|비지배지분 [member],Term 17,4299205108,Term 16,,Term 15,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 17,-4299205108,Term 16,,Term 15,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 17,,Term 16,49987163509,Term 15,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 17,,Term 16,-1430107868,Term 15,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,연결재무제표 [member],Term 17,,Term 16,48557055641,Term 15,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,,Term 16,48557055641,Term 15,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식기준보상,연결재무제표 [member],Term 17,-9317366236,Term 16,,Term 15,,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식기준보상,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본구성요소 [member],Term 17,-9317366236,Term 16,,Term 15,,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식기준보상,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,-9317366236,Term 16,,Term 15,,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본구성요소 [member],Term 17,,Term 16,16053528437,Term 15,,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,,Term 16,16053528437,Term 15,,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,연결재무제표 [member],Term 17,,Term 16,16053528437,Term 15,,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 17,-19458512997,Term 16,11879036721,Term 15,-20278648131,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본구성요소 [member],Term 17,-18139434036,Term 16,-19004134338,Term 15,-117631782499,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 17,4010086561524,Term 16,3937774554979,Term 15,3847747137435,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|비지배지분 [member],Term 17,-19338192039,Term 16,-16708527993,Term 15,-3456300758,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 17,4779275104059,Term 16,4744299877622,Term 15,4464397744195,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|주식발행초과금,Term 17,720480827092,Term 16,720480827092,Term 15,712701764092,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 17,71118560015,Term 16,75352826661,Term 15,10807414056,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 17,34525294500,Term 16,34525294500,Term 15,34508160000,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,4798613296098,Term 16,4761008405615,Term 15,4467854044953,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 17,1735019347862,Term 16,2018526858100,Term 15,1825732428259,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 17,449597948392,Term 16,537693630647,Term 15,793728286323,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_ShortTermDepositsNotClassifiedAsCashEquivalents,금융기관예치금,-,Term 17,74669238000,Term 16,101825500000,Term 15,57882300000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognition,당기손익-공정가치측정금융자산,-,Term 17,362939892414,Term 16,490839332272,Term 15,166463243160,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CurrentFinancialAssetsAtAmortisedCost,상각후원가측정금융자산,-,Term 17,30000000000,Term 16,,Term 15,,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_ShortTermTradeReceivable,매출채권,-,Term 17,285104514893,Term 16,295769466239,Term 15,283770117119,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,기타수취채권,-,Term 17,62646902451,Term 16,41647242846,Term 15,24723686702,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 17,1589648122,Term 16,3330887323,Term 15,19235955917,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 17,39587746609,Term 16,50130929669,Term 15,65445877705,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 17,408934396533,Term 16,493223642997,Term 15,414482961333,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners,매각예정비유동자산,-,Term 17,19949060448,Term 16,4066226107,Term 15,,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 17,4066763830297,Term 16,4098187074812,Term 15,3876185747488,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_LongTermDepositsNotClassifiedAsCashEquivalents,금융기관예치금,-,Term 17,21989149194,Term 16,19512730100,Term 15,17556864840,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentReceivablesGross,기타수취채권,-,Term 17,66737893651,Term 16,115162575008,Term 15,100546922493,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognition,당기손익-공정가치측정금융자산,-,Term 17,8017318251,Term 16,104256383649,Term 15,1128984127,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtAmortisedCost,상각후원가측정금융자산,-,Term 17,430315000,Term 16,811274982,Term 15,2125074983,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산,-,Term 17,6216765880,Term 16,4672325200,Term 15,705503210,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 17,2475276690492,Term 16,2541362150975,Term 15,2566328198231,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 17,357750954252,Term 16,201680029794,Term 15,208773970177,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 17,503268138559,Term 16,534228580408,Term 15,488815300039,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 17,128492275394,Term 16,146465714306,Term 15,227453263601,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_InvestmentsInAssociates,관계기업투자주식,-,Term 17,247279224799,Term 16,238445368790,Term 15,52514140370,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,-Standard account code not used-,순확정급여자산,-,Term 17,181406890326,Term 16,94729521034,Term 15,110633427860,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 17,57853971328,Term 16,84608399877,Term 15,82890358531,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_OtherNonCurrentAssets,기타비유동자산,-,Term 17,12044243171,Term 16,12252020689,Term 15,16713739026,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 17,5801783178159,Term 16,6116713932912,Term 15,5701918175747,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 17,831116935949,Term 16,1157485393842,Term 15,965946712547,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_ShortTermTradePayables,매입채무,-,Term 17,80676210540,Term 16,123410292397,Term 15,117617730697,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 17,223413563558,Term 16,199124082671,Term 15,154160189044,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,기타지급채무,-,Term 17,154937768894,Term 16,324998426639,Term 15,275762504709,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 17,41108987667,Term 16,89962740389,Term 15,6097005496,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CurrentContractLiabilities,계약부채,-,Term 17,36625353980,Term 16,37465486262,Term 15,42275345834,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CurrentProvisions,기타충당부채,-,Term 17,30597338613,Term 16,8906185258,Term 15,8652202062,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,리스유동부채,-,Term 17,69006139263,Term 16,94760913961,Term 15,132867105541,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 17,194751573434,Term 16,278857266265,Term 15,228514629164,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 17,191391138151,Term 16,214928661448,Term 15,271573719005,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,-Standard account code not used-,순확정급여부채,-,Term 17,4377774564,Term 16,4059129237,Term 15,3831674238,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 17,91265971878,Term 16,79488075447,Term 15,90075514181,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,기타충당부채,-,Term 17,9469113472,Term 16,11556811260,Term 15,18617523307,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,리스비유동부채,-,Term 17,64785225166,Term 16,96221153680,Term 15,133748488854,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 17,21493053071,Term 16,23603491824,Term 15,25300518425,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 17,1022508074100,Term 16,1372414055290,Term 15,1237520431552,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업의 소유주에게 귀속되는 자본,-,Term 17,4798613296098,Term 16,4761008405615,Term 15,4467854044953,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 17,34525294500,Term 16,34525294500,Term 15,34508160000,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_SharePremium,주식발행초과금,-,Term 17,720480827092,Term 16,720480827092,Term 15,712701764092,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 17,71118560015,Term 16,75352826661,Term 15,10807414056,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본구성요소,-,Term 17,-18139434036,Term 16,-19004134338,Term 15,-117631782499,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 17,-19458512997,Term 16,11879036721,Term 15,-20278648131,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 17,4010086561524,Term 16,3937774554979,Term 15,3847747137435,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배주주지분,-,Term 17,-19338192039,Term 16,-16708527993,Term 15,-3456300758,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 17,4779275104059,Term 16,4744299877622,Term 15,4464397744195,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채와 자본총계,-,Term 17,5801783178159,Term 16,6116713932912,Term 15,5701918175747,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 17,4134932512111,Term 16,4863128496699,Term 15,4432179039394,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 17,1337512406849,Term 16,1362639202428,Term 15,1265398064748,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 17,2797420105262,Term 16,3500489294271,Term 15,3166780974646,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 17,2583186849501,Term 16,3157131485221,Term 15,3023771855339,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익,-,Term 17,214233255761,Term 16,343357809050,Term 15,143009119307,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 17,22771702594,Term 16,10499109599,Term 15,11882548495,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 17,34413883142,Term 16,11410260207,Term 15,17026833385,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,dart_OtherGains,기타영업외손익,-,Term 17,13044673857,Term 16,-45496828367,Term 15,-113231972208,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,관계기업손익,-,Term 17,8858020099,Term 16,927626457,Term 15,660159537,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 17,224493769169,Term 16,297877456532,Term 15,25293021746,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 17,95229524211,Term 16,117019762555,Term 15,3424010057,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 17,129264244958,Term 16,180857693977,Term 15,21869011689,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 17,134474812450,Term 16,193680578727,Term 15,35132159662,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배주주지분,-,Term 17,-5210567492,Term 16,-12822884750,Term 15,-13263147973,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,-,Term 17,5482640916,Term 16,-47369483250,Term 15,7379173991,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정금융자산 평가손익,-,Term 17,-31630608,Term 16,109285659,Term 15,-306779895,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnHedgesOfNetInvestmentsInForeignOperationsNetOfTax,관계기업기타포괄손익지분,-,Term 17,-606664733,Term 16,260637659,Term 15,141746006,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업환산손익,-,Term 17,-31891807328,Term 16,31358419049,Term 15,5027564349,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,당기법인세비용차감후기타포괄손익,-,Term 17,-27047461753,Term 16,-15641140883,Term 15,12241704451,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,당기총포괄손익,-,Term 17,102216783205,Term 16,165216553094,Term 15,34110716140,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업의 소유주지분,-,Term 17,108599005752,Term 16,178468780329,Term 15,46911291120,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배주주지분,-,Term 17,-6382222547,Term 16,-13252227235,Term 15,-12800574980,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주기본주당이익,-,Term 17,1949,Term 16,2820,Term 15,512,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,보통주희석주당이익,-,Term 17,1948,Term 16,2818,Term 15,512,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,우선주기본주당이익,-,Term 17,1954,Term 16,2821,Term 15,517,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,우선주희석주당이익,-,Term 17,1954,Term 16,2821,Term 15,517,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동으로 인한 현금흐름,-,Term 17,151023730340,Term 16,691434410702,Term 15,554358724380,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업으로부터 창출된 현금흐름,-,Term 17,281138081103,Term 16,714854553223,Term 15,670456654579,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 17,6274261744,Term 16,4026044240,Term 15,4028241642,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자의 지급,-,Term 17,11472337649,Term 16,9899193484,Term 15,16008008153,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세의 납부,-,Term 17,124916274858,Term 16,17546993277,Term 15,104118163688,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동으로 인한 현금흐름,-,Term 17,-68513788688,Term 16,-708415251302,Term 15,-206408840887,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfShortTermFinancialInstruments,유동성 금융기관예치금의 순감소,-,Term 17,27325462000,Term 16,,Term 15,12162100000,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfCurrentFairValueFinancialAsset,유동성 당기손익-공정가치측정금융자산의 감소,-,Term 17,232549103448,Term 16,,Term 15,2991229925,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherNonCurrentFinancialAssets,상각후원가측정금융자산의 처분,-,Term 17,460580082,Term 16,1313800001,Term 15,6260017,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfLongTermFinancialInstruments,비유동성 금융기관예치금의 순감소,-,Term 17,,Term 16,,Term 15,353988000,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherCurrentFinancialAssets,기타포괄손익-공정가치측정금융자산의 처분,-,Term 17,730010465,Term 16,,Term 15,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfLoansAndReceivables,기타수취채권의 감소,-,Term 17,28546250251,Term 16,31526378078,Term 15,45815639463,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 17,4018992178,Term 16,3276022744,Term 15,24769903712,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 17,68619860,Term 16,414580271,Term 15,349269754,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 17,3105500000,Term 16,4226483920,Term 15,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfNonCurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정비유동자산의 처분,-,Term 17,6246100000,Term 16,,Term 15,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합 등으로 인한 순현금유입,-,Term 17,,Term 16,44874437795,Term 15,,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,-Standard account code not used-,관계기업으로부터의 배당금수익,-,Term 17,,Term 16,,Term 15,3750046,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities,기타의 현금유입액,-,Term 17,,Term 16,11434877000,Term 15,,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_PurchaseOfShortTermFinancialInstruments,유동성 금융기관예치금의 순증가,-,Term 17,,Term 16,43094000000,Term 15,,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_PurchaseOfCurrentFairValueFinancialAsset,유동성 당기손익-공정가치측정금융자산의 증가,-,Term 17,,Term 16,320522606869,Term 15,23523394856,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_PurchaseOfOtherNonCurrentFinancialAssets,유동성 상각후원가측정금융자산의 순증가,-,Term 17,30000000000,Term 16,,Term 15,,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_PurchaseOfLongTermFinancialInstruments,비유동성 금융기관예치금의 증가,-,Term 17,1500002760,Term 16,1503002760,Term 15,1500002760,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_PurchaseOfNonCurrentFairValueFinancialAsset,비유동성 당기손익-공정가치측정금융자산의 증가,-,Term 17,16917338331,Term 16,103516979920,Term 15,,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_PurchaseOfOtherCurrentFinancialAssets,기타포괄손익-공정가치측정금융자산의 취득,-,Term 17,2500004160,Term 16,3000080160,Term 15,,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_PurchaseOfLoansAndReceivables,기타수취채권의 증가,-,Term 17,10071148219,Term 16,29564010651,Term 15,3826463221,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 17,99289990911,Term 16,91182844178,Term 15,183021787650,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 17,35575628339,Term 16,29815783627,Term 15,31983791822,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,-Standard account code not used-,사용권자산의 증가,-,Term 17,125343250,Term 16,26671000,Term 15,2269650,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_PurchaseOfInvestmentsInAssociates,관계기업투자주식의 증가,-,Term 17,,Term 16,183255851946,Term 15,49003271845,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합 등으로 인한 순현금유출,-,Term 17,175584951002,Term 16,,Term 15,,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동으로 인한 현금흐름,-,Term 17,-154550827468,Term 16,-225980969342,Term 15,-215987303706,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 증가,-,Term 17,45369950991,Term 16,17070110907,Term 15,110605478453,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_IncreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 수취,-,Term 17,2012976000,Term 16,5297434200,Term 15,578239965,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금의 지급,-,Term 17,68147576757,Term 16,54834267960,Term 15,68530023595,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 감소,-,Term 17,22790212000,Term 16,33166492045,Term 15,49138368262,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_PaymentsOfFinanceLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 상환,-,Term 17,105600934697,Term 16,140273953288,Term 15,206758281113,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_AcquisitionOfTreasuryShares,자기주식의 취득,-,Term 17,2484434450,Term 16,18685151180,Term 15,,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_DecreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 반환,-,Term 17,2910596555,Term 16,1388649976,Term 15,2744349154,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,외화환산으로 인한 현금및현금성자산의 증감,-,Term 17,-16054796439,Term 16,-13072845734,Term 15,-11814668914,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalents,현금및현금성자산의 순증감,-,Term 17,-88095682255,Term 16,-256034655676,Term 15,120147910873,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초의 현금및현금성자산,-,Term 17,537693630647,Term 16,793728286323,Term 15,673580375450,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말의 현금및현금성자산,-,Term 17,449597948392,Term 16,537693630647,Term 15,793728286323,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 17,4744299877622,Term 16,4464397744195,Term 15,4498840803125,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배지분 [member],Term 17,-16708527993,Term 16,-3456300758,Term 15,9344274222,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,4761008405615,Term 16,4467854044953,Term 15,4489496528903,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본구성요소 [member],Term 17,-19004134338,Term 16,-117631782499,Term 15,-117631782499,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|주식발행초과금,Term 17,720480827092,Term 16,712701764092,Term 15,712701764092,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 17,3937774554979,Term 16,3847747137435,Term 15,3873789578852,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 17,34525294500,Term 16,34508160000,Term 15,34508160000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 17,75352826661,Term 16,10807414056,Term 15,10807414056,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 17,11879036721,Term 16,-20278648131,Term 15,-24678605598,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,134474812450,Term 16,193680578727,Term 15,35132159662,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 17,134474812450,Term 16,193680578727,Term 15,35132159662,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 17,129264244958,Term 16,180857693977,Term 15,21869011689,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|비지배지분 [member],Term 17,-5210567492,Term 16,-12822884750,Term 15,-13263147973,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,연결재무제표 [member],Term 17,5482640916,Term 16,-47369483250,Term 15,7379173991,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,5482640916,Term 16,-47369483250,Term 15,7379173991,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 17,5482640916,Term 16,-47369483250,Term 15,7379173991,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산 평가손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 17,-31630608,Term 16,109285659,Term 15,-306779895,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산 평가손익,연결재무제표 [member],Term 17,-31630608,Term 16,109285659,Term 15,-306779895,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ChangesInReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산 평가손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,-31630608,Term 16,109285659,Term 15,-306779895,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타포괄손익-공정가치측정금융자산 처분에 따른 대체,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 17,-20897896,Term 16,,Term 15,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타포괄손익-공정가치측정금융자산 처분에 따른 대체,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 17,20897896,Term 16,,Term 15,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 17,-576187970,Term 16,255539339,Term 15,127571405,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,-576187970,Term 16,255539339,Term 15,127571405,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,자본 [member]|비지배지분 [member],Term 17,-30476763,Term 16,5098320,Term 15,14174601,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,관계기업기타포괄손익지분,연결재무제표 [member],Term 17,-606664733,Term 16,260637659,Term 15,141746006,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,-30750629036,Term 16,31792859854,Term 15,4579165957,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|비지배지분 [member],Term 17,-1141178292,Term 16,-434440805,Term 15,448398392,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,연결재무제표 [member],Term 17,-31891807328,Term 16,31358419049,Term 15,5027564349,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 17,-30750629036,Term 16,31792859854,Term 15,4579165957,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 17,67624548925,Term 16,54853570065,Term 15,68553775070,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|비지배지분 [member],Term 17,546646607,Term 16,,Term 15,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,67624548925,Term 16,54853570065,Term 15,68553775070,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,연결재무제표 [member],Term 17,68171195532,Term 16,54853570065,Term 15,68553775070,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,주식발행,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 17,,Term 16,17134500,Term 15,,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,주식발행,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|주식발행초과금,Term 17,,Term 16,7779063000,Term 15,,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,주식발행,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,,Term 16,7796197500,Term 15,,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,주식발행,연결재무제표 [member],Term 17,,Term 16,7796197500,Term 15,,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식처분,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,10247005000,Term 16,115817520000,Term 15,,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식처분,연결재무제표 [member],Term 17,10247005000,Term 16,115817520000,Term 15,,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식처분,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 17,64938462,Term 16,14558249096,Term 15,,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식처분,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본구성요소 [member],Term 17,10182066538,Term 16,101259270904,Term 15,,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식취득,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,,Term 16,-18685151180,Term 15,,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식취득,연결재무제표 [member],Term 17,,Term 16,-18685151180,Term 15,,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,-Standard account code not used-,자기주식취득,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본구성요소 [member],Term 17,,Term 16,-18685151180,Term 15,,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,-4299205108,Term 16,,Term 15,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [member]|비지배지분 [member],Term 17,4299205108,Term 16,,Term 15,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 17,-4299205108,Term 16,,Term 15,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 17,,Term 16,49987163509,Term 15,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 17,,Term 16,-1430107868,Term 15,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,연결재무제표 [member],Term 17,,Term 16,48557055641,Term 15,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,,Term 16,48557055641,Term 15,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식기준보상,연결재무제표 [member],Term 17,-9317366236,Term 16,,Term 15,,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식기준보상,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본구성요소 [member],Term 17,-9317366236,Term 16,,Term 15,,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식기준보상,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,-9317366236,Term 16,,Term 15,,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본구성요소 [member],Term 17,,Term 16,16053528437,Term 15,,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,,Term 16,16053528437,Term 15,,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,dart_OtherTransactions,기타,연결재무제표 [member],Term 17,,Term 16,16053528437,Term 15,,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 17,-19458512997,Term 16,11879036721,Term 15,-20278648131,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본구성요소 [member],Term 17,-18139434036,Term 16,-19004134338,Term 15,-117631782499,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 17,4010086561524,Term 16,3937774554979,Term 15,3847747137435,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|비지배지분 [member],Term 17,-19338192039,Term 16,-16708527993,Term 15,-3456300758,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 17,4779275104059,Term 16,4744299877622,Term 15,4464397744195,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|주식발행초과금,Term 17,720480827092,Term 16,720480827092,Term 15,712701764092,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 17,71118560015,Term 16,75352826661,Term 15,10807414056,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 17,34525294500,Term 16,34525294500,Term 15,34508160000,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20230309000802,11011,2022,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 17,4798613296098,Term 16,4761008405615,Term 15,4467854044953,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 18,5886510888702,Term 17,5801783178159,Term 16,6116713932912,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 18,1952196456821,Term 17,1735019347862,Term 16,2018526858100,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 18,506379386493,Term 17,449597948392,Term 16,537693630647,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentFinancialAssetsAtAmortisedCost,상각후원가측정금융자산,-,Term 18,58630000000,Term 17,30000000000,Term 16,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss,당기손익-공정가치측정금융자산,-,Term 18,549634663158,Term 17,362939892414,Term 16,490839332272,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 18,1395767125,Term 17,1589648122,Term 16,3330887323,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentTradeReceivables,매출채권,-,Term 18,292900370185,Term 17,285104514893,Term 16,295769466239,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 18,394311802314,Term 17,408934396533,Term 16,493223642997,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners,매각예정비유동자산,-,Term 18,0,Term 17,19949060448,Term 16,4066226107,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_OtherCurrentAssets,기타유동자산,-,Term 18,40810673046,Term 17,39587746609,Term 16,50130929669,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_OtherCurrentReceivables,기타수취채권,-,Term 18,46359581121,Term 17,62646902451,Term 16,41647242846,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents,금융기관예치금,-,Term 18,61774213379,Term 17,74669238000,Term 16,101825500000,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 18,3934314431881,Term 17,4066763830297,Term 16,4098187074812,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 18,13846205025,Term 17,57853971328,Term 16,84608399877,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_IntangibleAssetsAndGoodwill,무형자산,-,Term 18,340680136431,Term 17,357750954252,Term 16,201680029794,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 18,496219430433,Term 17,503268138559,Term 16,534228580408,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod,관계기업투자주식,-,Term 18,287060733528,Term 17,247279224799,Term 16,238445368790,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_LongtermDeposits,금융기관예치금,-,Term 18,23988856981,Term 17,21989149194,Term 16,19512730100,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtAmortisedCost,상각후원가측정금융자산,-,Term 18,976580000,Term 17,430315000,Term 16,811274982,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss,당기손익-공정가치측정금융자산,-,Term 18,33031318251,Term 17,8017318251,Term 16,104256383649,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산,-,Term 18,6216765880,Term 17,6216765880,Term 16,4672325200,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentRecognisedAssetsDefinedBenefitPlan,순확정급여자산,-,Term 18,112607043654,Term 17,181406890326,Term 16,94729521034,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_OtherNoncurrentAssets,기타비유동자산,-,Term 18,9643263718,Term 17,12044243171,Term 16,12252020689,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_OtherNoncurrentReceivables,기타수취채권,-,Term 18,67356278864,Term 17,66737893651,Term 16,115162575008,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 18,2441603701077,Term 17,2475276690492,Term 16,2541362150975,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 18,101084118039,Term 17,128492275394,Term 16,146465714306,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 18,4872705211057,Term 17,4779275104059,Term 16,4744299877622,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업의 소유주에게 귀속되는 자본,-,Term 18,4897988125589,Term 17,4798613296098,Term 16,4761008405615,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 18,73397775430,Term 17,71118560015,Term 16,75352826661,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본구성요소,-,Term 18,-13324991010,Term 17,-18139434036,Term 16,-19004134338,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_AccumulatedOtherComprehensiveIncome,기타포괄손익누계액,-,Term 18,-18492151960,Term 17,-19458512997,Term 16,11879036721,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 18,34525294500,Term 17,34525294500,Term 16,34525294500,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 18,4101401371537,Term 17,4010086561524,Term 16,3937774554979,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_SharePremium,주식발행초과금,-,Term 18,720480827092,Term 17,720480827092,Term 16,720480827092,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배주주지분,-,Term 18,-25282914532,Term 17,-19338192039,Term 16,-16708527993,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채와자본총계,-,Term 18,5886510888702,Term 17,5801783178159,Term 16,6116713932912,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 18,813257101661,Term 17,831116935949,Term 16,1157485393842,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentContractLiabilities,계약부채,-,Term 18,33409778405,Term 17,36625353980,Term 16,37465486262,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,리스유동부채,-,Term 18,55346660805,Term 17,69006139263,Term 16,94760913961,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentProvisions,기타충당부채,-,Term 18,47465342867,Term 17,30597338613,Term 16,8906185258,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 18,22688183409,Term 17,41108987667,Term 16,89962740389,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_OtherCurrentLiabilities,기타유동부채,-,Term 18,198295675757,Term 17,194751573434,Term 16,278857266265,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_OtherCurrentPayables,기타지급채무,-,Term 18,125500534330,Term 17,154937768894,Term 16,324998426639,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 18,244108853364,Term 17,223413563558,Term 16,199124082671,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers,매입채무,-,Term 18,86442072724,Term 17,80676210540,Term 16,123410292397,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 18,1013805677645,Term 17,1022508074100,Term 16,1372414055290,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 18,200548575984,Term 17,191391138151,Term 16,214928661448,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 18,106367521222,Term 17,91265971878,Term 16,79488075447,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,리스비유동부채,-,Term 18,50947819097,Term 17,64785225166,Term 16,96221153680,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,기타충당부채,-,Term 18,10349002658,Term 17,9469113472,Term 16,11556811260,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan,순확정급여부채,-,Term 18,4493819499,Term 17,4377774564,Term 16,4059129237,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_OtherNoncurrentLiabilities,기타비유동부채,-,Term 18,28390413508,Term 17,21493053071,Term 16,23603491824,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,dart_NonOperatingProfitLoss,기타영업외손익,-,Term 18,-11604794732,Term 17,13044673857,Term 16,-45496828367,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익,-,Term 18,108171257062,Term 17,214233255761,Term 16,343357809050,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,당기총포괄손익,-,Term 18,133397969818,Term 17,102216783205,Term 16,165216553094,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배주주지분,-,Term 18,-5852768057,Term 17,-6382222547,Term 16,-13252227235,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업의 소유주지분,-,Term 18,139250737875,Term 17,108599005752,Term 16,178468780329,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 18,1155064685469,Term 17,1337512406849,Term 16,1362639202428,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,우선주기본주당이익,-,Term 18,2614,Term 17,1954,Term 16,2821,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,우선주희석주당이익,-,Term 18,2614,Term 17,1954,Term 16,2821,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주기본주당이익,-,Term 18,2609,Term 17,1949,Term 16,2820,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_DilutedEarningsLossPerShare,보통주희석주당이익,-,Term 18,2609,Term 17,1948,Term 16,2818,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 18,19166374797,Term 17,34413883142,Term 16,11410260207,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 18,161577461724,Term 17,22771702594,Term 16,10499109599,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 18,2518898907688,Term 17,2797420105262,Term 16,3500489294271,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 18,106754652265,Term 17,95229524211,Term 16,117019762555,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,당기법인세비용차감후기타포괄손익,-,Term 18,-40480959178,Term 17,-27047461753,Term 16,-15641140883,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,-,Term 18,449127731,Term 17,-31891807328,Term 16,31358419049,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업기타포괄손익지분,-,Term 18,887839826,Term 17,-606664733,Term 16,260637659,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정금융자산평가손익,-,Term 18,-458211,Term 17,-31630608,Term 16,109285659,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,-,Term 18,-41817468524,Term 17,5482640916,Term 16,-47369483250,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익,-,Term 18,173878928996,Term 17,129264244958,Term 16,180857693977,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배주주지분,-,Term 18,-6222916366,Term 17,-5210567492,Term 16,-12822884750,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 18,180101845362,Term 17,134474812450,Term 16,193680578727,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세차감전순이익,-,Term 18,280633581261,Term 17,224493769169,Term 16,297877456532,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 18,3673963593157,Term 17,4134932512111,Term 16,4863128496699,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_SellingGeneralAndAdministrativeExpense,판매비와 관리비,-,Term 18,2410727650626,Term 17,2583186849501,Term 16,3157131485221,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod,관계기업손익,-,Term 18,41656032004,Term 17,8858020099,Term 16,927626457,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초의 현금및현금성자산,-,Term 18,449597948392,Term 17,537693630647,Term 16,793728286323,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말의 현금및현금성자산,-,Term 18,506379386493,Term 17,449597948392,Term 16,537693630647,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동으로 인한 현금흐름,-,Term 18,-98619351026,Term 17,-154550827468,Term 16,-225980969342,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_DecreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 반환,-,Term 18,4840197081,Term 17,2910596555,Term 16,1388649976,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_IncreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 수취,-,Term 18,2450248000,Term 17,2012976000,Term 16,5297434200,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 증가,-,Term 18,40823433333,Term 17,45369950991,Term 16,17070110907,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 감소,-,Term 18,20299153462,Term 17,22790212000,Term 16,33166492045,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금의 지급,-,Term 18,47045103906,Term 17,68147576757,Term 16,54834267960,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 상환？,-,Term 18,69389612880,Term 17,105600934697,Term 16,140273953288,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,-,Term 18,318965030,Term 17,2484434450,Term 16,18685151180,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동으로 인한 현금흐름,-,Term 18,-186166228672,Term 17,-68513788688,Term 16,-708415251302,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfCurrentFairValueFinancialAsset,유동성 당기손익-공정가치측정금융자산의 순감소,-,Term 18,0,Term 17,232549103448,Term 16,,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산의 처분,-,Term 18,0,Term 17,730010465,Term 16,,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfNonCurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정비유동자산의 처분,-,Term 18,26542501310,Term 17,6246100000,Term 16,,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_PurchaseOfCurrentFairValueFinancialAsset,유동성 당기손익-공정가치측정금융자산의 순증가,-,Term 18,65303825196,Term 17,0,Term 16,,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_PurchaseOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산의 취득,-,Term 18,0,Term 17,2500004160,Term 16,3000080160,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_PurchaseOfInvestmentsInAssociates,종속기업및관계기업투자주식의 취득,-,Term 18,,Term 17,,Term 16,183255851946,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_PurchaseOfNonCurrentFairValueFinancialAsset,비유동성 당기손익-공정가치측정금융자산의 취득,-,Term 18,0,Term 17,16917338331,Term 16,103516979920,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,-Standard account code not used-,기타의 현금유입액,-,Term 18,2902814938,Term 17,0,Term 16,11434877000,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,-Standard account code not used-,기타수취채권의 감소,-,Term 18,30912429409,Term 17,28546250251,Term 16,31526378078,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,-Standard account code not used-,비유동성 금융기관예치금의 취득,-,Term 18,1106477374,Term 17,1500002760,Term 16,1503002760,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,-Standard account code not used-,기타수취채권의 증가,-,Term 18,18224949583,Term 17,10071148219,Term 16,29564010651,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,-Standard account code not used-,사업결합 등으로 인한 순현금유입,-,Term 18,,Term 17,,Term 16,44874437795,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,-Standard account code not used-,사업결합으로 인한 순현금유출,-,Term 18,0,Term 17,175584951002,Term 16,,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,-Standard account code not used-,유동성 상각후원가측정금융자산의 순증가,-,Term 18,28630000000,Term 17,30000000000,Term 16,320522606869,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,-Standard account code not used-,상각후원가측정 금융자산의 처분,-,Term 18,140415000,Term 17,460580082,Term 16,1313800001,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,-Standard account code not used-,비유동성 상각후원가측정금융자산의 취득,-,Term 18,686680000,Term 17,0,Term 16,,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_AdditionsToRightofuseAssets,사용권자산의 증가,-,Term 18,49185077,Term 17,125343250,Term 16,26671000,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments,유동성 금융기관예치금의 순감소,-,Term 18,12818224621,Term 17,27325462000,Term 16,-43094000000,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 18,89844275,Term 17,68619860,Term 16,414580271,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 18,1288829494,Term 17,3105500000,Term 16,4226483920,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 18,26648118986,Term 17,4018992178,Term 16,3276022744,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 18,39012379319,Term 17,35575628339,Term 16,29815783627,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 18,134495910156,Term 17,99289990911,Term 16,91182844178,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동으로 인한 현금흐름,-,Term 18,348227953524,Term 17,151023730340,Term 16,691434410702,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperations,영업으로부터 창출된 현금흐름,-,Term 18,405675378475,Term 17,281138081103,Term 16,714854553223,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세의 납부,-,Term 18,53423466062,Term 17,124916274858,Term 16,17546993277,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자의 지급,-,Term 18,15035702506,Term 17,11472337649,Term 16,9899193484,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 18,11011743617,Term 17,6274261744,Term 16,4026044240,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,외화환산으로 인한 현금및현금성자산 증감,-,Term 18,-6660935725,Term 17,-16054796439,Term 16,-13072845734,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalents,현금및현금성자산의 증감,-,Term 18,56781438101,Term 17,-88095682255,Term 16,-256034655676,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결대상범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 18,,Term 17,,Term 16,49987163509,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결대상범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 18,,Term 17,,Term 16,-1430107868,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결대상범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,,Term 17,,Term 16,48557055641,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결대상범위의 변동,연결재무제표 [member],Term 18,,Term 17,,Term 16,48557055641,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_DispositionOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,4614981434,Term 17,10247005000,Term 16,115817520000,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_DispositionOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 18,5238580957,Term 17,10182066538,Term 16,101259270904,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_DispositionOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 18,-623599523,Term 17,64938462,Term 16,14558249096,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_DispositionOfTreasuryShares,자기주식의 처분,연결재무제표 [member],Term 18,4614981434,Term 17,10247005000,Term 16,115817520000,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,4798613296098,Term 17,4761008405615,Term 16,4467854044953,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|비지배지분 [구성요소],Term 18,-19338192039,Term 17,-16708527993,Term 16,-3456300758,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 18,4779275104059,Term 17,4744299877622,Term 16,4464397744195,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 18,-18139434036,Term 17,-19004134338,Term 16,-117631782499,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 18,720480827092,Term 17,720480827092,Term 16,712701764092,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 18,71118560015,Term 17,75352826661,Term 16,10807414056,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 18,34525294500,Term 17,34525294500,Term 16,34508160000,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 18,4010086561524,Term 17,3937774554979,Term 16,3847747137435,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 18,-19458512997,Term 17,11879036721,Term 16,-20278648131,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산 처분에 따른 대체,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 18,,Term 17,-20897896,Term 16,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산 처분에 따른 대체,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 18,,Term 17,20897896,Term 16,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,46969566825,Term 17,67624548925,Term 16,54853570065,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|비지배지분 [구성요소],Term 18,91954436,Term 17,546646607,Term 16,,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,연결재무제표 [member],Term 18,47061521261,Term 17,68171195532,Term 16,54853570065,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 18,46969566825,Term 17,67624548925,Term 16,54853570065,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 18,73397775430,Term 17,71118560015,Term 16,75352826661,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 18,34525294500,Term 17,34525294500,Term 16,34525294500,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 18,4101401371537,Term 17,4010086561524,Term 16,3937774554979,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 18,-18492151960,Term 17,-19458512997,Term 16,11879036721,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 18,-13324991010,Term 17,-18139434036,Term 16,-19004134338,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,4897988125589,Term 17,4798613296098,Term 16,4761008405615,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|비지배지분 [구성요소],Term 18,-25282914532,Term 17,-19338192039,Term 16,-16708527993,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,연결재무제표 [member],Term 18,4872705211057,Term 17,4779275104059,Term 16,4744299877622,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 18,720480827092,Term 17,720480827092,Term 16,720480827092,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|비지배지분 [구성요소],Term 18,,Term 17,4299205108,Term 16,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,,Term 17,-4299205108,Term 16,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 18,,Term 17,-4299205108,Term 16,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,연결재무제표 [member],Term 18,-105172901,Term 17,-9317366236,Term 16,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,-105172901,Term 17,-9317366236,Term 16,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 18,-105172901,Term 17,-9317366236,Term 16,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,연결재무제표 [member],Term 18,2902814938,Term 17,,Term 16,16053528437,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 18,2902814938,Term 17,,Term 16,,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 18,,Term 17,,Term 16,16053528437,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,2902814938,Term 17,,Term 16,16053528437,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,지분의 발행,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 18,,Term 17,,Term 16,17134500,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,지분의 발행,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,,Term 17,,Term 16,7796197500,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,지분의 발행,연결재무제표 [member],Term 18,,Term 17,,Term 16,7796197500,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,지분의 발행,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 18,,Term 17,,Term 16,7779063000,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,연결재무제표 [member],Term 18,449127731,Term 17,-31891807328,Term 16,31358419049,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|비지배지분 [구성요소],Term 18,370103282,Term 17,-1141178292,Term 16,-434440805,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 18,79024449,Term 17,-30750629036,Term 16,31792859854,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,79024449,Term 17,-30750629036,Term 16,31792859854,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정금융자산평가손익,연결재무제표 [member],Term 18,-458211,Term 17,-31630608,Term 16,109285659,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정금융자산평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,-458211,Term 17,-31630608,Term 16,109285659,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정금융자산평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 18,-458211,Term 17,-31630608,Term 16,109285659,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,연결재무제표 [member],Term 18,-41817468524,Term 17,5482640916,Term 16,-47369483250,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,-41817468524,Term 17,5482640916,Term 16,-47369483250,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 18,-41817468524,Term 17,5482640916,Term 16,-47369483250,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,연결재무제표 [member],Term 18,173878928996,Term 17,129264244958,Term 16,180857693977,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 18,180101845362,Term 17,134474812450,Term 16,193680578727,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,180101845362,Term 17,134474812450,Term 16,193680578727,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|비지배지분 [구성요소],Term 18,-6222916366,Term 17,-5210567492,Term 16,-12822884750,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,318965030,Term 17,,Term 16,-18685151180,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,연결재무제표 [member],Term 18,318965030,Term 17,2484434450,Term 16,18685151180,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 18,318965030,Term 17,,Term 16,-18685151180,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업기타포괄손익지분,자본 [구성요소]|비지배지분 [구성요소],Term 18,45027,Term 17,-30476763,Term 16,5098320,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업기타포괄손익지분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,887794799,Term 17,-576187970,Term 16,255539339,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업기타포괄손익지분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 18,887794799,Term 17,-576187970,Term 16,255539339,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업기타포괄손익지분,연결재무제표 [member],Term 18,887839826,Term 17,-606664733,Term 16,260637659,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 18,5886510888702,Term 17,5801783178159,Term 16,6116713932912,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 18,1952196456821,Term 17,1735019347862,Term 16,2018526858100,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 18,506379386493,Term 17,449597948392,Term 16,537693630647,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentFinancialAssetsAtAmortisedCost,상각후원가측정금융자산,-,Term 18,58630000000,Term 17,30000000000,Term 16,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss,당기손익-공정가치측정금융자산,-,Term 18,549634663158,Term 17,362939892414,Term 16,490839332272,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 18,1395767125,Term 17,1589648122,Term 16,3330887323,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentTradeReceivables,매출채권,-,Term 18,292900370185,Term 17,285104514893,Term 16,295769466239,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 18,394311802314,Term 17,408934396533,Term 16,493223642997,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners,매각예정비유동자산,-,Term 18,0,Term 17,19949060448,Term 16,4066226107,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_OtherCurrentAssets,기타유동자산,-,Term 18,40810673046,Term 17,39587746609,Term 16,50130929669,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_OtherCurrentReceivables,기타수취채권,-,Term 18,46359581121,Term 17,62646902451,Term 16,41647242846,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents,금융기관예치금,-,Term 18,61774213379,Term 17,74669238000,Term 16,101825500000,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 18,3934314431881,Term 17,4066763830297,Term 16,4098187074812,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 18,13846205025,Term 17,57853971328,Term 16,84608399877,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_IntangibleAssetsAndGoodwill,무형자산,-,Term 18,340680136431,Term 17,357750954252,Term 16,201680029794,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 18,496219430433,Term 17,503268138559,Term 16,534228580408,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod,관계기업투자주식,-,Term 18,287060733528,Term 17,247279224799,Term 16,238445368790,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_LongtermDeposits,금융기관예치금,-,Term 18,23988856981,Term 17,21989149194,Term 16,19512730100,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtAmortisedCost,상각후원가측정금융자산,-,Term 18,976580000,Term 17,430315000,Term 16,811274982,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss,당기손익-공정가치측정금융자산,-,Term 18,33031318251,Term 17,8017318251,Term 16,104256383649,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산,-,Term 18,6216765880,Term 17,6216765880,Term 16,4672325200,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentRecognisedAssetsDefinedBenefitPlan,순확정급여자산,-,Term 18,112607043654,Term 17,181406890326,Term 16,94729521034,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_OtherNoncurrentAssets,기타비유동자산,-,Term 18,9643263718,Term 17,12044243171,Term 16,12252020689,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_OtherNoncurrentReceivables,기타수취채권,-,Term 18,67356278864,Term 17,66737893651,Term 16,115162575008,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 18,2441603701077,Term 17,2475276690492,Term 16,2541362150975,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 18,101084118039,Term 17,128492275394,Term 16,146465714306,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 18,4872705211057,Term 17,4779275104059,Term 16,4744299877622,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업의 소유주에게 귀속되는 자본,-,Term 18,4897988125589,Term 17,4798613296098,Term 16,4761008405615,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 18,73397775430,Term 17,71118560015,Term 16,75352826661,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본구성요소,-,Term 18,-13324991010,Term 17,-18139434036,Term 16,-19004134338,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_AccumulatedOtherComprehensiveIncome,기타포괄손익누계액,-,Term 18,-18492151960,Term 17,-19458512997,Term 16,11879036721,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 18,34525294500,Term 17,34525294500,Term 16,34525294500,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 18,4101401371537,Term 17,4010086561524,Term 16,3937774554979,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_SharePremium,주식발행초과금,-,Term 18,720480827092,Term 17,720480827092,Term 16,720480827092,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배주주지분,-,Term 18,-25282914532,Term 17,-19338192039,Term 16,-16708527993,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채와자본총계,-,Term 18,5886510888702,Term 17,5801783178159,Term 16,6116713932912,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 18,813257101661,Term 17,831116935949,Term 16,1157485393842,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentContractLiabilities,계약부채,-,Term 18,33409778405,Term 17,36625353980,Term 16,37465486262,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,리스유동부채,-,Term 18,55346660805,Term 17,69006139263,Term 16,94760913961,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentProvisions,기타충당부채,-,Term 18,47465342867,Term 17,30597338613,Term 16,8906185258,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 18,22688183409,Term 17,41108987667,Term 16,89962740389,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_OtherCurrentLiabilities,기타유동부채,-,Term 18,198295675757,Term 17,194751573434,Term 16,278857266265,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_OtherCurrentPayables,기타지급채무,-,Term 18,125500534330,Term 17,154937768894,Term 16,324998426639,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 18,244108853364,Term 17,223413563558,Term 16,199124082671,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers,매입채무,-,Term 18,86442072724,Term 17,80676210540,Term 16,123410292397,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 18,1013805677645,Term 17,1022508074100,Term 16,1372414055290,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 18,200548575984,Term 17,191391138151,Term 16,214928661448,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 18,106367521222,Term 17,91265971878,Term 16,79488075447,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,리스비유동부채,-,Term 18,50947819097,Term 17,64785225166,Term 16,96221153680,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,기타충당부채,-,Term 18,10349002658,Term 17,9469113472,Term 16,11556811260,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan,순확정급여부채,-,Term 18,4493819499,Term 17,4377774564,Term 16,4059129237,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_OtherNoncurrentLiabilities,기타비유동부채,-,Term 18,28390413508,Term 17,21493053071,Term 16,23603491824,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,dart_NonOperatingProfitLoss,기타영업외손익,-,Term 18,-11604794732,Term 17,13044673857,Term 16,-45496828367,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익,-,Term 18,108171257062,Term 17,214233255761,Term 16,343357809050,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,당기총포괄손익,-,Term 18,133397969818,Term 17,102216783205,Term 16,165216553094,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배주주지분,-,Term 18,-5852768057,Term 17,-6382222547,Term 16,-13252227235,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업의 소유주지분,-,Term 18,139250737875,Term 17,108599005752,Term 16,178468780329,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 18,1155064685469,Term 17,1337512406849,Term 16,1362639202428,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,우선주기본주당이익,-,Term 18,2614,Term 17,1954,Term 16,2821,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,우선주희석주당이익,-,Term 18,2614,Term 17,1954,Term 16,2821,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주기본주당이익,-,Term 18,2609,Term 17,1949,Term 16,2820,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_DilutedEarningsLossPerShare,보통주희석주당이익,-,Term 18,2609,Term 17,1948,Term 16,2818,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 18,19166374797,Term 17,34413883142,Term 16,11410260207,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 18,161577461724,Term 17,22771702594,Term 16,10499109599,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 18,2518898907688,Term 17,2797420105262,Term 16,3500489294271,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 18,106754652265,Term 17,95229524211,Term 16,117019762555,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,당기법인세비용차감후기타포괄손익,-,Term 18,-40480959178,Term 17,-27047461753,Term 16,-15641140883,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,-,Term 18,449127731,Term 17,-31891807328,Term 16,31358419049,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업기타포괄손익지분,-,Term 18,887839826,Term 17,-606664733,Term 16,260637659,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정금융자산평가손익,-,Term 18,-458211,Term 17,-31630608,Term 16,109285659,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,-,Term 18,-41817468524,Term 17,5482640916,Term 16,-47369483250,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익,-,Term 18,173878928996,Term 17,129264244958,Term 16,180857693977,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배주주지분,-,Term 18,-6222916366,Term 17,-5210567492,Term 16,-12822884750,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 18,180101845362,Term 17,134474812450,Term 16,193680578727,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세차감전순이익,-,Term 18,280633581261,Term 17,224493769169,Term 16,297877456532,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 18,3673963593157,Term 17,4134932512111,Term 16,4863128496699,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_SellingGeneralAndAdministrativeExpense,판매비와 관리비,-,Term 18,2410727650626,Term 17,2583186849501,Term 16,3157131485221,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod,관계기업손익,-,Term 18,41656032004,Term 17,8858020099,Term 16,927626457,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초의 현금및현금성자산,-,Term 18,449597948392,Term 17,537693630647,Term 16,793728286323,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말의 현금및현금성자산,-,Term 18,506379386493,Term 17,449597948392,Term 16,537693630647,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동으로 인한 현금흐름,-,Term 18,-98619351026,Term 17,-154550827468,Term 16,-225980969342,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_DecreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 반환,-,Term 18,4840197081,Term 17,2910596555,Term 16,1388649976,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_IncreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 수취,-,Term 18,2450248000,Term 17,2012976000,Term 16,5297434200,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 증가,-,Term 18,40823433333,Term 17,45369950991,Term 16,17070110907,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 감소,-,Term 18,20299153462,Term 17,22790212000,Term 16,33166492045,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금의 지급,-,Term 18,47045103906,Term 17,68147576757,Term 16,54834267960,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 상환？,-,Term 18,69389612880,Term 17,105600934697,Term 16,140273953288,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,-,Term 18,318965030,Term 17,2484434450,Term 16,18685151180,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동으로 인한 현금흐름,-,Term 18,-186166228672,Term 17,-68513788688,Term 16,-708415251302,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfCurrentFairValueFinancialAsset,유동성 당기손익-공정가치측정금융자산의 순감소,-,Term 18,0,Term 17,232549103448,Term 16,,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산의 처분,-,Term 18,0,Term 17,730010465,Term 16,,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfNonCurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정비유동자산의 처분,-,Term 18,26542501310,Term 17,6246100000,Term 16,,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_PurchaseOfCurrentFairValueFinancialAsset,유동성 당기손익-공정가치측정금융자산의 순증가,-,Term 18,65303825196,Term 17,0,Term 16,,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_PurchaseOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산의 취득,-,Term 18,0,Term 17,2500004160,Term 16,3000080160,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_PurchaseOfInvestmentsInAssociates,종속기업및관계기업투자주식의 취득,-,Term 18,,Term 17,,Term 16,183255851946,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_PurchaseOfNonCurrentFairValueFinancialAsset,비유동성 당기손익-공정가치측정금융자산의 취득,-,Term 18,0,Term 17,16917338331,Term 16,103516979920,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,-Standard account code not used-,기타의 현금유입액,-,Term 18,2902814938,Term 17,0,Term 16,11434877000,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,-Standard account code not used-,기타수취채권의 감소,-,Term 18,30912429409,Term 17,28546250251,Term 16,31526378078,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,-Standard account code not used-,비유동성 금융기관예치금의 취득,-,Term 18,1106477374,Term 17,1500002760,Term 16,1503002760,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,-Standard account code not used-,기타수취채권의 증가,-,Term 18,18224949583,Term 17,10071148219,Term 16,29564010651,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,-Standard account code not used-,사업결합 등으로 인한 순현금유입,-,Term 18,,Term 17,,Term 16,44874437795,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,-Standard account code not used-,사업결합으로 인한 순현금유출,-,Term 18,0,Term 17,175584951002,Term 16,,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,-Standard account code not used-,유동성 상각후원가측정금융자산의 순증가,-,Term 18,28630000000,Term 17,30000000000,Term 16,320522606869,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,-Standard account code not used-,상각후원가측정 금융자산의 처분,-,Term 18,140415000,Term 17,460580082,Term 16,1313800001,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,-Standard account code not used-,비유동성 상각후원가측정금융자산의 취득,-,Term 18,686680000,Term 17,0,Term 16,,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_AdditionsToRightofuseAssets,사용권자산의 증가,-,Term 18,49185077,Term 17,125343250,Term 16,26671000,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments,유동성 금융기관예치금의 순감소,-,Term 18,12818224621,Term 17,27325462000,Term 16,-43094000000,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 18,89844275,Term 17,68619860,Term 16,414580271,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 18,1288829494,Term 17,3105500000,Term 16,4226483920,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 18,26648118986,Term 17,4018992178,Term 16,3276022744,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 18,39012379319,Term 17,35575628339,Term 16,29815783627,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 18,134495910156,Term 17,99289990911,Term 16,91182844178,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동으로 인한 현금흐름,-,Term 18,348227953524,Term 17,151023730340,Term 16,691434410702,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperations,영업으로부터 창출된 현금흐름,-,Term 18,405675378475,Term 17,281138081103,Term 16,714854553223,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세의 납부,-,Term 18,53423466062,Term 17,124916274858,Term 16,17546993277,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자의 지급,-,Term 18,15035702506,Term 17,11472337649,Term 16,9899193484,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 18,11011743617,Term 17,6274261744,Term 16,4026044240,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,외화환산으로 인한 현금및현금성자산 증감,-,Term 18,-6660935725,Term 17,-16054796439,Term 16,-13072845734,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalents,현금및현금성자산의 증감,-,Term 18,56781438101,Term 17,-88095682255,Term 16,-256034655676,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결대상범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 18,,Term 17,,Term 16,49987163509,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결대상범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 18,,Term 17,,Term 16,-1430107868,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결대상범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,,Term 17,,Term 16,48557055641,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결대상범위의 변동,연결재무제표 [member],Term 18,,Term 17,,Term 16,48557055641,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_DispositionOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,4614981434,Term 17,10247005000,Term 16,115817520000,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_DispositionOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 18,5238580957,Term 17,10182066538,Term 16,101259270904,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_DispositionOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 18,-623599523,Term 17,64938462,Term 16,14558249096,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_DispositionOfTreasuryShares,자기주식의 처분,연결재무제표 [member],Term 18,4614981434,Term 17,10247005000,Term 16,115817520000,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,4798613296098,Term 17,4761008405615,Term 16,4467854044953,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|비지배지분 [구성요소],Term 18,-19338192039,Term 17,-16708527993,Term 16,-3456300758,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 18,4779275104059,Term 17,4744299877622,Term 16,4464397744195,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 18,-18139434036,Term 17,-19004134338,Term 16,-117631782499,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 18,720480827092,Term 17,720480827092,Term 16,712701764092,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 18,71118560015,Term 17,75352826661,Term 16,10807414056,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 18,34525294500,Term 17,34525294500,Term 16,34508160000,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 18,4010086561524,Term 17,3937774554979,Term 16,3847747137435,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 18,-19458512997,Term 17,11879036721,Term 16,-20278648131,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산 처분에 따른 대체,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 18,,Term 17,-20897896,Term 16,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산 처분에 따른 대체,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 18,,Term 17,20897896,Term 16,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,46969566825,Term 17,67624548925,Term 16,54853570065,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|비지배지분 [구성요소],Term 18,91954436,Term 17,546646607,Term 16,,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,연결재무제표 [member],Term 18,47061521261,Term 17,68171195532,Term 16,54853570065,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 18,46969566825,Term 17,67624548925,Term 16,54853570065,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 18,73397775430,Term 17,71118560015,Term 16,75352826661,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 18,34525294500,Term 17,34525294500,Term 16,34525294500,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 18,4101401371537,Term 17,4010086561524,Term 16,3937774554979,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 18,-18492151960,Term 17,-19458512997,Term 16,11879036721,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 18,-13324991010,Term 17,-18139434036,Term 16,-19004134338,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,4897988125589,Term 17,4798613296098,Term 16,4761008405615,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|비지배지분 [구성요소],Term 18,-25282914532,Term 17,-19338192039,Term 16,-16708527993,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,연결재무제표 [member],Term 18,4872705211057,Term 17,4779275104059,Term 16,4744299877622,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 18,720480827092,Term 17,720480827092,Term 16,720480827092,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|비지배지분 [구성요소],Term 18,,Term 17,4299205108,Term 16,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,,Term 17,-4299205108,Term 16,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 18,,Term 17,-4299205108,Term 16,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,연결재무제표 [member],Term 18,-105172901,Term 17,-9317366236,Term 16,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,-105172901,Term 17,-9317366236,Term 16,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 18,-105172901,Term 17,-9317366236,Term 16,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,연결재무제표 [member],Term 18,2902814938,Term 17,,Term 16,16053528437,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 18,2902814938,Term 17,,Term 16,,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 18,,Term 17,,Term 16,16053528437,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,2902814938,Term 17,,Term 16,16053528437,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,지분의 발행,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 18,,Term 17,,Term 16,17134500,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,지분의 발행,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,,Term 17,,Term 16,7796197500,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,지분의 발행,연결재무제표 [member],Term 18,,Term 17,,Term 16,7796197500,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,지분의 발행,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 18,,Term 17,,Term 16,7779063000,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,연결재무제표 [member],Term 18,449127731,Term 17,-31891807328,Term 16,31358419049,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|비지배지분 [구성요소],Term 18,370103282,Term 17,-1141178292,Term 16,-434440805,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 18,79024449,Term 17,-30750629036,Term 16,31792859854,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,79024449,Term 17,-30750629036,Term 16,31792859854,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정금융자산평가손익,연결재무제표 [member],Term 18,-458211,Term 17,-31630608,Term 16,109285659,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정금융자산평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,-458211,Term 17,-31630608,Term 16,109285659,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정금융자산평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 18,-458211,Term 17,-31630608,Term 16,109285659,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,연결재무제표 [member],Term 18,-41817468524,Term 17,5482640916,Term 16,-47369483250,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,-41817468524,Term 17,5482640916,Term 16,-47369483250,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 18,-41817468524,Term 17,5482640916,Term 16,-47369483250,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,연결재무제표 [member],Term 18,173878928996,Term 17,129264244958,Term 16,180857693977,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 18,180101845362,Term 17,134474812450,Term 16,193680578727,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,180101845362,Term 17,134474812450,Term 16,193680578727,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|비지배지분 [구성요소],Term 18,-6222916366,Term 17,-5210567492,Term 16,-12822884750,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,318965030,Term 17,,Term 16,-18685151180,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,연결재무제표 [member],Term 18,318965030,Term 17,2484434450,Term 16,18685151180,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 18,318965030,Term 17,,Term 16,-18685151180,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업기타포괄손익지분,자본 [구성요소]|비지배지분 [구성요소],Term 18,45027,Term 17,-30476763,Term 16,5098320,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업기타포괄손익지분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,887794799,Term 17,-576187970,Term 16,255539339,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업기타포괄손익지분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 18,887794799,Term 17,-576187970,Term 16,255539339,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업기타포괄손익지분,연결재무제표 [member],Term 18,887839826,Term 17,-606664733,Term 16,260637659,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 18,5886510888702,Term 17,5801783178159,Term 16,6116713932912,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 18,1952196456821,Term 17,1735019347862,Term 16,2018526858100,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 18,506379386493,Term 17,449597948392,Term 16,537693630647,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentFinancialAssetsAtAmortisedCost,상각후원가측정금융자산,-,Term 18,58630000000,Term 17,30000000000,Term 16,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss,당기손익-공정가치측정금융자산,-,Term 18,549634663158,Term 17,362939892414,Term 16,490839332272,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 18,1395767125,Term 17,1589648122,Term 16,3330887323,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentTradeReceivables,매출채권,-,Term 18,292900370185,Term 17,285104514893,Term 16,295769466239,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 18,394311802314,Term 17,408934396533,Term 16,493223642997,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners,매각예정비유동자산,-,Term 18,0,Term 17,19949060448,Term 16,4066226107,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_OtherCurrentAssets,기타유동자산,-,Term 18,40810673046,Term 17,39587746609,Term 16,50130929669,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_OtherCurrentReceivables,기타수취채권,-,Term 18,46359581121,Term 17,62646902451,Term 16,41647242846,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents,금융기관예치금,-,Term 18,61774213379,Term 17,74669238000,Term 16,101825500000,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 18,3934314431881,Term 17,4066763830297,Term 16,4098187074812,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 18,13846205025,Term 17,57853971328,Term 16,84608399877,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_IntangibleAssetsAndGoodwill,무형자산,-,Term 18,340680136431,Term 17,357750954252,Term 16,201680029794,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 18,496219430433,Term 17,503268138559,Term 16,534228580408,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod,관계기업투자주식,-,Term 18,287060733528,Term 17,247279224799,Term 16,238445368790,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_LongtermDeposits,금융기관예치금,-,Term 18,23988856981,Term 17,21989149194,Term 16,19512730100,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtAmortisedCost,상각후원가측정금융자산,-,Term 18,976580000,Term 17,430315000,Term 16,811274982,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss,당기손익-공정가치측정금융자산,-,Term 18,33031318251,Term 17,8017318251,Term 16,104256383649,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산,-,Term 18,6216765880,Term 17,6216765880,Term 16,4672325200,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentRecognisedAssetsDefinedBenefitPlan,순확정급여자산,-,Term 18,112607043654,Term 17,181406890326,Term 16,94729521034,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_OtherNoncurrentAssets,기타비유동자산,-,Term 18,9643263718,Term 17,12044243171,Term 16,12252020689,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_OtherNoncurrentReceivables,기타수취채권,-,Term 18,67356278864,Term 17,66737893651,Term 16,115162575008,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 18,2441603701077,Term 17,2475276690492,Term 16,2541362150975,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 18,101084118039,Term 17,128492275394,Term 16,146465714306,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 18,4872705211057,Term 17,4779275104059,Term 16,4744299877622,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업의 소유주에게 귀속되는 자본,-,Term 18,4897988125589,Term 17,4798613296098,Term 16,4761008405615,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 18,73397775430,Term 17,71118560015,Term 16,75352826661,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본구성요소,-,Term 18,-13324991010,Term 17,-18139434036,Term 16,-19004134338,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_AccumulatedOtherComprehensiveIncome,기타포괄손익누계액,-,Term 18,-18492151960,Term 17,-19458512997,Term 16,11879036721,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 18,34525294500,Term 17,34525294500,Term 16,34525294500,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 18,4101401371537,Term 17,4010086561524,Term 16,3937774554979,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_SharePremium,주식발행초과금,-,Term 18,720480827092,Term 17,720480827092,Term 16,720480827092,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배주주지분,-,Term 18,-25282914532,Term 17,-19338192039,Term 16,-16708527993,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채와자본총계,-,Term 18,5886510888702,Term 17,5801783178159,Term 16,6116713932912,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 18,813257101661,Term 17,831116935949,Term 16,1157485393842,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentContractLiabilities,계약부채,-,Term 18,33409778405,Term 17,36625353980,Term 16,37465486262,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,리스유동부채,-,Term 18,55346660805,Term 17,69006139263,Term 16,94760913961,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentProvisions,기타충당부채,-,Term 18,47465342867,Term 17,30597338613,Term 16,8906185258,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 18,22688183409,Term 17,41108987667,Term 16,89962740389,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_OtherCurrentLiabilities,기타유동부채,-,Term 18,198295675757,Term 17,194751573434,Term 16,278857266265,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_OtherCurrentPayables,기타지급채무,-,Term 18,125500534330,Term 17,154937768894,Term 16,324998426639,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 18,244108853364,Term 17,223413563558,Term 16,199124082671,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers,매입채무,-,Term 18,86442072724,Term 17,80676210540,Term 16,123410292397,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 18,1013805677645,Term 17,1022508074100,Term 16,1372414055290,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 18,200548575984,Term 17,191391138151,Term 16,214928661448,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 18,106367521222,Term 17,91265971878,Term 16,79488075447,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,리스비유동부채,-,Term 18,50947819097,Term 17,64785225166,Term 16,96221153680,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,기타충당부채,-,Term 18,10349002658,Term 17,9469113472,Term 16,11556811260,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan,순확정급여부채,-,Term 18,4493819499,Term 17,4377774564,Term 16,4059129237,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,BS,Statement of financial position,ifrs-full_OtherNoncurrentLiabilities,기타비유동부채,-,Term 18,28390413508,Term 17,21493053071,Term 16,23603491824,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,dart_NonOperatingProfitLoss,기타영업외손익,-,Term 18,-11604794732,Term 17,13044673857,Term 16,-45496828367,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익,-,Term 18,108171257062,Term 17,214233255761,Term 16,343357809050,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,당기총포괄손익,-,Term 18,133397969818,Term 17,102216783205,Term 16,165216553094,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배주주지분,-,Term 18,-5852768057,Term 17,-6382222547,Term 16,-13252227235,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업의 소유주지분,-,Term 18,139250737875,Term 17,108599005752,Term 16,178468780329,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 18,1155064685469,Term 17,1337512406849,Term 16,1362639202428,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,우선주기본주당이익,-,Term 18,2614,Term 17,1954,Term 16,2821,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,우선주희석주당이익,-,Term 18,2614,Term 17,1954,Term 16,2821,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주기본주당이익,-,Term 18,2609,Term 17,1949,Term 16,2820,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_DilutedEarningsLossPerShare,보통주희석주당이익,-,Term 18,2609,Term 17,1948,Term 16,2818,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 18,19166374797,Term 17,34413883142,Term 16,11410260207,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 18,161577461724,Term 17,22771702594,Term 16,10499109599,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 18,2518898907688,Term 17,2797420105262,Term 16,3500489294271,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 18,106754652265,Term 17,95229524211,Term 16,117019762555,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,당기법인세비용차감후기타포괄손익,-,Term 18,-40480959178,Term 17,-27047461753,Term 16,-15641140883,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,-,Term 18,449127731,Term 17,-31891807328,Term 16,31358419049,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업기타포괄손익지분,-,Term 18,887839826,Term 17,-606664733,Term 16,260637659,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정금융자산평가손익,-,Term 18,-458211,Term 17,-31630608,Term 16,109285659,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,-,Term 18,-41817468524,Term 17,5482640916,Term 16,-47369483250,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익,-,Term 18,173878928996,Term 17,129264244958,Term 16,180857693977,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배주주지분,-,Term 18,-6222916366,Term 17,-5210567492,Term 16,-12822884750,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 18,180101845362,Term 17,134474812450,Term 16,193680578727,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세차감전순이익,-,Term 18,280633581261,Term 17,224493769169,Term 16,297877456532,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 18,3673963593157,Term 17,4134932512111,Term 16,4863128496699,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_SellingGeneralAndAdministrativeExpense,판매비와 관리비,-,Term 18,2410727650626,Term 17,2583186849501,Term 16,3157131485221,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CIS,Statement of comprehensive income,ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod,관계기업손익,-,Term 18,41656032004,Term 17,8858020099,Term 16,927626457,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초의 현금및현금성자산,-,Term 18,449597948392,Term 17,537693630647,Term 16,793728286323,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말의 현금및현금성자산,-,Term 18,506379386493,Term 17,449597948392,Term 16,537693630647,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동으로 인한 현금흐름,-,Term 18,-98619351026,Term 17,-154550827468,Term 16,-225980969342,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_DecreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 반환,-,Term 18,4840197081,Term 17,2910596555,Term 16,1388649976,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_IncreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 수취,-,Term 18,2450248000,Term 17,2012976000,Term 16,5297434200,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 증가,-,Term 18,40823433333,Term 17,45369950991,Term 16,17070110907,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 감소,-,Term 18,20299153462,Term 17,22790212000,Term 16,33166492045,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금의 지급,-,Term 18,47045103906,Term 17,68147576757,Term 16,54834267960,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 상환？,-,Term 18,69389612880,Term 17,105600934697,Term 16,140273953288,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,-,Term 18,318965030,Term 17,2484434450,Term 16,18685151180,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동으로 인한 현금흐름,-,Term 18,-186166228672,Term 17,-68513788688,Term 16,-708415251302,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfCurrentFairValueFinancialAsset,유동성 당기손익-공정가치측정금융자산의 순감소,-,Term 18,0,Term 17,232549103448,Term 16,,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치금융자산의 처분,-,Term 18,0,Term 17,730010465,Term 16,,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfNonCurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정비유동자산의 처분,-,Term 18,26542501310,Term 17,6246100000,Term 16,,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_PurchaseOfCurrentFairValueFinancialAsset,유동성 당기손익-공정가치측정금융자산의 순증가,-,Term 18,65303825196,Term 17,0,Term 16,,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_PurchaseOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산의 취득,-,Term 18,0,Term 17,2500004160,Term 16,3000080160,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_PurchaseOfInvestmentsInAssociates,종속기업및관계기업투자주식의 취득,-,Term 18,,Term 17,,Term 16,183255851946,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,dart_PurchaseOfNonCurrentFairValueFinancialAsset,비유동성 당기손익-공정가치측정금융자산의 취득,-,Term 18,0,Term 17,16917338331,Term 16,103516979920,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,-Standard account code not used-,기타의 현금유입액,-,Term 18,2902814938,Term 17,0,Term 16,11434877000,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,-Standard account code not used-,기타수취채권의 감소,-,Term 18,30912429409,Term 17,28546250251,Term 16,31526378078,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,-Standard account code not used-,비유동성 금융기관예치금의 취득,-,Term 18,1106477374,Term 17,1500002760,Term 16,1503002760,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,-Standard account code not used-,기타수취채권의 증가,-,Term 18,18224949583,Term 17,10071148219,Term 16,29564010651,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,-Standard account code not used-,사업결합 등으로 인한 순현금유입,-,Term 18,,Term 17,,Term 16,44874437795,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,-Standard account code not used-,사업결합으로 인한 순현금유출,-,Term 18,0,Term 17,175584951002,Term 16,,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,-Standard account code not used-,유동성 상각후원가측정금융자산의 순증가,-,Term 18,28630000000,Term 17,30000000000,Term 16,320522606869,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,-Standard account code not used-,상각후원가측정 금융자산의 처분,-,Term 18,140415000,Term 17,460580082,Term 16,1313800001,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,-Standard account code not used-,비유동성 상각후원가측정금융자산의 취득,-,Term 18,686680000,Term 17,0,Term 16,,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_AdditionsToRightofuseAssets,사용권자산의 증가,-,Term 18,49185077,Term 17,125343250,Term 16,26671000,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments,유동성 금융기관예치금의 순감소,-,Term 18,12818224621,Term 17,27325462000,Term 16,-43094000000,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 18,89844275,Term 17,68619860,Term 16,414580271,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 18,1288829494,Term 17,3105500000,Term 16,4226483920,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 18,26648118986,Term 17,4018992178,Term 16,3276022744,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 18,39012379319,Term 17,35575628339,Term 16,29815783627,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 18,134495910156,Term 17,99289990911,Term 16,91182844178,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동으로 인한 현금흐름,-,Term 18,348227953524,Term 17,151023730340,Term 16,691434410702,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperations,영업으로부터 창출된 현금흐름,-,Term 18,405675378475,Term 17,281138081103,Term 16,714854553223,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세의 납부,-,Term 18,53423466062,Term 17,124916274858,Term 16,17546993277,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자의 지급,-,Term 18,15035702506,Term 17,11472337649,Term 16,9899193484,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 18,11011743617,Term 17,6274261744,Term 16,4026044240,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,외화환산으로 인한 현금및현금성자산 증감,-,Term 18,-6660935725,Term 17,-16054796439,Term 16,-13072845734,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalents,현금및현금성자산의 증감,-,Term 18,56781438101,Term 17,-88095682255,Term 16,-256034655676,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결대상범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 18,,Term 17,,Term 16,49987163509,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결대상범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 18,,Term 17,,Term 16,-1430107868,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결대상범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,,Term 17,,Term 16,48557055641,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결대상범위의 변동,연결재무제표 [member],Term 18,,Term 17,,Term 16,48557055641,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_DispositionOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,4614981434,Term 17,10247005000,Term 16,115817520000,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_DispositionOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 18,5238580957,Term 17,10182066538,Term 16,101259270904,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_DispositionOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 18,-623599523,Term 17,64938462,Term 16,14558249096,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_DispositionOfTreasuryShares,자기주식의 처분,연결재무제표 [member],Term 18,4614981434,Term 17,10247005000,Term 16,115817520000,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,4798613296098,Term 17,4761008405615,Term 16,4467854044953,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|비지배지분 [구성요소],Term 18,-19338192039,Term 17,-16708527993,Term 16,-3456300758,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 18,4779275104059,Term 17,4744299877622,Term 16,4464397744195,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 18,-18139434036,Term 17,-19004134338,Term 16,-117631782499,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 18,720480827092,Term 17,720480827092,Term 16,712701764092,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 18,71118560015,Term 17,75352826661,Term 16,10807414056,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 18,34525294500,Term 17,34525294500,Term 16,34508160000,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 18,4010086561524,Term 17,3937774554979,Term 16,3847747137435,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 18,-19458512997,Term 17,11879036721,Term 16,-20278648131,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산 처분에 따른 대체,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 18,,Term 17,-20897896,Term 16,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산 처분에 따른 대체,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 18,,Term 17,20897896,Term 16,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,46969566825,Term 17,67624548925,Term 16,54853570065,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|비지배지분 [구성요소],Term 18,91954436,Term 17,546646607,Term 16,,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,연결재무제표 [member],Term 18,47061521261,Term 17,68171195532,Term 16,54853570065,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 18,46969566825,Term 17,67624548925,Term 16,54853570065,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 18,73397775430,Term 17,71118560015,Term 16,75352826661,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 18,34525294500,Term 17,34525294500,Term 16,34525294500,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 18,4101401371537,Term 17,4010086561524,Term 16,3937774554979,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 18,-18492151960,Term 17,-19458512997,Term 16,11879036721,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 18,-13324991010,Term 17,-18139434036,Term 16,-19004134338,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,4897988125589,Term 17,4798613296098,Term 16,4761008405615,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|비지배지분 [구성요소],Term 18,-25282914532,Term 17,-19338192039,Term 16,-16708527993,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,연결재무제표 [member],Term 18,4872705211057,Term 17,4779275104059,Term 16,4744299877622,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 18,720480827092,Term 17,720480827092,Term 16,720480827092,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|비지배지분 [구성요소],Term 18,,Term 17,4299205108,Term 16,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,,Term 17,-4299205108,Term 16,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 18,,Term 17,-4299205108,Term 16,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,연결재무제표 [member],Term 18,-105172901,Term 17,-9317366236,Term 16,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,-105172901,Term 17,-9317366236,Term 16,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 18,-105172901,Term 17,-9317366236,Term 16,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,연결재무제표 [member],Term 18,2902814938,Term 17,,Term 16,16053528437,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 18,2902814938,Term 17,,Term 16,,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 18,,Term 17,,Term 16,16053528437,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,2902814938,Term 17,,Term 16,16053528437,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,지분의 발행,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 18,,Term 17,,Term 16,17134500,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,지분의 발행,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,,Term 17,,Term 16,7796197500,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,지분의 발행,연결재무제표 [member],Term 18,,Term 17,,Term 16,7796197500,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,지분의 발행,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 18,,Term 17,,Term 16,7779063000,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,연결재무제표 [member],Term 18,449127731,Term 17,-31891807328,Term 16,31358419049,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|비지배지분 [구성요소],Term 18,370103282,Term 17,-1141178292,Term 16,-434440805,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 18,79024449,Term 17,-30750629036,Term 16,31792859854,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,79024449,Term 17,-30750629036,Term 16,31792859854,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정금융자산평가손익,연결재무제표 [member],Term 18,-458211,Term 17,-31630608,Term 16,109285659,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정금융자산평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,-458211,Term 17,-31630608,Term 16,109285659,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정금융자산평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 18,-458211,Term 17,-31630608,Term 16,109285659,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,연결재무제표 [member],Term 18,-41817468524,Term 17,5482640916,Term 16,-47369483250,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,-41817468524,Term 17,5482640916,Term 16,-47369483250,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 18,-41817468524,Term 17,5482640916,Term 16,-47369483250,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,연결재무제표 [member],Term 18,173878928996,Term 17,129264244958,Term 16,180857693977,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 18,180101845362,Term 17,134474812450,Term 16,193680578727,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,180101845362,Term 17,134474812450,Term 16,193680578727,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|비지배지분 [구성요소],Term 18,-6222916366,Term 17,-5210567492,Term 16,-12822884750,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,318965030,Term 17,,Term 16,-18685151180,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,연결재무제표 [member],Term 18,318965030,Term 17,2484434450,Term 16,18685151180,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 18,318965030,Term 17,,Term 16,-18685151180,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업기타포괄손익지분,자본 [구성요소]|비지배지분 [구성요소],Term 18,45027,Term 17,-30476763,Term 16,5098320,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업기타포괄손익지분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 18,887794799,Term 17,-576187970,Term 16,255539339,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업기타포괄손익지분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 18,887794799,Term 17,-576187970,Term 16,255539339,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20240307000545,11011,2023,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업기타포괄손익지분,연결재무제표 [member],Term 18,887839826,Term 17,-606664733,Term 16,260637659,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 19,6783507800768,Term 18,5886510888702,Term 17,5801783178159,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 19,1734808826757,Term 18,1952196456821,Term 17,1735019347862,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 19,451543362844,Term 18,506379386493,Term 17,449597948392,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentFinancialAssetsAtAmortisedCost,상각후원가측정금융자산,-,Term 19,30000000000,Term 18,58630000000,Term 17,30000000000,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss,당기손익-공정가치측정금융자산,-,Term 19,226504379260,Term 18,549634663158,Term 17,362939892414,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 19,863754249,Term 18,1395767125,Term 17,1589648122,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentTradeReceivables,매출채권,-,Term 19,386339598982,Term 18,292900370185,Term 17,285104514893,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 19,497801286466,Term 18,394311802314,Term 17,408934396533,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners,매각예정비유동자산,-,Term 19,0,Term 18,0,Term 17,19949060448,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_OtherCurrentAssets,기타유동자산,-,Term 19,43556635015,Term 18,40810673046,Term 17,39587746609,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_OtherCurrentReceivables,기타수취채권,-,Term 19,51538106251,Term 18,46359581121,Term 17,62646902451,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents,금융기관예치금,-,Term 19,46661703690,Term 18,61774213379,Term 17,74669238000,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 19,5048698974011,Term 18,3934314431881,Term 17,4066763830297,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 19,50941924787,Term 18,13846205025,Term 17,57853971328,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_IntangibleAssetsAndGoodwill,무형자산,-,Term 19,1773943897518,Term 18,340680136431,Term 17,357750954252,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_InvestmentAccountedForUsingEquityMethod,관계기업투자주식,-,Term 19,5819500670,Term 18,287060733528,Term 17,247279224799,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 19,594687077636,Term 18,496219430433,Term 17,503268138559,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_LongtermDeposits,금융기관예치금,-,Term 19,26529014383,Term 18,23988856981,Term 17,21989149194,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtAmortisedCost,상각후원가측정금융자산,-,Term 19,964525000,Term 18,976580000,Term 17,430315000,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss,당기손익-공정가치측정금융자산,-,Term 19,9454592251,Term 18,33031318251,Term 17,8017318251,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산,-,Term 19,5063012560,Term 18,6216765880,Term 17,6216765880,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentRecognisedAssetsDefinedBenefitPlan,순확정급여자산,-,Term 19,75350672263,Term 18,112607043654,Term 17,181406890326,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_OtherNoncurrentAssets,기타비유동자산,-,Term 19,8348830264,Term 18,9643263718,Term 17,12044243171,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_OtherNoncurrentReceivables,기타수취채권,-,Term 19,63832374479,Term 18,67356278864,Term 17,66737893651,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 19,2296405530047,Term 18,2441603701077,Term 17,2475276690492,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 19,137358022153,Term 18,101084118039,Term 17,128492275394,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 19,5326007889106,Term 18,4872705211057,Term 17,4779275104059,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업의 소유주에게 귀속되는 자본,-,Term 19,5252371283408,Term 18,4897988125589,Term 17,4798613296098,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 19,-97250231856,Term 18,73397775430,Term 17,71118560015,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본구성요소,-,Term 19,-18266246371,Term 18,-13324991010,Term 17,-18139434036,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_AccumulatedOtherComprehensiveIncome,기타포괄손익누계액,-,Term 19,11925615841,Term 18,-18492151960,Term 17,-19458512997,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 19,34525294500,Term 18,34525294500,Term 17,34525294500,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 19,4600956024202,Term 18,4101401371537,Term 17,4010086561524,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_SharePremium,주식발행초과금,-,Term 19,720480827092,Term 18,720480827092,Term 17,720480827092,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배주주지분,-,Term 19,73636605698,Term 18,-25282914532,Term 17,-19338192039,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채와자본총계,-,Term 19,6783507800768,Term 18,5886510888702,Term 17,5801783178159,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 19,1095705144331,Term 18,813257101661,Term 17,831116935949,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentContractLiabilities,계약부채,-,Term 19,36018371304,Term 18,33409778405,Term 17,36625353980,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,리스유동부채,-,Term 19,61264289188,Term 18,55346660805,Term 17,69006139263,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentProvisions,기타충당부채,-,Term 19,76288195477,Term 18,47465342867,Term 17,30597338613,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 19,55008652808,Term 18,22688183409,Term 17,41108987667,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_OtherCurrentLiabilities,기타유동부채,-,Term 19,177293445809,Term 18,198295675757,Term 17,194751573434,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_OtherCurrentPayables,기타지급채무,-,Term 19,287672036903,Term 18,125500534330,Term 17,154937768894,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 19,306194906069,Term 18,244108853364,Term 17,223413563558,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers,매입채무,-,Term 19,95965246773,Term 18,86442072724,Term 17,80676210540,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 19,1457499911662,Term 18,1013805677645,Term 17,1022508074100,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 19,361794767331,Term 18,200548575984,Term 17,191391138151,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 19,235817308122,Term 18,106367521222,Term 17,91265971878,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,리스비유동부채,-,Term 19,72758957849,Term 18,50947819097,Term 17,64785225166,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,기타충당부채,-,Term 19,13581666804,Term 18,10349002658,Term 17,9469113472,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan,순확정급여부채,-,Term 19,6255776125,Term 18,4493819499,Term 17,4377774564,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_OtherNoncurrentLiabilities,기타비유동부채,-,Term 19,33381058431,Term 18,28390413508,Term 17,21493053071,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,dart_NonOperatingProfitLoss,기타영업외손익,-,Term 19,302438171470,Term 18,-11604794732,Term 17,13044673857,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익,-,Term 19,220481343913,Term 18,108171257062,Term 17,214233255761,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,당기총포괄이익,-,Term 19,600385955960,Term 18,133397969818,Term 17,102216783205,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배주주지분,-,Term 19,7549684539,Term 18,-5852768057,Term 17,-6382222547,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 19,592836271421,Term 18,139250737875,Term 17,108599005752,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 19,1138378200862,Term 18,1155064685469,Term 17,1337512406849,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,우선주기본주당이익,-,Term 19,8606,Term 18,2614,Term 17,1954,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,우선주희석주당이익,-,Term 19,8606,Term 18,2614,Term 17,1954,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주기본주당이익,-,Term 19,8601,Term 18,2609,Term 17,1949,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_DilutedEarningsLossPerShare,보통주희석주당이익 (단위: 원),-,Term 19,8600,Term 18,2609,Term 17,1948,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 19,42891624478,Term 18,19166374797,Term 17,34413883142,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 19,124302837964,Term 18,161577461724,Term 17,22771702594,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 19,2746732498324,Term 18,2518898907688,Term 17,2797420105262,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용(수익),-,Term 19,19163847751,Term 18,106754652265,Term 17,95229524211,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,세후기타포괄손익,-,Term 19,-1255417875,Term 18,-40480959178,Term 17,-27047461753,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,-,Term 19,28125571183,Term 18,449127731,Term 17,-31891807328,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,-,Term 19,2292375258,Term 18,887839826,Term 17,-606664733,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,-,Term 19,-887236303,Term 18,-458211,Term 17,-31630608,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,-,Term 19,-30786128013,Term 18,-41817468524,Term 17,5482640916,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 19,601641373835,Term 18,173878928996,Term 17,129264244958,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배주주지분,-,Term 19,8454160762,Term 18,-6222916366,Term 17,-5210567492,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 19,593187213073,Term 18,180101845362,Term 17,134474812450,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 19,620805221586,Term 18,280633581261,Term 17,224493769169,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 19,3885110699186,Term 18,3673963593157,Term 17,4134932512111,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_SellingGeneralAndAdministrativeExpense,판매비와관리비,-,Term 19,2526251154411,Term 18,2410727650626,Term 17,2583186849501,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod,관계기업손익,-,Term 19,16474492717,Term 18,41656032004,Term 17,8858020099,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초의 현금및현금성자산,-,Term 19,506379386493,Term 18,449597948392,Term 17,537693630647,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말의 현금및현금성자산,-,Term 19,451543362844,Term 18,506379386493,Term 17,449597948392,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동으로 인한 현금흐름,-,Term 19,-98829601873,Term 18,-98619351026,Term 17,-154550827468,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_AcquisitionOfTreasuryShares,자기주식의 취득,-,Term 19,10906786850,Term 18,318965030,Term 17,2484434450,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_DecreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 반환,-,Term 19,1250714895,Term 18,4840197081,Term 17,2910596555,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_IncreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 수취,-,Term 19,7488136000,Term 18,2450248000,Term 17,2012976000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금의 지급,-,Term 19,63109815914,Term 18,47045103906,Term 17,68147576757,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 상환,-,Term 19,65042910294,Term 18,69389612880,Term 17,105600934697,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromCurrentBorrowings,단기차입금의 증가,-,Term 19,61984835780,Term 18,40823433333,Term 17,45369950991,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_RepaymentsOfCurrentBorrowings,단기차입금의 감소,-,Term 19,27992345700,Term 18,20299153462,Term 17,22790212000,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동으로 인한 현금흐름,-,Term 19,-312170664712,Term 18,-186166228672,Term 17,-68513788688,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfCurrentFairValueFinancialAsset,유동성 당기손익-공정가치측정 금융자산의 순감소,-,Term 19,238900715972,Term 18,0,Term 17,232549103448,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산의처분,-,Term 19,,Term 18,,Term 17,730010465,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfNonCurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정비유동자산의 처분,-,Term 19,0,Term 18,26542501310,Term 17,6246100000,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_PurchaseOfCurrentFairValueFinancialAsset,유동성 당기손익-공정가치측정 금융자산의 순증가,-,Term 19,0,Term 18,65303825196,Term 17,0,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_PurchaseOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산의취득,-,Term 19,0,Term 18,0,Term 17,2500004160,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_PurchaseOfNonCurrentFairValueFinancialAsset,비유동성 당기손익-공정가치측정 금융자산의 취득,-,Term 19,308238045,Term 18,0,Term 17,16917338331,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,유동성 상각후원가측정 금융자산의 순증가,-,Term 19,0,Term 18,28630000000,Term 17,30000000000,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,취득세의 환급,-,Term 19,3354558340,Term 18,0,Term 17,,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,사용권자산의 증가,-,Term 19,38793000,Term 18,49185077,Term 17,125343250,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,기타수취채권의 감소,-,Term 19,9686183742,Term 18,30912429409,Term 17,28546250251,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,비유동성 금융기관예치금의 취득,-,Term 19,1500002760,Term 18,1106477374,Term 17,1500002760,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,기타수취채권의 증가,-,Term 19,8545760735,Term 18,18224949583,Term 17,10071148219,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,유동성 상각후원가측정 금융자산의 순감소,-,Term 19,28630000000,Term 18,0,Term 17,,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,비유동성 상각후원가측정 금융자산의 처분,-,Term 19,12055000,Term 18,140415000,Term 17,460580082,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,비유동성 상각후원가측정금융자산의 취득,-,Term 19,0,Term 18,686680000,Term 17,0,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,유동성 금융기관예치금의 순감소,-,Term 19,14313436689,Term 18,12818224621,Term 17,27325462000,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합으로 인한 순현금유출,-,Term 19,494044767599,Term 18,0,Term 17,175584951002,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities,기타의 현금유입액,-,Term 19,0,Term 18,2902814938,Term 17,0,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 19,4342896935,Term 18,89844275,Term 17,68619860,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 19,0,Term 18,1288829494,Term 17,3105500000,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 19,846756000,Term 18,26648118986,Term 17,4018992178,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 19,24854995209,Term 18,39012379319,Term 17,35575628339,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfInterestsInAssociates,관계기업투자주식의 취득,-,Term 19,1999992500,Term 18,0,Term 17,,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 19,80964717542,Term 18,134495910156,Term 17,99289990911,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동으로 인한 현금흐름,-,Term 19,334509652791,Term 18,348227953524,Term 17,151023730340,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperations,영업으로부터 창출된 현금흐름,-,Term 19,381401926387,Term 18,405675378475,Term 17,281138081103,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsOperatingActivities,배당금의 수취,-,Term 19,47796544838,Term 18,0,Term 17,,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세의 납부,-,Term 19,87285748386,Term 18,53423466062,Term 17,124916274858,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자의 지급,-,Term 19,17787145860,Term 18,15035702506,Term 17,11472337649,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 19,10384075812,Term 18,11011743617,Term 17,6274261744,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,외화환산으로 인한 현금및현금성자산의 증감,-,Term 19,21654590145,Term 18,-6660935725,Term 17,-16054796439,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalents,현금및현금성자산의 증감,-,Term 19,-54836023649,Term 18,56781438101,Term 17,-88095682255,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,연결재무제표 [member],Term 19,-83444516957,Term 18,,Term 17,,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [구성요소]|비지배지분 [구성요소],Term 19,87673660720,Term 18,,Term 17,,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,-171118177677,Term 18,,Term 17,,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,0,Term 18,,Term 17,,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,0,Term 18,,Term 17,,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,0,Term 18,,Term 17,,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,,Term 17,,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,-171118177677,Term 18,,Term 17,,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,,Term 17,,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 19,4872705211057,Term 18,4779275104059,Term 17,4744299877622,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|비지배지분 [구성요소],Term 19,-25282914532,Term 18,-19338192039,Term 17,-16708527993,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,4897988125589,Term 18,4798613296098,Term 17,4761008405615,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,-13324991010,Term 18,-18139434036,Term 17,-19004134338,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,-18492151960,Term 18,-19458512997,Term 17,11879036721,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,4101401371537,Term 18,4010086561524,Term 17,3937774554979,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,34525294500,Term 18,34525294500,Term 17,34525294500,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,73397775430,Term 18,71118560015,Term 17,75352826661,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,720480827092,Term 18,720480827092,Term 17,720480827092,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정 금융자산의 처분에 따른 대체,연결재무제표 [member],Term 19,,Term 18,,Term 17,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정 금융자산의 처분에 따른 대체,자본 [구성요소]|비지배지분 [구성요소],Term 19,,Term 18,,Term 17,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정 금융자산의 처분에 따른 대체,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,,Term 18,,Term 17,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정 금융자산의 처분에 따른 대체,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,,Term 18,,Term 17,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정 금융자산의 처분에 따른 대체,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,,Term 18,,Term 17,20897896,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정 금융자산의 처분에 따른 대체,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,,Term 18,,Term 17,-20897896,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정 금융자산의 처분에 따른 대체,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,,Term 18,,Term 17,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정 금융자산의 처분에 따른 대체,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,,Term 18,,Term 17,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정 금융자산의 처분에 따른 대체,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,,Term 18,,Term 17,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,연결재무제표 [member],Term 19,63131717279,Term 18,47061521261,Term 17,68171195532,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|비지배지분 [구성요소],Term 19,267866324,Term 18,91954436,Term 17,546646607,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,62863850955,Term 18,46969566825,Term 17,67624548925,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,0,Term 18,0,Term 17,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,0,Term 18,0,Term 17,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,62863850955,Term 18,46969566825,Term 17,67624548925,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,0,Term 17,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,0,Term 17,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,연결재무제표 [member],Term 19,5326007889106,Term 18,4872705211057,Term 17,4779275104059,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|비지배지분 [구성요소],Term 19,73636605698,Term 18,-25282914532,Term 17,-19338192039,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,5252371283408,Term 18,4897988125589,Term 17,4798613296098,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,-18266246371,Term 18,-13324991010,Term 17,-18139434036,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,11925615841,Term 18,-18492151960,Term 17,-19458512997,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,4600956024202,Term 18,4101401371537,Term 17,4010086561524,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,34525294500,Term 18,34525294500,Term 17,34525294500,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,-97250231856,Term 18,73397775430,Term 17,71118560015,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,720480827092,Term 18,720480827092,Term 17,720480827092,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,연결재무제표 [member],Term 19,,Term 18,,Term 17,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|비지배지분 [구성요소],Term 19,,Term 18,,Term 17,4299205108,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,,Term 18,,Term 17,-4299205108,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,,Term 18,,Term 17,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,,Term 18,,Term 17,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,,Term 18,,Term 17,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,,Term 18,,Term 17,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,,Term 18,,Term 17,-4299205108,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,,Term 18,,Term 17,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,연결재무제표 [member],Term 19,5040636914,Term 18,-105172901,Term 17,-9317366236,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|비지배지분 [구성요소],Term 19,3964041295,Term 18,0,Term 17,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,1076595619,Term 18,-105172901,Term 17,-9317366236,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,1076595619,Term 18,-105172901,Term 17,-9317366236,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,0,Term 18,0,Term 17,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,0,Term 17,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,0,Term 17,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,연결재무제표 [member],Term 19,,Term 18,2902814938,Term 17,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|비지배지분 [구성요소],Term 19,,Term 18,0,Term 17,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,,Term 18,2902814938,Term 17,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,,Term 18,0,Term 17,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,,Term 18,0,Term 17,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,,Term 18,0,Term 17,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,,Term 18,0,Term 17,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,,Term 18,2902814938,Term 17,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,,Term 18,0,Term 17,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,연결재무제표 [member],Term 19,28125571183,Term 18,449127731,Term 17,-31891807328,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|비지배지분 [구성요소],Term 19,-872231401,Term 18,370103282,Term 17,-1141178292,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,28997802584,Term 18,79024449,Term 17,-30750629036,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,0,Term 18,0,Term 17,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,28997802584,Term 18,79024449,Term 17,-30750629036,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,0,Term 17,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,0,Term 17,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,연결재무제표 [member],Term 19,-887236303,Term 18,-458211,Term 17,-31630608,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,자본 [구성요소]|비지배지분 [구성요소],Term 19,0,Term 18,0,Term 17,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,-887236303,Term 18,-458211,Term 17,-31630608,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,0,Term 18,0,Term 17,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,-887236303,Term 18,-458211,Term 17,-31630608,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,0,Term 17,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,0,Term 17,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,연결재무제표 [member],Term 19,-30786128013,Term 18,-41817468524,Term 17,5482640916,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|비지배지분 [구성요소],Term 19,-17418560,Term 18,0,Term 17,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,-30768709453,Term 18,-41817468524,Term 17,5482640916,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,0,Term 18,0,Term 17,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,0,Term 18,0,Term 17,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,-30768709453,Term 18,-41817468524,Term 17,5482640916,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,0,Term 17,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,0,Term 17,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 19,601641373835,Term 18,173878928996,Term 17,129264244958,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|비지배지분 [구성요소],Term 19,8454160762,Term 18,-6222916366,Term 17,-5210567492,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,593187213073,Term 18,180101845362,Term 17,134474812450,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,0,Term 18,0,Term 17,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,0,Term 18,0,Term 17,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,593187213073,Term 18,180101845362,Term 17,134474812450,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,0,Term 17,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,0,Term 17,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,연결재무제표 [member],Term 19,10906786850,Term 18,318965030,Term 17,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|비지배지분 [구성요소],Term 19,0,Term 18,0,Term 17,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,10906786850,Term 18,318965030,Term 17,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,10906786850,Term 18,318965030,Term 17,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,0,Term 18,0,Term 17,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,0,Term 17,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,0,Term 17,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_SaleOrIssueOfTreasuryShares,자기주식의 처분,연결재무제표 [member],Term 19,5359106261,Term 18,4614981434,Term 17,10247005000,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_SaleOrIssueOfTreasuryShares,자기주식의 처분,자본 [구성요소]|비지배지분 [구성요소],Term 19,0,Term 18,0,Term 17,0,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_SaleOrIssueOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,5359106261,Term 18,4614981434,Term 17,10247005000,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_SaleOrIssueOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,4888935870,Term 18,5238580957,Term 17,10182066538,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_SaleOrIssueOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,0,Term 18,0,Term 17,0,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_SaleOrIssueOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_SaleOrIssueOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,0,Term 17,0,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_SaleOrIssueOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,470170391,Term 18,-623599523,Term 17,64938462,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_SaleOrIssueOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,0,Term 17,0,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,연결재무제표 [member],Term 19,2292375258,Term 18,887839826,Term 17,-606664733,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,자본 [구성요소]|비지배지분 [구성요소],Term 19,-14826262,Term 18,45027,Term 17,-30476763,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,2307201520,Term 18,887794799,Term 17,-576187970,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,0,Term 18,0,Term 17,0,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,2307201520,Term 18,887794799,Term 17,-576187970,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,0,Term 17,0,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,0,Term 17,0,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 19,6783507800768,Term 18,5886510888702,Term 17,5801783178159,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 19,1734808826757,Term 18,1952196456821,Term 17,1735019347862,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 19,451543362844,Term 18,506379386493,Term 17,449597948392,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentFinancialAssetsAtAmortisedCost,상각후원가측정금융자산,-,Term 19,30000000000,Term 18,58630000000,Term 17,30000000000,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss,당기손익-공정가치측정금융자산,-,Term 19,226504379260,Term 18,549634663158,Term 17,362939892414,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 19,863754249,Term 18,1395767125,Term 17,1589648122,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentTradeReceivables,매출채권,-,Term 19,386339598982,Term 18,292900370185,Term 17,285104514893,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 19,497801286466,Term 18,394311802314,Term 17,408934396533,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners,매각예정비유동자산,-,Term 19,0,Term 18,0,Term 17,19949060448,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_OtherCurrentAssets,기타유동자산,-,Term 19,43556635015,Term 18,40810673046,Term 17,39587746609,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_OtherCurrentReceivables,기타수취채권,-,Term 19,51538106251,Term 18,46359581121,Term 17,62646902451,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents,금융기관예치금,-,Term 19,46661703690,Term 18,61774213379,Term 17,74669238000,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 19,5048698974011,Term 18,3934314431881,Term 17,4066763830297,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 19,50941924787,Term 18,13846205025,Term 17,57853971328,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_IntangibleAssetsAndGoodwill,무형자산,-,Term 19,1773943897518,Term 18,340680136431,Term 17,357750954252,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_InvestmentAccountedForUsingEquityMethod,관계기업투자주식,-,Term 19,5819500670,Term 18,287060733528,Term 17,247279224799,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 19,594687077636,Term 18,496219430433,Term 17,503268138559,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_LongtermDeposits,금융기관예치금,-,Term 19,26529014383,Term 18,23988856981,Term 17,21989149194,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtAmortisedCost,상각후원가측정금융자산,-,Term 19,964525000,Term 18,976580000,Term 17,430315000,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss,당기손익-공정가치측정금융자산,-,Term 19,9454592251,Term 18,33031318251,Term 17,8017318251,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산,-,Term 19,5063012560,Term 18,6216765880,Term 17,6216765880,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentRecognisedAssetsDefinedBenefitPlan,순확정급여자산,-,Term 19,75350672263,Term 18,112607043654,Term 17,181406890326,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_OtherNoncurrentAssets,기타비유동자산,-,Term 19,8348830264,Term 18,9643263718,Term 17,12044243171,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_OtherNoncurrentReceivables,기타수취채권,-,Term 19,63832374479,Term 18,67356278864,Term 17,66737893651,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 19,2296405530047,Term 18,2441603701077,Term 17,2475276690492,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 19,137358022153,Term 18,101084118039,Term 17,128492275394,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 19,5326007889106,Term 18,4872705211057,Term 17,4779275104059,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업의 소유주에게 귀속되는 자본,-,Term 19,5252371283408,Term 18,4897988125589,Term 17,4798613296098,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 19,-97250231856,Term 18,73397775430,Term 17,71118560015,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본구성요소,-,Term 19,-18266246371,Term 18,-13324991010,Term 17,-18139434036,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_AccumulatedOtherComprehensiveIncome,기타포괄손익누계액,-,Term 19,11925615841,Term 18,-18492151960,Term 17,-19458512997,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 19,34525294500,Term 18,34525294500,Term 17,34525294500,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 19,4600956024202,Term 18,4101401371537,Term 17,4010086561524,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_SharePremium,주식발행초과금,-,Term 19,720480827092,Term 18,720480827092,Term 17,720480827092,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배주주지분,-,Term 19,73636605698,Term 18,-25282914532,Term 17,-19338192039,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채와자본총계,-,Term 19,6783507800768,Term 18,5886510888702,Term 17,5801783178159,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 19,1095705144331,Term 18,813257101661,Term 17,831116935949,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentContractLiabilities,계약부채,-,Term 19,36018371304,Term 18,33409778405,Term 17,36625353980,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,리스유동부채,-,Term 19,61264289188,Term 18,55346660805,Term 17,69006139263,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentProvisions,기타충당부채,-,Term 19,76288195477,Term 18,47465342867,Term 17,30597338613,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 19,55008652808,Term 18,22688183409,Term 17,41108987667,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_OtherCurrentLiabilities,기타유동부채,-,Term 19,177293445809,Term 18,198295675757,Term 17,194751573434,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_OtherCurrentPayables,기타지급채무,-,Term 19,287672036903,Term 18,125500534330,Term 17,154937768894,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 19,306194906069,Term 18,244108853364,Term 17,223413563558,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers,매입채무,-,Term 19,95965246773,Term 18,86442072724,Term 17,80676210540,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 19,1457499911662,Term 18,1013805677645,Term 17,1022508074100,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 19,361794767331,Term 18,200548575984,Term 17,191391138151,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 19,235817308122,Term 18,106367521222,Term 17,91265971878,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,리스비유동부채,-,Term 19,72758957849,Term 18,50947819097,Term 17,64785225166,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,기타충당부채,-,Term 19,13581666804,Term 18,10349002658,Term 17,9469113472,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan,순확정급여부채,-,Term 19,6255776125,Term 18,4493819499,Term 17,4377774564,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_OtherNoncurrentLiabilities,기타비유동부채,-,Term 19,33381058431,Term 18,28390413508,Term 17,21493053071,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,dart_NonOperatingProfitLoss,기타영업외손익,-,Term 19,302438171470,Term 18,-11604794732,Term 17,13044673857,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익,-,Term 19,220481343913,Term 18,108171257062,Term 17,214233255761,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,당기총포괄이익,-,Term 19,600385955960,Term 18,133397969818,Term 17,102216783205,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배주주지분,-,Term 19,7549684539,Term 18,-5852768057,Term 17,-6382222547,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 19,592836271421,Term 18,139250737875,Term 17,108599005752,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 19,1138378200862,Term 18,1155064685469,Term 17,1337512406849,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,우선주기본주당이익,-,Term 19,8606,Term 18,2614,Term 17,1954,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,우선주희석주당이익,-,Term 19,8606,Term 18,2614,Term 17,1954,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주기본주당이익,-,Term 19,8601,Term 18,2609,Term 17,1949,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_DilutedEarningsLossPerShare,보통주희석주당이익 (단위: 원),-,Term 19,8600,Term 18,2609,Term 17,1948,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 19,42891624478,Term 18,19166374797,Term 17,34413883142,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 19,124302837964,Term 18,161577461724,Term 17,22771702594,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 19,2746732498324,Term 18,2518898907688,Term 17,2797420105262,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용(수익),-,Term 19,19163847751,Term 18,106754652265,Term 17,95229524211,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,세후기타포괄손익,-,Term 19,-1255417875,Term 18,-40480959178,Term 17,-27047461753,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,-,Term 19,28125571183,Term 18,449127731,Term 17,-31891807328,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,-,Term 19,2292375258,Term 18,887839826,Term 17,-606664733,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,-,Term 19,-887236303,Term 18,-458211,Term 17,-31630608,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,-,Term 19,-30786128013,Term 18,-41817468524,Term 17,5482640916,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 19,601641373835,Term 18,173878928996,Term 17,129264244958,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배주주지분,-,Term 19,8454160762,Term 18,-6222916366,Term 17,-5210567492,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 19,593187213073,Term 18,180101845362,Term 17,134474812450,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 19,620805221586,Term 18,280633581261,Term 17,224493769169,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 19,3885110699186,Term 18,3673963593157,Term 17,4134932512111,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_SellingGeneralAndAdministrativeExpense,판매비와관리비,-,Term 19,2526251154411,Term 18,2410727650626,Term 17,2583186849501,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod,관계기업손익,-,Term 19,16474492717,Term 18,41656032004,Term 17,8858020099,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초의 현금및현금성자산,-,Term 19,506379386493,Term 18,449597948392,Term 17,537693630647,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말의 현금및현금성자산,-,Term 19,451543362844,Term 18,506379386493,Term 17,449597948392,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동으로 인한 현금흐름,-,Term 19,-98829601873,Term 18,-98619351026,Term 17,-154550827468,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_AcquisitionOfTreasuryShares,자기주식의 취득,-,Term 19,10906786850,Term 18,318965030,Term 17,2484434450,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_DecreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 반환,-,Term 19,1250714895,Term 18,4840197081,Term 17,2910596555,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_IncreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 수취,-,Term 19,7488136000,Term 18,2450248000,Term 17,2012976000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금의 지급,-,Term 19,63109815914,Term 18,47045103906,Term 17,68147576757,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 상환,-,Term 19,65042910294,Term 18,69389612880,Term 17,105600934697,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromCurrentBorrowings,단기차입금의 증가,-,Term 19,61984835780,Term 18,40823433333,Term 17,45369950991,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_RepaymentsOfCurrentBorrowings,단기차입금의 감소,-,Term 19,27992345700,Term 18,20299153462,Term 17,22790212000,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동으로 인한 현금흐름,-,Term 19,-312170664712,Term 18,-186166228672,Term 17,-68513788688,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfCurrentFairValueFinancialAsset,유동성 당기손익-공정가치측정 금융자산의 순감소,-,Term 19,238900715972,Term 18,0,Term 17,232549103448,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산의처분,-,Term 19,,Term 18,,Term 17,730010465,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfNonCurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정비유동자산의 처분,-,Term 19,0,Term 18,26542501310,Term 17,6246100000,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_PurchaseOfCurrentFairValueFinancialAsset,유동성 당기손익-공정가치측정 금융자산의 순증가,-,Term 19,0,Term 18,65303825196,Term 17,0,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_PurchaseOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산의취득,-,Term 19,0,Term 18,0,Term 17,2500004160,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_PurchaseOfNonCurrentFairValueFinancialAsset,비유동성 당기손익-공정가치측정 금융자산의 취득,-,Term 19,308238045,Term 18,0,Term 17,16917338331,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,유동성 상각후원가측정 금융자산의 순증가,-,Term 19,0,Term 18,28630000000,Term 17,30000000000,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,취득세의 환급,-,Term 19,3354558340,Term 18,0,Term 17,,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,사용권자산의 증가,-,Term 19,38793000,Term 18,49185077,Term 17,125343250,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,기타수취채권의 감소,-,Term 19,9686183742,Term 18,30912429409,Term 17,28546250251,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,비유동성 금융기관예치금의 취득,-,Term 19,1500002760,Term 18,1106477374,Term 17,1500002760,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,기타수취채권의 증가,-,Term 19,8545760735,Term 18,18224949583,Term 17,10071148219,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,유동성 상각후원가측정 금융자산의 순감소,-,Term 19,28630000000,Term 18,0,Term 17,,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,비유동성 상각후원가측정 금융자산의 처분,-,Term 19,12055000,Term 18,140415000,Term 17,460580082,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,비유동성 상각후원가측정금융자산의 취득,-,Term 19,0,Term 18,686680000,Term 17,0,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,유동성 금융기관예치금의 순감소,-,Term 19,14313436689,Term 18,12818224621,Term 17,27325462000,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합으로 인한 순현금유출,-,Term 19,494044767599,Term 18,0,Term 17,175584951002,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities,기타의 현금유입액,-,Term 19,0,Term 18,2902814938,Term 17,0,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 19,4342896935,Term 18,89844275,Term 17,68619860,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 19,0,Term 18,1288829494,Term 17,3105500000,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 19,846756000,Term 18,26648118986,Term 17,4018992178,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 19,24854995209,Term 18,39012379319,Term 17,35575628339,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfInterestsInAssociates,관계기업투자주식의 취득,-,Term 19,1999992500,Term 18,0,Term 17,,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 19,80964717542,Term 18,134495910156,Term 17,99289990911,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동으로 인한 현금흐름,-,Term 19,334509652791,Term 18,348227953524,Term 17,151023730340,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperations,영업으로부터 창출된 현금흐름,-,Term 19,381401926387,Term 18,405675378475,Term 17,281138081103,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsOperatingActivities,배당금의 수취,-,Term 19,47796544838,Term 18,0,Term 17,,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세의 납부,-,Term 19,87285748386,Term 18,53423466062,Term 17,124916274858,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자의 지급,-,Term 19,17787145860,Term 18,15035702506,Term 17,11472337649,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 19,10384075812,Term 18,11011743617,Term 17,6274261744,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,외화환산으로 인한 현금및현금성자산의 증감,-,Term 19,21654590145,Term 18,-6660935725,Term 17,-16054796439,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalents,현금및현금성자산의 증감,-,Term 19,-54836023649,Term 18,56781438101,Term 17,-88095682255,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,연결재무제표 [member],Term 19,-83444516957,Term 18,,Term 17,,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [구성요소]|비지배지분 [구성요소],Term 19,87673660720,Term 18,,Term 17,,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,-171118177677,Term 18,,Term 17,,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,0,Term 18,,Term 17,,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,0,Term 18,,Term 17,,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,0,Term 18,,Term 17,,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,,Term 17,,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,-171118177677,Term 18,,Term 17,,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,,Term 17,,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 19,4872705211057,Term 18,4779275104059,Term 17,4744299877622,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|비지배지분 [구성요소],Term 19,-25282914532,Term 18,-19338192039,Term 17,-16708527993,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,4897988125589,Term 18,4798613296098,Term 17,4761008405615,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,-13324991010,Term 18,-18139434036,Term 17,-19004134338,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,-18492151960,Term 18,-19458512997,Term 17,11879036721,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,4101401371537,Term 18,4010086561524,Term 17,3937774554979,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,34525294500,Term 18,34525294500,Term 17,34525294500,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,73397775430,Term 18,71118560015,Term 17,75352826661,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,720480827092,Term 18,720480827092,Term 17,720480827092,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정 금융자산의 처분에 따른 대체,연결재무제표 [member],Term 19,,Term 18,,Term 17,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정 금융자산의 처분에 따른 대체,자본 [구성요소]|비지배지분 [구성요소],Term 19,,Term 18,,Term 17,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정 금융자산의 처분에 따른 대체,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,,Term 18,,Term 17,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정 금융자산의 처분에 따른 대체,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,,Term 18,,Term 17,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정 금융자산의 처분에 따른 대체,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,,Term 18,,Term 17,20897896,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정 금융자산의 처분에 따른 대체,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,,Term 18,,Term 17,-20897896,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정 금융자산의 처분에 따른 대체,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,,Term 18,,Term 17,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정 금융자산의 처분에 따른 대체,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,,Term 18,,Term 17,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정 금융자산의 처분에 따른 대체,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,,Term 18,,Term 17,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,연결재무제표 [member],Term 19,63131717279,Term 18,47061521261,Term 17,68171195532,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|비지배지분 [구성요소],Term 19,267866324,Term 18,91954436,Term 17,546646607,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,62863850955,Term 18,46969566825,Term 17,67624548925,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,0,Term 18,0,Term 17,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,0,Term 18,0,Term 17,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,62863850955,Term 18,46969566825,Term 17,67624548925,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,0,Term 17,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,0,Term 17,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,연결재무제표 [member],Term 19,5326007889106,Term 18,4872705211057,Term 17,4779275104059,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|비지배지분 [구성요소],Term 19,73636605698,Term 18,-25282914532,Term 17,-19338192039,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,5252371283408,Term 18,4897988125589,Term 17,4798613296098,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,-18266246371,Term 18,-13324991010,Term 17,-18139434036,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,11925615841,Term 18,-18492151960,Term 17,-19458512997,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,4600956024202,Term 18,4101401371537,Term 17,4010086561524,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,34525294500,Term 18,34525294500,Term 17,34525294500,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,-97250231856,Term 18,73397775430,Term 17,71118560015,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,720480827092,Term 18,720480827092,Term 17,720480827092,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,연결재무제표 [member],Term 19,,Term 18,,Term 17,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|비지배지분 [구성요소],Term 19,,Term 18,,Term 17,4299205108,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,,Term 18,,Term 17,-4299205108,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,,Term 18,,Term 17,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,,Term 18,,Term 17,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,,Term 18,,Term 17,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,,Term 18,,Term 17,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,,Term 18,,Term 17,-4299205108,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,,Term 18,,Term 17,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,연결재무제표 [member],Term 19,5040636914,Term 18,-105172901,Term 17,-9317366236,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|비지배지분 [구성요소],Term 19,3964041295,Term 18,0,Term 17,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,1076595619,Term 18,-105172901,Term 17,-9317366236,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,1076595619,Term 18,-105172901,Term 17,-9317366236,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,0,Term 18,0,Term 17,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,0,Term 17,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,0,Term 17,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,연결재무제표 [member],Term 19,,Term 18,2902814938,Term 17,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|비지배지분 [구성요소],Term 19,,Term 18,0,Term 17,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,,Term 18,2902814938,Term 17,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,,Term 18,0,Term 17,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,,Term 18,0,Term 17,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,,Term 18,0,Term 17,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,,Term 18,0,Term 17,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,,Term 18,2902814938,Term 17,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,,Term 18,0,Term 17,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,연결재무제표 [member],Term 19,28125571183,Term 18,449127731,Term 17,-31891807328,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|비지배지분 [구성요소],Term 19,-872231401,Term 18,370103282,Term 17,-1141178292,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,28997802584,Term 18,79024449,Term 17,-30750629036,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,0,Term 18,0,Term 17,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,28997802584,Term 18,79024449,Term 17,-30750629036,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,0,Term 17,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,0,Term 17,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,연결재무제표 [member],Term 19,-887236303,Term 18,-458211,Term 17,-31630608,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,자본 [구성요소]|비지배지분 [구성요소],Term 19,0,Term 18,0,Term 17,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,-887236303,Term 18,-458211,Term 17,-31630608,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,0,Term 18,0,Term 17,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,-887236303,Term 18,-458211,Term 17,-31630608,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,0,Term 17,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,0,Term 17,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,연결재무제표 [member],Term 19,-30786128013,Term 18,-41817468524,Term 17,5482640916,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|비지배지분 [구성요소],Term 19,-17418560,Term 18,0,Term 17,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,-30768709453,Term 18,-41817468524,Term 17,5482640916,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,0,Term 18,0,Term 17,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,0,Term 18,0,Term 17,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,-30768709453,Term 18,-41817468524,Term 17,5482640916,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,0,Term 17,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,0,Term 17,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 19,601641373835,Term 18,173878928996,Term 17,129264244958,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|비지배지분 [구성요소],Term 19,8454160762,Term 18,-6222916366,Term 17,-5210567492,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,593187213073,Term 18,180101845362,Term 17,134474812450,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,0,Term 18,0,Term 17,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,0,Term 18,0,Term 17,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,593187213073,Term 18,180101845362,Term 17,134474812450,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,0,Term 17,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,0,Term 17,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,연결재무제표 [member],Term 19,10906786850,Term 18,318965030,Term 17,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|비지배지분 [구성요소],Term 19,0,Term 18,0,Term 17,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,10906786850,Term 18,318965030,Term 17,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,10906786850,Term 18,318965030,Term 17,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,0,Term 18,0,Term 17,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,0,Term 17,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,0,Term 17,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_SaleOrIssueOfTreasuryShares,자기주식의 처분,연결재무제표 [member],Term 19,5359106261,Term 18,4614981434,Term 17,10247005000,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_SaleOrIssueOfTreasuryShares,자기주식의 처분,자본 [구성요소]|비지배지분 [구성요소],Term 19,0,Term 18,0,Term 17,0,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_SaleOrIssueOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,5359106261,Term 18,4614981434,Term 17,10247005000,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_SaleOrIssueOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,4888935870,Term 18,5238580957,Term 17,10182066538,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_SaleOrIssueOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,0,Term 18,0,Term 17,0,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_SaleOrIssueOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_SaleOrIssueOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,0,Term 17,0,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_SaleOrIssueOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,470170391,Term 18,-623599523,Term 17,64938462,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_SaleOrIssueOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,0,Term 17,0,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,연결재무제표 [member],Term 19,2292375258,Term 18,887839826,Term 17,-606664733,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,자본 [구성요소]|비지배지분 [구성요소],Term 19,-14826262,Term 18,45027,Term 17,-30476763,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,2307201520,Term 18,887794799,Term 17,-576187970,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,0,Term 18,0,Term 17,0,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,2307201520,Term 18,887794799,Term 17,-576187970,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,0,Term 17,0,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,0,Term 17,0,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 19,6783507800768,Term 18,5886510888702,Term 17,5801783178159,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 19,1734808826757,Term 18,1952196456821,Term 17,1735019347862,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 19,451543362844,Term 18,506379386493,Term 17,449597948392,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentFinancialAssetsAtAmortisedCost,상각후원가측정금융자산,-,Term 19,30000000000,Term 18,58630000000,Term 17,30000000000,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss,당기손익-공정가치측정금융자산,-,Term 19,226504379260,Term 18,549634663158,Term 17,362939892414,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 19,863754249,Term 18,1395767125,Term 17,1589648122,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentTradeReceivables,매출채권,-,Term 19,386339598982,Term 18,292900370185,Term 17,285104514893,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 19,497801286466,Term 18,394311802314,Term 17,408934396533,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners,매각예정비유동자산,-,Term 19,0,Term 18,0,Term 17,19949060448,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_OtherCurrentAssets,기타유동자산,-,Term 19,43556635015,Term 18,40810673046,Term 17,39587746609,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_OtherCurrentReceivables,기타수취채권,-,Term 19,51538106251,Term 18,46359581121,Term 17,62646902451,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents,금융기관예치금,-,Term 19,46661703690,Term 18,61774213379,Term 17,74669238000,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 19,5048698974011,Term 18,3934314431881,Term 17,4066763830297,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 19,50941924787,Term 18,13846205025,Term 17,57853971328,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_IntangibleAssetsAndGoodwill,무형자산,-,Term 19,1773943897518,Term 18,340680136431,Term 17,357750954252,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_InvestmentAccountedForUsingEquityMethod,관계기업투자주식,-,Term 19,5819500670,Term 18,287060733528,Term 17,247279224799,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 19,594687077636,Term 18,496219430433,Term 17,503268138559,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_LongtermDeposits,금융기관예치금,-,Term 19,26529014383,Term 18,23988856981,Term 17,21989149194,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtAmortisedCost,상각후원가측정금융자산,-,Term 19,964525000,Term 18,976580000,Term 17,430315000,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss,당기손익-공정가치측정금융자산,-,Term 19,9454592251,Term 18,33031318251,Term 17,8017318251,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산,-,Term 19,5063012560,Term 18,6216765880,Term 17,6216765880,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentRecognisedAssetsDefinedBenefitPlan,순확정급여자산,-,Term 19,75350672263,Term 18,112607043654,Term 17,181406890326,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_OtherNoncurrentAssets,기타비유동자산,-,Term 19,8348830264,Term 18,9643263718,Term 17,12044243171,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_OtherNoncurrentReceivables,기타수취채권,-,Term 19,63832374479,Term 18,67356278864,Term 17,66737893651,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 19,2296405530047,Term 18,2441603701077,Term 17,2475276690492,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 19,137358022153,Term 18,101084118039,Term 17,128492275394,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 19,5326007889106,Term 18,4872705211057,Term 17,4779275104059,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업의 소유주에게 귀속되는 자본,-,Term 19,5252371283408,Term 18,4897988125589,Term 17,4798613296098,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 19,-97250231856,Term 18,73397775430,Term 17,71118560015,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본구성요소,-,Term 19,-18266246371,Term 18,-13324991010,Term 17,-18139434036,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_AccumulatedOtherComprehensiveIncome,기타포괄손익누계액,-,Term 19,11925615841,Term 18,-18492151960,Term 17,-19458512997,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 19,34525294500,Term 18,34525294500,Term 17,34525294500,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 19,4600956024202,Term 18,4101401371537,Term 17,4010086561524,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_SharePremium,주식발행초과금,-,Term 19,720480827092,Term 18,720480827092,Term 17,720480827092,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배주주지분,-,Term 19,73636605698,Term 18,-25282914532,Term 17,-19338192039,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채와자본총계,-,Term 19,6783507800768,Term 18,5886510888702,Term 17,5801783178159,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 19,1095705144331,Term 18,813257101661,Term 17,831116935949,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentContractLiabilities,계약부채,-,Term 19,36018371304,Term 18,33409778405,Term 17,36625353980,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,리스유동부채,-,Term 19,61264289188,Term 18,55346660805,Term 17,69006139263,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentProvisions,기타충당부채,-,Term 19,76288195477,Term 18,47465342867,Term 17,30597338613,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 19,55008652808,Term 18,22688183409,Term 17,41108987667,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_OtherCurrentLiabilities,기타유동부채,-,Term 19,177293445809,Term 18,198295675757,Term 17,194751573434,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_OtherCurrentPayables,기타지급채무,-,Term 19,287672036903,Term 18,125500534330,Term 17,154937768894,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 19,306194906069,Term 18,244108853364,Term 17,223413563558,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers,매입채무,-,Term 19,95965246773,Term 18,86442072724,Term 17,80676210540,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 19,1457499911662,Term 18,1013805677645,Term 17,1022508074100,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 19,361794767331,Term 18,200548575984,Term 17,191391138151,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 19,235817308122,Term 18,106367521222,Term 17,91265971878,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,리스비유동부채,-,Term 19,72758957849,Term 18,50947819097,Term 17,64785225166,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,기타충당부채,-,Term 19,13581666804,Term 18,10349002658,Term 17,9469113472,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan,순확정급여부채,-,Term 19,6255776125,Term 18,4493819499,Term 17,4377774564,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,BS,Statement of financial position,ifrs-full_OtherNoncurrentLiabilities,기타비유동부채,-,Term 19,33381058431,Term 18,28390413508,Term 17,21493053071,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,dart_NonOperatingProfitLoss,기타영업외손익,-,Term 19,302438171470,Term 18,-11604794732,Term 17,13044673857,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익,-,Term 19,220481343913,Term 18,108171257062,Term 17,214233255761,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,당기총포괄이익,-,Term 19,600385955960,Term 18,133397969818,Term 17,102216783205,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배주주지분,-,Term 19,7549684539,Term 18,-5852768057,Term 17,-6382222547,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 19,592836271421,Term 18,139250737875,Term 17,108599005752,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 19,1138378200862,Term 18,1155064685469,Term 17,1337512406849,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,우선주기본주당이익,-,Term 19,8606,Term 18,2614,Term 17,1954,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,-Standard account code not used-,우선주희석주당이익,-,Term 19,8606,Term 18,2614,Term 17,1954,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주기본주당이익,-,Term 19,8601,Term 18,2609,Term 17,1949,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_DilutedEarningsLossPerShare,보통주희석주당이익 (단위: 원),-,Term 19,8600,Term 18,2609,Term 17,1948,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 19,42891624478,Term 18,19166374797,Term 17,34413883142,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 19,124302837964,Term 18,161577461724,Term 17,22771702594,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 19,2746732498324,Term 18,2518898907688,Term 17,2797420105262,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용(수익),-,Term 19,19163847751,Term 18,106754652265,Term 17,95229524211,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,세후기타포괄손익,-,Term 19,-1255417875,Term 18,-40480959178,Term 17,-27047461753,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,-,Term 19,28125571183,Term 18,449127731,Term 17,-31891807328,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,-,Term 19,2292375258,Term 18,887839826,Term 17,-606664733,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,-,Term 19,-887236303,Term 18,-458211,Term 17,-31630608,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,-,Term 19,-30786128013,Term 18,-41817468524,Term 17,5482640916,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 19,601641373835,Term 18,173878928996,Term 17,129264244958,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배주주지분,-,Term 19,8454160762,Term 18,-6222916366,Term 17,-5210567492,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 19,593187213073,Term 18,180101845362,Term 17,134474812450,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 19,620805221586,Term 18,280633581261,Term 17,224493769169,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 19,3885110699186,Term 18,3673963593157,Term 17,4134932512111,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_SellingGeneralAndAdministrativeExpense,판매비와관리비,-,Term 19,2526251154411,Term 18,2410727650626,Term 17,2583186849501,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CIS,Statement of comprehensive income,ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod,관계기업손익,-,Term 19,16474492717,Term 18,41656032004,Term 17,8858020099,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초의 현금및현금성자산,-,Term 19,506379386493,Term 18,449597948392,Term 17,537693630647,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말의 현금및현금성자산,-,Term 19,451543362844,Term 18,506379386493,Term 17,449597948392,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동으로 인한 현금흐름,-,Term 19,-98829601873,Term 18,-98619351026,Term 17,-154550827468,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_AcquisitionOfTreasuryShares,자기주식의 취득,-,Term 19,10906786850,Term 18,318965030,Term 17,2484434450,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_DecreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 반환,-,Term 19,1250714895,Term 18,4840197081,Term 17,2910596555,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_IncreaseInGuaranteeDepositsAsFinancialActivities,임대보증금의 수취,-,Term 19,7488136000,Term 18,2450248000,Term 17,2012976000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금의 지급,-,Term 19,63109815914,Term 18,47045103906,Term 17,68147576757,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 상환,-,Term 19,65042910294,Term 18,69389612880,Term 17,105600934697,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromCurrentBorrowings,단기차입금의 증가,-,Term 19,61984835780,Term 18,40823433333,Term 17,45369950991,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_RepaymentsOfCurrentBorrowings,단기차입금의 감소,-,Term 19,27992345700,Term 18,20299153462,Term 17,22790212000,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동으로 인한 현금흐름,-,Term 19,-312170664712,Term 18,-186166228672,Term 17,-68513788688,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfCurrentFairValueFinancialAsset,유동성 당기손익-공정가치측정 금융자산의 순감소,-,Term 19,238900715972,Term 18,0,Term 17,232549103448,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산의처분,-,Term 19,,Term 18,,Term 17,730010465,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_ProceedsFromSalesOfNonCurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정비유동자산의 처분,-,Term 19,0,Term 18,26542501310,Term 17,6246100000,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_PurchaseOfCurrentFairValueFinancialAsset,유동성 당기손익-공정가치측정 금융자산의 순증가,-,Term 19,0,Term 18,65303825196,Term 17,0,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_PurchaseOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산의취득,-,Term 19,0,Term 18,0,Term 17,2500004160,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,dart_PurchaseOfNonCurrentFairValueFinancialAsset,비유동성 당기손익-공정가치측정 금융자산의 취득,-,Term 19,308238045,Term 18,0,Term 17,16917338331,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,유동성 상각후원가측정 금융자산의 순증가,-,Term 19,0,Term 18,28630000000,Term 17,30000000000,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,취득세의 환급,-,Term 19,3354558340,Term 18,0,Term 17,,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,사용권자산의 증가,-,Term 19,38793000,Term 18,49185077,Term 17,125343250,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,기타수취채권의 감소,-,Term 19,9686183742,Term 18,30912429409,Term 17,28546250251,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,비유동성 금융기관예치금의 취득,-,Term 19,1500002760,Term 18,1106477374,Term 17,1500002760,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,기타수취채권의 증가,-,Term 19,8545760735,Term 18,18224949583,Term 17,10071148219,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,유동성 상각후원가측정 금융자산의 순감소,-,Term 19,28630000000,Term 18,0,Term 17,,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,비유동성 상각후원가측정 금융자산의 처분,-,Term 19,12055000,Term 18,140415000,Term 17,460580082,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,비유동성 상각후원가측정금융자산의 취득,-,Term 19,0,Term 18,686680000,Term 17,0,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,-Standard account code not used-,유동성 금융기관예치금의 순감소,-,Term 19,14313436689,Term 18,12818224621,Term 17,27325462000,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합으로 인한 순현금유출,-,Term 19,494044767599,Term 18,0,Term 17,175584951002,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities,기타의 현금유입액,-,Term 19,0,Term 18,2902814938,Term 17,0,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 19,4342896935,Term 18,89844275,Term 17,68619860,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 19,0,Term 18,1288829494,Term 17,3105500000,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 19,846756000,Term 18,26648118986,Term 17,4018992178,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 19,24854995209,Term 18,39012379319,Term 17,35575628339,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfInterestsInAssociates,관계기업투자주식의 취득,-,Term 19,1999992500,Term 18,0,Term 17,,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 19,80964717542,Term 18,134495910156,Term 17,99289990911,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동으로 인한 현금흐름,-,Term 19,334509652791,Term 18,348227953524,Term 17,151023730340,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperations,영업으로부터 창출된 현금흐름,-,Term 19,381401926387,Term 18,405675378475,Term 17,281138081103,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsOperatingActivities,배당금의 수취,-,Term 19,47796544838,Term 18,0,Term 17,,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세의 납부,-,Term 19,87285748386,Term 18,53423466062,Term 17,124916274858,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자의 지급,-,Term 19,17787145860,Term 18,15035702506,Term 17,11472337649,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 19,10384075812,Term 18,11011743617,Term 17,6274261744,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,외화환산으로 인한 현금및현금성자산의 증감,-,Term 19,21654590145,Term 18,-6660935725,Term 17,-16054796439,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalents,현금및현금성자산의 증감,-,Term 19,-54836023649,Term 18,56781438101,Term 17,-88095682255,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,연결재무제표 [member],Term 19,-83444516957,Term 18,,Term 17,,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [구성요소]|비지배지분 [구성요소],Term 19,87673660720,Term 18,,Term 17,,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,-171118177677,Term 18,,Term 17,,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,0,Term 18,,Term 17,,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,0,Term 18,,Term 17,,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,0,Term 18,,Term 17,,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,,Term 17,,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,-171118177677,Term 18,,Term 17,,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_ChangesInConsolidatedCompanies,연결범위의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,,Term 17,,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 19,4872705211057,Term 18,4779275104059,Term 17,4744299877622,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|비지배지분 [구성요소],Term 19,-25282914532,Term 18,-19338192039,Term 17,-16708527993,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,4897988125589,Term 18,4798613296098,Term 17,4761008405615,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,-13324991010,Term 18,-18139434036,Term 17,-19004134338,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,-18492151960,Term 18,-19458512997,Term 17,11879036721,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,4101401371537,Term 18,4010086561524,Term 17,3937774554979,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,34525294500,Term 18,34525294500,Term 17,34525294500,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,73397775430,Term 18,71118560015,Term 17,75352826661,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,720480827092,Term 18,720480827092,Term 17,720480827092,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정 금융자산의 처분에 따른 대체,연결재무제표 [member],Term 19,,Term 18,,Term 17,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정 금융자산의 처분에 따른 대체,자본 [구성요소]|비지배지분 [구성요소],Term 19,,Term 18,,Term 17,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정 금융자산의 처분에 따른 대체,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,,Term 18,,Term 17,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정 금융자산의 처분에 따른 대체,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,,Term 18,,Term 17,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정 금융자산의 처분에 따른 대체,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,,Term 18,,Term 17,20897896,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정 금융자산의 처분에 따른 대체,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,,Term 18,,Term 17,-20897896,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정 금융자산의 처분에 따른 대체,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,,Term 18,,Term 17,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정 금융자산의 처분에 따른 대체,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,,Term 18,,Term 17,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_CumulativeGainLossOnDisposalOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정 금융자산의 처분에 따른 대체,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,,Term 18,,Term 17,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,연결재무제표 [member],Term 19,63131717279,Term 18,47061521261,Term 17,68171195532,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|비지배지분 [구성요소],Term 19,267866324,Term 18,91954436,Term 17,546646607,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,62863850955,Term 18,46969566825,Term 17,67624548925,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,0,Term 18,0,Term 17,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,0,Term 18,0,Term 17,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,62863850955,Term 18,46969566825,Term 17,67624548925,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,0,Term 17,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,연차배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,0,Term 17,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,연결재무제표 [member],Term 19,5326007889106,Term 18,4872705211057,Term 17,4779275104059,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|비지배지분 [구성요소],Term 19,73636605698,Term 18,-25282914532,Term 17,-19338192039,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,5252371283408,Term 18,4897988125589,Term 17,4798613296098,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,-18266246371,Term 18,-13324991010,Term 17,-18139434036,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,11925615841,Term 18,-18492151960,Term 17,-19458512997,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,4600956024202,Term 18,4101401371537,Term 17,4010086561524,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,34525294500,Term 18,34525294500,Term 17,34525294500,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,-97250231856,Term 18,73397775430,Term 17,71118560015,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,720480827092,Term 18,720480827092,Term 17,720480827092,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,연결재무제표 [member],Term 19,,Term 18,,Term 17,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|비지배지분 [구성요소],Term 19,,Term 18,,Term 17,4299205108,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,,Term 18,,Term 17,-4299205108,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,,Term 18,,Term 17,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,,Term 18,,Term 17,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,,Term 18,,Term 17,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,,Term 18,,Term 17,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,,Term 18,,Term 17,-4299205108,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,종속기업의 지분율 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,,Term 18,,Term 17,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,연결재무제표 [member],Term 19,5040636914,Term 18,-105172901,Term 17,-9317366236,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|비지배지분 [구성요소],Term 19,3964041295,Term 18,0,Term 17,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,1076595619,Term 18,-105172901,Term 17,-9317366236,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,1076595619,Term 18,-105172901,Term 17,-9317366236,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,0,Term 18,0,Term 17,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,0,Term 17,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식기준보상,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,0,Term 17,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,연결재무제표 [member],Term 19,,Term 18,2902814938,Term 17,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|비지배지분 [구성요소],Term 19,,Term 18,0,Term 17,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,,Term 18,2902814938,Term 17,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,,Term 18,0,Term 17,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,,Term 18,0,Term 17,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,,Term 18,0,Term 17,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,,Term 18,0,Term 17,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,,Term 18,2902814938,Term 17,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,기타,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,,Term 18,0,Term 17,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,연결재무제표 [member],Term 19,28125571183,Term 18,449127731,Term 17,-31891807328,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|비지배지분 [구성요소],Term 19,-872231401,Term 18,370103282,Term 17,-1141178292,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,28997802584,Term 18,79024449,Term 17,-30750629036,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,0,Term 18,0,Term 17,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,28997802584,Term 18,79024449,Term 17,-30750629036,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,0,Term 17,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,0,Term 17,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,연결재무제표 [member],Term 19,-887236303,Term 18,-458211,Term 17,-31630608,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,자본 [구성요소]|비지배지분 [구성요소],Term 19,0,Term 18,0,Term 17,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,-887236303,Term 18,-458211,Term 17,-31630608,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,0,Term 18,0,Term 17,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,-887236303,Term 18,-458211,Term 17,-31630608,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,0,Term 17,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치측정자산평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,0,Term 17,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,연결재무제표 [member],Term 19,-30786128013,Term 18,-41817468524,Term 17,5482640916,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|비지배지분 [구성요소],Term 19,-17418560,Term 18,0,Term 17,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,-30768709453,Term 18,-41817468524,Term 17,5482640916,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,0,Term 18,0,Term 17,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,0,Term 18,0,Term 17,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,-30768709453,Term 18,-41817468524,Term 17,5482640916,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,0,Term 17,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,0,Term 17,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 19,601641373835,Term 18,173878928996,Term 17,129264244958,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|비지배지분 [구성요소],Term 19,8454160762,Term 18,-6222916366,Term 17,-5210567492,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,593187213073,Term 18,180101845362,Term 17,134474812450,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,0,Term 18,0,Term 17,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,0,Term 18,0,Term 17,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,593187213073,Term 18,180101845362,Term 17,134474812450,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,0,Term 17,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,0,Term 17,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,연결재무제표 [member],Term 19,10906786850,Term 18,318965030,Term 17,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|비지배지분 [구성요소],Term 19,0,Term 18,0,Term 17,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,10906786850,Term 18,318965030,Term 17,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,10906786850,Term 18,318965030,Term 17,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,0,Term 18,0,Term 17,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,0,Term 17,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_PurchaseOfTreasuryShares,자기주식의 취득,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,0,Term 17,,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_SaleOrIssueOfTreasuryShares,자기주식의 처분,연결재무제표 [member],Term 19,5359106261,Term 18,4614981434,Term 17,10247005000,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_SaleOrIssueOfTreasuryShares,자기주식의 처분,자본 [구성요소]|비지배지분 [구성요소],Term 19,0,Term 18,0,Term 17,0,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_SaleOrIssueOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,5359106261,Term 18,4614981434,Term 17,10247005000,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_SaleOrIssueOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,4888935870,Term 18,5238580957,Term 17,10182066538,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_SaleOrIssueOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,0,Term 18,0,Term 17,0,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_SaleOrIssueOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_SaleOrIssueOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,0,Term 17,0,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_SaleOrIssueOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,470170391,Term 18,-623599523,Term 17,64938462,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_SaleOrIssueOfTreasuryShares,자기주식의 처분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,0,Term 17,0,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,연결재무제표 [member],Term 19,2292375258,Term 18,887839826,Term 17,-606664733,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,자본 [구성요소]|비지배지분 [구성요소],Term 19,-14826262,Term 18,45027,Term 17,-30476763,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 19,2307201520,Term 18,887794799,Term 17,-576187970,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 19,0,Term 18,0,Term 17,0,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 19,2307201520,Term 18,887794799,Term 17,-576187970,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 19,0,Term 18,0,Term 17,0,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 19,0,Term 18,0,Term 17,0,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20250317000429,11011,2024,00583424,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,관계기업 기타포괄손익지분,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|주식발행초과금 [구성요소],Term 19,0,Term 18,0,Term 17,0,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,090430,아모레퍼시픽
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 20,1982768917805,Term 19,2163074840988,Term 18,1691202854302,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 20,434105464098,Term 19,647104059171,Term 18,396643798594,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_ShortTermDepositsNotClassifiedAsCashEquivalents,단기금융상품,-,Term 20,58536528000,Term 19,72263450599,Term 18,16900000000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,기타채권,-,Term 20,637791666835,Term 19,645650629829,Term 18,581868123660,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_ShortTermTradeReceivable,매출채권,-,Term 20,585564696288,Term 19,611044864691,Term 18,556088266669,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,-Standard account code not used-,기타채권,-,Term 20,52226970547,Term 19,34605765138,Term 18,25779856991,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 20,808965987719,Term 19,746323199447,Term 18,614747846838,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 20,373764592,Term 19,1089659831,Term 18,23590117,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 20,42995506561,Term 19,50643842111,Term 18,81019495093,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 20,4818646865905,Term 19,4330594821983,Term 18,3584671429863,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_LongTermDepositsNotClassifiedAsCashEquivalents,장기금융상품,-,Term 20,20000000,Term 19,24000000,Term 18,24000000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentReceivablesGross,장기기타채권,-,Term 20,50353958215,Term 19,80180225757,Term 18,78324507595,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates,관계기업및공동기업투자,-,Term 20,59998748118,Term 19,56559112536,Term 18,52392994727,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 20,38749519773,Term 19,37441744173,Term 18,21123266919,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 20,2329834013415,Term 19,2036044655189,Term 18,1813288570135,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 20,219793014823,Term 19,273157209374,Term 18,0,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 20,24759532927,Term 19,42239252222,Term 18,45184246888,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 20,2063442867186,Term 19,1787313564367,Term 18,1544973448428,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 20,9768003713,Term 19,9467262843,Term 18,10397354014,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_OtherNonCurrentAssets,기타비유동자산,-,Term 20,21927207735,Term 19,8167795522,Term 18,18963041157,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 20,6801415783710,Term 19,6493669662971,Term 18,5275874284165,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 20,1479723875311,Term 19,1771203779670,Term 18,1358883491897,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,매입채무 및 기타유동채무,-,Term 20,779910998828,Term 19,1034527055707,Term 18,848560014566,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_ShortTermTradePayables,단기매입채무,-,Term 20,251186196633,Term 19,290674359917,Term 18,215581212474,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,-Standard account code not used-,기타채무,-,Term 20,338733244659,Term 19,352651064454,Term 18,258640013188,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 20,186412985536,Term 19,287644127872,Term 18,210810384650,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_CurrentPortionOfLongtermBorrowings,유동성장기차입금,-,Term 20,3578572000,Term 19,3566080000,Term 18,13566080000,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_CurrentPortionOfBonds,유동성사채,-,Term 20,,Term 19,99991423464,Term 18,149962324254,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 20,180411503449,Term 19,200760674566,Term 18,192627804993,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_CurrentProvisionsForReturnedGoods,환불부채,-,Term 20,15621411384,Term 19,17506962997,Term 18,16700325094,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 20,349310770860,Term 19,351652442060,Term 18,199699051620,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 20,154469190790,Term 19,166756644340,Term 18,101296295624,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 20,472496209534,Term 19,485378218165,Term 18,322970664268,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentPayables,장기매입채무 및 기타비유동채무,-,Term 20,57308752150,Term 19,47598060022,Term 18,114364255911,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_LongTermBorrowingsGross,장기차입금,-,Term 20,22801783421,Term 19,3566080000,Term 18,7132160000,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,-Standard account code not used-,장기기타채무,-,Term 20,,Term 19,8646253131,Term 18,,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_BondsIssued,사채,-,Term 20,29999854078,Term 19,29999727873,Term 18,99907049975,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_LongTermGuaranteeDepositWithholdings,장기예수보증금,-,Term 20,4507114651,Term 19,5385999018,Term 18,7325045936,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_PostemploymentBenefitObligations,퇴직급여부채,-,Term 20,48752783196,Term 19,67532645988,Term 18,34256838606,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 20,131795665327,Term 19,95549343156,Term 18,119995728100,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialLiabilities,기타비유동금융부채,-,Term 20,157269496925,Term 19,227136200242,Term 18,23936993871,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 20,77369511936,Term 19,47561968757,Term 18,30416847780,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 20,1952220084845,Term 19,2256581997835,Term 18,1681854156165,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업소유지분,-,Term 20,4755979504489,Term 19,4146733740179,Term 18,3512066419513,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 20,88589470000,Term 19,88589470000,Term 18,88589470000,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 20,97325737783,Term 19,97325737783,Term 18,97325737783,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금(결손금),-,Term 20,4805404131407,Term 19,4174881534589,Term 18,3563364542417,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 20,-124122981721,Term 19,-96636000943,Term 18,-121624601514,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_OtherCapitalAdjustments,기타자본항목,-,Term 20,-111216852980,Term 19,-117427001250,Term 18,-115588729173,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배지분,-,Term 20,93216194376,Term 19,90353924957,Term 18,81953708487,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 20,4849195698865,Term 19,4237087665136,Term 18,3594020128000,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,자본과부채총계,-,Term 20,6801415783710,Term 19,6493669662971,Term 18,5275874284165,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_Revenue,매출액,-,Term 20,7844506057131,Term 19,7685424230297,Term 18,6747536801608,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_CostOfSales,매출원가,-,Term 20,2962930553558,Term 19,2917246274571,Term 18,2696414092278,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_GrossProfit,매출총이익,-,Term 20,4881575503573,Term 19,4768177955726,Term 18,4051122709330,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 20,3660710772262,Term 19,3591766708822,Term 18,3011872573693,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,dart_OperatingIncomeLoss,영업이익(손실),-,Term 20,1220864731311,Term 19,1176411246904,Term 18,1039250135637,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_FinanceIncome,금융수익,-,Term 20,15434807035,Term 19,17086461393,Term 18,6486158742,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_FinanceCosts,금융원가,-,Term 20,21616953222,Term 19,17773035035,Term 18,12707249161,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,dart_OtherGains,기타영업외수익,-,Term 20,44819578890,Term 19,32917076235,Term 18,24006227891,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,dart_OtherLosses,기타영업외비용,-,Term 20,145452166970,Term 19,123480423267,Term 18,99710960281,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,-Standard account code not used-,지분법손익,-,Term 20,7024275269,Term 19,6919863873,Term 18,-1319193795,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익(손실),-,Term 20,1121074272313,Term 19,1092081190103,Term 18,956005119033,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 20,307973132289,Term 19,303908097869,Term 18,263726412686,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 20,813101140024,Term 19,788173092234,Term 18,692278706347,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 20,797628672879,Term 19,778097707167,Term 18,682743154211,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배지분,-,Term 20,15472467145,Term 19,10075385067,Term 18,9535552136,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_BasicEarningsLossPerShare,기본 및 희석 보통주당이익,-,Term 20,47596,Term 19,46431,Term 18,40740,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_DilutedEarningsLossPerShare,기본 및 희석 우선주당이익,-,Term 20,47647,Term 19,46481,Term 18,40790,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 20,813101140024,Term 19,788173092234,Term 18,692278706347,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 20,-10164589640,Term 19,13688171271,Term 18,203490317,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되지 않는 항목,-,Term 20,17224431473,Term 19,-13553148202,Term 18,-12578758749,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),-,Term 20,18549466745,Term 19,-11691231674,Term 18,-11813991316,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,-,Term 20,-1327783683,Term 19,-1906910378,Term 18,-764767433,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,-,Term 20,2748411,Term 19,44993850,Term 18,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax,당기손익으로 재분류될 수 있는 항목(세후기타포괄손익),-,Term 20,-27389021113,Term 19,27241319473,Term 18,12782249066,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,dart_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법 적용대상 관계기업과 공동기업의 기타포괄손익에 대한 지분(세후기타포괄손익),-,Term 20,-215096850,Term 19,88177739,Term 18,216104407,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업장환산외환차이(세후기타포괄손익),-,Term 20,-27173924263,Term 19,27153141734,Term 18,12566144659,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄손익,-,Term 20,802936550384,Term 19,801861263505,Term 18,692482196664,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 20,787456912990,Term 19,792025521227,Term 18,683409427015,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배지분,-,Term 20,15479637394,Term 19,9835742278,Term 18,9072769649,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동현금흐름,-,Term 20,1004842472035,Term 19,1139641474935,Term 18,817116843804,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_ProfitLossForStatementOfCashFlows,당기순이익(손실),-,Term 20,813101140024,Term 19,788173092234,Term 18,692278706347,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,수익ㆍ비용의가감,-,Term 20,626194542524,Term 19,651911831070,Term 18,520574156305,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForDepreciationExpense,감가상각비,-,Term 20,233925508629,Term 19,223940938745,Term 18,135694205295,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 20,28295853267,Term 19,27078995902,Term 18,21752965806,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 20,50474494996,Term 19,46396918588,Term 18,43993371189,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비,-,Term 20,595482883,Term 19,231152265,Term 18,-182012119,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타의 대손상각비,-,Term 20,120354050,Term 19,498555701,Term 18,-958326063,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 20,12507879942,Term 19,13870018114,Term 18,10135518970,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 20,2555055538,Term 19,2210056526,Term 18,1269641235,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치 측정 금융자산 평가이익,-,Term 20,,Term 19,,Term 18,910411462,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치 측정 금융자산 평가손실,-,Term 20,,Term 19,48496900,Term 18,882420015,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융부채 평가손실,-,Term 20,2431280464,Term 19,,Term 18,,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfFinancialAssets,당기손익-공정가치 측정 금융자산 처분손실,-,Term 20,22428828,Term 19,29066269,Term 18,,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfFinancialAssets,당기손익-공정가치 측정 금융자산 처분이익,-,Term 20,,Term 19,1370300650,Term 18,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융부채 평가이익,-,Term 20,-3205933336,Term 19,-1405338340,Term 18,-527375520,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 20,7796049548,Term 19,7471500310,Term 18,10130107174,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfInvestmentProperty,투자부동산처분손실,-,Term 20,122712135,Term 19,12145224,Term 18,,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfIntangibleAssets,무형자산처분손실,-,Term 20,1179758364,Term 19,1709806609,Term 18,435956321,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분손실,-,Term 20,12559557,Term 19,40106066,Term 18,,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfPropertyPlantAndEquipment,유형자산손상차손,-,Term 20,958695011,Term 19,8172548599,Term 18,10847999340,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,투자부동산손상차손,-,Term 20,2723414919,Term 19,2076269660,Term 18,931553838,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfIntangibleAssets,무형자산손상차손,-,Term 20,56925461,Term 19,41517092546,Term 18,28981153390,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 20,307973132289,Term 19,303908097869,Term 18,263726412686,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestIncome,이자수익,-,Term 20,4984491548,Term 19,8700706278,Term 18,3836339122,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,배당금수익,-,Term 20,933000000,Term 19,28256000,Term 18,19281900,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 20,1444637923,Term 19,1771727446,Term 18,992074598,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 20,3539815333,Term 19,6156226718,Term 18,2007434469,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentProperty,투자부동산처분이익,-,Term 20,3740590000,Term 19,112545282,Term 18,,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfIntangibleAssets,무형자산처분이익,-,Term 20,466778724,Term 19,226562693,Term 18,59960552,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분이익,-,Term 20,-217521224,Term 19,-58412806,Term 18,,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForProfitsOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 20,7024275269,Term 19,6919863873,Term 18,-1319193795,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,자산수증이익,-,Term 20,,Term 19,,Term 18,-33126944,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForBargainPurchaseGains,염가매수차익,-,Term 20,,Term 19,549994737,Term 18,,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업활동으로인한자산ㆍ부채의변동,-,Term 20,-97771906662,Term 19,15693436344,Term 18,-154376186486,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable,매출채권,-,Term 20,22475967366,Term 19,-22581565164,Term 18,3678536884,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInTradeAndOtherReceivables,기타채권,-,Term 20,4352829222,Term 19,17762470159,Term 18,840888309,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산,-,Term 20,-67826527783,Term 19,-31006365565,Term 18,-43471253195,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산,-,Term 20,12117381977,Term 19,-6138979641,Term 18,-57652675241,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,기타유동금융자산,-,Term 20,,Term 19,734507866,Term 18,,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInOtherNonCurrentNonFinancialAssets,기타비유동자산,-,Term 20,-7901977197,Term 19,,Term 18,-3945464731,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable,매입채무,-,Term 20,-30067851787,Term 19,2410984772,Term 18,-42740446487,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInTradeAndOtherPayables,기타채무,-,Term 20,22469667835,Term 19,70917430472,Term 18,21884680463,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,환불부채,-,Term 20,-549255134,Term 19,-874540704,Term 18,-7970704222,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 20,-12986505720,Term 19,30299904461,Term 18,30050165944,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채,-,Term 20,-8576068399,Term 19,21482822264,Term 18,5310730780,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInWithholdingsBanks,예수보증금,-,Term 20,-554689404,Term 19,-2382570699,Term 18,380920581,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,퇴직금의 지급,-,Term 20,7374041609,Term 19,4565340718,Term 18,4438869046,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInPostemploymentBenefitObligations,퇴직급여부채의 관계사 전입,-,Term 20,825666713,Term 19,-461390214,Term 18,961181937,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInFairValueOfPlanAssets,사외적립자산의 기여,-,Term 20,-54936455806,Term 19,-66366829778,Term 18,-64309539715,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherNonCurrentLiabilities,기타비유동부채,-,Term 20,30759953064,Term 19,6462898833,Term 18,7045661253,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자수취(영업),-,Term 20,4959977013,Term 19,7587742626,Term 18,4612293973,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsOperatingActivities,배당금수취(영업),-,Term 20,4227270000,Term 19,2901037478,Term 18,2483354511,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자지급(영업),-,Term 20,8700381507,Term 19,10180156104,Term 18,11628566111,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세납부(환급),-,Term 20,337168169357,Term 19,316445508713,Term 18,236826914735,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동현금흐름,-,Term 20,-745883641217,Term 19,-461380844546,Term 18,-430292259476,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,단기금융상품의 감소,-,Term 20,76200000999,Term 19,15055168850,Term 18,7043340694,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,단기기타채권의 감소,-,Term 20,894557167,Term 19,37975273738,Term 18,2418554769,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,장기금융상품의 감소,-,Term 20,4000000,Term 19,,Term 18,492738779,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,장기기타채권의 감소,-,Term 20,9748658623,Term 19,64308271893,Term 18,19766011640,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,기타비유동금융자산의 감소,-,Term 20,1173000000,Term 19,558934331,Term 18,,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 20,6797791333,Term 19,12659860186,Term 18,3295995994,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 20,4760000000,Term 19,340000000,Term 18,,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 20,9906597662,Term 19,463027231,Term 18,95000000,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합으로 인한 순현금흐름 유입,-,Term 20,,Term 19,2666361770,Term 18,,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,종속기업의 설립,-,Term 20,,Term 19,50000010000,Term 18,7846162460,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,단기금융상품의 증가,-,Term 20,62500000000,Term 19,70341850599,Term 18,5000000000,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,단기기타채권의 증가,-,Term 20,178968162,Term 19,254010544,Term 18,695071784,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,장기기타채권의 증가,-,Term 20,3927857300,Term 19,65426828092,Term 18,11320272647,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_PurchaseOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 취득,-,Term 20,,Term 19,,Term 18,200000000,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 20,505743484068,Term 19,326089104184,Term 18,356284941186,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 20,13128703763,Term 19,8973731170,Term 18,7842597936,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,사업결합으로 인한 현금유출,-,Term 20,269889233708,Term 19,174322227956,Term 18,89907180259,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동현금흐름,-,Term 20,-465737759835,Term 19,-429403943010,Term 18,-378036987192,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 차입,-,Term 20,96944735692,Term 19,271711203706,Term 18,323462505217,74,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_ProceedsFromLongTermBorrowings,장기차입금의 차입,-,Term 20,22736389421,Term 19,,Term 18,2356000000,75,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_ProceedsFromBonds,사채의 증가,-,Term 20,,Term 19,29999620000,Term 18,,76,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 상환,-,Term 20,194202086120,Term 19,323425777729,Term 18,237236106490,77,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities,유동성장기차입금의 상환,-,Term 20,3567121000,Term 19,13566080000,Term 18,25064090038,78,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_RepaymentsOfBonds,사채의 상환,-,Term 20,100000000000,Term 19,150000000000,Term 18,262437762000,79,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,전환사채의 상환,-,Term 20,,Term 19,,Term 18,-5377972602,80,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,리스부채의 지급,-,Term 20,91236233038,Term 19,80342388920,Term 18,139468422,81,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,종속기업투자의 취득,-,Term 20,,Term 19,-5190000000,Term 18,-11875640983,82,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,배당금의 지급,-,Term 20,196413444790,Term 19,158590520067,Term 18,161724451874,83,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,현금및현금성자산의 증가(감소),-,Term 20,-206778929017,Term 19,248856687379,Term 18,8787597136,85,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,기초의 현금및현금성자산,-,Term 20,647104059171,Term 19,396643798594,Term 18,386194252722,86,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,현금및현금성자산의 환율변동효과,-,Term 20,-300879719,Term 19,-695843313,Term 18,224665532,87,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,해외사업환산차이,-,Term 20,-5918786337,Term 19,2299416511,Term 18,1437283204,88,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말현금및현금성자산,-,Term 20,434105464098,Term 19,647104059171,Term 18,396643798594,89,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 20,88589470000,Term 19,88589470000,Term 18,88589470000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,4174881534589,Term 19,3563364542417,Term 18,3044143111385,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,-96636000943,Term 19,-121624601514,Term 18,-132783664248,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 20,97325737783,Term 19,97325737783,Term 18,97325737783,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 20,4237087665136,Term 19,3594020128000,Term 18,3081783034671,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배지분 [member],Term 20,90353924957,Term 19,81953708487,Term 18,85547807496,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,4146733740179,Term 19,3512066419513,Term 18,2996235227175,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 20,-117427001250,Term 19,-115588729173,Term 18,-101039427745,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,,Term 19,,Term 18,-1394297397,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,,Term 19,,Term 18,-725417902,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,연결재무제표 [member],Term 20,,Term 19,,Term 18,-2119715299,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,,Term 19,,Term 18,-2119715299,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,797628672879,Term 19,778097707167,Term 18,682743154211,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,797628672879,Term 19,778097707167,Term 18,682743154211,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|비지배지분 [member],Term 20,15472467145,Term 19,10075385067,Term 18,9535552136,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 20,813101140024,Term 19,788173092234,Term 18,692278706347,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,18312461353,Term 19,-11105780361,Term 18,-11201797236,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,18312461353,Term 19,-11105780361,Term 18,-11201797236,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,연결재무제표 [member],Term 20,18549466745,Term 19,-11691231674,Term 18,-11813991316,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|비지배지분 [member],Term 20,237005392,Term 19,-585451313,Term 18,-612194080,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|비지배지분 [member],Term 20,,Term 19,,Term 18,-33673837,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,-1327783683,Term 19,-1906910378,Term 18,-731093596,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,-1327783683,Term 19,-1906910378,Term 18,-731093596,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,연결재무제표 [member],Term 20,-1327783683,Term 19,-1906910378,Term 18,-764767433,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,연결재무제표 [member],Term 20,2748411,Term 19,44993850,Term 18,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,2748411,Term 19,44993850,Term 18,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,2748411,Term 19,44993850,Term 18,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분으로 인한 재분류,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,-999988875,Term 19,,Term 18,,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분으로 인한 재분류,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,999988875,Term 19,,Term 18,,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,연결재무제표 [member],Term 20,-215096850,Term 19,88177739,Term 18,216104407,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,-215096850,Term 19,88177739,Term 18,216104407,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,-215096850,Term 19,88177739,Term 18,216104407,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,연결재무제표 [member],Term 20,-27173924263,Term 19,27153141734,Term 18,12566144659,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|비지배지분 [member],Term 20,-229835143,Term 19,345808524,Term 18,183085430,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,-26944089120,Term 19,26807333210,Term 18,12383059229,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,-26944089120,Term 19,26807333210,Term 18,12383059229,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,184421296950,Term 19,155098219951,Term 18,150909217950,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,연결재무제표 [member],Term 20,196421296950,Term 19,158378373762,Term 18,161734054457,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|비지배지분 [member],Term 20,12000000000,Term 19,3280153811,Term 18,10824836507,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,184421296950,Term 19,155098219951,Term 18,150909217950,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,연결재무제표 [member],Term 20,5592780295,Term 19,-415352607,Term 18,-16391333579,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,6210148270,Term 19,-2259980610,Term 18,-14549301428,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 20,6210148270,Term 19,-1838272077,Term 18,-14549301428,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|비지배지분 [member],Term 20,-617367975,Term 19,1844628003,Term 18,-1842032151,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,,Term 19,-421708533,Term 18,-16410596,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,,Term 19,,Term 18,16410596,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|비지배지분 [member],Term 20,93216194376,Term 19,90353924957,Term 18,81953708487,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,4755979504489,Term 19,4146733740179,Term 18,3512066419513,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 20,-111216852980,Term 19,-117427001250,Term 18,-115588729173,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 20,97325737783,Term 19,97325737783,Term 18,97325737783,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 20,88589470000,Term 19,88589470000,Term 18,88589470000,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 20,4849195698865,Term 19,4237087665136,Term 18,3594020128000,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,-124122981721,Term 19,-96636000943,Term 18,-121624601514,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,4805404131407,Term 19,4174881534589,Term 18,3563364542417,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 20,1982768917805,Term 19,2163074840988,Term 18,1691202854302,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 20,434105464098,Term 19,647104059171,Term 18,396643798594,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_ShortTermDepositsNotClassifiedAsCashEquivalents,단기금융상품,-,Term 20,58536528000,Term 19,72263450599,Term 18,16900000000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,기타채권,-,Term 20,637791666835,Term 19,645650629829,Term 18,581868123660,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_ShortTermTradeReceivable,매출채권,-,Term 20,585564696288,Term 19,611044864691,Term 18,556088266669,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,-Standard account code not used-,기타채권,-,Term 20,52226970547,Term 19,34605765138,Term 18,25779856991,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 20,808965987719,Term 19,746323199447,Term 18,614747846838,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 20,373764592,Term 19,1089659831,Term 18,23590117,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 20,42995506561,Term 19,50643842111,Term 18,81019495093,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 20,4818646865905,Term 19,4330594821983,Term 18,3584671429863,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_LongTermDepositsNotClassifiedAsCashEquivalents,장기금융상품,-,Term 20,20000000,Term 19,24000000,Term 18,24000000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentReceivablesGross,장기기타채권,-,Term 20,50353958215,Term 19,80180225757,Term 18,78324507595,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates,관계기업및공동기업투자,-,Term 20,59998748118,Term 19,56559112536,Term 18,52392994727,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 20,38749519773,Term 19,37441744173,Term 18,21123266919,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 20,2329834013415,Term 19,2036044655189,Term 18,1813288570135,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 20,219793014823,Term 19,273157209374,Term 18,0,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 20,24759532927,Term 19,42239252222,Term 18,45184246888,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 20,2063442867186,Term 19,1787313564367,Term 18,1544973448428,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 20,9768003713,Term 19,9467262843,Term 18,10397354014,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_OtherNonCurrentAssets,기타비유동자산,-,Term 20,21927207735,Term 19,8167795522,Term 18,18963041157,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 20,6801415783710,Term 19,6493669662971,Term 18,5275874284165,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 20,1479723875311,Term 19,1771203779670,Term 18,1358883491897,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,매입채무 및 기타유동채무,-,Term 20,779910998828,Term 19,1034527055707,Term 18,848560014566,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_ShortTermTradePayables,단기매입채무,-,Term 20,251186196633,Term 19,290674359917,Term 18,215581212474,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,-Standard account code not used-,기타채무,-,Term 20,338733244659,Term 19,352651064454,Term 18,258640013188,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 20,186412985536,Term 19,287644127872,Term 18,210810384650,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_CurrentPortionOfLongtermBorrowings,유동성장기차입금,-,Term 20,3578572000,Term 19,3566080000,Term 18,13566080000,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_CurrentPortionOfBonds,유동성사채,-,Term 20,,Term 19,99991423464,Term 18,149962324254,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 20,180411503449,Term 19,200760674566,Term 18,192627804993,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_CurrentProvisionsForReturnedGoods,환불부채,-,Term 20,15621411384,Term 19,17506962997,Term 18,16700325094,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 20,349310770860,Term 19,351652442060,Term 18,199699051620,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 20,154469190790,Term 19,166756644340,Term 18,101296295624,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 20,472496209534,Term 19,485378218165,Term 18,322970664268,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentPayables,장기매입채무 및 기타비유동채무,-,Term 20,57308752150,Term 19,47598060022,Term 18,114364255911,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_LongTermBorrowingsGross,장기차입금,-,Term 20,22801783421,Term 19,3566080000,Term 18,7132160000,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,-Standard account code not used-,장기기타채무,-,Term 20,,Term 19,8646253131,Term 18,,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_BondsIssued,사채,-,Term 20,29999854078,Term 19,29999727873,Term 18,99907049975,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_LongTermGuaranteeDepositWithholdings,장기예수보증금,-,Term 20,4507114651,Term 19,5385999018,Term 18,7325045936,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_PostemploymentBenefitObligations,퇴직급여부채,-,Term 20,48752783196,Term 19,67532645988,Term 18,34256838606,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 20,131795665327,Term 19,95549343156,Term 18,119995728100,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialLiabilities,기타비유동금융부채,-,Term 20,157269496925,Term 19,227136200242,Term 18,23936993871,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 20,77369511936,Term 19,47561968757,Term 18,30416847780,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 20,1952220084845,Term 19,2256581997835,Term 18,1681854156165,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업소유지분,-,Term 20,4755979504489,Term 19,4146733740179,Term 18,3512066419513,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 20,88589470000,Term 19,88589470000,Term 18,88589470000,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 20,97325737783,Term 19,97325737783,Term 18,97325737783,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금(결손금),-,Term 20,4805404131407,Term 19,4174881534589,Term 18,3563364542417,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 20,-124122981721,Term 19,-96636000943,Term 18,-121624601514,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_OtherCapitalAdjustments,기타자본항목,-,Term 20,-111216852980,Term 19,-117427001250,Term 18,-115588729173,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배지분,-,Term 20,93216194376,Term 19,90353924957,Term 18,81953708487,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 20,4849195698865,Term 19,4237087665136,Term 18,3594020128000,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,자본과부채총계,-,Term 20,6801415783710,Term 19,6493669662971,Term 18,5275874284165,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_Revenue,매출액,-,Term 20,7844506057131,Term 19,7685424230297,Term 18,6747536801608,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_CostOfSales,매출원가,-,Term 20,2962930553558,Term 19,2917246274571,Term 18,2696414092278,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_GrossProfit,매출총이익,-,Term 20,4881575503573,Term 19,4768177955726,Term 18,4051122709330,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 20,3660710772262,Term 19,3591766708822,Term 18,3011872573693,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,dart_OperatingIncomeLoss,영업이익(손실),-,Term 20,1220864731311,Term 19,1176411246904,Term 18,1039250135637,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_FinanceIncome,금융수익,-,Term 20,15434807035,Term 19,17086461393,Term 18,6486158742,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_FinanceCosts,금융원가,-,Term 20,21616953222,Term 19,17773035035,Term 18,12707249161,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,dart_OtherGains,기타영업외수익,-,Term 20,44819578890,Term 19,32917076235,Term 18,24006227891,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,dart_OtherLosses,기타영업외비용,-,Term 20,145452166970,Term 19,123480423267,Term 18,99710960281,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,-Standard account code not used-,지분법손익,-,Term 20,7024275269,Term 19,6919863873,Term 18,-1319193795,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익(손실),-,Term 20,1121074272313,Term 19,1092081190103,Term 18,956005119033,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 20,307973132289,Term 19,303908097869,Term 18,263726412686,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 20,813101140024,Term 19,788173092234,Term 18,692278706347,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 20,797628672879,Term 19,778097707167,Term 18,682743154211,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배지분,-,Term 20,15472467145,Term 19,10075385067,Term 18,9535552136,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_BasicEarningsLossPerShare,기본 및 희석 보통주당이익,-,Term 20,47596,Term 19,46431,Term 18,40740,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_DilutedEarningsLossPerShare,기본 및 희석 우선주당이익,-,Term 20,47647,Term 19,46481,Term 18,40790,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 20,813101140024,Term 19,788173092234,Term 18,692278706347,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 20,-10164589640,Term 19,13688171271,Term 18,203490317,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되지 않는 항목,-,Term 20,17224431473,Term 19,-13553148202,Term 18,-12578758749,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),-,Term 20,18549466745,Term 19,-11691231674,Term 18,-11813991316,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,-,Term 20,-1327783683,Term 19,-1906910378,Term 18,-764767433,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,-,Term 20,2748411,Term 19,44993850,Term 18,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax,당기손익으로 재분류될 수 있는 항목(세후기타포괄손익),-,Term 20,-27389021113,Term 19,27241319473,Term 18,12782249066,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,dart_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법 적용대상 관계기업과 공동기업의 기타포괄손익에 대한 지분(세후기타포괄손익),-,Term 20,-215096850,Term 19,88177739,Term 18,216104407,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업장환산외환차이(세후기타포괄손익),-,Term 20,-27173924263,Term 19,27153141734,Term 18,12566144659,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄손익,-,Term 20,802936550384,Term 19,801861263505,Term 18,692482196664,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 20,787456912990,Term 19,792025521227,Term 18,683409427015,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배지분,-,Term 20,15479637394,Term 19,9835742278,Term 18,9072769649,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동현금흐름,-,Term 20,1004842472035,Term 19,1139641474935,Term 18,817116843804,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_ProfitLossForStatementOfCashFlows,당기순이익(손실),-,Term 20,813101140024,Term 19,788173092234,Term 18,692278706347,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,수익ㆍ비용의가감,-,Term 20,626194542524,Term 19,651911831070,Term 18,520574156305,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForDepreciationExpense,감가상각비,-,Term 20,233925508629,Term 19,223940938745,Term 18,135694205295,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 20,28295853267,Term 19,27078995902,Term 18,21752965806,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 20,50474494996,Term 19,46396918588,Term 18,43993371189,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비,-,Term 20,595482883,Term 19,231152265,Term 18,-182012119,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타의 대손상각비,-,Term 20,120354050,Term 19,498555701,Term 18,-958326063,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 20,12507879942,Term 19,13870018114,Term 18,10135518970,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 20,2555055538,Term 19,2210056526,Term 18,1269641235,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치 측정 금융자산 평가이익,-,Term 20,,Term 19,,Term 18,910411462,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치 측정 금융자산 평가손실,-,Term 20,,Term 19,48496900,Term 18,882420015,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융부채 평가손실,-,Term 20,2431280464,Term 19,,Term 18,,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfFinancialAssets,당기손익-공정가치 측정 금융자산 처분손실,-,Term 20,22428828,Term 19,29066269,Term 18,,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfFinancialAssets,당기손익-공정가치 측정 금융자산 처분이익,-,Term 20,,Term 19,1370300650,Term 18,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융부채 평가이익,-,Term 20,-3205933336,Term 19,-1405338340,Term 18,-527375520,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 20,7796049548,Term 19,7471500310,Term 18,10130107174,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfInvestmentProperty,투자부동산처분손실,-,Term 20,122712135,Term 19,12145224,Term 18,,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfIntangibleAssets,무형자산처분손실,-,Term 20,1179758364,Term 19,1709806609,Term 18,435956321,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분손실,-,Term 20,12559557,Term 19,40106066,Term 18,,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfPropertyPlantAndEquipment,유형자산손상차손,-,Term 20,958695011,Term 19,8172548599,Term 18,10847999340,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,투자부동산손상차손,-,Term 20,2723414919,Term 19,2076269660,Term 18,931553838,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfIntangibleAssets,무형자산손상차손,-,Term 20,56925461,Term 19,41517092546,Term 18,28981153390,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 20,307973132289,Term 19,303908097869,Term 18,263726412686,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestIncome,이자수익,-,Term 20,4984491548,Term 19,8700706278,Term 18,3836339122,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,배당금수익,-,Term 20,933000000,Term 19,28256000,Term 18,19281900,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 20,1444637923,Term 19,1771727446,Term 18,992074598,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 20,3539815333,Term 19,6156226718,Term 18,2007434469,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentProperty,투자부동산처분이익,-,Term 20,3740590000,Term 19,112545282,Term 18,,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfIntangibleAssets,무형자산처분이익,-,Term 20,466778724,Term 19,226562693,Term 18,59960552,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분이익,-,Term 20,-217521224,Term 19,-58412806,Term 18,,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForProfitsOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 20,7024275269,Term 19,6919863873,Term 18,-1319193795,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,자산수증이익,-,Term 20,,Term 19,,Term 18,-33126944,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForBargainPurchaseGains,염가매수차익,-,Term 20,,Term 19,549994737,Term 18,,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업활동으로인한자산ㆍ부채의변동,-,Term 20,-97771906662,Term 19,15693436344,Term 18,-154376186486,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable,매출채권,-,Term 20,22475967366,Term 19,-22581565164,Term 18,3678536884,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInTradeAndOtherReceivables,기타채권,-,Term 20,4352829222,Term 19,17762470159,Term 18,840888309,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산,-,Term 20,-67826527783,Term 19,-31006365565,Term 18,-43471253195,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산,-,Term 20,12117381977,Term 19,-6138979641,Term 18,-57652675241,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,기타유동금융자산,-,Term 20,,Term 19,734507866,Term 18,,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInOtherNonCurrentNonFinancialAssets,기타비유동자산,-,Term 20,-7901977197,Term 19,,Term 18,-3945464731,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable,매입채무,-,Term 20,-30067851787,Term 19,2410984772,Term 18,-42740446487,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInTradeAndOtherPayables,기타채무,-,Term 20,22469667835,Term 19,70917430472,Term 18,21884680463,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,환불부채,-,Term 20,-549255134,Term 19,-874540704,Term 18,-7970704222,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 20,-12986505720,Term 19,30299904461,Term 18,30050165944,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채,-,Term 20,-8576068399,Term 19,21482822264,Term 18,5310730780,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInWithholdingsBanks,예수보증금,-,Term 20,-554689404,Term 19,-2382570699,Term 18,380920581,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,퇴직금의 지급,-,Term 20,7374041609,Term 19,4565340718,Term 18,4438869046,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInPostemploymentBenefitObligations,퇴직급여부채의 관계사 전입,-,Term 20,825666713,Term 19,-461390214,Term 18,961181937,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInFairValueOfPlanAssets,사외적립자산의 기여,-,Term 20,-54936455806,Term 19,-66366829778,Term 18,-64309539715,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherNonCurrentLiabilities,기타비유동부채,-,Term 20,30759953064,Term 19,6462898833,Term 18,7045661253,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자수취(영업),-,Term 20,4959977013,Term 19,7587742626,Term 18,4612293973,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsOperatingActivities,배당금수취(영업),-,Term 20,4227270000,Term 19,2901037478,Term 18,2483354511,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자지급(영업),-,Term 20,8700381507,Term 19,10180156104,Term 18,11628566111,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세납부(환급),-,Term 20,337168169357,Term 19,316445508713,Term 18,236826914735,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동현금흐름,-,Term 20,-745883641217,Term 19,-461380844546,Term 18,-430292259476,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,단기금융상품의 감소,-,Term 20,76200000999,Term 19,15055168850,Term 18,7043340694,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,단기기타채권의 감소,-,Term 20,894557167,Term 19,37975273738,Term 18,2418554769,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,장기금융상품의 감소,-,Term 20,4000000,Term 19,,Term 18,492738779,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,장기기타채권의 감소,-,Term 20,9748658623,Term 19,64308271893,Term 18,19766011640,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,기타비유동금융자산의 감소,-,Term 20,1173000000,Term 19,558934331,Term 18,,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 20,6797791333,Term 19,12659860186,Term 18,3295995994,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 20,4760000000,Term 19,340000000,Term 18,,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 20,9906597662,Term 19,463027231,Term 18,95000000,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합으로 인한 순현금흐름 유입,-,Term 20,,Term 19,2666361770,Term 18,,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,종속기업의 설립,-,Term 20,,Term 19,50000010000,Term 18,7846162460,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,단기금융상품의 증가,-,Term 20,62500000000,Term 19,70341850599,Term 18,5000000000,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,단기기타채권의 증가,-,Term 20,178968162,Term 19,254010544,Term 18,695071784,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,장기기타채권의 증가,-,Term 20,3927857300,Term 19,65426828092,Term 18,11320272647,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_PurchaseOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 취득,-,Term 20,,Term 19,,Term 18,200000000,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 20,505743484068,Term 19,326089104184,Term 18,356284941186,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 20,13128703763,Term 19,8973731170,Term 18,7842597936,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,사업결합으로 인한 현금유출,-,Term 20,269889233708,Term 19,174322227956,Term 18,89907180259,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동현금흐름,-,Term 20,-465737759835,Term 19,-429403943010,Term 18,-378036987192,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 차입,-,Term 20,96944735692,Term 19,271711203706,Term 18,323462505217,74,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_ProceedsFromLongTermBorrowings,장기차입금의 차입,-,Term 20,22736389421,Term 19,,Term 18,2356000000,75,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_ProceedsFromBonds,사채의 증가,-,Term 20,,Term 19,29999620000,Term 18,,76,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 상환,-,Term 20,194202086120,Term 19,323425777729,Term 18,237236106490,77,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities,유동성장기차입금의 상환,-,Term 20,3567121000,Term 19,13566080000,Term 18,25064090038,78,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_RepaymentsOfBonds,사채의 상환,-,Term 20,100000000000,Term 19,150000000000,Term 18,262437762000,79,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,전환사채의 상환,-,Term 20,,Term 19,,Term 18,-5377972602,80,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,리스부채의 지급,-,Term 20,91236233038,Term 19,80342388920,Term 18,139468422,81,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,종속기업투자의 취득,-,Term 20,,Term 19,-5190000000,Term 18,-11875640983,82,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,배당금의 지급,-,Term 20,196413444790,Term 19,158590520067,Term 18,161724451874,83,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,현금및현금성자산의 증가(감소),-,Term 20,-206778929017,Term 19,248856687379,Term 18,8787597136,85,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,기초의 현금및현금성자산,-,Term 20,647104059171,Term 19,396643798594,Term 18,386194252722,86,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,현금및현금성자산의 환율변동효과,-,Term 20,-300879719,Term 19,-695843313,Term 18,224665532,87,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,해외사업환산차이,-,Term 20,-5918786337,Term 19,2299416511,Term 18,1437283204,88,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말현금및현금성자산,-,Term 20,434105464098,Term 19,647104059171,Term 18,396643798594,89,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 20,88589470000,Term 19,88589470000,Term 18,88589470000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,4174881534589,Term 19,3563364542417,Term 18,3044143111385,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,-96636000943,Term 19,-121624601514,Term 18,-132783664248,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 20,97325737783,Term 19,97325737783,Term 18,97325737783,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 20,4237087665136,Term 19,3594020128000,Term 18,3081783034671,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배지분 [member],Term 20,90353924957,Term 19,81953708487,Term 18,85547807496,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,4146733740179,Term 19,3512066419513,Term 18,2996235227175,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 20,-117427001250,Term 19,-115588729173,Term 18,-101039427745,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,,Term 19,,Term 18,-1394297397,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,,Term 19,,Term 18,-725417902,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,연결재무제표 [member],Term 20,,Term 19,,Term 18,-2119715299,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,,Term 19,,Term 18,-2119715299,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,797628672879,Term 19,778097707167,Term 18,682743154211,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,797628672879,Term 19,778097707167,Term 18,682743154211,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|비지배지분 [member],Term 20,15472467145,Term 19,10075385067,Term 18,9535552136,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 20,813101140024,Term 19,788173092234,Term 18,692278706347,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,18312461353,Term 19,-11105780361,Term 18,-11201797236,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,18312461353,Term 19,-11105780361,Term 18,-11201797236,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,연결재무제표 [member],Term 20,18549466745,Term 19,-11691231674,Term 18,-11813991316,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|비지배지분 [member],Term 20,237005392,Term 19,-585451313,Term 18,-612194080,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|비지배지분 [member],Term 20,,Term 19,,Term 18,-33673837,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,-1327783683,Term 19,-1906910378,Term 18,-731093596,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,-1327783683,Term 19,-1906910378,Term 18,-731093596,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,연결재무제표 [member],Term 20,-1327783683,Term 19,-1906910378,Term 18,-764767433,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,연결재무제표 [member],Term 20,2748411,Term 19,44993850,Term 18,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,2748411,Term 19,44993850,Term 18,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,2748411,Term 19,44993850,Term 18,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분으로 인한 재분류,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,-999988875,Term 19,,Term 18,,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분으로 인한 재분류,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,999988875,Term 19,,Term 18,,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,연결재무제표 [member],Term 20,-215096850,Term 19,88177739,Term 18,216104407,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,-215096850,Term 19,88177739,Term 18,216104407,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,-215096850,Term 19,88177739,Term 18,216104407,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,연결재무제표 [member],Term 20,-27173924263,Term 19,27153141734,Term 18,12566144659,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|비지배지분 [member],Term 20,-229835143,Term 19,345808524,Term 18,183085430,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,-26944089120,Term 19,26807333210,Term 18,12383059229,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,-26944089120,Term 19,26807333210,Term 18,12383059229,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,184421296950,Term 19,155098219951,Term 18,150909217950,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,연결재무제표 [member],Term 20,196421296950,Term 19,158378373762,Term 18,161734054457,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|비지배지분 [member],Term 20,12000000000,Term 19,3280153811,Term 18,10824836507,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,184421296950,Term 19,155098219951,Term 18,150909217950,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,연결재무제표 [member],Term 20,5592780295,Term 19,-415352607,Term 18,-16391333579,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,6210148270,Term 19,-2259980610,Term 18,-14549301428,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 20,6210148270,Term 19,-1838272077,Term 18,-14549301428,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|비지배지분 [member],Term 20,-617367975,Term 19,1844628003,Term 18,-1842032151,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,,Term 19,-421708533,Term 18,-16410596,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,,Term 19,,Term 18,16410596,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|비지배지분 [member],Term 20,93216194376,Term 19,90353924957,Term 18,81953708487,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,4755979504489,Term 19,4146733740179,Term 18,3512066419513,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 20,-111216852980,Term 19,-117427001250,Term 18,-115588729173,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 20,97325737783,Term 19,97325737783,Term 18,97325737783,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 20,88589470000,Term 19,88589470000,Term 18,88589470000,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 20,4849195698865,Term 19,4237087665136,Term 18,3594020128000,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,-124122981721,Term 19,-96636000943,Term 18,-121624601514,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,4805404131407,Term 19,4174881534589,Term 18,3563364542417,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 20,1982768917805,Term 19,2163074840988,Term 18,1691202854302,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 20,434105464098,Term 19,647104059171,Term 18,396643798594,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_ShortTermDepositsNotClassifiedAsCashEquivalents,단기금융상품,-,Term 20,58536528000,Term 19,72263450599,Term 18,16900000000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,기타채권,-,Term 20,637791666835,Term 19,645650629829,Term 18,581868123660,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_ShortTermTradeReceivable,매출채권,-,Term 20,585564696288,Term 19,611044864691,Term 18,556088266669,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,-Standard account code not used-,기타채권,-,Term 20,52226970547,Term 19,34605765138,Term 18,25779856991,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 20,808965987719,Term 19,746323199447,Term 18,614747846838,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 20,373764592,Term 19,1089659831,Term 18,23590117,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 20,42995506561,Term 19,50643842111,Term 18,81019495093,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 20,4818646865905,Term 19,4330594821983,Term 18,3584671429863,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_LongTermDepositsNotClassifiedAsCashEquivalents,장기금융상품,-,Term 20,20000000,Term 19,24000000,Term 18,24000000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentReceivablesGross,장기기타채권,-,Term 20,50353958215,Term 19,80180225757,Term 18,78324507595,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates,관계기업및공동기업투자,-,Term 20,59998748118,Term 19,56559112536,Term 18,52392994727,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 20,38749519773,Term 19,37441744173,Term 18,21123266919,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 20,2329834013415,Term 19,2036044655189,Term 18,1813288570135,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 20,219793014823,Term 19,273157209374,Term 18,0,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 20,24759532927,Term 19,42239252222,Term 18,45184246888,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 20,2063442867186,Term 19,1787313564367,Term 18,1544973448428,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 20,9768003713,Term 19,9467262843,Term 18,10397354014,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_OtherNonCurrentAssets,기타비유동자산,-,Term 20,21927207735,Term 19,8167795522,Term 18,18963041157,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 20,6801415783710,Term 19,6493669662971,Term 18,5275874284165,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 20,1479723875311,Term 19,1771203779670,Term 18,1358883491897,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,매입채무 및 기타유동채무,-,Term 20,779910998828,Term 19,1034527055707,Term 18,848560014566,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_ShortTermTradePayables,단기매입채무,-,Term 20,251186196633,Term 19,290674359917,Term 18,215581212474,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,-Standard account code not used-,기타채무,-,Term 20,338733244659,Term 19,352651064454,Term 18,258640013188,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 20,186412985536,Term 19,287644127872,Term 18,210810384650,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_CurrentPortionOfLongtermBorrowings,유동성장기차입금,-,Term 20,3578572000,Term 19,3566080000,Term 18,13566080000,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_CurrentPortionOfBonds,유동성사채,-,Term 20,,Term 19,99991423464,Term 18,149962324254,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 20,180411503449,Term 19,200760674566,Term 18,192627804993,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_CurrentProvisionsForReturnedGoods,환불부채,-,Term 20,15621411384,Term 19,17506962997,Term 18,16700325094,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 20,349310770860,Term 19,351652442060,Term 18,199699051620,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 20,154469190790,Term 19,166756644340,Term 18,101296295624,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 20,472496209534,Term 19,485378218165,Term 18,322970664268,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentPayables,장기매입채무 및 기타비유동채무,-,Term 20,57308752150,Term 19,47598060022,Term 18,114364255911,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_LongTermBorrowingsGross,장기차입금,-,Term 20,22801783421,Term 19,3566080000,Term 18,7132160000,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,-Standard account code not used-,장기기타채무,-,Term 20,,Term 19,8646253131,Term 18,,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_BondsIssued,사채,-,Term 20,29999854078,Term 19,29999727873,Term 18,99907049975,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_LongTermGuaranteeDepositWithholdings,장기예수보증금,-,Term 20,4507114651,Term 19,5385999018,Term 18,7325045936,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_PostemploymentBenefitObligations,퇴직급여부채,-,Term 20,48752783196,Term 19,67532645988,Term 18,34256838606,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 20,131795665327,Term 19,95549343156,Term 18,119995728100,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialLiabilities,기타비유동금융부채,-,Term 20,157269496925,Term 19,227136200242,Term 18,23936993871,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 20,77369511936,Term 19,47561968757,Term 18,30416847780,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 20,1952220084845,Term 19,2256581997835,Term 18,1681854156165,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업소유지분,-,Term 20,4755979504489,Term 19,4146733740179,Term 18,3512066419513,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 20,88589470000,Term 19,88589470000,Term 18,88589470000,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 20,97325737783,Term 19,97325737783,Term 18,97325737783,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금(결손금),-,Term 20,4805404131407,Term 19,4174881534589,Term 18,3563364542417,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 20,-124122981721,Term 19,-96636000943,Term 18,-121624601514,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_OtherCapitalAdjustments,기타자본항목,-,Term 20,-111216852980,Term 19,-117427001250,Term 18,-115588729173,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배지분,-,Term 20,93216194376,Term 19,90353924957,Term 18,81953708487,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 20,4849195698865,Term 19,4237087665136,Term 18,3594020128000,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,자본과부채총계,-,Term 20,6801415783710,Term 19,6493669662971,Term 18,5275874284165,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_Revenue,매출액,-,Term 20,7844506057131,Term 19,7685424230297,Term 18,6747536801608,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_CostOfSales,매출원가,-,Term 20,2962930553558,Term 19,2917246274571,Term 18,2696414092278,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_GrossProfit,매출총이익,-,Term 20,4881575503573,Term 19,4768177955726,Term 18,4051122709330,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 20,3660710772262,Term 19,3591766708822,Term 18,3011872573693,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,dart_OperatingIncomeLoss,영업이익(손실),-,Term 20,1220864731311,Term 19,1176411246904,Term 18,1039250135637,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_FinanceIncome,금융수익,-,Term 20,15434807035,Term 19,17086461393,Term 18,6486158742,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_FinanceCosts,금융원가,-,Term 20,21616953222,Term 19,17773035035,Term 18,12707249161,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,dart_OtherGains,기타영업외수익,-,Term 20,44819578890,Term 19,32917076235,Term 18,24006227891,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,dart_OtherLosses,기타영업외비용,-,Term 20,145452166970,Term 19,123480423267,Term 18,99710960281,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,-Standard account code not used-,지분법손익,-,Term 20,7024275269,Term 19,6919863873,Term 18,-1319193795,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익(손실),-,Term 20,1121074272313,Term 19,1092081190103,Term 18,956005119033,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 20,307973132289,Term 19,303908097869,Term 18,263726412686,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 20,813101140024,Term 19,788173092234,Term 18,692278706347,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 20,797628672879,Term 19,778097707167,Term 18,682743154211,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배지분,-,Term 20,15472467145,Term 19,10075385067,Term 18,9535552136,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_BasicEarningsLossPerShare,기본 및 희석 보통주당이익,-,Term 20,47596,Term 19,46431,Term 18,40740,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_DilutedEarningsLossPerShare,기본 및 희석 우선주당이익,-,Term 20,47647,Term 19,46481,Term 18,40790,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 20,813101140024,Term 19,788173092234,Term 18,692278706347,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 20,-10164589640,Term 19,13688171271,Term 18,203490317,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되지 않는 항목,-,Term 20,17224431473,Term 19,-13553148202,Term 18,-12578758749,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),-,Term 20,18549466745,Term 19,-11691231674,Term 18,-11813991316,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,-,Term 20,-1327783683,Term 19,-1906910378,Term 18,-764767433,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,-,Term 20,2748411,Term 19,44993850,Term 18,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax,당기손익으로 재분류될 수 있는 항목(세후기타포괄손익),-,Term 20,-27389021113,Term 19,27241319473,Term 18,12782249066,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,dart_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법 적용대상 관계기업과 공동기업의 기타포괄손익에 대한 지분(세후기타포괄손익),-,Term 20,-215096850,Term 19,88177739,Term 18,216104407,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업장환산외환차이(세후기타포괄손익),-,Term 20,-27173924263,Term 19,27153141734,Term 18,12566144659,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄손익,-,Term 20,802936550384,Term 19,801861263505,Term 18,692482196664,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 20,787456912990,Term 19,792025521227,Term 18,683409427015,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배지분,-,Term 20,15479637394,Term 19,9835742278,Term 18,9072769649,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동현금흐름,-,Term 20,1004842472035,Term 19,1139641474935,Term 18,817116843804,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_ProfitLossForStatementOfCashFlows,당기순이익(손실),-,Term 20,813101140024,Term 19,788173092234,Term 18,692278706347,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,수익ㆍ비용의가감,-,Term 20,626194542524,Term 19,651911831070,Term 18,520574156305,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForDepreciationExpense,감가상각비,-,Term 20,233925508629,Term 19,223940938745,Term 18,135694205295,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 20,28295853267,Term 19,27078995902,Term 18,21752965806,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 20,50474494996,Term 19,46396918588,Term 18,43993371189,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비,-,Term 20,595482883,Term 19,231152265,Term 18,-182012119,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타의 대손상각비,-,Term 20,120354050,Term 19,498555701,Term 18,-958326063,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 20,12507879942,Term 19,13870018114,Term 18,10135518970,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 20,2555055538,Term 19,2210056526,Term 18,1269641235,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치 측정 금융자산 평가이익,-,Term 20,,Term 19,,Term 18,910411462,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치 측정 금융자산 평가손실,-,Term 20,,Term 19,48496900,Term 18,882420015,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융부채 평가손실,-,Term 20,2431280464,Term 19,,Term 18,,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfFinancialAssets,당기손익-공정가치 측정 금융자산 처분손실,-,Term 20,22428828,Term 19,29066269,Term 18,,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfFinancialAssets,당기손익-공정가치 측정 금융자산 처분이익,-,Term 20,,Term 19,1370300650,Term 18,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융부채 평가이익,-,Term 20,-3205933336,Term 19,-1405338340,Term 18,-527375520,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 20,7796049548,Term 19,7471500310,Term 18,10130107174,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfInvestmentProperty,투자부동산처분손실,-,Term 20,122712135,Term 19,12145224,Term 18,,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfIntangibleAssets,무형자산처분손실,-,Term 20,1179758364,Term 19,1709806609,Term 18,435956321,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분손실,-,Term 20,12559557,Term 19,40106066,Term 18,,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfPropertyPlantAndEquipment,유형자산손상차손,-,Term 20,958695011,Term 19,8172548599,Term 18,10847999340,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,투자부동산손상차손,-,Term 20,2723414919,Term 19,2076269660,Term 18,931553838,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfIntangibleAssets,무형자산손상차손,-,Term 20,56925461,Term 19,41517092546,Term 18,28981153390,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 20,307973132289,Term 19,303908097869,Term 18,263726412686,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestIncome,이자수익,-,Term 20,4984491548,Term 19,8700706278,Term 18,3836339122,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,배당금수익,-,Term 20,933000000,Term 19,28256000,Term 18,19281900,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 20,1444637923,Term 19,1771727446,Term 18,992074598,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 20,3539815333,Term 19,6156226718,Term 18,2007434469,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentProperty,투자부동산처분이익,-,Term 20,3740590000,Term 19,112545282,Term 18,,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfIntangibleAssets,무형자산처분이익,-,Term 20,466778724,Term 19,226562693,Term 18,59960552,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분이익,-,Term 20,-217521224,Term 19,-58412806,Term 18,,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForProfitsOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 20,7024275269,Term 19,6919863873,Term 18,-1319193795,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,자산수증이익,-,Term 20,,Term 19,,Term 18,-33126944,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForBargainPurchaseGains,염가매수차익,-,Term 20,,Term 19,549994737,Term 18,,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업활동으로인한자산ㆍ부채의변동,-,Term 20,-97771906662,Term 19,15693436344,Term 18,-154376186486,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable,매출채권,-,Term 20,22475967366,Term 19,-22581565164,Term 18,3678536884,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInTradeAndOtherReceivables,기타채권,-,Term 20,4352829222,Term 19,17762470159,Term 18,840888309,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산,-,Term 20,-67826527783,Term 19,-31006365565,Term 18,-43471253195,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산,-,Term 20,12117381977,Term 19,-6138979641,Term 18,-57652675241,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,기타유동금융자산,-,Term 20,,Term 19,734507866,Term 18,,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInOtherNonCurrentNonFinancialAssets,기타비유동자산,-,Term 20,-7901977197,Term 19,,Term 18,-3945464731,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable,매입채무,-,Term 20,-30067851787,Term 19,2410984772,Term 18,-42740446487,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInTradeAndOtherPayables,기타채무,-,Term 20,22469667835,Term 19,70917430472,Term 18,21884680463,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,환불부채,-,Term 20,-549255134,Term 19,-874540704,Term 18,-7970704222,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 20,-12986505720,Term 19,30299904461,Term 18,30050165944,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채,-,Term 20,-8576068399,Term 19,21482822264,Term 18,5310730780,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInWithholdingsBanks,예수보증금,-,Term 20,-554689404,Term 19,-2382570699,Term 18,380920581,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,퇴직금의 지급,-,Term 20,7374041609,Term 19,4565340718,Term 18,4438869046,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInPostemploymentBenefitObligations,퇴직급여부채의 관계사 전입,-,Term 20,825666713,Term 19,-461390214,Term 18,961181937,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInFairValueOfPlanAssets,사외적립자산의 기여,-,Term 20,-54936455806,Term 19,-66366829778,Term 18,-64309539715,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherNonCurrentLiabilities,기타비유동부채,-,Term 20,30759953064,Term 19,6462898833,Term 18,7045661253,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자수취(영업),-,Term 20,4959977013,Term 19,7587742626,Term 18,4612293973,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsOperatingActivities,배당금수취(영업),-,Term 20,4227270000,Term 19,2901037478,Term 18,2483354511,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자지급(영업),-,Term 20,8700381507,Term 19,10180156104,Term 18,11628566111,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세납부(환급),-,Term 20,337168169357,Term 19,316445508713,Term 18,236826914735,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동현금흐름,-,Term 20,-745883641217,Term 19,-461380844546,Term 18,-430292259476,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,단기금융상품의 감소,-,Term 20,76200000999,Term 19,15055168850,Term 18,7043340694,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,단기기타채권의 감소,-,Term 20,894557167,Term 19,37975273738,Term 18,2418554769,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,장기금융상품의 감소,-,Term 20,4000000,Term 19,,Term 18,492738779,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,장기기타채권의 감소,-,Term 20,9748658623,Term 19,64308271893,Term 18,19766011640,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,기타비유동금융자산의 감소,-,Term 20,1173000000,Term 19,558934331,Term 18,,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 20,6797791333,Term 19,12659860186,Term 18,3295995994,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 20,4760000000,Term 19,340000000,Term 18,,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 20,9906597662,Term 19,463027231,Term 18,95000000,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합으로 인한 순현금흐름 유입,-,Term 20,,Term 19,2666361770,Term 18,,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,종속기업의 설립,-,Term 20,,Term 19,50000010000,Term 18,7846162460,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,단기금융상품의 증가,-,Term 20,62500000000,Term 19,70341850599,Term 18,5000000000,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,단기기타채권의 증가,-,Term 20,178968162,Term 19,254010544,Term 18,695071784,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,장기기타채권의 증가,-,Term 20,3927857300,Term 19,65426828092,Term 18,11320272647,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_PurchaseOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 취득,-,Term 20,,Term 19,,Term 18,200000000,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 20,505743484068,Term 19,326089104184,Term 18,356284941186,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 20,13128703763,Term 19,8973731170,Term 18,7842597936,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,사업결합으로 인한 현금유출,-,Term 20,269889233708,Term 19,174322227956,Term 18,89907180259,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동현금흐름,-,Term 20,-465737759835,Term 19,-429403943010,Term 18,-378036987192,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 차입,-,Term 20,96944735692,Term 19,271711203706,Term 18,323462505217,74,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_ProceedsFromLongTermBorrowings,장기차입금의 차입,-,Term 20,22736389421,Term 19,,Term 18,2356000000,75,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_ProceedsFromBonds,사채의 증가,-,Term 20,,Term 19,29999620000,Term 18,,76,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 상환,-,Term 20,194202086120,Term 19,323425777729,Term 18,237236106490,77,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities,유동성장기차입금의 상환,-,Term 20,3567121000,Term 19,13566080000,Term 18,25064090038,78,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_RepaymentsOfBonds,사채의 상환,-,Term 20,100000000000,Term 19,150000000000,Term 18,262437762000,79,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,전환사채의 상환,-,Term 20,,Term 19,,Term 18,-5377972602,80,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,리스부채의 지급,-,Term 20,91236233038,Term 19,80342388920,Term 18,139468422,81,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,종속기업투자의 취득,-,Term 20,,Term 19,-5190000000,Term 18,-11875640983,82,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,배당금의 지급,-,Term 20,196413444790,Term 19,158590520067,Term 18,161724451874,83,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,현금및현금성자산의 증가(감소),-,Term 20,-206778929017,Term 19,248856687379,Term 18,8787597136,85,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,기초의 현금및현금성자산,-,Term 20,647104059171,Term 19,396643798594,Term 18,386194252722,86,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,현금및현금성자산의 환율변동효과,-,Term 20,-300879719,Term 19,-695843313,Term 18,224665532,87,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,해외사업환산차이,-,Term 20,-5918786337,Term 19,2299416511,Term 18,1437283204,88,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말현금및현금성자산,-,Term 20,434105464098,Term 19,647104059171,Term 18,396643798594,89,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 20,88589470000,Term 19,88589470000,Term 18,88589470000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,4174881534589,Term 19,3563364542417,Term 18,3044143111385,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,-96636000943,Term 19,-121624601514,Term 18,-132783664248,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 20,97325737783,Term 19,97325737783,Term 18,97325737783,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 20,4237087665136,Term 19,3594020128000,Term 18,3081783034671,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배지분 [member],Term 20,90353924957,Term 19,81953708487,Term 18,85547807496,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,4146733740179,Term 19,3512066419513,Term 18,2996235227175,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 20,-117427001250,Term 19,-115588729173,Term 18,-101039427745,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,,Term 19,,Term 18,-1394297397,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,,Term 19,,Term 18,-725417902,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,연결재무제표 [member],Term 20,,Term 19,,Term 18,-2119715299,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,,Term 19,,Term 18,-2119715299,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,797628672879,Term 19,778097707167,Term 18,682743154211,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,797628672879,Term 19,778097707167,Term 18,682743154211,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|비지배지분 [member],Term 20,15472467145,Term 19,10075385067,Term 18,9535552136,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 20,813101140024,Term 19,788173092234,Term 18,692278706347,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,18312461353,Term 19,-11105780361,Term 18,-11201797236,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,18312461353,Term 19,-11105780361,Term 18,-11201797236,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,연결재무제표 [member],Term 20,18549466745,Term 19,-11691231674,Term 18,-11813991316,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|비지배지분 [member],Term 20,237005392,Term 19,-585451313,Term 18,-612194080,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|비지배지분 [member],Term 20,,Term 19,,Term 18,-33673837,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,-1327783683,Term 19,-1906910378,Term 18,-731093596,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,-1327783683,Term 19,-1906910378,Term 18,-731093596,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,연결재무제표 [member],Term 20,-1327783683,Term 19,-1906910378,Term 18,-764767433,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,연결재무제표 [member],Term 20,2748411,Term 19,44993850,Term 18,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,2748411,Term 19,44993850,Term 18,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,2748411,Term 19,44993850,Term 18,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분으로 인한 재분류,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,-999988875,Term 19,,Term 18,,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분으로 인한 재분류,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,999988875,Term 19,,Term 18,,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,연결재무제표 [member],Term 20,-215096850,Term 19,88177739,Term 18,216104407,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,-215096850,Term 19,88177739,Term 18,216104407,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,-215096850,Term 19,88177739,Term 18,216104407,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,연결재무제표 [member],Term 20,-27173924263,Term 19,27153141734,Term 18,12566144659,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|비지배지분 [member],Term 20,-229835143,Term 19,345808524,Term 18,183085430,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,-26944089120,Term 19,26807333210,Term 18,12383059229,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,-26944089120,Term 19,26807333210,Term 18,12383059229,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,184421296950,Term 19,155098219951,Term 18,150909217950,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,연결재무제표 [member],Term 20,196421296950,Term 19,158378373762,Term 18,161734054457,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|비지배지분 [member],Term 20,12000000000,Term 19,3280153811,Term 18,10824836507,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,184421296950,Term 19,155098219951,Term 18,150909217950,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,연결재무제표 [member],Term 20,5592780295,Term 19,-415352607,Term 18,-16391333579,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,6210148270,Term 19,-2259980610,Term 18,-14549301428,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 20,6210148270,Term 19,-1838272077,Term 18,-14549301428,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|비지배지분 [member],Term 20,-617367975,Term 19,1844628003,Term 18,-1842032151,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,,Term 19,-421708533,Term 18,-16410596,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,,Term 19,,Term 18,16410596,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|비지배지분 [member],Term 20,93216194376,Term 19,90353924957,Term 18,81953708487,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,4755979504489,Term 19,4146733740179,Term 18,3512066419513,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 20,-111216852980,Term 19,-117427001250,Term 18,-115588729173,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 20,97325737783,Term 19,97325737783,Term 18,97325737783,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 20,88589470000,Term 19,88589470000,Term 18,88589470000,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 20,4849195698865,Term 19,4237087665136,Term 18,3594020128000,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,-124122981721,Term 19,-96636000943,Term 18,-121624601514,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,4805404131407,Term 19,4174881534589,Term 18,3563364542417,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 21,2472884295774,Term 20,1982768917805,Term 19,2163074840988,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 21,734520611733,Term 20,434105464098,Term 19,647104059171,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_ShortTermDepositsNotClassifiedAsCashEquivalents,단기금융상품,-,Term 21,95352448800,Term 20,58536528000,Term 19,72263450599,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,기타채권,-,Term 21,592964794438,Term 20,637791666835,Term 19,645650629829,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_ShortTermTradeReceivable,매출채권,-,Term 21,554857050527,Term 20,585564696288,Term 19,611044864691,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,-Standard account code not used-,기타채권,-,Term 21,38107743911,Term 20,52226970547,Term 19,34605765138,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 21,1000655942465,Term 20,808965987719,Term 19,746323199447,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 21,824675343,Term 20,373764592,Term 19,1089659831,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 21,48565822995,Term 20,42995506561,Term 19,50643842111,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 21,5082355121943,Term 20,4818646865905,Term 19,4330594821983,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_LongTermDepositsNotClassifiedAsCashEquivalents,장기금융상품,-,Term 21,20000000,Term 20,20000000,Term 19,24000000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentReceivablesGross,장기기타채권,-,Term 21,49092915577,Term 20,50353958215,Term 19,80180225757,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates,관계기업및공동기업투자,-,Term 21,59167859842,Term 20,59998748118,Term 19,56559112536,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 21,38593929168,Term 20,38749519773,Term 19,37441744173,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 21,2449112181346,Term 20,2329834013415,Term 19,2036044655189,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 21,204288160278,Term 20,219793014823,Term 19,273157209374,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 21,30129279961,Term 20,24759532927,Term 19,42239252222,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 21,2168719935017,Term 20,2063442867186,Term 19,1787313564367,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 21,28409958922,Term 20,9768003713,Term 19,9467262843,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_OtherNonCurrentAssets,기타비유동자산,-,Term 21,54820901832,Term 20,21927207735,Term 19,8167795522,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 21,7555239417717,Term 20,6801415783710,Term 19,6493669662971,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 21,1525844759254,Term 20,1479723875311,Term 19,1771203779670,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,매입채무 및 기타유동채무,-,Term 21,862367973560,Term 20,779910998828,Term 19,1034527055707,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_ShortTermTradePayables,단기매입채무,-,Term 21,270571519551,Term 20,251186196633,Term 19,290674359917,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,-Standard account code not used-,기타채무,-,Term 21,299660142515,Term 20,338733244659,Term 19,352651064454,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 21,256676145850,Term 20,186412985536,Term 19,287644127872,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_CurrentPortionOfLongtermBorrowings,유동성장기차입금,-,Term 21,5460181804,Term 20,3578572000,Term 19,3566080000,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_CurrentPortionOfBonds,유동성사채,-,Term 21,29999983840,Term 20,0,Term 19,99991423464,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 21,188801478806,Term 20,180411503449,Term 19,200760674566,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_CurrentProvisionsForReturnedGoods,유동반품충당부채,-,Term 21,12875692276,Term 20,15621411384,Term 19,17506962997,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 21,330577242027,Term 20,349310770860,Term 19,351652442060,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 21,131222372585,Term 20,154469190790,Term 19,166756644340,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 21,531561847107,Term 20,472496209534,Term 19,485378218165,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentPayables,장기매입채무 및 기타비유동채무,-,Term 21,21237095226,Term 20,57308752150,Term 19,47598060022,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_LongTermBorrowingsGross,장기차입금,-,Term 21,17341601617,Term 20,22801783421,Term 19,3566080000,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,-Standard account code not used-,장기기타채무,-,Term 21,0,Term 20,0,Term 19,8646253131,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_BondsIssued,사채,-,Term 21,0,Term 20,29999854078,Term 19,29999727873,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_LongTermGuaranteeDepositWithholdings,장기예수보증금,-,Term 21,3895493609,Term 20,4507114651,Term 19,5385999018,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_PostemploymentBenefitObligations,퇴직급여부채,-,Term 21,51421810319,Term 20,48752783196,Term 19,67532645988,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 21,121735464959,Term 20,131795665327,Term 19,95549343156,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialLiabilities,기타비유동금융부채,-,Term 21,263149536421,Term 20,157269496925,Term 19,227136200242,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 21,74017940182,Term 20,77369511936,Term 19,47561968757,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 21,2057406606361,Term 20,1952220084845,Term 19,2256581997835,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업소유지분,-,Term 21,5388010154330,Term 20,4755979504489,Term 19,4146733740179,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 21,88589470000,Term 20,88589470000,Term 19,88589470000,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 21,97325737783,Term 20,97325737783,Term 19,97325737783,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금(결손금),-,Term 21,5484022033744,Term 20,4805404131407,Term 19,4174881534589,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 21,-64495577286,Term 20,-124122981721,Term 19,-96636000943,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_OtherCapitalAdjustments,기타자본항목,-,Term 21,-217431509911,Term 20,-111216852980,Term 19,-117427001250,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배지분,-,Term 21,109822657026,Term 20,93216194376,Term 19,90353924957,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 21,5497832811356,Term 20,4849195698865,Term 19,4237087665136,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,자본과부채총계,-,Term 21,7555239417717,Term 20,6801415783710,Term 19,6493669662971,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_Revenue,매출액,-,Term 21,8091511297961,Term 20,7844506057131,Term 19,7685424230297,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_CostOfSales,매출원가,-,Term 21,3039883555040,Term 20,2962930553558,Term 19,2917246274571,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_GrossProfit,매출총이익,-,Term 21,5051627742921,Term 20,4881575503573,Term 19,4768177955726,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 21,3761997319316,Term 20,3660710772262,Term 19,3591766708822,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,dart_OperatingIncomeLoss,영업이익(손실),-,Term 21,1289630423605,Term 20,1220864731311,Term 19,1176411246904,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_FinanceIncome,금융수익,-,Term 21,9572005157,Term 20,15434807035,Term 19,17086461393,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_FinanceCosts,금융원가,-,Term 21,22886303361,Term 20,21616953222,Term 19,17773035035,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,dart_OtherGains,기타영업외수익,-,Term 21,54382716863,Term 20,44819578890,Term 19,32917076235,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,dart_OtherLosses,기타영업외비용,-,Term 21,148406751184,Term 20,145452166970,Term 19,123480423267,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,-Standard account code not used-,지분법손익,-,Term 21,5072767505,Term 20,7024275269,Term 19,6919863873,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익(손실),-,Term 21,1187364858585,Term 20,1121074272313,Term 19,1092081190103,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 21,326237006705,Term 20,307973132289,Term 19,303908097869,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 21,861127851880,Term 20,813101140024,Term 19,788173092234,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 21,844523495741,Term 20,797628672879,Term 19,778097707167,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배지분,-,Term 21,16604356139,Term 20,15472467145,Term 19,10075385067,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_BasicEarningsLossPerShare,기본 및 희석 보통주당이익,-,Term 21,50395,Term 20,47596,Term 19,46431,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_DilutedEarningsLossPerShare,기본 및 희석 우선주당이익,-,Term 21,50445,Term 20,47647,Term 19,46481,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 21,861127851880,Term 20,813101140024,Term 19,788173092234,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 21,79793999467,Term 20,-10164589640,Term 19,13688171271,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되지 않는 항목,-,Term 21,18624875033,Term 20,17224431473,Term 19,-13553148202,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),-,Term 21,18774536960,Term 20,18549466745,Term 19,-11691231674,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,-,Term 21,-149661927,Term 20,-1327783683,Term 19,-1906910378,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,-,Term 21,0,Term 20,2748411,Term 19,44993850,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax,당기손익으로 재분류될 수 있는 항목(세후기타포괄손익),-,Term 21,61169124434,Term 20,-27389021113,Term 19,27241319473,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,dart_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법 적용대상 관계기업과 공동기업의 기타포괄손익에 대한 지분(세후기타포괄손익),-,Term 21,234458815,Term 20,-215096850,Term 19,88177739,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업장환산외환차이(세후기타포괄손익),-,Term 21,60934665619,Term 20,-27173924263,Term 19,27153141734,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄손익,-,Term 21,940921851347,Term 20,802936550384,Term 19,801861263505,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 21,922666603722,Term 20,787456912990,Term 19,792025521227,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배지분,-,Term 21,18255247625,Term 20,15479637394,Term 19,9835742278,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동현금흐름,-,Term 21,984481666368,Term 20,1004842472035,Term 19,1139641474935,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_ProfitLossForStatementOfCashFlows,당기순이익(손실),-,Term 21,861127851880,Term 20,813101140024,Term 19,788173092234,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,수익ㆍ비용의가감,-,Term 21,655594377448,Term 20,626194542524,Term 19,651911831070,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForDepreciationExpense,감가상각비,-,Term 21,240917419595,Term 20,233925508629,Term 19,223940938745,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 21,34129748348,Term 20,28295853267,Term 19,27078995902,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 21,50413856656,Term 20,50474494996,Term 19,46396918588,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 21,12537198896,Term 20,12507879942,Term 19,13870018114,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비,-,Term 21,3729253285,Term 20,595482883,Term 19,231152265,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 21,1233674337,Term 20,2555055538,Term 19,2210056526,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 평가손실,-,Term 21,4921968498,Term 20,0,Term 19,48496900,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융부채 평가손실,-,Term 21,1380318713,Term 20,2431280464,Term 19,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 평가이익,-,Term 21,-1582418788,Term 20,0,Term 19,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융부채 평가이익,-,Term 21,-255798240,Term 20,-3205933336,Term 19,-1405338340,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 처분손실,-,Term 21,0,Term 20,22428828,Term 19,29066269,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 처분이익,-,Term 21,0,Term 20,0,Term 19,-1370300650,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 21,4947235977,Term 20,7796049548,Term 19,7471500310,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfInvestmentProperty,투자부동산처분손실,-,Term 21,0,Term 20,122712135,Term 19,12145224,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfIntangibleAssets,무형자산처분손실,-,Term 21,700100092,Term 20,1179758364,Term 19,1709806609,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분손실,-,Term 21,87136919,Term 20,12559557,Term 19,40106066,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfPropertyPlantAndEquipment,유형자산손상차손,-,Term 21,3695340823,Term 20,958695011,Term 19,8172548599,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,투자부동산손상차손,-,Term 21,0,Term 20,2723414919,Term 19,2076269660,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfIntangibleAssets,무형자산손상차손,-,Term 21,563290248,Term 20,56925461,Term 19,41517092546,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산손상차손,-,Term 21,338700185,Term 20,0,Term 19,0,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 21,326237006705,Term 20,307973132289,Term 19,303908097869,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestIncome,이자수익,-,Term 21,5680872283,Term 20,4984491548,Term 19,8700706278,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,배당금수익,-,Term 21,-186600000,Term 20,-933000000,Term 19,-28256000,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타의 대손상각비,-,Term 21,-1135147924,Term 20,120354050,Term 19,498555701,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 21,1645379301,Term 20,1444637923,Term 19,1771727446,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentsInAssociates,종속기업/관계기업/공동기업투자처분이익,-,Term 21,6259434084,Term 20,0,Term 19,0,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 21,7882228803,Term 20,3539815333,Term 19,6156226718,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentProperty,투자부동산처분이익,-,Term 21,424275509,Term 20,3740590000,Term 19,112545282,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfIntangibleAssets,무형자산처분이익,-,Term 21,31400000,Term 20,466778724,Term 19,226562693,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분이익,-,Term 21,50260469,Term 20,217521224,Term 19,58412806,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForProfitsOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 21,5072767505,Term 20,7024275269,Term 19,6919863873,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForBargainPurchaseGains,염가매수차익,-,Term 21,31288923,Term 20,0,Term 19,549994737,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업활동으로인한자산ㆍ부채의변동,-,Term 21,-232237308874,Term 20,-97771906662,Term 19,15693436344,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable,매출채권,-,Term 21,48830535465,Term 20,22475967366,Term 19,-22581565164,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInTradeAndOtherReceivables,기타채권,-,Term 21,7439955809,Term 20,4352829222,Term 19,17762470159,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산,-,Term 21,-147805686623,Term 20,-67826527783,Term 19,-31006365565,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산,-,Term 21,3246409858,Term 20,12117381977,Term 19,-6138979641,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInOtherNonCurrentNonFinancialAssets,기타비유동비금융자산,-,Term 21,0,Term 20,0,Term 19,734507866,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,기타비유동자산,-,Term 21,-5825558786,Term 20,-7901977197,Term 19,0,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable,매입채무,-,Term 21,5129900386,Term 20,-30067851787,Term 19,2410984772,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInTradeAndOtherPayables,기타채무,-,Term 21,-31106874116,Term 20,22469667835,Term 19,70917430472,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,환불부채,-,Term 21,-3017943114,Term 20,-549255134,Term 19,-874540704,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 21,-12476452211,Term 20,-12986505720,Term 19,30299904461,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채,-,Term 21,-33517901510,Term 20,-8576068399,Term 19,21482822264,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInWithholdingsBanks,예수보증금,-,Term 21,-1293303890,Term 20,-554689404,Term 19,-2382570699,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,퇴직금의 지급,-,Term 21,4891083551,Term 20,7374041609,Term 19,4565340718,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInPostemploymentBenefitObligations,퇴직급여부채의 관계사 전입,-,Term 21,561746152,Term 20,825666713,Term 19,-461390214,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInFairValueOfPlanAssets,사외적립자산의 기여,-,Term 21,-55921334529,Term 20,-54936455806,Term 19,-66366829778,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherNonCurrentLiabilities,기타비유동부채,-,Term 21,-1589718214,Term 20,30759953064,Term 19,6462898833,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자수취(영업),-,Term 21,4850875119,Term 20,4959977013,Term 19,7587742626,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsOperatingActivities,배당금수취(영업),-,Term 21,6384911352,Term 20,4227270000,Term 19,2901037478,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자지급(영업),-,Term 21,7982482336,Term 20,8700381507,Term 19,10180156104,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세납부(환급),-,Term 21,303256558221,Term 20,337168169357,Term 19,316445508713,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동현금흐름,-,Term 21,-465122432772,Term 20,-745883641217,Term 19,-461380844546,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,단기금융상품의 감소,-,Term 21,42000000000,Term 20,76200000999,Term 19,15055168850,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,단기기타채권의 감소,-,Term 21,7150005783,Term 20,894557167,Term 19,37975273738,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,장기금융상품의 감소,-,Term 21,0,Term 20,4000000,Term 19,0,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,장기기타채권의 감소,-,Term 21,2286461472,Term 20,9748658623,Term 19,64308271893,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,기타비유동금융자산의 감소,-,Term 21,0,Term 20,1173000000,Term 19,558934331,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentsInAssociates,관계기업에 대한 투자자산의 처분,-,Term 21,16943803,Term 20,0,Term 19,,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 21,17970989609,Term 20,6797791333,Term 19,12659860186,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 21,2360000000,Term 20,4760000000,Term 19,340000000,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 21,270342552,Term 20,9906597662,Term 19,463027231,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities,정부보조금의 수취,-,Term 21,253700000,Term 20,0,Term 19,0,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,종속기업 처분으로 인한 순현금유입액,-,Term 21,7364927342,Term 20,0,Term 19,2666361770,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,종속기업의 설립,-,Term 21,0,Term 20,0,Term 19,50000010000,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,단기금융상품의 증가,-,Term 21,76229000000,Term 20,62500000000,Term 19,70341850599,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,단기기타채권의 증가,-,Term 21,696100059,Term 20,178968162,Term 19,254010544,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,장기기타채권의 증가,-,Term 21,4563158125,Term 20,3927857300,Term 19,65426828092,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 21,321874697496,Term 20,505743484068,Term 19,326089104184,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_PurchaseOfInvestmentProperty,투자부동산의 취득,-,Term 21,12528920,Term 20,0,Term 19,0,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 21,10312236474,Term 20,13128703763,Term 19,8973731170,74,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합으로 인한 순현금 유출,-,Term 21,131108082259,Term 20,269889233708,Term 19,174322227956,75,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동현금흐름,-,Term 21,-238400403869,Term 20,-465737759835,Term 19,-429403943010,76,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 차입,-,Term 21,211508361822,Term 20,96944735692,Term 19,271711203706,77,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_ProceedsFromLongTermBorrowings,장기차입금의 차입,-,Term 21,0,Term 20,22736389421,Term 19,0,78,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,종속기업의 유상증자,-,Term 21,120000000,Term 20,0,Term 19,0,79,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,사채의 발행,-,Term 21,0,Term 20,0,Term 19,29999620000,80,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 상환,-,Term 21,160451258420,Term 20,194202086120,Term 19,323425777729,81,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities,유동성장기차입금의 상환,-,Term 21,3578572000,Term 20,3567121000,Term 19,13566080000,82,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_RepaymentsOfBonds,유동성사채의 상환,-,Term 21,0,Term 20,100000000000,Term 19,150000000000,83,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_PaymentsOfFinanceLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 지급,-,Term 21,85093142807,Term 20,91236233038,Term 19,80342388920,84,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries,종속기업투자의 취득,-,Term 21,14770273001,Term 20,0,Term 19,5190000000,85,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금지급,-,Term 21,186135519463,Term 20,196413444790,Term 19,158590520067,86,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,환율변동효과 반영전 현금및현금성자산의 순증가(감소),-,Term 21,280958829727,Term 20,-206778929017,Term 19,248856687379,87,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초현금및현금성자산,-,Term 21,434105464098,Term 20,647104059171,Term 19,396643798594,88,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,현금및현금성자산에 대한 환율변동효과,-,Term 21,325780165,Term 20,-300879719,Term 19,-695843313,89,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,해외사업환산차이,-,Term 21,19130537743,Term 20,-5918786337,Term 19,2299416511,90,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말현금및현금성자산,-,Term 21,734520611733,Term 20,434105464098,Term 19,647104059171,91,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 21,88589470000,Term 20,88589470000,Term 19,88589470000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,4805404131407,Term 20,,Term 19,,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 21,-124122981721,Term 20,-96636000943,Term 19,,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 21,97325737783,Term 20,97325737783,Term 19,97325737783,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 21,4849195698865,Term 20,,Term 19,,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배지분 [member],Term 21,93216194376,Term 20,90353924957,Term 19,81953708487,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,4755979504489,Term 20,,Term 19,,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 21,-111216852980,Term 20,,Term 19,,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,844523495741,Term 20,,Term 19,,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 21,861127851880,Term 20,813101140024,Term 19,788173092234,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,844523495741,Term 20,,Term 19,,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|비지배지분 [member],Term 21,16604356139,Term 20,15472467145,Term 19,10075385067,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,연결재무제표 [member],Term 21,18774536960,Term 20,18549466745,Term 19,-11691231674,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|비지배지분 [member],Term 21,258833414,Term 20,237005392,Term 19,-585451313,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,18515703546,Term 20,18312461353,Term 19,-11105780361,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,18515703546,Term 20,18312461353,Term 19,-11105780361,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 21,-149661927,Term 20,-1327783683,Term 19,-1906910378,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,-149661927,Term 20,-1327783683,Term 19,-1906910378,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,연결재무제표 [member],Term 21,-149661927,Term 20,-1327783683,Term 19,-1906910378,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,연결재무제표 [member],Term 21,,Term 20,2748411,Term 19,44993850,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,,Term 20,2748411,Term 19,44993850,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,,Term 20,2748411,Term 19,44993850,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,연결재무제표 [member],Term 21,234458815,Term 20,-215096850,Term 19,88177739,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,234458815,Term 20,-215096850,Term 19,88177739,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 21,234458815,Term 20,-215096850,Term 19,88177739,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,연결재무제표 [member],Term 21,60934665619,Term 20,-27173924263,Term 19,27153141734,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 21,59542607547,Term 20,-26944089120,Term 19,26807333210,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|비지배지분 [member],Term 21,1392058072,Term 20,-229835143,Term 19,345808524,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,59542607547,Term 20,-26944089120,Term 19,26807333210,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,184421296950,Term 20,,Term 19,,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|비지배지분 [member],Term 21,,Term 20,12000000000,Term 19,3280153811,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,연결재무제표 [member],Term 21,184421296950,Term 20,,Term 19,,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,184421296950,Term 20,,Term 19,,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,연결재무제표 [member],Term 21,-107863441906,Term 20,5592780295,Term 19,-415352607,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,,Term 20,,Term 19,-421708533,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 21,-106214656931,Term 20,6210148270,Term 19,-1838272077,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,-106214656931,Term 20,6210148270,Term 19,-2259980610,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|비지배지분 [member],Term 21,-1648784975,Term 20,-617367975,Term 19,1844628003,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 21,5497832811356,Term 20,4849195698865,Term 19,4237087665136,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,5388010154330,Term 20,,Term 19,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|비지배지분 [member],Term 21,109822657026,Term 20,93216194376,Term 19,90353924957,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 21,-217431509911,Term 20,,Term 19,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 21,97325737783,Term 20,97325737783,Term 19,97325737783,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 21,88589470000,Term 20,88589470000,Term 19,88589470000,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,5484022033744,Term 20,,Term 19,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 21,-64495577286,Term 20,,Term 19,-96636000943,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 21,2472884295774,Term 20,1982768917805,Term 19,2163074840988,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 21,734520611733,Term 20,434105464098,Term 19,647104059171,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_ShortTermDepositsNotClassifiedAsCashEquivalents,단기금융상품,-,Term 21,95352448800,Term 20,58536528000,Term 19,72263450599,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,기타채권,-,Term 21,592964794438,Term 20,637791666835,Term 19,645650629829,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_ShortTermTradeReceivable,매출채권,-,Term 21,554857050527,Term 20,585564696288,Term 19,611044864691,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,-Standard account code not used-,기타채권,-,Term 21,38107743911,Term 20,52226970547,Term 19,34605765138,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 21,1000655942465,Term 20,808965987719,Term 19,746323199447,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 21,824675343,Term 20,373764592,Term 19,1089659831,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 21,48565822995,Term 20,42995506561,Term 19,50643842111,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 21,5082355121943,Term 20,4818646865905,Term 19,4330594821983,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_LongTermDepositsNotClassifiedAsCashEquivalents,장기금융상품,-,Term 21,20000000,Term 20,20000000,Term 19,24000000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentReceivablesGross,장기기타채권,-,Term 21,49092915577,Term 20,50353958215,Term 19,80180225757,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates,관계기업및공동기업투자,-,Term 21,59167859842,Term 20,59998748118,Term 19,56559112536,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 21,38593929168,Term 20,38749519773,Term 19,37441744173,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 21,2449112181346,Term 20,2329834013415,Term 19,2036044655189,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 21,204288160278,Term 20,219793014823,Term 19,273157209374,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 21,30129279961,Term 20,24759532927,Term 19,42239252222,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 21,2168719935017,Term 20,2063442867186,Term 19,1787313564367,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 21,28409958922,Term 20,9768003713,Term 19,9467262843,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_OtherNonCurrentAssets,기타비유동자산,-,Term 21,54820901832,Term 20,21927207735,Term 19,8167795522,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 21,7555239417717,Term 20,6801415783710,Term 19,6493669662971,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 21,1525844759254,Term 20,1479723875311,Term 19,1771203779670,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,매입채무 및 기타유동채무,-,Term 21,862367973560,Term 20,779910998828,Term 19,1034527055707,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_ShortTermTradePayables,단기매입채무,-,Term 21,270571519551,Term 20,251186196633,Term 19,290674359917,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,-Standard account code not used-,기타채무,-,Term 21,299660142515,Term 20,338733244659,Term 19,352651064454,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 21,256676145850,Term 20,186412985536,Term 19,287644127872,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_CurrentPortionOfLongtermBorrowings,유동성장기차입금,-,Term 21,5460181804,Term 20,3578572000,Term 19,3566080000,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_CurrentPortionOfBonds,유동성사채,-,Term 21,29999983840,Term 20,0,Term 19,99991423464,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 21,188801478806,Term 20,180411503449,Term 19,200760674566,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_CurrentProvisionsForReturnedGoods,유동반품충당부채,-,Term 21,12875692276,Term 20,15621411384,Term 19,17506962997,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 21,330577242027,Term 20,349310770860,Term 19,351652442060,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 21,131222372585,Term 20,154469190790,Term 19,166756644340,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 21,531561847107,Term 20,472496209534,Term 19,485378218165,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentPayables,장기매입채무 및 기타비유동채무,-,Term 21,21237095226,Term 20,57308752150,Term 19,47598060022,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_LongTermBorrowingsGross,장기차입금,-,Term 21,17341601617,Term 20,22801783421,Term 19,3566080000,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,-Standard account code not used-,장기기타채무,-,Term 21,0,Term 20,0,Term 19,8646253131,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_BondsIssued,사채,-,Term 21,0,Term 20,29999854078,Term 19,29999727873,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_LongTermGuaranteeDepositWithholdings,장기예수보증금,-,Term 21,3895493609,Term 20,4507114651,Term 19,5385999018,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_PostemploymentBenefitObligations,퇴직급여부채,-,Term 21,51421810319,Term 20,48752783196,Term 19,67532645988,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 21,121735464959,Term 20,131795665327,Term 19,95549343156,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialLiabilities,기타비유동금융부채,-,Term 21,263149536421,Term 20,157269496925,Term 19,227136200242,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 21,74017940182,Term 20,77369511936,Term 19,47561968757,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 21,2057406606361,Term 20,1952220084845,Term 19,2256581997835,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업소유지분,-,Term 21,5388010154330,Term 20,4755979504489,Term 19,4146733740179,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 21,88589470000,Term 20,88589470000,Term 19,88589470000,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 21,97325737783,Term 20,97325737783,Term 19,97325737783,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금(결손금),-,Term 21,5484022033744,Term 20,4805404131407,Term 19,4174881534589,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 21,-64495577286,Term 20,-124122981721,Term 19,-96636000943,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_OtherCapitalAdjustments,기타자본항목,-,Term 21,-217431509911,Term 20,-111216852980,Term 19,-117427001250,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배지분,-,Term 21,109822657026,Term 20,93216194376,Term 19,90353924957,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 21,5497832811356,Term 20,4849195698865,Term 19,4237087665136,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,자본과부채총계,-,Term 21,7555239417717,Term 20,6801415783710,Term 19,6493669662971,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_Revenue,매출액,-,Term 21,8091511297961,Term 20,7844506057131,Term 19,7685424230297,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_CostOfSales,매출원가,-,Term 21,3039883555040,Term 20,2962930553558,Term 19,2917246274571,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_GrossProfit,매출총이익,-,Term 21,5051627742921,Term 20,4881575503573,Term 19,4768177955726,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 21,3761997319316,Term 20,3660710772262,Term 19,3591766708822,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,dart_OperatingIncomeLoss,영업이익(손실),-,Term 21,1289630423605,Term 20,1220864731311,Term 19,1176411246904,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_FinanceIncome,금융수익,-,Term 21,9572005157,Term 20,15434807035,Term 19,17086461393,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_FinanceCosts,금융원가,-,Term 21,22886303361,Term 20,21616953222,Term 19,17773035035,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,dart_OtherGains,기타영업외수익,-,Term 21,54382716863,Term 20,44819578890,Term 19,32917076235,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,dart_OtherLosses,기타영업외비용,-,Term 21,148406751184,Term 20,145452166970,Term 19,123480423267,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,-Standard account code not used-,지분법손익,-,Term 21,5072767505,Term 20,7024275269,Term 19,6919863873,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익(손실),-,Term 21,1187364858585,Term 20,1121074272313,Term 19,1092081190103,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 21,326237006705,Term 20,307973132289,Term 19,303908097869,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 21,861127851880,Term 20,813101140024,Term 19,788173092234,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 21,844523495741,Term 20,797628672879,Term 19,778097707167,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배지분,-,Term 21,16604356139,Term 20,15472467145,Term 19,10075385067,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_BasicEarningsLossPerShare,기본 및 희석 보통주당이익,-,Term 21,50395,Term 20,47596,Term 19,46431,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_DilutedEarningsLossPerShare,기본 및 희석 우선주당이익,-,Term 21,50445,Term 20,47647,Term 19,46481,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 21,861127851880,Term 20,813101140024,Term 19,788173092234,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 21,79793999467,Term 20,-10164589640,Term 19,13688171271,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되지 않는 항목,-,Term 21,18624875033,Term 20,17224431473,Term 19,-13553148202,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),-,Term 21,18774536960,Term 20,18549466745,Term 19,-11691231674,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,-,Term 21,-149661927,Term 20,-1327783683,Term 19,-1906910378,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,-,Term 21,0,Term 20,2748411,Term 19,44993850,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax,당기손익으로 재분류될 수 있는 항목(세후기타포괄손익),-,Term 21,61169124434,Term 20,-27389021113,Term 19,27241319473,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,dart_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법 적용대상 관계기업과 공동기업의 기타포괄손익에 대한 지분(세후기타포괄손익),-,Term 21,234458815,Term 20,-215096850,Term 19,88177739,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업장환산외환차이(세후기타포괄손익),-,Term 21,60934665619,Term 20,-27173924263,Term 19,27153141734,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄손익,-,Term 21,940921851347,Term 20,802936550384,Term 19,801861263505,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 21,922666603722,Term 20,787456912990,Term 19,792025521227,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배지분,-,Term 21,18255247625,Term 20,15479637394,Term 19,9835742278,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동현금흐름,-,Term 21,984481666368,Term 20,1004842472035,Term 19,1139641474935,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_ProfitLossForStatementOfCashFlows,당기순이익(손실),-,Term 21,861127851880,Term 20,813101140024,Term 19,788173092234,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,수익ㆍ비용의가감,-,Term 21,655594377448,Term 20,626194542524,Term 19,651911831070,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForDepreciationExpense,감가상각비,-,Term 21,240917419595,Term 20,233925508629,Term 19,223940938745,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 21,34129748348,Term 20,28295853267,Term 19,27078995902,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 21,50413856656,Term 20,50474494996,Term 19,46396918588,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 21,12537198896,Term 20,12507879942,Term 19,13870018114,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비,-,Term 21,3729253285,Term 20,595482883,Term 19,231152265,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 21,1233674337,Term 20,2555055538,Term 19,2210056526,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 평가손실,-,Term 21,4921968498,Term 20,0,Term 19,48496900,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융부채 평가손실,-,Term 21,1380318713,Term 20,2431280464,Term 19,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 평가이익,-,Term 21,-1582418788,Term 20,0,Term 19,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융부채 평가이익,-,Term 21,-255798240,Term 20,-3205933336,Term 19,-1405338340,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 처분손실,-,Term 21,0,Term 20,22428828,Term 19,29066269,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 처분이익,-,Term 21,0,Term 20,0,Term 19,-1370300650,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 21,4947235977,Term 20,7796049548,Term 19,7471500310,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfInvestmentProperty,투자부동산처분손실,-,Term 21,0,Term 20,122712135,Term 19,12145224,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfIntangibleAssets,무형자산처분손실,-,Term 21,700100092,Term 20,1179758364,Term 19,1709806609,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분손실,-,Term 21,87136919,Term 20,12559557,Term 19,40106066,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfPropertyPlantAndEquipment,유형자산손상차손,-,Term 21,3695340823,Term 20,958695011,Term 19,8172548599,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,투자부동산손상차손,-,Term 21,0,Term 20,2723414919,Term 19,2076269660,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfIntangibleAssets,무형자산손상차손,-,Term 21,563290248,Term 20,56925461,Term 19,41517092546,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산손상차손,-,Term 21,338700185,Term 20,0,Term 19,0,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 21,326237006705,Term 20,307973132289,Term 19,303908097869,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestIncome,이자수익,-,Term 21,5680872283,Term 20,4984491548,Term 19,8700706278,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,배당금수익,-,Term 21,-186600000,Term 20,-933000000,Term 19,-28256000,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타의 대손상각비,-,Term 21,-1135147924,Term 20,120354050,Term 19,498555701,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 21,1645379301,Term 20,1444637923,Term 19,1771727446,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentsInAssociates,종속기업/관계기업/공동기업투자처분이익,-,Term 21,6259434084,Term 20,0,Term 19,0,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 21,7882228803,Term 20,3539815333,Term 19,6156226718,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentProperty,투자부동산처분이익,-,Term 21,424275509,Term 20,3740590000,Term 19,112545282,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfIntangibleAssets,무형자산처분이익,-,Term 21,31400000,Term 20,466778724,Term 19,226562693,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분이익,-,Term 21,50260469,Term 20,217521224,Term 19,58412806,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForProfitsOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 21,5072767505,Term 20,7024275269,Term 19,6919863873,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForBargainPurchaseGains,염가매수차익,-,Term 21,31288923,Term 20,0,Term 19,549994737,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업활동으로인한자산ㆍ부채의변동,-,Term 21,-232237308874,Term 20,-97771906662,Term 19,15693436344,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable,매출채권,-,Term 21,48830535465,Term 20,22475967366,Term 19,-22581565164,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInTradeAndOtherReceivables,기타채권,-,Term 21,7439955809,Term 20,4352829222,Term 19,17762470159,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산,-,Term 21,-147805686623,Term 20,-67826527783,Term 19,-31006365565,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산,-,Term 21,3246409858,Term 20,12117381977,Term 19,-6138979641,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInOtherNonCurrentNonFinancialAssets,기타비유동비금융자산,-,Term 21,0,Term 20,0,Term 19,734507866,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,기타비유동자산,-,Term 21,-5825558786,Term 20,-7901977197,Term 19,0,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable,매입채무,-,Term 21,5129900386,Term 20,-30067851787,Term 19,2410984772,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInTradeAndOtherPayables,기타채무,-,Term 21,-31106874116,Term 20,22469667835,Term 19,70917430472,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,환불부채,-,Term 21,-3017943114,Term 20,-549255134,Term 19,-874540704,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 21,-12476452211,Term 20,-12986505720,Term 19,30299904461,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채,-,Term 21,-33517901510,Term 20,-8576068399,Term 19,21482822264,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInWithholdingsBanks,예수보증금,-,Term 21,-1293303890,Term 20,-554689404,Term 19,-2382570699,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,퇴직금의 지급,-,Term 21,4891083551,Term 20,7374041609,Term 19,4565340718,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInPostemploymentBenefitObligations,퇴직급여부채의 관계사 전입,-,Term 21,561746152,Term 20,825666713,Term 19,-461390214,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInFairValueOfPlanAssets,사외적립자산의 기여,-,Term 21,-55921334529,Term 20,-54936455806,Term 19,-66366829778,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherNonCurrentLiabilities,기타비유동부채,-,Term 21,-1589718214,Term 20,30759953064,Term 19,6462898833,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자수취(영업),-,Term 21,4850875119,Term 20,4959977013,Term 19,7587742626,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsOperatingActivities,배당금수취(영업),-,Term 21,6384911352,Term 20,4227270000,Term 19,2901037478,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자지급(영업),-,Term 21,7982482336,Term 20,8700381507,Term 19,10180156104,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세납부(환급),-,Term 21,303256558221,Term 20,337168169357,Term 19,316445508713,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동현금흐름,-,Term 21,-465122432772,Term 20,-745883641217,Term 19,-461380844546,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,단기금융상품의 감소,-,Term 21,42000000000,Term 20,76200000999,Term 19,15055168850,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,단기기타채권의 감소,-,Term 21,7150005783,Term 20,894557167,Term 19,37975273738,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,장기금융상품의 감소,-,Term 21,0,Term 20,4000000,Term 19,0,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,장기기타채권의 감소,-,Term 21,2286461472,Term 20,9748658623,Term 19,64308271893,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,기타비유동금융자산의 감소,-,Term 21,0,Term 20,1173000000,Term 19,558934331,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentsInAssociates,관계기업에 대한 투자자산의 처분,-,Term 21,16943803,Term 20,0,Term 19,,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 21,17970989609,Term 20,6797791333,Term 19,12659860186,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 21,2360000000,Term 20,4760000000,Term 19,340000000,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 21,270342552,Term 20,9906597662,Term 19,463027231,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities,정부보조금의 수취,-,Term 21,253700000,Term 20,0,Term 19,0,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,종속기업 처분으로 인한 순현금유입액,-,Term 21,7364927342,Term 20,0,Term 19,2666361770,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,종속기업의 설립,-,Term 21,0,Term 20,0,Term 19,50000010000,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,단기금융상품의 증가,-,Term 21,76229000000,Term 20,62500000000,Term 19,70341850599,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,단기기타채권의 증가,-,Term 21,696100059,Term 20,178968162,Term 19,254010544,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,장기기타채권의 증가,-,Term 21,4563158125,Term 20,3927857300,Term 19,65426828092,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 21,321874697496,Term 20,505743484068,Term 19,326089104184,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_PurchaseOfInvestmentProperty,투자부동산의 취득,-,Term 21,12528920,Term 20,0,Term 19,0,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 21,10312236474,Term 20,13128703763,Term 19,8973731170,74,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합으로 인한 순현금 유출,-,Term 21,131108082259,Term 20,269889233708,Term 19,174322227956,75,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동현금흐름,-,Term 21,-238400403869,Term 20,-465737759835,Term 19,-429403943010,76,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 차입,-,Term 21,211508361822,Term 20,96944735692,Term 19,271711203706,77,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_ProceedsFromLongTermBorrowings,장기차입금의 차입,-,Term 21,0,Term 20,22736389421,Term 19,0,78,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,종속기업의 유상증자,-,Term 21,120000000,Term 20,0,Term 19,0,79,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,사채의 발행,-,Term 21,0,Term 20,0,Term 19,29999620000,80,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 상환,-,Term 21,160451258420,Term 20,194202086120,Term 19,323425777729,81,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities,유동성장기차입금의 상환,-,Term 21,3578572000,Term 20,3567121000,Term 19,13566080000,82,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_RepaymentsOfBonds,유동성사채의 상환,-,Term 21,0,Term 20,100000000000,Term 19,150000000000,83,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_PaymentsOfFinanceLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 지급,-,Term 21,85093142807,Term 20,91236233038,Term 19,80342388920,84,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries,종속기업투자의 취득,-,Term 21,14770273001,Term 20,0,Term 19,5190000000,85,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금지급,-,Term 21,186135519463,Term 20,196413444790,Term 19,158590520067,86,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,환율변동효과 반영전 현금및현금성자산의 순증가(감소),-,Term 21,280958829727,Term 20,-206778929017,Term 19,248856687379,87,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초현금및현금성자산,-,Term 21,434105464098,Term 20,647104059171,Term 19,396643798594,88,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,현금및현금성자산에 대한 환율변동효과,-,Term 21,325780165,Term 20,-300879719,Term 19,-695843313,89,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,해외사업환산차이,-,Term 21,19130537743,Term 20,-5918786337,Term 19,2299416511,90,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말현금및현금성자산,-,Term 21,734520611733,Term 20,434105464098,Term 19,647104059171,91,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 21,88589470000,Term 20,88589470000,Term 19,88589470000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,4805404131407,Term 20,,Term 19,,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 21,-124122981721,Term 20,-96636000943,Term 19,,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 21,97325737783,Term 20,97325737783,Term 19,97325737783,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 21,4849195698865,Term 20,,Term 19,,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배지분 [member],Term 21,93216194376,Term 20,90353924957,Term 19,81953708487,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,4755979504489,Term 20,,Term 19,,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 21,-111216852980,Term 20,,Term 19,,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,844523495741,Term 20,,Term 19,,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 21,861127851880,Term 20,813101140024,Term 19,788173092234,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,844523495741,Term 20,,Term 19,,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|비지배지분 [member],Term 21,16604356139,Term 20,15472467145,Term 19,10075385067,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,연결재무제표 [member],Term 21,18774536960,Term 20,18549466745,Term 19,-11691231674,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|비지배지분 [member],Term 21,258833414,Term 20,237005392,Term 19,-585451313,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,18515703546,Term 20,18312461353,Term 19,-11105780361,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,18515703546,Term 20,18312461353,Term 19,-11105780361,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 21,-149661927,Term 20,-1327783683,Term 19,-1906910378,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,-149661927,Term 20,-1327783683,Term 19,-1906910378,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,연결재무제표 [member],Term 21,-149661927,Term 20,-1327783683,Term 19,-1906910378,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,연결재무제표 [member],Term 21,,Term 20,2748411,Term 19,44993850,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,,Term 20,2748411,Term 19,44993850,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,,Term 20,2748411,Term 19,44993850,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,연결재무제표 [member],Term 21,234458815,Term 20,-215096850,Term 19,88177739,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,234458815,Term 20,-215096850,Term 19,88177739,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 21,234458815,Term 20,-215096850,Term 19,88177739,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,연결재무제표 [member],Term 21,60934665619,Term 20,-27173924263,Term 19,27153141734,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 21,59542607547,Term 20,-26944089120,Term 19,26807333210,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|비지배지분 [member],Term 21,1392058072,Term 20,-229835143,Term 19,345808524,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,59542607547,Term 20,-26944089120,Term 19,26807333210,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,184421296950,Term 20,,Term 19,,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|비지배지분 [member],Term 21,,Term 20,12000000000,Term 19,3280153811,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,연결재무제표 [member],Term 21,184421296950,Term 20,,Term 19,,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,184421296950,Term 20,,Term 19,,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,연결재무제표 [member],Term 21,-107863441906,Term 20,5592780295,Term 19,-415352607,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,,Term 20,,Term 19,-421708533,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 21,-106214656931,Term 20,6210148270,Term 19,-1838272077,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,-106214656931,Term 20,6210148270,Term 19,-2259980610,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|비지배지분 [member],Term 21,-1648784975,Term 20,-617367975,Term 19,1844628003,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 21,5497832811356,Term 20,4849195698865,Term 19,4237087665136,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,5388010154330,Term 20,,Term 19,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|비지배지분 [member],Term 21,109822657026,Term 20,93216194376,Term 19,90353924957,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 21,-217431509911,Term 20,,Term 19,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 21,97325737783,Term 20,97325737783,Term 19,97325737783,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 21,88589470000,Term 20,88589470000,Term 19,88589470000,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,5484022033744,Term 20,,Term 19,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 21,-64495577286,Term 20,,Term 19,-96636000943,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 21,2472884295774,Term 20,1982768917805,Term 19,2163074840988,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 21,734520611733,Term 20,434105464098,Term 19,647104059171,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_ShortTermDepositsNotClassifiedAsCashEquivalents,단기금융상품,-,Term 21,95352448800,Term 20,58536528000,Term 19,72263450599,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,기타채권,-,Term 21,592964794438,Term 20,637791666835,Term 19,645650629829,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_ShortTermTradeReceivable,매출채권,-,Term 21,554857050527,Term 20,585564696288,Term 19,611044864691,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,-Standard account code not used-,기타채권,-,Term 21,38107743911,Term 20,52226970547,Term 19,34605765138,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 21,1000655942465,Term 20,808965987719,Term 19,746323199447,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 21,824675343,Term 20,373764592,Term 19,1089659831,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 21,48565822995,Term 20,42995506561,Term 19,50643842111,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 21,5082355121943,Term 20,4818646865905,Term 19,4330594821983,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_LongTermDepositsNotClassifiedAsCashEquivalents,장기금융상품,-,Term 21,20000000,Term 20,20000000,Term 19,24000000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentReceivablesGross,장기기타채권,-,Term 21,49092915577,Term 20,50353958215,Term 19,80180225757,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates,관계기업및공동기업투자,-,Term 21,59167859842,Term 20,59998748118,Term 19,56559112536,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 21,38593929168,Term 20,38749519773,Term 19,37441744173,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 21,2449112181346,Term 20,2329834013415,Term 19,2036044655189,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 21,204288160278,Term 20,219793014823,Term 19,273157209374,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 21,30129279961,Term 20,24759532927,Term 19,42239252222,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 21,2168719935017,Term 20,2063442867186,Term 19,1787313564367,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 21,28409958922,Term 20,9768003713,Term 19,9467262843,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_OtherNonCurrentAssets,기타비유동자산,-,Term 21,54820901832,Term 20,21927207735,Term 19,8167795522,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 21,7555239417717,Term 20,6801415783710,Term 19,6493669662971,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 21,1525844759254,Term 20,1479723875311,Term 19,1771203779670,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,매입채무 및 기타유동채무,-,Term 21,862367973560,Term 20,779910998828,Term 19,1034527055707,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_ShortTermTradePayables,단기매입채무,-,Term 21,270571519551,Term 20,251186196633,Term 19,290674359917,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,-Standard account code not used-,기타채무,-,Term 21,299660142515,Term 20,338733244659,Term 19,352651064454,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 21,256676145850,Term 20,186412985536,Term 19,287644127872,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_CurrentPortionOfLongtermBorrowings,유동성장기차입금,-,Term 21,5460181804,Term 20,3578572000,Term 19,3566080000,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_CurrentPortionOfBonds,유동성사채,-,Term 21,29999983840,Term 20,0,Term 19,99991423464,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 21,188801478806,Term 20,180411503449,Term 19,200760674566,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_CurrentProvisionsForReturnedGoods,유동반품충당부채,-,Term 21,12875692276,Term 20,15621411384,Term 19,17506962997,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 21,330577242027,Term 20,349310770860,Term 19,351652442060,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 21,131222372585,Term 20,154469190790,Term 19,166756644340,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 21,531561847107,Term 20,472496209534,Term 19,485378218165,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentPayables,장기매입채무 및 기타비유동채무,-,Term 21,21237095226,Term 20,57308752150,Term 19,47598060022,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_LongTermBorrowingsGross,장기차입금,-,Term 21,17341601617,Term 20,22801783421,Term 19,3566080000,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,-Standard account code not used-,장기기타채무,-,Term 21,0,Term 20,0,Term 19,8646253131,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_BondsIssued,사채,-,Term 21,0,Term 20,29999854078,Term 19,29999727873,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_LongTermGuaranteeDepositWithholdings,장기예수보증금,-,Term 21,3895493609,Term 20,4507114651,Term 19,5385999018,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_PostemploymentBenefitObligations,퇴직급여부채,-,Term 21,51421810319,Term 20,48752783196,Term 19,67532645988,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 21,121735464959,Term 20,131795665327,Term 19,95549343156,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialLiabilities,기타비유동금융부채,-,Term 21,263149536421,Term 20,157269496925,Term 19,227136200242,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 21,74017940182,Term 20,77369511936,Term 19,47561968757,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 21,2057406606361,Term 20,1952220084845,Term 19,2256581997835,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업소유지분,-,Term 21,5388010154330,Term 20,4755979504489,Term 19,4146733740179,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 21,88589470000,Term 20,88589470000,Term 19,88589470000,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 21,97325737783,Term 20,97325737783,Term 19,97325737783,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금(결손금),-,Term 21,5484022033744,Term 20,4805404131407,Term 19,4174881534589,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 21,-64495577286,Term 20,-124122981721,Term 19,-96636000943,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_OtherCapitalAdjustments,기타자본항목,-,Term 21,-217431509911,Term 20,-111216852980,Term 19,-117427001250,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배지분,-,Term 21,109822657026,Term 20,93216194376,Term 19,90353924957,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 21,5497832811356,Term 20,4849195698865,Term 19,4237087665136,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,자본과부채총계,-,Term 21,7555239417717,Term 20,6801415783710,Term 19,6493669662971,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_Revenue,매출액,-,Term 21,8091511297961,Term 20,7844506057131,Term 19,7685424230297,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_CostOfSales,매출원가,-,Term 21,3039883555040,Term 20,2962930553558,Term 19,2917246274571,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_GrossProfit,매출총이익,-,Term 21,5051627742921,Term 20,4881575503573,Term 19,4768177955726,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 21,3761997319316,Term 20,3660710772262,Term 19,3591766708822,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,dart_OperatingIncomeLoss,영업이익(손실),-,Term 21,1289630423605,Term 20,1220864731311,Term 19,1176411246904,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_FinanceIncome,금융수익,-,Term 21,9572005157,Term 20,15434807035,Term 19,17086461393,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_FinanceCosts,금융원가,-,Term 21,22886303361,Term 20,21616953222,Term 19,17773035035,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,dart_OtherGains,기타영업외수익,-,Term 21,54382716863,Term 20,44819578890,Term 19,32917076235,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,dart_OtherLosses,기타영업외비용,-,Term 21,148406751184,Term 20,145452166970,Term 19,123480423267,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,-Standard account code not used-,지분법손익,-,Term 21,5072767505,Term 20,7024275269,Term 19,6919863873,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익(손실),-,Term 21,1187364858585,Term 20,1121074272313,Term 19,1092081190103,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 21,326237006705,Term 20,307973132289,Term 19,303908097869,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 21,861127851880,Term 20,813101140024,Term 19,788173092234,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 21,844523495741,Term 20,797628672879,Term 19,778097707167,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배지분,-,Term 21,16604356139,Term 20,15472467145,Term 19,10075385067,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_BasicEarningsLossPerShare,기본 및 희석 보통주당이익,-,Term 21,50395,Term 20,47596,Term 19,46431,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_DilutedEarningsLossPerShare,기본 및 희석 우선주당이익,-,Term 21,50445,Term 20,47647,Term 19,46481,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 21,861127851880,Term 20,813101140024,Term 19,788173092234,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 21,79793999467,Term 20,-10164589640,Term 19,13688171271,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되지 않는 항목,-,Term 21,18624875033,Term 20,17224431473,Term 19,-13553148202,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),-,Term 21,18774536960,Term 20,18549466745,Term 19,-11691231674,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,-,Term 21,-149661927,Term 20,-1327783683,Term 19,-1906910378,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,-,Term 21,0,Term 20,2748411,Term 19,44993850,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax,당기손익으로 재분류될 수 있는 항목(세후기타포괄손익),-,Term 21,61169124434,Term 20,-27389021113,Term 19,27241319473,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,dart_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법 적용대상 관계기업과 공동기업의 기타포괄손익에 대한 지분(세후기타포괄손익),-,Term 21,234458815,Term 20,-215096850,Term 19,88177739,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업장환산외환차이(세후기타포괄손익),-,Term 21,60934665619,Term 20,-27173924263,Term 19,27153141734,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄손익,-,Term 21,940921851347,Term 20,802936550384,Term 19,801861263505,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 21,922666603722,Term 20,787456912990,Term 19,792025521227,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배지분,-,Term 21,18255247625,Term 20,15479637394,Term 19,9835742278,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동현금흐름,-,Term 21,984481666368,Term 20,1004842472035,Term 19,1139641474935,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_ProfitLossForStatementOfCashFlows,당기순이익(손실),-,Term 21,861127851880,Term 20,813101140024,Term 19,788173092234,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,수익ㆍ비용의가감,-,Term 21,655594377448,Term 20,626194542524,Term 19,651911831070,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForDepreciationExpense,감가상각비,-,Term 21,240917419595,Term 20,233925508629,Term 19,223940938745,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 21,34129748348,Term 20,28295853267,Term 19,27078995902,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 21,50413856656,Term 20,50474494996,Term 19,46396918588,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 21,12537198896,Term 20,12507879942,Term 19,13870018114,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비,-,Term 21,3729253285,Term 20,595482883,Term 19,231152265,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 21,1233674337,Term 20,2555055538,Term 19,2210056526,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 평가손실,-,Term 21,4921968498,Term 20,0,Term 19,48496900,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융부채 평가손실,-,Term 21,1380318713,Term 20,2431280464,Term 19,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 평가이익,-,Term 21,-1582418788,Term 20,0,Term 19,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융부채 평가이익,-,Term 21,-255798240,Term 20,-3205933336,Term 19,-1405338340,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 처분손실,-,Term 21,0,Term 20,22428828,Term 19,29066269,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 처분이익,-,Term 21,0,Term 20,0,Term 19,-1370300650,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 21,4947235977,Term 20,7796049548,Term 19,7471500310,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfInvestmentProperty,투자부동산처분손실,-,Term 21,0,Term 20,122712135,Term 19,12145224,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfIntangibleAssets,무형자산처분손실,-,Term 21,700100092,Term 20,1179758364,Term 19,1709806609,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분손실,-,Term 21,87136919,Term 20,12559557,Term 19,40106066,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfPropertyPlantAndEquipment,유형자산손상차손,-,Term 21,3695340823,Term 20,958695011,Term 19,8172548599,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,투자부동산손상차손,-,Term 21,0,Term 20,2723414919,Term 19,2076269660,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfIntangibleAssets,무형자산손상차손,-,Term 21,563290248,Term 20,56925461,Term 19,41517092546,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산손상차손,-,Term 21,338700185,Term 20,0,Term 19,0,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 21,326237006705,Term 20,307973132289,Term 19,303908097869,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestIncome,이자수익,-,Term 21,5680872283,Term 20,4984491548,Term 19,8700706278,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,배당금수익,-,Term 21,-186600000,Term 20,-933000000,Term 19,-28256000,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타의 대손상각비,-,Term 21,-1135147924,Term 20,120354050,Term 19,498555701,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 21,1645379301,Term 20,1444637923,Term 19,1771727446,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentsInAssociates,종속기업/관계기업/공동기업투자처분이익,-,Term 21,6259434084,Term 20,0,Term 19,0,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 21,7882228803,Term 20,3539815333,Term 19,6156226718,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentProperty,투자부동산처분이익,-,Term 21,424275509,Term 20,3740590000,Term 19,112545282,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfIntangibleAssets,무형자산처분이익,-,Term 21,31400000,Term 20,466778724,Term 19,226562693,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분이익,-,Term 21,50260469,Term 20,217521224,Term 19,58412806,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForProfitsOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 21,5072767505,Term 20,7024275269,Term 19,6919863873,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForBargainPurchaseGains,염가매수차익,-,Term 21,31288923,Term 20,0,Term 19,549994737,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업활동으로인한자산ㆍ부채의변동,-,Term 21,-232237308874,Term 20,-97771906662,Term 19,15693436344,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable,매출채권,-,Term 21,48830535465,Term 20,22475967366,Term 19,-22581565164,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInTradeAndOtherReceivables,기타채권,-,Term 21,7439955809,Term 20,4352829222,Term 19,17762470159,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산,-,Term 21,-147805686623,Term 20,-67826527783,Term 19,-31006365565,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산,-,Term 21,3246409858,Term 20,12117381977,Term 19,-6138979641,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInOtherNonCurrentNonFinancialAssets,기타비유동비금융자산,-,Term 21,0,Term 20,0,Term 19,734507866,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,기타비유동자산,-,Term 21,-5825558786,Term 20,-7901977197,Term 19,0,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable,매입채무,-,Term 21,5129900386,Term 20,-30067851787,Term 19,2410984772,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInTradeAndOtherPayables,기타채무,-,Term 21,-31106874116,Term 20,22469667835,Term 19,70917430472,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,환불부채,-,Term 21,-3017943114,Term 20,-549255134,Term 19,-874540704,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 21,-12476452211,Term 20,-12986505720,Term 19,30299904461,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채,-,Term 21,-33517901510,Term 20,-8576068399,Term 19,21482822264,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInWithholdingsBanks,예수보증금,-,Term 21,-1293303890,Term 20,-554689404,Term 19,-2382570699,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,퇴직금의 지급,-,Term 21,4891083551,Term 20,7374041609,Term 19,4565340718,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInPostemploymentBenefitObligations,퇴직급여부채의 관계사 전입,-,Term 21,561746152,Term 20,825666713,Term 19,-461390214,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInFairValueOfPlanAssets,사외적립자산의 기여,-,Term 21,-55921334529,Term 20,-54936455806,Term 19,-66366829778,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherNonCurrentLiabilities,기타비유동부채,-,Term 21,-1589718214,Term 20,30759953064,Term 19,6462898833,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자수취(영업),-,Term 21,4850875119,Term 20,4959977013,Term 19,7587742626,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsOperatingActivities,배당금수취(영업),-,Term 21,6384911352,Term 20,4227270000,Term 19,2901037478,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자지급(영업),-,Term 21,7982482336,Term 20,8700381507,Term 19,10180156104,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세납부(환급),-,Term 21,303256558221,Term 20,337168169357,Term 19,316445508713,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동현금흐름,-,Term 21,-465122432772,Term 20,-745883641217,Term 19,-461380844546,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,단기금융상품의 감소,-,Term 21,42000000000,Term 20,76200000999,Term 19,15055168850,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,단기기타채권의 감소,-,Term 21,7150005783,Term 20,894557167,Term 19,37975273738,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,장기금융상품의 감소,-,Term 21,0,Term 20,4000000,Term 19,0,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,장기기타채권의 감소,-,Term 21,2286461472,Term 20,9748658623,Term 19,64308271893,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,기타비유동금융자산의 감소,-,Term 21,0,Term 20,1173000000,Term 19,558934331,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentsInAssociates,관계기업에 대한 투자자산의 처분,-,Term 21,16943803,Term 20,0,Term 19,,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 21,17970989609,Term 20,6797791333,Term 19,12659860186,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 21,2360000000,Term 20,4760000000,Term 19,340000000,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 21,270342552,Term 20,9906597662,Term 19,463027231,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities,정부보조금의 수취,-,Term 21,253700000,Term 20,0,Term 19,0,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,종속기업 처분으로 인한 순현금유입액,-,Term 21,7364927342,Term 20,0,Term 19,2666361770,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,종속기업의 설립,-,Term 21,0,Term 20,0,Term 19,50000010000,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,단기금융상품의 증가,-,Term 21,76229000000,Term 20,62500000000,Term 19,70341850599,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,단기기타채권의 증가,-,Term 21,696100059,Term 20,178968162,Term 19,254010544,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,장기기타채권의 증가,-,Term 21,4563158125,Term 20,3927857300,Term 19,65426828092,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 21,321874697496,Term 20,505743484068,Term 19,326089104184,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_PurchaseOfInvestmentProperty,투자부동산의 취득,-,Term 21,12528920,Term 20,0,Term 19,0,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 21,10312236474,Term 20,13128703763,Term 19,8973731170,74,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합으로 인한 순현금 유출,-,Term 21,131108082259,Term 20,269889233708,Term 19,174322227956,75,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동현금흐름,-,Term 21,-238400403869,Term 20,-465737759835,Term 19,-429403943010,76,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 차입,-,Term 21,211508361822,Term 20,96944735692,Term 19,271711203706,77,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_ProceedsFromLongTermBorrowings,장기차입금의 차입,-,Term 21,0,Term 20,22736389421,Term 19,0,78,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,종속기업의 유상증자,-,Term 21,120000000,Term 20,0,Term 19,0,79,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,사채의 발행,-,Term 21,0,Term 20,0,Term 19,29999620000,80,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 상환,-,Term 21,160451258420,Term 20,194202086120,Term 19,323425777729,81,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities,유동성장기차입금의 상환,-,Term 21,3578572000,Term 20,3567121000,Term 19,13566080000,82,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_RepaymentsOfBonds,유동성사채의 상환,-,Term 21,0,Term 20,100000000000,Term 19,150000000000,83,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_PaymentsOfFinanceLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 지급,-,Term 21,85093142807,Term 20,91236233038,Term 19,80342388920,84,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries,종속기업투자의 취득,-,Term 21,14770273001,Term 20,0,Term 19,5190000000,85,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금지급,-,Term 21,186135519463,Term 20,196413444790,Term 19,158590520067,86,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,환율변동효과 반영전 현금및현금성자산의 순증가(감소),-,Term 21,280958829727,Term 20,-206778929017,Term 19,248856687379,87,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초현금및현금성자산,-,Term 21,434105464098,Term 20,647104059171,Term 19,396643798594,88,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,현금및현금성자산에 대한 환율변동효과,-,Term 21,325780165,Term 20,-300879719,Term 19,-695843313,89,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,해외사업환산차이,-,Term 21,19130537743,Term 20,-5918786337,Term 19,2299416511,90,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말현금및현금성자산,-,Term 21,734520611733,Term 20,434105464098,Term 19,647104059171,91,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 21,88589470000,Term 20,88589470000,Term 19,88589470000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,4805404131407,Term 20,,Term 19,,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 21,-124122981721,Term 20,-96636000943,Term 19,,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 21,97325737783,Term 20,97325737783,Term 19,97325737783,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 21,4849195698865,Term 20,,Term 19,,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배지분 [member],Term 21,93216194376,Term 20,90353924957,Term 19,81953708487,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,4755979504489,Term 20,,Term 19,,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 21,-111216852980,Term 20,,Term 19,,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,844523495741,Term 20,,Term 19,,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 21,861127851880,Term 20,813101140024,Term 19,788173092234,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,844523495741,Term 20,,Term 19,,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|비지배지분 [member],Term 21,16604356139,Term 20,15472467145,Term 19,10075385067,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,연결재무제표 [member],Term 21,18774536960,Term 20,18549466745,Term 19,-11691231674,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|비지배지분 [member],Term 21,258833414,Term 20,237005392,Term 19,-585451313,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,18515703546,Term 20,18312461353,Term 19,-11105780361,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,18515703546,Term 20,18312461353,Term 19,-11105780361,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 21,-149661927,Term 20,-1327783683,Term 19,-1906910378,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,-149661927,Term 20,-1327783683,Term 19,-1906910378,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,연결재무제표 [member],Term 21,-149661927,Term 20,-1327783683,Term 19,-1906910378,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,연결재무제표 [member],Term 21,,Term 20,2748411,Term 19,44993850,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,,Term 20,2748411,Term 19,44993850,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,,Term 20,2748411,Term 19,44993850,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,연결재무제표 [member],Term 21,234458815,Term 20,-215096850,Term 19,88177739,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,234458815,Term 20,-215096850,Term 19,88177739,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 21,234458815,Term 20,-215096850,Term 19,88177739,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,연결재무제표 [member],Term 21,60934665619,Term 20,-27173924263,Term 19,27153141734,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 21,59542607547,Term 20,-26944089120,Term 19,26807333210,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|비지배지분 [member],Term 21,1392058072,Term 20,-229835143,Term 19,345808524,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,59542607547,Term 20,-26944089120,Term 19,26807333210,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,184421296950,Term 20,,Term 19,,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|비지배지분 [member],Term 21,,Term 20,12000000000,Term 19,3280153811,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,연결재무제표 [member],Term 21,184421296950,Term 20,,Term 19,,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,184421296950,Term 20,,Term 19,,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,연결재무제표 [member],Term 21,-107863441906,Term 20,5592780295,Term 19,-415352607,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,,Term 20,,Term 19,-421708533,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 21,-106214656931,Term 20,6210148270,Term 19,-1838272077,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,-106214656931,Term 20,6210148270,Term 19,-2259980610,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|비지배지분 [member],Term 21,-1648784975,Term 20,-617367975,Term 19,1844628003,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 21,5497832811356,Term 20,4849195698865,Term 19,4237087665136,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,5388010154330,Term 20,,Term 19,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|비지배지분 [member],Term 21,109822657026,Term 20,93216194376,Term 19,90353924957,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 21,-217431509911,Term 20,,Term 19,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 21,97325737783,Term 20,97325737783,Term 19,97325737783,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 21,88589470000,Term 20,88589470000,Term 19,88589470000,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,5484022033744,Term 20,,Term 19,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 21,-64495577286,Term 20,,Term 19,-96636000943,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 22,2284388637755,Term 21,2472884295774,Term 20,1982768917805,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 22,655092563078,Term 21,734520611733,Term 20,434105464098,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_ShortTermDepositsNotClassifiedAsCashEquivalents,단기금융상품,-,Term 22,21974830400,Term 21,95352448800,Term 20,58536528000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,기타채권,-,Term 22,602885508474,Term 21,592964794438,Term 20,637791666835,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_ShortTermTradeReceivable,매출채권,-,Term 22,550861505948,Term 21,554857050527,Term 20,585564696288,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,-Standard account code not used-,기타채권,-,Term 22,52024002526,Term 21,38107743911,Term 20,52226970547,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 22,955432614662,Term 21,1000655942465,Term 20,808965987719,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 22,2687794247,Term 21,824675343,Term 20,373764592,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 22,46315326894,Term 21,48565822995,Term 20,42995506561,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 22,5018541014448,Term 21,5082355121943,Term 20,4818646865905,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_LongTermDepositsNotClassifiedAsCashEquivalents,장기금융상품,-,Term 22,23000000,Term 21,20000000,Term 20,20000000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentReceivablesGross,장기기타채권,-,Term 22,40637972467,Term 21,49092915577,Term 20,50353958215,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates,관계기업및공동기업투자,-,Term 22,60146908565,Term 21,59167859842,Term 20,59998748118,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 22,52397079036,Term 21,38593929168,Term 20,38749519773,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 22,2383867277039,Term 21,2449112181346,Term 20,2329834013415,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 22,180820799447,Term 21,204288160278,Term 20,219793014823,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 22,25933611138,Term 21,30129279961,Term 20,24759532927,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 22,2100587252176,Term 21,2168719935017,Term 20,2063442867186,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 22,64367260770,Term 21,28409958922,Term 20,9768003713,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_OtherNonCurrentAssets,기타비유동자산,-,Term 22,109759853810,Term 21,54820901832,Term 20,21927207735,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 22,7302929652203,Term 21,7555239417717,Term 20,6801415783710,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 22,1162757522705,Term 21,1525844759254,Term 20,1479723875311,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,매입채무 및 기타유동채무,-,Term 22,678040436130,Term 21,862367973560,Term 20,779910998828,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_ShortTermTradePayables,단기매입채무,-,Term 22,213187479186,Term 21,270571519551,Term 20,251186196633,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,-Standard account code not used-,기타채무,-,Term 22,241803567987,Term 21,299660142515,Term 20,338733244659,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 22,215544469417,Term 21,256676145850,Term 20,186412985536,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_CurrentPortionOfLongtermBorrowings,유동성장기차입금,-,Term 22,7504919540,Term 21,5460181804,Term 20,3578572000,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_CurrentPortionOfBonds,유동성사채,-,Term 22,0,Term 21,29999983840,Term 20,0,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 22,102379416709,Term 21,188801478806,Term 20,180411503449,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_CurrentProvisionsForReturnedGoods,유동반품충당부채,-,Term 22,13339134213,Term 21,12875692276,Term 20,15621411384,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 22,248426155665,Term 21,330577242027,Term 20,349310770860,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 22,120572379988,Term 21,131222372585,Term 20,154469190790,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 22,671336141249,Term 21,531561847107,Term 20,472496209534,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentPayables,장기매입채무 및 기타비유동채무,-,Term 22,24984549756,Term 21,21237095226,Term 20,57308752150,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_LongTermBorrowingsGross,장기차입금,-,Term 22,14783780077,Term 21,17341601617,Term 20,22801783421,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_BondsIssued,사채,-,Term 22,0,Term 21,0,Term 20,29999854078,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_LongTermGuaranteeDepositWithholdings,장기예수보증금,-,Term 22,10200769679,Term 21,3895493609,Term 20,4507114651,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_PostemploymentBenefitObligations,퇴직급여부채,-,Term 22,63616144843,Term 21,51421810319,Term 20,48752783196,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 22,165223257419,Term 21,121735464959,Term 20,131795665327,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialLiabilities,기타비유동금융부채,-,Term 22,375094983970,Term 21,263149536421,Term 20,157269496925,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 22,42417205261,Term 21,74017940182,Term 20,77369511936,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 22,1834093663954,Term 21,2057406606361,Term 20,1952220084845,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업소유지분,-,Term 22,5339282549902,Term 21,5388010154330,Term 20,4755979504489,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 22,88589470000,Term 21,88589470000,Term 20,88589470000,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 22,97325737783,Term 21,97325737783,Term 20,97325737783,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금(결손금),-,Term 22,5542446884994,Term 21,5484022033744,Term 20,4805404131407,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 22,-83209267310,Term 21,-64495577286,Term 20,-124122981721,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_OtherCapitalAdjustments,기타자본항목,-,Term 22,-305870275565,Term 21,-217431509911,Term 20,-111216852980,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배지분,-,Term 22,129553438347,Term 21,109822657026,Term 20,93216194376,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 22,5468835988249,Term 21,5497832811356,Term 20,4849195698865,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,자본과부채총계,-,Term 22,7302929652203,Term 21,7555239417717,Term 20,6801415783710,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_Revenue,매출액,-,Term 22,7185759184335,Term 21,8091511297961,Term 20,7844506057131,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_CostOfSales,매출원가,-,Term 22,3168512092765,Term 21,3039883555040,Term 20,2962930553558,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_GrossProfit,매출총이익,-,Term 22,4017247091570,Term 21,5051627742921,Term 20,4881575503573,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 22,3306124157201,Term 21,3761997319316,Term 20,3660710772262,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,dart_OperatingIncomeLoss,영업이익(손실),-,Term 22,711122934369,Term 21,1289630423605,Term 20,1220864731311,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_FinanceIncome,금융수익,-,Term 22,21588027756,Term 21,9572005157,Term 20,15434807035,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_FinanceCosts,금융원가,-,Term 22,27261631668,Term 21,22886303361,Term 20,21616953222,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,dart_OtherGains,기타영업외수익,-,Term 22,58855764285,Term 21,54382716863,Term 20,44819578890,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,dart_OtherLosses,기타영업외비용,-,Term 22,353493663488,Term 21,148406751184,Term 20,145452166970,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,-Standard account code not used-,지분법손익,-,Term 22,6957929498,Term 21,5072767505,Term 20,7024275269,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익(손실),-,Term 22,417769360752,Term 21,1187364858585,Term 20,1121074272313,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 22,159429313871,Term 21,326237006705,Term 20,307973132289,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 22,258340046881,Term 21,861127851880,Term 20,813101140024,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 22,236572425808,Term 21,844523495741,Term 20,797628672879,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배지분,-,Term 22,21767621073,Term 21,16604356139,Term 20,15472467145,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_BasicEarningsLossPerShare,기본 및 희석 보통주당이익,-,Term 22,14112,Term 21,50395,Term 20,47596,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_DilutedEarningsLossPerShare,기본 및 희석 우선주당이익,-,Term 22,14162,Term 21,50445,Term 20,47647,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 22,258340046881,Term 21,861127851880,Term 20,813101140024,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 22,7014594733,Term 21,79793999467,Term 20,-10164589640,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되지 않는 항목,-,Term 22,24289540593,Term 21,18624875033,Term 20,17224431473,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),-,Term 22,24289767415,Term 21,18774536960,Term 20,18549466745,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,-,Term 22,-197326822,Term 21,-149661927,Term 20,-1327783683,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,-,Term 22,197100000,Term 21,0,Term 20,2748411,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax,당기손익으로 재분류될 수 있는 항목(세후기타포괄손익),-,Term 22,-17274945860,Term 21,61169124434,Term 20,-27389021113,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,dart_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법 적용대상 관계기업과 공동기업의 기타포괄손익에 대한 지분(세후기타포괄손익),-,Term 22,21944749,Term 21,234458815,Term 20,-215096850,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업장환산외환차이(세후기타포괄손익),-,Term 22,-17296890609,Term 21,60934665619,Term 20,-27173924263,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄손익,-,Term 22,265354641614,Term 21,940921851347,Term 20,802936550384,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 22,240888502176,Term 21,922666603722,Term 20,787456912990,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배지분,-,Term 22,24466139438,Term 21,18255247625,Term 20,15479637394,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동현금흐름,-,Term 22,497299483100,Term 21,984481666368,Term 20,1004842472035,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_ProfitLossForStatementOfCashFlows,당기순이익(손실),-,Term 22,258340046881,Term 21,861127851880,Term 20,813101140024,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,수익ㆍ비용의가감,-,Term 22,678770999043,Term 21,655594377448,Term 20,626194542524,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForDepreciationExpense,감가상각비,-,Term 22,246887613016,Term 21,240917419595,Term 20,233925508629,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 22,41092465637,Term 21,34129748348,Term 20,28295853267,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 22,48421103671,Term 21,50413856656,Term 20,50474494996,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비,-,Term 22,-428896863,Term 21,3729253285,Term 20,595482883,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 22,14830609188,Term 21,12537198896,Term 20,12507879942,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 22,5088997246,Term 21,1233674337,Term 20,2555055538,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 평가손실,-,Term 22,6732536253,Term 21,4921968498,Term 20,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융부채 평가손실,-,Term 22,0,Term 21,1380318713,Term 20,2431280464,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 평가이익,-,Term 22,-4632564558,Term 21,-1582418788,Term 20,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융부채 평가이익,-,Term 22,0,Term 21,-255798240,Term 20,-3205933336,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 처분손실,-,Term 22,0,Term 21,0,Term 20,22428828,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 22,3417665095,Term 21,4947235977,Term 20,7796049548,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfInvestmentProperty,투자부동산처분손실,-,Term 22,36425687,Term 21,0,Term 20,122712135,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfIntangibleAssets,무형자산처분손실,-,Term 22,3010429856,Term 21,700100092,Term 20,1179758364,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분손실,-,Term 22,61581730,Term 21,87136919,Term 20,12559557,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfPropertyPlantAndEquipment,유형자산손상차손,-,Term 22,6796472886,Term 21,3695340823,Term 20,958695011,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,투자부동산손상차손,-,Term 22,0,Term 21,0,Term 20,2723414919,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfIntangibleAssets,무형자산손상차손,-,Term 22,177834742877,Term 21,563290248,Term 20,56925461,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산손상차손,-,Term 22,12183534981,Term 21,338700185,Term 20,0,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 22,159429313871,Term 21,326237006705,Term 20,307973132289,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestIncome,이자수익,-,Term 22,11331601645,Term 21,5680872283,Term 20,4984491548,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,배당금수익,-,Term 22,0,Term 21,-186600000,Term 20,-933000000,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타의 대손상각비,-,Term 22,-197792932,Term 21,-1135147924,Term 20,120354050,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 22,3011356217,Term 21,1645379301,Term 20,1444637923,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentsInAssociates,종속기업/관계기업/공동기업투자처분이익,-,Term 22,38088456,Term 21,6259434084,Term 20,0,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 22,20139865677,Term 21,7882228803,Term 20,3539815333,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentProperty,투자부동산처분이익,-,Term 22,146808846,Term 21,424275509,Term 20,3740590000,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfIntangibleAssets,무형자산처분이익,-,Term 22,93183291,Term 21,31400000,Term 20,466778724,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분이익,-,Term 22,74404968,Term 21,50260469,Term 20,217521224,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForProfitsOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 22,6957929498,Term 21,5072767505,Term 20,7024275269,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForBargainPurchaseGains,염가매수차익,-,Term 22,0,Term 21,31288923,Term 20,0,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업활동으로인한자산ㆍ부채의변동,-,Term 22,-199657616423,Term 21,-232237308874,Term 20,-97771906662,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable,매출채권,-,Term 22,12853602709,Term 21,48830535465,Term 20,22475967366,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInTradeAndOtherReceivables,기타채권,-,Term 22,-11283101681,Term 21,7439955809,Term 20,4352829222,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산,-,Term 22,62013447364,Term 21,-147805686623,Term 20,-67826527783,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산,-,Term 22,11453506140,Term 21,3246409858,Term 20,12117381977,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,기타비유동자산,-,Term 22,-3913036948,Term 21,-5825558786,Term 20,-7901977197,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable,매입채무,-,Term 22,-65158003482,Term 21,5129900386,Term 20,-30067851787,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInTradeAndOtherPayables,기타채무,-,Term 22,-49816791137,Term 21,-31106874116,Term 20,22469667835,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,환불부채,-,Term 22,481980735,Term 21,-3017943114,Term 20,-549255134,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 22,-72237655740,Term 21,-12476452211,Term 20,-12986505720,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채,-,Term 22,-33973949285,Term 21,-33517901510,Term 20,-8576068399,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInWithholdingsBanks,예수보증금,-,Term 22,5859634835,Term 21,-1293303890,Term 20,-554689404,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,퇴직금의 지급,-,Term 22,5830223526,Term 21,4891083551,Term 20,7374041609,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInPostemploymentBenefitObligations,퇴직급여부채의 관계사 전입,-,Term 22,129783254,Term 21,561746152,Term 20,825666713,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInFairValueOfPlanAssets,사외적립자산의 기여,-,Term 22,-44570790774,Term 21,-55921334529,Term 20,-54936455806,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherNonCurrentLiabilities,기타비유동부채,-,Term 22,-5666018887,Term 21,-1589718214,Term 20,30759953064,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자수취(영업),-,Term 22,9693585964,Term 21,4850875119,Term 20,4959977013,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsOperatingActivities,배당금수취(영업),-,Term 22,6013497709,Term 21,6384911352,Term 20,4227270000,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자지급(영업),-,Term 22,11779250888,Term 21,7982482336,Term 20,8700381507,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세납부(환급),-,Term 22,244081779186,Term 21,303256558221,Term 20,337168169357,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동현금흐름,-,Term 22,-197383721806,Term 21,-465122432772,Term 20,-745883641217,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,단기금융상품의 감소,-,Term 22,83471000000,Term 21,42000000000,Term 20,76200000999,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,단기기타채권의 감소,-,Term 22,4352892626,Term 21,7150005783,Term 20,894557167,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,장기금융상품의 감소,-,Term 22,0,Term 21,0,Term 20,4000000,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,장기기타채권의 감소,-,Term 22,3953324404,Term 21,2286461472,Term 20,9748658623,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,기타포괄손익-공정가치 측정 금융자산의 처분,-,Term 22,197100000,Term 21,0,Term 20,0,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,기타비유동금융자산의 감소,-,Term 22,0,Term 21,0,Term 20,1173000000,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentsInAssociates,관계기업에 대한 투자자산의 처분,-,Term 22,0,Term 21,16943803,Term 20,0,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 22,34405002695,Term 21,17970989609,Term 20,6797791333,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 22,576520000,Term 21,2360000000,Term 20,4760000000,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 22,4640939909,Term 21,270342552,Term 20,9906597662,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities,정부보조금의 수취,-,Term 22,19110000,Term 21,253700000,Term 20,0,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,종속기업 처분으로 인한 순현금유입액,-,Term 22,0,Term 21,7364927342,Term 20,0,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,단기금융상품의 증가,-,Term 22,7200000000,Term 21,76229000000,Term 20,62500000000,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,단기기타채권의 증가,-,Term 22,751760126,Term 21,696100059,Term 20,178968162,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,장기기타채권의 증가,-,Term 22,2028968475,Term 21,4563158125,Term 20,3927857300,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,기타포괄손익-공정가치 측정 금융자산의 취득,-,Term 22,536445000,Term 21,0,Term 20,0,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 22,157045694758,Term 21,321874697496,Term 20,505743484068,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_PurchaseOfInvestmentProperty,투자부동산의 취득,-,Term 22,0,Term 21,12528920,Term 20,0,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 22,9391190370,Term 21,10312236474,Term 20,13128703763,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합으로 인한 순현금 유출,-,Term 22,152045552711,Term 21,131108082259,Term 20,269889233708,74,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동현금흐름,-,Term 22,-373633368656,Term 21,-238400403869,Term 20,-465737759835,75,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 차입,-,Term 22,319949820109,Term 21,211508361822,Term 20,96944735692,76,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_ProceedsFromLongTermBorrowings,장기차입금의 차입,-,Term 22,5000000000,Term 21,0,Term 20,22736389421,77,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,종속기업의 유상증자,-,Term 22,0,Term 21,120000000,Term 20,0,78,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 상환,-,Term 22,364155453328,Term 21,160451258420,Term 20,194202086120,79,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities,유동성장기차입금의 상환,-,Term 22,5708202529,Term 21,3578572000,Term 20,3567121000,80,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_RepaymentsOfBonds,유동성사채의 상환,-,Term 22,30000000000,Term 21,0,Term 20,100000000000,81,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_PaymentsOfFinanceLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 지급,-,Term 22,85831436888,Term 21,85093142807,Term 20,91236233038,82,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries,종속기업투자의 취득,-,Term 22,11723995920,Term 21,14770273001,Term 20,0,83,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금지급,-,Term 22,201164100100,Term 21,186135519463,Term 20,196413444790,84,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,환율변동효과 반영전 현금및현금성자산의 순증가(감소),-,Term 22,-73717607362,Term 21,280958829727,Term 20,-206778929017,85,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초현금및현금성자산,-,Term 22,734520611733,Term 21,434105464098,Term 20,647104059171,86,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,현금및현금성자산에 대한 환율변동효과,-,Term 22,-77301,Term 21,325780165,Term 20,-300879719,87,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,해외사업환산차이,-,Term 22,-5710363992,Term 21,19130537743,Term 20,-5918786337,88,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말현금및현금성자산,-,Term 22,655092563078,Term 21,734520611733,Term 20,434105464098,89,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 22,88589470000,Term 21,88589470000,Term 20,88589470000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,5484022033744,Term 21,4805404131407,Term 20,4174881534589,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 22,-64495577286,Term 21,-124122981721,Term 20,-96636000943,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 22,97325737783,Term 21,97325737783,Term 20,97325737783,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 22,5497832811356,Term 21,4849195698865,Term 20,4237087665136,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배지분 [member],Term 22,109822657026,Term 21,93216194376,Term 20,90353924957,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,5388010154330,Term 21,4755979504489,Term 20,4146733740179,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 22,-217431509911,Term 21,-111216852980,Term 20,-117427001250,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,236572425808,Term 21,844523495741,Term 20,797628672879,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 22,258340046881,Term 21,861127851880,Term 20,813101140024,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,236572425808,Term 21,844523495741,Term 20,797628672879,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|비지배지분 [member],Term 22,21767621073,Term 21,16604356139,Term 20,15472467145,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,연결재무제표 [member],Term 22,24289767415,Term 21,18774536960,Term 20,18549466745,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|비지배지분 [member],Term 22,1457101023,Term 21,258833414,Term 20,237005392,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,22832666392,Term 21,18515703546,Term 20,18312461353,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,22832666392,Term 21,18515703546,Term 20,18312461353,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 22,-197326822,Term 21,-149661927,Term 20,-1327783683,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,-197326822,Term 21,-149661927,Term 20,-1327783683,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,연결재무제표 [member],Term 22,-197326822,Term 21,-149661927,Term 20,-1327783683,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,197100000,Term 21,,Term 20,2748411,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,197100000,Term 21,,Term 20,2748411,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,연결재무제표 [member],Term 22,197100000,Term 21,,Term 20,2748411,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분으로 인한 재분류,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 22,,Term 21,,Term 20,999988875,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분으로 인한 재분류,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,,Term 21,,Term 20,-999988875,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,연결재무제표 [member],Term 22,21944749,Term 21,234458815,Term 20,-215096850,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,21944749,Term 21,234458815,Term 20,-215096850,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 22,21944749,Term 21,234458815,Term 20,-215096850,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,연결재무제표 [member],Term 22,-17296890609,Term 21,60934665619,Term 20,-27173924263,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|비지배지분 [member],Term 22,1241417342,Term 21,1392058072,Term 20,-229835143,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 22,-18538307951,Term 21,59542607547,Term 20,-26944089120,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,-18538307951,Term 21,59542607547,Term 20,-26944089120,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,201177340950,Term 21,184421296950,Term 20,184421296950,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|비지배지분 [member],Term 22,,Term 21,,Term 20,12000000000,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,연결재무제표 [member],Term 22,201177340950,Term 21,184421296950,Term 20,196421296950,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,201177340950,Term 21,184421296950,Term 20,184421296950,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 22,-88438765654,Term 21,-106214656931,Term 20,6210148270,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,-88438765654,Term 21,-106214656931,Term 20,6210148270,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|비지배지분 [member],Term 22,-4735358117,Term 21,-1648784975,Term 20,-617367975,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,연결재무제표 [member],Term 22,-93174123771,Term 21,-107863441906,Term 20,5592780295,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 22,97325737783,Term 21,97325737783,Term 20,97325737783,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 22,88589470000,Term 21,88589470000,Term 20,88589470000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,5542446884994,Term 21,5484022033744,Term 20,4805404131407,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 22,-83209267310,Term 21,-64495577286,Term 20,-124122981721,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 22,-305870275565,Term 21,-217431509911,Term 20,-111216852980,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,5339282549902,Term 21,5388010154330,Term 20,4755979504489,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 22,5468835988249,Term 21,5497832811356,Term 20,4849195698865,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|비지배지분 [member],Term 22,129553438347,Term 21,109822657026,Term 20,93216194376,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 22,2284388637755,Term 21,2472884295774,Term 20,1982768917805,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 22,655092563078,Term 21,734520611733,Term 20,434105464098,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_ShortTermDepositsNotClassifiedAsCashEquivalents,단기금융상품,-,Term 22,21974830400,Term 21,95352448800,Term 20,58536528000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,기타채권,-,Term 22,602885508474,Term 21,592964794438,Term 20,637791666835,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_ShortTermTradeReceivable,매출채권,-,Term 22,550861505948,Term 21,554857050527,Term 20,585564696288,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,-Standard account code not used-,기타채권,-,Term 22,52024002526,Term 21,38107743911,Term 20,52226970547,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 22,955432614662,Term 21,1000655942465,Term 20,808965987719,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 22,2687794247,Term 21,824675343,Term 20,373764592,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 22,46315326894,Term 21,48565822995,Term 20,42995506561,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 22,5018541014448,Term 21,5082355121943,Term 20,4818646865905,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_LongTermDepositsNotClassifiedAsCashEquivalents,장기금융상품,-,Term 22,23000000,Term 21,20000000,Term 20,20000000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentReceivablesGross,장기기타채권,-,Term 22,40637972467,Term 21,49092915577,Term 20,50353958215,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates,관계기업및공동기업투자,-,Term 22,60146908565,Term 21,59167859842,Term 20,59998748118,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 22,52397079036,Term 21,38593929168,Term 20,38749519773,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 22,2383867277039,Term 21,2449112181346,Term 20,2329834013415,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 22,180820799447,Term 21,204288160278,Term 20,219793014823,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 22,25933611138,Term 21,30129279961,Term 20,24759532927,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 22,2100587252176,Term 21,2168719935017,Term 20,2063442867186,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 22,64367260770,Term 21,28409958922,Term 20,9768003713,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_OtherNonCurrentAssets,기타비유동자산,-,Term 22,109759853810,Term 21,54820901832,Term 20,21927207735,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 22,7302929652203,Term 21,7555239417717,Term 20,6801415783710,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 22,1162757522705,Term 21,1525844759254,Term 20,1479723875311,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,매입채무 및 기타유동채무,-,Term 22,678040436130,Term 21,862367973560,Term 20,779910998828,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_ShortTermTradePayables,단기매입채무,-,Term 22,213187479186,Term 21,270571519551,Term 20,251186196633,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,-Standard account code not used-,기타채무,-,Term 22,241803567987,Term 21,299660142515,Term 20,338733244659,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 22,215544469417,Term 21,256676145850,Term 20,186412985536,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_CurrentPortionOfLongtermBorrowings,유동성장기차입금,-,Term 22,7504919540,Term 21,5460181804,Term 20,3578572000,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_CurrentPortionOfBonds,유동성사채,-,Term 22,0,Term 21,29999983840,Term 20,0,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 22,102379416709,Term 21,188801478806,Term 20,180411503449,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_CurrentProvisionsForReturnedGoods,유동반품충당부채,-,Term 22,13339134213,Term 21,12875692276,Term 20,15621411384,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 22,248426155665,Term 21,330577242027,Term 20,349310770860,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 22,120572379988,Term 21,131222372585,Term 20,154469190790,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 22,671336141249,Term 21,531561847107,Term 20,472496209534,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentPayables,장기매입채무 및 기타비유동채무,-,Term 22,24984549756,Term 21,21237095226,Term 20,57308752150,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_LongTermBorrowingsGross,장기차입금,-,Term 22,14783780077,Term 21,17341601617,Term 20,22801783421,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_BondsIssued,사채,-,Term 22,0,Term 21,0,Term 20,29999854078,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_LongTermGuaranteeDepositWithholdings,장기예수보증금,-,Term 22,10200769679,Term 21,3895493609,Term 20,4507114651,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_PostemploymentBenefitObligations,퇴직급여부채,-,Term 22,63616144843,Term 21,51421810319,Term 20,48752783196,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 22,165223257419,Term 21,121735464959,Term 20,131795665327,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialLiabilities,기타비유동금융부채,-,Term 22,375094983970,Term 21,263149536421,Term 20,157269496925,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 22,42417205261,Term 21,74017940182,Term 20,77369511936,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 22,1834093663954,Term 21,2057406606361,Term 20,1952220084845,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업소유지분,-,Term 22,5339282549902,Term 21,5388010154330,Term 20,4755979504489,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 22,88589470000,Term 21,88589470000,Term 20,88589470000,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 22,97325737783,Term 21,97325737783,Term 20,97325737783,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금(결손금),-,Term 22,5542446884994,Term 21,5484022033744,Term 20,4805404131407,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 22,-83209267310,Term 21,-64495577286,Term 20,-124122981721,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_OtherCapitalAdjustments,기타자본항목,-,Term 22,-305870275565,Term 21,-217431509911,Term 20,-111216852980,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배지분,-,Term 22,129553438347,Term 21,109822657026,Term 20,93216194376,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 22,5468835988249,Term 21,5497832811356,Term 20,4849195698865,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,자본과부채총계,-,Term 22,7302929652203,Term 21,7555239417717,Term 20,6801415783710,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_Revenue,매출액,-,Term 22,7185759184335,Term 21,8091511297961,Term 20,7844506057131,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_CostOfSales,매출원가,-,Term 22,3168512092765,Term 21,3039883555040,Term 20,2962930553558,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_GrossProfit,매출총이익,-,Term 22,4017247091570,Term 21,5051627742921,Term 20,4881575503573,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 22,3306124157201,Term 21,3761997319316,Term 20,3660710772262,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,dart_OperatingIncomeLoss,영업이익(손실),-,Term 22,711122934369,Term 21,1289630423605,Term 20,1220864731311,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_FinanceIncome,금융수익,-,Term 22,21588027756,Term 21,9572005157,Term 20,15434807035,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_FinanceCosts,금융원가,-,Term 22,27261631668,Term 21,22886303361,Term 20,21616953222,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,dart_OtherGains,기타영업외수익,-,Term 22,58855764285,Term 21,54382716863,Term 20,44819578890,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,dart_OtherLosses,기타영업외비용,-,Term 22,353493663488,Term 21,148406751184,Term 20,145452166970,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,-Standard account code not used-,지분법손익,-,Term 22,6957929498,Term 21,5072767505,Term 20,7024275269,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익(손실),-,Term 22,417769360752,Term 21,1187364858585,Term 20,1121074272313,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 22,159429313871,Term 21,326237006705,Term 20,307973132289,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 22,258340046881,Term 21,861127851880,Term 20,813101140024,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 22,236572425808,Term 21,844523495741,Term 20,797628672879,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배지분,-,Term 22,21767621073,Term 21,16604356139,Term 20,15472467145,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_BasicEarningsLossPerShare,기본 및 희석 보통주당이익,-,Term 22,14112,Term 21,50395,Term 20,47596,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_DilutedEarningsLossPerShare,기본 및 희석 우선주당이익,-,Term 22,14162,Term 21,50445,Term 20,47647,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 22,258340046881,Term 21,861127851880,Term 20,813101140024,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 22,7014594733,Term 21,79793999467,Term 20,-10164589640,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되지 않는 항목,-,Term 22,24289540593,Term 21,18624875033,Term 20,17224431473,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),-,Term 22,24289767415,Term 21,18774536960,Term 20,18549466745,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,-,Term 22,-197326822,Term 21,-149661927,Term 20,-1327783683,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,-,Term 22,197100000,Term 21,0,Term 20,2748411,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax,당기손익으로 재분류될 수 있는 항목(세후기타포괄손익),-,Term 22,-17274945860,Term 21,61169124434,Term 20,-27389021113,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,dart_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법 적용대상 관계기업과 공동기업의 기타포괄손익에 대한 지분(세후기타포괄손익),-,Term 22,21944749,Term 21,234458815,Term 20,-215096850,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업장환산외환차이(세후기타포괄손익),-,Term 22,-17296890609,Term 21,60934665619,Term 20,-27173924263,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄손익,-,Term 22,265354641614,Term 21,940921851347,Term 20,802936550384,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 22,240888502176,Term 21,922666603722,Term 20,787456912990,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배지분,-,Term 22,24466139438,Term 21,18255247625,Term 20,15479637394,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동현금흐름,-,Term 22,497299483100,Term 21,984481666368,Term 20,1004842472035,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_ProfitLossForStatementOfCashFlows,당기순이익(손실),-,Term 22,258340046881,Term 21,861127851880,Term 20,813101140024,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,수익ㆍ비용의가감,-,Term 22,678770999043,Term 21,655594377448,Term 20,626194542524,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForDepreciationExpense,감가상각비,-,Term 22,246887613016,Term 21,240917419595,Term 20,233925508629,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 22,41092465637,Term 21,34129748348,Term 20,28295853267,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 22,48421103671,Term 21,50413856656,Term 20,50474494996,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비,-,Term 22,-428896863,Term 21,3729253285,Term 20,595482883,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 22,14830609188,Term 21,12537198896,Term 20,12507879942,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 22,5088997246,Term 21,1233674337,Term 20,2555055538,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 평가손실,-,Term 22,6732536253,Term 21,4921968498,Term 20,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융부채 평가손실,-,Term 22,0,Term 21,1380318713,Term 20,2431280464,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 평가이익,-,Term 22,-4632564558,Term 21,-1582418788,Term 20,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융부채 평가이익,-,Term 22,0,Term 21,-255798240,Term 20,-3205933336,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 처분손실,-,Term 22,0,Term 21,0,Term 20,22428828,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 22,3417665095,Term 21,4947235977,Term 20,7796049548,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfInvestmentProperty,투자부동산처분손실,-,Term 22,36425687,Term 21,0,Term 20,122712135,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfIntangibleAssets,무형자산처분손실,-,Term 22,3010429856,Term 21,700100092,Term 20,1179758364,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분손실,-,Term 22,61581730,Term 21,87136919,Term 20,12559557,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfPropertyPlantAndEquipment,유형자산손상차손,-,Term 22,6796472886,Term 21,3695340823,Term 20,958695011,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,투자부동산손상차손,-,Term 22,0,Term 21,0,Term 20,2723414919,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfIntangibleAssets,무형자산손상차손,-,Term 22,177834742877,Term 21,563290248,Term 20,56925461,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산손상차손,-,Term 22,12183534981,Term 21,338700185,Term 20,0,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 22,159429313871,Term 21,326237006705,Term 20,307973132289,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestIncome,이자수익,-,Term 22,11331601645,Term 21,5680872283,Term 20,4984491548,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,배당금수익,-,Term 22,0,Term 21,-186600000,Term 20,-933000000,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타의 대손상각비,-,Term 22,-197792932,Term 21,-1135147924,Term 20,120354050,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 22,3011356217,Term 21,1645379301,Term 20,1444637923,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentsInAssociates,종속기업/관계기업/공동기업투자처분이익,-,Term 22,38088456,Term 21,6259434084,Term 20,0,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 22,20139865677,Term 21,7882228803,Term 20,3539815333,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentProperty,투자부동산처분이익,-,Term 22,146808846,Term 21,424275509,Term 20,3740590000,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfIntangibleAssets,무형자산처분이익,-,Term 22,93183291,Term 21,31400000,Term 20,466778724,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분이익,-,Term 22,74404968,Term 21,50260469,Term 20,217521224,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForProfitsOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 22,6957929498,Term 21,5072767505,Term 20,7024275269,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForBargainPurchaseGains,염가매수차익,-,Term 22,0,Term 21,31288923,Term 20,0,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업활동으로인한자산ㆍ부채의변동,-,Term 22,-199657616423,Term 21,-232237308874,Term 20,-97771906662,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable,매출채권,-,Term 22,12853602709,Term 21,48830535465,Term 20,22475967366,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInTradeAndOtherReceivables,기타채권,-,Term 22,-11283101681,Term 21,7439955809,Term 20,4352829222,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산,-,Term 22,62013447364,Term 21,-147805686623,Term 20,-67826527783,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산,-,Term 22,11453506140,Term 21,3246409858,Term 20,12117381977,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,기타비유동자산,-,Term 22,-3913036948,Term 21,-5825558786,Term 20,-7901977197,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable,매입채무,-,Term 22,-65158003482,Term 21,5129900386,Term 20,-30067851787,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInTradeAndOtherPayables,기타채무,-,Term 22,-49816791137,Term 21,-31106874116,Term 20,22469667835,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,환불부채,-,Term 22,481980735,Term 21,-3017943114,Term 20,-549255134,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 22,-72237655740,Term 21,-12476452211,Term 20,-12986505720,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채,-,Term 22,-33973949285,Term 21,-33517901510,Term 20,-8576068399,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInWithholdingsBanks,예수보증금,-,Term 22,5859634835,Term 21,-1293303890,Term 20,-554689404,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,퇴직금의 지급,-,Term 22,5830223526,Term 21,4891083551,Term 20,7374041609,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInPostemploymentBenefitObligations,퇴직급여부채의 관계사 전입,-,Term 22,129783254,Term 21,561746152,Term 20,825666713,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInFairValueOfPlanAssets,사외적립자산의 기여,-,Term 22,-44570790774,Term 21,-55921334529,Term 20,-54936455806,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherNonCurrentLiabilities,기타비유동부채,-,Term 22,-5666018887,Term 21,-1589718214,Term 20,30759953064,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자수취(영업),-,Term 22,9693585964,Term 21,4850875119,Term 20,4959977013,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsOperatingActivities,배당금수취(영업),-,Term 22,6013497709,Term 21,6384911352,Term 20,4227270000,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자지급(영업),-,Term 22,11779250888,Term 21,7982482336,Term 20,8700381507,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세납부(환급),-,Term 22,244081779186,Term 21,303256558221,Term 20,337168169357,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동현금흐름,-,Term 22,-197383721806,Term 21,-465122432772,Term 20,-745883641217,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,단기금융상품의 감소,-,Term 22,83471000000,Term 21,42000000000,Term 20,76200000999,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,단기기타채권의 감소,-,Term 22,4352892626,Term 21,7150005783,Term 20,894557167,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,장기금융상품의 감소,-,Term 22,0,Term 21,0,Term 20,4000000,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,장기기타채권의 감소,-,Term 22,3953324404,Term 21,2286461472,Term 20,9748658623,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,기타포괄손익-공정가치 측정 금융자산의 처분,-,Term 22,197100000,Term 21,0,Term 20,0,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,기타비유동금융자산의 감소,-,Term 22,0,Term 21,0,Term 20,1173000000,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentsInAssociates,관계기업에 대한 투자자산의 처분,-,Term 22,0,Term 21,16943803,Term 20,0,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 22,34405002695,Term 21,17970989609,Term 20,6797791333,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 22,576520000,Term 21,2360000000,Term 20,4760000000,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 22,4640939909,Term 21,270342552,Term 20,9906597662,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities,정부보조금의 수취,-,Term 22,19110000,Term 21,253700000,Term 20,0,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,종속기업 처분으로 인한 순현금유입액,-,Term 22,0,Term 21,7364927342,Term 20,0,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,단기금융상품의 증가,-,Term 22,7200000000,Term 21,76229000000,Term 20,62500000000,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,단기기타채권의 증가,-,Term 22,751760126,Term 21,696100059,Term 20,178968162,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,장기기타채권의 증가,-,Term 22,2028968475,Term 21,4563158125,Term 20,3927857300,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,기타포괄손익-공정가치 측정 금융자산의 취득,-,Term 22,536445000,Term 21,0,Term 20,0,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 22,157045694758,Term 21,321874697496,Term 20,505743484068,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_PurchaseOfInvestmentProperty,투자부동산의 취득,-,Term 22,0,Term 21,12528920,Term 20,0,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 22,9391190370,Term 21,10312236474,Term 20,13128703763,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합으로 인한 순현금 유출,-,Term 22,152045552711,Term 21,131108082259,Term 20,269889233708,74,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동현금흐름,-,Term 22,-373633368656,Term 21,-238400403869,Term 20,-465737759835,75,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 차입,-,Term 22,319949820109,Term 21,211508361822,Term 20,96944735692,76,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_ProceedsFromLongTermBorrowings,장기차입금의 차입,-,Term 22,5000000000,Term 21,0,Term 20,22736389421,77,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,종속기업의 유상증자,-,Term 22,0,Term 21,120000000,Term 20,0,78,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 상환,-,Term 22,364155453328,Term 21,160451258420,Term 20,194202086120,79,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities,유동성장기차입금의 상환,-,Term 22,5708202529,Term 21,3578572000,Term 20,3567121000,80,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_RepaymentsOfBonds,유동성사채의 상환,-,Term 22,30000000000,Term 21,0,Term 20,100000000000,81,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_PaymentsOfFinanceLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 지급,-,Term 22,85831436888,Term 21,85093142807,Term 20,91236233038,82,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries,종속기업투자의 취득,-,Term 22,11723995920,Term 21,14770273001,Term 20,0,83,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금지급,-,Term 22,201164100100,Term 21,186135519463,Term 20,196413444790,84,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,환율변동효과 반영전 현금및현금성자산의 순증가(감소),-,Term 22,-73717607362,Term 21,280958829727,Term 20,-206778929017,85,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초현금및현금성자산,-,Term 22,734520611733,Term 21,434105464098,Term 20,647104059171,86,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,현금및현금성자산에 대한 환율변동효과,-,Term 22,-77301,Term 21,325780165,Term 20,-300879719,87,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,해외사업환산차이,-,Term 22,-5710363992,Term 21,19130537743,Term 20,-5918786337,88,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말현금및현금성자산,-,Term 22,655092563078,Term 21,734520611733,Term 20,434105464098,89,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 22,88589470000,Term 21,88589470000,Term 20,88589470000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,5484022033744,Term 21,4805404131407,Term 20,4174881534589,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 22,-64495577286,Term 21,-124122981721,Term 20,-96636000943,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 22,97325737783,Term 21,97325737783,Term 20,97325737783,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 22,5497832811356,Term 21,4849195698865,Term 20,4237087665136,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배지분 [member],Term 22,109822657026,Term 21,93216194376,Term 20,90353924957,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,5388010154330,Term 21,4755979504489,Term 20,4146733740179,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 22,-217431509911,Term 21,-111216852980,Term 20,-117427001250,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,236572425808,Term 21,844523495741,Term 20,797628672879,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 22,258340046881,Term 21,861127851880,Term 20,813101140024,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,236572425808,Term 21,844523495741,Term 20,797628672879,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|비지배지분 [member],Term 22,21767621073,Term 21,16604356139,Term 20,15472467145,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,연결재무제표 [member],Term 22,24289767415,Term 21,18774536960,Term 20,18549466745,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|비지배지분 [member],Term 22,1457101023,Term 21,258833414,Term 20,237005392,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,22832666392,Term 21,18515703546,Term 20,18312461353,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,22832666392,Term 21,18515703546,Term 20,18312461353,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 22,-197326822,Term 21,-149661927,Term 20,-1327783683,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,-197326822,Term 21,-149661927,Term 20,-1327783683,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,연결재무제표 [member],Term 22,-197326822,Term 21,-149661927,Term 20,-1327783683,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,197100000,Term 21,,Term 20,2748411,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,197100000,Term 21,,Term 20,2748411,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,연결재무제표 [member],Term 22,197100000,Term 21,,Term 20,2748411,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분으로 인한 재분류,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 22,,Term 21,,Term 20,999988875,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분으로 인한 재분류,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,,Term 21,,Term 20,-999988875,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,연결재무제표 [member],Term 22,21944749,Term 21,234458815,Term 20,-215096850,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,21944749,Term 21,234458815,Term 20,-215096850,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 22,21944749,Term 21,234458815,Term 20,-215096850,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,연결재무제표 [member],Term 22,-17296890609,Term 21,60934665619,Term 20,-27173924263,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|비지배지분 [member],Term 22,1241417342,Term 21,1392058072,Term 20,-229835143,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 22,-18538307951,Term 21,59542607547,Term 20,-26944089120,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,-18538307951,Term 21,59542607547,Term 20,-26944089120,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,201177340950,Term 21,184421296950,Term 20,184421296950,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|비지배지분 [member],Term 22,,Term 21,,Term 20,12000000000,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,연결재무제표 [member],Term 22,201177340950,Term 21,184421296950,Term 20,196421296950,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,201177340950,Term 21,184421296950,Term 20,184421296950,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 22,-88438765654,Term 21,-106214656931,Term 20,6210148270,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,-88438765654,Term 21,-106214656931,Term 20,6210148270,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|비지배지분 [member],Term 22,-4735358117,Term 21,-1648784975,Term 20,-617367975,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,연결재무제표 [member],Term 22,-93174123771,Term 21,-107863441906,Term 20,5592780295,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 22,97325737783,Term 21,97325737783,Term 20,97325737783,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 22,88589470000,Term 21,88589470000,Term 20,88589470000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,5542446884994,Term 21,5484022033744,Term 20,4805404131407,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 22,-83209267310,Term 21,-64495577286,Term 20,-124122981721,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 22,-305870275565,Term 21,-217431509911,Term 20,-111216852980,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,5339282549902,Term 21,5388010154330,Term 20,4755979504489,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 22,5468835988249,Term 21,5497832811356,Term 20,4849195698865,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|비지배지분 [member],Term 22,129553438347,Term 21,109822657026,Term 20,93216194376,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 22,2284388637755,Term 21,2472884295774,Term 20,1982768917805,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 22,655092563078,Term 21,734520611733,Term 20,434105464098,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_ShortTermDepositsNotClassifiedAsCashEquivalents,단기금융상품,-,Term 22,21974830400,Term 21,95352448800,Term 20,58536528000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,기타채권,-,Term 22,602885508474,Term 21,592964794438,Term 20,637791666835,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_ShortTermTradeReceivable,매출채권,-,Term 22,550861505948,Term 21,554857050527,Term 20,585564696288,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,-Standard account code not used-,기타채권,-,Term 22,52024002526,Term 21,38107743911,Term 20,52226970547,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 22,955432614662,Term 21,1000655942465,Term 20,808965987719,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 22,2687794247,Term 21,824675343,Term 20,373764592,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 22,46315326894,Term 21,48565822995,Term 20,42995506561,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 22,5018541014448,Term 21,5082355121943,Term 20,4818646865905,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_LongTermDepositsNotClassifiedAsCashEquivalents,장기금융상품,-,Term 22,23000000,Term 21,20000000,Term 20,20000000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentReceivablesGross,장기기타채권,-,Term 22,40637972467,Term 21,49092915577,Term 20,50353958215,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates,관계기업및공동기업투자,-,Term 22,60146908565,Term 21,59167859842,Term 20,59998748118,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 22,52397079036,Term 21,38593929168,Term 20,38749519773,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 22,2383867277039,Term 21,2449112181346,Term 20,2329834013415,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 22,180820799447,Term 21,204288160278,Term 20,219793014823,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 22,25933611138,Term 21,30129279961,Term 20,24759532927,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 22,2100587252176,Term 21,2168719935017,Term 20,2063442867186,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 22,64367260770,Term 21,28409958922,Term 20,9768003713,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_OtherNonCurrentAssets,기타비유동자산,-,Term 22,109759853810,Term 21,54820901832,Term 20,21927207735,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 22,7302929652203,Term 21,7555239417717,Term 20,6801415783710,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 22,1162757522705,Term 21,1525844759254,Term 20,1479723875311,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,매입채무 및 기타유동채무,-,Term 22,678040436130,Term 21,862367973560,Term 20,779910998828,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_ShortTermTradePayables,단기매입채무,-,Term 22,213187479186,Term 21,270571519551,Term 20,251186196633,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,-Standard account code not used-,기타채무,-,Term 22,241803567987,Term 21,299660142515,Term 20,338733244659,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 22,215544469417,Term 21,256676145850,Term 20,186412985536,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_CurrentPortionOfLongtermBorrowings,유동성장기차입금,-,Term 22,7504919540,Term 21,5460181804,Term 20,3578572000,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_CurrentPortionOfBonds,유동성사채,-,Term 22,0,Term 21,29999983840,Term 20,0,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 22,102379416709,Term 21,188801478806,Term 20,180411503449,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_CurrentProvisionsForReturnedGoods,유동반품충당부채,-,Term 22,13339134213,Term 21,12875692276,Term 20,15621411384,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 22,248426155665,Term 21,330577242027,Term 20,349310770860,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 22,120572379988,Term 21,131222372585,Term 20,154469190790,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 22,671336141249,Term 21,531561847107,Term 20,472496209534,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentPayables,장기매입채무 및 기타비유동채무,-,Term 22,24984549756,Term 21,21237095226,Term 20,57308752150,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_LongTermBorrowingsGross,장기차입금,-,Term 22,14783780077,Term 21,17341601617,Term 20,22801783421,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_BondsIssued,사채,-,Term 22,0,Term 21,0,Term 20,29999854078,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_LongTermGuaranteeDepositWithholdings,장기예수보증금,-,Term 22,10200769679,Term 21,3895493609,Term 20,4507114651,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_PostemploymentBenefitObligations,퇴직급여부채,-,Term 22,63616144843,Term 21,51421810319,Term 20,48752783196,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 22,165223257419,Term 21,121735464959,Term 20,131795665327,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialLiabilities,기타비유동금융부채,-,Term 22,375094983970,Term 21,263149536421,Term 20,157269496925,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 22,42417205261,Term 21,74017940182,Term 20,77369511936,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 22,1834093663954,Term 21,2057406606361,Term 20,1952220084845,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업소유지분,-,Term 22,5339282549902,Term 21,5388010154330,Term 20,4755979504489,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 22,88589470000,Term 21,88589470000,Term 20,88589470000,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 22,97325737783,Term 21,97325737783,Term 20,97325737783,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금(결손금),-,Term 22,5542446884994,Term 21,5484022033744,Term 20,4805404131407,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 22,-83209267310,Term 21,-64495577286,Term 20,-124122981721,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_OtherCapitalAdjustments,기타자본항목,-,Term 22,-305870275565,Term 21,-217431509911,Term 20,-111216852980,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배지분,-,Term 22,129553438347,Term 21,109822657026,Term 20,93216194376,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 22,5468835988249,Term 21,5497832811356,Term 20,4849195698865,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,자본과부채총계,-,Term 22,7302929652203,Term 21,7555239417717,Term 20,6801415783710,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_Revenue,매출액,-,Term 22,7185759184335,Term 21,8091511297961,Term 20,7844506057131,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_CostOfSales,매출원가,-,Term 22,3168512092765,Term 21,3039883555040,Term 20,2962930553558,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_GrossProfit,매출총이익,-,Term 22,4017247091570,Term 21,5051627742921,Term 20,4881575503573,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 22,3306124157201,Term 21,3761997319316,Term 20,3660710772262,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,dart_OperatingIncomeLoss,영업이익(손실),-,Term 22,711122934369,Term 21,1289630423605,Term 20,1220864731311,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_FinanceIncome,금융수익,-,Term 22,21588027756,Term 21,9572005157,Term 20,15434807035,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_FinanceCosts,금융원가,-,Term 22,27261631668,Term 21,22886303361,Term 20,21616953222,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,dart_OtherGains,기타영업외수익,-,Term 22,58855764285,Term 21,54382716863,Term 20,44819578890,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,dart_OtherLosses,기타영업외비용,-,Term 22,353493663488,Term 21,148406751184,Term 20,145452166970,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,-Standard account code not used-,지분법손익,-,Term 22,6957929498,Term 21,5072767505,Term 20,7024275269,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익(손실),-,Term 22,417769360752,Term 21,1187364858585,Term 20,1121074272313,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 22,159429313871,Term 21,326237006705,Term 20,307973132289,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 22,258340046881,Term 21,861127851880,Term 20,813101140024,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 22,236572425808,Term 21,844523495741,Term 20,797628672879,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배지분,-,Term 22,21767621073,Term 21,16604356139,Term 20,15472467145,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_BasicEarningsLossPerShare,기본 및 희석 보통주당이익,-,Term 22,14112,Term 21,50395,Term 20,47596,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_DilutedEarningsLossPerShare,기본 및 희석 우선주당이익,-,Term 22,14162,Term 21,50445,Term 20,47647,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 22,258340046881,Term 21,861127851880,Term 20,813101140024,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 22,7014594733,Term 21,79793999467,Term 20,-10164589640,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되지 않는 항목,-,Term 22,24289540593,Term 21,18624875033,Term 20,17224431473,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),-,Term 22,24289767415,Term 21,18774536960,Term 20,18549466745,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,-,Term 22,-197326822,Term 21,-149661927,Term 20,-1327783683,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,-,Term 22,197100000,Term 21,0,Term 20,2748411,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax,당기손익으로 재분류될 수 있는 항목(세후기타포괄손익),-,Term 22,-17274945860,Term 21,61169124434,Term 20,-27389021113,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,dart_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법 적용대상 관계기업과 공동기업의 기타포괄손익에 대한 지분(세후기타포괄손익),-,Term 22,21944749,Term 21,234458815,Term 20,-215096850,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업장환산외환차이(세후기타포괄손익),-,Term 22,-17296890609,Term 21,60934665619,Term 20,-27173924263,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄손익,-,Term 22,265354641614,Term 21,940921851347,Term 20,802936550384,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 22,240888502176,Term 21,922666603722,Term 20,787456912990,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배지분,-,Term 22,24466139438,Term 21,18255247625,Term 20,15479637394,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동현금흐름,-,Term 22,497299483100,Term 21,984481666368,Term 20,1004842472035,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_ProfitLossForStatementOfCashFlows,당기순이익(손실),-,Term 22,258340046881,Term 21,861127851880,Term 20,813101140024,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,수익ㆍ비용의가감,-,Term 22,678770999043,Term 21,655594377448,Term 20,626194542524,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForDepreciationExpense,감가상각비,-,Term 22,246887613016,Term 21,240917419595,Term 20,233925508629,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 22,41092465637,Term 21,34129748348,Term 20,28295853267,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 22,48421103671,Term 21,50413856656,Term 20,50474494996,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비,-,Term 22,-428896863,Term 21,3729253285,Term 20,595482883,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 22,14830609188,Term 21,12537198896,Term 20,12507879942,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 22,5088997246,Term 21,1233674337,Term 20,2555055538,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 평가손실,-,Term 22,6732536253,Term 21,4921968498,Term 20,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융부채 평가손실,-,Term 22,0,Term 21,1380318713,Term 20,2431280464,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 평가이익,-,Term 22,-4632564558,Term 21,-1582418788,Term 20,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융부채 평가이익,-,Term 22,0,Term 21,-255798240,Term 20,-3205933336,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 처분손실,-,Term 22,0,Term 21,0,Term 20,22428828,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 22,3417665095,Term 21,4947235977,Term 20,7796049548,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfInvestmentProperty,투자부동산처분손실,-,Term 22,36425687,Term 21,0,Term 20,122712135,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfIntangibleAssets,무형자산처분손실,-,Term 22,3010429856,Term 21,700100092,Term 20,1179758364,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분손실,-,Term 22,61581730,Term 21,87136919,Term 20,12559557,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfPropertyPlantAndEquipment,유형자산손상차손,-,Term 22,6796472886,Term 21,3695340823,Term 20,958695011,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,투자부동산손상차손,-,Term 22,0,Term 21,0,Term 20,2723414919,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfIntangibleAssets,무형자산손상차손,-,Term 22,177834742877,Term 21,563290248,Term 20,56925461,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산손상차손,-,Term 22,12183534981,Term 21,338700185,Term 20,0,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 22,159429313871,Term 21,326237006705,Term 20,307973132289,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestIncome,이자수익,-,Term 22,11331601645,Term 21,5680872283,Term 20,4984491548,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,배당금수익,-,Term 22,0,Term 21,-186600000,Term 20,-933000000,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타의 대손상각비,-,Term 22,-197792932,Term 21,-1135147924,Term 20,120354050,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 22,3011356217,Term 21,1645379301,Term 20,1444637923,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentsInAssociates,종속기업/관계기업/공동기업투자처분이익,-,Term 22,38088456,Term 21,6259434084,Term 20,0,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 22,20139865677,Term 21,7882228803,Term 20,3539815333,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentProperty,투자부동산처분이익,-,Term 22,146808846,Term 21,424275509,Term 20,3740590000,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfIntangibleAssets,무형자산처분이익,-,Term 22,93183291,Term 21,31400000,Term 20,466778724,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분이익,-,Term 22,74404968,Term 21,50260469,Term 20,217521224,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForProfitsOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 22,6957929498,Term 21,5072767505,Term 20,7024275269,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForBargainPurchaseGains,염가매수차익,-,Term 22,0,Term 21,31288923,Term 20,0,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업활동으로인한자산ㆍ부채의변동,-,Term 22,-199657616423,Term 21,-232237308874,Term 20,-97771906662,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable,매출채권,-,Term 22,12853602709,Term 21,48830535465,Term 20,22475967366,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInTradeAndOtherReceivables,기타채권,-,Term 22,-11283101681,Term 21,7439955809,Term 20,4352829222,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산,-,Term 22,62013447364,Term 21,-147805686623,Term 20,-67826527783,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산,-,Term 22,11453506140,Term 21,3246409858,Term 20,12117381977,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,기타비유동자산,-,Term 22,-3913036948,Term 21,-5825558786,Term 20,-7901977197,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable,매입채무,-,Term 22,-65158003482,Term 21,5129900386,Term 20,-30067851787,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInTradeAndOtherPayables,기타채무,-,Term 22,-49816791137,Term 21,-31106874116,Term 20,22469667835,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,환불부채,-,Term 22,481980735,Term 21,-3017943114,Term 20,-549255134,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 22,-72237655740,Term 21,-12476452211,Term 20,-12986505720,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채,-,Term 22,-33973949285,Term 21,-33517901510,Term 20,-8576068399,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInWithholdingsBanks,예수보증금,-,Term 22,5859634835,Term 21,-1293303890,Term 20,-554689404,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,퇴직금의 지급,-,Term 22,5830223526,Term 21,4891083551,Term 20,7374041609,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInPostemploymentBenefitObligations,퇴직급여부채의 관계사 전입,-,Term 22,129783254,Term 21,561746152,Term 20,825666713,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInFairValueOfPlanAssets,사외적립자산의 기여,-,Term 22,-44570790774,Term 21,-55921334529,Term 20,-54936455806,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherNonCurrentLiabilities,기타비유동부채,-,Term 22,-5666018887,Term 21,-1589718214,Term 20,30759953064,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자수취(영업),-,Term 22,9693585964,Term 21,4850875119,Term 20,4959977013,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsOperatingActivities,배당금수취(영업),-,Term 22,6013497709,Term 21,6384911352,Term 20,4227270000,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자지급(영업),-,Term 22,11779250888,Term 21,7982482336,Term 20,8700381507,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세납부(환급),-,Term 22,244081779186,Term 21,303256558221,Term 20,337168169357,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동현금흐름,-,Term 22,-197383721806,Term 21,-465122432772,Term 20,-745883641217,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,단기금융상품의 감소,-,Term 22,83471000000,Term 21,42000000000,Term 20,76200000999,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,단기기타채권의 감소,-,Term 22,4352892626,Term 21,7150005783,Term 20,894557167,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,장기금융상품의 감소,-,Term 22,0,Term 21,0,Term 20,4000000,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,장기기타채권의 감소,-,Term 22,3953324404,Term 21,2286461472,Term 20,9748658623,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,기타포괄손익-공정가치 측정 금융자산의 처분,-,Term 22,197100000,Term 21,0,Term 20,0,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,기타비유동금융자산의 감소,-,Term 22,0,Term 21,0,Term 20,1173000000,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentsInAssociates,관계기업에 대한 투자자산의 처분,-,Term 22,0,Term 21,16943803,Term 20,0,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 22,34405002695,Term 21,17970989609,Term 20,6797791333,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 22,576520000,Term 21,2360000000,Term 20,4760000000,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 22,4640939909,Term 21,270342552,Term 20,9906597662,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities,정부보조금의 수취,-,Term 22,19110000,Term 21,253700000,Term 20,0,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,종속기업 처분으로 인한 순현금유입액,-,Term 22,0,Term 21,7364927342,Term 20,0,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,단기금융상품의 증가,-,Term 22,7200000000,Term 21,76229000000,Term 20,62500000000,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,단기기타채권의 증가,-,Term 22,751760126,Term 21,696100059,Term 20,178968162,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,장기기타채권의 증가,-,Term 22,2028968475,Term 21,4563158125,Term 20,3927857300,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,기타포괄손익-공정가치 측정 금융자산의 취득,-,Term 22,536445000,Term 21,0,Term 20,0,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 22,157045694758,Term 21,321874697496,Term 20,505743484068,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_PurchaseOfInvestmentProperty,투자부동산의 취득,-,Term 22,0,Term 21,12528920,Term 20,0,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 22,9391190370,Term 21,10312236474,Term 20,13128703763,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합으로 인한 순현금 유출,-,Term 22,152045552711,Term 21,131108082259,Term 20,269889233708,74,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동현금흐름,-,Term 22,-373633368656,Term 21,-238400403869,Term 20,-465737759835,75,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 차입,-,Term 22,319949820109,Term 21,211508361822,Term 20,96944735692,76,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_ProceedsFromLongTermBorrowings,장기차입금의 차입,-,Term 22,5000000000,Term 21,0,Term 20,22736389421,77,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,종속기업의 유상증자,-,Term 22,0,Term 21,120000000,Term 20,0,78,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 상환,-,Term 22,364155453328,Term 21,160451258420,Term 20,194202086120,79,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities,유동성장기차입금의 상환,-,Term 22,5708202529,Term 21,3578572000,Term 20,3567121000,80,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_RepaymentsOfBonds,유동성사채의 상환,-,Term 22,30000000000,Term 21,0,Term 20,100000000000,81,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_PaymentsOfFinanceLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 지급,-,Term 22,85831436888,Term 21,85093142807,Term 20,91236233038,82,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries,종속기업투자의 취득,-,Term 22,11723995920,Term 21,14770273001,Term 20,0,83,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금지급,-,Term 22,201164100100,Term 21,186135519463,Term 20,196413444790,84,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,환율변동효과 반영전 현금및현금성자산의 순증가(감소),-,Term 22,-73717607362,Term 21,280958829727,Term 20,-206778929017,85,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초현금및현금성자산,-,Term 22,734520611733,Term 21,434105464098,Term 20,647104059171,86,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,현금및현금성자산에 대한 환율변동효과,-,Term 22,-77301,Term 21,325780165,Term 20,-300879719,87,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,해외사업환산차이,-,Term 22,-5710363992,Term 21,19130537743,Term 20,-5918786337,88,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말현금및현금성자산,-,Term 22,655092563078,Term 21,734520611733,Term 20,434105464098,89,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 22,88589470000,Term 21,88589470000,Term 20,88589470000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,5484022033744,Term 21,4805404131407,Term 20,4174881534589,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 22,-64495577286,Term 21,-124122981721,Term 20,-96636000943,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 22,97325737783,Term 21,97325737783,Term 20,97325737783,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 22,5497832811356,Term 21,4849195698865,Term 20,4237087665136,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배지분 [member],Term 22,109822657026,Term 21,93216194376,Term 20,90353924957,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,5388010154330,Term 21,4755979504489,Term 20,4146733740179,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 22,-217431509911,Term 21,-111216852980,Term 20,-117427001250,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,236572425808,Term 21,844523495741,Term 20,797628672879,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 22,258340046881,Term 21,861127851880,Term 20,813101140024,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,236572425808,Term 21,844523495741,Term 20,797628672879,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|비지배지분 [member],Term 22,21767621073,Term 21,16604356139,Term 20,15472467145,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,연결재무제표 [member],Term 22,24289767415,Term 21,18774536960,Term 20,18549466745,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|비지배지분 [member],Term 22,1457101023,Term 21,258833414,Term 20,237005392,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,22832666392,Term 21,18515703546,Term 20,18312461353,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,22832666392,Term 21,18515703546,Term 20,18312461353,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 22,-197326822,Term 21,-149661927,Term 20,-1327783683,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,-197326822,Term 21,-149661927,Term 20,-1327783683,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,연결재무제표 [member],Term 22,-197326822,Term 21,-149661927,Term 20,-1327783683,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,197100000,Term 21,,Term 20,2748411,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,197100000,Term 21,,Term 20,2748411,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,연결재무제표 [member],Term 22,197100000,Term 21,,Term 20,2748411,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분으로 인한 재분류,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 22,,Term 21,,Term 20,999988875,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분으로 인한 재분류,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,,Term 21,,Term 20,-999988875,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,연결재무제표 [member],Term 22,21944749,Term 21,234458815,Term 20,-215096850,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,21944749,Term 21,234458815,Term 20,-215096850,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 22,21944749,Term 21,234458815,Term 20,-215096850,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,연결재무제표 [member],Term 22,-17296890609,Term 21,60934665619,Term 20,-27173924263,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|비지배지분 [member],Term 22,1241417342,Term 21,1392058072,Term 20,-229835143,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 22,-18538307951,Term 21,59542607547,Term 20,-26944089120,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,-18538307951,Term 21,59542607547,Term 20,-26944089120,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,201177340950,Term 21,184421296950,Term 20,184421296950,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|비지배지분 [member],Term 22,,Term 21,,Term 20,12000000000,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,연결재무제표 [member],Term 22,201177340950,Term 21,184421296950,Term 20,196421296950,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,201177340950,Term 21,184421296950,Term 20,184421296950,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 22,-88438765654,Term 21,-106214656931,Term 20,6210148270,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,-88438765654,Term 21,-106214656931,Term 20,6210148270,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|비지배지분 [member],Term 22,-4735358117,Term 21,-1648784975,Term 20,-617367975,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,연결재무제표 [member],Term 22,-93174123771,Term 21,-107863441906,Term 20,5592780295,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 22,97325737783,Term 21,97325737783,Term 20,97325737783,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 22,88589470000,Term 21,88589470000,Term 20,88589470000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,5542446884994,Term 21,5484022033744,Term 20,4805404131407,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 22,-83209267310,Term 21,-64495577286,Term 20,-124122981721,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 22,-305870275565,Term 21,-217431509911,Term 20,-111216852980,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,5339282549902,Term 21,5388010154330,Term 20,4755979504489,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 22,5468835988249,Term 21,5497832811356,Term 20,4849195698865,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|비지배지분 [member],Term 22,129553438347,Term 21,109822657026,Term 20,93216194376,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 23,7220285811725,Term 22,7302929652203,Term 21,7555239417717,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 23,2429583603574,Term 22,2284388637755,Term 21,2472884295774,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 23,910348037982,Term 22,655092563078,Term 21,734520611733,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CurrentTradeReceivables,매출채권,-,Term 23,529076344154,Term 22,550861505948,Term 21,554857050527,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 23,884515142151,Term 22,955432614662,Term 21,1000655942465,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentAssets,기타유동자산,-,Term 23,45271354734,Term 22,46315326894,Term 21,48565822995,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 23,5508065693,Term 22,2687794247,Term 21,824675343,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentReceivables,기타채권,-,Term 23,38386687660,Term 22,52024002526,Term 21,38107743911,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents,단기금융상품,-,Term 23,16477971200,Term 22,21974830400,Term 21,95352448800,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 23,4790702208151,Term 22,5018541014448,Term 21,5082355121943,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 23,34125353691,Term 22,52397079036,Term 21,38593929168,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_IntangibleAssetsAndGoodwill,무형자산,-,Term 23,2007877629243,Term 22,2100587252176,Term 21,2168719935017,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_InvestmentAccountedForUsingEquityMethod,관계기업및공동기업투자,-,Term 23,61771210888,Term 22,60146908565,Term 21,59167859842,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 23,45974090552,Term 22,25933611138,Term 21,30129279961,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_LongtermDeposits,장기금융상품,-,Term 23,23000000,Term 22,23000000,Term 21,20000000,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentAssets,기타비유동자산,-,Term 23,70587172824,Term 22,109759853810,Term 21,54820901832,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 23,79877043683,Term 22,64367260770,Term 21,28409958922,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentReceivables,장기기타채권,-,Term 23,31032978196,Term 22,40637972467,Term 21,49092915577,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 23,2307114070178,Term 22,2383867277039,Term 21,2449112181346,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 23,152319658896,Term 22,180820799447,Term 21,204288160278,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 23,5548926465800,Term 22,5468835988249,Term 21,5497832811356,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업소유주지분,-,Term 23,5433451058889,Term 22,5339282549902,Term 21,5388010154330,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 23,97325737783,Term 22,97325737783,Term 21,97325737783,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본항목,-,Term 23,-260224352418,Term 22,-305870275565,Term 21,-217431509911,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_AccumulatedOtherComprehensiveIncome,기타포괄손익누계액,-,Term 23,-96665276609,Term 22,-83209267310,Term 21,-64495577286,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 23,88589470000,Term 22,88589470000,Term 21,88589470000,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 23,5604425480133,Term 22,5542446884994,Term 21,5484022033744,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배지분,-,Term 23,115475406911,Term 22,129553438347,Term 21,109822657026,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채와 자본 총계,-,Term 23,7220285811725,Term 22,7302929652203,Term 21,7555239417717,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 23,1089658847771,Term 22,1162757522705,Term 21,1525844759254,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,-Standard account code not used-,단기차입금,-,Term 23,138182509535,Term 22,215544469417,Term 21,256676145850,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,-Standard account code not used-,유동성장기차입금,-,Term 23,7790336487,Term 22,7504919540,Term 21,5460181804,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CurrentBondsIssuedAndCurrentPortionOfNoncurrentBondsIssued,유동성사채,-,Term 23,0,Term 22,0,Term 21,29999983840,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CurrentRefundsProvision,환불부채,-,Term 23,11578946312,Term 22,13339134213,Term 21,12875692276,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 23,45524846342,Term 22,102379416709,Term 21,188801478806,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 23,309681059345,Term 22,248426155665,Term 21,330577242027,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentLiabilities,기타 유동부채,-,Term 23,96798747084,Term 22,120572379988,Term 21,131222372585,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentPayables,기타채무,-,Term 23,226704100602,Term 22,241803567987,Term 21,299660142515,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers,매입채무,-,Term 23,253398302064,Term 22,213187479186,Term 21,270571519551,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 23,1671359345925,Term 22,1834093663954,Term 21,2057406606361,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 23,581700498154,Term 22,671336141249,Term 21,531561847107,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,-Standard account code not used-,예수보증금,-,Term 23,9741129137,Term 22,10200769679,Term 21,3895493609,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 23,147859534986,Term 22,165223257419,Term 21,121735464959,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_NoncurrentPortionOfNoncurrentLoansReceived,장기차입금,-,Term 23,1993443590,Term 22,14783780077,Term 21,17341601617,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan,퇴직급여부채,-,Term 23,57381078977,Term 22,63616144843,Term 21,51421810319,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialLiabilities,기타비유동금융부채,-,Term 23,317768045372,Term 22,375094983970,Term 21,263149536421,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentLiabilities,기타 비유동 부채,-,Term 23,46957266092,Term 22,42417205261,Term 21,74017940182,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,dart_OperatingIncomeLoss,영업이익,-,Term 23,486981224742,Term 22,711122934369,Term 21,1289630423605,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,dart_OtherGains,기타영업외수익,-,Term 23,46582397077,Term 22,58855764285,Term 21,54382716863,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,dart_OtherLosses,기타영업외비용,-,Term 23,274827614677,Term 22,353493663488,Term 21,148406751184,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_CostOfSales,매출원가,-,Term 23,3177921081645,Term 22,3168512092765,Term 21,3039883555040,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,-Standard account code not used-,기본 우선주당이익,-,Term 23,8563,Term 22,14162,Term 21,50445,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,-Standard account code not used-,희석 우선주당이익,-,Term 23,8563,Term 22,14162,Term 21,50445,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_BasicEarningsLossPerShare,기본 보통주당이익,-,Term 23,8513,Term 22,14112,Term 21,50395,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_DilutedEarningsLossPerShare,희석 보통주당이익,-,Term 23,8513,Term 22,14112,Term 21,50395,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_FinanceCosts,금융원가,-,Term 23,39052274245,Term 22,27261631668,Term 21,22886303361,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_FinanceIncome,금융수익,-,Term 23,48968915334,Term 22,21588027756,Term 21,9572005157,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_GrossProfit,매출총이익,-,Term 23,3626918288484,Term 22,4017247091570,Term 21,5051627742921,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 23,112859158403,Term 22,159429313871,Term 21,326237006705,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 23,163524219980,Term 22,258340046881,Term 21,861127851880,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배지분,-,Term 23,20768740624,Term 22,21767621073,Term 21,16604356139,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 23,142755479356,Term 22,236572425808,Term 21,844523495741,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 23,276383378383,Term 22,417769360752,Term 21,1187364858585,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_Revenue,매출액,-,Term 23,6804839370129,Term 22,7185759184335,Term 21,8091511297961,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_SellingGeneralAndAdministrativeExpense,판매비와관리비,-,Term 23,3139937063742,Term 22,3306124157201,Term 21,3761997319316,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 23,7730730152,Term 22,6957929498,Term 21,5072767505,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄이익,-,Term 23,136065139024,Term 22,265354641614,Term 21,940921851347,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배지분,-,Term 23,20413564234,Term 22,24466139438,Term 21,18255247625,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 23,115651574790,Term 22,240888502176,Term 21,922666603722,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 23,-27459080956,Term 22,7014594733,Term 21,79793999467,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되는 항목,-,Term 23,-12966067430,Term 22,-17274945860,Term 21,61169124434,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업환산손익,-,Term 23,-14468688939,Term 22,-17296890609,Term 21,60934665619,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,-,Term 23,1502621509,Term 22,21944749,Term 21,234458815,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되지 않는 항목,-,Term 23,-14493013526,Term 22,24289540593,Term 21,18624875033,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,-,Term 23,-44771090,Term 22,-226822,Term 21,-149661927,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,-,Term 23,-14448242436,Term 22,24289767415,Term 21,18774536960,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 23,163524219980,Term 22,258340046881,Term 21,861127851880,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초의 현금및현금성자산,-,Term 23,655092563078,Term 22,734520611733,Term 21,434105464098,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말의 현금및현금성자산,-,Term 23,910348037982,Term 22,655092563078,Term 21,734520611733,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동으로 인한 현금흐름,-,Term 23,-268201685330,Term 22,-373633368656,Term 21,-238400403869,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_PaymentForConsolidatedCapitalTransactions,연결자본거래로 인한 변동,-,Term 23,12182000,Term 22,0,Term 21,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,재무활동으로 인한 현금유입액,-,Term 23,68752436418,Term 22,324949820109,Term 21,211628361822,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,재무활동으로 인한 현금유출액,-,Term 23,336954121748,Term 22,698583188765,Term 21,450028765691,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,예수보증금의 수령,-,Term 23,2281004811,Term 22,0,Term 21,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,장기차입금의 차입,-,Term 23,0,Term 22,5000000000,Term 21,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,유동성장기차입금의 상환,-,Term 23,12504919540,Term 22,5708202529,Term 21,3578572000,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,예수보증금의 지급,-,Term 23,2285992867,Term 22,0,Term 21,0,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금의 지급,-,Term 23,97124600150,Term 22,201164100100,Term 21,186135519463,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries,비지배지분의 취득,-,Term 23,0,Term 22,11723995920,Term 21,14770273001,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 지급,-,Term 23,77523016101,Term 22,85831436888,Term 21,85093142807,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests,종속기업의 유상증자,-,Term 23,0,Term 22,0,Term 21,120000000,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromCurrentBorrowings,단기차입금의 차입,-,Term 23,66471431607,Term 22,319949820109,Term 21,211508361822,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfBondsNotesAndDebentures,유동성사채의 상환,-,Term 23,0,Term 22,30000000000,Term 21,0,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfCurrentBorrowings,단기차입금의 상환,-,Term 23,147503411090,Term 22,364155453328,Term 21,160451258420,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동으로 인한 현금흐름,-,Term 23,-140774747630,Term 22,-197383721806,Term 21,-465122432772,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익-공정가치 측정 금융자산의 감소,-,Term 23,147444361,Term 22,0,Term 21,0,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치 측정 금융자산의 처분,-,Term 23,0,Term 22,197100000,Term 21,0,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentsInSubsidiaries,종속기업 처분으로 인한 순현금유입액,-,Term 23,0,Term 22,0,Term 21,7364927342,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfLongTermLoansAndReceivables,장기기타채권의 감소,-,Term 23,13569453414,Term 22,3953324404,Term 21,2286461472,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfNonCurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정자산의 처분,-,Term 23,10607576553,Term 22,0,Term 21,0,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfShortTermFinancialInstruments,단기금융상품의 감소,-,Term 23,5518167924,Term 22,83471000000,Term 21,42000000000,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfShortTermLoansAndReceivables,단기기타채권의 감소,-,Term 23,2003884990,Term 22,4352892626,Term 21,7150005783,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익-공정가치 측정 금융자산의 취득,-,Term 23,1406880000,Term 22,0,Term 21,0,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_PurchaseOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산의취득,-,Term 23,0,Term 22,536445000,Term 21,0,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_PurchaseOfLongTermLoansAndReceivables,장기기타채권의 증가,-,Term 23,2495184656,Term 22,2028968475,Term 21,4563158125,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_PurchaseOfShortTermFinancialInstruments,단기금융상품의 증가,-,Term 23,0,Term 22,7200000000,Term 21,76229000000,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_PurchaseOfShortTermLoansAndReceivables,단기기타채권의 증가,-,Term 23,891463446,Term 22,751760126,Term 21,696100059,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합으로 인한 순현금유출액,-,Term 23,42226006685,Term 22,152045552711,Term 21,131108082259,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_InflowsOfCashFromInvestingActivities,투자활동으로 인한 현금유입액,-,Term 23,69758341538,Term 22,131615889634,Term 21,79673370561,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities,공동기업투자의 처분,-,Term 23,4472515425,Term 22,0,Term 21,16943803,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_OutflowsOfCashFromInvestingActivities,투자활동으로 인한 현금유출액,-,Term 23,210533089168,Term 22,328999611440,Term 21,544795803333,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities,국고보조금의 수취,-,Term 23,297900000,Term 22,19110000,Term 21,253700000,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 23,798429624,Term 22,4640939909,Term 21,270342552,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 23,10078205814,Term 22,576520000,Term 21,2360000000,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 23,22264763433,Term 22,34405002695,Term 21,17970989609,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 23,11095215663,Term 22,9391190370,Term 21,10312236474,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfInvestmentProperty,투자부동산의 취득,-,Term 23,0,Term 22,0,Term 21,12528920,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 23,152418338718,Term 22,157045694758,Term 21,321874697496,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동으로 인한 현금흐름,-,Term 23,659061627244,Term 22,497299483100,Term 21,984481666368,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업활동으로 인한 자산부채의 변동,-,Term 23,113424453984,Term 22,-199657616423,Term 21,-232237308874,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInOtherNonCurrentNonFinancialAssets,기타비유동자산,-,Term 23,-3529410936,Term 22,-3913036948,Term 21,-5825558786,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherNonCurrentLiabilities,기타비유동부채,-,Term 23,5973809642,Term 22,-5666018887,Term 21,-1589718214,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInProvisionsForReturnedGoods,환불부채,-,Term 23,-1781499741,Term 22,481980735,Term 21,-3017943114,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 23,45642050773,Term 22,-72237655740,Term 21,-12476452211,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,퇴직급여부채의 관계사 전입,-,Term 23,63983179,Term 22,129783254,Term 21,561746152,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,예수보증금,-,Term 23,34324,Term 22,5859634835,Term 21,-1293303890,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산,-,Term 23,75399386528,Term 22,62013447364,Term 21,-147805686623,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산,-,Term 23,7783706027,Term 22,11453506140,Term 21,3246409858,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables,기타채권,-,Term 23,12235677287,Term 22,-11283101681,Term 21,7439955809,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable,매출채권,-,Term 23,23545052313,Term 22,12853602709,Term 21,48830535465,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채,-,Term 23,-27241015124,Term 22,-33973949285,Term 21,-33517901510,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInOtherOperatingPayables,기타채무,-,Term 23,-30530710825,Term 22,-49816791137,Term 21,-31106874116,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable,매입채무,-,Term 23,39379494117,Term 22,-65158003482,Term 21,5129900386,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset,사외적립자산,-,Term 23,26599447041,Term 22,44570790774,Term 21,55921334529,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset,퇴직금의 지급,-,Term 23,6916656539,Term 22,5830223526,Term 21,4891083551,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,수익ㆍ비용의가감,-,Term 23,536269020585,Term 22,678770999043,Term 21,655594377448,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비(대손충당금환입),-,Term 23,1294475720,Term 22,-428896863,Term 21,3729253285,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForBargainPurchaseGains,염가매수차익,-,Term 23,0,Term 22,0,Term 21,31288923,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 23,12574109819,Term 22,20139865677,Term 21,7882228803,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 23,2168413249,Term 22,3011356217,Term 21,1645379301,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfIntangibleAssets,무형자산처분이익,-,Term 23,138768242,Term 22,93183291,Term 21,31400000,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentProperty,투자부동산처분이익,-,Term 23,4648837954,Term 22,146808846,Term 21,424275509,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정자산처분이익,-,Term 23,2775048994,Term 22,0,Term 21,0,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치 측정 금융자산 평가이익,-,Term 23,18722387548,Term 22,4632564558,Term 21,1582418788,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfIntangibleAssets,무형자산손상차손,-,Term 23,112204887141,Term 22,177834742877,Term 21,563290248,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfPropertyPlantAndEquipment,유형자산손상차손,-,Term 23,6555409177,Term 22,6796472886,Term 21,3695340823,74,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 23,19366715671,Term 22,14830609188,Term 21,12537198896,75,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfIntangibleAssets,무형자산처분손실,-,Term 23,6390206970,Term 22,3010429856,Term 21,700100092,76,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfInvestmentProperty,투자부동산처분손실,-,Term 23,10751933,Term 22,36425687,Term 21,0,77,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 23,9405747018,Term 22,3417665095,Term 21,4947235977,78,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치 측정 금융자산 평가손실,-,Term 23,14582257107,Term 22,6732536253,Term 21,4921968498,79,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 23,3588155054,Term 22,5088997246,Term 21,1233674337,80,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 23,43856005073,Term 22,48421103671,Term 21,50413856656,81,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForReversalsOfBadDebtExpenses,기타대손충당금환입,-,Term 23,181795254,Term 22,197792932,Term 21,1135147924,82,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_GainsOnDisposalsOfFairValueFinancialAsset,당기손익-공정가치 측정 금융자산 처분이익,-,Term 23,3016089,Term 22,0,Term 21,0,83,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_GainsOnSaleOfInvestmentsInSubsidiaries,종속기업처분이익,-,Term 23,0,Term 22,38088456,Term 21,6259434084,84,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_GainsOnValuationOfFairValueFinancialLiabilities,당기손익-공정가치 측정 금융부채 평가이익,-,Term 23,0,Term 22,0,Term 21,255798240,85,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ImpairmentLossesOnInvestmentProperty,투자부동산손상차손,-,Term 23,896541999,Term 22,0,Term 21,0,86,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_LossesOnValuationOfFairValueFinancialLiabilities,당기손익-공정가치 측정 금융부채 평가손실,-,Term 23,5481920,Term 22,0,Term 21,1380318713,87,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분이익,-,Term 23,3395246737,Term 22,74404968,Term 21,50260469,88,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분손실,-,Term 23,242452048,Term 22,61581730,Term 21,87136919,89,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,공동기업처분이익,-,Term 23,2062573050,Term 22,0,Term 21,0,90,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산손상차손,-,Term 23,16070474902,Term 22,12183534981,Term 21,338700185,91,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 23,37773195056,Term 22,41092465637,Term 21,34129748348,92,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDepreciationExpense,감가상각비,-,Term 23,232093988438,Term 22,246887613016,Term 21,240917419595,93,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 23,112859158403,Term 22,159429313871,Term 21,326237006705,94,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForInterestIncome,이자수익,-,Term 23,26357835957,Term 22,11331601645,Term 21,5680872283,95,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_RevenueFromDividends,배당금수익,-,Term 23,168120000,Term 22,0,Term 21,186600000,96,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 23,7730730152,Term 22,6957929498,Term 21,5072767505,97,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsOperatingActivities,배당금의 수취,-,Term 23,5895060000,Term 22,6013497709,Term 21,6384911352,98,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세의 납부,-,Term 23,166490102118,Term 22,244081779186,Term 21,303256558221,99,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자의 지급,-,Term 23,16147404861,Term 22,11779250888,Term 21,7982482336,100,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 23,22586379674,Term 22,9693585964,Term 21,4850875119,101,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 23,163524219980,Term 22,258340046881,Term 21,861127851880,102,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,외화환산으로 인한 현금및현금성자산의 변동,-,Term 23,5170280620,Term 22,-5710441293,Term 21,19456317908,103,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,현금및현금성자산의 증가(감소),-,Term 23,250085194284,Term 22,-73717607362,Term 21,280958829727,104,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 23,5468835988249,Term 22,5497832811356,Term 21,4849195698865,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|비지배지분 [구성요소],Term 23,129553438347,Term 22,109822657026,Term 21,93216194376,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,5339282549902,Term 22,5388010154330,Term 21,4755979504489,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,-305870275565,Term 22,-217431509911,Term 21,-111216852980,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,-83209267310,Term 22,-64495577286,Term 21,-124122981721,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,5542446884994,Term 22,5484022033744,Term 21,4805404131407,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,88589470000,Term 22,88589470000,Term 21,88589470000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,97325737783,Term 22,97325737783,Term 21,97325737783,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,67128988950,Term 22,201177340950,Term 21,184421296950,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|비지배지분 [구성요소],Term 23,30000000000,Term 22,0,Term 21,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,연결재무제표 [member],Term 23,97128988950,Term 22,201177340950,Term 21,184421296950,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,0,Term 22,0,Term 21,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,67128988950,Term 22,201177340950,Term 21,184421296950,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,0,Term 22,0,Term 21,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,연결재무제표 [member],Term 23,5548926465800,Term 22,5468835988249,Term 21,5497832811356,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|비지배지분 [구성요소],Term 23,115475406911,Term 22,129553438347,Term 21,109822657026,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,5433451058889,Term 22,5339282549902,Term 21,5388010154330,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,88589470000,Term 22,88589470000,Term 21,88589470000,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,5604425480133,Term 22,5542446884994,Term 21,5484022033744,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,-96665276609,Term 22,-83209267310,Term 21,-64495577286,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,-260224352418,Term 22,-305870275565,Term 21,-217431509911,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,97325737783,Term 22,97325737783,Term 21,97325737783,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,45645923147,Term 22,-88438765654,Term 21,-106214656931,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|비지배지분 [구성요소],Term 23,-4491595670,Term 22,-4735358117,Term 21,-1648784975,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,연결재무제표 [member],Term 23,41154327477,Term 22,-93174123771,Term 21,-107863441906,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,45645923147,Term 22,-88438765654,Term 21,-106214656931,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,0,Term 22,0,Term 21,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,-14905028256,Term 22,-18538307951,Term 21,59542607547,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|비지배지분 [구성요소],Term 23,436339317,Term 22,1241417342,Term 21,1392058072,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,연결재무제표 [member],Term 23,-14468688939,Term 22,-17296890609,Term 21,60934665619,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,0,Term 22,0,Term 21,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,-14905028256,Term 22,-18538307951,Term 21,59542607547,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,-45654236,Term 22,-226822,Term 21,-149661927,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|비지배지분 [구성요소],Term 23,883146,Term 22,0,Term 21,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,연결재무제표 [member],Term 23,-44771090,Term 22,-226822,Term 21,-149661927,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,0,Term 22,0,Term 21,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,7948316,Term 22,197100000,Term 21,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,-53602552,Term 22,-197326822,Term 21,-149661927,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,연결재무제표 [member],Term 23,-14448242436,Term 22,24289767415,Term 21,18774536960,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|비지배지분 [구성요소],Term 23,-792398853,Term 22,1457101023,Term 21,258833414,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,-13655843583,Term 22,22832666392,Term 21,18515703546,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,0,Term 22,0,Term 21,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,0,Term 22,0,Term 21,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,-13655843583,Term 22,22832666392,Term 21,18515703546,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 23,163524219980,Term 22,258340046881,Term 21,861127851880,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|비지배지분 [구성요소],Term 23,20768740624,Term 22,21767621073,Term 21,16604356139,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,142755479356,Term 22,236572425808,Term 21,844523495741,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,0,Term 22,0,Term 21,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,0,Term 22,0,Term 21,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,142755479356,Term 22,236572425808,Term 21,844523495741,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,연결재무제표 [member],Term 23,1502621509,Term 22,21944749,Term 21,234458815,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|비지배지분 [구성요소],Term 23,0,Term 22,0,Term 21,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,1502621509,Term 22,21944749,Term 21,234458815,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,1502621509,Term 22,21944749,Term 21,234458815,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,0,Term 22,0,Term 21,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 23,7220285811725,Term 22,7302929652203,Term 21,7555239417717,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 23,2429583603574,Term 22,2284388637755,Term 21,2472884295774,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 23,910348037982,Term 22,655092563078,Term 21,734520611733,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CurrentTradeReceivables,매출채권,-,Term 23,529076344154,Term 22,550861505948,Term 21,554857050527,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 23,884515142151,Term 22,955432614662,Term 21,1000655942465,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentAssets,기타유동자산,-,Term 23,45271354734,Term 22,46315326894,Term 21,48565822995,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 23,5508065693,Term 22,2687794247,Term 21,824675343,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentReceivables,기타채권,-,Term 23,38386687660,Term 22,52024002526,Term 21,38107743911,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents,단기금융상품,-,Term 23,16477971200,Term 22,21974830400,Term 21,95352448800,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 23,4790702208151,Term 22,5018541014448,Term 21,5082355121943,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 23,34125353691,Term 22,52397079036,Term 21,38593929168,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_IntangibleAssetsAndGoodwill,무형자산,-,Term 23,2007877629243,Term 22,2100587252176,Term 21,2168719935017,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_InvestmentAccountedForUsingEquityMethod,관계기업및공동기업투자,-,Term 23,61771210888,Term 22,60146908565,Term 21,59167859842,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 23,45974090552,Term 22,25933611138,Term 21,30129279961,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_LongtermDeposits,장기금융상품,-,Term 23,23000000,Term 22,23000000,Term 21,20000000,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentAssets,기타비유동자산,-,Term 23,70587172824,Term 22,109759853810,Term 21,54820901832,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 23,79877043683,Term 22,64367260770,Term 21,28409958922,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentReceivables,장기기타채권,-,Term 23,31032978196,Term 22,40637972467,Term 21,49092915577,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 23,2307114070178,Term 22,2383867277039,Term 21,2449112181346,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 23,152319658896,Term 22,180820799447,Term 21,204288160278,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 23,5548926465800,Term 22,5468835988249,Term 21,5497832811356,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업소유주지분,-,Term 23,5433451058889,Term 22,5339282549902,Term 21,5388010154330,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 23,97325737783,Term 22,97325737783,Term 21,97325737783,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본항목,-,Term 23,-260224352418,Term 22,-305870275565,Term 21,-217431509911,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_AccumulatedOtherComprehensiveIncome,기타포괄손익누계액,-,Term 23,-96665276609,Term 22,-83209267310,Term 21,-64495577286,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 23,88589470000,Term 22,88589470000,Term 21,88589470000,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 23,5604425480133,Term 22,5542446884994,Term 21,5484022033744,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배지분,-,Term 23,115475406911,Term 22,129553438347,Term 21,109822657026,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채와 자본 총계,-,Term 23,7220285811725,Term 22,7302929652203,Term 21,7555239417717,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 23,1089658847771,Term 22,1162757522705,Term 21,1525844759254,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,-Standard account code not used-,단기차입금,-,Term 23,138182509535,Term 22,215544469417,Term 21,256676145850,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,-Standard account code not used-,유동성장기차입금,-,Term 23,7790336487,Term 22,7504919540,Term 21,5460181804,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CurrentBondsIssuedAndCurrentPortionOfNoncurrentBondsIssued,유동성사채,-,Term 23,0,Term 22,0,Term 21,29999983840,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CurrentRefundsProvision,환불부채,-,Term 23,11578946312,Term 22,13339134213,Term 21,12875692276,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 23,45524846342,Term 22,102379416709,Term 21,188801478806,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 23,309681059345,Term 22,248426155665,Term 21,330577242027,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentLiabilities,기타 유동부채,-,Term 23,96798747084,Term 22,120572379988,Term 21,131222372585,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentPayables,기타채무,-,Term 23,226704100602,Term 22,241803567987,Term 21,299660142515,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers,매입채무,-,Term 23,253398302064,Term 22,213187479186,Term 21,270571519551,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 23,1671359345925,Term 22,1834093663954,Term 21,2057406606361,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 23,581700498154,Term 22,671336141249,Term 21,531561847107,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,-Standard account code not used-,예수보증금,-,Term 23,9741129137,Term 22,10200769679,Term 21,3895493609,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 23,147859534986,Term 22,165223257419,Term 21,121735464959,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_NoncurrentPortionOfNoncurrentLoansReceived,장기차입금,-,Term 23,1993443590,Term 22,14783780077,Term 21,17341601617,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan,퇴직급여부채,-,Term 23,57381078977,Term 22,63616144843,Term 21,51421810319,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialLiabilities,기타비유동금융부채,-,Term 23,317768045372,Term 22,375094983970,Term 21,263149536421,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentLiabilities,기타 비유동 부채,-,Term 23,46957266092,Term 22,42417205261,Term 21,74017940182,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,dart_OperatingIncomeLoss,영업이익,-,Term 23,486981224742,Term 22,711122934369,Term 21,1289630423605,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,dart_OtherGains,기타영업외수익,-,Term 23,46582397077,Term 22,58855764285,Term 21,54382716863,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,dart_OtherLosses,기타영업외비용,-,Term 23,274827614677,Term 22,353493663488,Term 21,148406751184,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_CostOfSales,매출원가,-,Term 23,3177921081645,Term 22,3168512092765,Term 21,3039883555040,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,-Standard account code not used-,기본 우선주당이익,-,Term 23,8563,Term 22,14162,Term 21,50445,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,-Standard account code not used-,희석 우선주당이익,-,Term 23,8563,Term 22,14162,Term 21,50445,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_BasicEarningsLossPerShare,기본 보통주당이익,-,Term 23,8513,Term 22,14112,Term 21,50395,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_DilutedEarningsLossPerShare,희석 보통주당이익,-,Term 23,8513,Term 22,14112,Term 21,50395,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_FinanceCosts,금융원가,-,Term 23,39052274245,Term 22,27261631668,Term 21,22886303361,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_FinanceIncome,금융수익,-,Term 23,48968915334,Term 22,21588027756,Term 21,9572005157,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_GrossProfit,매출총이익,-,Term 23,3626918288484,Term 22,4017247091570,Term 21,5051627742921,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 23,112859158403,Term 22,159429313871,Term 21,326237006705,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 23,163524219980,Term 22,258340046881,Term 21,861127851880,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배지분,-,Term 23,20768740624,Term 22,21767621073,Term 21,16604356139,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 23,142755479356,Term 22,236572425808,Term 21,844523495741,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 23,276383378383,Term 22,417769360752,Term 21,1187364858585,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_Revenue,매출액,-,Term 23,6804839370129,Term 22,7185759184335,Term 21,8091511297961,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_SellingGeneralAndAdministrativeExpense,판매비와관리비,-,Term 23,3139937063742,Term 22,3306124157201,Term 21,3761997319316,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 23,7730730152,Term 22,6957929498,Term 21,5072767505,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄이익,-,Term 23,136065139024,Term 22,265354641614,Term 21,940921851347,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배지분,-,Term 23,20413564234,Term 22,24466139438,Term 21,18255247625,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 23,115651574790,Term 22,240888502176,Term 21,922666603722,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 23,-27459080956,Term 22,7014594733,Term 21,79793999467,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되는 항목,-,Term 23,-12966067430,Term 22,-17274945860,Term 21,61169124434,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업환산손익,-,Term 23,-14468688939,Term 22,-17296890609,Term 21,60934665619,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,-,Term 23,1502621509,Term 22,21944749,Term 21,234458815,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되지 않는 항목,-,Term 23,-14493013526,Term 22,24289540593,Term 21,18624875033,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,-,Term 23,-44771090,Term 22,-226822,Term 21,-149661927,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,-,Term 23,-14448242436,Term 22,24289767415,Term 21,18774536960,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 23,163524219980,Term 22,258340046881,Term 21,861127851880,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초의 현금및현금성자산,-,Term 23,655092563078,Term 22,734520611733,Term 21,434105464098,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말의 현금및현금성자산,-,Term 23,910348037982,Term 22,655092563078,Term 21,734520611733,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동으로 인한 현금흐름,-,Term 23,-268201685330,Term 22,-373633368656,Term 21,-238400403869,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_PaymentForConsolidatedCapitalTransactions,연결자본거래로 인한 변동,-,Term 23,12182000,Term 22,0,Term 21,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,재무활동으로 인한 현금유입액,-,Term 23,68752436418,Term 22,324949820109,Term 21,211628361822,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,재무활동으로 인한 현금유출액,-,Term 23,336954121748,Term 22,698583188765,Term 21,450028765691,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,예수보증금의 수령,-,Term 23,2281004811,Term 22,0,Term 21,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,장기차입금의 차입,-,Term 23,0,Term 22,5000000000,Term 21,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,유동성장기차입금의 상환,-,Term 23,12504919540,Term 22,5708202529,Term 21,3578572000,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,예수보증금의 지급,-,Term 23,2285992867,Term 22,0,Term 21,0,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금의 지급,-,Term 23,97124600150,Term 22,201164100100,Term 21,186135519463,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries,비지배지분의 취득,-,Term 23,0,Term 22,11723995920,Term 21,14770273001,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 지급,-,Term 23,77523016101,Term 22,85831436888,Term 21,85093142807,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests,종속기업의 유상증자,-,Term 23,0,Term 22,0,Term 21,120000000,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromCurrentBorrowings,단기차입금의 차입,-,Term 23,66471431607,Term 22,319949820109,Term 21,211508361822,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfBondsNotesAndDebentures,유동성사채의 상환,-,Term 23,0,Term 22,30000000000,Term 21,0,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfCurrentBorrowings,단기차입금의 상환,-,Term 23,147503411090,Term 22,364155453328,Term 21,160451258420,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동으로 인한 현금흐름,-,Term 23,-140774747630,Term 22,-197383721806,Term 21,-465122432772,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익-공정가치 측정 금융자산의 감소,-,Term 23,147444361,Term 22,0,Term 21,0,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치 측정 금융자산의 처분,-,Term 23,0,Term 22,197100000,Term 21,0,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentsInSubsidiaries,종속기업 처분으로 인한 순현금유입액,-,Term 23,0,Term 22,0,Term 21,7364927342,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfLongTermLoansAndReceivables,장기기타채권의 감소,-,Term 23,13569453414,Term 22,3953324404,Term 21,2286461472,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfNonCurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정자산의 처분,-,Term 23,10607576553,Term 22,0,Term 21,0,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfShortTermFinancialInstruments,단기금융상품의 감소,-,Term 23,5518167924,Term 22,83471000000,Term 21,42000000000,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfShortTermLoansAndReceivables,단기기타채권의 감소,-,Term 23,2003884990,Term 22,4352892626,Term 21,7150005783,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익-공정가치 측정 금융자산의 취득,-,Term 23,1406880000,Term 22,0,Term 21,0,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_PurchaseOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산의취득,-,Term 23,0,Term 22,536445000,Term 21,0,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_PurchaseOfLongTermLoansAndReceivables,장기기타채권의 증가,-,Term 23,2495184656,Term 22,2028968475,Term 21,4563158125,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_PurchaseOfShortTermFinancialInstruments,단기금융상품의 증가,-,Term 23,0,Term 22,7200000000,Term 21,76229000000,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_PurchaseOfShortTermLoansAndReceivables,단기기타채권의 증가,-,Term 23,891463446,Term 22,751760126,Term 21,696100059,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합으로 인한 순현금유출액,-,Term 23,42226006685,Term 22,152045552711,Term 21,131108082259,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_InflowsOfCashFromInvestingActivities,투자활동으로 인한 현금유입액,-,Term 23,69758341538,Term 22,131615889634,Term 21,79673370561,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities,공동기업투자의 처분,-,Term 23,4472515425,Term 22,0,Term 21,16943803,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_OutflowsOfCashFromInvestingActivities,투자활동으로 인한 현금유출액,-,Term 23,210533089168,Term 22,328999611440,Term 21,544795803333,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities,국고보조금의 수취,-,Term 23,297900000,Term 22,19110000,Term 21,253700000,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 23,798429624,Term 22,4640939909,Term 21,270342552,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 23,10078205814,Term 22,576520000,Term 21,2360000000,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 23,22264763433,Term 22,34405002695,Term 21,17970989609,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 23,11095215663,Term 22,9391190370,Term 21,10312236474,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfInvestmentProperty,투자부동산의 취득,-,Term 23,0,Term 22,0,Term 21,12528920,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 23,152418338718,Term 22,157045694758,Term 21,321874697496,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동으로 인한 현금흐름,-,Term 23,659061627244,Term 22,497299483100,Term 21,984481666368,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업활동으로 인한 자산부채의 변동,-,Term 23,113424453984,Term 22,-199657616423,Term 21,-232237308874,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInOtherNonCurrentNonFinancialAssets,기타비유동자산,-,Term 23,-3529410936,Term 22,-3913036948,Term 21,-5825558786,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherNonCurrentLiabilities,기타비유동부채,-,Term 23,5973809642,Term 22,-5666018887,Term 21,-1589718214,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInProvisionsForReturnedGoods,환불부채,-,Term 23,-1781499741,Term 22,481980735,Term 21,-3017943114,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 23,45642050773,Term 22,-72237655740,Term 21,-12476452211,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,퇴직급여부채의 관계사 전입,-,Term 23,63983179,Term 22,129783254,Term 21,561746152,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,예수보증금,-,Term 23,34324,Term 22,5859634835,Term 21,-1293303890,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산,-,Term 23,75399386528,Term 22,62013447364,Term 21,-147805686623,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산,-,Term 23,7783706027,Term 22,11453506140,Term 21,3246409858,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables,기타채권,-,Term 23,12235677287,Term 22,-11283101681,Term 21,7439955809,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable,매출채권,-,Term 23,23545052313,Term 22,12853602709,Term 21,48830535465,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채,-,Term 23,-27241015124,Term 22,-33973949285,Term 21,-33517901510,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInOtherOperatingPayables,기타채무,-,Term 23,-30530710825,Term 22,-49816791137,Term 21,-31106874116,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable,매입채무,-,Term 23,39379494117,Term 22,-65158003482,Term 21,5129900386,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset,사외적립자산,-,Term 23,26599447041,Term 22,44570790774,Term 21,55921334529,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset,퇴직금의 지급,-,Term 23,6916656539,Term 22,5830223526,Term 21,4891083551,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,수익ㆍ비용의가감,-,Term 23,536269020585,Term 22,678770999043,Term 21,655594377448,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비(대손충당금환입),-,Term 23,1294475720,Term 22,-428896863,Term 21,3729253285,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForBargainPurchaseGains,염가매수차익,-,Term 23,0,Term 22,0,Term 21,31288923,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 23,12574109819,Term 22,20139865677,Term 21,7882228803,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 23,2168413249,Term 22,3011356217,Term 21,1645379301,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfIntangibleAssets,무형자산처분이익,-,Term 23,138768242,Term 22,93183291,Term 21,31400000,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentProperty,투자부동산처분이익,-,Term 23,4648837954,Term 22,146808846,Term 21,424275509,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정자산처분이익,-,Term 23,2775048994,Term 22,0,Term 21,0,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치 측정 금융자산 평가이익,-,Term 23,18722387548,Term 22,4632564558,Term 21,1582418788,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfIntangibleAssets,무형자산손상차손,-,Term 23,112204887141,Term 22,177834742877,Term 21,563290248,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfPropertyPlantAndEquipment,유형자산손상차손,-,Term 23,6555409177,Term 22,6796472886,Term 21,3695340823,74,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 23,19366715671,Term 22,14830609188,Term 21,12537198896,75,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfIntangibleAssets,무형자산처분손실,-,Term 23,6390206970,Term 22,3010429856,Term 21,700100092,76,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfInvestmentProperty,투자부동산처분손실,-,Term 23,10751933,Term 22,36425687,Term 21,0,77,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 23,9405747018,Term 22,3417665095,Term 21,4947235977,78,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치 측정 금융자산 평가손실,-,Term 23,14582257107,Term 22,6732536253,Term 21,4921968498,79,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 23,3588155054,Term 22,5088997246,Term 21,1233674337,80,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 23,43856005073,Term 22,48421103671,Term 21,50413856656,81,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForReversalsOfBadDebtExpenses,기타대손충당금환입,-,Term 23,181795254,Term 22,197792932,Term 21,1135147924,82,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_GainsOnDisposalsOfFairValueFinancialAsset,당기손익-공정가치 측정 금융자산 처분이익,-,Term 23,3016089,Term 22,0,Term 21,0,83,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_GainsOnSaleOfInvestmentsInSubsidiaries,종속기업처분이익,-,Term 23,0,Term 22,38088456,Term 21,6259434084,84,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_GainsOnValuationOfFairValueFinancialLiabilities,당기손익-공정가치 측정 금융부채 평가이익,-,Term 23,0,Term 22,0,Term 21,255798240,85,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ImpairmentLossesOnInvestmentProperty,투자부동산손상차손,-,Term 23,896541999,Term 22,0,Term 21,0,86,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_LossesOnValuationOfFairValueFinancialLiabilities,당기손익-공정가치 측정 금융부채 평가손실,-,Term 23,5481920,Term 22,0,Term 21,1380318713,87,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분이익,-,Term 23,3395246737,Term 22,74404968,Term 21,50260469,88,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분손실,-,Term 23,242452048,Term 22,61581730,Term 21,87136919,89,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,공동기업처분이익,-,Term 23,2062573050,Term 22,0,Term 21,0,90,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산손상차손,-,Term 23,16070474902,Term 22,12183534981,Term 21,338700185,91,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 23,37773195056,Term 22,41092465637,Term 21,34129748348,92,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDepreciationExpense,감가상각비,-,Term 23,232093988438,Term 22,246887613016,Term 21,240917419595,93,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 23,112859158403,Term 22,159429313871,Term 21,326237006705,94,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForInterestIncome,이자수익,-,Term 23,26357835957,Term 22,11331601645,Term 21,5680872283,95,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_RevenueFromDividends,배당금수익,-,Term 23,168120000,Term 22,0,Term 21,186600000,96,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 23,7730730152,Term 22,6957929498,Term 21,5072767505,97,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsOperatingActivities,배당금의 수취,-,Term 23,5895060000,Term 22,6013497709,Term 21,6384911352,98,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세의 납부,-,Term 23,166490102118,Term 22,244081779186,Term 21,303256558221,99,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자의 지급,-,Term 23,16147404861,Term 22,11779250888,Term 21,7982482336,100,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 23,22586379674,Term 22,9693585964,Term 21,4850875119,101,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 23,163524219980,Term 22,258340046881,Term 21,861127851880,102,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,외화환산으로 인한 현금및현금성자산의 변동,-,Term 23,5170280620,Term 22,-5710441293,Term 21,19456317908,103,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,현금및현금성자산의 증가(감소),-,Term 23,250085194284,Term 22,-73717607362,Term 21,280958829727,104,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 23,5468835988249,Term 22,5497832811356,Term 21,4849195698865,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|비지배지분 [구성요소],Term 23,129553438347,Term 22,109822657026,Term 21,93216194376,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,5339282549902,Term 22,5388010154330,Term 21,4755979504489,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,-305870275565,Term 22,-217431509911,Term 21,-111216852980,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,-83209267310,Term 22,-64495577286,Term 21,-124122981721,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,5542446884994,Term 22,5484022033744,Term 21,4805404131407,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,88589470000,Term 22,88589470000,Term 21,88589470000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,97325737783,Term 22,97325737783,Term 21,97325737783,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,67128988950,Term 22,201177340950,Term 21,184421296950,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|비지배지분 [구성요소],Term 23,30000000000,Term 22,0,Term 21,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,연결재무제표 [member],Term 23,97128988950,Term 22,201177340950,Term 21,184421296950,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,0,Term 22,0,Term 21,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,67128988950,Term 22,201177340950,Term 21,184421296950,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,0,Term 22,0,Term 21,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,연결재무제표 [member],Term 23,5548926465800,Term 22,5468835988249,Term 21,5497832811356,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|비지배지분 [구성요소],Term 23,115475406911,Term 22,129553438347,Term 21,109822657026,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,5433451058889,Term 22,5339282549902,Term 21,5388010154330,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,88589470000,Term 22,88589470000,Term 21,88589470000,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,5604425480133,Term 22,5542446884994,Term 21,5484022033744,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,-96665276609,Term 22,-83209267310,Term 21,-64495577286,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,-260224352418,Term 22,-305870275565,Term 21,-217431509911,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,97325737783,Term 22,97325737783,Term 21,97325737783,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,45645923147,Term 22,-88438765654,Term 21,-106214656931,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|비지배지분 [구성요소],Term 23,-4491595670,Term 22,-4735358117,Term 21,-1648784975,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,연결재무제표 [member],Term 23,41154327477,Term 22,-93174123771,Term 21,-107863441906,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,45645923147,Term 22,-88438765654,Term 21,-106214656931,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,0,Term 22,0,Term 21,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,-14905028256,Term 22,-18538307951,Term 21,59542607547,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|비지배지분 [구성요소],Term 23,436339317,Term 22,1241417342,Term 21,1392058072,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,연결재무제표 [member],Term 23,-14468688939,Term 22,-17296890609,Term 21,60934665619,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,0,Term 22,0,Term 21,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,-14905028256,Term 22,-18538307951,Term 21,59542607547,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,-45654236,Term 22,-226822,Term 21,-149661927,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|비지배지분 [구성요소],Term 23,883146,Term 22,0,Term 21,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,연결재무제표 [member],Term 23,-44771090,Term 22,-226822,Term 21,-149661927,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,0,Term 22,0,Term 21,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,7948316,Term 22,197100000,Term 21,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,-53602552,Term 22,-197326822,Term 21,-149661927,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,연결재무제표 [member],Term 23,-14448242436,Term 22,24289767415,Term 21,18774536960,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|비지배지분 [구성요소],Term 23,-792398853,Term 22,1457101023,Term 21,258833414,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,-13655843583,Term 22,22832666392,Term 21,18515703546,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,0,Term 22,0,Term 21,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,0,Term 22,0,Term 21,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,-13655843583,Term 22,22832666392,Term 21,18515703546,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 23,163524219980,Term 22,258340046881,Term 21,861127851880,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|비지배지분 [구성요소],Term 23,20768740624,Term 22,21767621073,Term 21,16604356139,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,142755479356,Term 22,236572425808,Term 21,844523495741,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,0,Term 22,0,Term 21,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,0,Term 22,0,Term 21,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,142755479356,Term 22,236572425808,Term 21,844523495741,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,연결재무제표 [member],Term 23,1502621509,Term 22,21944749,Term 21,234458815,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|비지배지분 [구성요소],Term 23,0,Term 22,0,Term 21,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,1502621509,Term 22,21944749,Term 21,234458815,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,1502621509,Term 22,21944749,Term 21,234458815,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,0,Term 22,0,Term 21,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 23,7220285811725,Term 22,7302929652203,Term 21,7555239417717,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 23,2429583603574,Term 22,2284388637755,Term 21,2472884295774,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 23,910348037982,Term 22,655092563078,Term 21,734520611733,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CurrentTradeReceivables,매출채권,-,Term 23,529076344154,Term 22,550861505948,Term 21,554857050527,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 23,884515142151,Term 22,955432614662,Term 21,1000655942465,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentAssets,기타유동자산,-,Term 23,45271354734,Term 22,46315326894,Term 21,48565822995,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 23,5508065693,Term 22,2687794247,Term 21,824675343,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentReceivables,기타채권,-,Term 23,38386687660,Term 22,52024002526,Term 21,38107743911,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents,단기금융상품,-,Term 23,16477971200,Term 22,21974830400,Term 21,95352448800,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 23,4790702208151,Term 22,5018541014448,Term 21,5082355121943,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 23,34125353691,Term 22,52397079036,Term 21,38593929168,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_IntangibleAssetsAndGoodwill,무형자산,-,Term 23,2007877629243,Term 22,2100587252176,Term 21,2168719935017,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_InvestmentAccountedForUsingEquityMethod,관계기업및공동기업투자,-,Term 23,61771210888,Term 22,60146908565,Term 21,59167859842,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 23,45974090552,Term 22,25933611138,Term 21,30129279961,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_LongtermDeposits,장기금융상품,-,Term 23,23000000,Term 22,23000000,Term 21,20000000,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentAssets,기타비유동자산,-,Term 23,70587172824,Term 22,109759853810,Term 21,54820901832,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 23,79877043683,Term 22,64367260770,Term 21,28409958922,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentReceivables,장기기타채권,-,Term 23,31032978196,Term 22,40637972467,Term 21,49092915577,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 23,2307114070178,Term 22,2383867277039,Term 21,2449112181346,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 23,152319658896,Term 22,180820799447,Term 21,204288160278,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 23,5548926465800,Term 22,5468835988249,Term 21,5497832811356,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업소유주지분,-,Term 23,5433451058889,Term 22,5339282549902,Term 21,5388010154330,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 23,97325737783,Term 22,97325737783,Term 21,97325737783,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본항목,-,Term 23,-260224352418,Term 22,-305870275565,Term 21,-217431509911,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_AccumulatedOtherComprehensiveIncome,기타포괄손익누계액,-,Term 23,-96665276609,Term 22,-83209267310,Term 21,-64495577286,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 23,88589470000,Term 22,88589470000,Term 21,88589470000,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 23,5604425480133,Term 22,5542446884994,Term 21,5484022033744,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배지분,-,Term 23,115475406911,Term 22,129553438347,Term 21,109822657026,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채와 자본 총계,-,Term 23,7220285811725,Term 22,7302929652203,Term 21,7555239417717,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 23,1089658847771,Term 22,1162757522705,Term 21,1525844759254,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,-Standard account code not used-,단기차입금,-,Term 23,138182509535,Term 22,215544469417,Term 21,256676145850,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,-Standard account code not used-,유동성장기차입금,-,Term 23,7790336487,Term 22,7504919540,Term 21,5460181804,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CurrentBondsIssuedAndCurrentPortionOfNoncurrentBondsIssued,유동성사채,-,Term 23,0,Term 22,0,Term 21,29999983840,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CurrentRefundsProvision,환불부채,-,Term 23,11578946312,Term 22,13339134213,Term 21,12875692276,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 23,45524846342,Term 22,102379416709,Term 21,188801478806,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 23,309681059345,Term 22,248426155665,Term 21,330577242027,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentLiabilities,기타 유동부채,-,Term 23,96798747084,Term 22,120572379988,Term 21,131222372585,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentPayables,기타채무,-,Term 23,226704100602,Term 22,241803567987,Term 21,299660142515,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers,매입채무,-,Term 23,253398302064,Term 22,213187479186,Term 21,270571519551,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 23,1671359345925,Term 22,1834093663954,Term 21,2057406606361,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 23,581700498154,Term 22,671336141249,Term 21,531561847107,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,-Standard account code not used-,예수보증금,-,Term 23,9741129137,Term 22,10200769679,Term 21,3895493609,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 23,147859534986,Term 22,165223257419,Term 21,121735464959,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_NoncurrentPortionOfNoncurrentLoansReceived,장기차입금,-,Term 23,1993443590,Term 22,14783780077,Term 21,17341601617,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan,퇴직급여부채,-,Term 23,57381078977,Term 22,63616144843,Term 21,51421810319,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialLiabilities,기타비유동금융부채,-,Term 23,317768045372,Term 22,375094983970,Term 21,263149536421,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentLiabilities,기타 비유동 부채,-,Term 23,46957266092,Term 22,42417205261,Term 21,74017940182,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,dart_OperatingIncomeLoss,영업이익,-,Term 23,486981224742,Term 22,711122934369,Term 21,1289630423605,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,dart_OtherGains,기타영업외수익,-,Term 23,46582397077,Term 22,58855764285,Term 21,54382716863,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,dart_OtherLosses,기타영업외비용,-,Term 23,274827614677,Term 22,353493663488,Term 21,148406751184,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_CostOfSales,매출원가,-,Term 23,3177921081645,Term 22,3168512092765,Term 21,3039883555040,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,-Standard account code not used-,기본 우선주당이익,-,Term 23,8563,Term 22,14162,Term 21,50445,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,-Standard account code not used-,희석 우선주당이익,-,Term 23,8563,Term 22,14162,Term 21,50445,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_BasicEarningsLossPerShare,기본 보통주당이익,-,Term 23,8513,Term 22,14112,Term 21,50395,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_DilutedEarningsLossPerShare,희석 보통주당이익,-,Term 23,8513,Term 22,14112,Term 21,50395,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_FinanceCosts,금융원가,-,Term 23,39052274245,Term 22,27261631668,Term 21,22886303361,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_FinanceIncome,금융수익,-,Term 23,48968915334,Term 22,21588027756,Term 21,9572005157,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_GrossProfit,매출총이익,-,Term 23,3626918288484,Term 22,4017247091570,Term 21,5051627742921,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 23,112859158403,Term 22,159429313871,Term 21,326237006705,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 23,163524219980,Term 22,258340046881,Term 21,861127851880,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배지분,-,Term 23,20768740624,Term 22,21767621073,Term 21,16604356139,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 23,142755479356,Term 22,236572425808,Term 21,844523495741,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 23,276383378383,Term 22,417769360752,Term 21,1187364858585,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_Revenue,매출액,-,Term 23,6804839370129,Term 22,7185759184335,Term 21,8091511297961,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_SellingGeneralAndAdministrativeExpense,판매비와관리비,-,Term 23,3139937063742,Term 22,3306124157201,Term 21,3761997319316,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 23,7730730152,Term 22,6957929498,Term 21,5072767505,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄이익,-,Term 23,136065139024,Term 22,265354641614,Term 21,940921851347,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배지분,-,Term 23,20413564234,Term 22,24466139438,Term 21,18255247625,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 23,115651574790,Term 22,240888502176,Term 21,922666603722,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 23,-27459080956,Term 22,7014594733,Term 21,79793999467,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되는 항목,-,Term 23,-12966067430,Term 22,-17274945860,Term 21,61169124434,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업환산손익,-,Term 23,-14468688939,Term 22,-17296890609,Term 21,60934665619,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,-,Term 23,1502621509,Term 22,21944749,Term 21,234458815,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되지 않는 항목,-,Term 23,-14493013526,Term 22,24289540593,Term 21,18624875033,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,-,Term 23,-44771090,Term 22,-226822,Term 21,-149661927,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,-,Term 23,-14448242436,Term 22,24289767415,Term 21,18774536960,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 23,163524219980,Term 22,258340046881,Term 21,861127851880,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초의 현금및현금성자산,-,Term 23,655092563078,Term 22,734520611733,Term 21,434105464098,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말의 현금및현금성자산,-,Term 23,910348037982,Term 22,655092563078,Term 21,734520611733,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동으로 인한 현금흐름,-,Term 23,-268201685330,Term 22,-373633368656,Term 21,-238400403869,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_PaymentForConsolidatedCapitalTransactions,연결자본거래로 인한 변동,-,Term 23,12182000,Term 22,0,Term 21,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,재무활동으로 인한 현금유입액,-,Term 23,68752436418,Term 22,324949820109,Term 21,211628361822,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,재무활동으로 인한 현금유출액,-,Term 23,336954121748,Term 22,698583188765,Term 21,450028765691,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,예수보증금의 수령,-,Term 23,2281004811,Term 22,0,Term 21,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,장기차입금의 차입,-,Term 23,0,Term 22,5000000000,Term 21,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,유동성장기차입금의 상환,-,Term 23,12504919540,Term 22,5708202529,Term 21,3578572000,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,예수보증금의 지급,-,Term 23,2285992867,Term 22,0,Term 21,0,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금의 지급,-,Term 23,97124600150,Term 22,201164100100,Term 21,186135519463,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries,비지배지분의 취득,-,Term 23,0,Term 22,11723995920,Term 21,14770273001,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 지급,-,Term 23,77523016101,Term 22,85831436888,Term 21,85093142807,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests,종속기업의 유상증자,-,Term 23,0,Term 22,0,Term 21,120000000,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromCurrentBorrowings,단기차입금의 차입,-,Term 23,66471431607,Term 22,319949820109,Term 21,211508361822,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfBondsNotesAndDebentures,유동성사채의 상환,-,Term 23,0,Term 22,30000000000,Term 21,0,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfCurrentBorrowings,단기차입금의 상환,-,Term 23,147503411090,Term 22,364155453328,Term 21,160451258420,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동으로 인한 현금흐름,-,Term 23,-140774747630,Term 22,-197383721806,Term 21,-465122432772,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익-공정가치 측정 금융자산의 감소,-,Term 23,147444361,Term 22,0,Term 21,0,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치 측정 금융자산의 처분,-,Term 23,0,Term 22,197100000,Term 21,0,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentsInSubsidiaries,종속기업 처분으로 인한 순현금유입액,-,Term 23,0,Term 22,0,Term 21,7364927342,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfLongTermLoansAndReceivables,장기기타채권의 감소,-,Term 23,13569453414,Term 22,3953324404,Term 21,2286461472,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfNonCurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정자산의 처분,-,Term 23,10607576553,Term 22,0,Term 21,0,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfShortTermFinancialInstruments,단기금융상품의 감소,-,Term 23,5518167924,Term 22,83471000000,Term 21,42000000000,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfShortTermLoansAndReceivables,단기기타채권의 감소,-,Term 23,2003884990,Term 22,4352892626,Term 21,7150005783,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익-공정가치 측정 금융자산의 취득,-,Term 23,1406880000,Term 22,0,Term 21,0,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_PurchaseOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산의취득,-,Term 23,0,Term 22,536445000,Term 21,0,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_PurchaseOfLongTermLoansAndReceivables,장기기타채권의 증가,-,Term 23,2495184656,Term 22,2028968475,Term 21,4563158125,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_PurchaseOfShortTermFinancialInstruments,단기금융상품의 증가,-,Term 23,0,Term 22,7200000000,Term 21,76229000000,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_PurchaseOfShortTermLoansAndReceivables,단기기타채권의 증가,-,Term 23,891463446,Term 22,751760126,Term 21,696100059,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합으로 인한 순현금유출액,-,Term 23,42226006685,Term 22,152045552711,Term 21,131108082259,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_InflowsOfCashFromInvestingActivities,투자활동으로 인한 현금유입액,-,Term 23,69758341538,Term 22,131615889634,Term 21,79673370561,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities,공동기업투자의 처분,-,Term 23,4472515425,Term 22,0,Term 21,16943803,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_OutflowsOfCashFromInvestingActivities,투자활동으로 인한 현금유출액,-,Term 23,210533089168,Term 22,328999611440,Term 21,544795803333,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities,국고보조금의 수취,-,Term 23,297900000,Term 22,19110000,Term 21,253700000,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 23,798429624,Term 22,4640939909,Term 21,270342552,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 23,10078205814,Term 22,576520000,Term 21,2360000000,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 23,22264763433,Term 22,34405002695,Term 21,17970989609,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 23,11095215663,Term 22,9391190370,Term 21,10312236474,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfInvestmentProperty,투자부동산의 취득,-,Term 23,0,Term 22,0,Term 21,12528920,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 23,152418338718,Term 22,157045694758,Term 21,321874697496,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동으로 인한 현금흐름,-,Term 23,659061627244,Term 22,497299483100,Term 21,984481666368,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업활동으로 인한 자산부채의 변동,-,Term 23,113424453984,Term 22,-199657616423,Term 21,-232237308874,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInOtherNonCurrentNonFinancialAssets,기타비유동자산,-,Term 23,-3529410936,Term 22,-3913036948,Term 21,-5825558786,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherNonCurrentLiabilities,기타비유동부채,-,Term 23,5973809642,Term 22,-5666018887,Term 21,-1589718214,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInProvisionsForReturnedGoods,환불부채,-,Term 23,-1781499741,Term 22,481980735,Term 21,-3017943114,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 23,45642050773,Term 22,-72237655740,Term 21,-12476452211,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,퇴직급여부채의 관계사 전입,-,Term 23,63983179,Term 22,129783254,Term 21,561746152,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,예수보증금,-,Term 23,34324,Term 22,5859634835,Term 21,-1293303890,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산,-,Term 23,75399386528,Term 22,62013447364,Term 21,-147805686623,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산,-,Term 23,7783706027,Term 22,11453506140,Term 21,3246409858,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables,기타채권,-,Term 23,12235677287,Term 22,-11283101681,Term 21,7439955809,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable,매출채권,-,Term 23,23545052313,Term 22,12853602709,Term 21,48830535465,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채,-,Term 23,-27241015124,Term 22,-33973949285,Term 21,-33517901510,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInOtherOperatingPayables,기타채무,-,Term 23,-30530710825,Term 22,-49816791137,Term 21,-31106874116,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable,매입채무,-,Term 23,39379494117,Term 22,-65158003482,Term 21,5129900386,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset,사외적립자산,-,Term 23,26599447041,Term 22,44570790774,Term 21,55921334529,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset,퇴직금의 지급,-,Term 23,6916656539,Term 22,5830223526,Term 21,4891083551,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,수익ㆍ비용의가감,-,Term 23,536269020585,Term 22,678770999043,Term 21,655594377448,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비(대손충당금환입),-,Term 23,1294475720,Term 22,-428896863,Term 21,3729253285,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForBargainPurchaseGains,염가매수차익,-,Term 23,0,Term 22,0,Term 21,31288923,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 23,12574109819,Term 22,20139865677,Term 21,7882228803,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 23,2168413249,Term 22,3011356217,Term 21,1645379301,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfIntangibleAssets,무형자산처분이익,-,Term 23,138768242,Term 22,93183291,Term 21,31400000,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentProperty,투자부동산처분이익,-,Term 23,4648837954,Term 22,146808846,Term 21,424275509,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정자산처분이익,-,Term 23,2775048994,Term 22,0,Term 21,0,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치 측정 금융자산 평가이익,-,Term 23,18722387548,Term 22,4632564558,Term 21,1582418788,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfIntangibleAssets,무형자산손상차손,-,Term 23,112204887141,Term 22,177834742877,Term 21,563290248,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfPropertyPlantAndEquipment,유형자산손상차손,-,Term 23,6555409177,Term 22,6796472886,Term 21,3695340823,74,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 23,19366715671,Term 22,14830609188,Term 21,12537198896,75,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfIntangibleAssets,무형자산처분손실,-,Term 23,6390206970,Term 22,3010429856,Term 21,700100092,76,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfInvestmentProperty,투자부동산처분손실,-,Term 23,10751933,Term 22,36425687,Term 21,0,77,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 23,9405747018,Term 22,3417665095,Term 21,4947235977,78,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치 측정 금융자산 평가손실,-,Term 23,14582257107,Term 22,6732536253,Term 21,4921968498,79,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 23,3588155054,Term 22,5088997246,Term 21,1233674337,80,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 23,43856005073,Term 22,48421103671,Term 21,50413856656,81,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForReversalsOfBadDebtExpenses,기타대손충당금환입,-,Term 23,181795254,Term 22,197792932,Term 21,1135147924,82,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_GainsOnDisposalsOfFairValueFinancialAsset,당기손익-공정가치 측정 금융자산 처분이익,-,Term 23,3016089,Term 22,0,Term 21,0,83,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_GainsOnSaleOfInvestmentsInSubsidiaries,종속기업처분이익,-,Term 23,0,Term 22,38088456,Term 21,6259434084,84,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_GainsOnValuationOfFairValueFinancialLiabilities,당기손익-공정가치 측정 금융부채 평가이익,-,Term 23,0,Term 22,0,Term 21,255798240,85,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ImpairmentLossesOnInvestmentProperty,투자부동산손상차손,-,Term 23,896541999,Term 22,0,Term 21,0,86,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_LossesOnValuationOfFairValueFinancialLiabilities,당기손익-공정가치 측정 금융부채 평가손실,-,Term 23,5481920,Term 22,0,Term 21,1380318713,87,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분이익,-,Term 23,3395246737,Term 22,74404968,Term 21,50260469,88,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분손실,-,Term 23,242452048,Term 22,61581730,Term 21,87136919,89,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,공동기업처분이익,-,Term 23,2062573050,Term 22,0,Term 21,0,90,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산손상차손,-,Term 23,16070474902,Term 22,12183534981,Term 21,338700185,91,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 23,37773195056,Term 22,41092465637,Term 21,34129748348,92,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDepreciationExpense,감가상각비,-,Term 23,232093988438,Term 22,246887613016,Term 21,240917419595,93,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 23,112859158403,Term 22,159429313871,Term 21,326237006705,94,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForInterestIncome,이자수익,-,Term 23,26357835957,Term 22,11331601645,Term 21,5680872283,95,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_RevenueFromDividends,배당금수익,-,Term 23,168120000,Term 22,0,Term 21,186600000,96,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 23,7730730152,Term 22,6957929498,Term 21,5072767505,97,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsOperatingActivities,배당금의 수취,-,Term 23,5895060000,Term 22,6013497709,Term 21,6384911352,98,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세의 납부,-,Term 23,166490102118,Term 22,244081779186,Term 21,303256558221,99,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자의 지급,-,Term 23,16147404861,Term 22,11779250888,Term 21,7982482336,100,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 23,22586379674,Term 22,9693585964,Term 21,4850875119,101,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 23,163524219980,Term 22,258340046881,Term 21,861127851880,102,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,외화환산으로 인한 현금및현금성자산의 변동,-,Term 23,5170280620,Term 22,-5710441293,Term 21,19456317908,103,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,현금및현금성자산의 증가(감소),-,Term 23,250085194284,Term 22,-73717607362,Term 21,280958829727,104,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 23,5468835988249,Term 22,5497832811356,Term 21,4849195698865,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|비지배지분 [구성요소],Term 23,129553438347,Term 22,109822657026,Term 21,93216194376,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,5339282549902,Term 22,5388010154330,Term 21,4755979504489,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,-305870275565,Term 22,-217431509911,Term 21,-111216852980,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,-83209267310,Term 22,-64495577286,Term 21,-124122981721,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,5542446884994,Term 22,5484022033744,Term 21,4805404131407,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,88589470000,Term 22,88589470000,Term 21,88589470000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,97325737783,Term 22,97325737783,Term 21,97325737783,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,67128988950,Term 22,201177340950,Term 21,184421296950,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|비지배지분 [구성요소],Term 23,30000000000,Term 22,0,Term 21,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,연결재무제표 [member],Term 23,97128988950,Term 22,201177340950,Term 21,184421296950,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,0,Term 22,0,Term 21,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,67128988950,Term 22,201177340950,Term 21,184421296950,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,0,Term 22,0,Term 21,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,연결재무제표 [member],Term 23,5548926465800,Term 22,5468835988249,Term 21,5497832811356,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|비지배지분 [구성요소],Term 23,115475406911,Term 22,129553438347,Term 21,109822657026,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,5433451058889,Term 22,5339282549902,Term 21,5388010154330,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,88589470000,Term 22,88589470000,Term 21,88589470000,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,5604425480133,Term 22,5542446884994,Term 21,5484022033744,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,-96665276609,Term 22,-83209267310,Term 21,-64495577286,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,-260224352418,Term 22,-305870275565,Term 21,-217431509911,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,97325737783,Term 22,97325737783,Term 21,97325737783,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,45645923147,Term 22,-88438765654,Term 21,-106214656931,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|비지배지분 [구성요소],Term 23,-4491595670,Term 22,-4735358117,Term 21,-1648784975,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,연결재무제표 [member],Term 23,41154327477,Term 22,-93174123771,Term 21,-107863441906,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,45645923147,Term 22,-88438765654,Term 21,-106214656931,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,0,Term 22,0,Term 21,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,-14905028256,Term 22,-18538307951,Term 21,59542607547,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|비지배지분 [구성요소],Term 23,436339317,Term 22,1241417342,Term 21,1392058072,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,연결재무제표 [member],Term 23,-14468688939,Term 22,-17296890609,Term 21,60934665619,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,0,Term 22,0,Term 21,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,-14905028256,Term 22,-18538307951,Term 21,59542607547,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,-45654236,Term 22,-226822,Term 21,-149661927,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|비지배지분 [구성요소],Term 23,883146,Term 22,0,Term 21,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,연결재무제표 [member],Term 23,-44771090,Term 22,-226822,Term 21,-149661927,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,0,Term 22,0,Term 21,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,7948316,Term 22,197100000,Term 21,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,-53602552,Term 22,-197326822,Term 21,-149661927,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,연결재무제표 [member],Term 23,-14448242436,Term 22,24289767415,Term 21,18774536960,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|비지배지분 [구성요소],Term 23,-792398853,Term 22,1457101023,Term 21,258833414,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,-13655843583,Term 22,22832666392,Term 21,18515703546,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,0,Term 22,0,Term 21,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,0,Term 22,0,Term 21,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,-13655843583,Term 22,22832666392,Term 21,18515703546,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 23,163524219980,Term 22,258340046881,Term 21,861127851880,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|비지배지분 [구성요소],Term 23,20768740624,Term 22,21767621073,Term 21,16604356139,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,142755479356,Term 22,236572425808,Term 21,844523495741,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,0,Term 22,0,Term 21,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,0,Term 22,0,Term 21,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,142755479356,Term 22,236572425808,Term 21,844523495741,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,연결재무제표 [member],Term 23,1502621509,Term 22,21944749,Term 21,234458815,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|비지배지분 [구성요소],Term 23,0,Term 22,0,Term 21,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,1502621509,Term 22,21944749,Term 21,234458815,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,1502621509,Term 22,21944749,Term 21,234458815,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,0,Term 22,0,Term 21,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_Assets,자산 총계,-,Term 24,7405784092201,Term 23,7220285811725,Term 22,7302929652203,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 24,2856048500735,Term 23,2429583603574,Term 22,2284388637755,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 24,1253469878367,Term 23,910348037982,Term 22,655092563078,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CurrentTradeReceivables,매출채권,-,Term 24,576205113721,Term 23,529076344154,Term 22,550861505948,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 24,922418157031,Term 23,884515142151,Term 22,955432614662,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentAssets,기타유동자산,-,Term 24,52465237154,Term 23,45271354734,Term 22,46315326894,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 24,4352814406,Term 23,5508065693,Term 22,2687794247,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentReceivables,기타채권,-,Term 24,30655383256,Term 23,38386687660,Term 22,52024002526,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents,단기금융상품,-,Term 24,16481916800,Term 23,16477971200,Term 22,21974830400,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 24,4549735591466,Term 23,4790702208151,Term 22,5018541014448,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 24,34730969596,Term 23,34125353691,Term 22,52397079036,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_IntangibleAssetsAndGoodwill,무형자산,-,Term 24,1964277226876,Term 23,2007877629243,Term 22,2100587252176,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_InvestmentAccountedForUsingEquityMethod,관계기업및공동기업투자,-,Term 24,57876225470,Term 23,61771210888,Term 22,60146908565,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 24,65194503689,Term 23,45974090552,Term 22,25933611138,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_LongtermDeposits,장기금융상품,-,Term 24,23000000,Term 23,23000000,Term 22,23000000,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentAssets,기타비유동자산,-,Term 24,18090955028,Term 23,70587172824,Term 22,109759853810,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 24,31966761345,Term 23,79877043683,Term 22,64367260770,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentReceivables,장기기타채권,-,Term 24,28572485130,Term 23,31032978196,Term 22,40637972467,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 24,2226368549375,Term 23,2307114070178,Term 22,2383867277039,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 24,122634914957,Term 23,152319658896,Term 22,180820799447,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_Equity,자본 총계,-,Term 24,5685920091079,Term 23,5548926465800,Term 22,5468835988249,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업소유주지분,-,Term 24,5566264371939,Term 23,5433451058889,Term 22,5339282549902,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 24,97325737783,Term 23,97325737783,Term 22,97325737783,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본항목,-,Term 24,-297701911404,Term 23,-260224352418,Term 22,-305870275565,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_AccumulatedOtherComprehensiveIncome,기타포괄손익누계액,-,Term 24,-17528901762,Term 23,-96665276609,Term 22,-83209267310,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 24,88589470000,Term 23,88589470000,Term 22,88589470000,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 24,5695579977322,Term 23,5604425480133,Term 22,5542446884994,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배지분,-,Term 24,119655719140,Term 23,115475406911,Term 22,129553438347,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채와 자본 총계,-,Term 24,7405784092201,Term 23,7220285811725,Term 22,7302929652203,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 24,1295900316472,Term 23,1089658847771,Term 22,1162757522705,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CurrentPortionOfLongtermBorrowings,유동성장기차입금,-,Term 24,1993443590,Term 23,7790336487,Term 22,7504919540,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CurrentRefundsProvision,환불부채,-,Term 24,12165316348,Term 23,11578946312,Term 22,13339134213,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 24,66915906521,Term 23,45524846342,Term 22,102379416709,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 24,470505326911,Term 23,309681059345,Term 22,248426155665,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentLiabilities,기타유동부채,-,Term 24,72481574932,Term 23,96798747084,Term 22,120572379988,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentPayables,기타채무,-,Term 24,199506237169,Term 23,226704100602,Term 22,241803567987,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 24,241330029491,Term 23,138182509535,Term 22,215544469417,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers,매입채무,-,Term 24,231002481510,Term 23,253398302064,Term 22,213187479186,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_Liabilities,부채 총계,-,Term 24,1719864001122,Term 23,1671359345925,Term 22,1834093663954,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 24,423963684650,Term 23,581700498154,Term 22,671336141249,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,dart_LongTermGuaranteeDepositWithholdingsNet,예수보증금,-,Term 24,5816707551,Term 23,9741129137,Term 22,10200769679,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 24,127838780237,Term 23,147859534986,Term 22,165223257419,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_LongtermBorrowings,장기차입금,-,Term 24,0,Term 23,1993443590,Term 22,14783780077,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan,퇴직급여부채,-,Term 24,61140758953,Term 23,57381078977,Term 22,63616144843,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialLiabilities,기타비유동금융부채,-,Term 24,178369594748,Term 23,317768045372,Term 22,375094983970,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentLiabilities,기타비유동부채,-,Term 24,50797843161,Term 23,46957266092,Term 22,42417205261,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,dart_OperatingIncomeLoss,영업이익,-,Term 24,459045912180,Term 23,486981224742,Term 22,711122934369,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,dart_OtherGains,기타영업외수익,-,Term 24,26395321490,Term 23,46582397077,Term 22,58855764285,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,dart_OtherLosses,기타영업외비용,-,Term 24,215484387559,Term 23,274827614677,Term 22,353493663488,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_CostOfSales,매출원가,-,Term 24,3251086359896,Term 23,3177921081645,Term 22,3168512092765,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,dart_BasicEarningsLossPerSharePreferredStock,기본 우선주당이익,-,Term 24,11331,Term 23,8563,Term 22,14162,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,dart_DilutedEarningsLossPerSharePreferredStock,희석 우선주당이익,-,Term 24,11331,Term 23,8563,Term 22,14162,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_BasicEarningsLossPerShare,기본주당이익(단위: 원),-,Term 24,11281,Term 23,8513,Term 22,14112,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_DilutedEarningsLossPerShare,희석주당이익(단위: 원),-,Term 24,11281,Term 23,8513,Term 22,14112,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_FinanceCosts,금융원가,-,Term 24,21136677993,Term 23,39052274245,Term 22,27261631668,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_FinanceIncome,금융수익,-,Term 24,62038101402,Term 23,48968915334,Term 22,21588027756,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_GrossProfit,매출총이익,-,Term 24,3560832396845,Term 23,3626918288484,Term 22,4017247091570,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 24,112748613963,Term 23,112859158403,Term 22,159429313871,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_ProfitLoss,당기순이익,-,Term 24,203887730139,Term 23,163524219980,Term 22,258340046881,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배지분,-,Term 24,14752971711,Term 23,20768740624,Term 22,21767621073,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 24,189134758428,Term 23,142755479356,Term 22,236572425808,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 24,316636344102,Term 23,276383378383,Term 22,417769360752,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_Revenue,매출액,-,Term 24,6811918756741,Term 23,6804839370129,Term 22,7185759184335,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_SellingGeneralAndAdministrativeExpense,판매비와관리비,-,Term 24,3101786484665,Term 23,3139937063742,Term 22,3306124157201,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 24,5778074582,Term 23,7730730152,Term 22,6957929498,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,당기총포괄이익,-,Term 24,250885696445,Term 23,136065139024,Term 22,265354641614,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배지분,-,Term 24,21843857459,Term 23,20413564234,Term 22,24466139438,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 24,229041838986,Term 23,115651574790,Term 22,240888502176,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 24,46997966306,Term 23,-27459080956,Term 22,7014594733,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되는 항목,-,Term 24,87663490249,Term 23,-12966067430,Term 22,-17274945860,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업환산손익,-,Term 24,87663490249,Term 23,-14468688939,Term 22,-17296890609,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,-,Term 24,0,Term 23,1502621509,Term 22,21944749,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되지 않는 항목:,-,Term 24,-40665523943,Term 23,-14493013526,Term 22,24289540593,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,-,Term 24,-420661737,Term 23,-44771090,Term 22,-226822,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),-,Term 24,-40244862206,Term 23,-14448242436,Term 22,24289767415,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익,-,Term 24,203887730139,Term 23,163524219980,Term 22,258340046881,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초의 현금및현금성자산,-,Term 24,910348037982,Term 23,655092563078,Term 22,734520611733,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말의 현금및현금성자산,-,Term 24,1253469878367,Term 23,910348037982,Term 22,655092563078,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동으로 인한 현금흐름,-,Term 24,-53379075866,Term 23,-268201685330,Term 22,-373633368656,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_DecreaseInGuaranteeDepositsAsFinancialActivities,예수보증금의 지급,-,Term 24,153100000,Term 23,2285992867,Term 22,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_IncreaseInGuaranteeDepositsAsFinancialActivities,예수보증금의 수령,-,Term 24,0,Term 23,2281004811,Term 22,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_PaymentForConsolidatedCapitalTransactions,연결자본거래로 인한 변동,-,Term 24,0,Term 23,12182000,Term 22,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromLongTermBorrowings,장기차입금의 차입,-,Term 24,0,Term 23,0,Term 22,5000000000,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,재무활동으로 인한 현금유입액,-,Term 24,198034356560,Term 23,68752436418,Term 22,324949820109,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,재무활동으로 인한 현금유출액,-,Term 24,251413432426,Term 23,336954121748,Term 22,698583188765,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,유동성장기차입금의 상환,-,Term 24,7790336487,Term 23,12504919540,Term 22,5708202529,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금의 지급,-,Term 24,59751585994,Term 23,97124600150,Term 22,201164100100,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries,비지배지분의 취득,-,Term 24,120953000,Term 23,0,Term 22,11723995920,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 지급,-,Term 24,71291069342,Term 23,77523016101,Term 22,85831436888,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromCurrentBorrowings,단기차입금의 차입,-,Term 24,198034356560,Term 23,66471431607,Term 22,319949820109,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfBondsNotesAndDebentures,유동성사채의 상환,-,Term 24,0,Term 23,0,Term 22,30000000000,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfCurrentBorrowings,단기차입금의 상환,-,Term 24,112306387603,Term 23,147503411090,Term 22,364155453328,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동으로 인한 현금흐름,-,Term 24,-152177113918,Term 23,-140774747630,Term 22,-197383721806,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익-공정가치 측정 금융자산의 감소,-,Term 24,118000000,Term 23,147444361,Term 22,0,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치 측정 금융자산의 처분,-,Term 24,0,Term 23,0,Term 22,197100000,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentsInJointVentures,공동기업의 처분,-,Term 24,0,Term 23,4472515425,Term 22,0,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfLongTermLoansAndReceivables,장기기타채권의 감소,-,Term 24,4669705611,Term 23,13569453414,Term 22,3953324404,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfNonCurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정자산의 처분,-,Term 24,0,Term 23,10607576553,Term 22,0,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfShortTermFinancialInstruments,단기금융상품의 감소,-,Term 24,7000000000,Term 23,5518167924,Term 22,83471000000,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfShortTermLoansAndReceivables,단기기타채권의 감소,-,Term 24,831495113,Term 23,2003884990,Term 22,4352892626,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익-공정가치 측정 금융자산의 증가,-,Term 24,5017415555,Term 23,1406880000,Term 22,0,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_PurchaseOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치 측정 금융자산의 증가,-,Term 24,0,Term 23,0,Term 22,536445000,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_PurchaseOfLongTermLoansAndReceivables,장기기타채권의 증가,-,Term 24,2661720524,Term 23,2495184656,Term 22,2028968475,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_PurchaseOfShortTermFinancialInstruments,단기금융상품의 증가,-,Term 24,7000000000,Term 23,0,Term 22,7200000000,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_PurchaseOfShortTermLoansAndReceivables,단기기타채권의 증가,-,Term 24,2587977443,Term 23,891463446,Term 22,751760126,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합으로 인한 순현금유출액,-,Term 24,0,Term 23,42226006685,Term 22,152045552711,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_InflowsOfCashFromInvestingActivities,투자활동으로 인한 현금유입액,-,Term 24,14384355031,Term 23,69758341538,Term 22,131615889634,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_OutflowsOfCashFromInvestingActivities,투자활동으로 인한 현금유출액,-,Term 24,166561468949,Term 23,210533089168,Term 22,328999611440,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities,국고보조금의 수취,-,Term 24,205398919,Term 23,297900000,Term 22,19110000,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 24,40363636,Term 23,798429624,Term 22,4640939909,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 24,0,Term 23,10078205814,Term 22,576520000,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 24,1519391752,Term 23,22264763433,Term 22,34405002695,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 24,16151302648,Term 23,11095215663,Term 22,9391190370,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfInterestsInAssociates,관계기업의 취득,-,Term 24,2000000000,Term 23,0,Term 22,0,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 24,131143052779,Term 23,152418338718,Term 22,157045694758,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동으로 인한 현금흐름,-,Term 24,527630110092,Term 23,659061627244,Term 22,497299483100,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업활동으로 인한 자산부채의 변동,-,Term 24,-113977431746,Term 23,113424453984,Term 22,-199657616423,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInOtherNonCurrentNonFinancialAssets,기타비유동자산,-,Term 24,380051773,Term 23,-3529410936,Term 22,-3913036948,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherNonCurrentLiabilities,기타비유동부채,-,Term 24,9155451419,Term 23,5973809642,Term 22,-5666018887,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInProvisionsForReturnedGoods,환불부채,-,Term 24,387088783,Term 23,-1781499741,Term 22,481980735,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 24,16107593829,Term 23,45642050773,Term 22,-72237655740,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,퇴직급여부채의 관계사 전입,-,Term 24,474753186,Term 23,63983179,Term 22,129783254,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,예수보증금,-,Term 24,3695913,Term 23,34324,Term 22,5859634835,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산,-,Term 24,-3294746419,Term 23,75399386528,Term 22,62013447364,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산,-,Term 24,-285751635,Term 23,7783706027,Term 22,11453506140,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables,기타채권,-,Term 24,18080001759,Term 23,12235677287,Term 22,-11283101681,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable,매출채권,-,Term 24,-32512956032,Term 23,23545052313,Term 22,12853602709,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채,-,Term 24,-27330313643,Term 23,-27241015124,Term 22,-33973949285,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInOtherOperatingPayables,기타채무,-,Term 24,-27625599793,Term 23,-30530710825,Term 22,-49816791137,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable,매입채무,-,Term 24,-33017881463,Term 23,39379494117,Term 22,-65158003482,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset,사외적립자산,-,Term 24,-29140665601,Term 23,-26599447041,Term 22,-44570790774,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset,퇴직금의 지급,-,Term 24,5358153822,Term 23,6916656539,Term 22,5830223526,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,수익ㆍ비용의 가감,-,Term 24,512542970578,Term 23,536269020585,Term 22,678770999043,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비(대손충당금환입),-,Term 24,713134900,Term 23,1294475720,Term 22,-428896863,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 24,1242248536,Term 23,12574109819,Term 22,20139865677,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 24,9249386201,Term 23,2168413249,Term 22,3011356217,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfIntangibleAssets,무형자산처분이익,-,Term 24,37363636,Term 23,138768242,Term 22,93183291,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentProperty,투자부동산처분이익,-,Term 24,0,Term 23,4648837954,Term 22,146808846,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정자산처분이익,-,Term 24,0,Term 23,2775048994,Term 22,0,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치 측정 금융자산 평가이익,-,Term 24,19067544007,Term 23,18722387548,Term 22,4632564558,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfIntangibleAssets,무형자산손상차손,-,Term 24,93440164020,Term 23,112204887141,Term 22,177834742877,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfPropertyPlantAndEquipment,유형자산손상차손,-,Term 24,7184444737,Term 23,6555409177,Term 22,6796472886,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 24,17267275143,Term 23,19366715671,Term 22,14830609188,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfIntangibleAssets,무형자산처분손실,-,Term 24,1317475199,Term 23,6390206970,Term 22,3010429856,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfInvestmentProperty,투자부동산처분손실,-,Term 24,0,Term 23,10751933,Term 22,36425687,74,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 24,6396855172,Term 23,9405747018,Term 22,3417665095,75,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치 측정 금융자산 평가손실,-,Term 24,184733262,Term 23,14582257107,Term 22,6732536253,76,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 24,19376426283,Term 23,3588155054,Term 22,5088997246,77,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타대손충당금환입,-,Term 24,-398129715,Term 23,-181795254,Term 22,-197792932,78,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForOtherExpenseByFunction,기타영업외비용,-,Term 24,568044465,Term 23,0,Term 22,0,79,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForProfitsOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 24,5778074582,Term 23,7730730152,Term 22,6957929498,80,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 24,44446120510,Term 23,43856005073,Term 22,48421103671,81,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_GainsOnDisposalsOfFairValueFinancialAsset,당기손익-공정가치 측정 금융자산 처분이익,-,Term 24,0,Term 23,3016089,Term 22,0,82,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_GainsOnSaleOfInvestmentsInSubsidiaries,종속기업처분이익,-,Term 24,0,Term 23,0,Term 22,38088456,83,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ImpairmentLossesOnInvestmentProperty,투자부동산손상차손,-,Term 24,629291595,Term 23,896541999,Term 22,0,84,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_LossesOnValuationOfFairValueFinancialLiabilities,당기손익-공정가치 측정 금융부채 평가손실,-,Term 24,0,Term 23,5481920,Term 22,0,85,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분이익,-,Term 24,123684429,Term 23,3395246737,Term 22,74404968,86,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분손실,-,Term 24,78774666,Term 23,242452048,Term 22,61581730,87,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,공동기업처분이익,-,Term 24,0,Term 23,2062573050,Term 22,0,88,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산손상차손,-,Term 24,22067106551,Term 23,16070474902,Term 22,12183534981,89,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 24,34341000860,Term 23,37773195056,Term 22,41092465637,90,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDepreciationExpense,감가상각비,-,Term 24,221266864790,Term 23,232093988438,Term 22,246887613016,91,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDividendIncome,배당금수익,-,Term 24,1781612,Term 23,168120000,Term 22,0,92,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 24,112748613962,Term 23,112859158403,Term 22,159429313871,93,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForInterestIncome,이자수익,-,Term 24,33585142819,Term 23,26357835957,Term 22,11331601645,94,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsOperatingActivities,배당금의 수취,-,Term 24,11674841612,Term 23,5895060000,Term 22,6013497709,95,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세의 납부,-,Term 24,103530506202,Term 23,166490102118,Term 22,244081779186,96,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자의 지급,-,Term 24,18559777623,Term 23,16147404861,Term 22,11779250888,97,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 24,35592283334,Term 23,22586379674,Term 22,9693585964,98,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ProfitLoss,당기순이익,-,Term 24,203887730139,Term 23,163524219980,Term 22,258340046881,99,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,외화환산으로 인한 현금및현금성자산의 변동,-,Term 24,21047920077,Term 23,5170280620,Term 22,-5710441293,100,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,현금및현금성자산의 증감,-,Term 24,322073920308,Term 23,250085194284,Term 22,-73717607362,101,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 24,5548926465800,Term 23,5468835988249,Term 22,5497832811356,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|비지배지분 [구성요소],Term 24,115475406911,Term 23,129553438347,Term 22,109822657026,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,5433451058889,Term 23,5339282549902,Term 22,5388010154330,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,-260224352418,Term 23,-305870275565,Term 22,-217431509911,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,-96665276609,Term 23,-83209267310,Term 22,-64495577286,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,5604425480133,Term 23,5542446884994,Term 22,5484022033744,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,88589470000,Term 23,88589470000,Term 22,88589470000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,97325737783,Term 23,97325737783,Term 22,97325737783,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,58750966950,Term 23,67128988950,Term 22,201177340950,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|비지배지분 [구성요소],Term 24,1004431844,Term 23,30000000000,Term 22,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,연결재무제표 [member],Term 24,59755398794,Term 23,97128988950,Term 22,201177340950,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,0,Term 23,0,Term 22,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,58750966950,Term 23,67128988950,Term 22,201177340950,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,0,Term 23,0,Term 22,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,연결재무제표 [member],Term 24,5685920091079,Term 23,5548926465800,Term 22,5468835988249,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|비지배지분 [구성요소],Term 24,119655719140,Term 23,115475406911,Term 22,129553438347,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,5566264371939,Term 23,5433451058889,Term 22,5339282549902,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,88589470000,Term 23,88589470000,Term 22,88589470000,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,5695579977322,Term 23,5604425480133,Term 22,5542446884994,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,-17528901762,Term 23,-96665276609,Term 22,-83209267310,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,-297701911404,Term 23,-260224352418,Term 22,-305870275565,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,97325737783,Term 23,97325737783,Term 22,97325737783,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,-37477558986,Term 23,45645923147,Term 22,-88438765654,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|비지배지분 [구성요소],Term 24,-16659113386,Term 23,-4491595670,Term 22,-4735358117,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,연결재무제표 [member],Term 24,-54136672372,Term 23,41154327477,Term 22,-93174123771,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,-37477558986,Term 23,45645923147,Term 22,-88438765654,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,0,Term 23,0,Term 22,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,79557036584,Term 23,-14905028256,Term 22,-18538307951,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|비지배지분 [구성요소],Term 24,8106453665,Term 23,436339317,Term 22,1241417342,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,연결재무제표 [member],Term 24,87663490249,Term 23,-14468688939,Term 22,-17296890609,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,0,Term 23,0,Term 22,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,79557036584,Term 23,-14905028256,Term 22,-18538307951,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,-420661737,Term 23,-45654236,Term 22,-226822,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|비지배지분 [구성요소],Term 24,0,Term 23,883146,Term 22,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,연결재무제표 [member],Term 24,-420661737,Term 23,-44771090,Term 22,-226822,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,0,Term 23,0,Term 22,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,0,Term 23,7948316,Term 22,197100000,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,-420661737,Term 23,-53602552,Term 22,-197326822,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),연결재무제표 [member],Term 24,-40244862206,Term 23,-14448242436,Term 22,24289767415,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|비지배지분 [구성요소],Term 24,-1015567917,Term 23,-792398853,Term 22,1457101023,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,-39229294289,Term 23,-13655843583,Term 22,22832666392,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,0,Term 23,0,Term 22,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,0,Term 23,0,Term 22,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,-39229294289,Term 23,-13655843583,Term 22,22832666392,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,연결재무제표 [member],Term 24,203887730139,Term 23,163524219980,Term 22,258340046881,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|비지배지분 [구성요소],Term 24,14752971711,Term 23,20768740624,Term 22,21767621073,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,189134758428,Term 23,142755479356,Term 22,236572425808,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,0,Term 23,0,Term 22,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,0,Term 23,0,Term 22,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,189134758428,Term 23,142755479356,Term 22,236572425808,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,연결재무제표 [member],Term 24,0,Term 23,1502621509,Term 22,21944749,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|비지배지분 [구성요소],Term 24,0,Term 23,0,Term 22,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,0,Term 23,1502621509,Term 22,21944749,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,0,Term 23,1502621509,Term 22,21944749,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,0,Term 23,0,Term 22,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_Assets,자산 총계,-,Term 24,7405784092201,Term 23,7220285811725,Term 22,7302929652203,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 24,2856048500735,Term 23,2429583603574,Term 22,2284388637755,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 24,1253469878367,Term 23,910348037982,Term 22,655092563078,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CurrentTradeReceivables,매출채권,-,Term 24,576205113721,Term 23,529076344154,Term 22,550861505948,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 24,922418157031,Term 23,884515142151,Term 22,955432614662,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentAssets,기타유동자산,-,Term 24,52465237154,Term 23,45271354734,Term 22,46315326894,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 24,4352814406,Term 23,5508065693,Term 22,2687794247,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentReceivables,기타채권,-,Term 24,30655383256,Term 23,38386687660,Term 22,52024002526,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents,단기금융상품,-,Term 24,16481916800,Term 23,16477971200,Term 22,21974830400,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 24,4549735591466,Term 23,4790702208151,Term 22,5018541014448,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 24,34730969596,Term 23,34125353691,Term 22,52397079036,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_IntangibleAssetsAndGoodwill,무형자산,-,Term 24,1964277226876,Term 23,2007877629243,Term 22,2100587252176,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_InvestmentAccountedForUsingEquityMethod,관계기업및공동기업투자,-,Term 24,57876225470,Term 23,61771210888,Term 22,60146908565,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 24,65194503689,Term 23,45974090552,Term 22,25933611138,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_LongtermDeposits,장기금융상품,-,Term 24,23000000,Term 23,23000000,Term 22,23000000,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentAssets,기타비유동자산,-,Term 24,18090955028,Term 23,70587172824,Term 22,109759853810,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 24,31966761345,Term 23,79877043683,Term 22,64367260770,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentReceivables,장기기타채권,-,Term 24,28572485130,Term 23,31032978196,Term 22,40637972467,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 24,2226368549375,Term 23,2307114070178,Term 22,2383867277039,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 24,122634914957,Term 23,152319658896,Term 22,180820799447,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_Equity,자본 총계,-,Term 24,5685920091079,Term 23,5548926465800,Term 22,5468835988249,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업소유주지분,-,Term 24,5566264371939,Term 23,5433451058889,Term 22,5339282549902,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 24,97325737783,Term 23,97325737783,Term 22,97325737783,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본항목,-,Term 24,-297701911404,Term 23,-260224352418,Term 22,-305870275565,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_AccumulatedOtherComprehensiveIncome,기타포괄손익누계액,-,Term 24,-17528901762,Term 23,-96665276609,Term 22,-83209267310,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 24,88589470000,Term 23,88589470000,Term 22,88589470000,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 24,5695579977322,Term 23,5604425480133,Term 22,5542446884994,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배지분,-,Term 24,119655719140,Term 23,115475406911,Term 22,129553438347,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채와 자본 총계,-,Term 24,7405784092201,Term 23,7220285811725,Term 22,7302929652203,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 24,1295900316472,Term 23,1089658847771,Term 22,1162757522705,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CurrentPortionOfLongtermBorrowings,유동성장기차입금,-,Term 24,1993443590,Term 23,7790336487,Term 22,7504919540,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CurrentRefundsProvision,환불부채,-,Term 24,12165316348,Term 23,11578946312,Term 22,13339134213,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 24,66915906521,Term 23,45524846342,Term 22,102379416709,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 24,470505326911,Term 23,309681059345,Term 22,248426155665,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentLiabilities,기타유동부채,-,Term 24,72481574932,Term 23,96798747084,Term 22,120572379988,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentPayables,기타채무,-,Term 24,199506237169,Term 23,226704100602,Term 22,241803567987,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 24,241330029491,Term 23,138182509535,Term 22,215544469417,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers,매입채무,-,Term 24,231002481510,Term 23,253398302064,Term 22,213187479186,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_Liabilities,부채 총계,-,Term 24,1719864001122,Term 23,1671359345925,Term 22,1834093663954,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 24,423963684650,Term 23,581700498154,Term 22,671336141249,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,dart_LongTermGuaranteeDepositWithholdingsNet,예수보증금,-,Term 24,5816707551,Term 23,9741129137,Term 22,10200769679,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 24,127838780237,Term 23,147859534986,Term 22,165223257419,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_LongtermBorrowings,장기차입금,-,Term 24,0,Term 23,1993443590,Term 22,14783780077,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan,퇴직급여부채,-,Term 24,61140758953,Term 23,57381078977,Term 22,63616144843,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialLiabilities,기타비유동금융부채,-,Term 24,178369594748,Term 23,317768045372,Term 22,375094983970,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentLiabilities,기타비유동부채,-,Term 24,50797843161,Term 23,46957266092,Term 22,42417205261,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,dart_OperatingIncomeLoss,영업이익,-,Term 24,459045912180,Term 23,486981224742,Term 22,711122934369,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,dart_OtherGains,기타영업외수익,-,Term 24,26395321490,Term 23,46582397077,Term 22,58855764285,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,dart_OtherLosses,기타영업외비용,-,Term 24,215484387559,Term 23,274827614677,Term 22,353493663488,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_CostOfSales,매출원가,-,Term 24,3251086359896,Term 23,3177921081645,Term 22,3168512092765,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,dart_BasicEarningsLossPerSharePreferredStock,기본 우선주당이익,-,Term 24,11331,Term 23,8563,Term 22,14162,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,dart_DilutedEarningsLossPerSharePreferredStock,희석 우선주당이익,-,Term 24,11331,Term 23,8563,Term 22,14162,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_BasicEarningsLossPerShare,기본주당이익(단위: 원),-,Term 24,11281,Term 23,8513,Term 22,14112,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_DilutedEarningsLossPerShare,희석주당이익(단위: 원),-,Term 24,11281,Term 23,8513,Term 22,14112,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_FinanceCosts,금융원가,-,Term 24,21136677993,Term 23,39052274245,Term 22,27261631668,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_FinanceIncome,금융수익,-,Term 24,62038101402,Term 23,48968915334,Term 22,21588027756,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_GrossProfit,매출총이익,-,Term 24,3560832396845,Term 23,3626918288484,Term 22,4017247091570,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 24,112748613963,Term 23,112859158403,Term 22,159429313871,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_ProfitLoss,당기순이익,-,Term 24,203887730139,Term 23,163524219980,Term 22,258340046881,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배지분,-,Term 24,14752971711,Term 23,20768740624,Term 22,21767621073,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 24,189134758428,Term 23,142755479356,Term 22,236572425808,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 24,316636344102,Term 23,276383378383,Term 22,417769360752,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_Revenue,매출액,-,Term 24,6811918756741,Term 23,6804839370129,Term 22,7185759184335,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_SellingGeneralAndAdministrativeExpense,판매비와관리비,-,Term 24,3101786484665,Term 23,3139937063742,Term 22,3306124157201,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 24,5778074582,Term 23,7730730152,Term 22,6957929498,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,당기총포괄이익,-,Term 24,250885696445,Term 23,136065139024,Term 22,265354641614,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배지분,-,Term 24,21843857459,Term 23,20413564234,Term 22,24466139438,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 24,229041838986,Term 23,115651574790,Term 22,240888502176,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 24,46997966306,Term 23,-27459080956,Term 22,7014594733,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되는 항목,-,Term 24,87663490249,Term 23,-12966067430,Term 22,-17274945860,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업환산손익,-,Term 24,87663490249,Term 23,-14468688939,Term 22,-17296890609,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,-,Term 24,0,Term 23,1502621509,Term 22,21944749,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되지 않는 항목:,-,Term 24,-40665523943,Term 23,-14493013526,Term 22,24289540593,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,-,Term 24,-420661737,Term 23,-44771090,Term 22,-226822,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),-,Term 24,-40244862206,Term 23,-14448242436,Term 22,24289767415,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익,-,Term 24,203887730139,Term 23,163524219980,Term 22,258340046881,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초의 현금및현금성자산,-,Term 24,910348037982,Term 23,655092563078,Term 22,734520611733,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말의 현금및현금성자산,-,Term 24,1253469878367,Term 23,910348037982,Term 22,655092563078,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동으로 인한 현금흐름,-,Term 24,-53379075866,Term 23,-268201685330,Term 22,-373633368656,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_DecreaseInGuaranteeDepositsAsFinancialActivities,예수보증금의 지급,-,Term 24,153100000,Term 23,2285992867,Term 22,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_IncreaseInGuaranteeDepositsAsFinancialActivities,예수보증금의 수령,-,Term 24,0,Term 23,2281004811,Term 22,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_PaymentForConsolidatedCapitalTransactions,연결자본거래로 인한 변동,-,Term 24,0,Term 23,12182000,Term 22,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromLongTermBorrowings,장기차입금의 차입,-,Term 24,0,Term 23,0,Term 22,5000000000,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,재무활동으로 인한 현금유입액,-,Term 24,198034356560,Term 23,68752436418,Term 22,324949820109,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,재무활동으로 인한 현금유출액,-,Term 24,251413432426,Term 23,336954121748,Term 22,698583188765,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,유동성장기차입금의 상환,-,Term 24,7790336487,Term 23,12504919540,Term 22,5708202529,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금의 지급,-,Term 24,59751585994,Term 23,97124600150,Term 22,201164100100,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries,비지배지분의 취득,-,Term 24,120953000,Term 23,0,Term 22,11723995920,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 지급,-,Term 24,71291069342,Term 23,77523016101,Term 22,85831436888,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromCurrentBorrowings,단기차입금의 차입,-,Term 24,198034356560,Term 23,66471431607,Term 22,319949820109,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfBondsNotesAndDebentures,유동성사채의 상환,-,Term 24,0,Term 23,0,Term 22,30000000000,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfCurrentBorrowings,단기차입금의 상환,-,Term 24,112306387603,Term 23,147503411090,Term 22,364155453328,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동으로 인한 현금흐름,-,Term 24,-152177113918,Term 23,-140774747630,Term 22,-197383721806,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익-공정가치 측정 금융자산의 감소,-,Term 24,118000000,Term 23,147444361,Term 22,0,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치 측정 금융자산의 처분,-,Term 24,0,Term 23,0,Term 22,197100000,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentsInJointVentures,공동기업의 처분,-,Term 24,0,Term 23,4472515425,Term 22,0,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfLongTermLoansAndReceivables,장기기타채권의 감소,-,Term 24,4669705611,Term 23,13569453414,Term 22,3953324404,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfNonCurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정자산의 처분,-,Term 24,0,Term 23,10607576553,Term 22,0,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfShortTermFinancialInstruments,단기금융상품의 감소,-,Term 24,7000000000,Term 23,5518167924,Term 22,83471000000,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfShortTermLoansAndReceivables,단기기타채권의 감소,-,Term 24,831495113,Term 23,2003884990,Term 22,4352892626,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익-공정가치 측정 금융자산의 증가,-,Term 24,5017415555,Term 23,1406880000,Term 22,0,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_PurchaseOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치 측정 금융자산의 증가,-,Term 24,0,Term 23,0,Term 22,536445000,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_PurchaseOfLongTermLoansAndReceivables,장기기타채권의 증가,-,Term 24,2661720524,Term 23,2495184656,Term 22,2028968475,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_PurchaseOfShortTermFinancialInstruments,단기금융상품의 증가,-,Term 24,7000000000,Term 23,0,Term 22,7200000000,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_PurchaseOfShortTermLoansAndReceivables,단기기타채권의 증가,-,Term 24,2587977443,Term 23,891463446,Term 22,751760126,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합으로 인한 순현금유출액,-,Term 24,0,Term 23,42226006685,Term 22,152045552711,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_InflowsOfCashFromInvestingActivities,투자활동으로 인한 현금유입액,-,Term 24,14384355031,Term 23,69758341538,Term 22,131615889634,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_OutflowsOfCashFromInvestingActivities,투자활동으로 인한 현금유출액,-,Term 24,166561468949,Term 23,210533089168,Term 22,328999611440,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities,국고보조금의 수취,-,Term 24,205398919,Term 23,297900000,Term 22,19110000,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 24,40363636,Term 23,798429624,Term 22,4640939909,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 24,0,Term 23,10078205814,Term 22,576520000,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 24,1519391752,Term 23,22264763433,Term 22,34405002695,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 24,16151302648,Term 23,11095215663,Term 22,9391190370,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfInterestsInAssociates,관계기업의 취득,-,Term 24,2000000000,Term 23,0,Term 22,0,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 24,131143052779,Term 23,152418338718,Term 22,157045694758,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동으로 인한 현금흐름,-,Term 24,527630110092,Term 23,659061627244,Term 22,497299483100,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업활동으로 인한 자산부채의 변동,-,Term 24,-113977431746,Term 23,113424453984,Term 22,-199657616423,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInOtherNonCurrentNonFinancialAssets,기타비유동자산,-,Term 24,380051773,Term 23,-3529410936,Term 22,-3913036948,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherNonCurrentLiabilities,기타비유동부채,-,Term 24,9155451419,Term 23,5973809642,Term 22,-5666018887,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInProvisionsForReturnedGoods,환불부채,-,Term 24,387088783,Term 23,-1781499741,Term 22,481980735,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 24,16107593829,Term 23,45642050773,Term 22,-72237655740,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,퇴직급여부채의 관계사 전입,-,Term 24,474753186,Term 23,63983179,Term 22,129783254,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,예수보증금,-,Term 24,3695913,Term 23,34324,Term 22,5859634835,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산,-,Term 24,-3294746419,Term 23,75399386528,Term 22,62013447364,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산,-,Term 24,-285751635,Term 23,7783706027,Term 22,11453506140,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables,기타채권,-,Term 24,18080001759,Term 23,12235677287,Term 22,-11283101681,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable,매출채권,-,Term 24,-32512956032,Term 23,23545052313,Term 22,12853602709,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채,-,Term 24,-27330313643,Term 23,-27241015124,Term 22,-33973949285,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInOtherOperatingPayables,기타채무,-,Term 24,-27625599793,Term 23,-30530710825,Term 22,-49816791137,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable,매입채무,-,Term 24,-33017881463,Term 23,39379494117,Term 22,-65158003482,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset,사외적립자산,-,Term 24,-29140665601,Term 23,-26599447041,Term 22,-44570790774,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset,퇴직금의 지급,-,Term 24,5358153822,Term 23,6916656539,Term 22,5830223526,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,수익ㆍ비용의 가감,-,Term 24,512542970578,Term 23,536269020585,Term 22,678770999043,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비(대손충당금환입),-,Term 24,713134900,Term 23,1294475720,Term 22,-428896863,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 24,1242248536,Term 23,12574109819,Term 22,20139865677,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 24,9249386201,Term 23,2168413249,Term 22,3011356217,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfIntangibleAssets,무형자산처분이익,-,Term 24,37363636,Term 23,138768242,Term 22,93183291,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentProperty,투자부동산처분이익,-,Term 24,0,Term 23,4648837954,Term 22,146808846,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정자산처분이익,-,Term 24,0,Term 23,2775048994,Term 22,0,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치 측정 금융자산 평가이익,-,Term 24,19067544007,Term 23,18722387548,Term 22,4632564558,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfIntangibleAssets,무형자산손상차손,-,Term 24,93440164020,Term 23,112204887141,Term 22,177834742877,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfPropertyPlantAndEquipment,유형자산손상차손,-,Term 24,7184444737,Term 23,6555409177,Term 22,6796472886,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 24,17267275143,Term 23,19366715671,Term 22,14830609188,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfIntangibleAssets,무형자산처분손실,-,Term 24,1317475199,Term 23,6390206970,Term 22,3010429856,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfInvestmentProperty,투자부동산처분손실,-,Term 24,0,Term 23,10751933,Term 22,36425687,74,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 24,6396855172,Term 23,9405747018,Term 22,3417665095,75,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치 측정 금융자산 평가손실,-,Term 24,184733262,Term 23,14582257107,Term 22,6732536253,76,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 24,19376426283,Term 23,3588155054,Term 22,5088997246,77,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타대손충당금환입,-,Term 24,-398129715,Term 23,-181795254,Term 22,-197792932,78,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForOtherExpenseByFunction,기타영업외비용,-,Term 24,568044465,Term 23,0,Term 22,0,79,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForProfitsOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 24,5778074582,Term 23,7730730152,Term 22,6957929498,80,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 24,44446120510,Term 23,43856005073,Term 22,48421103671,81,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_GainsOnDisposalsOfFairValueFinancialAsset,당기손익-공정가치 측정 금융자산 처분이익,-,Term 24,0,Term 23,3016089,Term 22,0,82,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_GainsOnSaleOfInvestmentsInSubsidiaries,종속기업처분이익,-,Term 24,0,Term 23,0,Term 22,38088456,83,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ImpairmentLossesOnInvestmentProperty,투자부동산손상차손,-,Term 24,629291595,Term 23,896541999,Term 22,0,84,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_LossesOnValuationOfFairValueFinancialLiabilities,당기손익-공정가치 측정 금융부채 평가손실,-,Term 24,0,Term 23,5481920,Term 22,0,85,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분이익,-,Term 24,123684429,Term 23,3395246737,Term 22,74404968,86,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분손실,-,Term 24,78774666,Term 23,242452048,Term 22,61581730,87,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,공동기업처분이익,-,Term 24,0,Term 23,2062573050,Term 22,0,88,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산손상차손,-,Term 24,22067106551,Term 23,16070474902,Term 22,12183534981,89,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 24,34341000860,Term 23,37773195056,Term 22,41092465637,90,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDepreciationExpense,감가상각비,-,Term 24,221266864790,Term 23,232093988438,Term 22,246887613016,91,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDividendIncome,배당금수익,-,Term 24,1781612,Term 23,168120000,Term 22,0,92,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 24,112748613962,Term 23,112859158403,Term 22,159429313871,93,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForInterestIncome,이자수익,-,Term 24,33585142819,Term 23,26357835957,Term 22,11331601645,94,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsOperatingActivities,배당금의 수취,-,Term 24,11674841612,Term 23,5895060000,Term 22,6013497709,95,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세의 납부,-,Term 24,103530506202,Term 23,166490102118,Term 22,244081779186,96,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자의 지급,-,Term 24,18559777623,Term 23,16147404861,Term 22,11779250888,97,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 24,35592283334,Term 23,22586379674,Term 22,9693585964,98,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ProfitLoss,당기순이익,-,Term 24,203887730139,Term 23,163524219980,Term 22,258340046881,99,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,외화환산으로 인한 현금및현금성자산의 변동,-,Term 24,21047920077,Term 23,5170280620,Term 22,-5710441293,100,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,현금및현금성자산의 증감,-,Term 24,322073920308,Term 23,250085194284,Term 22,-73717607362,101,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 24,5548926465800,Term 23,5468835988249,Term 22,5497832811356,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|비지배지분 [구성요소],Term 24,115475406911,Term 23,129553438347,Term 22,109822657026,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,5433451058889,Term 23,5339282549902,Term 22,5388010154330,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,-260224352418,Term 23,-305870275565,Term 22,-217431509911,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,-96665276609,Term 23,-83209267310,Term 22,-64495577286,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,5604425480133,Term 23,5542446884994,Term 22,5484022033744,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,88589470000,Term 23,88589470000,Term 22,88589470000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,97325737783,Term 23,97325737783,Term 22,97325737783,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,58750966950,Term 23,67128988950,Term 22,201177340950,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|비지배지분 [구성요소],Term 24,1004431844,Term 23,30000000000,Term 22,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,연결재무제표 [member],Term 24,59755398794,Term 23,97128988950,Term 22,201177340950,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,0,Term 23,0,Term 22,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,58750966950,Term 23,67128988950,Term 22,201177340950,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,0,Term 23,0,Term 22,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,연결재무제표 [member],Term 24,5685920091079,Term 23,5548926465800,Term 22,5468835988249,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|비지배지분 [구성요소],Term 24,119655719140,Term 23,115475406911,Term 22,129553438347,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,5566264371939,Term 23,5433451058889,Term 22,5339282549902,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,88589470000,Term 23,88589470000,Term 22,88589470000,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,5695579977322,Term 23,5604425480133,Term 22,5542446884994,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,-17528901762,Term 23,-96665276609,Term 22,-83209267310,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,-297701911404,Term 23,-260224352418,Term 22,-305870275565,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,97325737783,Term 23,97325737783,Term 22,97325737783,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,-37477558986,Term 23,45645923147,Term 22,-88438765654,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|비지배지분 [구성요소],Term 24,-16659113386,Term 23,-4491595670,Term 22,-4735358117,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,연결재무제표 [member],Term 24,-54136672372,Term 23,41154327477,Term 22,-93174123771,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,-37477558986,Term 23,45645923147,Term 22,-88438765654,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,0,Term 23,0,Term 22,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,79557036584,Term 23,-14905028256,Term 22,-18538307951,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|비지배지분 [구성요소],Term 24,8106453665,Term 23,436339317,Term 22,1241417342,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,연결재무제표 [member],Term 24,87663490249,Term 23,-14468688939,Term 22,-17296890609,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,0,Term 23,0,Term 22,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,79557036584,Term 23,-14905028256,Term 22,-18538307951,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,-420661737,Term 23,-45654236,Term 22,-226822,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|비지배지분 [구성요소],Term 24,0,Term 23,883146,Term 22,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,연결재무제표 [member],Term 24,-420661737,Term 23,-44771090,Term 22,-226822,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,0,Term 23,0,Term 22,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,0,Term 23,7948316,Term 22,197100000,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,-420661737,Term 23,-53602552,Term 22,-197326822,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),연결재무제표 [member],Term 24,-40244862206,Term 23,-14448242436,Term 22,24289767415,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|비지배지분 [구성요소],Term 24,-1015567917,Term 23,-792398853,Term 22,1457101023,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,-39229294289,Term 23,-13655843583,Term 22,22832666392,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,0,Term 23,0,Term 22,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,0,Term 23,0,Term 22,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,-39229294289,Term 23,-13655843583,Term 22,22832666392,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,연결재무제표 [member],Term 24,203887730139,Term 23,163524219980,Term 22,258340046881,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|비지배지분 [구성요소],Term 24,14752971711,Term 23,20768740624,Term 22,21767621073,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,189134758428,Term 23,142755479356,Term 22,236572425808,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,0,Term 23,0,Term 22,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,0,Term 23,0,Term 22,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,189134758428,Term 23,142755479356,Term 22,236572425808,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,연결재무제표 [member],Term 24,0,Term 23,1502621509,Term 22,21944749,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|비지배지분 [구성요소],Term 24,0,Term 23,0,Term 22,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,0,Term 23,1502621509,Term 22,21944749,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,0,Term 23,1502621509,Term 22,21944749,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,0,Term 23,0,Term 22,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_Assets,자산 총계,-,Term 24,7405784092201,Term 23,7220285811725,Term 22,7302929652203,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 24,2856048500735,Term 23,2429583603574,Term 22,2284388637755,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 24,1253469878367,Term 23,910348037982,Term 22,655092563078,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CurrentTradeReceivables,매출채권,-,Term 24,576205113721,Term 23,529076344154,Term 22,550861505948,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 24,922418157031,Term 23,884515142151,Term 22,955432614662,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentAssets,기타유동자산,-,Term 24,52465237154,Term 23,45271354734,Term 22,46315326894,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 24,4352814406,Term 23,5508065693,Term 22,2687794247,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentReceivables,기타채권,-,Term 24,30655383256,Term 23,38386687660,Term 22,52024002526,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents,단기금융상품,-,Term 24,16481916800,Term 23,16477971200,Term 22,21974830400,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 24,4549735591466,Term 23,4790702208151,Term 22,5018541014448,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 24,34730969596,Term 23,34125353691,Term 22,52397079036,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_IntangibleAssetsAndGoodwill,무형자산,-,Term 24,1964277226876,Term 23,2007877629243,Term 22,2100587252176,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_InvestmentAccountedForUsingEquityMethod,관계기업및공동기업투자,-,Term 24,57876225470,Term 23,61771210888,Term 22,60146908565,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 24,65194503689,Term 23,45974090552,Term 22,25933611138,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_LongtermDeposits,장기금융상품,-,Term 24,23000000,Term 23,23000000,Term 22,23000000,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentAssets,기타비유동자산,-,Term 24,18090955028,Term 23,70587172824,Term 22,109759853810,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 24,31966761345,Term 23,79877043683,Term 22,64367260770,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentReceivables,장기기타채권,-,Term 24,28572485130,Term 23,31032978196,Term 22,40637972467,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 24,2226368549375,Term 23,2307114070178,Term 22,2383867277039,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 24,122634914957,Term 23,152319658896,Term 22,180820799447,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_Equity,자본 총계,-,Term 24,5685920091079,Term 23,5548926465800,Term 22,5468835988249,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업소유주지분,-,Term 24,5566264371939,Term 23,5433451058889,Term 22,5339282549902,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 24,97325737783,Term 23,97325737783,Term 22,97325737783,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본항목,-,Term 24,-297701911404,Term 23,-260224352418,Term 22,-305870275565,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_AccumulatedOtherComprehensiveIncome,기타포괄손익누계액,-,Term 24,-17528901762,Term 23,-96665276609,Term 22,-83209267310,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 24,88589470000,Term 23,88589470000,Term 22,88589470000,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 24,5695579977322,Term 23,5604425480133,Term 22,5542446884994,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배지분,-,Term 24,119655719140,Term 23,115475406911,Term 22,129553438347,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채와 자본 총계,-,Term 24,7405784092201,Term 23,7220285811725,Term 22,7302929652203,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 24,1295900316472,Term 23,1089658847771,Term 22,1162757522705,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CurrentPortionOfLongtermBorrowings,유동성장기차입금,-,Term 24,1993443590,Term 23,7790336487,Term 22,7504919540,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CurrentRefundsProvision,환불부채,-,Term 24,12165316348,Term 23,11578946312,Term 22,13339134213,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 24,66915906521,Term 23,45524846342,Term 22,102379416709,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 24,470505326911,Term 23,309681059345,Term 22,248426155665,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentLiabilities,기타유동부채,-,Term 24,72481574932,Term 23,96798747084,Term 22,120572379988,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentPayables,기타채무,-,Term 24,199506237169,Term 23,226704100602,Term 22,241803567987,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 24,241330029491,Term 23,138182509535,Term 22,215544469417,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers,매입채무,-,Term 24,231002481510,Term 23,253398302064,Term 22,213187479186,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_Liabilities,부채 총계,-,Term 24,1719864001122,Term 23,1671359345925,Term 22,1834093663954,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 24,423963684650,Term 23,581700498154,Term 22,671336141249,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,dart_LongTermGuaranteeDepositWithholdingsNet,예수보증금,-,Term 24,5816707551,Term 23,9741129137,Term 22,10200769679,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 24,127838780237,Term 23,147859534986,Term 22,165223257419,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_LongtermBorrowings,장기차입금,-,Term 24,0,Term 23,1993443590,Term 22,14783780077,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan,퇴직급여부채,-,Term 24,61140758953,Term 23,57381078977,Term 22,63616144843,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialLiabilities,기타비유동금융부채,-,Term 24,178369594748,Term 23,317768045372,Term 22,375094983970,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentLiabilities,기타비유동부채,-,Term 24,50797843161,Term 23,46957266092,Term 22,42417205261,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,dart_OperatingIncomeLoss,영업이익,-,Term 24,459045912180,Term 23,486981224742,Term 22,711122934369,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,dart_OtherGains,기타영업외수익,-,Term 24,26395321490,Term 23,46582397077,Term 22,58855764285,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,dart_OtherLosses,기타영업외비용,-,Term 24,215484387559,Term 23,274827614677,Term 22,353493663488,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_CostOfSales,매출원가,-,Term 24,3251086359896,Term 23,3177921081645,Term 22,3168512092765,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,dart_BasicEarningsLossPerSharePreferredStock,기본 우선주당이익,-,Term 24,11331,Term 23,8563,Term 22,14162,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,dart_DilutedEarningsLossPerSharePreferredStock,희석 우선주당이익,-,Term 24,11331,Term 23,8563,Term 22,14162,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_BasicEarningsLossPerShare,기본주당이익(단위: 원),-,Term 24,11281,Term 23,8513,Term 22,14112,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_DilutedEarningsLossPerShare,희석주당이익(단위: 원),-,Term 24,11281,Term 23,8513,Term 22,14112,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_FinanceCosts,금융원가,-,Term 24,21136677993,Term 23,39052274245,Term 22,27261631668,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_FinanceIncome,금융수익,-,Term 24,62038101402,Term 23,48968915334,Term 22,21588027756,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_GrossProfit,매출총이익,-,Term 24,3560832396845,Term 23,3626918288484,Term 22,4017247091570,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 24,112748613963,Term 23,112859158403,Term 22,159429313871,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_ProfitLoss,당기순이익,-,Term 24,203887730139,Term 23,163524219980,Term 22,258340046881,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배지분,-,Term 24,14752971711,Term 23,20768740624,Term 22,21767621073,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 24,189134758428,Term 23,142755479356,Term 22,236572425808,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 24,316636344102,Term 23,276383378383,Term 22,417769360752,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_Revenue,매출액,-,Term 24,6811918756741,Term 23,6804839370129,Term 22,7185759184335,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_SellingGeneralAndAdministrativeExpense,판매비와관리비,-,Term 24,3101786484665,Term 23,3139937063742,Term 22,3306124157201,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 24,5778074582,Term 23,7730730152,Term 22,6957929498,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,당기총포괄이익,-,Term 24,250885696445,Term 23,136065139024,Term 22,265354641614,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배지분,-,Term 24,21843857459,Term 23,20413564234,Term 22,24466139438,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 24,229041838986,Term 23,115651574790,Term 22,240888502176,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 24,46997966306,Term 23,-27459080956,Term 22,7014594733,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되는 항목,-,Term 24,87663490249,Term 23,-12966067430,Term 22,-17274945860,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업환산손익,-,Term 24,87663490249,Term 23,-14468688939,Term 22,-17296890609,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,-,Term 24,0,Term 23,1502621509,Term 22,21944749,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되지 않는 항목:,-,Term 24,-40665523943,Term 23,-14493013526,Term 22,24289540593,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,-,Term 24,-420661737,Term 23,-44771090,Term 22,-226822,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),-,Term 24,-40244862206,Term 23,-14448242436,Term 22,24289767415,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익,-,Term 24,203887730139,Term 23,163524219980,Term 22,258340046881,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초의 현금및현금성자산,-,Term 24,910348037982,Term 23,655092563078,Term 22,734520611733,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말의 현금및현금성자산,-,Term 24,1253469878367,Term 23,910348037982,Term 22,655092563078,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동으로 인한 현금흐름,-,Term 24,-53379075866,Term 23,-268201685330,Term 22,-373633368656,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_DecreaseInGuaranteeDepositsAsFinancialActivities,예수보증금의 지급,-,Term 24,153100000,Term 23,2285992867,Term 22,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_IncreaseInGuaranteeDepositsAsFinancialActivities,예수보증금의 수령,-,Term 24,0,Term 23,2281004811,Term 22,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_PaymentForConsolidatedCapitalTransactions,연결자본거래로 인한 변동,-,Term 24,0,Term 23,12182000,Term 22,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromLongTermBorrowings,장기차입금의 차입,-,Term 24,0,Term 23,0,Term 22,5000000000,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,재무활동으로 인한 현금유입액,-,Term 24,198034356560,Term 23,68752436418,Term 22,324949820109,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,재무활동으로 인한 현금유출액,-,Term 24,251413432426,Term 23,336954121748,Term 22,698583188765,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,유동성장기차입금의 상환,-,Term 24,7790336487,Term 23,12504919540,Term 22,5708202529,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금의 지급,-,Term 24,59751585994,Term 23,97124600150,Term 22,201164100100,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries,비지배지분의 취득,-,Term 24,120953000,Term 23,0,Term 22,11723995920,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 지급,-,Term 24,71291069342,Term 23,77523016101,Term 22,85831436888,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromCurrentBorrowings,단기차입금의 차입,-,Term 24,198034356560,Term 23,66471431607,Term 22,319949820109,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfBondsNotesAndDebentures,유동성사채의 상환,-,Term 24,0,Term 23,0,Term 22,30000000000,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfCurrentBorrowings,단기차입금의 상환,-,Term 24,112306387603,Term 23,147503411090,Term 22,364155453328,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동으로 인한 현금흐름,-,Term 24,-152177113918,Term 23,-140774747630,Term 22,-197383721806,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익-공정가치 측정 금융자산의 감소,-,Term 24,118000000,Term 23,147444361,Term 22,0,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치 측정 금융자산의 처분,-,Term 24,0,Term 23,0,Term 22,197100000,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentsInJointVentures,공동기업의 처분,-,Term 24,0,Term 23,4472515425,Term 22,0,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfLongTermLoansAndReceivables,장기기타채권의 감소,-,Term 24,4669705611,Term 23,13569453414,Term 22,3953324404,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfNonCurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정자산의 처분,-,Term 24,0,Term 23,10607576553,Term 22,0,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfShortTermFinancialInstruments,단기금융상품의 감소,-,Term 24,7000000000,Term 23,5518167924,Term 22,83471000000,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfShortTermLoansAndReceivables,단기기타채권의 감소,-,Term 24,831495113,Term 23,2003884990,Term 22,4352892626,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익-공정가치 측정 금융자산의 증가,-,Term 24,5017415555,Term 23,1406880000,Term 22,0,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_PurchaseOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치 측정 금융자산의 증가,-,Term 24,0,Term 23,0,Term 22,536445000,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_PurchaseOfLongTermLoansAndReceivables,장기기타채권의 증가,-,Term 24,2661720524,Term 23,2495184656,Term 22,2028968475,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_PurchaseOfShortTermFinancialInstruments,단기금융상품의 증가,-,Term 24,7000000000,Term 23,0,Term 22,7200000000,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_PurchaseOfShortTermLoansAndReceivables,단기기타채권의 증가,-,Term 24,2587977443,Term 23,891463446,Term 22,751760126,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합으로 인한 순현금유출액,-,Term 24,0,Term 23,42226006685,Term 22,152045552711,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_InflowsOfCashFromInvestingActivities,투자활동으로 인한 현금유입액,-,Term 24,14384355031,Term 23,69758341538,Term 22,131615889634,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_OutflowsOfCashFromInvestingActivities,투자활동으로 인한 현금유출액,-,Term 24,166561468949,Term 23,210533089168,Term 22,328999611440,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities,국고보조금의 수취,-,Term 24,205398919,Term 23,297900000,Term 22,19110000,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 24,40363636,Term 23,798429624,Term 22,4640939909,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 24,0,Term 23,10078205814,Term 22,576520000,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 24,1519391752,Term 23,22264763433,Term 22,34405002695,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 24,16151302648,Term 23,11095215663,Term 22,9391190370,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfInterestsInAssociates,관계기업의 취득,-,Term 24,2000000000,Term 23,0,Term 22,0,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 24,131143052779,Term 23,152418338718,Term 22,157045694758,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동으로 인한 현금흐름,-,Term 24,527630110092,Term 23,659061627244,Term 22,497299483100,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업활동으로 인한 자산부채의 변동,-,Term 24,-113977431746,Term 23,113424453984,Term 22,-199657616423,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInOtherNonCurrentNonFinancialAssets,기타비유동자산,-,Term 24,380051773,Term 23,-3529410936,Term 22,-3913036948,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherNonCurrentLiabilities,기타비유동부채,-,Term 24,9155451419,Term 23,5973809642,Term 22,-5666018887,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInProvisionsForReturnedGoods,환불부채,-,Term 24,387088783,Term 23,-1781499741,Term 22,481980735,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 24,16107593829,Term 23,45642050773,Term 22,-72237655740,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,퇴직급여부채의 관계사 전입,-,Term 24,474753186,Term 23,63983179,Term 22,129783254,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,예수보증금,-,Term 24,3695913,Term 23,34324,Term 22,5859634835,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산,-,Term 24,-3294746419,Term 23,75399386528,Term 22,62013447364,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산,-,Term 24,-285751635,Term 23,7783706027,Term 22,11453506140,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables,기타채권,-,Term 24,18080001759,Term 23,12235677287,Term 22,-11283101681,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable,매출채권,-,Term 24,-32512956032,Term 23,23545052313,Term 22,12853602709,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채,-,Term 24,-27330313643,Term 23,-27241015124,Term 22,-33973949285,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInOtherOperatingPayables,기타채무,-,Term 24,-27625599793,Term 23,-30530710825,Term 22,-49816791137,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable,매입채무,-,Term 24,-33017881463,Term 23,39379494117,Term 22,-65158003482,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset,사외적립자산,-,Term 24,-29140665601,Term 23,-26599447041,Term 22,-44570790774,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset,퇴직금의 지급,-,Term 24,5358153822,Term 23,6916656539,Term 22,5830223526,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,수익ㆍ비용의 가감,-,Term 24,512542970578,Term 23,536269020585,Term 22,678770999043,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비(대손충당금환입),-,Term 24,713134900,Term 23,1294475720,Term 22,-428896863,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 24,1242248536,Term 23,12574109819,Term 22,20139865677,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 24,9249386201,Term 23,2168413249,Term 22,3011356217,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfIntangibleAssets,무형자산처분이익,-,Term 24,37363636,Term 23,138768242,Term 22,93183291,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentProperty,투자부동산처분이익,-,Term 24,0,Term 23,4648837954,Term 22,146808846,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정자산처분이익,-,Term 24,0,Term 23,2775048994,Term 22,0,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치 측정 금융자산 평가이익,-,Term 24,19067544007,Term 23,18722387548,Term 22,4632564558,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfIntangibleAssets,무형자산손상차손,-,Term 24,93440164020,Term 23,112204887141,Term 22,177834742877,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfPropertyPlantAndEquipment,유형자산손상차손,-,Term 24,7184444737,Term 23,6555409177,Term 22,6796472886,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 24,17267275143,Term 23,19366715671,Term 22,14830609188,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfIntangibleAssets,무형자산처분손실,-,Term 24,1317475199,Term 23,6390206970,Term 22,3010429856,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfInvestmentProperty,투자부동산처분손실,-,Term 24,0,Term 23,10751933,Term 22,36425687,74,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 24,6396855172,Term 23,9405747018,Term 22,3417665095,75,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치 측정 금융자산 평가손실,-,Term 24,184733262,Term 23,14582257107,Term 22,6732536253,76,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 24,19376426283,Term 23,3588155054,Term 22,5088997246,77,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타대손충당금환입,-,Term 24,-398129715,Term 23,-181795254,Term 22,-197792932,78,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForOtherExpenseByFunction,기타영업외비용,-,Term 24,568044465,Term 23,0,Term 22,0,79,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForProfitsOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 24,5778074582,Term 23,7730730152,Term 22,6957929498,80,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 24,44446120510,Term 23,43856005073,Term 22,48421103671,81,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_GainsOnDisposalsOfFairValueFinancialAsset,당기손익-공정가치 측정 금융자산 처분이익,-,Term 24,0,Term 23,3016089,Term 22,0,82,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_GainsOnSaleOfInvestmentsInSubsidiaries,종속기업처분이익,-,Term 24,0,Term 23,0,Term 22,38088456,83,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ImpairmentLossesOnInvestmentProperty,투자부동산손상차손,-,Term 24,629291595,Term 23,896541999,Term 22,0,84,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_LossesOnValuationOfFairValueFinancialLiabilities,당기손익-공정가치 측정 금융부채 평가손실,-,Term 24,0,Term 23,5481920,Term 22,0,85,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분이익,-,Term 24,123684429,Term 23,3395246737,Term 22,74404968,86,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분손실,-,Term 24,78774666,Term 23,242452048,Term 22,61581730,87,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,공동기업처분이익,-,Term 24,0,Term 23,2062573050,Term 22,0,88,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산손상차손,-,Term 24,22067106551,Term 23,16070474902,Term 22,12183534981,89,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 24,34341000860,Term 23,37773195056,Term 22,41092465637,90,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDepreciationExpense,감가상각비,-,Term 24,221266864790,Term 23,232093988438,Term 22,246887613016,91,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDividendIncome,배당금수익,-,Term 24,1781612,Term 23,168120000,Term 22,0,92,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 24,112748613962,Term 23,112859158403,Term 22,159429313871,93,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForInterestIncome,이자수익,-,Term 24,33585142819,Term 23,26357835957,Term 22,11331601645,94,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsOperatingActivities,배당금의 수취,-,Term 24,11674841612,Term 23,5895060000,Term 22,6013497709,95,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세의 납부,-,Term 24,103530506202,Term 23,166490102118,Term 22,244081779186,96,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자의 지급,-,Term 24,18559777623,Term 23,16147404861,Term 22,11779250888,97,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 24,35592283334,Term 23,22586379674,Term 22,9693585964,98,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ProfitLoss,당기순이익,-,Term 24,203887730139,Term 23,163524219980,Term 22,258340046881,99,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,외화환산으로 인한 현금및현금성자산의 변동,-,Term 24,21047920077,Term 23,5170280620,Term 22,-5710441293,100,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,현금및현금성자산의 증감,-,Term 24,322073920308,Term 23,250085194284,Term 22,-73717607362,101,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 24,5548926465800,Term 23,5468835988249,Term 22,5497832811356,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|비지배지분 [구성요소],Term 24,115475406911,Term 23,129553438347,Term 22,109822657026,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,5433451058889,Term 23,5339282549902,Term 22,5388010154330,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,-260224352418,Term 23,-305870275565,Term 22,-217431509911,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,-96665276609,Term 23,-83209267310,Term 22,-64495577286,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,5604425480133,Term 23,5542446884994,Term 22,5484022033744,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,88589470000,Term 23,88589470000,Term 22,88589470000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,97325737783,Term 23,97325737783,Term 22,97325737783,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,58750966950,Term 23,67128988950,Term 22,201177340950,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|비지배지분 [구성요소],Term 24,1004431844,Term 23,30000000000,Term 22,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,연결재무제표 [member],Term 24,59755398794,Term 23,97128988950,Term 22,201177340950,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,0,Term 23,0,Term 22,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,58750966950,Term 23,67128988950,Term 22,201177340950,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,0,Term 23,0,Term 22,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,연결재무제표 [member],Term 24,5685920091079,Term 23,5548926465800,Term 22,5468835988249,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|비지배지분 [구성요소],Term 24,119655719140,Term 23,115475406911,Term 22,129553438347,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,5566264371939,Term 23,5433451058889,Term 22,5339282549902,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,88589470000,Term 23,88589470000,Term 22,88589470000,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,5695579977322,Term 23,5604425480133,Term 22,5542446884994,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,-17528901762,Term 23,-96665276609,Term 22,-83209267310,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,-297701911404,Term 23,-260224352418,Term 22,-305870275565,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,97325737783,Term 23,97325737783,Term 22,97325737783,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,-37477558986,Term 23,45645923147,Term 22,-88438765654,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|비지배지분 [구성요소],Term 24,-16659113386,Term 23,-4491595670,Term 22,-4735358117,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,연결재무제표 [member],Term 24,-54136672372,Term 23,41154327477,Term 22,-93174123771,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,-37477558986,Term 23,45645923147,Term 22,-88438765654,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,0,Term 23,0,Term 22,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,79557036584,Term 23,-14905028256,Term 22,-18538307951,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|비지배지분 [구성요소],Term 24,8106453665,Term 23,436339317,Term 22,1241417342,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,연결재무제표 [member],Term 24,87663490249,Term 23,-14468688939,Term 22,-17296890609,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,0,Term 23,0,Term 22,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,79557036584,Term 23,-14905028256,Term 22,-18538307951,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,-420661737,Term 23,-45654236,Term 22,-226822,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|비지배지분 [구성요소],Term 24,0,Term 23,883146,Term 22,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,연결재무제표 [member],Term 24,-420661737,Term 23,-44771090,Term 22,-226822,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,0,Term 23,0,Term 22,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,0,Term 23,7948316,Term 22,197100000,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,-420661737,Term 23,-53602552,Term 22,-197326822,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),연결재무제표 [member],Term 24,-40244862206,Term 23,-14448242436,Term 22,24289767415,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|비지배지분 [구성요소],Term 24,-1015567917,Term 23,-792398853,Term 22,1457101023,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,-39229294289,Term 23,-13655843583,Term 22,22832666392,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,0,Term 23,0,Term 22,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,0,Term 23,0,Term 22,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,-39229294289,Term 23,-13655843583,Term 22,22832666392,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,연결재무제표 [member],Term 24,203887730139,Term 23,163524219980,Term 22,258340046881,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|비지배지분 [구성요소],Term 24,14752971711,Term 23,20768740624,Term 22,21767621073,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,189134758428,Term 23,142755479356,Term 22,236572425808,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,0,Term 23,0,Term 22,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,0,Term 23,0,Term 22,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,189134758428,Term 23,142755479356,Term 22,236572425808,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,연결재무제표 [member],Term 24,0,Term 23,1502621509,Term 22,21944749,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|비지배지분 [구성요소],Term 24,0,Term 23,0,Term 22,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,0,Term 23,1502621509,Term 22,21944749,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,0,Term 23,1502621509,Term 22,21944749,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,0,Term 23,0,Term 22,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,051900,LG생활건강
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 7,62817954586,Term 6,47475785739,Term 5,44799712618,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 7,29618192919,Term 6,17454914496,Term 5,8900968698,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,매출채권및기타채권,-,Term 7,10599063509,Term 6,9721698135,Term 5,10906863374,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 7,16148060,Term 6,2980327418,Term 5,188392057,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 7,3141874298,Term 6,1052428167,Term 5,2785300487,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 7,18560580552,Term 6,16099123190,Term 5,21854204841,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 7,882095248,Term 6,167294333,Term 5,163983161,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 7,29010706735,Term 6,13049423769,Term 5,13264308272,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentReceivablesGross,매출채권및기타채권,-,Term 7,0,Term 6,0,Term 5,577011035,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 7,4261695166,Term 6,2482360241,Term 5,3375956140,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_OtherNonCurrentAssets,기타비유동자산,-,Term 7,0,Term 6,0,Term 5,101905229,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 7,4975399413,Term 6,3698611184,Term 5,3951740880,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 7,13197575572,Term 6,2871845622,Term 5,3025725629,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 7,1224897255,Term 6,1001951822,Term 5,596446720,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_GoodwillGross,영업권,-,Term 7,281379700,Term 6,0,Term 5,0,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 7,5069759629,Term 6,2994654900,Term 5,1635522639,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 7,91828661321,Term 6,60525209508,Term 5,58064020890,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 7,29046487205,Term 6,48864802988,Term 5,48013307638,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,매입채무및기타채무,-,Term 7,13078038893,Term 6,12265527987,Term 5,9635321990,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 7,6000000000,Term 6,0,Term 5,7000000000,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,유동리스부채,-,Term 7,3876383488,Term 6,1367212865,Term 5,1578105561,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_CurrentPortionOfConvertibleRedeemablePreferredStockLiabilities,유동성전환상환우선주부채,-,Term 7,0,Term 6,16356668053,Term 5,14351170311,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 7,465564388,Term 6,15690794922,Term 5,14791958691,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 7,2759338917,Term 6,1408825324,Term 5,458424783,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_CurrentProvisions,유동충당부채,-,Term 7,0,Term 6,151920518,Term 5,0,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 7,2867161519,Term 6,1623853319,Term 5,198326302,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 7,11082258968,Term 6,2263653555,Term 5,1784344132,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,비유동리스부채,-,Term 7,9415098332,Term 6,1324093070,Term 5,1147221776,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_ConvertibleRedeemablePreferredStockLiabilities,전환상환우선주부채,-,Term 7,0,Term 6,0,Term 5,0,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 7,58715506,Term 6,0,Term 5,0,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,-Standard account code not used-,순확정급여부채,-,Term 7,452728585,Term 6,75913988,Term 5,312725742,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,비유동충당부채,-,Term 7,1155716545,Term 6,863646497,Term 5,324396614,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 7,0,Term 6,0,Term 5,0,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 7,40128746173,Term 6,51128456543,Term 5,49797651770,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 7,51699915148,Term 6,8750181259,Term 5,7439980985,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 7,3447104000,Term 6,2982160000,Term 5,2982160000,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,-Standard account code not used-,기타불입자본,-,Term 7,44262935494,Term 6,8261130924,Term 5,8031071952,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본,-,Term 7,2107948808,Term 6,2770983396,Term 5,1244162365,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 7,-616682991,Term 6,-72725606,Term 5,-5095983,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금(결손금),-,Term 7,2498609837,Term 6,-5191367455,Term 5,-4812317349,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배지분,-,Term 7,0,Term 6,646571706,Term 5,826388135,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 7,51699915148,Term 6,9396752965,Term 5,8266369120,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채및자본총계,-,Term 7,91828661321,Term 6,60525209508,Term 5,58064020890,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 7,219939337665,Term 6,158999740099,Term 5,102627923034,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 7,58586370450,Term 6,45748443940,Term 5,31797313074,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 7,161352967215,Term 6,113251296159,Term 5,70830609960,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 7,146883270338,Term 6,106098878471,Term 5,76801537530,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익(손실),-,Term 7,14469696877,Term 6,7152417688,Term 5,-5970927570,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,dart_OtherGains,기타수익,-,Term 7,828202472,Term 6,453868182,Term 5,359396267,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,dart_OtherLosses,기타비용,-,Term 7,684487692,Term 6,2702738673,Term 5,384003261,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 7,1398331160,Term 6,825207193,Term 5,663581712,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 7,7157864163,Term 6,4651334073,Term 5,3491662510,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익(손실),-,Term 7,8853878654,Term 6,1077420317,Term 5,-8823615362,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용(수익),-,Term 7,962161387,Term 6,1146223212,Term 5,-1237243690,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 7,7891717267,Term 6,-68802895,Term 5,-7586371672,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 7,7891717267,Term 6,-319045438,Term 5,-8213685126,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배지분,-,Term 7,0,Term 6,250242543,Term 5,627313454,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 7,-745697360,Term 6,-127634291,Term 5,-165570484,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류되지 않는 항목,-,Term 7,-201739975,Term 6,-60004668,Term 5,-162091681,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채의 재측정요소,-,Term 7,-258640993,Term 6,-76929061,Term 5,-207809848,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,dart_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss,법인세효과,-,Term 7,-56901018,Term 6,-16924393,Term 5,-45718167,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류되는 항목,-,Term 7,-543957385,Term 6,-67629623,Term 5,-3478803,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax,해외사업환산손익,-,Term 7,-543957385,Term 6,-67629623,Term 5,-3478803,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄손익,-,Term 7,7146019907,Term 6,-196437186,Term 5,-7751942156,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 7,7146019907,Term 6,-446679729,Term 5,-8379255610,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배지분,-,Term 7,0,Term 6,250242543,Term 5,627313454,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주 기본주당손익,-,Term 7,1269,Term 6,-12,Term 5,-1348,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_DilutedEarningsLossPerShare,보통주 희석주당손익,-,Term 7,1251,Term 6,-12,Term 5,-1348,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동현금흐름,-,Term 7,12777511272,Term 6,22630045629,Term 5,-18157991433,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_ProfitLossForStatementOfCashFlows,당기순이익(손실),-,Term 7,7891717267,Term 6,-68802895,Term 5,-7586371672,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,현금의 유출·유입이 없는 비용·수익등의 가감,-,Term 7,14118849110,Term 6,15087467155,Term 5,6696054835,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 7,962161387,Term 6,1146223212,Term 5,-1237243690,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 7,277507443,Term 6,290533122,Term 5,194438595,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비,-,Term 7,257906602,Term 6,2222856234,Term 5,434063682,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타의 대손상각비,-,Term 7,30210418,Term 6,1372600296,Term 5,3000000,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,재고자산폐기손실,-,Term 7,0,Term 6,257661763,Term 5,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForWritedownsOfInventories,재고자산평가손실,-,Term 7,437388133,Term 6,415482761,Term 5,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 7,2190639054,Term 6,2206369684,Term 5,1679935988,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 7,1051997393,Term 6,820497550,Term 5,602081982,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,기타장기종업원급여,-,Term 7,58715506,Term 6,0,Term 5,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForDepreciationExpense,유형자산감가상각비,-,Term 7,1604235327,Term 6,1328394876,Term 5,816045442,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,사용권자산감가상각비,-,Term 7,3274375974,Term 6,2074942760,Term 5,1680551413,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnEvaluationOfDerivativeFinancialLiabilities,파생상품평가손실,-,Term 7,3140267309,Term 6,2006104508,Term 5,1576003723,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForShareBasedPayment,주식보상비용,-,Term 7,375837022,Term 6,526249601,Term 5,880295490,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 7,393850574,Term 6,223996148,Term 5,126281943,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 7,414345482,Term 6,111383868,Term 5,17255499,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnAbandonmentOfPropertyPlantAndEquipment,유형자산폐기손실,-,Term 7,146451006,Term 6,0,Term 5,0,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfPropertyPlantAndEquipment,유형자산손상차손,-,Term 7,0,Term 6,130586662,Term 5,0,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,이연매출,-,Term 7,0,Term 6,-140483,Term 5,126076153,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,급여,-,Term 7,0,Term 6,75498840,Term 5,466705280,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForExpenseOfProvisions,충당부채전입액,-,Term 7,0,Term 6,600000000,Term 5,0,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForMiscellaneousLosses,잡손실,-,Term 7,0,Term 6,80593021,Term 5,0,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForInterestIncome,이자수익,-,Term 7,162221450,Term 6,146620003,Term 5,105293911,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 7,11976098,Term 6,1194460,Term 5,5854953,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfBadDebtExpenses,기타의대손상각비환입,-,Term 7,13038552,Term 6,0,Term 5,0,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 7,2522642,Term 6,604000153,Term 5,292720058,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForMiscellaneousIncome,잡이익,-,Term 7,36398003,Term 6,42952652,Term 5,0,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfProvisions,충당부채환입액,-,Term 7,270882775,Term 6,0,Term 5,0,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfDerivativeFinancialLiabilities,파생상품평가이익,-,Term 7,0,Term 6,0,Term 5,265567743,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfFairValueFinancialAssets,당기손익인식금융자산평가이익,-,Term 7,0,Term 6,7600000,Term 5,0,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,운전자본의 변동,-,Term 7,-6748086570,Term 6,8090905418,Term 5,-16766814702,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInTradeAndOtherReceivables,유동매출채권및기타채권의 감소(증가),-,Term 7,-1312348964,Term 6,3880652614,Term 5,-11426078560,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInOtherCurrentFinancialAssets,기타유동금융자산의 감소(증가),-,Term 7,0,Term 6,-76660811,Term 5,-1665000,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산의 감소(증가),-,Term 7,-2090311851,Term 6,1656804417,Term 5,528901797,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산의 감소(증가),-,Term 7,-2789110003,Term 6,5255562579,Term 5,-15530561406,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInLongTermTradeAndOtherNonCurrentReceivables,비유동매출채권및기타채권의 증가,-,Term 7,0,Term 6,-26865634,Term 5,-577011035,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherNonCurrentLiabilities,기타비유동부채의 증가(감소),-,Term 7,0,Term 6,107596022,Term 5,-100204429,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInTradeAndOtherPayables,매입채무 및 기타채무의 증가(감소),-,Term 7,-695460299,Term 6,-7018799632,Term 5,11243319674,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채의 증가(감소),-,Term 7,148285808,Term 6,4889272848,Term 5,417934163,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채의 증가(감소),-,Term 7,1350513593,Term 6,557581380,Term 5,-691177651,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInCurrentProvisions,유동충당부채의 증가(감소),-,Term 7,-153614858,Term 6,0,Term 5,0,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInNonCurrentProvisions,비유동충당부채의 증가(감소),-,Term 7,-329117225,Term 6,0,Term 5,0,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInPresentValueOfDefinedBenefitObligation,순확정급여부채의 증가(감소),-,Term 7,-386294858,Term 6,-630423501,Term 5,-173330835,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInFairValueOfPlanAssets,퇴직연금운용자산의 감소(증가),-,Term 7,-490627913,Term 6,-503814864,Term 5,-456941420,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 7,114751468,Term 6,318660065,Term 5,48614202,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세납부(환급),-,Term 7,2599720003,Term 6,798184114,Term 5,549474096,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동현금흐름,-,Term 7,-2520262334,Term 6,-4810100382,Term 5,-4653299039,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherCurrentFinancialAssets,기타유동금융자산의 감소,-,Term 7,10969000000,Term 6,461375000,Term 5,511838198,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익공정가치측정금융자산의 감소,-,Term 7,2007600000,Term 6,0,Term 5,1590000000,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 감소,-,Term 7,839528233,Term 6,100000000,Term 5,0,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 감소,-,Term 7,304193747,Term 6,13745455,Term 5,48178916,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities,정부보조금의 수취,-,Term 7,480000000,Term 6,0,Term 5,0,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,합병으로 인한 순현금흐름,-,Term 7,514231416,Term 6,0,Term 5,0,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_PurchaseOfOtherCurrentFinancialAssets,기타유동금융자산의 증가,-,Term 7,10000000000,Term 6,0,Term 5,964758689,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익공정가치측정금융자산의 증가,-,Term 7,0,Term 6,2003000000,Term 5,1147000000,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 증가,-,Term 7,4216438709,Term 6,1325386853,Term 5,2628502451,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 증가,-,Term 7,588682142,Term 6,591900839,Term 5,453102588,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_PurchaseOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 증가,-,Term 7,2829694879,Term 6,1464933145,Term 5,1609952425,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동현금흐름,-,Term 7,1998616548,Term 6,-9246931329,Term 5,26109656257,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 증가,-,Term 7,10000000000,Term 6,0,Term 5,3404910810,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_ProceedsFromLongTermBorrowings,장기차입금의 증가,-,Term 7,0,Term 6,0,Term 5,583737926,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,전환상환우선주 발행,-,Term 7,0,Term 6,0,Term 5,27636045910,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,리스 인센티브의 수령,-,Term 7,1007454368,Term 6,0,Term 5,0,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_ProceedsFromExerciseOfShareOptions,주식선택권행사,-,Term 7,219600000,Term 6,0,Term 5,0,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 상환,-,Term 7,4000000000,Term 6,7000000000,Term 5,3380850810,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_RepaymentsOfLongTermBorrowings,장기차입금의 상환,-,Term 7,0,Term 6,0,Term 5,200000000,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,리스부채의 상환,-,Term 7,3134895393,Term 6,1934921936,Term 5,1705392671,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsFinancingActivities,이자지급,-,Term 7,193542427,Term 6,112009393,Term 5,228794908,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,종속기업주식의 추가취득,-,Term 7,1900000000,Term 6,200000000,Term 5,0,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,현금의 증가,-,Term 7,12255865486,Term 6,8573013918,Term 5,3298365785,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초현금및현금성자산,-,Term 7,17454914496,Term 6,8900968698,Term 5,5567041780,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,현금및현금성자산에 대한 환율변동효과,-,Term 7,-92587063,Term 6,-19068120,Term 5,35561133,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말현금및현금성자산,-,Term 7,29618192919,Term 6,17454914496,Term 5,8900968698,74,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,2982160000,Term 6,2982160000,Term 5,2800000000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,-5191367455,Term 6,-4812317349,Term 5,3563459458,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 7,9396752965,Term 6,8266369120,Term 5,8641823489,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배지분 [member],Term 7,646571706,Term 6,826388135,Term 5,199074681,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,8750181259,Term 6,7439980985,Term 5,8442748808,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,8261130924,Term 6,8031071952,Term 5,1245124430,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,2770983396,Term 6,1244162365,Term 5,835782100,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,-72725606,Term 6,-5095983,Term 5,-1617180,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 7,7891717267,Term 6,-68802895,Term 5,-7586371672,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,7891717267,Term 6,-319045438,Term 5,-8213685126,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,0,Term 6,0,Term 5,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,0,Term 6,0,Term 5,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,0,Term 6,0,Term 5,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,7891717267,Term 6,-319045438,Term 5,-8213685126,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|비지배지분 [member],Term 7,0,Term 6,250242543,Term 5,627313454,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,0,Term 6,0,Term 5,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,-201739975,Term 6,-60004668,Term 5,-162091681,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,0,Term 6,0,Term 5,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,0,Term 6,0,Term 5,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,0,Term 6,0,Term 5,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,0,Term 6,0,Term 5,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,-201739975,Term 6,-60004668,Term 5,-162091681,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|비지배지분 [member],Term 7,0,Term 6,0,Term 5,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,연결재무제표 [member],Term 7,-201739975,Term 6,-60004668,Term 5,-162091681,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|비지배지분 [member],Term 7,0,Term 6,0,Term 5,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,-543957385,Term 6,-67629623,Term 5,-3478803,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,0,Term 6,0,Term 5,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,연결재무제표 [member],Term 7,-543957385,Term 6,-67629623,Term 5,-3478803,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,0,Term 6,0,Term 5,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,-543957385,Term 6,-67629623,Term 5,-3478803,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,0,Term 6,0,Term 5,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,0,Term 6,0,Term 5,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식보상비용,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,6000000,Term 6,0,Term 5,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식보상비용,연결재무제표 [member],Term 7,504475850,Term 6,796550593,Term 5,880295490,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식보상비용,자본 [member]|비지배지분 [member],Term 7,0,Term 6,0,Term 5,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식보상비용,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,504475850,Term 6,796550593,Term 5,880295490,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식보상비용,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,431240000,Term 6,0,Term 5,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식보상비용,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,67235850,Term 6,796550593,Term 5,880295490,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식보상비용,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,0,Term 6,0,Term 5,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식보상비용,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,0,Term 6,0,Term 5,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,0,Term 6,0,Term 5,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,0,Term 6,0,Term 5,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,0,Term 6,0,Term 5,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,0,Term 6,0,Term 5,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,0,Term 6,0,Term 5,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|비지배지분 [member],Term 7,-646571706,Term 6,0,Term 5,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,연결재무제표 [member],Term 7,-646571706,Term 6,0,Term 5,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,0,Term 6,0,Term 5,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,종속기업지분 추가취득,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,0,Term 6,0,Term 5,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,종속기업지분 추가취득,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,0,Term 6,0,Term 5,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,종속기업지분 추가취득,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,0,Term 6,0,Term 5,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,종속기업지분 추가취득,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,0,Term 6,0,Term 5,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,종속기업지분 추가취득,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,0,Term 6,0,Term 5,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,종속기업지분 추가취득,자본 [member]|비지배지분 [member],Term 7,0,Term 6,0,Term 5,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,종속기업지분 추가취득,연결재무제표 [member],Term 7,0,Term 6,0,Term 5,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,종속기업지분 추가취득,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,0,Term 6,0,Term 5,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|비지배지분 [member],Term 7,0,Term 6,-430058972,Term 5,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,-1253428294,Term 6,230058972,Term 5,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,-1253428294,Term 6,230058972,Term 5,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,0,Term 6,0,Term 5,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,0,Term 6,0,Term 5,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,0,Term 6,0,Term 5,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,0,Term 6,0,Term 5,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,연결재무제표 [member],Term 7,-1253428294,Term 6,-200000000,Term 5,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,연결재무제표 [member],Term 7,0,Term 6,730270438,Term 5,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|비지배지분 [member],Term 7,0,Term 6,0,Term 5,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,0,Term 6,730270438,Term 5,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,0,Term 6,0,Term 5,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,0,Term 6,730270438,Term 5,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,0,Term 6,0,Term 5,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,0,Term 6,0,Term 5,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,0,Term 6,0,Term 5,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,0,Term 6,0,Term 5,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,0,Term 6,0,Term 5,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,-730270438,Term 6,0,Term 5,-471915225,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,36823992864,Term 6,0,Term 5,6785947522,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,36552666426,Term 6,0,Term 5,6496192297,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|비지배지분 [member],Term 7,0,Term 6,0,Term 5,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,연결재무제표 [member],Term 7,36552666426,Term 6,0,Term 5,6496192297,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,458944000,Term 6,0,Term 5,182160000,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,3447104000,Term 6,2982160000,Term 5,2982160000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,2498609837,Term 6,-5191367455,Term 5,-4812317349,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,-616682991,Term 6,-72725606,Term 5,-5095983,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,2107948808,Term 6,2770983396,Term 5,1244162365,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,44262935494,Term 6,8261130924,Term 5,8031071952,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,51699915148,Term 6,8750181259,Term 5,7439980985,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 7,51699915148,Term 6,9396752965,Term 5,8266369120,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|비지배지분 [member],Term 7,0,Term 6,646571706,Term 5,826388135,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 7,62817954586,Term 6,47475785739,Term 5,44799712618,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 7,29618192919,Term 6,17454914496,Term 5,8900968698,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,매출채권및기타채권,-,Term 7,10599063509,Term 6,9721698135,Term 5,10906863374,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 7,16148060,Term 6,2980327418,Term 5,188392057,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 7,3141874298,Term 6,1052428167,Term 5,2785300487,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 7,18560580552,Term 6,16099123190,Term 5,21854204841,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 7,882095248,Term 6,167294333,Term 5,163983161,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 7,29010706735,Term 6,13049423769,Term 5,13264308272,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentReceivablesGross,매출채권및기타채권,-,Term 7,0,Term 6,0,Term 5,577011035,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 7,4261695166,Term 6,2482360241,Term 5,3375956140,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_OtherNonCurrentAssets,기타비유동자산,-,Term 7,0,Term 6,0,Term 5,101905229,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 7,4975399413,Term 6,3698611184,Term 5,3951740880,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 7,13197575572,Term 6,2871845622,Term 5,3025725629,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 7,1224897255,Term 6,1001951822,Term 5,596446720,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_GoodwillGross,영업권,-,Term 7,281379700,Term 6,0,Term 5,0,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 7,5069759629,Term 6,2994654900,Term 5,1635522639,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 7,91828661321,Term 6,60525209508,Term 5,58064020890,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 7,29046487205,Term 6,48864802988,Term 5,48013307638,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,매입채무및기타채무,-,Term 7,13078038893,Term 6,12265527987,Term 5,9635321990,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 7,6000000000,Term 6,0,Term 5,7000000000,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,유동리스부채,-,Term 7,3876383488,Term 6,1367212865,Term 5,1578105561,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_CurrentPortionOfConvertibleRedeemablePreferredStockLiabilities,유동성전환상환우선주부채,-,Term 7,0,Term 6,16356668053,Term 5,14351170311,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 7,465564388,Term 6,15690794922,Term 5,14791958691,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 7,2759338917,Term 6,1408825324,Term 5,458424783,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_CurrentProvisions,유동충당부채,-,Term 7,0,Term 6,151920518,Term 5,0,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 7,2867161519,Term 6,1623853319,Term 5,198326302,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 7,11082258968,Term 6,2263653555,Term 5,1784344132,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,비유동리스부채,-,Term 7,9415098332,Term 6,1324093070,Term 5,1147221776,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_ConvertibleRedeemablePreferredStockLiabilities,전환상환우선주부채,-,Term 7,0,Term 6,0,Term 5,0,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 7,58715506,Term 6,0,Term 5,0,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,-Standard account code not used-,순확정급여부채,-,Term 7,452728585,Term 6,75913988,Term 5,312725742,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,비유동충당부채,-,Term 7,1155716545,Term 6,863646497,Term 5,324396614,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 7,0,Term 6,0,Term 5,0,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 7,40128746173,Term 6,51128456543,Term 5,49797651770,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 7,51699915148,Term 6,8750181259,Term 5,7439980985,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 7,3447104000,Term 6,2982160000,Term 5,2982160000,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,-Standard account code not used-,기타불입자본,-,Term 7,44262935494,Term 6,8261130924,Term 5,8031071952,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본,-,Term 7,2107948808,Term 6,2770983396,Term 5,1244162365,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 7,-616682991,Term 6,-72725606,Term 5,-5095983,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금(결손금),-,Term 7,2498609837,Term 6,-5191367455,Term 5,-4812317349,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배지분,-,Term 7,0,Term 6,646571706,Term 5,826388135,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 7,51699915148,Term 6,9396752965,Term 5,8266369120,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채및자본총계,-,Term 7,91828661321,Term 6,60525209508,Term 5,58064020890,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 7,219939337665,Term 6,158999740099,Term 5,102627923034,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 7,58586370450,Term 6,45748443940,Term 5,31797313074,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 7,161352967215,Term 6,113251296159,Term 5,70830609960,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 7,146883270338,Term 6,106098878471,Term 5,76801537530,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익(손실),-,Term 7,14469696877,Term 6,7152417688,Term 5,-5970927570,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,dart_OtherGains,기타수익,-,Term 7,828202472,Term 6,453868182,Term 5,359396267,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,dart_OtherLosses,기타비용,-,Term 7,684487692,Term 6,2702738673,Term 5,384003261,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 7,1398331160,Term 6,825207193,Term 5,663581712,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 7,7157864163,Term 6,4651334073,Term 5,3491662510,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익(손실),-,Term 7,8853878654,Term 6,1077420317,Term 5,-8823615362,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용(수익),-,Term 7,962161387,Term 6,1146223212,Term 5,-1237243690,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 7,7891717267,Term 6,-68802895,Term 5,-7586371672,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 7,7891717267,Term 6,-319045438,Term 5,-8213685126,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배지분,-,Term 7,0,Term 6,250242543,Term 5,627313454,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 7,-745697360,Term 6,-127634291,Term 5,-165570484,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류되지 않는 항목,-,Term 7,-201739975,Term 6,-60004668,Term 5,-162091681,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채의 재측정요소,-,Term 7,-258640993,Term 6,-76929061,Term 5,-207809848,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,dart_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss,법인세효과,-,Term 7,-56901018,Term 6,-16924393,Term 5,-45718167,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류되는 항목,-,Term 7,-543957385,Term 6,-67629623,Term 5,-3478803,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax,해외사업환산손익,-,Term 7,-543957385,Term 6,-67629623,Term 5,-3478803,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄손익,-,Term 7,7146019907,Term 6,-196437186,Term 5,-7751942156,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 7,7146019907,Term 6,-446679729,Term 5,-8379255610,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배지분,-,Term 7,0,Term 6,250242543,Term 5,627313454,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주 기본주당손익,-,Term 7,1269,Term 6,-12,Term 5,-1348,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_DilutedEarningsLossPerShare,보통주 희석주당손익,-,Term 7,1251,Term 6,-12,Term 5,-1348,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동현금흐름,-,Term 7,12777511272,Term 6,22630045629,Term 5,-18157991433,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_ProfitLossForStatementOfCashFlows,당기순이익(손실),-,Term 7,7891717267,Term 6,-68802895,Term 5,-7586371672,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,현금의 유출·유입이 없는 비용·수익등의 가감,-,Term 7,14118849110,Term 6,15087467155,Term 5,6696054835,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 7,962161387,Term 6,1146223212,Term 5,-1237243690,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 7,277507443,Term 6,290533122,Term 5,194438595,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비,-,Term 7,257906602,Term 6,2222856234,Term 5,434063682,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타의 대손상각비,-,Term 7,30210418,Term 6,1372600296,Term 5,3000000,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,재고자산폐기손실,-,Term 7,0,Term 6,257661763,Term 5,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForWritedownsOfInventories,재고자산평가손실,-,Term 7,437388133,Term 6,415482761,Term 5,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 7,2190639054,Term 6,2206369684,Term 5,1679935988,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 7,1051997393,Term 6,820497550,Term 5,602081982,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,기타장기종업원급여,-,Term 7,58715506,Term 6,0,Term 5,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForDepreciationExpense,유형자산감가상각비,-,Term 7,1604235327,Term 6,1328394876,Term 5,816045442,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,사용권자산감가상각비,-,Term 7,3274375974,Term 6,2074942760,Term 5,1680551413,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnEvaluationOfDerivativeFinancialLiabilities,파생상품평가손실,-,Term 7,3140267309,Term 6,2006104508,Term 5,1576003723,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForShareBasedPayment,주식보상비용,-,Term 7,375837022,Term 6,526249601,Term 5,880295490,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 7,393850574,Term 6,223996148,Term 5,126281943,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 7,414345482,Term 6,111383868,Term 5,17255499,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnAbandonmentOfPropertyPlantAndEquipment,유형자산폐기손실,-,Term 7,146451006,Term 6,0,Term 5,0,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfPropertyPlantAndEquipment,유형자산손상차손,-,Term 7,0,Term 6,130586662,Term 5,0,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,이연매출,-,Term 7,0,Term 6,-140483,Term 5,126076153,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,급여,-,Term 7,0,Term 6,75498840,Term 5,466705280,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForExpenseOfProvisions,충당부채전입액,-,Term 7,0,Term 6,600000000,Term 5,0,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForMiscellaneousLosses,잡손실,-,Term 7,0,Term 6,80593021,Term 5,0,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForInterestIncome,이자수익,-,Term 7,162221450,Term 6,146620003,Term 5,105293911,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 7,11976098,Term 6,1194460,Term 5,5854953,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfBadDebtExpenses,기타의대손상각비환입,-,Term 7,13038552,Term 6,0,Term 5,0,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 7,2522642,Term 6,604000153,Term 5,292720058,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForMiscellaneousIncome,잡이익,-,Term 7,36398003,Term 6,42952652,Term 5,0,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfProvisions,충당부채환입액,-,Term 7,270882775,Term 6,0,Term 5,0,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfDerivativeFinancialLiabilities,파생상품평가이익,-,Term 7,0,Term 6,0,Term 5,265567743,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfFairValueFinancialAssets,당기손익인식금융자산평가이익,-,Term 7,0,Term 6,7600000,Term 5,0,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,운전자본의 변동,-,Term 7,-6748086570,Term 6,8090905418,Term 5,-16766814702,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInTradeAndOtherReceivables,유동매출채권및기타채권의 감소(증가),-,Term 7,-1312348964,Term 6,3880652614,Term 5,-11426078560,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInOtherCurrentFinancialAssets,기타유동금융자산의 감소(증가),-,Term 7,0,Term 6,-76660811,Term 5,-1665000,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산의 감소(증가),-,Term 7,-2090311851,Term 6,1656804417,Term 5,528901797,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산의 감소(증가),-,Term 7,-2789110003,Term 6,5255562579,Term 5,-15530561406,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInLongTermTradeAndOtherNonCurrentReceivables,비유동매출채권및기타채권의 증가,-,Term 7,0,Term 6,-26865634,Term 5,-577011035,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherNonCurrentLiabilities,기타비유동부채의 증가(감소),-,Term 7,0,Term 6,107596022,Term 5,-100204429,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInTradeAndOtherPayables,매입채무 및 기타채무의 증가(감소),-,Term 7,-695460299,Term 6,-7018799632,Term 5,11243319674,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채의 증가(감소),-,Term 7,148285808,Term 6,4889272848,Term 5,417934163,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채의 증가(감소),-,Term 7,1350513593,Term 6,557581380,Term 5,-691177651,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInCurrentProvisions,유동충당부채의 증가(감소),-,Term 7,-153614858,Term 6,0,Term 5,0,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInNonCurrentProvisions,비유동충당부채의 증가(감소),-,Term 7,-329117225,Term 6,0,Term 5,0,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInPresentValueOfDefinedBenefitObligation,순확정급여부채의 증가(감소),-,Term 7,-386294858,Term 6,-630423501,Term 5,-173330835,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInFairValueOfPlanAssets,퇴직연금운용자산의 감소(증가),-,Term 7,-490627913,Term 6,-503814864,Term 5,-456941420,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 7,114751468,Term 6,318660065,Term 5,48614202,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세납부(환급),-,Term 7,2599720003,Term 6,798184114,Term 5,549474096,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동현금흐름,-,Term 7,-2520262334,Term 6,-4810100382,Term 5,-4653299039,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherCurrentFinancialAssets,기타유동금융자산의 감소,-,Term 7,10969000000,Term 6,461375000,Term 5,511838198,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익공정가치측정금융자산의 감소,-,Term 7,2007600000,Term 6,0,Term 5,1590000000,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 감소,-,Term 7,839528233,Term 6,100000000,Term 5,0,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 감소,-,Term 7,304193747,Term 6,13745455,Term 5,48178916,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities,정부보조금의 수취,-,Term 7,480000000,Term 6,0,Term 5,0,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,합병으로 인한 순현금흐름,-,Term 7,514231416,Term 6,0,Term 5,0,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_PurchaseOfOtherCurrentFinancialAssets,기타유동금융자산의 증가,-,Term 7,10000000000,Term 6,0,Term 5,964758689,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익공정가치측정금융자산의 증가,-,Term 7,0,Term 6,2003000000,Term 5,1147000000,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 증가,-,Term 7,4216438709,Term 6,1325386853,Term 5,2628502451,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 증가,-,Term 7,588682142,Term 6,591900839,Term 5,453102588,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_PurchaseOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 증가,-,Term 7,2829694879,Term 6,1464933145,Term 5,1609952425,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동현금흐름,-,Term 7,1998616548,Term 6,-9246931329,Term 5,26109656257,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 증가,-,Term 7,10000000000,Term 6,0,Term 5,3404910810,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_ProceedsFromLongTermBorrowings,장기차입금의 증가,-,Term 7,0,Term 6,0,Term 5,583737926,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,전환상환우선주 발행,-,Term 7,0,Term 6,0,Term 5,27636045910,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,리스 인센티브의 수령,-,Term 7,1007454368,Term 6,0,Term 5,0,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_ProceedsFromExerciseOfShareOptions,주식선택권행사,-,Term 7,219600000,Term 6,0,Term 5,0,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 상환,-,Term 7,4000000000,Term 6,7000000000,Term 5,3380850810,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_RepaymentsOfLongTermBorrowings,장기차입금의 상환,-,Term 7,0,Term 6,0,Term 5,200000000,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,리스부채의 상환,-,Term 7,3134895393,Term 6,1934921936,Term 5,1705392671,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsFinancingActivities,이자지급,-,Term 7,193542427,Term 6,112009393,Term 5,228794908,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,종속기업주식의 추가취득,-,Term 7,1900000000,Term 6,200000000,Term 5,0,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,현금의 증가,-,Term 7,12255865486,Term 6,8573013918,Term 5,3298365785,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초현금및현금성자산,-,Term 7,17454914496,Term 6,8900968698,Term 5,5567041780,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,현금및현금성자산에 대한 환율변동효과,-,Term 7,-92587063,Term 6,-19068120,Term 5,35561133,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말현금및현금성자산,-,Term 7,29618192919,Term 6,17454914496,Term 5,8900968698,74,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,2982160000,Term 6,2982160000,Term 5,2800000000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,-5191367455,Term 6,-4812317349,Term 5,3563459458,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 7,9396752965,Term 6,8266369120,Term 5,8641823489,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배지분 [member],Term 7,646571706,Term 6,826388135,Term 5,199074681,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,8750181259,Term 6,7439980985,Term 5,8442748808,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,8261130924,Term 6,8031071952,Term 5,1245124430,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,2770983396,Term 6,1244162365,Term 5,835782100,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,-72725606,Term 6,-5095983,Term 5,-1617180,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 7,7891717267,Term 6,-68802895,Term 5,-7586371672,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,7891717267,Term 6,-319045438,Term 5,-8213685126,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,0,Term 6,0,Term 5,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,0,Term 6,0,Term 5,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,0,Term 6,0,Term 5,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,7891717267,Term 6,-319045438,Term 5,-8213685126,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|비지배지분 [member],Term 7,0,Term 6,250242543,Term 5,627313454,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,0,Term 6,0,Term 5,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,-201739975,Term 6,-60004668,Term 5,-162091681,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,0,Term 6,0,Term 5,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,0,Term 6,0,Term 5,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,0,Term 6,0,Term 5,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,0,Term 6,0,Term 5,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,-201739975,Term 6,-60004668,Term 5,-162091681,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|비지배지분 [member],Term 7,0,Term 6,0,Term 5,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,연결재무제표 [member],Term 7,-201739975,Term 6,-60004668,Term 5,-162091681,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|비지배지분 [member],Term 7,0,Term 6,0,Term 5,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,-543957385,Term 6,-67629623,Term 5,-3478803,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,0,Term 6,0,Term 5,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,연결재무제표 [member],Term 7,-543957385,Term 6,-67629623,Term 5,-3478803,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,0,Term 6,0,Term 5,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,-543957385,Term 6,-67629623,Term 5,-3478803,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,0,Term 6,0,Term 5,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,0,Term 6,0,Term 5,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식보상비용,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,6000000,Term 6,0,Term 5,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식보상비용,연결재무제표 [member],Term 7,504475850,Term 6,796550593,Term 5,880295490,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식보상비용,자본 [member]|비지배지분 [member],Term 7,0,Term 6,0,Term 5,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식보상비용,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,504475850,Term 6,796550593,Term 5,880295490,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식보상비용,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,431240000,Term 6,0,Term 5,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식보상비용,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,67235850,Term 6,796550593,Term 5,880295490,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식보상비용,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,0,Term 6,0,Term 5,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식보상비용,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,0,Term 6,0,Term 5,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,0,Term 6,0,Term 5,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,0,Term 6,0,Term 5,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,0,Term 6,0,Term 5,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,0,Term 6,0,Term 5,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,0,Term 6,0,Term 5,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|비지배지분 [member],Term 7,-646571706,Term 6,0,Term 5,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,연결재무제표 [member],Term 7,-646571706,Term 6,0,Term 5,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,0,Term 6,0,Term 5,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,종속기업지분 추가취득,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,0,Term 6,0,Term 5,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,종속기업지분 추가취득,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,0,Term 6,0,Term 5,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,종속기업지분 추가취득,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,0,Term 6,0,Term 5,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,종속기업지분 추가취득,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,0,Term 6,0,Term 5,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,종속기업지분 추가취득,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,0,Term 6,0,Term 5,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,종속기업지분 추가취득,자본 [member]|비지배지분 [member],Term 7,0,Term 6,0,Term 5,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,종속기업지분 추가취득,연결재무제표 [member],Term 7,0,Term 6,0,Term 5,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,종속기업지분 추가취득,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,0,Term 6,0,Term 5,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|비지배지분 [member],Term 7,0,Term 6,-430058972,Term 5,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,-1253428294,Term 6,230058972,Term 5,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,-1253428294,Term 6,230058972,Term 5,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,0,Term 6,0,Term 5,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,0,Term 6,0,Term 5,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,0,Term 6,0,Term 5,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,0,Term 6,0,Term 5,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,연결재무제표 [member],Term 7,-1253428294,Term 6,-200000000,Term 5,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,연결재무제표 [member],Term 7,0,Term 6,730270438,Term 5,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|비지배지분 [member],Term 7,0,Term 6,0,Term 5,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,0,Term 6,730270438,Term 5,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,0,Term 6,0,Term 5,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,0,Term 6,730270438,Term 5,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,0,Term 6,0,Term 5,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,0,Term 6,0,Term 5,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,0,Term 6,0,Term 5,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,0,Term 6,0,Term 5,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,0,Term 6,0,Term 5,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,-730270438,Term 6,0,Term 5,-471915225,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,36823992864,Term 6,0,Term 5,6785947522,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,36552666426,Term 6,0,Term 5,6496192297,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|비지배지분 [member],Term 7,0,Term 6,0,Term 5,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,연결재무제표 [member],Term 7,36552666426,Term 6,0,Term 5,6496192297,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,458944000,Term 6,0,Term 5,182160000,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,3447104000,Term 6,2982160000,Term 5,2982160000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,2498609837,Term 6,-5191367455,Term 5,-4812317349,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,-616682991,Term 6,-72725606,Term 5,-5095983,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,2107948808,Term 6,2770983396,Term 5,1244162365,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,44262935494,Term 6,8261130924,Term 5,8031071952,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,51699915148,Term 6,8750181259,Term 5,7439980985,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 7,51699915148,Term 6,9396752965,Term 5,8266369120,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|비지배지분 [member],Term 7,0,Term 6,646571706,Term 5,826388135,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 7,62817954586,Term 6,47475785739,Term 5,44799712618,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 7,29618192919,Term 6,17454914496,Term 5,8900968698,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,매출채권및기타채권,-,Term 7,10599063509,Term 6,9721698135,Term 5,10906863374,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 7,16148060,Term 6,2980327418,Term 5,188392057,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 7,3141874298,Term 6,1052428167,Term 5,2785300487,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 7,18560580552,Term 6,16099123190,Term 5,21854204841,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 7,882095248,Term 6,167294333,Term 5,163983161,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 7,29010706735,Term 6,13049423769,Term 5,13264308272,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentReceivablesGross,매출채권및기타채권,-,Term 7,0,Term 6,0,Term 5,577011035,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 7,4261695166,Term 6,2482360241,Term 5,3375956140,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_OtherNonCurrentAssets,기타비유동자산,-,Term 7,0,Term 6,0,Term 5,101905229,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 7,4975399413,Term 6,3698611184,Term 5,3951740880,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 7,13197575572,Term 6,2871845622,Term 5,3025725629,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 7,1224897255,Term 6,1001951822,Term 5,596446720,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_GoodwillGross,영업권,-,Term 7,281379700,Term 6,0,Term 5,0,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 7,5069759629,Term 6,2994654900,Term 5,1635522639,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 7,91828661321,Term 6,60525209508,Term 5,58064020890,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 7,29046487205,Term 6,48864802988,Term 5,48013307638,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,매입채무및기타채무,-,Term 7,13078038893,Term 6,12265527987,Term 5,9635321990,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 7,6000000000,Term 6,0,Term 5,7000000000,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,유동리스부채,-,Term 7,3876383488,Term 6,1367212865,Term 5,1578105561,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_CurrentPortionOfConvertibleRedeemablePreferredStockLiabilities,유동성전환상환우선주부채,-,Term 7,0,Term 6,16356668053,Term 5,14351170311,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 7,465564388,Term 6,15690794922,Term 5,14791958691,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 7,2759338917,Term 6,1408825324,Term 5,458424783,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_CurrentProvisions,유동충당부채,-,Term 7,0,Term 6,151920518,Term 5,0,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 7,2867161519,Term 6,1623853319,Term 5,198326302,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 7,11082258968,Term 6,2263653555,Term 5,1784344132,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,비유동리스부채,-,Term 7,9415098332,Term 6,1324093070,Term 5,1147221776,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_ConvertibleRedeemablePreferredStockLiabilities,전환상환우선주부채,-,Term 7,0,Term 6,0,Term 5,0,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 7,58715506,Term 6,0,Term 5,0,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,-Standard account code not used-,순확정급여부채,-,Term 7,452728585,Term 6,75913988,Term 5,312725742,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,비유동충당부채,-,Term 7,1155716545,Term 6,863646497,Term 5,324396614,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 7,0,Term 6,0,Term 5,0,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 7,40128746173,Term 6,51128456543,Term 5,49797651770,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 7,51699915148,Term 6,8750181259,Term 5,7439980985,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 7,3447104000,Term 6,2982160000,Term 5,2982160000,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,-Standard account code not used-,기타불입자본,-,Term 7,44262935494,Term 6,8261130924,Term 5,8031071952,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본,-,Term 7,2107948808,Term 6,2770983396,Term 5,1244162365,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 7,-616682991,Term 6,-72725606,Term 5,-5095983,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금(결손금),-,Term 7,2498609837,Term 6,-5191367455,Term 5,-4812317349,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배지분,-,Term 7,0,Term 6,646571706,Term 5,826388135,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 7,51699915148,Term 6,9396752965,Term 5,8266369120,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채및자본총계,-,Term 7,91828661321,Term 6,60525209508,Term 5,58064020890,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 7,219939337665,Term 6,158999740099,Term 5,102627923034,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 7,58586370450,Term 6,45748443940,Term 5,31797313074,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 7,161352967215,Term 6,113251296159,Term 5,70830609960,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 7,146883270338,Term 6,106098878471,Term 5,76801537530,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익(손실),-,Term 7,14469696877,Term 6,7152417688,Term 5,-5970927570,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,dart_OtherGains,기타수익,-,Term 7,828202472,Term 6,453868182,Term 5,359396267,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,dart_OtherLosses,기타비용,-,Term 7,684487692,Term 6,2702738673,Term 5,384003261,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 7,1398331160,Term 6,825207193,Term 5,663581712,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 7,7157864163,Term 6,4651334073,Term 5,3491662510,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익(손실),-,Term 7,8853878654,Term 6,1077420317,Term 5,-8823615362,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용(수익),-,Term 7,962161387,Term 6,1146223212,Term 5,-1237243690,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 7,7891717267,Term 6,-68802895,Term 5,-7586371672,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 7,7891717267,Term 6,-319045438,Term 5,-8213685126,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배지분,-,Term 7,0,Term 6,250242543,Term 5,627313454,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 7,-745697360,Term 6,-127634291,Term 5,-165570484,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류되지 않는 항목,-,Term 7,-201739975,Term 6,-60004668,Term 5,-162091681,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채의 재측정요소,-,Term 7,-258640993,Term 6,-76929061,Term 5,-207809848,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,dart_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss,법인세효과,-,Term 7,-56901018,Term 6,-16924393,Term 5,-45718167,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류되는 항목,-,Term 7,-543957385,Term 6,-67629623,Term 5,-3478803,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax,해외사업환산손익,-,Term 7,-543957385,Term 6,-67629623,Term 5,-3478803,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄손익,-,Term 7,7146019907,Term 6,-196437186,Term 5,-7751942156,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 7,7146019907,Term 6,-446679729,Term 5,-8379255610,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배지분,-,Term 7,0,Term 6,250242543,Term 5,627313454,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주 기본주당손익,-,Term 7,1269,Term 6,-12,Term 5,-1348,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CIS,Statement of comprehensive income,ifrs-full_DilutedEarningsLossPerShare,보통주 희석주당손익,-,Term 7,1251,Term 6,-12,Term 5,-1348,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동현금흐름,-,Term 7,12777511272,Term 6,22630045629,Term 5,-18157991433,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_ProfitLossForStatementOfCashFlows,당기순이익(손실),-,Term 7,7891717267,Term 6,-68802895,Term 5,-7586371672,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,현금의 유출·유입이 없는 비용·수익등의 가감,-,Term 7,14118849110,Term 6,15087467155,Term 5,6696054835,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 7,962161387,Term 6,1146223212,Term 5,-1237243690,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 7,277507443,Term 6,290533122,Term 5,194438595,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비,-,Term 7,257906602,Term 6,2222856234,Term 5,434063682,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타의 대손상각비,-,Term 7,30210418,Term 6,1372600296,Term 5,3000000,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,재고자산폐기손실,-,Term 7,0,Term 6,257661763,Term 5,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForWritedownsOfInventories,재고자산평가손실,-,Term 7,437388133,Term 6,415482761,Term 5,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 7,2190639054,Term 6,2206369684,Term 5,1679935988,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 7,1051997393,Term 6,820497550,Term 5,602081982,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,기타장기종업원급여,-,Term 7,58715506,Term 6,0,Term 5,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForDepreciationExpense,유형자산감가상각비,-,Term 7,1604235327,Term 6,1328394876,Term 5,816045442,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,사용권자산감가상각비,-,Term 7,3274375974,Term 6,2074942760,Term 5,1680551413,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnEvaluationOfDerivativeFinancialLiabilities,파생상품평가손실,-,Term 7,3140267309,Term 6,2006104508,Term 5,1576003723,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForShareBasedPayment,주식보상비용,-,Term 7,375837022,Term 6,526249601,Term 5,880295490,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 7,393850574,Term 6,223996148,Term 5,126281943,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 7,414345482,Term 6,111383868,Term 5,17255499,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnAbandonmentOfPropertyPlantAndEquipment,유형자산폐기손실,-,Term 7,146451006,Term 6,0,Term 5,0,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfPropertyPlantAndEquipment,유형자산손상차손,-,Term 7,0,Term 6,130586662,Term 5,0,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,이연매출,-,Term 7,0,Term 6,-140483,Term 5,126076153,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,급여,-,Term 7,0,Term 6,75498840,Term 5,466705280,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForExpenseOfProvisions,충당부채전입액,-,Term 7,0,Term 6,600000000,Term 5,0,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForMiscellaneousLosses,잡손실,-,Term 7,0,Term 6,80593021,Term 5,0,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForInterestIncome,이자수익,-,Term 7,162221450,Term 6,146620003,Term 5,105293911,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 7,11976098,Term 6,1194460,Term 5,5854953,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfBadDebtExpenses,기타의대손상각비환입,-,Term 7,13038552,Term 6,0,Term 5,0,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 7,2522642,Term 6,604000153,Term 5,292720058,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForMiscellaneousIncome,잡이익,-,Term 7,36398003,Term 6,42952652,Term 5,0,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfProvisions,충당부채환입액,-,Term 7,270882775,Term 6,0,Term 5,0,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfDerivativeFinancialLiabilities,파생상품평가이익,-,Term 7,0,Term 6,0,Term 5,265567743,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfFairValueFinancialAssets,당기손익인식금융자산평가이익,-,Term 7,0,Term 6,7600000,Term 5,0,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,운전자본의 변동,-,Term 7,-6748086570,Term 6,8090905418,Term 5,-16766814702,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInTradeAndOtherReceivables,유동매출채권및기타채권의 감소(증가),-,Term 7,-1312348964,Term 6,3880652614,Term 5,-11426078560,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInOtherCurrentFinancialAssets,기타유동금융자산의 감소(증가),-,Term 7,0,Term 6,-76660811,Term 5,-1665000,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산의 감소(증가),-,Term 7,-2090311851,Term 6,1656804417,Term 5,528901797,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산의 감소(증가),-,Term 7,-2789110003,Term 6,5255562579,Term 5,-15530561406,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInLongTermTradeAndOtherNonCurrentReceivables,비유동매출채권및기타채권의 증가,-,Term 7,0,Term 6,-26865634,Term 5,-577011035,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherNonCurrentLiabilities,기타비유동부채의 증가(감소),-,Term 7,0,Term 6,107596022,Term 5,-100204429,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInTradeAndOtherPayables,매입채무 및 기타채무의 증가(감소),-,Term 7,-695460299,Term 6,-7018799632,Term 5,11243319674,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채의 증가(감소),-,Term 7,148285808,Term 6,4889272848,Term 5,417934163,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채의 증가(감소),-,Term 7,1350513593,Term 6,557581380,Term 5,-691177651,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInCurrentProvisions,유동충당부채의 증가(감소),-,Term 7,-153614858,Term 6,0,Term 5,0,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInNonCurrentProvisions,비유동충당부채의 증가(감소),-,Term 7,-329117225,Term 6,0,Term 5,0,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInPresentValueOfDefinedBenefitObligation,순확정급여부채의 증가(감소),-,Term 7,-386294858,Term 6,-630423501,Term 5,-173330835,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInFairValueOfPlanAssets,퇴직연금운용자산의 감소(증가),-,Term 7,-490627913,Term 6,-503814864,Term 5,-456941420,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 7,114751468,Term 6,318660065,Term 5,48614202,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세납부(환급),-,Term 7,2599720003,Term 6,798184114,Term 5,549474096,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동현금흐름,-,Term 7,-2520262334,Term 6,-4810100382,Term 5,-4653299039,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherCurrentFinancialAssets,기타유동금융자산의 감소,-,Term 7,10969000000,Term 6,461375000,Term 5,511838198,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익공정가치측정금융자산의 감소,-,Term 7,2007600000,Term 6,0,Term 5,1590000000,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 감소,-,Term 7,839528233,Term 6,100000000,Term 5,0,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 감소,-,Term 7,304193747,Term 6,13745455,Term 5,48178916,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities,정부보조금의 수취,-,Term 7,480000000,Term 6,0,Term 5,0,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,합병으로 인한 순현금흐름,-,Term 7,514231416,Term 6,0,Term 5,0,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_PurchaseOfOtherCurrentFinancialAssets,기타유동금융자산의 증가,-,Term 7,10000000000,Term 6,0,Term 5,964758689,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익공정가치측정금융자산의 증가,-,Term 7,0,Term 6,2003000000,Term 5,1147000000,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 증가,-,Term 7,4216438709,Term 6,1325386853,Term 5,2628502451,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 증가,-,Term 7,588682142,Term 6,591900839,Term 5,453102588,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_PurchaseOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 증가,-,Term 7,2829694879,Term 6,1464933145,Term 5,1609952425,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동현금흐름,-,Term 7,1998616548,Term 6,-9246931329,Term 5,26109656257,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 증가,-,Term 7,10000000000,Term 6,0,Term 5,3404910810,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_ProceedsFromLongTermBorrowings,장기차입금의 증가,-,Term 7,0,Term 6,0,Term 5,583737926,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,전환상환우선주 발행,-,Term 7,0,Term 6,0,Term 5,27636045910,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,리스 인센티브의 수령,-,Term 7,1007454368,Term 6,0,Term 5,0,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_ProceedsFromExerciseOfShareOptions,주식선택권행사,-,Term 7,219600000,Term 6,0,Term 5,0,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 상환,-,Term 7,4000000000,Term 6,7000000000,Term 5,3380850810,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_RepaymentsOfLongTermBorrowings,장기차입금의 상환,-,Term 7,0,Term 6,0,Term 5,200000000,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,리스부채의 상환,-,Term 7,3134895393,Term 6,1934921936,Term 5,1705392671,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsFinancingActivities,이자지급,-,Term 7,193542427,Term 6,112009393,Term 5,228794908,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,-Standard account code not used-,종속기업주식의 추가취득,-,Term 7,1900000000,Term 6,200000000,Term 5,0,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,현금의 증가,-,Term 7,12255865486,Term 6,8573013918,Term 5,3298365785,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초현금및현금성자산,-,Term 7,17454914496,Term 6,8900968698,Term 5,5567041780,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,현금및현금성자산에 대한 환율변동효과,-,Term 7,-92587063,Term 6,-19068120,Term 5,35561133,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말현금및현금성자산,-,Term 7,29618192919,Term 6,17454914496,Term 5,8900968698,74,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,2982160000,Term 6,2982160000,Term 5,2800000000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,-5191367455,Term 6,-4812317349,Term 5,3563459458,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 7,9396752965,Term 6,8266369120,Term 5,8641823489,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배지분 [member],Term 7,646571706,Term 6,826388135,Term 5,199074681,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,8750181259,Term 6,7439980985,Term 5,8442748808,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,8261130924,Term 6,8031071952,Term 5,1245124430,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,2770983396,Term 6,1244162365,Term 5,835782100,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,-72725606,Term 6,-5095983,Term 5,-1617180,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 7,7891717267,Term 6,-68802895,Term 5,-7586371672,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,7891717267,Term 6,-319045438,Term 5,-8213685126,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,0,Term 6,0,Term 5,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,0,Term 6,0,Term 5,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,0,Term 6,0,Term 5,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,7891717267,Term 6,-319045438,Term 5,-8213685126,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|비지배지분 [member],Term 7,0,Term 6,250242543,Term 5,627313454,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,0,Term 6,0,Term 5,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,-201739975,Term 6,-60004668,Term 5,-162091681,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,0,Term 6,0,Term 5,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,0,Term 6,0,Term 5,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,0,Term 6,0,Term 5,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,0,Term 6,0,Term 5,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,-201739975,Term 6,-60004668,Term 5,-162091681,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|비지배지분 [member],Term 7,0,Term 6,0,Term 5,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,연결재무제표 [member],Term 7,-201739975,Term 6,-60004668,Term 5,-162091681,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|비지배지분 [member],Term 7,0,Term 6,0,Term 5,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,-543957385,Term 6,-67629623,Term 5,-3478803,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,0,Term 6,0,Term 5,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,연결재무제표 [member],Term 7,-543957385,Term 6,-67629623,Term 5,-3478803,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,0,Term 6,0,Term 5,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,-543957385,Term 6,-67629623,Term 5,-3478803,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,0,Term 6,0,Term 5,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,0,Term 6,0,Term 5,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식보상비용,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,6000000,Term 6,0,Term 5,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식보상비용,연결재무제표 [member],Term 7,504475850,Term 6,796550593,Term 5,880295490,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식보상비용,자본 [member]|비지배지분 [member],Term 7,0,Term 6,0,Term 5,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식보상비용,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,504475850,Term 6,796550593,Term 5,880295490,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식보상비용,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,431240000,Term 6,0,Term 5,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식보상비용,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,67235850,Term 6,796550593,Term 5,880295490,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식보상비용,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,0,Term 6,0,Term 5,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식보상비용,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,0,Term 6,0,Term 5,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,0,Term 6,0,Term 5,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,0,Term 6,0,Term 5,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,0,Term 6,0,Term 5,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,0,Term 6,0,Term 5,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,0,Term 6,0,Term 5,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|비지배지분 [member],Term 7,-646571706,Term 6,0,Term 5,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,연결재무제표 [member],Term 7,-646571706,Term 6,0,Term 5,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,0,Term 6,0,Term 5,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,종속기업지분 추가취득,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,0,Term 6,0,Term 5,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,종속기업지분 추가취득,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,0,Term 6,0,Term 5,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,종속기업지분 추가취득,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,0,Term 6,0,Term 5,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,종속기업지분 추가취득,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,0,Term 6,0,Term 5,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,종속기업지분 추가취득,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,0,Term 6,0,Term 5,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,종속기업지분 추가취득,자본 [member]|비지배지분 [member],Term 7,0,Term 6,0,Term 5,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,종속기업지분 추가취득,연결재무제표 [member],Term 7,0,Term 6,0,Term 5,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_PurchaseDispostionOfAssociatesOrJointVenture,종속기업지분 추가취득,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,0,Term 6,0,Term 5,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|비지배지분 [member],Term 7,0,Term 6,-430058972,Term 5,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,-1253428294,Term 6,230058972,Term 5,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,-1253428294,Term 6,230058972,Term 5,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,0,Term 6,0,Term 5,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,0,Term 6,0,Term 5,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,0,Term 6,0,Term 5,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,0,Term 6,0,Term 5,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,연결재무제표 [member],Term 7,-1253428294,Term 6,-200000000,Term 5,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,연결재무제표 [member],Term 7,0,Term 6,730270438,Term 5,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|비지배지분 [member],Term 7,0,Term 6,0,Term 5,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,0,Term 6,730270438,Term 5,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,0,Term 6,0,Term 5,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,0,Term 6,730270438,Term 5,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,0,Term 6,0,Term 5,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,0,Term 6,0,Term 5,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,0,Term 6,0,Term 5,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,0,Term 6,0,Term 5,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,0,Term 6,0,Term 5,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,-730270438,Term 6,0,Term 5,-471915225,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,36823992864,Term 6,0,Term 5,6785947522,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,36552666426,Term 6,0,Term 5,6496192297,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|비지배지분 [member],Term 7,0,Term 6,0,Term 5,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,연결재무제표 [member],Term 7,36552666426,Term 6,0,Term 5,6496192297,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,458944000,Term 6,0,Term 5,182160000,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 7,3447104000,Term 6,2982160000,Term 5,2982160000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 7,2498609837,Term 6,-5191367455,Term 5,-4812317349,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 7,-616682991,Term 6,-72725606,Term 5,-5095983,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 7,2107948808,Term 6,2770983396,Term 5,1244162365,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 7,44262935494,Term 6,8261130924,Term 5,8031071952,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 7,51699915148,Term 6,8750181259,Term 5,7439980985,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 7,51699915148,Term 6,9396752965,Term 5,8266369120,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20210331000895,11011,2020,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|비지배지분 [member],Term 7,0,Term 6,646571706,Term 5,826388135,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 8,90318935738,Term 7,62817954586,Term 6,47475785739,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 8,33798982850,Term 7,29618192919,Term 6,17454914496,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,매출채권및기타채권,-,Term 8,13762670732,Term 7,10599063509,Term 6,9721698135,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 8,4500000,Term 7,16148060,Term 6,2980327418,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 8,4411681350,Term 7,3141874298,Term 6,1052428167,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 8,37831063627,Term 7,18560580552,Term 6,16099123190,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 8,510037179,Term 7,882095248,Term 6,167294333,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 8,36109894412,Term 7,29010706735,Term 6,13049423769,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 8,5371226327,Term 7,4261695166,Term 6,2482360241,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,-Standard account code not used-,당기손익-공정가치측정금융자산,-,Term 8,1000000000,Term 7,0,Term 6,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 8,7168215109,Term 7,4975399413,Term 6,3698611184,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 8,13636505106,Term 7,13197575572,Term 6,2871845622,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 8,1329453993,Term 7,1224897255,Term 6,1001951822,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,dart_GoodwillGross,영업권,-,Term 8,281379700,Term 7,281379700,Term 6,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 8,7323114177,Term 7,5069759629,Term 6,2994654900,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 8,126428830150,Term 7,91828661321,Term 6,60525209508,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 8,50064266575,Term 7,29046487205,Term 6,48864802988,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,매입채무및기타채무,-,Term 8,21981885604,Term 7,13078038893,Term 6,12265527987,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 8,16500000000,Term 7,6000000000,Term 6,0,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,유동리스부채,-,Term 8,4936164190,Term 7,3876383488,Term 6,1367212865,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,dart_CurrentPortionOfConvertibleRedeemablePreferredStockLiabilities,유동성전환상환우선주부채,-,Term 8,0,Term 7,0,Term 6,16356668053,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 8,1149090600,Term 7,660564388,Term 6,15690794922,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 8,2280165383,Term 7,2564338917,Term 6,1408825324,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_CurrentProvisions,유동충당부채,-,Term 8,0,Term 7,0,Term 6,151920518,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 8,3216960798,Term 7,2867161519,Term 6,1623853319,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 8,10363482951,Term 7,11082258968,Term 6,2263653555,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,비유동리스부채,-,Term 8,7585564539,Term 7,9415098332,Term 6,1324093070,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 8,87046588,Term 7,58715506,Term 6,0,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,-Standard account code not used-,순확정급여부채,-,Term 8,1368720434,Term 7,452728585,Term 6,75913988,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,비유동충당부채,-,Term 8,1322151390,Term 7,1155716545,Term 6,863646497,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 8,60427749526,Term 7,40128746173,Term 6,51128456543,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 8,66001080624,Term 7,51699915148,Term 6,8750181259,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 8,3495104000,Term 7,3447104000,Term 6,2982160000,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,-Standard account code not used-,기타불입자본,-,Term 8,46718489482,Term 7,44262935494,Term 6,8261130924,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본,-,Term 8,1858558700,Term 7,2107948808,Term 6,2770983396,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 8,-47054324,Term 7,-616682991,Term 6,-72725606,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금(결손금),-,Term 8,13975982766,Term 7,2498609837,Term 6,-5191367455,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배지분,-,Term 8,0,Term 7,0,Term 6,646571706,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 8,66001080624,Term 7,51699915148,Term 6,9396752965,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채및자본총계,-,Term 8,126428830150,Term 7,91828661321,Term 6,60525209508,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 8,259146144182,Term 7,219939337665,Term 6,158999740099,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 8,71623461550,Term 7,58586370450,Term 6,45748443940,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 8,187522682632,Term 7,161352967215,Term 6,113251296159,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 8,173249530478,Term 7,146883270338,Term 6,106098878471,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익(손실),-,Term 8,14273152154,Term 7,14469696877,Term 6,7152417688,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,dart_OtherGains,기타수익,-,Term 8,416907223,Term 7,828202472,Term 6,453868182,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,dart_OtherLosses,기타비용,-,Term 8,684415176,Term 7,684487692,Term 6,2702738673,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 8,1988995348,Term 7,1398331160,Term 6,825207193,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 8,2256960051,Term 7,7157864163,Term 6,4651334073,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익(손실),-,Term 8,13737679498,Term 7,8853878654,Term 6,1077420317,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용(수익),-,Term 8,2338852470,Term 7,962161387,Term 6,1146223212,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 8,11398827028,Term 7,7891717267,Term 6,-68802895,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 8,11398827028,Term 7,7891717267,Term 6,-319045438,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배지분,-,Term 8,0,Term 7,0,Term 6,250242543,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 8,648174568,Term 7,-745697360,Term 6,-127634291,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류되는 항목,-,Term 8,569628667,Term 7,-543957385,Term 6,-67629623,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax,해외사업환산손익,-,Term 8,569628667,Term 7,-543957385,Term 6,-67629623,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류되지 않는 항목,-,Term 8,78545901,Term 7,-201739975,Term 6,-60004668,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채의 재측정요소,-,Term 8,100699873,Term 7,-258640993,Term 6,-76929061,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,dart_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss,법인세효과,-,Term 8,22153972,Term 7,-56901018,Term 6,-16924393,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄손익,-,Term 8,12047001596,Term 7,7146019907,Term 6,-196437186,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 8,12047001596,Term 7,7146019907,Term 6,-446679729,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배지분,-,Term 8,0,Term 7,0,Term 6,250242543,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주 기본주당손익,-,Term 8,1642,Term 7,1269,Term 6,-12,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_DilutedEarningsLossPerShare,보통주 희석주당손익,-,Term 8,1621,Term 7,1251,Term 6,-12,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동현금흐름,-,Term 8,4585024805,Term 7,12777511272,Term 6,22630045629,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_ProfitLossForStatementOfCashFlows,당기순이익(손실),-,Term 8,11398827028,Term 7,7891717267,Term 6,-68802895,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,현금의 유출·유입이 없는 비용·수익등의 가감,-,Term 8,11864998671,Term 7,14118849110,Term 6,15087467155,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 8,2338852470,Term 7,962161387,Term 6,1146223212,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 8,116614958,Term 7,277507443,Term 6,290533122,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비,-,Term 8,33331477,Term 7,257906602,Term 6,2222856234,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타의 대손상각비,-,Term 8,0,Term 7,30210418,Term 6,1372600296,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForWritedownsOfInventories,재고자산평가손실,-,Term 8,0,Term 7,437388133,Term 6,415482761,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,지급수수료,-,Term 8,114522441,Term 7,0,Term 6,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 8,648254268,Term 7,2190639054,Term 6,2206369684,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 8,1505471332,Term 7,1051997393,Term 6,820497550,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,기타장기종업원급여,-,Term 8,28331082,Term 7,58715506,Term 6,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForDepreciationExpense,유형자산감가상각비,-,Term 8,2090706225,Term 7,1604235327,Term 6,1328394876,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,사용권자산감가상각비,-,Term 8,4863676473,Term 7,3274375974,Term 6,2074942760,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForShareBasedPayment,주식보상비용,-,Term 8,497990000,Term 7,375837022,Term 6,526249601,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 8,340057933,Term 7,393850574,Term 6,223996148,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 8,22440670,Term 7,414345482,Term 6,111383868,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnAbandonmentOfPropertyPlantAndEquipment,유형자산폐기손실,-,Term 8,271407000,Term 7,146451006,Term 6,0,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnEvaluationOfDerivativeFinancialLiabilities,파생상품평가손실,-,Term 8,0,Term 7,3140267309,Term 6,2006104508,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForMiscellaneousLosses,잡손실,-,Term 8,43236015,Term 7,0,Term 6,80593021,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfPropertyPlantAndEquipment,유형자산손상차손,-,Term 8,0,Term 7,0,Term 6,130586662,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,재고자산폐기손실,-,Term 8,0,Term 7,0,Term 6,257661763,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,이연매출,-,Term 8,0,Term 7,0,Term 6,-140483,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,급여,-,Term 8,0,Term 7,0,Term 6,75498840,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForExpenseOfProvisions,충당부채전입액,-,Term 8,0,Term 7,0,Term 6,600000000,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForInterestIncome,이자수익,-,Term 8,91608715,Term 7,162221450,Term 6,146620003,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfInventories,재고자산평가손실환입,-,Term 8,383776739,Term 7,0,Term 6,0,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfBadDebtExpenses,기타의대손상각비환입,-,Term 8,0,Term 7,13038552,Term 6,0,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 8,150879966,Term 7,11976098,Term 6,1194460,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 8,423628253,Term 7,2522642,Term 6,604000153,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForMiscellaneousIncome,잡이익,-,Term 8,0,Term 7,36398003,Term 6,42952652,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfProvisions,충당부채환입액,-,Term 8,0,Term 7,270882775,Term 6,0,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfFairValueFinancialAssets,당기손익인식금융자산평가이익,-,Term 8,0,Term 7,0,Term 6,7600000,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,운전자본의 변동,-,Term 8,-14809797141,Term 7,-6748086570,Term 6,8090905418,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInTradeAndOtherReceivables,유동매출채권및기타채권의 감소(증가),-,Term 8,-2715495203,Term 7,-1312348964,Term 6,3880652614,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산의 감소(증가),-,Term 8,-2478345014,Term 7,-2090311851,Term 6,1656804417,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInOtherCurrentFinancialAssets,기타유동금융자산의 감소(증가),-,Term 8,0,Term 7,0,Term 6,-76660811,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산의 감소(증가),-,Term 8,-18886706336,Term 7,-2789110003,Term 6,5255562579,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInLongTermTradeAndOtherNonCurrentReceivables,비유동매출채권및기타채권의 증가,-,Term 8,0,Term 7,0,Term 6,-26865634,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherNonCurrentLiabilities,기타비유동부채의 증가(감소),-,Term 8,0,Term 7,0,Term 6,107596022,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInTradeAndOtherPayables,매입채무 및 기타채무의 증가(감소),-,Term 8,9399950880,Term 7,-695460299,Term 6,-7018799632,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채의 증가(감소),-,Term 8,643751676,Term 7,148285808,Term 6,4889272848,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채의 증가(감소),-,Term 8,-284173534,Term 7,1350513593,Term 6,557581380,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInCurrentProvisions,유동충당부채의 증가(감소),-,Term 8,0,Term 7,-153614858,Term 6,0,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInNonCurrentProvisions,비유동충당부채의 증가(감소),-,Term 8,0,Term 7,-329117225,Term 6,0,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInPresentValueOfDefinedBenefitObligation,순확정급여부채의 증가(감소),-,Term 8,-547299154,Term 7,-386294858,Term 6,-630423501,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInFairValueOfPlanAssets,퇴직연금운용자산의 감소(증가),-,Term 8,58519544,Term 7,-490627913,Term 6,-503814864,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 8,24126009,Term 7,114751468,Term 6,318660065,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세납부(환급),-,Term 8,3893129762,Term 7,2599720003,Term 6,798184114,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동현금흐름,-,Term 8,-7203428972,Term 7,-2520262334,Term 6,-4810100382,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherCurrentFinancialAssets,기타유동금융자산의 감소,-,Term 8,10000000,Term 7,10969000000,Term 6,461375000,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익공정가치측정금융자산의 감소,-,Term 8,0,Term 7,2007600000,Term 6,0,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 감소,-,Term 8,180470243,Term 7,839528233,Term 6,100000000,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 감소,-,Term 8,49528365,Term 7,304193747,Term 6,13745455,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities,정부보조금의 수취,-,Term 8,0,Term 7,480000000,Term 6,0,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,합병으로 인한 순현금흐름,-,Term 8,0,Term 7,514231416,Term 6,0,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_PurchaseOfOtherCurrentFinancialAssets,기타유동금융자산의 증가,-,Term 8,0,Term 7,10000000000,Term 6,0,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익공정가치측정금융자산의 증가,-,Term 8,1000000000,Term 7,0,Term 6,2003000000,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 증가,-,Term 8,4454194805,Term 7,4216438709,Term 6,1325386853,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 증가,-,Term 8,500274592,Term 7,588682142,Term 6,591900839,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_PurchaseOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 증가,-,Term 8,1488958183,Term 7,2829694879,Term 6,1464933145,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동현금흐름,-,Term 8,6900283116,Term 7,1998616548,Term 6,-9246931329,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 증가,-,Term 8,14500000000,Term 7,10000000000,Term 6,0,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,리스 인센티브의 수령,-,Term 8,0,Term 7,1007454368,Term 6,0,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_ProceedsFromExerciseOfShareOptions,주식선택권행사,-,Term 8,1756800000,Term 7,219600000,Term 6,0,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 상환,-,Term 8,4000000000,Term 7,4000000000,Term 6,7000000000,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,리스부채의 상환,-,Term 8,4953839886,Term 7,3134895393,Term 6,1934921936,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsFinancingActivities,이자지급,-,Term 8,402676998,Term 7,193542427,Term 6,112009393,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,종속기업주식의 추가취득,-,Term 8,0,Term 7,1900000000,Term 6,200000000,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,현금의 증가,-,Term 8,4281878949,Term 7,12255865486,Term 6,8573013918,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초현금및현금성자산,-,Term 8,29618192919,Term 7,17454914496,Term 6,8900968698,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,현금및현금성자산에 대한 환율변동효과,-,Term 8,-101089018,Term 7,-92587063,Term 6,-19068120,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말현금및현금성자산,-,Term 8,33798982850,Term 7,29618192919,Term 6,17454914496,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 8,51699915148,Term 7,9396752965,Term 6,8266369120,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배지분 [member],Term 8,0,Term 7,646571706,Term 6,826388135,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,51699915148,Term 7,8750181259,Term 6,7439980985,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,44262935494,Term 7,8261130924,Term 6,8031071952,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,2107948808,Term 7,2770983396,Term 6,1244162365,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,-616682991,Term 7,-72725606,Term 6,-5095983,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,2498609837,Term 7,-5191367455,Term 6,-4812317349,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,3447104000,Term 7,2982160000,Term 6,2982160000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,0,Term 7,0,Term 6,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,11398827028,Term 7,7891717267,Term 6,-319045438,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,0,Term 7,0,Term 6,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,0,Term 7,0,Term 6,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,0,Term 7,0,Term 6,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,11398827028,Term 7,7891717267,Term 6,-319045438,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 8,11398827028,Term 7,7891717267,Term 6,-68802895,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|비지배지분 [member],Term 8,0,Term 7,0,Term 6,250242543,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,연결재무제표 [member],Term 8,78545901,Term 7,-201739975,Term 6,-60004668,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|비지배지분 [member],Term 8,0,Term 7,0,Term 6,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,78545901,Term 7,-201739975,Term 6,-60004668,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,0,Term 7,0,Term 6,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,0,Term 7,0,Term 6,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,0,Term 7,0,Term 6,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,78545901,Term 7,-201739975,Term 6,-60004668,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,0,Term 7,0,Term 6,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,연결재무제표 [member],Term 8,569628667,Term 7,-543957385,Term 6,-67629623,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|비지배지분 [member],Term 8,0,Term 7,0,Term 6,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,569628667,Term 7,-543957385,Term 6,-67629623,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,0,Term 7,0,Term 6,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,0,Term 7,0,Term 6,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,0,Term 7,0,Term 6,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,0,Term 7,0,Term 6,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,569628667,Term 7,-543957385,Term 6,-67629623,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,연결재무제표 [member],Term 8,2254163880,Term 7,504475850,Term 6,796550593,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|비지배지분 [member],Term 8,0,Term 7,0,Term 6,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,48000000,Term 7,6000000,Term 6,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,0,Term 7,0,Term 6,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,0,Term 7,0,Term 6,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,249390108,Term 7,67235850,Term 6,796550593,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,2455553988,Term 7,431240000,Term 6,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,2254163880,Term 7,504475850,Term 6,796550593,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,0,Term 7,0,Term 6,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,연결재무제표 [member],Term 8,0,Term 7,-646571706,Term 6,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|비지배지분 [member],Term 8,0,Term 7,-646571706,Term 6,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,0,Term 7,0,Term 6,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,0,Term 7,0,Term 6,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,0,Term 7,0,Term 6,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,0,Term 7,0,Term 6,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,0,Term 7,0,Term 6,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,연결재무제표 [member],Term 8,0,Term 7,-1253428294,Term 6,-200000000,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|비지배지분 [member],Term 8,0,Term 7,0,Term 6,-430058972,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,0,Term 7,-1253428294,Term 6,230058972,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,0,Term 7,-1253428294,Term 6,230058972,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,0,Term 7,0,Term 6,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,0,Term 7,0,Term 6,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,0,Term 7,0,Term 6,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,0,Term 7,0,Term 6,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,0,Term 7,0,Term 6,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,0,Term 7,0,Term 6,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,0,Term 7,0,Term 6,730270438,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,0,Term 7,0,Term 6,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,0,Term 7,0,Term 6,730270438,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|비지배지분 [member],Term 8,0,Term 7,0,Term 6,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,연결재무제표 [member],Term 8,0,Term 7,0,Term 6,730270438,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,0,Term 7,0,Term 6,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,0,Term 7,458944000,Term 6,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,0,Term 7,0,Term 6,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,0,Term 7,0,Term 6,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,0,Term 7,-730270438,Term 6,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,0,Term 7,36823992864,Term 6,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,0,Term 7,36552666426,Term 6,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,연결재무제표 [member],Term 8,0,Term 7,36552666426,Term 6,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|비지배지분 [member],Term 8,0,Term 7,0,Term 6,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 8,66001080624,Term 7,51699915148,Term 6,9396752965,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|비지배지분 [member],Term 8,0,Term 7,0,Term 6,646571706,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,66001080624,Term 7,51699915148,Term 6,8750181259,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,46718489482,Term 7,44262935494,Term 6,8261130924,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,1858558700,Term 7,2107948808,Term 6,2770983396,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,47054324,Term 7,-616682991,Term 6,-72725606,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,13975982766,Term 7,2498609837,Term 6,-5191367455,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,3495104000,Term 7,3447104000,Term 6,2982160000,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 8,90318935738,Term 7,62817954586,Term 6,47475785739,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 8,33798982850,Term 7,29618192919,Term 6,17454914496,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,매출채권및기타채권,-,Term 8,13762670732,Term 7,10599063509,Term 6,9721698135,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 8,4500000,Term 7,16148060,Term 6,2980327418,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 8,4411681350,Term 7,3141874298,Term 6,1052428167,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 8,37831063627,Term 7,18560580552,Term 6,16099123190,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 8,510037179,Term 7,882095248,Term 6,167294333,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 8,36109894412,Term 7,29010706735,Term 6,13049423769,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 8,5371226327,Term 7,4261695166,Term 6,2482360241,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,-Standard account code not used-,당기손익-공정가치측정금융자산,-,Term 8,1000000000,Term 7,0,Term 6,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 8,7168215109,Term 7,4975399413,Term 6,3698611184,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 8,13636505106,Term 7,13197575572,Term 6,2871845622,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 8,1329453993,Term 7,1224897255,Term 6,1001951822,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,dart_GoodwillGross,영업권,-,Term 8,281379700,Term 7,281379700,Term 6,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 8,7323114177,Term 7,5069759629,Term 6,2994654900,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 8,126428830150,Term 7,91828661321,Term 6,60525209508,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 8,50064266575,Term 7,29046487205,Term 6,48864802988,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,매입채무및기타채무,-,Term 8,21981885604,Term 7,13078038893,Term 6,12265527987,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 8,16500000000,Term 7,6000000000,Term 6,0,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,유동리스부채,-,Term 8,4936164190,Term 7,3876383488,Term 6,1367212865,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,dart_CurrentPortionOfConvertibleRedeemablePreferredStockLiabilities,유동성전환상환우선주부채,-,Term 8,0,Term 7,0,Term 6,16356668053,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 8,1149090600,Term 7,660564388,Term 6,15690794922,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 8,2280165383,Term 7,2564338917,Term 6,1408825324,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_CurrentProvisions,유동충당부채,-,Term 8,0,Term 7,0,Term 6,151920518,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 8,3216960798,Term 7,2867161519,Term 6,1623853319,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 8,10363482951,Term 7,11082258968,Term 6,2263653555,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,비유동리스부채,-,Term 8,7585564539,Term 7,9415098332,Term 6,1324093070,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 8,87046588,Term 7,58715506,Term 6,0,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,-Standard account code not used-,순확정급여부채,-,Term 8,1368720434,Term 7,452728585,Term 6,75913988,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,비유동충당부채,-,Term 8,1322151390,Term 7,1155716545,Term 6,863646497,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 8,60427749526,Term 7,40128746173,Term 6,51128456543,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 8,66001080624,Term 7,51699915148,Term 6,8750181259,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 8,3495104000,Term 7,3447104000,Term 6,2982160000,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,-Standard account code not used-,기타불입자본,-,Term 8,46718489482,Term 7,44262935494,Term 6,8261130924,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본,-,Term 8,1858558700,Term 7,2107948808,Term 6,2770983396,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 8,-47054324,Term 7,-616682991,Term 6,-72725606,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금(결손금),-,Term 8,13975982766,Term 7,2498609837,Term 6,-5191367455,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배지분,-,Term 8,0,Term 7,0,Term 6,646571706,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 8,66001080624,Term 7,51699915148,Term 6,9396752965,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채및자본총계,-,Term 8,126428830150,Term 7,91828661321,Term 6,60525209508,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 8,259146144182,Term 7,219939337665,Term 6,158999740099,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 8,71623461550,Term 7,58586370450,Term 6,45748443940,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 8,187522682632,Term 7,161352967215,Term 6,113251296159,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 8,173249530478,Term 7,146883270338,Term 6,106098878471,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익(손실),-,Term 8,14273152154,Term 7,14469696877,Term 6,7152417688,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,dart_OtherGains,기타수익,-,Term 8,416907223,Term 7,828202472,Term 6,453868182,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,dart_OtherLosses,기타비용,-,Term 8,684415176,Term 7,684487692,Term 6,2702738673,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 8,1988995348,Term 7,1398331160,Term 6,825207193,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 8,2256960051,Term 7,7157864163,Term 6,4651334073,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익(손실),-,Term 8,13737679498,Term 7,8853878654,Term 6,1077420317,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용(수익),-,Term 8,2338852470,Term 7,962161387,Term 6,1146223212,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 8,11398827028,Term 7,7891717267,Term 6,-68802895,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 8,11398827028,Term 7,7891717267,Term 6,-319045438,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배지분,-,Term 8,0,Term 7,0,Term 6,250242543,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 8,648174568,Term 7,-745697360,Term 6,-127634291,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류되는 항목,-,Term 8,569628667,Term 7,-543957385,Term 6,-67629623,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax,해외사업환산손익,-,Term 8,569628667,Term 7,-543957385,Term 6,-67629623,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류되지 않는 항목,-,Term 8,78545901,Term 7,-201739975,Term 6,-60004668,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채의 재측정요소,-,Term 8,100699873,Term 7,-258640993,Term 6,-76929061,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,dart_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss,법인세효과,-,Term 8,22153972,Term 7,-56901018,Term 6,-16924393,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄손익,-,Term 8,12047001596,Term 7,7146019907,Term 6,-196437186,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 8,12047001596,Term 7,7146019907,Term 6,-446679729,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배지분,-,Term 8,0,Term 7,0,Term 6,250242543,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주 기본주당손익,-,Term 8,1642,Term 7,1269,Term 6,-12,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_DilutedEarningsLossPerShare,보통주 희석주당손익,-,Term 8,1621,Term 7,1251,Term 6,-12,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동현금흐름,-,Term 8,4585024805,Term 7,12777511272,Term 6,22630045629,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_ProfitLossForStatementOfCashFlows,당기순이익(손실),-,Term 8,11398827028,Term 7,7891717267,Term 6,-68802895,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,현금의 유출·유입이 없는 비용·수익등의 가감,-,Term 8,11864998671,Term 7,14118849110,Term 6,15087467155,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 8,2338852470,Term 7,962161387,Term 6,1146223212,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 8,116614958,Term 7,277507443,Term 6,290533122,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비,-,Term 8,33331477,Term 7,257906602,Term 6,2222856234,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타의 대손상각비,-,Term 8,0,Term 7,30210418,Term 6,1372600296,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForWritedownsOfInventories,재고자산평가손실,-,Term 8,0,Term 7,437388133,Term 6,415482761,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,지급수수료,-,Term 8,114522441,Term 7,0,Term 6,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 8,648254268,Term 7,2190639054,Term 6,2206369684,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 8,1505471332,Term 7,1051997393,Term 6,820497550,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,기타장기종업원급여,-,Term 8,28331082,Term 7,58715506,Term 6,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForDepreciationExpense,유형자산감가상각비,-,Term 8,2090706225,Term 7,1604235327,Term 6,1328394876,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,사용권자산감가상각비,-,Term 8,4863676473,Term 7,3274375974,Term 6,2074942760,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForShareBasedPayment,주식보상비용,-,Term 8,497990000,Term 7,375837022,Term 6,526249601,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 8,340057933,Term 7,393850574,Term 6,223996148,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 8,22440670,Term 7,414345482,Term 6,111383868,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnAbandonmentOfPropertyPlantAndEquipment,유형자산폐기손실,-,Term 8,271407000,Term 7,146451006,Term 6,0,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnEvaluationOfDerivativeFinancialLiabilities,파생상품평가손실,-,Term 8,0,Term 7,3140267309,Term 6,2006104508,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForMiscellaneousLosses,잡손실,-,Term 8,43236015,Term 7,0,Term 6,80593021,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfPropertyPlantAndEquipment,유형자산손상차손,-,Term 8,0,Term 7,0,Term 6,130586662,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,재고자산폐기손실,-,Term 8,0,Term 7,0,Term 6,257661763,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,이연매출,-,Term 8,0,Term 7,0,Term 6,-140483,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,급여,-,Term 8,0,Term 7,0,Term 6,75498840,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForExpenseOfProvisions,충당부채전입액,-,Term 8,0,Term 7,0,Term 6,600000000,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForInterestIncome,이자수익,-,Term 8,91608715,Term 7,162221450,Term 6,146620003,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfInventories,재고자산평가손실환입,-,Term 8,383776739,Term 7,0,Term 6,0,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfBadDebtExpenses,기타의대손상각비환입,-,Term 8,0,Term 7,13038552,Term 6,0,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 8,150879966,Term 7,11976098,Term 6,1194460,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 8,423628253,Term 7,2522642,Term 6,604000153,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForMiscellaneousIncome,잡이익,-,Term 8,0,Term 7,36398003,Term 6,42952652,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfProvisions,충당부채환입액,-,Term 8,0,Term 7,270882775,Term 6,0,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfFairValueFinancialAssets,당기손익인식금융자산평가이익,-,Term 8,0,Term 7,0,Term 6,7600000,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,운전자본의 변동,-,Term 8,-14809797141,Term 7,-6748086570,Term 6,8090905418,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInTradeAndOtherReceivables,유동매출채권및기타채권의 감소(증가),-,Term 8,-2715495203,Term 7,-1312348964,Term 6,3880652614,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산의 감소(증가),-,Term 8,-2478345014,Term 7,-2090311851,Term 6,1656804417,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInOtherCurrentFinancialAssets,기타유동금융자산의 감소(증가),-,Term 8,0,Term 7,0,Term 6,-76660811,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산의 감소(증가),-,Term 8,-18886706336,Term 7,-2789110003,Term 6,5255562579,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInLongTermTradeAndOtherNonCurrentReceivables,비유동매출채권및기타채권의 증가,-,Term 8,0,Term 7,0,Term 6,-26865634,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherNonCurrentLiabilities,기타비유동부채의 증가(감소),-,Term 8,0,Term 7,0,Term 6,107596022,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInTradeAndOtherPayables,매입채무 및 기타채무의 증가(감소),-,Term 8,9399950880,Term 7,-695460299,Term 6,-7018799632,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채의 증가(감소),-,Term 8,643751676,Term 7,148285808,Term 6,4889272848,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채의 증가(감소),-,Term 8,-284173534,Term 7,1350513593,Term 6,557581380,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInCurrentProvisions,유동충당부채의 증가(감소),-,Term 8,0,Term 7,-153614858,Term 6,0,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInNonCurrentProvisions,비유동충당부채의 증가(감소),-,Term 8,0,Term 7,-329117225,Term 6,0,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInPresentValueOfDefinedBenefitObligation,순확정급여부채의 증가(감소),-,Term 8,-547299154,Term 7,-386294858,Term 6,-630423501,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInFairValueOfPlanAssets,퇴직연금운용자산의 감소(증가),-,Term 8,58519544,Term 7,-490627913,Term 6,-503814864,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 8,24126009,Term 7,114751468,Term 6,318660065,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세납부(환급),-,Term 8,3893129762,Term 7,2599720003,Term 6,798184114,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동현금흐름,-,Term 8,-7203428972,Term 7,-2520262334,Term 6,-4810100382,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherCurrentFinancialAssets,기타유동금융자산의 감소,-,Term 8,10000000,Term 7,10969000000,Term 6,461375000,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익공정가치측정금융자산의 감소,-,Term 8,0,Term 7,2007600000,Term 6,0,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 감소,-,Term 8,180470243,Term 7,839528233,Term 6,100000000,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 감소,-,Term 8,49528365,Term 7,304193747,Term 6,13745455,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities,정부보조금의 수취,-,Term 8,0,Term 7,480000000,Term 6,0,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,합병으로 인한 순현금흐름,-,Term 8,0,Term 7,514231416,Term 6,0,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_PurchaseOfOtherCurrentFinancialAssets,기타유동금융자산의 증가,-,Term 8,0,Term 7,10000000000,Term 6,0,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익공정가치측정금융자산의 증가,-,Term 8,1000000000,Term 7,0,Term 6,2003000000,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 증가,-,Term 8,4454194805,Term 7,4216438709,Term 6,1325386853,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 증가,-,Term 8,500274592,Term 7,588682142,Term 6,591900839,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_PurchaseOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 증가,-,Term 8,1488958183,Term 7,2829694879,Term 6,1464933145,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동현금흐름,-,Term 8,6900283116,Term 7,1998616548,Term 6,-9246931329,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 증가,-,Term 8,14500000000,Term 7,10000000000,Term 6,0,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,리스 인센티브의 수령,-,Term 8,0,Term 7,1007454368,Term 6,0,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_ProceedsFromExerciseOfShareOptions,주식선택권행사,-,Term 8,1756800000,Term 7,219600000,Term 6,0,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 상환,-,Term 8,4000000000,Term 7,4000000000,Term 6,7000000000,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,리스부채의 상환,-,Term 8,4953839886,Term 7,3134895393,Term 6,1934921936,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsFinancingActivities,이자지급,-,Term 8,402676998,Term 7,193542427,Term 6,112009393,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,종속기업주식의 추가취득,-,Term 8,0,Term 7,1900000000,Term 6,200000000,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,현금의 증가,-,Term 8,4281878949,Term 7,12255865486,Term 6,8573013918,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초현금및현금성자산,-,Term 8,29618192919,Term 7,17454914496,Term 6,8900968698,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,현금및현금성자산에 대한 환율변동효과,-,Term 8,-101089018,Term 7,-92587063,Term 6,-19068120,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말현금및현금성자산,-,Term 8,33798982850,Term 7,29618192919,Term 6,17454914496,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 8,51699915148,Term 7,9396752965,Term 6,8266369120,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배지분 [member],Term 8,0,Term 7,646571706,Term 6,826388135,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,51699915148,Term 7,8750181259,Term 6,7439980985,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,44262935494,Term 7,8261130924,Term 6,8031071952,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,2107948808,Term 7,2770983396,Term 6,1244162365,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,-616682991,Term 7,-72725606,Term 6,-5095983,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,2498609837,Term 7,-5191367455,Term 6,-4812317349,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,3447104000,Term 7,2982160000,Term 6,2982160000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,0,Term 7,0,Term 6,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,11398827028,Term 7,7891717267,Term 6,-319045438,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,0,Term 7,0,Term 6,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,0,Term 7,0,Term 6,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,0,Term 7,0,Term 6,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,11398827028,Term 7,7891717267,Term 6,-319045438,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 8,11398827028,Term 7,7891717267,Term 6,-68802895,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|비지배지분 [member],Term 8,0,Term 7,0,Term 6,250242543,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,연결재무제표 [member],Term 8,78545901,Term 7,-201739975,Term 6,-60004668,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|비지배지분 [member],Term 8,0,Term 7,0,Term 6,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,78545901,Term 7,-201739975,Term 6,-60004668,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,0,Term 7,0,Term 6,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,0,Term 7,0,Term 6,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,0,Term 7,0,Term 6,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,78545901,Term 7,-201739975,Term 6,-60004668,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,0,Term 7,0,Term 6,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,연결재무제표 [member],Term 8,569628667,Term 7,-543957385,Term 6,-67629623,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|비지배지분 [member],Term 8,0,Term 7,0,Term 6,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,569628667,Term 7,-543957385,Term 6,-67629623,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,0,Term 7,0,Term 6,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,0,Term 7,0,Term 6,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,0,Term 7,0,Term 6,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,0,Term 7,0,Term 6,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,569628667,Term 7,-543957385,Term 6,-67629623,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,연결재무제표 [member],Term 8,2254163880,Term 7,504475850,Term 6,796550593,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|비지배지분 [member],Term 8,0,Term 7,0,Term 6,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,48000000,Term 7,6000000,Term 6,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,0,Term 7,0,Term 6,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,0,Term 7,0,Term 6,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,249390108,Term 7,67235850,Term 6,796550593,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,2455553988,Term 7,431240000,Term 6,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,2254163880,Term 7,504475850,Term 6,796550593,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,0,Term 7,0,Term 6,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,연결재무제표 [member],Term 8,0,Term 7,-646571706,Term 6,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|비지배지분 [member],Term 8,0,Term 7,-646571706,Term 6,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,0,Term 7,0,Term 6,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,0,Term 7,0,Term 6,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,0,Term 7,0,Term 6,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,0,Term 7,0,Term 6,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,0,Term 7,0,Term 6,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,연결재무제표 [member],Term 8,0,Term 7,-1253428294,Term 6,-200000000,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|비지배지분 [member],Term 8,0,Term 7,0,Term 6,-430058972,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,0,Term 7,-1253428294,Term 6,230058972,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,0,Term 7,-1253428294,Term 6,230058972,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,0,Term 7,0,Term 6,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,0,Term 7,0,Term 6,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,0,Term 7,0,Term 6,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,0,Term 7,0,Term 6,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,0,Term 7,0,Term 6,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,0,Term 7,0,Term 6,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,0,Term 7,0,Term 6,730270438,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,0,Term 7,0,Term 6,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,0,Term 7,0,Term 6,730270438,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|비지배지분 [member],Term 8,0,Term 7,0,Term 6,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,연결재무제표 [member],Term 8,0,Term 7,0,Term 6,730270438,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,0,Term 7,0,Term 6,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,0,Term 7,458944000,Term 6,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,0,Term 7,0,Term 6,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,0,Term 7,0,Term 6,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,0,Term 7,-730270438,Term 6,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,0,Term 7,36823992864,Term 6,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,0,Term 7,36552666426,Term 6,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,연결재무제표 [member],Term 8,0,Term 7,36552666426,Term 6,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|비지배지분 [member],Term 8,0,Term 7,0,Term 6,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 8,66001080624,Term 7,51699915148,Term 6,9396752965,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|비지배지분 [member],Term 8,0,Term 7,0,Term 6,646571706,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,66001080624,Term 7,51699915148,Term 6,8750181259,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,46718489482,Term 7,44262935494,Term 6,8261130924,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,1858558700,Term 7,2107948808,Term 6,2770983396,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,47054324,Term 7,-616682991,Term 6,-72725606,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,13975982766,Term 7,2498609837,Term 6,-5191367455,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,3495104000,Term 7,3447104000,Term 6,2982160000,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 8,90318935738,Term 7,62817954586,Term 6,47475785739,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 8,33798982850,Term 7,29618192919,Term 6,17454914496,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,매출채권및기타채권,-,Term 8,13762670732,Term 7,10599063509,Term 6,9721698135,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 8,4500000,Term 7,16148060,Term 6,2980327418,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 8,4411681350,Term 7,3141874298,Term 6,1052428167,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 8,37831063627,Term 7,18560580552,Term 6,16099123190,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 8,510037179,Term 7,882095248,Term 6,167294333,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 8,36109894412,Term 7,29010706735,Term 6,13049423769,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 8,5371226327,Term 7,4261695166,Term 6,2482360241,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,-Standard account code not used-,당기손익-공정가치측정금융자산,-,Term 8,1000000000,Term 7,0,Term 6,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 8,7168215109,Term 7,4975399413,Term 6,3698611184,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 8,13636505106,Term 7,13197575572,Term 6,2871845622,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 8,1329453993,Term 7,1224897255,Term 6,1001951822,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,dart_GoodwillGross,영업권,-,Term 8,281379700,Term 7,281379700,Term 6,0,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 8,7323114177,Term 7,5069759629,Term 6,2994654900,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 8,126428830150,Term 7,91828661321,Term 6,60525209508,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 8,50064266575,Term 7,29046487205,Term 6,48864802988,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,매입채무및기타채무,-,Term 8,21981885604,Term 7,13078038893,Term 6,12265527987,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 8,16500000000,Term 7,6000000000,Term 6,0,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,유동리스부채,-,Term 8,4936164190,Term 7,3876383488,Term 6,1367212865,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,dart_CurrentPortionOfConvertibleRedeemablePreferredStockLiabilities,유동성전환상환우선주부채,-,Term 8,0,Term 7,0,Term 6,16356668053,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 8,1149090600,Term 7,660564388,Term 6,15690794922,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 8,2280165383,Term 7,2564338917,Term 6,1408825324,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_CurrentProvisions,유동충당부채,-,Term 8,0,Term 7,0,Term 6,151920518,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 8,3216960798,Term 7,2867161519,Term 6,1623853319,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 8,10363482951,Term 7,11082258968,Term 6,2263653555,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,비유동리스부채,-,Term 8,7585564539,Term 7,9415098332,Term 6,1324093070,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 8,87046588,Term 7,58715506,Term 6,0,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,-Standard account code not used-,순확정급여부채,-,Term 8,1368720434,Term 7,452728585,Term 6,75913988,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,비유동충당부채,-,Term 8,1322151390,Term 7,1155716545,Term 6,863646497,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 8,60427749526,Term 7,40128746173,Term 6,51128456543,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 8,66001080624,Term 7,51699915148,Term 6,8750181259,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 8,3495104000,Term 7,3447104000,Term 6,2982160000,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,-Standard account code not used-,기타불입자본,-,Term 8,46718489482,Term 7,44262935494,Term 6,8261130924,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본,-,Term 8,1858558700,Term 7,2107948808,Term 6,2770983396,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 8,-47054324,Term 7,-616682991,Term 6,-72725606,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금(결손금),-,Term 8,13975982766,Term 7,2498609837,Term 6,-5191367455,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배지분,-,Term 8,0,Term 7,0,Term 6,646571706,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 8,66001080624,Term 7,51699915148,Term 6,9396752965,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채및자본총계,-,Term 8,126428830150,Term 7,91828661321,Term 6,60525209508,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 8,259146144182,Term 7,219939337665,Term 6,158999740099,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 8,71623461550,Term 7,58586370450,Term 6,45748443940,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 8,187522682632,Term 7,161352967215,Term 6,113251296159,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 8,173249530478,Term 7,146883270338,Term 6,106098878471,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익(손실),-,Term 8,14273152154,Term 7,14469696877,Term 6,7152417688,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,dart_OtherGains,기타수익,-,Term 8,416907223,Term 7,828202472,Term 6,453868182,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,dart_OtherLosses,기타비용,-,Term 8,684415176,Term 7,684487692,Term 6,2702738673,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 8,1988995348,Term 7,1398331160,Term 6,825207193,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 8,2256960051,Term 7,7157864163,Term 6,4651334073,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익(손실),-,Term 8,13737679498,Term 7,8853878654,Term 6,1077420317,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용(수익),-,Term 8,2338852470,Term 7,962161387,Term 6,1146223212,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 8,11398827028,Term 7,7891717267,Term 6,-68802895,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 8,11398827028,Term 7,7891717267,Term 6,-319045438,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배지분,-,Term 8,0,Term 7,0,Term 6,250242543,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 8,648174568,Term 7,-745697360,Term 6,-127634291,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류되는 항목,-,Term 8,569628667,Term 7,-543957385,Term 6,-67629623,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax,해외사업환산손익,-,Term 8,569628667,Term 7,-543957385,Term 6,-67629623,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류되지 않는 항목,-,Term 8,78545901,Term 7,-201739975,Term 6,-60004668,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채의 재측정요소,-,Term 8,100699873,Term 7,-258640993,Term 6,-76929061,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,dart_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss,법인세효과,-,Term 8,22153972,Term 7,-56901018,Term 6,-16924393,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄손익,-,Term 8,12047001596,Term 7,7146019907,Term 6,-196437186,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 8,12047001596,Term 7,7146019907,Term 6,-446679729,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배지분,-,Term 8,0,Term 7,0,Term 6,250242543,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주 기본주당손익,-,Term 8,1642,Term 7,1269,Term 6,-12,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CIS,Statement of comprehensive income,ifrs-full_DilutedEarningsLossPerShare,보통주 희석주당손익,-,Term 8,1621,Term 7,1251,Term 6,-12,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동현금흐름,-,Term 8,4585024805,Term 7,12777511272,Term 6,22630045629,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_ProfitLossForStatementOfCashFlows,당기순이익(손실),-,Term 8,11398827028,Term 7,7891717267,Term 6,-68802895,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,현금의 유출·유입이 없는 비용·수익등의 가감,-,Term 8,11864998671,Term 7,14118849110,Term 6,15087467155,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 8,2338852470,Term 7,962161387,Term 6,1146223212,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 8,116614958,Term 7,277507443,Term 6,290533122,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비,-,Term 8,33331477,Term 7,257906602,Term 6,2222856234,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타의 대손상각비,-,Term 8,0,Term 7,30210418,Term 6,1372600296,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForWritedownsOfInventories,재고자산평가손실,-,Term 8,0,Term 7,437388133,Term 6,415482761,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,지급수수료,-,Term 8,114522441,Term 7,0,Term 6,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 8,648254268,Term 7,2190639054,Term 6,2206369684,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 8,1505471332,Term 7,1051997393,Term 6,820497550,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,기타장기종업원급여,-,Term 8,28331082,Term 7,58715506,Term 6,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForDepreciationExpense,유형자산감가상각비,-,Term 8,2090706225,Term 7,1604235327,Term 6,1328394876,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,사용권자산감가상각비,-,Term 8,4863676473,Term 7,3274375974,Term 6,2074942760,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForShareBasedPayment,주식보상비용,-,Term 8,497990000,Term 7,375837022,Term 6,526249601,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 8,340057933,Term 7,393850574,Term 6,223996148,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 8,22440670,Term 7,414345482,Term 6,111383868,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnAbandonmentOfPropertyPlantAndEquipment,유형자산폐기손실,-,Term 8,271407000,Term 7,146451006,Term 6,0,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnEvaluationOfDerivativeFinancialLiabilities,파생상품평가손실,-,Term 8,0,Term 7,3140267309,Term 6,2006104508,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForMiscellaneousLosses,잡손실,-,Term 8,43236015,Term 7,0,Term 6,80593021,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfPropertyPlantAndEquipment,유형자산손상차손,-,Term 8,0,Term 7,0,Term 6,130586662,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,재고자산폐기손실,-,Term 8,0,Term 7,0,Term 6,257661763,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,이연매출,-,Term 8,0,Term 7,0,Term 6,-140483,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,급여,-,Term 8,0,Term 7,0,Term 6,75498840,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForExpenseOfProvisions,충당부채전입액,-,Term 8,0,Term 7,0,Term 6,600000000,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForInterestIncome,이자수익,-,Term 8,91608715,Term 7,162221450,Term 6,146620003,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfInventories,재고자산평가손실환입,-,Term 8,383776739,Term 7,0,Term 6,0,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfBadDebtExpenses,기타의대손상각비환입,-,Term 8,0,Term 7,13038552,Term 6,0,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 8,150879966,Term 7,11976098,Term 6,1194460,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 8,423628253,Term 7,2522642,Term 6,604000153,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForMiscellaneousIncome,잡이익,-,Term 8,0,Term 7,36398003,Term 6,42952652,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfProvisions,충당부채환입액,-,Term 8,0,Term 7,270882775,Term 6,0,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfFairValueFinancialAssets,당기손익인식금융자산평가이익,-,Term 8,0,Term 7,0,Term 6,7600000,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,운전자본의 변동,-,Term 8,-14809797141,Term 7,-6748086570,Term 6,8090905418,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInTradeAndOtherReceivables,유동매출채권및기타채권의 감소(증가),-,Term 8,-2715495203,Term 7,-1312348964,Term 6,3880652614,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산의 감소(증가),-,Term 8,-2478345014,Term 7,-2090311851,Term 6,1656804417,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInOtherCurrentFinancialAssets,기타유동금융자산의 감소(증가),-,Term 8,0,Term 7,0,Term 6,-76660811,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산의 감소(증가),-,Term 8,-18886706336,Term 7,-2789110003,Term 6,5255562579,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInLongTermTradeAndOtherNonCurrentReceivables,비유동매출채권및기타채권의 증가,-,Term 8,0,Term 7,0,Term 6,-26865634,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherNonCurrentLiabilities,기타비유동부채의 증가(감소),-,Term 8,0,Term 7,0,Term 6,107596022,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInTradeAndOtherPayables,매입채무 및 기타채무의 증가(감소),-,Term 8,9399950880,Term 7,-695460299,Term 6,-7018799632,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채의 증가(감소),-,Term 8,643751676,Term 7,148285808,Term 6,4889272848,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채의 증가(감소),-,Term 8,-284173534,Term 7,1350513593,Term 6,557581380,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInCurrentProvisions,유동충당부채의 증가(감소),-,Term 8,0,Term 7,-153614858,Term 6,0,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInNonCurrentProvisions,비유동충당부채의 증가(감소),-,Term 8,0,Term 7,-329117225,Term 6,0,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInPresentValueOfDefinedBenefitObligation,순확정급여부채의 증가(감소),-,Term 8,-547299154,Term 7,-386294858,Term 6,-630423501,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInFairValueOfPlanAssets,퇴직연금운용자산의 감소(증가),-,Term 8,58519544,Term 7,-490627913,Term 6,-503814864,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 8,24126009,Term 7,114751468,Term 6,318660065,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세납부(환급),-,Term 8,3893129762,Term 7,2599720003,Term 6,798184114,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동현금흐름,-,Term 8,-7203428972,Term 7,-2520262334,Term 6,-4810100382,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherCurrentFinancialAssets,기타유동금융자산의 감소,-,Term 8,10000000,Term 7,10969000000,Term 6,461375000,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익공정가치측정금융자산의 감소,-,Term 8,0,Term 7,2007600000,Term 6,0,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 감소,-,Term 8,180470243,Term 7,839528233,Term 6,100000000,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 감소,-,Term 8,49528365,Term 7,304193747,Term 6,13745455,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities,정부보조금의 수취,-,Term 8,0,Term 7,480000000,Term 6,0,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,합병으로 인한 순현금흐름,-,Term 8,0,Term 7,514231416,Term 6,0,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_PurchaseOfOtherCurrentFinancialAssets,기타유동금융자산의 증가,-,Term 8,0,Term 7,10000000000,Term 6,0,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익공정가치측정금융자산의 증가,-,Term 8,1000000000,Term 7,0,Term 6,2003000000,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 증가,-,Term 8,4454194805,Term 7,4216438709,Term 6,1325386853,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 증가,-,Term 8,500274592,Term 7,588682142,Term 6,591900839,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_PurchaseOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 증가,-,Term 8,1488958183,Term 7,2829694879,Term 6,1464933145,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동현금흐름,-,Term 8,6900283116,Term 7,1998616548,Term 6,-9246931329,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 증가,-,Term 8,14500000000,Term 7,10000000000,Term 6,0,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,리스 인센티브의 수령,-,Term 8,0,Term 7,1007454368,Term 6,0,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_ProceedsFromExerciseOfShareOptions,주식선택권행사,-,Term 8,1756800000,Term 7,219600000,Term 6,0,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 상환,-,Term 8,4000000000,Term 7,4000000000,Term 6,7000000000,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,리스부채의 상환,-,Term 8,4953839886,Term 7,3134895393,Term 6,1934921936,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsFinancingActivities,이자지급,-,Term 8,402676998,Term 7,193542427,Term 6,112009393,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,-Standard account code not used-,종속기업주식의 추가취득,-,Term 8,0,Term 7,1900000000,Term 6,200000000,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,현금의 증가,-,Term 8,4281878949,Term 7,12255865486,Term 6,8573013918,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초현금및현금성자산,-,Term 8,29618192919,Term 7,17454914496,Term 6,8900968698,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,현금및현금성자산에 대한 환율변동효과,-,Term 8,-101089018,Term 7,-92587063,Term 6,-19068120,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말현금및현금성자산,-,Term 8,33798982850,Term 7,29618192919,Term 6,17454914496,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 8,51699915148,Term 7,9396752965,Term 6,8266369120,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배지분 [member],Term 8,0,Term 7,646571706,Term 6,826388135,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,51699915148,Term 7,8750181259,Term 6,7439980985,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,44262935494,Term 7,8261130924,Term 6,8031071952,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,2107948808,Term 7,2770983396,Term 6,1244162365,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,-616682991,Term 7,-72725606,Term 6,-5095983,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,2498609837,Term 7,-5191367455,Term 6,-4812317349,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,3447104000,Term 7,2982160000,Term 6,2982160000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,0,Term 7,0,Term 6,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,11398827028,Term 7,7891717267,Term 6,-319045438,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,0,Term 7,0,Term 6,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,0,Term 7,0,Term 6,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,0,Term 7,0,Term 6,0,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,11398827028,Term 7,7891717267,Term 6,-319045438,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 8,11398827028,Term 7,7891717267,Term 6,-68802895,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|비지배지분 [member],Term 8,0,Term 7,0,Term 6,250242543,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,연결재무제표 [member],Term 8,78545901,Term 7,-201739975,Term 6,-60004668,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|비지배지분 [member],Term 8,0,Term 7,0,Term 6,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,78545901,Term 7,-201739975,Term 6,-60004668,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,0,Term 7,0,Term 6,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,0,Term 7,0,Term 6,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,0,Term 7,0,Term 6,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,78545901,Term 7,-201739975,Term 6,-60004668,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,0,Term 7,0,Term 6,0,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,연결재무제표 [member],Term 8,569628667,Term 7,-543957385,Term 6,-67629623,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|비지배지분 [member],Term 8,0,Term 7,0,Term 6,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,569628667,Term 7,-543957385,Term 6,-67629623,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,0,Term 7,0,Term 6,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,0,Term 7,0,Term 6,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,0,Term 7,0,Term 6,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,0,Term 7,0,Term 6,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,569628667,Term 7,-543957385,Term 6,-67629623,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,연결재무제표 [member],Term 8,2254163880,Term 7,504475850,Term 6,796550593,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|비지배지분 [member],Term 8,0,Term 7,0,Term 6,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,48000000,Term 7,6000000,Term 6,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,0,Term 7,0,Term 6,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,0,Term 7,0,Term 6,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,249390108,Term 7,67235850,Term 6,796550593,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,2455553988,Term 7,431240000,Term 6,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,2254163880,Term 7,504475850,Term 6,796550593,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,0,Term 7,0,Term 6,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,연결재무제표 [member],Term 8,0,Term 7,-646571706,Term 6,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|비지배지분 [member],Term 8,0,Term 7,-646571706,Term 6,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,0,Term 7,0,Term 6,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,0,Term 7,0,Term 6,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,0,Term 7,0,Term 6,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,0,Term 7,0,Term 6,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,합병,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,0,Term 7,0,Term 6,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,연결재무제표 [member],Term 8,0,Term 7,-1253428294,Term 6,-200000000,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|비지배지분 [member],Term 8,0,Term 7,0,Term 6,-430058972,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,0,Term 7,-1253428294,Term 6,230058972,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,0,Term 7,-1253428294,Term 6,230058972,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,0,Term 7,0,Term 6,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,0,Term 7,0,Term 6,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,0,Term 7,0,Term 6,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,0,Term 7,0,Term 6,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,0,Term 7,0,Term 6,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,0,Term 7,0,Term 6,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,0,Term 7,0,Term 6,730270438,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,0,Term 7,0,Term 6,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,0,Term 7,0,Term 6,730270438,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|비지배지분 [member],Term 8,0,Term 7,0,Term 6,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,연결재무제표 [member],Term 8,0,Term 7,0,Term 6,730270438,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,-Standard account code not used-,전환상환우선주 조건 변경,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,0,Term 7,0,Term 6,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,0,Term 7,458944000,Term 6,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,0,Term 7,0,Term 6,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,0,Term 7,0,Term 6,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,0,Term 7,-730270438,Term 6,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,0,Term 7,36823992864,Term 6,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,0,Term 7,36552666426,Term 6,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,연결재무제표 [member],Term 8,0,Term 7,36552666426,Term 6,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|비지배지분 [member],Term 8,0,Term 7,0,Term 6,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 8,66001080624,Term 7,51699915148,Term 6,9396752965,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|비지배지분 [member],Term 8,0,Term 7,0,Term 6,646571706,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 8,66001080624,Term 7,51699915148,Term 6,8750181259,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 8,46718489482,Term 7,44262935494,Term 6,8261130924,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 8,1858558700,Term 7,2107948808,Term 6,2770983396,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 8,47054324,Term 7,-616682991,Term 6,-72725606,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금(결손금),Term 8,13975982766,Term 7,2498609837,Term 6,-5191367455,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20220331002148,11011,2021,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 8,3495104000,Term 7,3447104000,Term 6,2982160000,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 9,137024020095,Term 8,90318935738,Term 7,62817954586,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 9,57253261626,Term 8,33798982850,Term 7,29618192919,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,매출채권및기타채권,-,Term 9,21070155714,Term 8,13762670732,Term 7,10599063509,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 9,908796506,Term 8,4500000,Term 7,16148060,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 9,6317755640,Term 8,4411681350,Term 7,3141874298,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 9,50460161074,Term 8,37831063627,Term 7,18560580552,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 9,1013889535,Term 8,510037179,Term 7,882095248,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 9,47098602719,Term 8,36109894412,Term 7,29010706735,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 9,6686564078,Term 8,5371226327,Term 7,4261695166,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,-Standard account code not used-,당기손익-공정가치측정금융자산,-,Term 9,1183996000,Term 8,1000000000,Term 7,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 9,8776936033,Term 8,7168215109,Term 7,4975399413,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 9,16046761157,Term 8,13636505106,Term 7,13197575572,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 9,2105886103,Term 8,1329453993,Term 7,1224897255,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,dart_GoodwillGross,영업권,-,Term 9,,Term 8,281379700,Term 7,281379700,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 9,11272898927,Term 8,7323114177,Term 7,5069759629,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,dart_InvestedAssetForPostemploymentBenefit,순확정급여자산,-,Term 9,1025560421,Term 8,,Term 7,,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 9,184122622814,Term 8,126428830150,Term 7,91828661321,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 9,76266539344,Term 8,50064266575,Term 7,29046487205,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,매입채무및기타채무,-,Term 9,27459512720,Term 8,21981885604,Term 7,13078038893,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 9,21500000000,Term 8,16500000000,Term 7,6000000000,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,유동리스부채,-,Term 9,7246522656,Term 8,4936164190,Term 7,3876383488,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 9,1330459085,Term 8,1149090600,Term 7,660564388,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 9,6431037858,Term 8,2280165383,Term 7,2564338917,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_CurrentProvisions,유동충당부채,-,Term 9,246941371,Term 8,,Term 7,,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 9,12052065654,Term 8,3216960798,Term 7,2867161519,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 9,7598088754,Term 8,10363482951,Term 7,11082258968,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,비유동리스부채,-,Term 9,5800785246,Term 8,7585564539,Term 7,9415098332,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 9,121312824,Term 8,87046588,Term 7,58715506,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,-Standard account code not used-,순확정급여부채,-,Term 9,111223052,Term 8,1368720434,Term 7,452728585,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,비유동충당부채,-,Term 9,1564767632,Term 8,1322151390,Term 7,1155716545,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 9,83864628098,Term 8,60427749526,Term 7,40128746173,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 9,100257994716,Term 8,66001080624,Term 7,51699915148,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 9,3592604000,Term 8,3495104000,Term 7,3447104000,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,-Standard account code not used-,기타불입자본,-,Term 9,52142603182,Term 8,46718489482,Term 7,44262935494,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본,-,Term 9,670133075,Term 8,1858558700,Term 7,2107948808,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 9,522402509,Term 8,-47054324,Term 7,-616682991,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 9,43330251950,Term 8,13975982766,Term 7,2498609837,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 9,100257994716,Term 8,66001080624,Term 7,51699915148,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채및자본총계,-,Term 9,184122622814,Term 8,126428830150,Term 7,91828661321,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 9,397698119336,Term 8,259146144182,Term 7,219939337665,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 9,106223475243,Term 8,71623461550,Term 7,58586370450,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 9,291474644093,Term 8,187522682632,Term 7,161352967215,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 9,252246164696,Term 8,173249530478,Term 7,146883270338,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익,-,Term 9,39228479397,Term 8,14273152154,Term 7,14469696877,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,dart_OtherGains,기타수익,-,Term 9,240688824,Term 8,416907223,Term 7,828202472,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,dart_OtherLosses,기타비용,-,Term 9,698304007,Term 8,684415176,Term 7,684487692,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 9,5607858950,Term 8,1988995348,Term 7,1398331160,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 9,5455522583,Term 8,2256960051,Term 7,7157864163,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 9,38923200581,Term 8,13737679498,Term 7,8853878654,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 9,8968524288,Term 8,2338852470,Term 7,962161387,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익,-,Term 9,29954676293,Term 8,11398827028,Term 7,7891717267,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 9,29954676293,Term 8,11398827028,Term 7,7891717267,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 9,-30950276,Term 8,648174568,Term 7,-745697360,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류되는 항목,-,Term 9,569456833,Term 8,569628667,Term 7,-543957385,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax,해외사업환산손익,-,Term 9,569456833,Term 8,569628667,Term 7,-543957385,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류되지 않는 항목,-,Term 9,-600407109,Term 8,78545901,Term 7,-201739975,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채(자산)의 재측정요소,-,Term 9,-782470285,Term 8,100699873,Term 7,-258640993,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,dart_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss,순확정급여부채(자산)의 재측정요소 법인세효과,-,Term 9,-182063176,Term 8,22153972,Term 7,-56901018,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄손익,-,Term 9,29923726017,Term 8,12047001596,Term 7,7146019907,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 9,29923726017,Term 8,12047001596,Term 7,7146019907,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주 기본주당손익,-,Term 9,4221,Term 8,1642,Term 7,1269,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_DilutedEarningsLossPerShare,보통주 희석주당손익,-,Term 9,4212,Term 8,1621,Term 7,1251,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동현금흐름,-,Term 9,31630786168,Term 8,4585024805,Term 7,12777511272,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_ProfitLossForStatementOfCashFlows,당기순이익,-,Term 9,29954676293,Term 8,11398827028,Term 7,7891717267,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,현금의 유출·유입이 없는 비용·수익등의 가감,-,Term 9,26035253885,Term 8,11808657685,Term 7,14118849110,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 9,8968524288,Term 8,2338852470,Term 7,962161387,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 9,1153644565,Term 8,116614958,Term 7,277507443,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비,-,Term 9,,Term 8,-31649480,Term 7,257906602,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타의 대손상각비,-,Term 9,,Term 8,8639971,Term 7,30210418,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForWritedownsOfInventories,재고자산평가손실,-,Term 9,2197661834,Term 8,,Term 7,437388133,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,지급수수료,-,Term 9,43773635,Term 8,114522441,Term 7,,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 9,1035577089,Term 8,648254268,Term 7,2190639054,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 9,1670204682,Term 8,1505471332,Term 7,1051997393,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,기타장기종업원급여,-,Term 9,34266236,Term 8,28331082,Term 7,58715506,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForDepreciationExpense,감가상각비,-,Term 9,3770759899,Term 8,2090706225,Term 7,1604235327,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,사용권자산감가상각비,-,Term 9,6611789049,Term 8,4863676473,Term 7,3274375974,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnEvaluationOfDerivativeFinancialLiabilities,파생상품평가손실,-,Term 9,,Term 8,,Term 7,3140267309,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForShareBasedPayment,주식보상비용,-,Term 9,500025095,Term 8,497990000,Term 7,375837022,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 9,372523191,Term 8,340057933,Term 7,393850574,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 9,6174968,Term 8,22440670,Term 7,414345482,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnAbandonmentOfPropertyPlantAndEquipment,유형자산폐기손실,-,Term 9,161828721,Term 8,271407000,Term 7,146451006,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,광고선전비,-,Term 9,250000,Term 8,,Term 7,,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForMiscellaneousLosses,잡손실,-,Term 9,26875152,Term 8,43236015,Term 7,,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForProductWarrantyExpenses,판매보증비,-,Term 9,64189298,Term 8,,Term 7,,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,영업권손상차손,-,Term 9,281379700,Term 8,,Term 7,,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForInterestIncome,이자수익,-,Term 9,229996808,Term 8,91608715,Term 7,162221450,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,대손상각비환입,-,Term 9,3357125,Term 8,,Term 7,,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalAllowanceDoubtfulAccounts,기타의 대손상각비환입,-,Term 9,22120436,Term 8,,Term 7,13038552,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 9,273289182,Term 8,423628253,Term 7,2522642,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfInventories,재고자산평가손실환입,-,Term 9,,Term 8,383776739,Term 7,,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 9,151433966,Term 8,150879966,Term 7,11976098,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치측정금융자산평가이익,-,Term 9,-183996000,Term 8,,Term 7,,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForMiscellaneousIncome,잡이익,-,Term 9,,Term 8,,Term 7,36398003,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfProvisions,충당부채환입액,-,Term 9,,Term 8,,Term 7,270882775,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,운전자본의 변동,-,Term 9,-20265150119,Term 8,-14753456155,Term 7,-6748086570,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInTradeAndOtherReceivables,매출채권및기타채권의 증가,-,Term 9,-7681960754,Term 8,-2652914189,Term 7,-1312348964,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산의 증가,-,Term 9,-3542398099,Term 8,-2484585042,Term 7,-2090311851,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산의 증가,-,Term 9,-14754289827,Term 8,-18886706336,Term 7,-2789110003,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInTradeAndOtherPayables,매입채무 및 기타채무의 증가,-,Term 9,6146049316,Term 8,9399950880,Term 7,-695460299,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채의 증가,-,Term 9,152309540,Term 8,643751676,Term 7,148285808,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채의 감소(증가),-,Term 9,4150872475,Term 8,-284173534,Term 7,1350513593,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInPresentValueOfDefinedBenefitObligation,순확정급여부채(자산)의 증가,-,Term 9,-1291491458,Term 8,-547299154,Term 7,-386294858,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInFairValueOfPlanAssets,퇴직연금운용자산의 증가(감소),-,Term 9,-3444241312,Term 8,58519544,Term 7,-490627913,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInCurrentProvisions,유동충당부채의 증가(감소),-,Term 9,,Term 8,,Term 7,-153614858,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInNonCurrentProvisions,비유동충당부채의 증가(감소),-,Term 9,,Term 8,,Term 7,-329117225,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 9,123336491,Term 8,24126009,Term 7,114751468,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세납부,-,Term 9,4217330382,Term 8,3893129762,Term 7,2599720003,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동현금흐름,-,Term 9,-9121425060,Term 8,-7203428972,Term 7,-2520262334,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherCurrentFinancialAssets,기타유동금융자산의 감소,-,Term 9,,Term 8,10000000,Term 7,10969000000,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 감소,-,Term 9,279094371,Term 8,180470243,Term 7,839528233,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 감소,-,Term 9,18582000,Term 8,49528365,Term 7,304193747,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익공정가치측정금융자산의 감소,-,Term 9,,Term 8,,Term 7,2007600000,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities,정부보조금의 수취,-,Term 9,,Term 8,,Term 7,480000000,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,합병으로 인한 순현금흐름,-,Term 9,,Term 8,,Term 7,514231416,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_PurchaseOfOtherCurrentFinancialAssets,기타유동금융자산의 증가,-,Term 9,162550,Term 8,,Term 7,10000000000,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익공정가치측정금융자산의 증가,-,Term 9,,Term 8,1000000000,Term 7,,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 증가,-,Term 9,5699661194,Term 8,4454194805,Term 7,4216438709,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 증가,-,Term 9,1224429839,Term 8,500274592,Term 7,588682142,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_PurchaseOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 증가,-,Term 9,2494847848,Term 8,1488958183,Term 7,2829694879,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동현금흐름,-,Term 9,1440557771,Term 8,6900283116,Term 7,1998616548,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 차입,-,Term 9,9000000000,Term 8,14500000000,Term 7,10000000000,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_ProceedsFromExerciseOfShareOptions,주식선택권 행사,-,Term 9,3645500000,Term 8,1756800000,Term 7,219600000,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,리스 인센티브의 수령,-,Term 9,,Term 8,,Term 7,1007454368,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 상환,-,Term 9,4000000000,Term 8,4000000000,Term 7,4000000000,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,리스부채의 상환,-,Term 9,6589669212,Term 8,4953839886,Term 7,3134895393,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsFinancingActivities,이자지급,-,Term 9,615273017,Term 8,402676998,Term 7,193542427,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries,종속기업주식의 추가취득,-,Term 9,,Term 8,,Term 7,1900000000,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,현금의 증가,-,Term 9,23949918879,Term 8,4281878949,Term 7,12255865486,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초현금및현금성자산,-,Term 9,33798982850,Term 8,29618192919,Term 7,17454914496,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,현금및현금성자산에 대한 환율변동효과,-,Term 9,-495640103,Term 8,-101089018,Term 7,-92587063,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말현금및현금성자산,-,Term 9,57253261626,Term 8,33798982850,Term 7,29618192919,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 9,1858558700,Term 8,2107948808,Term 7,2770983396,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 9,46718489482,Term 8,44262935494,Term 7,8261130924,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 9,3495104000,Term 8,3447104000,Term 7,2982160000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배지분 [member],Term 9,,Term 8,,Term 7,646571706,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 9,66001080624,Term 8,51699915148,Term 7,9396752965,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 9,66001080624,Term 8,51699915148,Term 7,8750181259,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 9,-47054324,Term 8,-616682991,Term 7,-72725606,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 9,13975982766,Term 8,2498609837,Term 7,-5191367455,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,연결재무제표 [member],Term 9,29954676293,Term 8,11398827028,Term 7,7891717267,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 9,29954676293,Term 8,11398827028,Term 7,7891717267,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 9,29954676293,Term 8,11398827028,Term 7,7891717267,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,연결재무제표 [member],Term 9,-600407109,Term 8,78545901,Term 7,-201739975,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 9,-600407109,Term 8,78545901,Term 7,-201739975,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 9,-600407109,Term 8,78545901,Term 7,-201739975,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 9,569456833,Term 8,569628667,Term 7,-543957385,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,연결재무제표 [member],Term 9,569456833,Term 8,569628667,Term 7,-543957385,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 9,569456833,Term 8,569628667,Term 7,-543957385,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 9,-1188425625,Term 8,-249390108,Term 7,67235850,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 9,4333188075,Term 8,2254163880,Term 7,504475850,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,연결재무제표 [member],Term 9,4333188075,Term 8,2254163880,Term 7,504475850,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 9,97500000,Term 8,48000000,Term 7,6000000,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 9,5424113700,Term 8,2455553988,Term 7,431240000,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,동일지배합병,연결재무제표 [member],Term 9,,Term 8,,Term 7,-646571706,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,동일지배합병,자본 [member]|비지배지분 [member],Term 9,,Term 8,,Term 7,-646571706,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 9,,Term 8,,Term 7,-1253428294,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 9,,Term 8,,Term 7,-1253428294,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,연결재무제표 [member],Term 9,,Term 8,,Term 7,-1253428294,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 9,,Term 8,,Term 7,36823992864,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 9,,Term 8,,Term 7,-730270438,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 9,,Term 8,,Term 7,458944000,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,연결재무제표 [member],Term 9,,Term 8,,Term 7,36552666426,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 9,,Term 8,,Term 7,36552666426,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 9,3592604000,Term 8,3495104000,Term 7,3447104000,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 9,670133075,Term 8,1858558700,Term 7,2107948808,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 9,52142603182,Term 8,46718489482,Term 7,44262935494,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 9,100257994716,Term 8,66001080624,Term 7,51699915148,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 9,100257994716,Term 8,66001080624,Term 7,51699915148,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 9,43330251950,Term 8,13975982766,Term 7,2498609837,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 9,522402509,Term 8,-47054324,Term 7,-616682991,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 9,137024020095,Term 8,90318935738,Term 7,62817954586,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 9,57253261626,Term 8,33798982850,Term 7,29618192919,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,매출채권및기타채권,-,Term 9,21070155714,Term 8,13762670732,Term 7,10599063509,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 9,908796506,Term 8,4500000,Term 7,16148060,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 9,6317755640,Term 8,4411681350,Term 7,3141874298,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 9,50460161074,Term 8,37831063627,Term 7,18560580552,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 9,1013889535,Term 8,510037179,Term 7,882095248,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 9,47098602719,Term 8,36109894412,Term 7,29010706735,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 9,6686564078,Term 8,5371226327,Term 7,4261695166,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,-Standard account code not used-,당기손익-공정가치측정금융자산,-,Term 9,1183996000,Term 8,1000000000,Term 7,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 9,8776936033,Term 8,7168215109,Term 7,4975399413,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 9,16046761157,Term 8,13636505106,Term 7,13197575572,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 9,2105886103,Term 8,1329453993,Term 7,1224897255,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,dart_GoodwillGross,영업권,-,Term 9,,Term 8,281379700,Term 7,281379700,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 9,11272898927,Term 8,7323114177,Term 7,5069759629,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,dart_InvestedAssetForPostemploymentBenefit,순확정급여자산,-,Term 9,1025560421,Term 8,,Term 7,,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 9,184122622814,Term 8,126428830150,Term 7,91828661321,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 9,76266539344,Term 8,50064266575,Term 7,29046487205,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,매입채무및기타채무,-,Term 9,27459512720,Term 8,21981885604,Term 7,13078038893,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 9,21500000000,Term 8,16500000000,Term 7,6000000000,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,유동리스부채,-,Term 9,7246522656,Term 8,4936164190,Term 7,3876383488,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 9,1330459085,Term 8,1149090600,Term 7,660564388,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 9,6431037858,Term 8,2280165383,Term 7,2564338917,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_CurrentProvisions,유동충당부채,-,Term 9,246941371,Term 8,,Term 7,,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 9,12052065654,Term 8,3216960798,Term 7,2867161519,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 9,7598088754,Term 8,10363482951,Term 7,11082258968,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,비유동리스부채,-,Term 9,5800785246,Term 8,7585564539,Term 7,9415098332,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 9,121312824,Term 8,87046588,Term 7,58715506,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,-Standard account code not used-,순확정급여부채,-,Term 9,111223052,Term 8,1368720434,Term 7,452728585,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,비유동충당부채,-,Term 9,1564767632,Term 8,1322151390,Term 7,1155716545,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 9,83864628098,Term 8,60427749526,Term 7,40128746173,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 9,100257994716,Term 8,66001080624,Term 7,51699915148,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 9,3592604000,Term 8,3495104000,Term 7,3447104000,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,-Standard account code not used-,기타불입자본,-,Term 9,52142603182,Term 8,46718489482,Term 7,44262935494,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본,-,Term 9,670133075,Term 8,1858558700,Term 7,2107948808,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 9,522402509,Term 8,-47054324,Term 7,-616682991,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 9,43330251950,Term 8,13975982766,Term 7,2498609837,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 9,100257994716,Term 8,66001080624,Term 7,51699915148,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채및자본총계,-,Term 9,184122622814,Term 8,126428830150,Term 7,91828661321,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 9,397698119336,Term 8,259146144182,Term 7,219939337665,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 9,106223475243,Term 8,71623461550,Term 7,58586370450,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 9,291474644093,Term 8,187522682632,Term 7,161352967215,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 9,252246164696,Term 8,173249530478,Term 7,146883270338,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익,-,Term 9,39228479397,Term 8,14273152154,Term 7,14469696877,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,dart_OtherGains,기타수익,-,Term 9,240688824,Term 8,416907223,Term 7,828202472,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,dart_OtherLosses,기타비용,-,Term 9,698304007,Term 8,684415176,Term 7,684487692,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 9,5607858950,Term 8,1988995348,Term 7,1398331160,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 9,5455522583,Term 8,2256960051,Term 7,7157864163,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 9,38923200581,Term 8,13737679498,Term 7,8853878654,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 9,8968524288,Term 8,2338852470,Term 7,962161387,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익,-,Term 9,29954676293,Term 8,11398827028,Term 7,7891717267,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 9,29954676293,Term 8,11398827028,Term 7,7891717267,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 9,-30950276,Term 8,648174568,Term 7,-745697360,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류되는 항목,-,Term 9,569456833,Term 8,569628667,Term 7,-543957385,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax,해외사업환산손익,-,Term 9,569456833,Term 8,569628667,Term 7,-543957385,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류되지 않는 항목,-,Term 9,-600407109,Term 8,78545901,Term 7,-201739975,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채(자산)의 재측정요소,-,Term 9,-782470285,Term 8,100699873,Term 7,-258640993,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,dart_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss,순확정급여부채(자산)의 재측정요소 법인세효과,-,Term 9,-182063176,Term 8,22153972,Term 7,-56901018,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄손익,-,Term 9,29923726017,Term 8,12047001596,Term 7,7146019907,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 9,29923726017,Term 8,12047001596,Term 7,7146019907,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주 기본주당손익,-,Term 9,4221,Term 8,1642,Term 7,1269,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_DilutedEarningsLossPerShare,보통주 희석주당손익,-,Term 9,4212,Term 8,1621,Term 7,1251,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동현금흐름,-,Term 9,31630786168,Term 8,4585024805,Term 7,12777511272,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_ProfitLossForStatementOfCashFlows,당기순이익,-,Term 9,29954676293,Term 8,11398827028,Term 7,7891717267,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,현금의 유출·유입이 없는 비용·수익등의 가감,-,Term 9,26035253885,Term 8,11808657685,Term 7,14118849110,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 9,8968524288,Term 8,2338852470,Term 7,962161387,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 9,1153644565,Term 8,116614958,Term 7,277507443,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비,-,Term 9,,Term 8,-31649480,Term 7,257906602,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타의 대손상각비,-,Term 9,,Term 8,8639971,Term 7,30210418,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForWritedownsOfInventories,재고자산평가손실,-,Term 9,2197661834,Term 8,,Term 7,437388133,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,지급수수료,-,Term 9,43773635,Term 8,114522441,Term 7,,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 9,1035577089,Term 8,648254268,Term 7,2190639054,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 9,1670204682,Term 8,1505471332,Term 7,1051997393,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,기타장기종업원급여,-,Term 9,34266236,Term 8,28331082,Term 7,58715506,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForDepreciationExpense,감가상각비,-,Term 9,3770759899,Term 8,2090706225,Term 7,1604235327,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,사용권자산감가상각비,-,Term 9,6611789049,Term 8,4863676473,Term 7,3274375974,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnEvaluationOfDerivativeFinancialLiabilities,파생상품평가손실,-,Term 9,,Term 8,,Term 7,3140267309,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForShareBasedPayment,주식보상비용,-,Term 9,500025095,Term 8,497990000,Term 7,375837022,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 9,372523191,Term 8,340057933,Term 7,393850574,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 9,6174968,Term 8,22440670,Term 7,414345482,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnAbandonmentOfPropertyPlantAndEquipment,유형자산폐기손실,-,Term 9,161828721,Term 8,271407000,Term 7,146451006,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,광고선전비,-,Term 9,250000,Term 8,,Term 7,,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForMiscellaneousLosses,잡손실,-,Term 9,26875152,Term 8,43236015,Term 7,,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForProductWarrantyExpenses,판매보증비,-,Term 9,64189298,Term 8,,Term 7,,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,영업권손상차손,-,Term 9,281379700,Term 8,,Term 7,,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForInterestIncome,이자수익,-,Term 9,229996808,Term 8,91608715,Term 7,162221450,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,대손상각비환입,-,Term 9,3357125,Term 8,,Term 7,,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalAllowanceDoubtfulAccounts,기타의 대손상각비환입,-,Term 9,22120436,Term 8,,Term 7,13038552,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 9,273289182,Term 8,423628253,Term 7,2522642,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfInventories,재고자산평가손실환입,-,Term 9,,Term 8,383776739,Term 7,,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 9,151433966,Term 8,150879966,Term 7,11976098,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치측정금융자산평가이익,-,Term 9,-183996000,Term 8,,Term 7,,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForMiscellaneousIncome,잡이익,-,Term 9,,Term 8,,Term 7,36398003,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfProvisions,충당부채환입액,-,Term 9,,Term 8,,Term 7,270882775,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,운전자본의 변동,-,Term 9,-20265150119,Term 8,-14753456155,Term 7,-6748086570,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInTradeAndOtherReceivables,매출채권및기타채권의 증가,-,Term 9,-7681960754,Term 8,-2652914189,Term 7,-1312348964,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산의 증가,-,Term 9,-3542398099,Term 8,-2484585042,Term 7,-2090311851,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산의 증가,-,Term 9,-14754289827,Term 8,-18886706336,Term 7,-2789110003,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInTradeAndOtherPayables,매입채무 및 기타채무의 증가,-,Term 9,6146049316,Term 8,9399950880,Term 7,-695460299,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채의 증가,-,Term 9,152309540,Term 8,643751676,Term 7,148285808,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채의 감소(증가),-,Term 9,4150872475,Term 8,-284173534,Term 7,1350513593,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInPresentValueOfDefinedBenefitObligation,순확정급여부채(자산)의 증가,-,Term 9,-1291491458,Term 8,-547299154,Term 7,-386294858,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInFairValueOfPlanAssets,퇴직연금운용자산의 증가(감소),-,Term 9,-3444241312,Term 8,58519544,Term 7,-490627913,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInCurrentProvisions,유동충당부채의 증가(감소),-,Term 9,,Term 8,,Term 7,-153614858,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInNonCurrentProvisions,비유동충당부채의 증가(감소),-,Term 9,,Term 8,,Term 7,-329117225,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 9,123336491,Term 8,24126009,Term 7,114751468,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세납부,-,Term 9,4217330382,Term 8,3893129762,Term 7,2599720003,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동현금흐름,-,Term 9,-9121425060,Term 8,-7203428972,Term 7,-2520262334,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherCurrentFinancialAssets,기타유동금융자산의 감소,-,Term 9,,Term 8,10000000,Term 7,10969000000,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 감소,-,Term 9,279094371,Term 8,180470243,Term 7,839528233,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 감소,-,Term 9,18582000,Term 8,49528365,Term 7,304193747,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익공정가치측정금융자산의 감소,-,Term 9,,Term 8,,Term 7,2007600000,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities,정부보조금의 수취,-,Term 9,,Term 8,,Term 7,480000000,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,합병으로 인한 순현금흐름,-,Term 9,,Term 8,,Term 7,514231416,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_PurchaseOfOtherCurrentFinancialAssets,기타유동금융자산의 증가,-,Term 9,162550,Term 8,,Term 7,10000000000,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익공정가치측정금융자산의 증가,-,Term 9,,Term 8,1000000000,Term 7,,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 증가,-,Term 9,5699661194,Term 8,4454194805,Term 7,4216438709,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 증가,-,Term 9,1224429839,Term 8,500274592,Term 7,588682142,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_PurchaseOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 증가,-,Term 9,2494847848,Term 8,1488958183,Term 7,2829694879,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동현금흐름,-,Term 9,1440557771,Term 8,6900283116,Term 7,1998616548,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 차입,-,Term 9,9000000000,Term 8,14500000000,Term 7,10000000000,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_ProceedsFromExerciseOfShareOptions,주식선택권 행사,-,Term 9,3645500000,Term 8,1756800000,Term 7,219600000,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,리스 인센티브의 수령,-,Term 9,,Term 8,,Term 7,1007454368,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 상환,-,Term 9,4000000000,Term 8,4000000000,Term 7,4000000000,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,리스부채의 상환,-,Term 9,6589669212,Term 8,4953839886,Term 7,3134895393,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsFinancingActivities,이자지급,-,Term 9,615273017,Term 8,402676998,Term 7,193542427,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries,종속기업주식의 추가취득,-,Term 9,,Term 8,,Term 7,1900000000,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,현금의 증가,-,Term 9,23949918879,Term 8,4281878949,Term 7,12255865486,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초현금및현금성자산,-,Term 9,33798982850,Term 8,29618192919,Term 7,17454914496,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,현금및현금성자산에 대한 환율변동효과,-,Term 9,-495640103,Term 8,-101089018,Term 7,-92587063,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말현금및현금성자산,-,Term 9,57253261626,Term 8,33798982850,Term 7,29618192919,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 9,1858558700,Term 8,2107948808,Term 7,2770983396,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 9,46718489482,Term 8,44262935494,Term 7,8261130924,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 9,3495104000,Term 8,3447104000,Term 7,2982160000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배지분 [member],Term 9,,Term 8,,Term 7,646571706,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 9,66001080624,Term 8,51699915148,Term 7,9396752965,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 9,66001080624,Term 8,51699915148,Term 7,8750181259,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 9,-47054324,Term 8,-616682991,Term 7,-72725606,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 9,13975982766,Term 8,2498609837,Term 7,-5191367455,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,연결재무제표 [member],Term 9,29954676293,Term 8,11398827028,Term 7,7891717267,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 9,29954676293,Term 8,11398827028,Term 7,7891717267,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 9,29954676293,Term 8,11398827028,Term 7,7891717267,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,연결재무제표 [member],Term 9,-600407109,Term 8,78545901,Term 7,-201739975,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 9,-600407109,Term 8,78545901,Term 7,-201739975,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 9,-600407109,Term 8,78545901,Term 7,-201739975,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 9,569456833,Term 8,569628667,Term 7,-543957385,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,연결재무제표 [member],Term 9,569456833,Term 8,569628667,Term 7,-543957385,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 9,569456833,Term 8,569628667,Term 7,-543957385,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 9,-1188425625,Term 8,-249390108,Term 7,67235850,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 9,4333188075,Term 8,2254163880,Term 7,504475850,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,연결재무제표 [member],Term 9,4333188075,Term 8,2254163880,Term 7,504475850,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 9,97500000,Term 8,48000000,Term 7,6000000,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 9,5424113700,Term 8,2455553988,Term 7,431240000,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,동일지배합병,연결재무제표 [member],Term 9,,Term 8,,Term 7,-646571706,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,동일지배합병,자본 [member]|비지배지분 [member],Term 9,,Term 8,,Term 7,-646571706,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 9,,Term 8,,Term 7,-1253428294,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 9,,Term 8,,Term 7,-1253428294,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,연결재무제표 [member],Term 9,,Term 8,,Term 7,-1253428294,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 9,,Term 8,,Term 7,36823992864,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 9,,Term 8,,Term 7,-730270438,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 9,,Term 8,,Term 7,458944000,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,연결재무제표 [member],Term 9,,Term 8,,Term 7,36552666426,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 9,,Term 8,,Term 7,36552666426,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 9,3592604000,Term 8,3495104000,Term 7,3447104000,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 9,670133075,Term 8,1858558700,Term 7,2107948808,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 9,52142603182,Term 8,46718489482,Term 7,44262935494,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 9,100257994716,Term 8,66001080624,Term 7,51699915148,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 9,100257994716,Term 8,66001080624,Term 7,51699915148,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 9,43330251950,Term 8,13975982766,Term 7,2498609837,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 9,522402509,Term 8,-47054324,Term 7,-616682991,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 9,137024020095,Term 8,90318935738,Term 7,62817954586,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 9,57253261626,Term 8,33798982850,Term 7,29618192919,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,매출채권및기타채권,-,Term 9,21070155714,Term 8,13762670732,Term 7,10599063509,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 9,908796506,Term 8,4500000,Term 7,16148060,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 9,6317755640,Term 8,4411681350,Term 7,3141874298,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 9,50460161074,Term 8,37831063627,Term 7,18560580552,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 9,1013889535,Term 8,510037179,Term 7,882095248,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 9,47098602719,Term 8,36109894412,Term 7,29010706735,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 9,6686564078,Term 8,5371226327,Term 7,4261695166,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,-Standard account code not used-,당기손익-공정가치측정금융자산,-,Term 9,1183996000,Term 8,1000000000,Term 7,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 9,8776936033,Term 8,7168215109,Term 7,4975399413,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 9,16046761157,Term 8,13636505106,Term 7,13197575572,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 9,2105886103,Term 8,1329453993,Term 7,1224897255,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,dart_GoodwillGross,영업권,-,Term 9,,Term 8,281379700,Term 7,281379700,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 9,11272898927,Term 8,7323114177,Term 7,5069759629,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,dart_InvestedAssetForPostemploymentBenefit,순확정급여자산,-,Term 9,1025560421,Term 8,,Term 7,,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 9,184122622814,Term 8,126428830150,Term 7,91828661321,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 9,76266539344,Term 8,50064266575,Term 7,29046487205,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,매입채무및기타채무,-,Term 9,27459512720,Term 8,21981885604,Term 7,13078038893,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 9,21500000000,Term 8,16500000000,Term 7,6000000000,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,유동리스부채,-,Term 9,7246522656,Term 8,4936164190,Term 7,3876383488,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 9,1330459085,Term 8,1149090600,Term 7,660564388,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 9,6431037858,Term 8,2280165383,Term 7,2564338917,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_CurrentProvisions,유동충당부채,-,Term 9,246941371,Term 8,,Term 7,,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 9,12052065654,Term 8,3216960798,Term 7,2867161519,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 9,7598088754,Term 8,10363482951,Term 7,11082258968,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,비유동리스부채,-,Term 9,5800785246,Term 8,7585564539,Term 7,9415098332,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 9,121312824,Term 8,87046588,Term 7,58715506,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,-Standard account code not used-,순확정급여부채,-,Term 9,111223052,Term 8,1368720434,Term 7,452728585,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,비유동충당부채,-,Term 9,1564767632,Term 8,1322151390,Term 7,1155716545,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 9,83864628098,Term 8,60427749526,Term 7,40128746173,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 9,100257994716,Term 8,66001080624,Term 7,51699915148,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 9,3592604000,Term 8,3495104000,Term 7,3447104000,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,-Standard account code not used-,기타불입자본,-,Term 9,52142603182,Term 8,46718489482,Term 7,44262935494,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본,-,Term 9,670133075,Term 8,1858558700,Term 7,2107948808,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 9,522402509,Term 8,-47054324,Term 7,-616682991,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 9,43330251950,Term 8,13975982766,Term 7,2498609837,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 9,100257994716,Term 8,66001080624,Term 7,51699915148,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채및자본총계,-,Term 9,184122622814,Term 8,126428830150,Term 7,91828661321,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 9,397698119336,Term 8,259146144182,Term 7,219939337665,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 9,106223475243,Term 8,71623461550,Term 7,58586370450,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 9,291474644093,Term 8,187522682632,Term 7,161352967215,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 9,252246164696,Term 8,173249530478,Term 7,146883270338,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익,-,Term 9,39228479397,Term 8,14273152154,Term 7,14469696877,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,dart_OtherGains,기타수익,-,Term 9,240688824,Term 8,416907223,Term 7,828202472,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,dart_OtherLosses,기타비용,-,Term 9,698304007,Term 8,684415176,Term 7,684487692,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 9,5607858950,Term 8,1988995348,Term 7,1398331160,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 9,5455522583,Term 8,2256960051,Term 7,7157864163,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 9,38923200581,Term 8,13737679498,Term 7,8853878654,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 9,8968524288,Term 8,2338852470,Term 7,962161387,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익,-,Term 9,29954676293,Term 8,11398827028,Term 7,7891717267,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 9,29954676293,Term 8,11398827028,Term 7,7891717267,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 9,-30950276,Term 8,648174568,Term 7,-745697360,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류되는 항목,-,Term 9,569456833,Term 8,569628667,Term 7,-543957385,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax,해외사업환산손익,-,Term 9,569456833,Term 8,569628667,Term 7,-543957385,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류되지 않는 항목,-,Term 9,-600407109,Term 8,78545901,Term 7,-201739975,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채(자산)의 재측정요소,-,Term 9,-782470285,Term 8,100699873,Term 7,-258640993,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,dart_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss,순확정급여부채(자산)의 재측정요소 법인세효과,-,Term 9,-182063176,Term 8,22153972,Term 7,-56901018,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄손익,-,Term 9,29923726017,Term 8,12047001596,Term 7,7146019907,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 9,29923726017,Term 8,12047001596,Term 7,7146019907,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주 기본주당손익,-,Term 9,4221,Term 8,1642,Term 7,1269,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CIS,Statement of comprehensive income,ifrs-full_DilutedEarningsLossPerShare,보통주 희석주당손익,-,Term 9,4212,Term 8,1621,Term 7,1251,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동현금흐름,-,Term 9,31630786168,Term 8,4585024805,Term 7,12777511272,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_ProfitLossForStatementOfCashFlows,당기순이익,-,Term 9,29954676293,Term 8,11398827028,Term 7,7891717267,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,현금의 유출·유입이 없는 비용·수익등의 가감,-,Term 9,26035253885,Term 8,11808657685,Term 7,14118849110,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 9,8968524288,Term 8,2338852470,Term 7,962161387,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 9,1153644565,Term 8,116614958,Term 7,277507443,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비,-,Term 9,,Term 8,-31649480,Term 7,257906602,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타의 대손상각비,-,Term 9,,Term 8,8639971,Term 7,30210418,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForWritedownsOfInventories,재고자산평가손실,-,Term 9,2197661834,Term 8,,Term 7,437388133,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,지급수수료,-,Term 9,43773635,Term 8,114522441,Term 7,,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 9,1035577089,Term 8,648254268,Term 7,2190639054,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 9,1670204682,Term 8,1505471332,Term 7,1051997393,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,기타장기종업원급여,-,Term 9,34266236,Term 8,28331082,Term 7,58715506,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForDepreciationExpense,감가상각비,-,Term 9,3770759899,Term 8,2090706225,Term 7,1604235327,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,사용권자산감가상각비,-,Term 9,6611789049,Term 8,4863676473,Term 7,3274375974,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnEvaluationOfDerivativeFinancialLiabilities,파생상품평가손실,-,Term 9,,Term 8,,Term 7,3140267309,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForShareBasedPayment,주식보상비용,-,Term 9,500025095,Term 8,497990000,Term 7,375837022,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 9,372523191,Term 8,340057933,Term 7,393850574,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 9,6174968,Term 8,22440670,Term 7,414345482,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnAbandonmentOfPropertyPlantAndEquipment,유형자산폐기손실,-,Term 9,161828721,Term 8,271407000,Term 7,146451006,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,광고선전비,-,Term 9,250000,Term 8,,Term 7,,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForMiscellaneousLosses,잡손실,-,Term 9,26875152,Term 8,43236015,Term 7,,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForProductWarrantyExpenses,판매보증비,-,Term 9,64189298,Term 8,,Term 7,,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,영업권손상차손,-,Term 9,281379700,Term 8,,Term 7,,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForInterestIncome,이자수익,-,Term 9,229996808,Term 8,91608715,Term 7,162221450,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,대손상각비환입,-,Term 9,3357125,Term 8,,Term 7,,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalAllowanceDoubtfulAccounts,기타의 대손상각비환입,-,Term 9,22120436,Term 8,,Term 7,13038552,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 9,273289182,Term 8,423628253,Term 7,2522642,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfInventories,재고자산평가손실환입,-,Term 9,,Term 8,383776739,Term 7,,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 9,151433966,Term 8,150879966,Term 7,11976098,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치측정금융자산평가이익,-,Term 9,-183996000,Term 8,,Term 7,,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForMiscellaneousIncome,잡이익,-,Term 9,,Term 8,,Term 7,36398003,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfProvisions,충당부채환입액,-,Term 9,,Term 8,,Term 7,270882775,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,운전자본의 변동,-,Term 9,-20265150119,Term 8,-14753456155,Term 7,-6748086570,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInTradeAndOtherReceivables,매출채권및기타채권의 증가,-,Term 9,-7681960754,Term 8,-2652914189,Term 7,-1312348964,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산의 증가,-,Term 9,-3542398099,Term 8,-2484585042,Term 7,-2090311851,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산의 증가,-,Term 9,-14754289827,Term 8,-18886706336,Term 7,-2789110003,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInTradeAndOtherPayables,매입채무 및 기타채무의 증가,-,Term 9,6146049316,Term 8,9399950880,Term 7,-695460299,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채의 증가,-,Term 9,152309540,Term 8,643751676,Term 7,148285808,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채의 감소(증가),-,Term 9,4150872475,Term 8,-284173534,Term 7,1350513593,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInPresentValueOfDefinedBenefitObligation,순확정급여부채(자산)의 증가,-,Term 9,-1291491458,Term 8,-547299154,Term 7,-386294858,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInFairValueOfPlanAssets,퇴직연금운용자산의 증가(감소),-,Term 9,-3444241312,Term 8,58519544,Term 7,-490627913,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInCurrentProvisions,유동충당부채의 증가(감소),-,Term 9,,Term 8,,Term 7,-153614858,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInNonCurrentProvisions,비유동충당부채의 증가(감소),-,Term 9,,Term 8,,Term 7,-329117225,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 9,123336491,Term 8,24126009,Term 7,114751468,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세납부,-,Term 9,4217330382,Term 8,3893129762,Term 7,2599720003,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동현금흐름,-,Term 9,-9121425060,Term 8,-7203428972,Term 7,-2520262334,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherCurrentFinancialAssets,기타유동금융자산의 감소,-,Term 9,,Term 8,10000000,Term 7,10969000000,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 감소,-,Term 9,279094371,Term 8,180470243,Term 7,839528233,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 감소,-,Term 9,18582000,Term 8,49528365,Term 7,304193747,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익공정가치측정금융자산의 감소,-,Term 9,,Term 8,,Term 7,2007600000,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities,정부보조금의 수취,-,Term 9,,Term 8,,Term 7,480000000,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,합병으로 인한 순현금흐름,-,Term 9,,Term 8,,Term 7,514231416,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_PurchaseOfOtherCurrentFinancialAssets,기타유동금융자산의 증가,-,Term 9,162550,Term 8,,Term 7,10000000000,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익공정가치측정금융자산의 증가,-,Term 9,,Term 8,1000000000,Term 7,,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 증가,-,Term 9,5699661194,Term 8,4454194805,Term 7,4216438709,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 증가,-,Term 9,1224429839,Term 8,500274592,Term 7,588682142,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_PurchaseOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 증가,-,Term 9,2494847848,Term 8,1488958183,Term 7,2829694879,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동현금흐름,-,Term 9,1440557771,Term 8,6900283116,Term 7,1998616548,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 차입,-,Term 9,9000000000,Term 8,14500000000,Term 7,10000000000,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_ProceedsFromExerciseOfShareOptions,주식선택권 행사,-,Term 9,3645500000,Term 8,1756800000,Term 7,219600000,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,리스 인센티브의 수령,-,Term 9,,Term 8,,Term 7,1007454368,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 상환,-,Term 9,4000000000,Term 8,4000000000,Term 7,4000000000,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,-Standard account code not used-,리스부채의 상환,-,Term 9,6589669212,Term 8,4953839886,Term 7,3134895393,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsFinancingActivities,이자지급,-,Term 9,615273017,Term 8,402676998,Term 7,193542427,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries,종속기업주식의 추가취득,-,Term 9,,Term 8,,Term 7,1900000000,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,현금의 증가,-,Term 9,23949918879,Term 8,4281878949,Term 7,12255865486,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초현금및현금성자산,-,Term 9,33798982850,Term 8,29618192919,Term 7,17454914496,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,현금및현금성자산에 대한 환율변동효과,-,Term 9,-495640103,Term 8,-101089018,Term 7,-92587063,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말현금및현금성자산,-,Term 9,57253261626,Term 8,33798982850,Term 7,29618192919,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 9,1858558700,Term 8,2107948808,Term 7,2770983396,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 9,46718489482,Term 8,44262935494,Term 7,8261130924,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 9,3495104000,Term 8,3447104000,Term 7,2982160000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배지분 [member],Term 9,,Term 8,,Term 7,646571706,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 9,66001080624,Term 8,51699915148,Term 7,9396752965,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 9,66001080624,Term 8,51699915148,Term 7,8750181259,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 9,-47054324,Term 8,-616682991,Term 7,-72725606,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 9,13975982766,Term 8,2498609837,Term 7,-5191367455,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,연결재무제표 [member],Term 9,29954676293,Term 8,11398827028,Term 7,7891717267,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 9,29954676293,Term 8,11398827028,Term 7,7891717267,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 9,29954676293,Term 8,11398827028,Term 7,7891717267,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,연결재무제표 [member],Term 9,-600407109,Term 8,78545901,Term 7,-201739975,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 9,-600407109,Term 8,78545901,Term 7,-201739975,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,-Standard account code not used-,순확정급여부채의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 9,-600407109,Term 8,78545901,Term 7,-201739975,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 9,569456833,Term 8,569628667,Term 7,-543957385,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,연결재무제표 [member],Term 9,569456833,Term 8,569628667,Term 7,-543957385,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 9,569456833,Term 8,569628667,Term 7,-543957385,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 9,-1188425625,Term 8,-249390108,Term 7,67235850,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 9,4333188075,Term 8,2254163880,Term 7,504475850,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,연결재무제표 [member],Term 9,4333188075,Term 8,2254163880,Term 7,504475850,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 9,97500000,Term 8,48000000,Term 7,6000000,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_ShareBasedPaymentTransactions,주식선택권,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 9,5424113700,Term 8,2455553988,Term 7,431240000,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,동일지배합병,연결재무제표 [member],Term 9,,Term 8,,Term 7,-646571706,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_IncreaseDecreaseThroughBusinessCombinations,동일지배합병,자본 [member]|비지배지분 [member],Term 9,,Term 8,,Term 7,-646571706,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 9,,Term 8,,Term 7,-1253428294,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 9,,Term 8,,Term 7,-1253428294,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분과의 거래,연결재무제표 [member],Term 9,,Term 8,,Term 7,-1253428294,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 9,,Term 8,,Term 7,36823992864,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 9,,Term 8,,Term 7,-730270438,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 9,,Term 8,,Term 7,458944000,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,연결재무제표 [member],Term 9,,Term 8,,Term 7,36552666426,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,dart_CompoundFinancialInstrumentConversion,전환상환우선주 보통주전환,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 9,,Term 8,,Term 7,36552666426,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 9,3592604000,Term 8,3495104000,Term 7,3447104000,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본,Term 9,670133075,Term 8,1858558700,Term 7,2107948808,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타불입자본,Term 9,52142603182,Term 8,46718489482,Term 7,44262935494,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 9,100257994716,Term 8,66001080624,Term 7,51699915148,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 9,100257994716,Term 8,66001080624,Term 7,51699915148,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 9,43330251950,Term 8,13975982766,Term 7,2498609837,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20230329001036,11011,2022,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 9,522402509,Term 8,-47054324,Term 7,-616682991,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 10,287309488243,Term 9,183130939633,Term 8,126428830150,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 10,219307995672,Term 9,137024020095,Term 8,90318935738,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 10,125334572532,Term 9,57253261626,Term 8,33798982850,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 10,389566187,Term 9,1013889535,Term 8,510037179,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 10,56520972365,Term 9,50460161074,Term 8,37831063627,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentAssets,기타유동자산,-,Term 10,6229597684,Term 9,6317755640,Term 8,4411681350,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 10,7828065195,Term 9,908796506,Term 8,4500000,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,매출채권및기타채권,-,Term 10,23005221709,Term 9,21070155714,Term 8,13762670732,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 10,68001492571,Term 9,46106919538,Term 8,36109894412,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,dart_GoodwillGross,영업권,-,Term 10,195996061,Term 9,281379700,Term 8,281379700,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,dart_InvestedAssetForPostemploymentBenefit,순확정급여자산,-,Term 10,1241439984,Term 9,1025560421,Term 8,,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,-Standard account code not used-,당기손익-공정가치측정금융자산,-,Term 10,5874522413,Term 9,1183996000,Term 8,1000000000,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 10,14449983263,Term 9,9999836046,Term 8,7323114177,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 10,4102330070,Term 9,2105886103,Term 8,1329453993,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 10,11851640591,Term 9,6686564078,Term 8,5371226327,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 10,14188421514,Term 9,8776936033,Term 8,7168215109,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 10,16097158675,Term 9,16046761157,Term 8,13636505106,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 10,196948868778,Term 9,99266311538,Term 8,66001080624,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업의 소유주에게 귀속되는 자본,-,Term 10,196948868778,Term 9,99266311538,Term 8,66001080624,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본,-,Term 10,7905337847,Term 9,670133075,Term 8,1858558700,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 10,611288220,Term 9,522402509,Term 8,-47054324,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,-Standard account code not used-,기타불입자본,-,Term 10,61090126022,Term 9,52142603182,Term 8,46718489482,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 10,3637689000,Term 9,3592604000,Term 8,3495104000,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 10,123704427689,Term 9,42338568772,Term 8,13975982766,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채및자본총계,-,Term 10,287309488243,Term 9,183130939633,Term 8,126428830150,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 10,82296421377,Term 9,76266539341,Term 8,50064266575,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,-Standard account code not used-,전환사채,-,Term 10,2316242030,Term 9,,Term 8,,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,유동 리스부채,-,Term 10,6603906979,Term 9,7246522656,Term 8,4936164190,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_CurrentProvisions,유동충당부채,-,Term 10,874477690,Term 9,246941371,Term 8,,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 10,18407737623,Term 9,12052065651,Term 8,3216960798,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 10,2342962892,Term 9,1330459085,Term 8,1149090600,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentLiabilities,기타 유동부채,-,Term 10,5644185807,Term 9,6431037858,Term 8,2280165383,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 10,7500000000,Term 9,21500000000,Term 8,16500000000,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,매입채무및기타채무,-,Term 10,38606908356,Term 9,27459512720,Term 8,21981885604,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 10,90360619465,Term 9,83864628095,Term 8,60427749526,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 10,8064198088,Term 9,7598088754,Term 8,10363482951,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,-Standard account code not used-,순확정급여부채,-,Term 10,330714601,Term 9,111223052,Term 8,1368720434,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,비유동 리스부채,-,Term 10,5818653278,Term 9,5800785246,Term 8,7585564539,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,비유동충당부채,-,Term 10,1806879130,Term 9,1564767632,Term 8,1322151390,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_OtherNoncurrentLiabilities,기타 비유동 부채,-,Term 10,107951079,Term 9,121312824,Term 8,87046588,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익,-,Term 10,104193724865,Term 9,39228479397,Term 8,14273152154,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,dart_OtherGains,기타수익,-,Term 10,441741128,Term 9,240688824,Term 8,416907223,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,dart_OtherLosses,기타비용,-,Term 10,1246484531,Term 9,416924307,Term 8,684415176,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 10,291254657539,Term 9,252246164696,Term 8,173249530478,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄이익,-,Term 10,81454744628,Term 9,28932042839,Term 8,12047001596,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 10,81454744628,Term 9,28932042839,Term 8,12047001596,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 10,128360982155,Term 9,106223475243,Term 8,71623461550,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주 기본주당손익,-,Term 10,11245,Term 9,4081,Term 8,1642,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_DilutedEarningsLossPerShare,보통주 희석주당손익,-,Term 10,11096,Term 9,4072,Term 8,1621,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 10,6601270655,Term 9,5455522583,Term 8,2256960051,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 10,9035639020,Term 9,5607858950,Term 8,1988995348,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 10,395448382404,Term 9,291474644093,Term 8,187522682632,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용(수익),-,Term 10,24277298875,Term 9,10241587166,Term 8,2338852470,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 10,-91306324,Term 9,-30950276,Term 8,648174568,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류되는 항목,-,Term 10,88885711,Term 9,569456833,Term 8,569628667,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax,해외사업장환산외환차이(세전기타포괄이익),-,Term 10,88885711,Term 9,569456833,Term 8,569628667,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류되지 않는 항목,-,Term 10,-180192035,Term 9,-600407109,Term 8,78545901,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,-Standard account code not used-,순확정급여부채의 재측정요소 법인세효과,-,Term 10,52183967,Term 9,182063176,Term 8,-22153972,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여자산의 재측정요소,-,Term 10,-232376002,Term 9,-782470285,Term 8,100699873,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익,-,Term 10,81546050952,Term 9,28962993115,Term 8,11398827028,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 10,81546050952,Term 9,28962993115,Term 8,11398827028,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 10,105823349827,Term 9,39204580281,Term 8,13737679498,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 10,523809364559,Term 9,397698119336,Term 8,259146144182,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초현금및현금성자산,-,Term 10,57253261626,Term 9,33798982850,Term 8,29618192919,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말현금및현금성자산,-,Term 10,125334572532,Term 9,57253261626,Term 8,33798982850,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동현금흐름,-,Term 10,-11480920710,Term 9,1440557771,Term 8,6900283116,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 차입,-,Term 10,,Term 9,9000000000,Term 8,14500000000,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_RepaymentsOfLongTermBorrowings,장기차입금의 상환,-,Term 10,41431000,Term 9,,Term 8,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 상환,-,Term 10,14083186080,Term 9,4000000000,Term 8,4000000000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,리스부채의 상환,-,Term 10,8605183174,Term 9,6589669212,Term 8,4953839886,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,주식선택권의 행사,-,Term 10,,Term 9,3645500000,Term 8,1756800000,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,전환사채 발행,-,Term 10,3000000000,Term 9,,Term 8,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsFinancingActivities,이자지급,-,Term 10,748686256,Term 9,615273017,Term 8,402676998,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromIssuingShares,유상증자,-,Term 10,8997565800,Term 9,,Term 8,,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동현금흐름,-,Term 10,-28280436368,Term 9,-9121425060,Term 8,-7203428972,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익-공정가치측정금융자산의 감소,-,Term 10,28221844734,Term 9,,Term 8,,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherCurrentFinancialAssets,기타유동금융자산의 감소,-,Term 10,335292614266,Term 9,,Term 8,10000000,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 감소,-,Term 10,26708870,Term 9,279094371,Term 8,180470243,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익-공정가치측정금융자산의 증가,-,Term 10,32225706286,Term 9,,Term 8,1000000000,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_PurchaseOfOtherCurrentFinancialAssets,기타유동금융자산의 증가,-,Term 10,335599523661,Term 9,162550,Term 8,,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_PurchaseOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 증가,-,Term 10,12087011290,Term 9,2494847848,Term 8,1488958183,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities,사업결합으로 인한 순현금유출,-,Term 10,-64783795,Term 9,,Term 8,,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 감소,-,Term 10,29875457,Term 9,18582000,Term 8,49528365,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 증가,-,Term 10,2215700675,Term 9,1224429839,Term 8,500274592,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 증가,-,Term 10,9658753988,Term 9,5699661194,Term 8,4454194805,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동현금흐름,-,Term 10,107840961394,Term 9,31630786168,Term 8,4585024805,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,운전자본의 변동,-,Term 10,1114001132,Term 9,-20265150119,Term 8,-14753456155,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInFairValueOfPlanAssets,퇴직연금운용자산의 증가,-,Term 10,-1319506174,Term 9,-3444241312,Term 8,58519544,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInTradeAndOtherCurrentReceivables,매출채권및기타채권의 증가,-,Term 10,-1723941211,Term 9,-7681960754,Term 8,-2652914189,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채의 증가,-,Term 10,395413258,Term 9,152309540,Term 8,643751676,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInPostemploymentBenefitObligations,퇴직급여충당부채의 감소,-,Term 10,-970172987,Term 9,-1291491458,Term 8,-547299154,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산의 증가,-,Term 10,-4537103259,Term 9,-14754289827,Term 8,-18886706336,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산의 감소(증가),-,Term 10,107414407,Term 9,-3542398099,Term 8,-2484585042,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채의 증가(감소),-,Term 10,-790639961,Term 9,4150872475,Term 8,-284173534,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables,매입채무및기타채무의 증가,-,Term 10,9952537059,Term 9,6146049316,Term 8,9399950880,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,현금의 유출·유입이 없는 비용·수익등의 가감,-,Term 10,39899321808,Term 9,27026937063,Term 8,11808657685,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비,-,Term 10,400595508,Term 9,,Term 8,-31649480,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 10,33216637,Term 9,151433966,Term 8,150879966,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 10,672365722,Term 9,273289182,Term 8,423628253,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfFinancialAssets,당기손익-공정가치측정금융자산처분이익,-,Term 10,221844734,Term 9,183996000,Term 8,,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfDerivativeFinancialAssets,파생금융자산평가이익,-,Term 10,43171638,Term 9,,Term 8,,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치측정금융자산평가이익,-,Term 10,464820127,Term 9,,Term 8,,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 10,1265495714,Term 9,1035577089,Term 8,648254268,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnAbandonmentOfPropertyPlantAndEquipment,유형자산폐기손실,-,Term 10,400966077,Term 9,161828721,Term 8,271407000,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 10,41771085,Term 9,6174968,Term 8,22440670,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 10,434788227,Term 9,1153644565,Term 8,116614958,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForMiscellaneousLosses,잡손실 조정,-,Term 10,,Term 9,26875152,Term 8,43236015,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타의대손상각비,-,Term 10,2998801,Term 9,,Term 8,8639971,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForProductWarrantyExpenses,판매보증비 조정,-,Term 10,159805759,Term 9,64189298,Term 8,,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 10,2060915144,Term 9,1670204682,Term 8,1505471332,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfBadDebtExpenses,기타의 대손상각비 환입,-,Term 10,,Term 9,22120436,Term 8,,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfInventories,재고자산평가손실환입,-,Term 10,1626304417,Term 9,,Term 8,383776739,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForShareBasedPayment,주식보상비용,-,Term 10,3001167581,Term 9,500025095,Term 8,497990000,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForWritedownsOfInventories,재고자산평가손실,-,Term 10,,Term 9,2197661834,Term 8,,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,광고선전비,-,Term 10,,Term 9,250000,Term 8,,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,사용권자산감가상각비,-,Term 10,8741095662,Term 9,6611789049,Term 8,4863676473,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,지급수수료,-,Term 10,85532598,Term 9,43773635,Term 8,114522441,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,대손상각비환입,-,Term 10,,Term 9,3357125,Term 8,,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,소모품비,-,Term 10,125000000,Term 9,,Term 8,,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,기타장기종업원급여,-,Term 10,,Term 9,34266236,Term 8,28331082,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,영업권손상차손,-,Term 10,281379700,Term 9,,Term 8,,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,기타장기종업원급여의 환입,-,Term 10,13361745,Term 9,,Term 8,,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 10,443696199,Term 9,372523191,Term 8,340057933,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForDepreciationExpense,유형자산감가상각비,-,Term 10,4738400949,Term 9,3770759899,Term 8,2090706225,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 10,24277298875,Term 9,10241587166,Term 8,2338852470,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForInterestIncome,이자수익,-,Term 10,3486501051,Term 9,229996808,Term 8,91608715,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세납부,-,Term 10,17461223521,Term 9,4217330382,Term 8,3893129762,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 10,2742811023,Term 9,123336491,Term 8,24126009,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_ProfitLoss,당기순이익,-,Term 10,81546050952,Term 9,28962993115,Term 8,11398827028,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,현금및현금성자산에 대한 환율변동효과,-,Term 10,1706590,Term 9,-495640103,Term 8,-101089018,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,현금의 증가,-,Term 10,68079604316,Term 9,23949918879,Term 8,4281878949,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누계액 [구성요소],Term 10,88885711,Term 9,569456833,Term 8,569628667,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,연결재무제표 [member],Term 10,88885711,Term 9,569456833,Term 8,569628667,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 10,88885711,Term 9,569456833,Term 8,569628667,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 10,99266311538,Term 9,66001080624,Term 8,51699915148,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 10,99266311538,Term 9,66001080624,Term 8,51699915148,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 10,3592604000,Term 9,3495104000,Term 8,3447104000,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 10,42338568772,Term 9,13975982766,Term 8,2498609837,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누계액 [구성요소],Term 10,522402509,Term 9,-47054324,Term 8,-616682991,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 10,670133075,Term 9,1858558700,Term 8,2107948808,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타불입자본,Term 10,52142603182,Term 9,46718489482,Term 8,44262935494,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_ReclassificationAdjustments,순확정급여부채의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 10,-180192035,Term 9,-600407109,Term 8,78545901,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_ReclassificationAdjustments,순확정급여부채의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 10,-180192035,Term 9,-600407109,Term 8,78545901,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_ReclassificationAdjustments,순확정급여부채의 재측정요소,연결재무제표 [member],Term 10,-180192035,Term 9,-600407109,Term 8,78545901,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 10,7905337847,Term 9,670133075,Term 8,1858558700,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누계액 [구성요소],Term 10,611288220,Term 9,522402509,Term 8,-47054324,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 10,123704427689,Term 9,42338568772,Term 8,13975982766,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타불입자본,Term 10,61090126022,Term 9,52142603182,Term 8,46718489482,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 10,3637689000,Term 9,3592604000,Term 8,3495104000,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,연결재무제표 [member],Term 10,196948868778,Term 9,99266311538,Term 8,66001080624,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 10,196948868778,Term 9,99266311538,Term 8,66001080624,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,연결재무제표 [member],Term 10,7235204772,Term 9,4333188075,Term 8,2254163880,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 10,,Term 9,97500000,Term 8,48000000,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 10,7235204772,Term 9,-1188425625,Term 8,-249390108,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타불입자본,Term 10,,Term 9,5424113700,Term 8,2455553988,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 10,7235204772,Term 9,4333188075,Term 8,2254163880,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,유상증자,연결재무제표 [member],Term 10,8992607840,Term 9,,Term 8,,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,유상증자,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 10,8992607840,Term 9,,Term 8,,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,유상증자,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타불입자본,Term 10,8947522840,Term 9,,Term 8,,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,유상증자,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 10,45085000,Term 9,,Term 8,,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 10,81546050952,Term 9,28962993115,Term 8,11398827028,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,연결재무제표 [member],Term 10,81546050952,Term 9,28962993115,Term 8,11398827028,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 10,81546050952,Term 9,28962993115,Term 8,11398827028,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 10,287309488243,Term 9,183130939633,Term 8,126428830150,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 10,219307995672,Term 9,137024020095,Term 8,90318935738,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 10,125334572532,Term 9,57253261626,Term 8,33798982850,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 10,389566187,Term 9,1013889535,Term 8,510037179,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 10,56520972365,Term 9,50460161074,Term 8,37831063627,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentAssets,기타유동자산,-,Term 10,6229597684,Term 9,6317755640,Term 8,4411681350,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 10,7828065195,Term 9,908796506,Term 8,4500000,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,매출채권및기타채권,-,Term 10,23005221709,Term 9,21070155714,Term 8,13762670732,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 10,68001492571,Term 9,46106919538,Term 8,36109894412,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,dart_GoodwillGross,영업권,-,Term 10,195996061,Term 9,281379700,Term 8,281379700,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,dart_InvestedAssetForPostemploymentBenefit,순확정급여자산,-,Term 10,1241439984,Term 9,1025560421,Term 8,,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,-Standard account code not used-,당기손익-공정가치측정금융자산,-,Term 10,5874522413,Term 9,1183996000,Term 8,1000000000,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 10,14449983263,Term 9,9999836046,Term 8,7323114177,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 10,4102330070,Term 9,2105886103,Term 8,1329453993,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 10,11851640591,Term 9,6686564078,Term 8,5371226327,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 10,14188421514,Term 9,8776936033,Term 8,7168215109,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 10,16097158675,Term 9,16046761157,Term 8,13636505106,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 10,196948868778,Term 9,99266311538,Term 8,66001080624,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업의 소유주에게 귀속되는 자본,-,Term 10,196948868778,Term 9,99266311538,Term 8,66001080624,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본,-,Term 10,7905337847,Term 9,670133075,Term 8,1858558700,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 10,611288220,Term 9,522402509,Term 8,-47054324,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,-Standard account code not used-,기타불입자본,-,Term 10,61090126022,Term 9,52142603182,Term 8,46718489482,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 10,3637689000,Term 9,3592604000,Term 8,3495104000,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 10,123704427689,Term 9,42338568772,Term 8,13975982766,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채및자본총계,-,Term 10,287309488243,Term 9,183130939633,Term 8,126428830150,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 10,82296421377,Term 9,76266539341,Term 8,50064266575,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,-Standard account code not used-,전환사채,-,Term 10,2316242030,Term 9,,Term 8,,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,유동 리스부채,-,Term 10,6603906979,Term 9,7246522656,Term 8,4936164190,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_CurrentProvisions,유동충당부채,-,Term 10,874477690,Term 9,246941371,Term 8,,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 10,18407737623,Term 9,12052065651,Term 8,3216960798,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 10,2342962892,Term 9,1330459085,Term 8,1149090600,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentLiabilities,기타 유동부채,-,Term 10,5644185807,Term 9,6431037858,Term 8,2280165383,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 10,7500000000,Term 9,21500000000,Term 8,16500000000,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,매입채무및기타채무,-,Term 10,38606908356,Term 9,27459512720,Term 8,21981885604,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 10,90360619465,Term 9,83864628095,Term 8,60427749526,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 10,8064198088,Term 9,7598088754,Term 8,10363482951,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,-Standard account code not used-,순확정급여부채,-,Term 10,330714601,Term 9,111223052,Term 8,1368720434,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,비유동 리스부채,-,Term 10,5818653278,Term 9,5800785246,Term 8,7585564539,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,비유동충당부채,-,Term 10,1806879130,Term 9,1564767632,Term 8,1322151390,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_OtherNoncurrentLiabilities,기타 비유동 부채,-,Term 10,107951079,Term 9,121312824,Term 8,87046588,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익,-,Term 10,104193724865,Term 9,39228479397,Term 8,14273152154,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,dart_OtherGains,기타수익,-,Term 10,441741128,Term 9,240688824,Term 8,416907223,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,dart_OtherLosses,기타비용,-,Term 10,1246484531,Term 9,416924307,Term 8,684415176,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 10,291254657539,Term 9,252246164696,Term 8,173249530478,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄이익,-,Term 10,81454744628,Term 9,28932042839,Term 8,12047001596,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 10,81454744628,Term 9,28932042839,Term 8,12047001596,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 10,128360982155,Term 9,106223475243,Term 8,71623461550,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주 기본주당손익,-,Term 10,11245,Term 9,4081,Term 8,1642,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_DilutedEarningsLossPerShare,보통주 희석주당손익,-,Term 10,11096,Term 9,4072,Term 8,1621,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 10,6601270655,Term 9,5455522583,Term 8,2256960051,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 10,9035639020,Term 9,5607858950,Term 8,1988995348,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 10,395448382404,Term 9,291474644093,Term 8,187522682632,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용(수익),-,Term 10,24277298875,Term 9,10241587166,Term 8,2338852470,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 10,-91306324,Term 9,-30950276,Term 8,648174568,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류되는 항목,-,Term 10,88885711,Term 9,569456833,Term 8,569628667,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax,해외사업장환산외환차이(세전기타포괄이익),-,Term 10,88885711,Term 9,569456833,Term 8,569628667,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류되지 않는 항목,-,Term 10,-180192035,Term 9,-600407109,Term 8,78545901,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,-Standard account code not used-,순확정급여부채의 재측정요소 법인세효과,-,Term 10,52183967,Term 9,182063176,Term 8,-22153972,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여자산의 재측정요소,-,Term 10,-232376002,Term 9,-782470285,Term 8,100699873,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익,-,Term 10,81546050952,Term 9,28962993115,Term 8,11398827028,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 10,81546050952,Term 9,28962993115,Term 8,11398827028,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 10,105823349827,Term 9,39204580281,Term 8,13737679498,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 10,523809364559,Term 9,397698119336,Term 8,259146144182,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초현금및현금성자산,-,Term 10,57253261626,Term 9,33798982850,Term 8,29618192919,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말현금및현금성자산,-,Term 10,125334572532,Term 9,57253261626,Term 8,33798982850,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동현금흐름,-,Term 10,-11480920710,Term 9,1440557771,Term 8,6900283116,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 차입,-,Term 10,,Term 9,9000000000,Term 8,14500000000,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_RepaymentsOfLongTermBorrowings,장기차입금의 상환,-,Term 10,41431000,Term 9,,Term 8,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 상환,-,Term 10,14083186080,Term 9,4000000000,Term 8,4000000000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,리스부채의 상환,-,Term 10,8605183174,Term 9,6589669212,Term 8,4953839886,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,주식선택권의 행사,-,Term 10,,Term 9,3645500000,Term 8,1756800000,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,전환사채 발행,-,Term 10,3000000000,Term 9,,Term 8,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsFinancingActivities,이자지급,-,Term 10,748686256,Term 9,615273017,Term 8,402676998,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromIssuingShares,유상증자,-,Term 10,8997565800,Term 9,,Term 8,,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동현금흐름,-,Term 10,-28280436368,Term 9,-9121425060,Term 8,-7203428972,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익-공정가치측정금융자산의 감소,-,Term 10,28221844734,Term 9,,Term 8,,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherCurrentFinancialAssets,기타유동금융자산의 감소,-,Term 10,335292614266,Term 9,,Term 8,10000000,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 감소,-,Term 10,26708870,Term 9,279094371,Term 8,180470243,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익-공정가치측정금융자산의 증가,-,Term 10,32225706286,Term 9,,Term 8,1000000000,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_PurchaseOfOtherCurrentFinancialAssets,기타유동금융자산의 증가,-,Term 10,335599523661,Term 9,162550,Term 8,,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_PurchaseOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 증가,-,Term 10,12087011290,Term 9,2494847848,Term 8,1488958183,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities,사업결합으로 인한 순현금유출,-,Term 10,-64783795,Term 9,,Term 8,,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 감소,-,Term 10,29875457,Term 9,18582000,Term 8,49528365,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 증가,-,Term 10,2215700675,Term 9,1224429839,Term 8,500274592,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 증가,-,Term 10,9658753988,Term 9,5699661194,Term 8,4454194805,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동현금흐름,-,Term 10,107840961394,Term 9,31630786168,Term 8,4585024805,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,운전자본의 변동,-,Term 10,1114001132,Term 9,-20265150119,Term 8,-14753456155,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInFairValueOfPlanAssets,퇴직연금운용자산의 증가,-,Term 10,-1319506174,Term 9,-3444241312,Term 8,58519544,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInTradeAndOtherCurrentReceivables,매출채권및기타채권의 증가,-,Term 10,-1723941211,Term 9,-7681960754,Term 8,-2652914189,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채의 증가,-,Term 10,395413258,Term 9,152309540,Term 8,643751676,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInPostemploymentBenefitObligations,퇴직급여충당부채의 감소,-,Term 10,-970172987,Term 9,-1291491458,Term 8,-547299154,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산의 증가,-,Term 10,-4537103259,Term 9,-14754289827,Term 8,-18886706336,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산의 감소(증가),-,Term 10,107414407,Term 9,-3542398099,Term 8,-2484585042,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채의 증가(감소),-,Term 10,-790639961,Term 9,4150872475,Term 8,-284173534,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables,매입채무및기타채무의 증가,-,Term 10,9952537059,Term 9,6146049316,Term 8,9399950880,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,현금의 유출·유입이 없는 비용·수익등의 가감,-,Term 10,39899321808,Term 9,27026937063,Term 8,11808657685,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비,-,Term 10,400595508,Term 9,,Term 8,-31649480,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 10,33216637,Term 9,151433966,Term 8,150879966,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 10,672365722,Term 9,273289182,Term 8,423628253,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfFinancialAssets,당기손익-공정가치측정금융자산처분이익,-,Term 10,221844734,Term 9,183996000,Term 8,,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfDerivativeFinancialAssets,파생금융자산평가이익,-,Term 10,43171638,Term 9,,Term 8,,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치측정금융자산평가이익,-,Term 10,464820127,Term 9,,Term 8,,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 10,1265495714,Term 9,1035577089,Term 8,648254268,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnAbandonmentOfPropertyPlantAndEquipment,유형자산폐기손실,-,Term 10,400966077,Term 9,161828721,Term 8,271407000,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 10,41771085,Term 9,6174968,Term 8,22440670,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 10,434788227,Term 9,1153644565,Term 8,116614958,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForMiscellaneousLosses,잡손실 조정,-,Term 10,,Term 9,26875152,Term 8,43236015,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타의대손상각비,-,Term 10,2998801,Term 9,,Term 8,8639971,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForProductWarrantyExpenses,판매보증비 조정,-,Term 10,159805759,Term 9,64189298,Term 8,,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 10,2060915144,Term 9,1670204682,Term 8,1505471332,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfBadDebtExpenses,기타의 대손상각비 환입,-,Term 10,,Term 9,22120436,Term 8,,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfInventories,재고자산평가손실환입,-,Term 10,1626304417,Term 9,,Term 8,383776739,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForShareBasedPayment,주식보상비용,-,Term 10,3001167581,Term 9,500025095,Term 8,497990000,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForWritedownsOfInventories,재고자산평가손실,-,Term 10,,Term 9,2197661834,Term 8,,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,광고선전비,-,Term 10,,Term 9,250000,Term 8,,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,사용권자산감가상각비,-,Term 10,8741095662,Term 9,6611789049,Term 8,4863676473,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,지급수수료,-,Term 10,85532598,Term 9,43773635,Term 8,114522441,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,대손상각비환입,-,Term 10,,Term 9,3357125,Term 8,,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,소모품비,-,Term 10,125000000,Term 9,,Term 8,,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,기타장기종업원급여,-,Term 10,,Term 9,34266236,Term 8,28331082,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,영업권손상차손,-,Term 10,281379700,Term 9,,Term 8,,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,기타장기종업원급여의 환입,-,Term 10,13361745,Term 9,,Term 8,,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 10,443696199,Term 9,372523191,Term 8,340057933,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForDepreciationExpense,유형자산감가상각비,-,Term 10,4738400949,Term 9,3770759899,Term 8,2090706225,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 10,24277298875,Term 9,10241587166,Term 8,2338852470,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForInterestIncome,이자수익,-,Term 10,3486501051,Term 9,229996808,Term 8,91608715,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세납부,-,Term 10,17461223521,Term 9,4217330382,Term 8,3893129762,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 10,2742811023,Term 9,123336491,Term 8,24126009,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_ProfitLoss,당기순이익,-,Term 10,81546050952,Term 9,28962993115,Term 8,11398827028,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,현금및현금성자산에 대한 환율변동효과,-,Term 10,1706590,Term 9,-495640103,Term 8,-101089018,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,현금의 증가,-,Term 10,68079604316,Term 9,23949918879,Term 8,4281878949,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누계액 [구성요소],Term 10,88885711,Term 9,569456833,Term 8,569628667,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,연결재무제표 [member],Term 10,88885711,Term 9,569456833,Term 8,569628667,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 10,88885711,Term 9,569456833,Term 8,569628667,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 10,99266311538,Term 9,66001080624,Term 8,51699915148,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 10,99266311538,Term 9,66001080624,Term 8,51699915148,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 10,3592604000,Term 9,3495104000,Term 8,3447104000,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 10,42338568772,Term 9,13975982766,Term 8,2498609837,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누계액 [구성요소],Term 10,522402509,Term 9,-47054324,Term 8,-616682991,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 10,670133075,Term 9,1858558700,Term 8,2107948808,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타불입자본,Term 10,52142603182,Term 9,46718489482,Term 8,44262935494,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_ReclassificationAdjustments,순확정급여부채의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 10,-180192035,Term 9,-600407109,Term 8,78545901,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_ReclassificationAdjustments,순확정급여부채의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 10,-180192035,Term 9,-600407109,Term 8,78545901,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_ReclassificationAdjustments,순확정급여부채의 재측정요소,연결재무제표 [member],Term 10,-180192035,Term 9,-600407109,Term 8,78545901,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 10,7905337847,Term 9,670133075,Term 8,1858558700,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누계액 [구성요소],Term 10,611288220,Term 9,522402509,Term 8,-47054324,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 10,123704427689,Term 9,42338568772,Term 8,13975982766,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타불입자본,Term 10,61090126022,Term 9,52142603182,Term 8,46718489482,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 10,3637689000,Term 9,3592604000,Term 8,3495104000,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,연결재무제표 [member],Term 10,196948868778,Term 9,99266311538,Term 8,66001080624,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 10,196948868778,Term 9,99266311538,Term 8,66001080624,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,연결재무제표 [member],Term 10,7235204772,Term 9,4333188075,Term 8,2254163880,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 10,,Term 9,97500000,Term 8,48000000,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 10,7235204772,Term 9,-1188425625,Term 8,-249390108,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타불입자본,Term 10,,Term 9,5424113700,Term 8,2455553988,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 10,7235204772,Term 9,4333188075,Term 8,2254163880,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,유상증자,연결재무제표 [member],Term 10,8992607840,Term 9,,Term 8,,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,유상증자,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 10,8992607840,Term 9,,Term 8,,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,유상증자,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타불입자본,Term 10,8947522840,Term 9,,Term 8,,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,유상증자,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 10,45085000,Term 9,,Term 8,,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 10,81546050952,Term 9,28962993115,Term 8,11398827028,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,연결재무제표 [member],Term 10,81546050952,Term 9,28962993115,Term 8,11398827028,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 10,81546050952,Term 9,28962993115,Term 8,11398827028,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 10,287309488243,Term 9,183130939633,Term 8,126428830150,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 10,219307995672,Term 9,137024020095,Term 8,90318935738,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 10,125334572532,Term 9,57253261626,Term 8,33798982850,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 10,389566187,Term 9,1013889535,Term 8,510037179,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 10,56520972365,Term 9,50460161074,Term 8,37831063627,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentAssets,기타유동자산,-,Term 10,6229597684,Term 9,6317755640,Term 8,4411681350,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 10,7828065195,Term 9,908796506,Term 8,4500000,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,매출채권및기타채권,-,Term 10,23005221709,Term 9,21070155714,Term 8,13762670732,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 10,68001492571,Term 9,46106919538,Term 8,36109894412,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,dart_GoodwillGross,영업권,-,Term 10,195996061,Term 9,281379700,Term 8,281379700,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,dart_InvestedAssetForPostemploymentBenefit,순확정급여자산,-,Term 10,1241439984,Term 9,1025560421,Term 8,,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,-Standard account code not used-,당기손익-공정가치측정금융자산,-,Term 10,5874522413,Term 9,1183996000,Term 8,1000000000,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 10,14449983263,Term 9,9999836046,Term 8,7323114177,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 10,4102330070,Term 9,2105886103,Term 8,1329453993,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 10,11851640591,Term 9,6686564078,Term 8,5371226327,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 10,14188421514,Term 9,8776936033,Term 8,7168215109,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 10,16097158675,Term 9,16046761157,Term 8,13636505106,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 10,196948868778,Term 9,99266311538,Term 8,66001080624,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업의 소유주에게 귀속되는 자본,-,Term 10,196948868778,Term 9,99266311538,Term 8,66001080624,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본,-,Term 10,7905337847,Term 9,670133075,Term 8,1858558700,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 10,611288220,Term 9,522402509,Term 8,-47054324,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,-Standard account code not used-,기타불입자본,-,Term 10,61090126022,Term 9,52142603182,Term 8,46718489482,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 10,3637689000,Term 9,3592604000,Term 8,3495104000,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 10,123704427689,Term 9,42338568772,Term 8,13975982766,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채및자본총계,-,Term 10,287309488243,Term 9,183130939633,Term 8,126428830150,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 10,82296421377,Term 9,76266539341,Term 8,50064266575,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,-Standard account code not used-,전환사채,-,Term 10,2316242030,Term 9,,Term 8,,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,유동 리스부채,-,Term 10,6603906979,Term 9,7246522656,Term 8,4936164190,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_CurrentProvisions,유동충당부채,-,Term 10,874477690,Term 9,246941371,Term 8,,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 10,18407737623,Term 9,12052065651,Term 8,3216960798,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 10,2342962892,Term 9,1330459085,Term 8,1149090600,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentLiabilities,기타 유동부채,-,Term 10,5644185807,Term 9,6431037858,Term 8,2280165383,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 10,7500000000,Term 9,21500000000,Term 8,16500000000,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,매입채무및기타채무,-,Term 10,38606908356,Term 9,27459512720,Term 8,21981885604,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 10,90360619465,Term 9,83864628095,Term 8,60427749526,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 10,8064198088,Term 9,7598088754,Term 8,10363482951,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,-Standard account code not used-,순확정급여부채,-,Term 10,330714601,Term 9,111223052,Term 8,1368720434,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,비유동 리스부채,-,Term 10,5818653278,Term 9,5800785246,Term 8,7585564539,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,비유동충당부채,-,Term 10,1806879130,Term 9,1564767632,Term 8,1322151390,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,BS,Statement of financial position,ifrs-full_OtherNoncurrentLiabilities,기타 비유동 부채,-,Term 10,107951079,Term 9,121312824,Term 8,87046588,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익,-,Term 10,104193724865,Term 9,39228479397,Term 8,14273152154,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,dart_OtherGains,기타수익,-,Term 10,441741128,Term 9,240688824,Term 8,416907223,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,dart_OtherLosses,기타비용,-,Term 10,1246484531,Term 9,416924307,Term 8,684415176,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 10,291254657539,Term 9,252246164696,Term 8,173249530478,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄이익,-,Term 10,81454744628,Term 9,28932042839,Term 8,12047001596,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 10,81454744628,Term 9,28932042839,Term 8,12047001596,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 10,128360982155,Term 9,106223475243,Term 8,71623461550,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주 기본주당손익,-,Term 10,11245,Term 9,4081,Term 8,1642,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_DilutedEarningsLossPerShare,보통주 희석주당손익,-,Term 10,11096,Term 9,4072,Term 8,1621,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 10,6601270655,Term 9,5455522583,Term 8,2256960051,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 10,9035639020,Term 9,5607858950,Term 8,1988995348,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 10,395448382404,Term 9,291474644093,Term 8,187522682632,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용(수익),-,Term 10,24277298875,Term 9,10241587166,Term 8,2338852470,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 10,-91306324,Term 9,-30950276,Term 8,648174568,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류되는 항목,-,Term 10,88885711,Term 9,569456833,Term 8,569628667,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax,해외사업장환산외환차이(세전기타포괄이익),-,Term 10,88885711,Term 9,569456833,Term 8,569628667,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류되지 않는 항목,-,Term 10,-180192035,Term 9,-600407109,Term 8,78545901,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,-Standard account code not used-,순확정급여부채의 재측정요소 법인세효과,-,Term 10,52183967,Term 9,182063176,Term 8,-22153972,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여자산의 재측정요소,-,Term 10,-232376002,Term 9,-782470285,Term 8,100699873,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익,-,Term 10,81546050952,Term 9,28962993115,Term 8,11398827028,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 10,81546050952,Term 9,28962993115,Term 8,11398827028,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 10,105823349827,Term 9,39204580281,Term 8,13737679498,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 10,523809364559,Term 9,397698119336,Term 8,259146144182,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초현금및현금성자산,-,Term 10,57253261626,Term 9,33798982850,Term 8,29618192919,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말현금및현금성자산,-,Term 10,125334572532,Term 9,57253261626,Term 8,33798982850,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동현금흐름,-,Term 10,-11480920710,Term 9,1440557771,Term 8,6900283116,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 차입,-,Term 10,,Term 9,9000000000,Term 8,14500000000,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_RepaymentsOfLongTermBorrowings,장기차입금의 상환,-,Term 10,41431000,Term 9,,Term 8,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 상환,-,Term 10,14083186080,Term 9,4000000000,Term 8,4000000000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,리스부채의 상환,-,Term 10,8605183174,Term 9,6589669212,Term 8,4953839886,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,주식선택권의 행사,-,Term 10,,Term 9,3645500000,Term 8,1756800000,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,전환사채 발행,-,Term 10,3000000000,Term 9,,Term 8,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsFinancingActivities,이자지급,-,Term 10,748686256,Term 9,615273017,Term 8,402676998,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromIssuingShares,유상증자,-,Term 10,8997565800,Term 9,,Term 8,,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동현금흐름,-,Term 10,-28280436368,Term 9,-9121425060,Term 8,-7203428972,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익-공정가치측정금융자산의 감소,-,Term 10,28221844734,Term 9,,Term 8,,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherCurrentFinancialAssets,기타유동금융자산의 감소,-,Term 10,335292614266,Term 9,,Term 8,10000000,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 감소,-,Term 10,26708870,Term 9,279094371,Term 8,180470243,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익-공정가치측정금융자산의 증가,-,Term 10,32225706286,Term 9,,Term 8,1000000000,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_PurchaseOfOtherCurrentFinancialAssets,기타유동금융자산의 증가,-,Term 10,335599523661,Term 9,162550,Term 8,,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_PurchaseOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 증가,-,Term 10,12087011290,Term 9,2494847848,Term 8,1488958183,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities,사업결합으로 인한 순현금유출,-,Term 10,-64783795,Term 9,,Term 8,,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 감소,-,Term 10,29875457,Term 9,18582000,Term 8,49528365,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 증가,-,Term 10,2215700675,Term 9,1224429839,Term 8,500274592,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 증가,-,Term 10,9658753988,Term 9,5699661194,Term 8,4454194805,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동현금흐름,-,Term 10,107840961394,Term 9,31630786168,Term 8,4585024805,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,운전자본의 변동,-,Term 10,1114001132,Term 9,-20265150119,Term 8,-14753456155,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInFairValueOfPlanAssets,퇴직연금운용자산의 증가,-,Term 10,-1319506174,Term 9,-3444241312,Term 8,58519544,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInTradeAndOtherCurrentReceivables,매출채권및기타채권의 증가,-,Term 10,-1723941211,Term 9,-7681960754,Term 8,-2652914189,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채의 증가,-,Term 10,395413258,Term 9,152309540,Term 8,643751676,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInPostemploymentBenefitObligations,퇴직급여충당부채의 감소,-,Term 10,-970172987,Term 9,-1291491458,Term 8,-547299154,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산의 증가,-,Term 10,-4537103259,Term 9,-14754289827,Term 8,-18886706336,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산의 감소(증가),-,Term 10,107414407,Term 9,-3542398099,Term 8,-2484585042,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채의 증가(감소),-,Term 10,-790639961,Term 9,4150872475,Term 8,-284173534,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables,매입채무및기타채무의 증가,-,Term 10,9952537059,Term 9,6146049316,Term 8,9399950880,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,현금의 유출·유입이 없는 비용·수익등의 가감,-,Term 10,39899321808,Term 9,27026937063,Term 8,11808657685,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비,-,Term 10,400595508,Term 9,,Term 8,-31649480,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 10,33216637,Term 9,151433966,Term 8,150879966,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 10,672365722,Term 9,273289182,Term 8,423628253,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfFinancialAssets,당기손익-공정가치측정금융자산처분이익,-,Term 10,221844734,Term 9,183996000,Term 8,,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfDerivativeFinancialAssets,파생금융자산평가이익,-,Term 10,43171638,Term 9,,Term 8,,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치측정금융자산평가이익,-,Term 10,464820127,Term 9,,Term 8,,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 10,1265495714,Term 9,1035577089,Term 8,648254268,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnAbandonmentOfPropertyPlantAndEquipment,유형자산폐기손실,-,Term 10,400966077,Term 9,161828721,Term 8,271407000,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 10,41771085,Term 9,6174968,Term 8,22440670,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 10,434788227,Term 9,1153644565,Term 8,116614958,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForMiscellaneousLosses,잡손실 조정,-,Term 10,,Term 9,26875152,Term 8,43236015,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타의대손상각비,-,Term 10,2998801,Term 9,,Term 8,8639971,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForProductWarrantyExpenses,판매보증비 조정,-,Term 10,159805759,Term 9,64189298,Term 8,,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 10,2060915144,Term 9,1670204682,Term 8,1505471332,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfBadDebtExpenses,기타의 대손상각비 환입,-,Term 10,,Term 9,22120436,Term 8,,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfInventories,재고자산평가손실환입,-,Term 10,1626304417,Term 9,,Term 8,383776739,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForShareBasedPayment,주식보상비용,-,Term 10,3001167581,Term 9,500025095,Term 8,497990000,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,dart_AdjustmentsForWritedownsOfInventories,재고자산평가손실,-,Term 10,,Term 9,2197661834,Term 8,,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,광고선전비,-,Term 10,,Term 9,250000,Term 8,,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,사용권자산감가상각비,-,Term 10,8741095662,Term 9,6611789049,Term 8,4863676473,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,지급수수료,-,Term 10,85532598,Term 9,43773635,Term 8,114522441,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,대손상각비환입,-,Term 10,,Term 9,3357125,Term 8,,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,소모품비,-,Term 10,125000000,Term 9,,Term 8,,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,기타장기종업원급여,-,Term 10,,Term 9,34266236,Term 8,28331082,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,영업권손상차손,-,Term 10,281379700,Term 9,,Term 8,,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,-Standard account code not used-,기타장기종업원급여의 환입,-,Term 10,13361745,Term 9,,Term 8,,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 10,443696199,Term 9,372523191,Term 8,340057933,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForDepreciationExpense,유형자산감가상각비,-,Term 10,4738400949,Term 9,3770759899,Term 8,2090706225,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 10,24277298875,Term 9,10241587166,Term 8,2338852470,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForInterestIncome,이자수익,-,Term 10,3486501051,Term 9,229996808,Term 8,91608715,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세납부,-,Term 10,17461223521,Term 9,4217330382,Term 8,3893129762,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 10,2742811023,Term 9,123336491,Term 8,24126009,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_ProfitLoss,당기순이익,-,Term 10,81546050952,Term 9,28962993115,Term 8,11398827028,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,현금및현금성자산에 대한 환율변동효과,-,Term 10,1706590,Term 9,-495640103,Term 8,-101089018,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,현금의 증가,-,Term 10,68079604316,Term 9,23949918879,Term 8,4281878949,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누계액 [구성요소],Term 10,88885711,Term 9,569456833,Term 8,569628667,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,연결재무제표 [member],Term 10,88885711,Term 9,569456833,Term 8,569628667,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 10,88885711,Term 9,569456833,Term 8,569628667,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 10,99266311538,Term 9,66001080624,Term 8,51699915148,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 10,99266311538,Term 9,66001080624,Term 8,51699915148,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 10,3592604000,Term 9,3495104000,Term 8,3447104000,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 10,42338568772,Term 9,13975982766,Term 8,2498609837,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누계액 [구성요소],Term 10,522402509,Term 9,-47054324,Term 8,-616682991,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 10,670133075,Term 9,1858558700,Term 8,2107948808,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타불입자본,Term 10,52142603182,Term 9,46718489482,Term 8,44262935494,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_ReclassificationAdjustments,순확정급여부채의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 10,-180192035,Term 9,-600407109,Term 8,78545901,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_ReclassificationAdjustments,순확정급여부채의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 10,-180192035,Term 9,-600407109,Term 8,78545901,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,dart_ReclassificationAdjustments,순확정급여부채의 재측정요소,연결재무제표 [member],Term 10,-180192035,Term 9,-600407109,Term 8,78545901,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 10,7905337847,Term 9,670133075,Term 8,1858558700,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누계액 [구성요소],Term 10,611288220,Term 9,522402509,Term 8,-47054324,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 10,123704427689,Term 9,42338568772,Term 8,13975982766,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타불입자본,Term 10,61090126022,Term 9,52142603182,Term 8,46718489482,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 10,3637689000,Term 9,3592604000,Term 8,3495104000,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,연결재무제표 [member],Term 10,196948868778,Term 9,99266311538,Term 8,66001080624,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 10,196948868778,Term 9,99266311538,Term 8,66001080624,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,연결재무제표 [member],Term 10,7235204772,Term 9,4333188075,Term 8,2254163880,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 10,,Term 9,97500000,Term 8,48000000,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 10,7235204772,Term 9,-1188425625,Term 8,-249390108,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타불입자본,Term 10,,Term 9,5424113700,Term 8,2455553988,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 10,7235204772,Term 9,4333188075,Term 8,2254163880,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,유상증자,연결재무제표 [member],Term 10,8992607840,Term 9,,Term 8,,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,유상증자,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 10,8992607840,Term 9,,Term 8,,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,유상증자,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타불입자본,Term 10,8947522840,Term 9,,Term 8,,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,유상증자,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 10,45085000,Term 9,,Term 8,,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 10,81546050952,Term 9,28962993115,Term 8,11398827028,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,연결재무제표 [member],Term 10,81546050952,Term 9,28962993115,Term 8,11398827028,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20240321000964,11011,2023,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 10,81546050952,Term 9,28962993115,Term 8,11398827028,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 11,565143563187,Term 10,287309488243,Term 9,183130939633,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 11,286027445388,Term 10,219307995672,Term 9,137024020095,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,-Standard account code not used-,당기손익-공정가치측정금융자산,-,Term 11,4043223237,Term 10,,Term 9,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 11,90366354391,Term 10,125334572532,Term 9,57253261626,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 11,472876908,Term 10,389566187,Term 9,1013889535,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 11,109745676962,Term 10,56520972365,Term 9,50460161074,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentAssets,기타유동자산,-,Term 11,7821538019,Term 10,6229597684,Term 9,6317755640,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 11,25630369792,Term 10,7828065195,Term 9,908796506,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,매출채권및기타채권,-,Term 11,47947406079,Term 10,23005221709,Term 9,21070155714,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 11,279116117799,Term 10,68001492571,Term 9,46106919538,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,dart_GoodwillGross,영업권,-,Term 11,195996061,Term 10,195996061,Term 9,281379700,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,dart_InvestedAssetForPostemploymentBenefit,순확정급여자산,-,Term 11,,Term 10,1241439984,Term 9,1025560421,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,-Standard account code not used-,당기손익-공정가치측정금융자산,-,Term 11,28378245326,Term 10,5874522413,Term 9,1183996000,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 11,45782255963,Term 10,14449983263,Term 9,9999836046,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 11,5632651682,Term 10,4102330070,Term 9,2105886103,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 11,33606731961,Term 10,11851640591,Term 9,6686564078,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 11,51364428813,Term 10,14188421514,Term 9,8776936033,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 11,114155807993,Term 10,16097158675,Term 9,16046761157,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 11,323524073990,Term 10,196948868778,Term 9,99266311538,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업의 소유주에게 귀속되는 자본,-,Term 11,323524073990,Term 10,196948868778,Term 9,99266311538,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본,-,Term 11,12700744497,Term 10,7905337847,Term 9,670133075,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 11,1072011419,Term 10,611288220,Term 9,522402509,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,-Standard account code not used-,기타불입자본,-,Term 11,76846523149,Term 10,61090126022,Term 9,52142603182,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 11,3812589000,Term 10,3637689000,Term 9,3592604000,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 11,229092205925,Term 10,123704427689,Term 9,42338568772,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채및자본총계,-,Term 11,565143563187,Term 10,287309488243,Term 9,183130939633,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 11,145136758580,Term 10,82296421377,Term 9,76266539341,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,-Standard account code not used-,전환사채,-,Term 11,2572180483,Term 10,2316242030,Term 9,,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,유동리스부채,-,Term 11,18645082840,Term 10,6603906979,Term 9,7246522656,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_CurrentProvisions,유동충당부채,-,Term 11,1653801852,Term 10,874477690,Term 9,246941371,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 11,42856299419,Term 10,18407737623,Term 9,12052065651,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 11,5350429353,Term 10,2342962892,Term 9,1330459085,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentLiabilities,기타유동부채,-,Term 11,5681734611,Term 10,5644185807,Term 9,6431037858,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 11,,Term 10,7500000000,Term 9,21500000000,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,매입채무및기타채무,-,Term 11,68377230022,Term 10,38606908356,Term 9,27459512720,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 11,241619489197,Term 10,90360619465,Term 9,83864628095,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 11,96482730617,Term 10,8064198088,Term 9,7598088754,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,-Standard account code not used-,순확정급여부채,-,Term 11,624543020,Term 10,330714601,Term 9,111223052,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,비유동리스부채,-,Term 11,88072925105,Term 10,5818653278,Term 9,5800785246,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,비유동충당부채,-,Term 11,7640406051,Term 10,1806879130,Term 9,1564767632,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_OtherNoncurrentLiabilities,기타비유동부채,-,Term 11,144856441,Term 10,107951079,Term 9,121312824,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익,-,Term 11,122705544449,Term 10,104193724865,Term 9,39228479397,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,dart_OtherGains,기타수익,-,Term 11,829265503,Term 10,441741128,Term 9,240688824,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,dart_OtherLosses,기타비용,-,Term 11,1862558727,Term 10,1246484531,Term 9,416924307,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 11,420894155120,Term 10,291254657539,Term 9,252246164696,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄이익,-,Term 11,105848501435,Term 10,81454744628,Term 9,28932042839,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 11,105848501435,Term 10,81454744628,Term 9,28932042839,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 11,179154162732,Term 10,128360982155,Term 9,106223475243,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주 기본주당이익,-,Term 11,2875,Term 10,2249,Term 9,816,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_DilutedEarningsLossPerShare,보통주 희석주당이익,-,Term 11,2819,Term 10,2219,Term 9,814,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 11,17237605550,Term 10,6601270655,Term 9,5455522583,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 11,28866042194,Term 10,9035639020,Term 9,5607858950,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 11,543599699569,Term 10,395448382404,Term 9,291474644093,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 11,25710251902,Term 10,24277298875,Term 9,10241587166,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 11,-1741934532,Term 10,-91306324,Term 9,-30950276,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류되는 항목,-,Term 11,460723199,Term 10,88885711,Term 9,569456833,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax,해외사업장환산외환차이(세전기타포괄이익),-,Term 11,460723199,Term 10,88885711,Term 9,569456833,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류 되지 않는 항목,-,Term 11,-2202657731,Term 10,-180192035,Term 9,-600407109,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,-Standard account code not used-,순확정급여부채의 재측정요소 법인세효과,-,Term 11,660952324,Term 10,52183967,Term 9,182063176,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채의 재측정요소,-,Term 11,-2863610055,Term 10,-232376002,Term 9,-782470285,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익,-,Term 11,107590435967,Term 10,81546050952,Term 9,28962993115,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 11,107590435967,Term 10,81546050952,Term 9,28962993115,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 11,133300687869,Term 10,105823349827,Term 9,39204580281,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 11,722753862301,Term 10,523809364559,Term 9,397698119336,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초현금및현금성자산,-,Term 11,125334572532,Term 10,57253261626,Term 9,33798982850,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말현금및현금성자산,-,Term 11,90366354391,Term 10,125334572532,Term 9,57253261626,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동현금흐름,-,Term 11,-4830388701,Term 10,-11480920710,Term 9,1440557771,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AcquisitionOfTreasuryShares,자기주식의 취득,-,Term 11,59943891000,Term 10,,Term 9,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_DecreaseInGuaranteeDepositsAsFinancialActivities,보증금의 감소,-,Term 11,90000000,Term 10,,Term 9,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_ProceedsFromConvertibleBonds,전환사채의 발행,-,Term 11,,Term 10,3000000000,Term 9,,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_ProceedsFromExerciseOfShareOptions,주식선택권 행사,-,Term 11,1010668300,Term 10,,Term 9,3645500000,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 차입,-,Term 11,,Term 10,,Term 9,9000000000,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_RepaymentsOfLongTermBorrowings,장기차입금의 상환,-,Term 11,,Term 10,41431000,Term 9,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 상환,-,Term 11,7500000000,Term 10,14083186080,Term 9,4000000000,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,리스부채의 상환,-,Term 11,9141812292,Term 10,8605183174,Term 9,6589669212,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsFinancingActivities,이자지급,-,Term 11,3494536736,Term 10,748686256,Term 9,615273017,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromIssuingShares,유상증자,-,Term 11,74329183027,Term 10,8997565800,Term 9,,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동현금흐름,-,Term 11,-109655123978,Term 10,-28280436368,Term 9,-9121425060,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익-공정가치측정금융자산의 감소,-,Term 11,266138422243,Term 10,28221844734,Term 9,,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherCurrentFinancialAssets,기타유동금융자산의 감소,-,Term 11,22648887672,Term 10,335292614266,Term 9,,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 감소,-,Term 11,310913567,Term 10,26708870,Term 9,279094371,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익-공정가치측정금융자산의 증가,-,Term 11,286763315509,Term 10,32225706286,Term 9,,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_PurchaseOfOtherCurrentFinancialAssets,기타유동금융자산의 증가,-,Term 11,39346963127,Term 10,335599523661,Term 9,162550,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_PurchaseOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 증가,-,Term 11,24960610043,Term 10,12087011290,Term 9,2494847848,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities,사업결합으로 인한 순현금유출,-,Term 11,,Term 10,-64783795,Term 9,,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 감소,-,Term 11,139514197,Term 10,29875457,Term 9,18582000,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 증가,-,Term 11,2788205288,Term 10,2215700675,Term 9,1224429839,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 증가,-,Term 11,45033767690,Term 10,9658753988,Term 9,5699661194,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동현금흐름,-,Term 11,79124161730,Term 10,107840961394,Term 9,31630786168,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,운전자본의 변동,-,Term 11,-58343573486,Term 10,1114001132,Term 9,-20265150119,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInFairValueOfPlanAssets,퇴직연금운용자산의 증가,-,Term 11,-2571495490,Term 10,-1319506174,Term 9,-3444241312,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInTradeAndOtherCurrentReceivables,매출채권및기타채권의 증가,-,Term 11,-20293730385,Term 10,-1723941211,Term 9,-7681960754,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채의 증가,-,Term 11,791650887,Term 10,395413258,Term 9,152309540,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInPostemploymentBenefitObligations,퇴직급여충당부채의 증가(감소),-,Term 11,-1302169660,Term 10,-970172987,Term 9,-1291491458,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산의 증가,-,Term 11,-63490544425,Term 10,-4537103259,Term 9,-14754289827,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산의 감소(증가),-,Term 11,-3039634613,Term 10,107414407,Term 9,-3542398099,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채의 증가(감소),-,Term 11,237548804,Term 10,-790639961,Term 9,4150872475,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables,매입채무및기타채무의 증가,-,Term 11,31324801396,Term 10,9952537059,Term 9,6146049316,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,현금의 유출·유입이 없는 비용·수익등의 가감,-,Term 11,54519839838,Term 10,39899321808,Term 9,27026937063,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비,-,Term 11,7666101,Term 10,400595508,Term 9,,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 11,607101741,Term 10,33216637,Term 9,151433966,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 11,6419709480,Term 10,672365722,Term 9,273289182,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfFinancialAssets,당기손익-공정가치측정금융자산처분이익,-,Term 11,4178504476,Term 10,221844734,Term 9,183996000,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfDerivativeFinancialAssets,파생상품평가이익,-,Term 11,,Term 10,43171638,Term 9,,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치측정금융자산평가이익,-,Term 11,1573437849,Term 10,464820127,Term 9,,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfIntangibleAssets,영업권손상차손,-,Term 11,,Term 10,281379700,Term 9,,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 11,3769628254,Term 10,1265495714,Term 9,1035577089,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnAbandonmentOfPropertyPlantAndEquipment,유형자산폐기손실,-,Term 11,120586314,Term 10,400966077,Term 9,161828721,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 11,208989616,Term 10,41771085,Term 9,6174968,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnEvaluationOfDerivativeFinancialAssets,파생상품평가손실,-,Term 11,2587870464,Term 10,,Term 9,,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 11,1058986843,Term 10,434788227,Term 9,1153644565,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForMiscellaneousLosses,잡손실,-,Term 11,1455399,Term 10,,Term 9,26875152,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타의대손상각비,-,Term 11,195490550,Term 10,2998801,Term 9,,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForProductWarrantyExpenses,판매보증비,-,Term 11,1029301357,Term 10,159805759,Term 9,64189298,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 11,2545323498,Term 10,2060915144,Term 9,1670204682,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfBadDebtExpenses,기타의대손상각비환입,-,Term 11,,Term 10,,Term 9,22120436,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfInventories,재고자산평가손실환입,-,Term 11,,Term 10,1626304417,Term 9,,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForShareBasedPayment,주식보상비용,-,Term 11,3282450609,Term 10,3001167581,Term 9,500025095,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForWritedownsOfInventories,재고자산평가손실,-,Term 11,9919224786,Term 10,,Term 9,2197661834,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,광고선전비,-,Term 11,,Term 10,,Term 9,250000,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,배당수익,-,Term 11,417744413,Term 10,,Term 9,,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,기타장기종업원급여,-,Term 11,36905362,Term 10,,Term 9,34266236,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,유가증권처분이익,-,Term 11,22380029,Term 10,,Term 9,,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,기타장기종업원급여환입,-,Term 11,,Term 10,13361745,Term 9,,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,외주용역비,-,Term 11,-64251158,Term 10,,Term 9,,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,사용권자산상각비,-,Term 11,15318803941,Term 10,8741095662,Term 9,6611789049,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,지급수수료,-,Term 11,199792722,Term 10,85532598,Term 9,43773635,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,대손상각비환입,-,Term 11,,Term 10,,Term 9,3357125,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,소모품비,-,Term 11,144342405,Term 10,125000000,Term 9,,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,차량유지비,-,Term 11,-18176171,Term 10,,Term 9,,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 11,882221546,Term 10,443696199,Term 9,372523191,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForDepreciationExpense,유형자산상각비,-,Term 11,6289661606,Term 10,4738400949,Term 9,3770759899,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 11,25710251902,Term 10,24277298875,Term 9,10241587166,74,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForInterestIncome,이자수익,-,Term 11,5487808120,Term 10,3486501051,Term 9,229996808,75,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsOperatingActivities,배당금 수취,-,Term 11,417744413,Term 10,,Term 9,,76,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세 납부,-,Term 11,29960233912,Term 10,17461223521,Term 9,4217330382,77,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 11,4899948910,Term 10,2742811023,Term 9,123336491,78,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_ProfitLoss,당기순이익,-,Term 11,107590435967,Term 10,81546050952,Term 9,28962993115,79,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,현금및현금성자산에 대한 환율변동효과,-,Term 11,393132808,Term 10,1706590,Term 9,-495640103,80,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,현금의 증가,-,Term 11,-35361350949,Term 10,68079604316,Term 9,23949918879,81,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누계액 [구성요소],Term 11,460723199,Term 10,88885711,Term 9,569456833,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,연결재무제표 [member],Term 11,460723199,Term 10,88885711,Term 9,569456833,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 11,460723199,Term 10,88885711,Term 9,569456833,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 11,196948868778,Term 10,99266311538,Term 9,66001080624,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 11,196948868778,Term 10,99266311538,Term 9,66001080624,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타불입자본,Term 11,61090126022,Term 10,52142603182,Term 9,46718489482,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 11,3637689000,Term 10,3592604000,Term 9,3495104000,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 11,123704427689,Term 10,42338568772,Term 9,13975982766,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누계액 [구성요소],Term 11,611288220,Term 10,522402509,Term 9,-47054324,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 11,7905337847,Term 10,670133075,Term 9,1858558700,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_ReclassificationAdjustments,순확정급여자산(부채)의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 11,-2202657731,Term 10,-180192035,Term 9,-600407109,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_ReclassificationAdjustments,순확정급여자산(부채)의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 11,-2202657731,Term 10,-180192035,Term 9,-600407109,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_ReclassificationAdjustments,순확정급여자산(부채)의 재측정요소,연결재무제표 [member],Term 11,-2202657731,Term 10,-180192035,Term 9,-600407109,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타불입자본,Term 11,-59943891000,Term 10,,Term 9,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 11,-59943891000,Term 10,,Term 9,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식,연결재무제표 [member],Term 11,-59943891000,Term 10,,Term 9,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 11,229092205925,Term 10,123704427689,Term 9,42338568772,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누계액 [구성요소],Term 11,1072011419,Term 10,611288220,Term 9,522402509,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 11,12700744497,Term 10,7905337847,Term 9,670133075,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타불입자본,Term 11,76846523149,Term 10,61090126022,Term 9,52142603182,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 11,323524073990,Term 10,196948868778,Term 9,99266311538,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,연결재무제표 [member],Term 11,323524073990,Term 10,196948868778,Term 9,99266311538,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 11,3812589000,Term 10,3637689000,Term 9,3592604000,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,연결재무제표 [member],Term 11,6341411750,Term 10,7235204772,Term 9,4333188075,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 11,6341411750,Term 10,7235204772,Term 9,4333188075,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타불입자본,Term 11,1525605100,Term 10,,Term 9,5424113700,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 11,4795406650,Term 10,7235204772,Term 9,-1188425625,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 11,20400000,Term 10,,Term 9,97500000,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,유상증자,연결재무제표 [member],Term 11,74329183027,Term 10,8992607840,Term 9,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,유상증자,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타불입자본,Term 11,74174683027,Term 10,8947522840,Term 9,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,유상증자,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 11,154500000,Term 10,45085000,Term 9,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,유상증자,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 11,74329183027,Term 10,8992607840,Term 9,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 11,107590435967,Term 10,81546050952,Term 9,28962993115,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,연결재무제표 [member],Term 11,107590435967,Term 10,81546050952,Term 9,28962993115,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 11,107590435967,Term 10,81546050952,Term 9,28962993115,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 11,565143563187,Term 10,287309488243,Term 9,183130939633,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 11,286027445388,Term 10,219307995672,Term 9,137024020095,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,-Standard account code not used-,당기손익-공정가치측정금융자산,-,Term 11,4043223237,Term 10,,Term 9,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 11,90366354391,Term 10,125334572532,Term 9,57253261626,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 11,472876908,Term 10,389566187,Term 9,1013889535,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 11,109745676962,Term 10,56520972365,Term 9,50460161074,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentAssets,기타유동자산,-,Term 11,7821538019,Term 10,6229597684,Term 9,6317755640,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 11,25630369792,Term 10,7828065195,Term 9,908796506,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,매출채권및기타채권,-,Term 11,47947406079,Term 10,23005221709,Term 9,21070155714,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 11,279116117799,Term 10,68001492571,Term 9,46106919538,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,dart_GoodwillGross,영업권,-,Term 11,195996061,Term 10,195996061,Term 9,281379700,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,dart_InvestedAssetForPostemploymentBenefit,순확정급여자산,-,Term 11,,Term 10,1241439984,Term 9,1025560421,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,-Standard account code not used-,당기손익-공정가치측정금융자산,-,Term 11,28378245326,Term 10,5874522413,Term 9,1183996000,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 11,45782255963,Term 10,14449983263,Term 9,9999836046,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 11,5632651682,Term 10,4102330070,Term 9,2105886103,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 11,33606731961,Term 10,11851640591,Term 9,6686564078,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 11,51364428813,Term 10,14188421514,Term 9,8776936033,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 11,114155807993,Term 10,16097158675,Term 9,16046761157,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 11,323524073990,Term 10,196948868778,Term 9,99266311538,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업의 소유주에게 귀속되는 자본,-,Term 11,323524073990,Term 10,196948868778,Term 9,99266311538,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본,-,Term 11,12700744497,Term 10,7905337847,Term 9,670133075,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 11,1072011419,Term 10,611288220,Term 9,522402509,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,-Standard account code not used-,기타불입자본,-,Term 11,76846523149,Term 10,61090126022,Term 9,52142603182,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 11,3812589000,Term 10,3637689000,Term 9,3592604000,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 11,229092205925,Term 10,123704427689,Term 9,42338568772,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채및자본총계,-,Term 11,565143563187,Term 10,287309488243,Term 9,183130939633,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 11,145136758580,Term 10,82296421377,Term 9,76266539341,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,-Standard account code not used-,전환사채,-,Term 11,2572180483,Term 10,2316242030,Term 9,,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,유동리스부채,-,Term 11,18645082840,Term 10,6603906979,Term 9,7246522656,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_CurrentProvisions,유동충당부채,-,Term 11,1653801852,Term 10,874477690,Term 9,246941371,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 11,42856299419,Term 10,18407737623,Term 9,12052065651,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 11,5350429353,Term 10,2342962892,Term 9,1330459085,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentLiabilities,기타유동부채,-,Term 11,5681734611,Term 10,5644185807,Term 9,6431037858,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 11,,Term 10,7500000000,Term 9,21500000000,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,매입채무및기타채무,-,Term 11,68377230022,Term 10,38606908356,Term 9,27459512720,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 11,241619489197,Term 10,90360619465,Term 9,83864628095,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 11,96482730617,Term 10,8064198088,Term 9,7598088754,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,-Standard account code not used-,순확정급여부채,-,Term 11,624543020,Term 10,330714601,Term 9,111223052,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,비유동리스부채,-,Term 11,88072925105,Term 10,5818653278,Term 9,5800785246,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,비유동충당부채,-,Term 11,7640406051,Term 10,1806879130,Term 9,1564767632,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_OtherNoncurrentLiabilities,기타비유동부채,-,Term 11,144856441,Term 10,107951079,Term 9,121312824,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익,-,Term 11,122705544449,Term 10,104193724865,Term 9,39228479397,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,dart_OtherGains,기타수익,-,Term 11,829265503,Term 10,441741128,Term 9,240688824,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,dart_OtherLosses,기타비용,-,Term 11,1862558727,Term 10,1246484531,Term 9,416924307,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 11,420894155120,Term 10,291254657539,Term 9,252246164696,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄이익,-,Term 11,105848501435,Term 10,81454744628,Term 9,28932042839,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 11,105848501435,Term 10,81454744628,Term 9,28932042839,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 11,179154162732,Term 10,128360982155,Term 9,106223475243,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주 기본주당이익,-,Term 11,2875,Term 10,2249,Term 9,816,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_DilutedEarningsLossPerShare,보통주 희석주당이익,-,Term 11,2819,Term 10,2219,Term 9,814,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 11,17237605550,Term 10,6601270655,Term 9,5455522583,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 11,28866042194,Term 10,9035639020,Term 9,5607858950,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 11,543599699569,Term 10,395448382404,Term 9,291474644093,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 11,25710251902,Term 10,24277298875,Term 9,10241587166,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 11,-1741934532,Term 10,-91306324,Term 9,-30950276,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류되는 항목,-,Term 11,460723199,Term 10,88885711,Term 9,569456833,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax,해외사업장환산외환차이(세전기타포괄이익),-,Term 11,460723199,Term 10,88885711,Term 9,569456833,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류 되지 않는 항목,-,Term 11,-2202657731,Term 10,-180192035,Term 9,-600407109,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,-Standard account code not used-,순확정급여부채의 재측정요소 법인세효과,-,Term 11,660952324,Term 10,52183967,Term 9,182063176,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채의 재측정요소,-,Term 11,-2863610055,Term 10,-232376002,Term 9,-782470285,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익,-,Term 11,107590435967,Term 10,81546050952,Term 9,28962993115,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 11,107590435967,Term 10,81546050952,Term 9,28962993115,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 11,133300687869,Term 10,105823349827,Term 9,39204580281,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 11,722753862301,Term 10,523809364559,Term 9,397698119336,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초현금및현금성자산,-,Term 11,125334572532,Term 10,57253261626,Term 9,33798982850,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말현금및현금성자산,-,Term 11,90366354391,Term 10,125334572532,Term 9,57253261626,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동현금흐름,-,Term 11,-4830388701,Term 10,-11480920710,Term 9,1440557771,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AcquisitionOfTreasuryShares,자기주식의 취득,-,Term 11,59943891000,Term 10,,Term 9,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_DecreaseInGuaranteeDepositsAsFinancialActivities,보증금의 감소,-,Term 11,90000000,Term 10,,Term 9,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_ProceedsFromConvertibleBonds,전환사채의 발행,-,Term 11,,Term 10,3000000000,Term 9,,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_ProceedsFromExerciseOfShareOptions,주식선택권 행사,-,Term 11,1010668300,Term 10,,Term 9,3645500000,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 차입,-,Term 11,,Term 10,,Term 9,9000000000,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_RepaymentsOfLongTermBorrowings,장기차입금의 상환,-,Term 11,,Term 10,41431000,Term 9,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 상환,-,Term 11,7500000000,Term 10,14083186080,Term 9,4000000000,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,리스부채의 상환,-,Term 11,9141812292,Term 10,8605183174,Term 9,6589669212,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsFinancingActivities,이자지급,-,Term 11,3494536736,Term 10,748686256,Term 9,615273017,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromIssuingShares,유상증자,-,Term 11,74329183027,Term 10,8997565800,Term 9,,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동현금흐름,-,Term 11,-109655123978,Term 10,-28280436368,Term 9,-9121425060,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익-공정가치측정금융자산의 감소,-,Term 11,266138422243,Term 10,28221844734,Term 9,,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherCurrentFinancialAssets,기타유동금융자산의 감소,-,Term 11,22648887672,Term 10,335292614266,Term 9,,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 감소,-,Term 11,310913567,Term 10,26708870,Term 9,279094371,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익-공정가치측정금융자산의 증가,-,Term 11,286763315509,Term 10,32225706286,Term 9,,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_PurchaseOfOtherCurrentFinancialAssets,기타유동금융자산의 증가,-,Term 11,39346963127,Term 10,335599523661,Term 9,162550,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_PurchaseOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 증가,-,Term 11,24960610043,Term 10,12087011290,Term 9,2494847848,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities,사업결합으로 인한 순현금유출,-,Term 11,,Term 10,-64783795,Term 9,,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 감소,-,Term 11,139514197,Term 10,29875457,Term 9,18582000,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 증가,-,Term 11,2788205288,Term 10,2215700675,Term 9,1224429839,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 증가,-,Term 11,45033767690,Term 10,9658753988,Term 9,5699661194,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동현금흐름,-,Term 11,79124161730,Term 10,107840961394,Term 9,31630786168,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,운전자본의 변동,-,Term 11,-58343573486,Term 10,1114001132,Term 9,-20265150119,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInFairValueOfPlanAssets,퇴직연금운용자산의 증가,-,Term 11,-2571495490,Term 10,-1319506174,Term 9,-3444241312,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInTradeAndOtherCurrentReceivables,매출채권및기타채권의 증가,-,Term 11,-20293730385,Term 10,-1723941211,Term 9,-7681960754,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채의 증가,-,Term 11,791650887,Term 10,395413258,Term 9,152309540,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInPostemploymentBenefitObligations,퇴직급여충당부채의 증가(감소),-,Term 11,-1302169660,Term 10,-970172987,Term 9,-1291491458,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산의 증가,-,Term 11,-63490544425,Term 10,-4537103259,Term 9,-14754289827,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산의 감소(증가),-,Term 11,-3039634613,Term 10,107414407,Term 9,-3542398099,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채의 증가(감소),-,Term 11,237548804,Term 10,-790639961,Term 9,4150872475,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables,매입채무및기타채무의 증가,-,Term 11,31324801396,Term 10,9952537059,Term 9,6146049316,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,현금의 유출·유입이 없는 비용·수익등의 가감,-,Term 11,54519839838,Term 10,39899321808,Term 9,27026937063,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비,-,Term 11,7666101,Term 10,400595508,Term 9,,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 11,607101741,Term 10,33216637,Term 9,151433966,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 11,6419709480,Term 10,672365722,Term 9,273289182,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfFinancialAssets,당기손익-공정가치측정금융자산처분이익,-,Term 11,4178504476,Term 10,221844734,Term 9,183996000,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfDerivativeFinancialAssets,파생상품평가이익,-,Term 11,,Term 10,43171638,Term 9,,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치측정금융자산평가이익,-,Term 11,1573437849,Term 10,464820127,Term 9,,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfIntangibleAssets,영업권손상차손,-,Term 11,,Term 10,281379700,Term 9,,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 11,3769628254,Term 10,1265495714,Term 9,1035577089,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnAbandonmentOfPropertyPlantAndEquipment,유형자산폐기손실,-,Term 11,120586314,Term 10,400966077,Term 9,161828721,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 11,208989616,Term 10,41771085,Term 9,6174968,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnEvaluationOfDerivativeFinancialAssets,파생상품평가손실,-,Term 11,2587870464,Term 10,,Term 9,,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 11,1058986843,Term 10,434788227,Term 9,1153644565,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForMiscellaneousLosses,잡손실,-,Term 11,1455399,Term 10,,Term 9,26875152,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타의대손상각비,-,Term 11,195490550,Term 10,2998801,Term 9,,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForProductWarrantyExpenses,판매보증비,-,Term 11,1029301357,Term 10,159805759,Term 9,64189298,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 11,2545323498,Term 10,2060915144,Term 9,1670204682,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfBadDebtExpenses,기타의대손상각비환입,-,Term 11,,Term 10,,Term 9,22120436,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfInventories,재고자산평가손실환입,-,Term 11,,Term 10,1626304417,Term 9,,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForShareBasedPayment,주식보상비용,-,Term 11,3282450609,Term 10,3001167581,Term 9,500025095,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForWritedownsOfInventories,재고자산평가손실,-,Term 11,9919224786,Term 10,,Term 9,2197661834,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,광고선전비,-,Term 11,,Term 10,,Term 9,250000,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,배당수익,-,Term 11,417744413,Term 10,,Term 9,,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,기타장기종업원급여,-,Term 11,36905362,Term 10,,Term 9,34266236,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,유가증권처분이익,-,Term 11,22380029,Term 10,,Term 9,,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,기타장기종업원급여환입,-,Term 11,,Term 10,13361745,Term 9,,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,외주용역비,-,Term 11,-64251158,Term 10,,Term 9,,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,사용권자산상각비,-,Term 11,15318803941,Term 10,8741095662,Term 9,6611789049,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,지급수수료,-,Term 11,199792722,Term 10,85532598,Term 9,43773635,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,대손상각비환입,-,Term 11,,Term 10,,Term 9,3357125,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,소모품비,-,Term 11,144342405,Term 10,125000000,Term 9,,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,차량유지비,-,Term 11,-18176171,Term 10,,Term 9,,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 11,882221546,Term 10,443696199,Term 9,372523191,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForDepreciationExpense,유형자산상각비,-,Term 11,6289661606,Term 10,4738400949,Term 9,3770759899,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 11,25710251902,Term 10,24277298875,Term 9,10241587166,74,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForInterestIncome,이자수익,-,Term 11,5487808120,Term 10,3486501051,Term 9,229996808,75,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsOperatingActivities,배당금 수취,-,Term 11,417744413,Term 10,,Term 9,,76,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세 납부,-,Term 11,29960233912,Term 10,17461223521,Term 9,4217330382,77,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 11,4899948910,Term 10,2742811023,Term 9,123336491,78,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_ProfitLoss,당기순이익,-,Term 11,107590435967,Term 10,81546050952,Term 9,28962993115,79,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,현금및현금성자산에 대한 환율변동효과,-,Term 11,393132808,Term 10,1706590,Term 9,-495640103,80,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,현금의 증가,-,Term 11,-35361350949,Term 10,68079604316,Term 9,23949918879,81,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누계액 [구성요소],Term 11,460723199,Term 10,88885711,Term 9,569456833,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,연결재무제표 [member],Term 11,460723199,Term 10,88885711,Term 9,569456833,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 11,460723199,Term 10,88885711,Term 9,569456833,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 11,196948868778,Term 10,99266311538,Term 9,66001080624,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 11,196948868778,Term 10,99266311538,Term 9,66001080624,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타불입자본,Term 11,61090126022,Term 10,52142603182,Term 9,46718489482,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 11,3637689000,Term 10,3592604000,Term 9,3495104000,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 11,123704427689,Term 10,42338568772,Term 9,13975982766,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누계액 [구성요소],Term 11,611288220,Term 10,522402509,Term 9,-47054324,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 11,7905337847,Term 10,670133075,Term 9,1858558700,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_ReclassificationAdjustments,순확정급여자산(부채)의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 11,-2202657731,Term 10,-180192035,Term 9,-600407109,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_ReclassificationAdjustments,순확정급여자산(부채)의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 11,-2202657731,Term 10,-180192035,Term 9,-600407109,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_ReclassificationAdjustments,순확정급여자산(부채)의 재측정요소,연결재무제표 [member],Term 11,-2202657731,Term 10,-180192035,Term 9,-600407109,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타불입자본,Term 11,-59943891000,Term 10,,Term 9,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 11,-59943891000,Term 10,,Term 9,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식,연결재무제표 [member],Term 11,-59943891000,Term 10,,Term 9,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 11,229092205925,Term 10,123704427689,Term 9,42338568772,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누계액 [구성요소],Term 11,1072011419,Term 10,611288220,Term 9,522402509,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 11,12700744497,Term 10,7905337847,Term 9,670133075,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타불입자본,Term 11,76846523149,Term 10,61090126022,Term 9,52142603182,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 11,323524073990,Term 10,196948868778,Term 9,99266311538,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,연결재무제표 [member],Term 11,323524073990,Term 10,196948868778,Term 9,99266311538,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 11,3812589000,Term 10,3637689000,Term 9,3592604000,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,연결재무제표 [member],Term 11,6341411750,Term 10,7235204772,Term 9,4333188075,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 11,6341411750,Term 10,7235204772,Term 9,4333188075,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타불입자본,Term 11,1525605100,Term 10,,Term 9,5424113700,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 11,4795406650,Term 10,7235204772,Term 9,-1188425625,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 11,20400000,Term 10,,Term 9,97500000,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,유상증자,연결재무제표 [member],Term 11,74329183027,Term 10,8992607840,Term 9,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,유상증자,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타불입자본,Term 11,74174683027,Term 10,8947522840,Term 9,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,유상증자,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 11,154500000,Term 10,45085000,Term 9,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,유상증자,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 11,74329183027,Term 10,8992607840,Term 9,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 11,107590435967,Term 10,81546050952,Term 9,28962993115,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,연결재무제표 [member],Term 11,107590435967,Term 10,81546050952,Term 9,28962993115,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 11,107590435967,Term 10,81546050952,Term 9,28962993115,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,IS,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 11,565143563187,Term 10,287309488243,Term 9,183130939633,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 11,286027445388,Term 10,219307995672,Term 9,137024020095,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,-Standard account code not used-,당기손익-공정가치측정금융자산,-,Term 11,4043223237,Term 10,,Term 9,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 11,90366354391,Term 10,125334572532,Term 9,57253261626,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxAssets,당기법인세자산,-,Term 11,472876908,Term 10,389566187,Term 9,1013889535,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 11,109745676962,Term 10,56520972365,Term 9,50460161074,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentAssets,기타유동자산,-,Term 11,7821538019,Term 10,6229597684,Term 9,6317755640,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 11,25630369792,Term 10,7828065195,Term 9,908796506,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,매출채권및기타채권,-,Term 11,47947406079,Term 10,23005221709,Term 9,21070155714,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 11,279116117799,Term 10,68001492571,Term 9,46106919538,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,dart_GoodwillGross,영업권,-,Term 11,195996061,Term 10,195996061,Term 9,281379700,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,dart_InvestedAssetForPostemploymentBenefit,순확정급여자산,-,Term 11,,Term 10,1241439984,Term 9,1025560421,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,-Standard account code not used-,당기손익-공정가치측정금융자산,-,Term 11,28378245326,Term 10,5874522413,Term 9,1183996000,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 11,45782255963,Term 10,14449983263,Term 9,9999836046,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 11,5632651682,Term 10,4102330070,Term 9,2105886103,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 11,33606731961,Term 10,11851640591,Term 9,6686564078,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 11,51364428813,Term 10,14188421514,Term 9,8776936033,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 11,114155807993,Term 10,16097158675,Term 9,16046761157,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 11,323524073990,Term 10,196948868778,Term 9,99266311538,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업의 소유주에게 귀속되는 자본,-,Term 11,323524073990,Term 10,196948868778,Term 9,99266311538,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본,-,Term 11,12700744497,Term 10,7905337847,Term 9,670133075,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 11,1072011419,Term 10,611288220,Term 9,522402509,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,-Standard account code not used-,기타불입자본,-,Term 11,76846523149,Term 10,61090126022,Term 9,52142603182,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 11,3812589000,Term 10,3637689000,Term 9,3592604000,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 11,229092205925,Term 10,123704427689,Term 9,42338568772,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채및자본총계,-,Term 11,565143563187,Term 10,287309488243,Term 9,183130939633,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 11,145136758580,Term 10,82296421377,Term 9,76266539341,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,-Standard account code not used-,전환사채,-,Term 11,2572180483,Term 10,2316242030,Term 9,,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_CurrentLeaseLiabilities,유동리스부채,-,Term 11,18645082840,Term 10,6603906979,Term 9,7246522656,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_CurrentProvisions,유동충당부채,-,Term 11,1653801852,Term 10,874477690,Term 9,246941371,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 11,42856299419,Term 10,18407737623,Term 9,12052065651,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 11,5350429353,Term 10,2342962892,Term 9,1330459085,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_OtherCurrentLiabilities,기타유동부채,-,Term 11,5681734611,Term 10,5644185807,Term 9,6431037858,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 11,,Term 10,7500000000,Term 9,21500000000,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,매입채무및기타채무,-,Term 11,68377230022,Term 10,38606908356,Term 9,27459512720,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 11,241619489197,Term 10,90360619465,Term 9,83864628095,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 11,96482730617,Term 10,8064198088,Term 9,7598088754,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,-Standard account code not used-,순확정급여부채,-,Term 11,624543020,Term 10,330714601,Term 9,111223052,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_NoncurrentLeaseLiabilities,비유동리스부채,-,Term 11,88072925105,Term 10,5818653278,Term 9,5800785246,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_NoncurrentProvisions,비유동충당부채,-,Term 11,7640406051,Term 10,1806879130,Term 9,1564767632,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,BS,Statement of financial position,ifrs-full_OtherNoncurrentLiabilities,기타비유동부채,-,Term 11,144856441,Term 10,107951079,Term 9,121312824,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,dart_OperatingIncomeLoss,영업이익,-,Term 11,122705544449,Term 10,104193724865,Term 9,39228479397,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,dart_OtherGains,기타수익,-,Term 11,829265503,Term 10,441741128,Term 9,240688824,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,dart_OtherLosses,기타비용,-,Term 11,1862558727,Term 10,1246484531,Term 9,416924307,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 11,420894155120,Term 10,291254657539,Term 9,252246164696,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄이익,-,Term 11,105848501435,Term 10,81454744628,Term 9,28932042839,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 11,105848501435,Term 10,81454744628,Term 9,28932042839,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_CostOfSales,매출원가,-,Term 11,179154162732,Term 10,128360982155,Term 9,106223475243,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_BasicEarningsLossPerShare,보통주 기본주당이익,-,Term 11,2875,Term 10,2249,Term 9,816,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_DilutedEarningsLossPerShare,보통주 희석주당이익,-,Term 11,2819,Term 10,2219,Term 9,814,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceCosts,금융비용,-,Term 11,17237605550,Term 10,6601270655,Term 9,5455522583,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_FinanceIncome,금융수익,-,Term 11,28866042194,Term 10,9035639020,Term 9,5607858950,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_GrossProfit,매출총이익,-,Term 11,543599699569,Term 10,395448382404,Term 9,291474644093,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 11,25710251902,Term 10,24277298875,Term 9,10241587166,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 11,-1741934532,Term 10,-91306324,Term 9,-30950276,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류되는 항목,-,Term 11,460723199,Term 10,88885711,Term 9,569456833,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax,해외사업장환산외환차이(세전기타포괄이익),-,Term 11,460723199,Term 10,88885711,Term 9,569456833,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossBeforeTax,당기손익으로 재분류 되지 않는 항목,-,Term 11,-2202657731,Term 10,-180192035,Term 9,-600407109,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,-Standard account code not used-,순확정급여부채의 재측정요소 법인세효과,-,Term 11,660952324,Term 10,52183967,Term 9,182063176,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,순확정급여부채의 재측정요소,-,Term 11,-2863610055,Term 10,-232376002,Term 9,-782470285,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익,-,Term 11,107590435967,Term 10,81546050952,Term 9,28962993115,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업 소유주지분,-,Term 11,107590435967,Term 10,81546050952,Term 9,28962993115,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 11,133300687869,Term 10,105823349827,Term 9,39204580281,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CIS,Statement of comprehensive income,ifrs-full_Revenue,매출액,-,Term 11,722753862301,Term 10,523809364559,Term 9,397698119336,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초현금및현금성자산,-,Term 11,125334572532,Term 10,57253261626,Term 9,33798982850,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말현금및현금성자산,-,Term 11,90366354391,Term 10,125334572532,Term 9,57253261626,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동현금흐름,-,Term 11,-4830388701,Term 10,-11480920710,Term 9,1440557771,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AcquisitionOfTreasuryShares,자기주식의 취득,-,Term 11,59943891000,Term 10,,Term 9,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_DecreaseInGuaranteeDepositsAsFinancialActivities,보증금의 감소,-,Term 11,90000000,Term 10,,Term 9,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_ProceedsFromConvertibleBonds,전환사채의 발행,-,Term 11,,Term 10,3000000000,Term 9,,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_ProceedsFromExerciseOfShareOptions,주식선택권 행사,-,Term 11,1010668300,Term 10,,Term 9,3645500000,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 차입,-,Term 11,,Term 10,,Term 9,9000000000,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_RepaymentsOfLongTermBorrowings,장기차입금의 상환,-,Term 11,,Term 10,41431000,Term 9,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 상환,-,Term 11,7500000000,Term 10,14083186080,Term 9,4000000000,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,리스부채의 상환,-,Term 11,9141812292,Term 10,8605183174,Term 9,6589669212,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsFinancingActivities,이자지급,-,Term 11,3494536736,Term 10,748686256,Term 9,615273017,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromIssuingShares,유상증자,-,Term 11,74329183027,Term 10,8997565800,Term 9,,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동현금흐름,-,Term 11,-109655123978,Term 10,-28280436368,Term 9,-9121425060,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익-공정가치측정금융자산의 감소,-,Term 11,266138422243,Term 10,28221844734,Term 9,,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherCurrentFinancialAssets,기타유동금융자산의 감소,-,Term 11,22648887672,Term 10,335292614266,Term 9,,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_ProceedsFromSalesOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 감소,-,Term 11,310913567,Term 10,26708870,Term 9,279094371,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익-공정가치측정금융자산의 증가,-,Term 11,286763315509,Term 10,32225706286,Term 9,,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_PurchaseOfOtherCurrentFinancialAssets,기타유동금융자산의 증가,-,Term 11,39346963127,Term 10,335599523661,Term 9,162550,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_PurchaseOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 증가,-,Term 11,24960610043,Term 10,12087011290,Term 9,2494847848,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities,사업결합으로 인한 순현금유출,-,Term 11,,Term 10,-64783795,Term 9,,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 감소,-,Term 11,139514197,Term 10,29875457,Term 9,18582000,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 증가,-,Term 11,2788205288,Term 10,2215700675,Term 9,1224429839,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 증가,-,Term 11,45033767690,Term 10,9658753988,Term 9,5699661194,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동현금흐름,-,Term 11,79124161730,Term 10,107840961394,Term 9,31630786168,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,운전자본의 변동,-,Term 11,-58343573486,Term 10,1114001132,Term 9,-20265150119,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInFairValueOfPlanAssets,퇴직연금운용자산의 증가,-,Term 11,-2571495490,Term 10,-1319506174,Term 9,-3444241312,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInTradeAndOtherCurrentReceivables,매출채권및기타채권의 증가,-,Term 11,-20293730385,Term 10,-1723941211,Term 9,-7681960754,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채의 증가,-,Term 11,791650887,Term 10,395413258,Term 9,152309540,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInPostemploymentBenefitObligations,퇴직급여충당부채의 증가(감소),-,Term 11,-1302169660,Term 10,-970172987,Term 9,-1291491458,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산의 증가,-,Term 11,-63490544425,Term 10,-4537103259,Term 9,-14754289827,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산의 감소(증가),-,Term 11,-3039634613,Term 10,107414407,Term 9,-3542398099,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채의 증가(감소),-,Term 11,237548804,Term 10,-790639961,Term 9,4150872475,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables,매입채무및기타채무의 증가,-,Term 11,31324801396,Term 10,9952537059,Term 9,6146049316,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,현금의 유출·유입이 없는 비용·수익등의 가감,-,Term 11,54519839838,Term 10,39899321808,Term 9,27026937063,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비,-,Term 11,7666101,Term 10,400595508,Term 9,,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 11,607101741,Term 10,33216637,Term 9,151433966,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 11,6419709480,Term 10,672365722,Term 9,273289182,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfFinancialAssets,당기손익-공정가치측정금융자산처분이익,-,Term 11,4178504476,Term 10,221844734,Term 9,183996000,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfDerivativeFinancialAssets,파생상품평가이익,-,Term 11,,Term 10,43171638,Term 9,,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치측정금융자산평가이익,-,Term 11,1573437849,Term 10,464820127,Term 9,,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfIntangibleAssets,영업권손상차손,-,Term 11,,Term 10,281379700,Term 9,,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 11,3769628254,Term 10,1265495714,Term 9,1035577089,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnAbandonmentOfPropertyPlantAndEquipment,유형자산폐기손실,-,Term 11,120586314,Term 10,400966077,Term 9,161828721,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 11,208989616,Term 10,41771085,Term 9,6174968,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnEvaluationOfDerivativeFinancialAssets,파생상품평가손실,-,Term 11,2587870464,Term 10,,Term 9,,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 11,1058986843,Term 10,434788227,Term 9,1153644565,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForMiscellaneousLosses,잡손실,-,Term 11,1455399,Term 10,,Term 9,26875152,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타의대손상각비,-,Term 11,195490550,Term 10,2998801,Term 9,,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForProductWarrantyExpenses,판매보증비,-,Term 11,1029301357,Term 10,159805759,Term 9,64189298,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 11,2545323498,Term 10,2060915144,Term 9,1670204682,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfBadDebtExpenses,기타의대손상각비환입,-,Term 11,,Term 10,,Term 9,22120436,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForReversalsOfInventories,재고자산평가손실환입,-,Term 11,,Term 10,1626304417,Term 9,,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForShareBasedPayment,주식보상비용,-,Term 11,3282450609,Term 10,3001167581,Term 9,500025095,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,dart_AdjustmentsForWritedownsOfInventories,재고자산평가손실,-,Term 11,9919224786,Term 10,,Term 9,2197661834,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,광고선전비,-,Term 11,,Term 10,,Term 9,250000,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,배당수익,-,Term 11,417744413,Term 10,,Term 9,,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,기타장기종업원급여,-,Term 11,36905362,Term 10,,Term 9,34266236,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,유가증권처분이익,-,Term 11,22380029,Term 10,,Term 9,,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,기타장기종업원급여환입,-,Term 11,,Term 10,13361745,Term 9,,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,외주용역비,-,Term 11,-64251158,Term 10,,Term 9,,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,사용권자산상각비,-,Term 11,15318803941,Term 10,8741095662,Term 9,6611789049,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,지급수수료,-,Term 11,199792722,Term 10,85532598,Term 9,43773635,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,대손상각비환입,-,Term 11,,Term 10,,Term 9,3357125,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,소모품비,-,Term 11,144342405,Term 10,125000000,Term 9,,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,-Standard account code not used-,차량유지비,-,Term 11,-18176171,Term 10,,Term 9,,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 11,882221546,Term 10,443696199,Term 9,372523191,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForDepreciationExpense,유형자산상각비,-,Term 11,6289661606,Term 10,4738400949,Term 9,3770759899,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 11,25710251902,Term 10,24277298875,Term 9,10241587166,74,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_AdjustmentsForInterestIncome,이자수익,-,Term 11,5487808120,Term 10,3486501051,Term 9,229996808,75,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsOperatingActivities,배당금 수취,-,Term 11,417744413,Term 10,,Term 9,,76,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세 납부,-,Term 11,29960233912,Term 10,17461223521,Term 9,4217330382,77,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 11,4899948910,Term 10,2742811023,Term 9,123336491,78,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_ProfitLoss,당기순이익,-,Term 11,107590435967,Term 10,81546050952,Term 9,28962993115,79,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,현금및현금성자산에 대한 환율변동효과,-,Term 11,393132808,Term 10,1706590,Term 9,-495640103,80,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,현금의 증가,-,Term 11,-35361350949,Term 10,68079604316,Term 9,23949918879,81,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누계액 [구성요소],Term 11,460723199,Term 10,88885711,Term 9,569456833,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,연결재무제표 [member],Term 11,460723199,Term 10,88885711,Term 9,569456833,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 11,460723199,Term 10,88885711,Term 9,569456833,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 11,196948868778,Term 10,99266311538,Term 9,66001080624,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 11,196948868778,Term 10,99266311538,Term 9,66001080624,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타불입자본,Term 11,61090126022,Term 10,52142603182,Term 9,46718489482,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 11,3637689000,Term 10,3592604000,Term 9,3495104000,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 11,123704427689,Term 10,42338568772,Term 9,13975982766,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누계액 [구성요소],Term 11,611288220,Term 10,522402509,Term 9,-47054324,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 11,7905337847,Term 10,670133075,Term 9,1858558700,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_ReclassificationAdjustments,순확정급여자산(부채)의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 11,-2202657731,Term 10,-180192035,Term 9,-600407109,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_ReclassificationAdjustments,순확정급여자산(부채)의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 11,-2202657731,Term 10,-180192035,Term 9,-600407109,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_ReclassificationAdjustments,순확정급여자산(부채)의 재측정요소,연결재무제표 [member],Term 11,-2202657731,Term 10,-180192035,Term 9,-600407109,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타불입자본,Term 11,-59943891000,Term 10,,Term 9,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 11,-59943891000,Term 10,,Term 9,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,dart_TreasuryShareTransactions,자기주식,연결재무제표 [member],Term 11,-59943891000,Term 10,,Term 9,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 11,229092205925,Term 10,123704427689,Term 9,42338568772,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누계액 [구성요소],Term 11,1072011419,Term 10,611288220,Term 9,522402509,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 11,12700744497,Term 10,7905337847,Term 9,670133075,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타불입자본,Term 11,76846523149,Term 10,61090126022,Term 9,52142603182,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 11,323524073990,Term 10,196948868778,Term 9,99266311538,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,연결재무제표 [member],Term 11,323524073990,Term 10,196948868778,Term 9,99266311538,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 11,3812589000,Term 10,3637689000,Term 9,3592604000,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,연결재무제표 [member],Term 11,6341411750,Term 10,7235204772,Term 9,4333188075,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 11,6341411750,Term 10,7235204772,Term 9,4333188075,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타불입자본,Term 11,1525605100,Term 10,,Term 9,5424113700,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 11,4795406650,Term 10,7235204772,Term 9,-1188425625,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions,주식선택권,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 11,20400000,Term 10,,Term 9,97500000,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,유상증자,연결재무제표 [member],Term 11,74329183027,Term 10,8992607840,Term 9,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,유상증자,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타불입자본,Term 11,74174683027,Term 10,8947522840,Term 9,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,유상증자,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 11,154500000,Term 10,45085000,Term 9,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_IssueOfEquity,유상증자,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 11,74329183027,Term 10,8992607840,Term 9,,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 11,107590435967,Term 10,81546050952,Term 9,28962993115,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,연결재무제표 [member],Term 11,107590435967,Term 10,81546050952,Term 9,28962993115,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
20250321001576,11011,2024,01190568,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 11,107590435967,Term 10,81546050952,Term 9,28962993115,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,CF,278470,에이피알
